data_5iej_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5iej _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.6 mt . . . . . 0 N--CA 1.458 -0.058 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -87.27 -11.56 49.26 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.16 0.584 . . . . 0.0 111.329 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -123.07 113.65 19.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.1 mm -122.47 131.55 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.626 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -89.87 149.81 22.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.53 ' H ' HD23 ' A' ' 8' ' ' LEU . 66.3 mt -115.17 135.59 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 118.115 0.416 . . . . 0.0 110.108 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.58 121.96 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 12.2 tp10 -150.55 157.49 43.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.806 -173.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.36 -10.49 19.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 112.508 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.538 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 48.0 mt-10 -133.2 132.92 22.44 Favored Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 121.919 -0.488 . . . . 0.0 110.369 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 52.3 Cg_exo -59.41 -21.41 61.1 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.329 2.686 . . . . 0.0 113.2 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.94 -43.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.165 -0.335 . . . . 0.0 110.682 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.0 -25.63 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.76 -30.62 70.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.308 -0.245 . . . . 0.0 110.56 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mmt -82.42 -22.7 35.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.319 -0.238 . . . . 0.0 110.808 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mtp -73.94 -35.44 64.56 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.218 0.463 . . . . 0.0 110.179 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.37 -33.77 74.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.171 -0.331 . . . . 0.0 110.138 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.41 -25.53 60.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.297 -0.252 . . . . 0.0 110.359 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.76 -41.55 23.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.907 0.321 . . . . 0.0 111.136 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.16 -24.89 59.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.872 -0.518 . . . . 0.0 111.937 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.755 0.707 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -85.33 -21.4 28.94 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.554 0.616 . . . . 0.0 112.126 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.2 -26.0 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.25 0.477 . . . . 0.0 111.244 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.03 18.31 13.7 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 122.17 -0.331 . . . . 0.0 111.536 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.87 34.02 18.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.448 0.699 . . . . 0.0 112.388 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -85.64 162.49 18.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.907 0.883 . . . . 0.0 109.102 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m -111.32 85.22 5.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.116 -0.365 . . . . 0.0 110.393 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.27 156.97 62.41 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.732 2.288 . . . . 0.0 110.038 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.15 -9.14 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.18 173.82 33.27 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 119.302 0.955 . . . . 0.0 113.126 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -144.0 141.09 29.96 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.202 1.001 . . . . 0.0 109.014 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.48 162.18 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 122.892 0.477 . . . . 0.0 111.091 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.35 -11.79 29.27 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.524 0.73 . . . . 0.0 111.858 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -149.29 157.99 43.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.947 -0.471 . . . . 0.0 110.491 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -71.55 -22.47 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 122.574 0.35 . . . . 0.0 110.223 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.87 -26.51 66.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.978 -0.451 . . . . 0.0 109.983 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -26.15 55.62 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.49 -30.56 63.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.255 0.527 . . . . 0.0 109.839 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.47 -37.43 68.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.78 64.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.373 -0.204 . . . . 0.0 111.074 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -22.27 29.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.453 0.301 . . . . 0.0 111.062 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.19 -21.85 10.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.75 -14.92 62.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.335 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -100.02 -12.49 19.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.089 0.956 . . . . 0.0 110.681 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.11 -168.49 52.09 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.58 23.36 62.66 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.44 -0.447 . . . . 0.0 112.231 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 mt -135.57 148.01 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.697 0.748 . . . . 0.0 109.343 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -120.0 -30.32 4.73 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.59 178.83 9.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.811 0.444 . . . . 0.0 109.913 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.36 163.1 39.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 mm -113.21 140.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.4 tp -140.71 129.53 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.551 0.215 . . . . 0.0 110.996 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.16 154.08 26.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.421 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.94 -11.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 122.893 0.477 . . . . 0.0 109.903 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 124.159 0.984 . . . . 0.0 111.97 -177.421 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.529 0.15 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.45 -11.96 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.601 2.867 . . . . 0.0 111.653 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.25 -22.7 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 122.046 -0.409 . . . . 0.0 110.797 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.29 75.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.06 -17.96 60.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.164 -0.335 . . . . 0.0 111.227 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.33 -29.41 57.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.56 -34.52 72.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.61 -21.06 60.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.053 -0.404 . . . . 0.0 110.81 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.25 -16.59 42.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.514 0.325 . . . . 0.0 111.459 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -104.08 23.81 12.4 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.447 0.699 . . . . 0.0 111.775 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 53.83 41.83 31.93 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.865 0.866 . . . . 0.0 112.662 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.96 87.83 23.67 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.12 164.47 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 124.844 3.696 . . . . 0.0 114.27 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.19 169.3 17.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.975 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.06 141.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.277 1.031 . . . . 0.0 109.27 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.04 150.14 22.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.572 0.225 . . . . 0.0 110.764 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.47 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.89 0.476 . . . . 0.0 110.017 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -160.67 158.73 29.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.212 -0.305 . . . . 0.0 111.112 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.92 113.26 4.14 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.88 -163.52 29.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.8 m -76.88 160.41 29.24 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.237 0.542 . . . . 0.0 110.753 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.99 -3.12 56.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.694 0.398 . . . . 0.0 111.96 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -92.73 -0.46 57.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.584 0.354 . . . . 0.0 111.441 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -84.23 8.35 16.11 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.43 0.692 . . . . 0.0 112.02 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.415 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.7 m -136.9 154.68 31.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.752 0.821 . . . . 0.0 110.728 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -72.33 169.27 16.62 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.384 0.673 . . . . 0.0 111.487 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.9 p -61.94 -15.83 46.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -74.82 -24.24 58.59 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.939 0.336 . . . . 0.0 110.268 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.415 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 10.1 m-85 -86.01 -22.48 27.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -84.39 -14.53 49.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.801 0.441 . . . . 0.0 110.895 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.69 -33.55 14.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.732 0.413 . . . . 0.0 110.475 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -83.0 160.65 60.07 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.48 152.15 69.9 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.24 2.627 . . . . 0.0 111.181 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.24 154.39 33.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.002 0.521 . . . . 0.0 111.102 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.06 154.63 48.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.711 0.804 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -86.94 165.63 15.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.062 0.545 . . . . 0.0 109.658 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.15 -49.38 12.59 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.33 140.01 21.51 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.052 1.835 . . . . 0.0 111.161 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -110.4 152.34 26.38 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.065 0.46 . . . . 0.0 110.54 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 108' ' ' GLY . 8.8 t -154.26 164.61 38.28 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.028 0.931 . . . . 0.0 108.849 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -58.59 -27.57 64.77 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -84.04 -36.01 23.41 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.084 0.402 . . . . 0.0 111.256 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 105' ' ' THR . . . -79.3 -25.24 59.62 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.12 -30.26 11.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.122 0.461 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.34 69.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.73 -20.81 30.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.684 0.394 . . . . 0.0 111.107 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.24 61.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.477 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.4 mt -77.5 -28.42 52.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.0 -20.28 61.05 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.977 0.353 . . . . 0.0 110.874 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.47 -20.6 26.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.534 0.333 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -91.32 -50.63 5.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.819 0.282 . . . . 0.0 110.546 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.96 2.92 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.328 1.051 . . . . 0.0 112.88 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.173 -1.394 . . . . 0.0 110.0 178.446 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.419 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -4.14 58.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 175.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.408 ' HB3' HG12 ' A' ' 32' ' ' VAL . 24.0 mp0 -120.37 109.68 15.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.671 0.789 . . . . 0.0 111.438 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 mm -116.62 130.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 O-C-N 123.514 0.509 . . . . 0.0 110.086 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 145.31 25.11 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.541 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.7 mt -113.33 130.57 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.769 0.828 . . . . 0.0 109.237 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.29 117.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -141.26 162.98 34.19 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.626 0.77 . . . . 0.0 110.512 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -84.02 -9.95 58.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.454 0.301 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.6 145.51 40.78 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.839 0.456 . . . . 0.0 109.836 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.07 -14.75 26.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.116 2.544 . . . . 0.0 111.202 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -74.89 -30.32 61.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 117.771 0.26 . . . . 0.0 110.626 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mm -84.91 -30.17 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.77 69.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.8 tpp -78.91 -28.23 43.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.9 ttt -70.39 -29.99 66.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.16 -29.48 60.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.499 0.32 . . . . 0.0 110.483 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.88 -23.79 61.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.893 0.315 . . . . 0.0 110.266 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.48 -40.72 42.05 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.438 -0.164 . . . . 0.0 111.432 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.74 -24.66 53.02 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.266 0.484 . . . . 0.0 111.96 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.66 -20.35 56.76 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.704 0.684 . . . . 0.0 110.364 176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.2 -27.66 35.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.875 0.307 . . . . 0.0 110.585 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.4 t -79.76 -22.59 12.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 122.504 0.322 . . . . 0.0 110.859 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.77 13.56 34.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.793 0.437 . . . . 0.0 111.815 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 53.49 29.2 8.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 112.4 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -85.62 161.05 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.629 0.772 . . . . 0.0 109.202 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.8 m -105.83 117.47 57.69 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.6 162.83 27.19 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.322 2.681 . . . . 0.0 110.107 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 6' ' ' GLN . 26.7 m -135.12 -18.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.47 172.75 32.33 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.136 0.425 . . . . 0.0 112.147 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.3 p -139.14 142.02 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 108.464 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.33 152.87 23.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.792 0.329 . . . . 0.0 110.297 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -100.83 1.32 39.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.24 0.616 . . . . 0.0 112.111 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -141.32 157.84 44.67 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 109.812 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.36 -22.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 122.416 -0.177 . . . . 0.0 110.8 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.85 -25.96 61.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.147 -0.346 . . . . 0.0 110.677 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.95 -27.12 60.96 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.24 -34.81 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.34 0.57 . . . . 0.0 110.066 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.36 -36.96 77.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.95 66.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.247 -0.283 . . . . 0.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -84.8 -20.84 30.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.77 0.259 . . . . 0.0 111.332 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.41 -24.2 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.855 0.298 . . . . 0.0 110.45 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -75.83 -14.57 60.29 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.249 -0.282 . . . . 0.0 110.79 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.85 -12.48 22.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.541 0.736 . . . . 0.0 111.035 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.94 53.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.61 11.33 84.17 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.67 147.99 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -121.94 -19.76 6.57 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.13 168.64 26.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.596 0.358 . . . . 0.0 110.097 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.35 34.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 111.49 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.04 129.3 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.68 130.37 56.8 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.806 0.442 . . . . 0.0 111.05 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.47 132.41 34.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.51 -11.26 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.737 0.415 . . . . 0.0 110.782 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.074 -179.847 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -11.69 31.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.669 2.913 . . . . 0.0 111.963 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.2 -19.33 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 O-C-N 122.118 -0.363 . . . . 0.0 110.237 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.75 -26.14 67.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.98 -17.98 59.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.159 -0.338 . . . . 0.0 110.555 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.37 -31.79 48.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.91 -34.12 76.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.06 -21.83 61.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.076 0.15 . . . . 0.0 110.691 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.89 -7.0 59.54 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.895 0.478 . . . . 0.0 110.826 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -114.7 15.01 17.64 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.708 0.803 . . . . 0.0 111.313 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.21 36.8 28.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.251 1.02 . . . . 0.0 112.927 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.7 mt -109.27 108.69 60.34 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.187 0.995 . . . . 0.0 108.366 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.74 154.85 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.733 2.955 . . . . 0.0 112.224 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.54 165.0 31.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.24 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.09 145.35 28.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.371 1.068 . . . . 0.0 108.416 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.14 153.24 18.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 111.308 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.17 148.17 37.8 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -159.95 170.97 20.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.63 0.253 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.77 95.31 0.23 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.71 -160.11 28.45 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.7 t -75.35 157.02 34.88 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.17 -4.43 29.62 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.071 0.549 . . . . 0.0 111.223 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.75 -1.4 34.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.9 11.28 33.8 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.676 0.79 . . . . 0.0 111.461 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 t -126.35 154.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.294 0.638 . . . . 0.0 109.795 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.0 152.46 23.76 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.172 0.589 . . . . 0.0 111.636 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.3 p -63.63 -17.45 62.92 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -77.56 -17.17 58.14 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 118.335 0.516 . . . . 0.0 110.729 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -89.75 -21.35 22.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -88.18 -11.21 47.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.977 0.511 . . . . 0.0 111.327 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.62 -27.26 12.43 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.281 0.632 . . . . 0.0 111.197 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.79 161.17 48.34 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 145.19 80.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.143 2.562 . . . . 0.0 112.608 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.2 m -140.62 154.27 21.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.699 0.8 . . . . 0.0 110.23 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 tp -145.87 146.45 31.12 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.1 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -85.01 158.77 20.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.878 0.471 . . . . 0.0 109.796 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -67.02 -36.22 10.62 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.82 125.32 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.402 2.068 . . . . 0.0 110.202 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -112.29 151.96 29.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.745 0.418 . . . . 0.0 110.854 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.9 p -142.64 159.28 42.53 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.161 0.984 . . . . 0.0 109.087 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -66.04 -26.34 67.46 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.829 -0.544 . . . . 0.0 111.174 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.63 -37.1 21.49 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 117.788 0.267 . . . . 0.0 111.536 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.48 -27.25 59.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.929 -0.373 . . . . 0.0 112.185 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.57 -29.4 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 117.696 0.748 . . . . 0.0 110.464 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.02 69.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.97 -21.16 29.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.365 0.666 . . . . 0.0 110.819 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.39 38.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.66 0.209 . . . . 0.0 110.664 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.62 -28.69 60.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -26.37 63.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.96 41.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.051 0.54 . . . . 0.0 111.752 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -90.98 -33.81 15.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.353 0.261 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -94.08 0.23 55.77 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.901 0.48 . . . . 0.0 111.844 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.22 -1.372 . . . . 0.0 109.767 179.157 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.68 -5.47 37.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.39 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 63.5 mt-30 -119.94 111.77 18.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.803 0.335 . . . . 0.0 111.541 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.21 135.4 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.093 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.38 132.3 36.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.0 mt -94.6 128.0 46.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.215 0.606 . . . . 0.0 109.487 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.41 115.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.066 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.89 162.98 32.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.057 0.543 . . . . 0.0 111.622 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.5 4.42 18.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.677 . . . . 0.0 110.374 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -141.11 110.69 6.51 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.804 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -55.75 -21.78 33.88 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.952 3.101 . . . . 0.0 113.875 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 tp -74.31 -33.7 63.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.214 0.461 . . . . 0.0 110.305 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.3 mm -77.73 -31.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.22 65.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.8 tpp -77.76 -31.83 52.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -74.52 -30.41 61.78 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.472 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.16 -29.95 68.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.2 -24.03 54.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.068 0.394 . . . . 0.0 110.193 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.9 -43.13 20.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.241 -0.287 . . . . 0.0 111.279 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.38 -28.33 59.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.188 0.449 . . . . 0.0 111.813 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -79.17 -17.65 54.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.514 0.597 . . . . 0.0 110.865 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.85 -26.16 27.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.039 0.381 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -82.86 -22.59 8.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 122.555 0.342 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.9 mt -101.11 16.35 25.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 51.97 37.36 20.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.862 0.865 . . . . 0.0 112.181 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.61 164.61 17.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.494 0.717 . . . . 0.0 109.528 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.0 m -117.46 71.8 7.02 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 122.537 0.335 . . . . 0.0 110.825 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.3 159.69 42.46 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.986 2.457 . . . . 0.0 110.114 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.2 m -123.81 -10.02 7.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.72 173.77 33.72 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 118.54 0.609 . . . . 0.0 112.291 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.3 m -140.25 139.24 35.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 109.337 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.32 158.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.231 0.612 . . . . 0.0 110.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -137.04 3.63 2.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.655 0.382 . . . . 0.0 111.763 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -139.04 149.71 44.94 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.04 -32.38 55.99 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 122.29 0.236 . . . . 0.0 111.311 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.85 69.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.953 -0.467 . . . . 0.0 110.945 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.49 -29.8 47.5 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.4 63.6 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.516 0.658 . . . . 0.0 110.541 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.92 -27.09 54.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.41 -24.67 61.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.149 -0.344 . . . . 0.0 110.883 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.07 -29.24 22.04 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.09 -21.95 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.564 0.62 . . . . 0.0 111.523 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -81.66 -14.72 56.3 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.07 -0.394 . . . . 0.0 111.021 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -91.9 -13.21 31.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.539 0.336 . . . . 0.0 111.519 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -164.8 42.18 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.61 24.98 61.58 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.306 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -127.79 144.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 117.433 0.616 . . . . 0.0 109.646 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -109.94 -27.87 9.02 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.23 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.06 178.56 7.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.156 0.583 . . . . 0.0 110.389 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.23 162.01 41.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.906 -0.496 . . . . 0.0 111.847 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.4 mt -116.22 126.62 73.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.11 133.06 56.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.876 0.47 . . . . 0.0 111.488 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.83 144.29 30.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -80.37 -11.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 122.754 0.422 . . . . 0.0 110.696 -176.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.71 -11.72 12.59 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.549 2.833 . . . . 0.0 111.494 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.47 -31.43 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 117.87 0.305 . . . . 0.0 110.775 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.99 86.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.956 -0.465 . . . . 0.0 110.289 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.0 -17.37 40.69 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.263 -0.273 . . . . 0.0 111.274 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -33.25 68.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.1 mt -73.88 -27.54 61.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.24 -23.0 61.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.928 0.331 . . . . 0.0 110.5 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.91 -19.37 40.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.315 0.246 . . . . 0.0 110.375 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -98.12 5.37 48.67 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.43 0.692 . . . . 0.0 111.491 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 57.37 27.6 14.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 112.534 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.6 mt -94.78 124.52 54.43 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.313 0.645 . . . . 0.0 109.327 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -59.89 150.26 78.92 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.894 3.063 . . . . 0.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -151.91 160.39 43.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.672 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.17 156.47 36.66 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.395 0.678 . . . . 0.0 109.498 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.73 160.62 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.35 0.595 . . . . 0.0 111.896 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.46 136.55 36.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.8 p -134.05 161.89 33.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.069 0.461 . . . . 0.0 111.96 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.04 -167.75 36.14 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.11 49.77 2.96 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -153.95 144.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.485 0.714 . . . . 0.0 110.033 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -105.42 -2.32 23.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.456 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.95 -2.87 33.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.042 0.537 . . . . 0.0 111.507 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -85.66 5.63 31.1 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.059 0.544 . . . . 0.0 111.813 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.64 154.73 19.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.137 0.575 . . . . 0.0 111.814 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.66 170.9 15.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.848 0.859 . . . . 0.0 111.179 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -62.85 -17.27 61.21 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -70.73 -29.78 66.12 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.778 -0.576 . . . . 0.0 110.195 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -81.02 -23.94 38.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -84.25 -10.37 57.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.82 0.448 . . . . 0.0 110.885 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -23.58 15.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.981 0.512 . . . . 0.0 110.913 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -97.19 163.86 19.01 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.286 0.634 . . . . 0.0 110.042 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.45 147.53 85.37 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.251 2.634 . . . . 0.0 112.084 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 m -140.36 154.07 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.486 0.714 . . . . 0.0 110.297 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.53 151.65 51.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.528 0.731 . . . . 0.0 109.953 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -74.35 156.76 36.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.502 ' CE ' ' HA ' ' A' ' 102' ' ' LYS . 1.9 tpmt? -71.1 -47.47 14.19 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.723 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.52 142.43 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.902 1.735 . . . . 0.0 109.804 172.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -115.56 157.83 23.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.928 0.891 . . . . 0.0 110.75 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -141.91 162.53 35.24 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 124.058 0.943 . . . . 0.0 109.46 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -64.67 -32.52 74.22 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 122.255 -0.278 . . . . 0.0 111.149 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.45 -34.44 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.712 0.233 . . . . 0.0 111.597 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.03 56.16 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.628 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.27 -27.51 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.954 0.877 . . . . 0.0 110.729 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.02 71.79 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.222 0.465 . . . . 0.0 110.294 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -82.78 -29.62 29.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.327 0.251 . . . . 0.0 110.419 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.65 -31.57 46.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.732 0.242 . . . . 0.0 111.221 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.36 -39.81 58.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.96 -26.8 65.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.497 -0.127 . . . . 0.0 110.802 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.26 -14.41 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.567 0.347 . . . . 0.0 111.566 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -91.25 -35.85 14.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.761 0.424 . . . . 0.0 110.78 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 tp -88.67 -12.15 43.26 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.116 -1.421 . . . . 0.0 110.165 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -12.67 40.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.477 0.311 . . . . 0.0 110.774 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.1 116.16 27.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.572 0.349 . . . . 0.0 111.469 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.42 128.76 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.418 0.687 . . . . 0.0 110.366 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -87.82 141.02 28.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.436 ' H ' HD22 ' A' ' 8' ' ' LEU . 90.0 mt -106.0 127.35 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.791 0.836 . . . . 0.0 109.21 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.0 126.87 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -155.07 165.87 35.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.255 0.622 . . . . 0.0 111.181 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -124.21 18.17 9.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.974 0.51 . . . . 0.0 110.242 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -137.77 126.86 14.85 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.727 0.811 . . . . 0.0 108.883 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.77 -18.68 32.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.411 2.741 . . . . 0.0 112.839 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.57 -25.5 35.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.26 0.482 . . . . 0.0 110.512 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.11 -26.05 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.43 84.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.011 -0.431 . . . . 0.0 110.843 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -77.26 -25.12 51.17 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 122.303 -0.248 . . . . 0.0 110.884 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 ttp -75.15 -32.17 61.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.429 -0.169 . . . . 0.0 110.688 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.67 -33.79 69.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.845 0.293 . . . . 0.0 110.68 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.71 -22.01 57.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.885 0.311 . . . . 0.0 110.451 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.75 -38.73 32.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.213 -0.305 . . . . 0.0 111.367 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -78.1 -23.44 47.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.562 0.619 . . . . 0.0 111.297 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.9 -18.54 58.25 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.439 0.563 . . . . 0.0 109.892 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.95 -28.04 35.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.05 0.386 . . . . 0.0 110.019 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -77.74 -23.59 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 122.615 0.366 . . . . 0.0 110.315 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.2 mt -93.04 8.2 40.98 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.793 0.437 . . . . 0.0 111.513 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.23 30.95 8.48 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.25 0.62 . . . . 0.0 111.47 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.0 OUTLIER -85.72 161.12 19.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 -177.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.406 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 94.4 m -107.97 98.99 28.31 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 122.357 0.263 . . . . 0.0 110.321 177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.92 158.76 54.58 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.907 2.405 . . . . 0.0 109.26 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.94 -11.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.31 172.75 32.17 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.313 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -133.97 143.18 48.01 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.968 0.907 . . . . 0.0 108.755 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.69 140.2 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.72 1.53 57.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -140.78 157.06 45.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.119 0.568 . . . . 0.0 109.878 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.3 -22.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 122.47 -0.144 . . . . 0.0 110.779 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.86 63.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -19.58 68.95 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.96 -36.85 48.6 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.738 0.769 . . . . 0.0 110.746 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.76 -30.23 40.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.22 -25.66 59.79 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.187 -0.321 . . . . 0.0 111.266 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -87.39 -26.76 23.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.67 0.388 . . . . 0.0 111.827 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -82.77 -22.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 118.191 0.45 . . . . 0.0 111.604 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.35 -14.66 62.67 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.122 0.419 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.27 -12.52 59.61 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.684 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 -174.8 54.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.82 85.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -133.72 149.38 30.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -129.67 -12.03 4.36 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.57 169.25 20.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.841 0.456 . . . . 0.0 110.101 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 158.63 44.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.581 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.46 127.46 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.43 126.16 55.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.814 0.446 . . . . 0.0 110.888 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -77.85 132.83 38.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.56 -13.26 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.21 -0.306 . . . . 0.0 110.323 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.241 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.35 -10.91 29.12 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.364 2.71 . . . . 0.0 111.401 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.77 -16.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.022 0.529 . . . . 0.0 111.064 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 -23.3 62.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.957 -0.465 . . . . 0.0 109.881 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.19 -19.03 57.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.04 -30.8 39.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.51 -30.13 66.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.31 -20.95 54.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.266 0.226 . . . . 0.0 110.652 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.97 -18.46 59.3 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -90.34 12.83 17.12 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.42 0.688 . . . . 0.0 110.449 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.44 31.93 21.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.812 1.245 . . . . 0.0 112.824 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -113.8 126.17 28.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.68 160.31 38.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.213 3.275 . . . . 0.0 112.338 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.06 171.72 15.94 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.25 149.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.776 0.831 . . . . 0.0 108.967 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.82 154.31 17.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.185 0.517 . . . . 0.0 111.413 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.54 125.03 22.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.6 t -154.69 169.57 23.59 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.64 126.78 1.55 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.56 -164.82 29.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -74.02 159.11 33.15 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 110.307 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.48 -8.68 59.61 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.53 0.332 . . . . 0.0 111.44 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.22 0.76 20.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.215 0.606 . . . . 0.0 112.135 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.0 p -124.1 11.77 8.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.142 0.577 . . . . 0.0 111.948 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.81 160.99 17.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.355 0.597 . . . . 0.0 112.576 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -64.8 -16.2 62.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -78.16 -16.71 57.66 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.717 0.69 . . . . 0.0 111.238 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -85.89 -24.46 26.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -79.02 -15.95 57.54 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.342 0.257 . . . . 0.0 111.012 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.88 -24.69 13.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.045 0.538 . . . . 0.0 111.523 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -90.39 160.32 39.77 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 123.187 0.595 . . . . 0.0 109.53 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -63.71 144.49 89.38 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.83 2.353 . . . . 0.0 110.666 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.17 154.35 20.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.737 0.815 . . . . 0.0 110.806 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -139.96 153.8 47.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -69.41 158.72 34.58 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 13.8 mmmm -62.33 -47.63 89.04 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.23 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.6 Cg_endo -71.43 135.15 25.95 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.427 1.418 . . . . 0.0 108.849 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.6 156.62 17.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.122 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.6 p -141.11 160.77 39.39 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.382 1.073 . . . . 0.0 108.702 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -62.36 -28.78 70.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.304 -0.248 . . . . 0.0 111.043 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.85 -29.1 27.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.336 -0.228 . . . . 0.0 110.97 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.51 -32.98 49.34 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.052 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -82.28 -24.47 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 117.841 0.82 . . . . 0.0 111.151 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.11 65.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.25 0.477 . . . . 0.0 109.964 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.23 -25.82 27.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.793 0.437 . . . . 0.0 111.549 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.79 -37.35 41.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.781 0.264 . . . . 0.0 110.778 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.37 -27.52 52.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.84 60.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.149 0.431 . . . . 0.0 110.672 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.21 -17.42 32.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.23 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.23 -47.56 7.43 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.16 18.02 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.452 1.101 . . . . 0.0 111.588 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.155 -179.148 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.13 -14.28 29.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.043 0.937 . . . . 0.0 109.681 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.414 ' HB3' HG13 ' A' ' 32' ' ' VAL . 23.1 mp0 -114.57 111.84 21.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.798 0.439 . . . . 0.0 111.619 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mm -118.41 130.43 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.226 0.61 . . . . 0.0 110.128 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.416 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -90.73 141.18 29.07 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.416 ' H ' HD21 ' A' ' 8' ' ' LEU . 96.7 mt -105.31 130.55 56.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.478 0.711 . . . . 0.0 109.78 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 t -127.61 117.97 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.588 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 14.2 tp10 -145.62 156.18 43.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.474 0.71 . . . . 0.0 109.744 -173.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -124.35 15.64 8.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.418 0.687 . . . . 0.0 111.416 -176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.588 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 15.9 tp10 -136.08 107.22 9.58 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.28 -25.02 36.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.626 2.884 . . . . 0.0 114.152 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -77.16 -37.93 52.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.407 0.549 . . . . 0.0 110.465 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.5 mt -79.33 -24.33 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.85 0.296 . . . . 0.0 110.536 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.9 mtt -76.97 -31.3 56.45 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.7 mtp -72.94 -23.77 60.72 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -34.25 63.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.327 -0.233 . . . . 0.0 110.666 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.34 -22.38 51.91 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.42 -37.46 57.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.69 -23.24 56.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.269 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -77.25 -23.46 51.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.926 0.33 . . . . 0.0 110.245 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.07 -32.27 26.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.303 0.241 . . . . 0.0 110.482 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -76.82 -19.77 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.6 tp -82.81 0.22 44.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.583 0.753 . . . . 0.0 110.542 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 53.89 28.8 8.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.861 0.865 . . . . 0.0 111.695 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -91.25 156.84 17.52 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.971 0.908 . . . . 0.0 110.74 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.0 m -92.64 121.61 65.8 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -78.59 161.68 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.168 3.245 . . . . 0.0 111.25 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.414 HG13 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -141.7 -18.7 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 173.07 32.58 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.398 0.545 . . . . 0.0 112.548 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.2 p -139.62 142.98 37.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.503 1.121 . . . . 0.0 108.46 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 156.03 21.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.83 -7.66 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.597 0.759 . . . . 0.0 111.563 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -152.61 161.22 42.87 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.668 0.387 . . . . 0.0 110.467 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.65 -22.55 26.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.186 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -27.23 63.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.72 -28.75 56.49 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.32 74.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.563 0.681 . . . . 0.0 109.496 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.94 -31.21 66.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 -24.92 63.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.372 -0.205 . . . . 0.0 111.08 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.348 0.259 . . . . 0.0 111.206 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -76.27 -25.23 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.899 0.318 . . . . 0.0 110.244 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -73.78 -14.78 61.17 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.352 -0.217 . . . . 0.0 110.856 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.4 -12.61 24.06 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.193 0.597 . . . . 0.0 111.007 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.82 -169.04 49.03 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.26 86.35 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.619 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.4 mt -129.16 147.97 33.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.78 -17.47 4.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.99 170.24 22.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.728 0.411 . . . . 0.0 110.43 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.93 162.53 41.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.624 0.249 . . . . 0.0 111.538 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.11 130.97 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.76 125.72 54.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.523 0.329 . . . . 0.0 110.958 -174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.54 129.9 34.85 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.53 -12.93 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.026 0.53 . . . . 0.0 110.9 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 123.163 0.585 . . . . 0.0 110.964 -177.218 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.471 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 42.1 p . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.6 Cg_exo -59.05 -16.49 33.15 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.976 1.784 . . . . 0.0 112.99 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.6 -21.67 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.038 0.381 . . . . 0.0 110.291 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.62 65.45 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.026 -0.421 . . . . 0.0 110.064 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.62 -19.66 60.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.339 -0.226 . . . . 0.0 110.66 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.92 51.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.42 -36.88 74.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.17 62.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.276 -0.265 . . . . 0.0 110.748 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 -15.19 54.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.405 0.282 . . . . 0.0 110.432 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -105.29 20.68 18.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.704 0.802 . . . . 0.0 111.403 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 59.02 35.76 24.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.035 0.934 . . . . 0.0 113.444 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.3 mt -118.59 97.62 50.84 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.97 161.14 26.89 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.079 3.186 . . . . 0.0 112.638 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -148.02 170.26 18.12 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.919 0.487 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.5 144.16 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -86.88 155.98 20.03 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.8 0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.05 125.98 18.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -161.93 164.71 28.34 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 110.618 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.45 95.61 0.57 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.43 165.04 12.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.7 m -147.58 28.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.55 0.34 . . . . 0.0 110.873 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -105.62 -50.88 3.11 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.71 -5.42 2.5 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.2 p -88.07 4.18 46.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.879 0.472 . . . . 0.0 112.131 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.43 154.44 30.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.336 0.588 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.98 179.86 7.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.0 108.972 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -57.53 -19.32 24.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.754 -0.591 . . . . 0.0 112.235 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -74.45 -24.63 59.09 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.991 -0.443 . . . . 0.0 110.749 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.56 -17.12 39.89 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.9 0.88 . . . . 0.0 109.396 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -88.26 -11.0 47.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.467 0.707 . . . . 0.0 110.37 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -111.98 -8.46 14.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.628 0.771 . . . . 0.0 111.785 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -137.84 139.56 26.82 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -53.11 154.89 12.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.854 3.036 . . . . 0.0 114.238 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.83 155.14 32.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.136 0.974 . . . . 0.0 110.259 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.3 tp -133.57 149.71 51.65 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -74.08 160.97 30.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -70.45 -42.4 15.05 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.418 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.01 141.15 43.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.5 2.134 . . . . 0.0 109.645 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -103.21 149.08 25.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 110.497 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.4 p -139.08 166.39 24.64 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.955 0.902 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mmm -65.65 -35.77 81.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.185 -0.322 . . . . 0.0 110.808 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.68 -28.38 26.43 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.388 0.275 . . . . 0.0 111.74 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.75 -28.81 64.36 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.6 t -83.91 -30.16 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.344 0.572 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.2 -27.84 60.98 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.39 -24.45 39.71 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.663 0.385 . . . . 0.0 110.244 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.24 64.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.183 -0.323 . . . . 0.0 110.394 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.21 -40.75 74.38 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.49 -18.89 61.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -23.27 24.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tt -91.79 -50.57 5.66 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.163 -0.336 . . . . 0.0 111.13 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.95 -1.12 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.913 -1.518 . . . . 0.0 110.06 178.669 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -79.93 -8.78 59.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.972 0.509 . . . . 0.0 111.585 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.438 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 65.2 mt-30 -121.04 114.62 21.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -119.88 131.98 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.47 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -91.39 145.03 24.97 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.47 ' H ' HD21 ' A' ' 8' ' ' LEU . 74.7 mt -113.34 130.95 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.1 117.71 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.19 163.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.21 -4.69 5.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.912 0.885 . . . . 0.0 110.538 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -153.75 136.8 10.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -56.74 -18.39 26.65 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.004 3.136 . . . . 0.0 114.52 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.62 -21.59 38.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.144 0.429 . . . . 0.0 111.671 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.11 -38.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.15 60.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.312 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.7 ttm -76.26 -32.8 59.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.0 tpt -81.5 -27.83 34.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.274 -0.266 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.48 -36.34 63.28 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -74.59 -21.69 59.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.82 -42.08 61.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.039 -0.413 . . . . 0.0 110.98 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -83.24 -22.78 33.0 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.91 -21.21 40.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.117 0.871 . . . . 0.0 111.076 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -85.58 -29.4 24.16 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.064 0.393 . . . . 0.0 111.314 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.39 -18.66 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 122.386 0.275 . . . . 0.0 111.23 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -99.33 18.15 18.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.119 0.567 . . . . 0.0 111.532 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 53.79 31.3 12.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.673 0.789 . . . . 0.0 112.227 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.51 165.72 16.89 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.639 0.776 . . . . 0.0 109.245 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -118.28 75.21 11.52 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 110.947 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.9 157.34 53.09 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.244 2.629 . . . . 0.0 109.78 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 30.1 m -122.75 -15.19 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.84 178.18 37.98 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.289 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 p -135.37 140.93 45.41 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.524 1.13 . . . . 0.0 108.876 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.51 147.16 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 110.431 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -92.1 2.19 56.73 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.41 0.684 . . . . 0.0 112.255 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -155.01 157.34 37.47 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.099 0.56 . . . . 0.0 110.065 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.48 -22.56 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.137 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.5 -26.04 64.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.36 59.27 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.02 67.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.714 0.757 . . . . 0.0 109.931 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.61 -37.54 68.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.79 -24.94 63.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -86.46 -22.7 26.33 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.314 0.506 . . . . 0.0 111.345 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.53 -28.22 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HB2' HH12 ' A' ' 75' ' ' ARG . 24.4 tt0 -82.52 -14.68 54.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.058 0.543 . . . . 0.0 111.559 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -108.16 -12.54 15.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.043 0.537 . . . . 0.0 112.197 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.71 165.82 38.94 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.15 136.06 18.82 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mt -144.7 146.1 20.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -101.09 -30.93 11.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 173.33 14.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.586 0.355 . . . . 0.0 110.343 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.1 158.23 43.95 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.98 128.27 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.64 119.09 34.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.182 0.593 . . . . 0.0 110.224 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.72 145.21 36.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.3 m -76.78 -11.79 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.69 -11.89 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.677 2.918 . . . . 0.0 112.499 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.61 -16.88 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.923 -0.486 . . . . 0.0 110.684 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.3 69.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.823 -0.548 . . . . 0.0 110.048 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.17 -18.07 60.26 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.389 0.276 . . . . 0.0 110.606 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.21 -30.34 38.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.22 -33.77 70.18 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.13 -23.11 61.26 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.063 0.145 . . . . 0.0 110.767 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.67 -16.83 56.82 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.419 HH12 ' HB2' ' A' ' 46' ' ' GLU . 97.6 mtt180 -99.57 16.87 21.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.684 0.794 . . . . 0.0 110.626 173.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.69 26.23 15.3 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 113.65 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.88 122.02 44.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.54 159.58 39.24 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.781 2.988 . . . . 0.0 111.453 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -147.3 164.5 33.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.56 144.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 124.048 0.939 . . . . 0.0 108.688 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -90.93 155.9 18.39 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.23 133.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -155.15 168.81 25.79 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.772 0.429 . . . . 0.0 111.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.95 118.4 0.95 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.57 -154.21 25.49 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -70.86 161.82 30.31 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.684 0.394 . . . . 0.0 110.337 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.99 -1.91 48.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.756 0.422 . . . . 0.0 112.043 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -100.88 0.55 38.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.231 0.612 . . . . 0.0 111.671 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -87.9 5.54 39.98 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.001 0.52 . . . . 0.0 112.12 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.0 m -123.08 154.58 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.488 0.715 . . . . 0.0 111.835 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.5 171.49 15.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.246 1.018 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -61.2 -18.18 56.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.164 0.586 . . . . 0.0 112.567 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -72.73 -24.7 61.01 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.735 0.698 . . . . 0.0 110.989 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.432 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 46.0 m-85 -84.43 -19.18 33.86 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.05 -10.37 50.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.064 0.546 . . . . 0.0 111.176 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.07 -15.06 14.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.349 0.66 . . . . 0.0 111.288 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -108.91 156.1 39.63 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 123.629 0.772 . . . . 0.0 109.585 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.91 151.58 83.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.197 2.598 . . . . 0.0 110.683 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.91 154.37 36.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.761 0.824 . . . . 0.0 110.688 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -135.64 157.2 47.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.821 0.848 . . . . 0.0 110.342 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -81.97 158.79 23.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -67.99 -53.44 20.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.816 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.44 141.71 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.048 1.832 . . . . 0.0 109.585 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -106.49 158.57 16.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.44 0.638 . . . . 0.0 111.681 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 p -137.49 164.25 29.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.768 1.227 . . . . 0.0 107.776 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.9 ttm -65.17 -29.12 69.92 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.001 -0.437 . . . . 0.0 110.883 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.32 -29.95 25.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.076 0.15 . . . . 0.0 110.904 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.95 -28.84 55.8 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.784 -0.453 . . . . 0.0 111.986 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.51 -24.65 8.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-N 117.864 0.832 . . . . 0.0 110.238 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 -28.98 65.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -85.11 -20.96 29.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.575 0.35 . . . . 0.0 110.983 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.89 -41.6 64.48 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.825 0.284 . . . . 0.0 110.314 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -78.92 -27.24 43.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.26 -20.1 60.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.939 0.336 . . . . 0.0 110.556 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.7 24.78 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.349 0.26 . . . . 0.0 111.3 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 tt -91.55 -51.81 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.875 0.307 . . . . 0.0 111.217 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.94 4.11 3.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.09 0.956 . . . . 0.0 113.214 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.828 -1.082 . . . . 0.0 109.966 178.86 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.375 0.607 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -74.28 -18.12 60.77 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.099 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.435 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 74.7 mt-30 -102.75 104.07 14.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.829 0.347 . . . . 0.0 110.713 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.23 130.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.573 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.41 129.61 35.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.7 mt -94.34 129.68 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.473 0.709 . . . . 0.0 109.3 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -130.23 103.52 8.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 13' ' ' GLU . 82.0 tt0 -157.61 142.87 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -92.88 -7.48 46.07 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 15.9 tp10 -99.38 104.97 30.16 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.38 -18.32 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.122 2.548 . . . . 0.0 112.061 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.91 -40.17 48.27 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.281 0.491 . . . . 0.0 110.291 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.15 -25.92 6.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.43 -39.47 77.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -74.39 -27.4 60.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.2 ttt -65.8 -33.26 75.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' A' ' 104' ' ' PHE . 7.6 tt -77.21 -30.92 54.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.909 -0.495 . . . . 0.0 110.338 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.12 -21.83 64.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.926 0.33 . . . . 0.0 110.297 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.72 -41.61 62.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 104' ' ' PHE . 67.0 m-85 -73.65 -13.9 61.07 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.452 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.37 -27.17 52.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.309 0.504 . . . . 0.0 110.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -84.29 -24.72 29.75 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -80.49 -19.81 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.21 -6.73 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.186 0.594 . . . . 0.0 110.827 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.46 27.18 6.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.613 ' HG2' ' H ' ' A' ' 30' ' ' THR . 24.5 ttpt -91.07 -175.62 4.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.321 0.648 . . . . 0.0 110.206 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.613 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 89.6 m -109.46 119.53 47.89 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 122.301 -0.249 . . . . 0.0 110.607 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.79 164.48 20.49 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.976 3.117 . . . . 0.0 111.162 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 28.7 m -139.65 -30.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.26 173.85 33.38 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 118.159 0.436 . . . . 0.0 112.532 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.1 m -140.64 142.09 35.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 108.723 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.14 157.46 25.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.207 0.603 . . . . 0.0 110.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -98.32 -3.51 37.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.044 0.538 . . . . 0.0 112.334 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.7 p -142.71 157.58 44.51 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.328 0.651 . . . . 0.0 109.746 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.8 -22.59 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 O-C-N 122.389 -0.194 . . . . 0.0 110.8 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.03 -27.65 67.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.477 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.97 -21.27 74.46 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.66 -30.34 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.249 0.524 . . . . 0.0 110.338 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.4 mt -72.37 -34.1 67.73 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.78 -25.36 49.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -87.35 -31.61 20.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.13 -22.02 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 118.142 0.428 . . . . 0.0 111.752 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.56 -14.84 62.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.233 -0.292 . . . . 0.0 110.502 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.06 -12.43 41.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.59 . . . . 0.0 110.756 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 -167.58 48.22 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 13.89 82.66 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.253 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 mt -135.83 145.58 31.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.774 0.829 . . . . 0.0 109.108 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -106.81 -29.62 9.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 177.68 8.27 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.753 0.421 . . . . 0.0 110.69 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.17 165.34 28.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.01 -0.431 . . . . 0.0 112.06 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.6 mt -125.97 133.33 69.22 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.55 140.34 46.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.507 0.723 . . . . 0.0 109.937 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.94 158.82 16.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.07 -11.47 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 122.886 0.475 . . . . 0.0 112.106 -175.779 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 12.4 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.655 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.1 Cg_exo -58.18 -13.78 17.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 113.753 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.83 -18.58 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 118.299 0.5 . . . . 0.0 110.332 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -25.82 66.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 109.909 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.55 -17.38 54.1 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.859 -0.525 . . . . 0.0 109.979 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.48 -24.05 46.13 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.24 -30.79 63.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 171.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -22.6 59.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.55 -20.18 54.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -91.89 7.62 41.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.95 0.9 . . . . 0.0 110.724 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t70 59.12 32.04 21.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.378 1.071 . . . . 0.0 112.78 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.5 mt -111.94 126.16 28.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.04 161.32 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.429 2.753 . . . . 0.0 111.865 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.37 170.82 19.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.084 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.6 t -138.42 150.32 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.896 0.878 . . . . 0.0 108.92 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 20.2 m-85 -94.26 163.22 13.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.71 127.92 20.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -160.55 170.24 21.32 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.721 0.408 . . . . 0.0 110.534 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.18 132.93 4.26 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.77 -160.49 28.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -72.46 149.18 44.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.997 0.399 . . . . 0.0 110.039 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -75.8 -6.64 51.67 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -110.21 3.94 20.51 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.737 0.415 . . . . 0.0 111.246 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 t -98.48 12.49 34.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.441 0.696 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.01 153.84 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.488 0.715 . . . . 0.0 109.701 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.71 159.86 32.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.243 0.544 . . . . 0.0 112.394 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.1 p -63.2 -17.25 62.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -68.02 -28.02 67.05 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.686 0.675 . . . . 0.0 110.28 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 44.1 m-85 -85.13 -20.87 29.62 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -84.17 -7.99 59.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.905 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -118.62 -9.88 10.16 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.071 0.548 . . . . 0.0 112.14 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -125.29 156.78 69.47 Favored Pre-proline 0 C--N 1.341 0.236 0 C-N-CA 123.022 0.529 . . . . 0.0 110.568 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -54.3 144.18 61.66 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.638 2.892 . . . . 0.0 112.85 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.34 153.9 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.443 0.697 . . . . 0.0 110.077 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -130.69 155.53 46.45 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.927 0.891 . . . . 0.0 109.903 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -74.04 167.32 21.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.063 0.545 . . . . 0.0 110.902 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -75.89 -47.4 3.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.442 -0.789 . . . . 0.0 112.159 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.96 164.27 25.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.618 2.212 . . . . 0.0 110.456 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.456 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 10.9 m-85 -133.94 158.57 43.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.998 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.1 p -142.11 159.12 42.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.3 mtt -65.1 -27.99 69.14 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.137 -0.352 . . . . 0.0 111.126 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.26 -25.63 29.23 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.476 0.179 . . . . 0.0 110.633 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.43 -40.19 28.7 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.8 m -74.64 -21.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.559 0.679 . . . . 0.0 111.066 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.92 -31.43 51.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.12 0.418 . . . . 0.0 110.401 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -81.93 -31.76 31.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.55 60.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.85 -41.37 64.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.64 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.447 -0.158 . . . . 0.0 111.153 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.87 -21.06 25.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 tt -91.96 -38.69 12.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.203 0.601 . . . . 0.0 112.576 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.71 -10.83 59.74 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.935 -179.53 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.38 -10.87 16.16 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.729 0.812 . . . . 0.0 110.852 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.461 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 80.9 mt-30 -134.16 120.11 19.68 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.93 132.15 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.636 0.585 . . . . 0.0 110.536 -172.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -88.97 143.49 26.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.452 ' H ' HD21 ' A' ' 8' ' ' LEU . 94.3 mt -112.06 134.2 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.114 0.566 . . . . 0.0 109.845 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 t -132.38 115.7 26.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 22.7 tp10 -145.56 157.69 43.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -106.79 -0.0 23.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 39.4 tt0 -139.95 129.4 13.68 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 118.307 0.503 . . . . 0.0 110.328 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 53.7 Cg_exo -57.48 -27.43 76.26 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.573 2.849 . . . . 0.0 113.655 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.39 -44.25 71.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.8 -26.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.37 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.623 0.192 . . . . 0.0 111.086 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.5 mtt -75.82 -26.7 57.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 tpt -76.25 -23.91 54.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -35.62 71.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.03 -21.72 56.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.452 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.09 -41.46 70.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.015 -0.428 . . . . 0.0 110.574 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.99 -23.15 62.13 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -85.07 -28.53 25.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.351 0.26 . . . . 0.0 110.677 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.78 -23.57 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.61 5.24 50.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.955 0.502 . . . . 0.0 111.531 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.66 35.9 12.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.544 0.737 . . . . 0.0 111.273 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -85.73 156.85 20.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.018 0.927 . . . . 0.0 111.123 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -91.27 120.23 68.49 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.87 162.49 29.44 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.317 2.678 . . . . 0.0 111.455 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 26.8 m -138.24 -31.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.094 0 C-N-CA 122.443 0.297 . . . . 0.0 111.235 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 176.08 35.79 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -140.26 143.08 35.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.46 155.54 37.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -100.44 1.52 41.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.407 0.683 . . . . 0.0 111.779 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -136.84 154.11 50.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.207 0.603 . . . . 0.0 109.933 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.34 -22.44 11.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.392 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.93 -26.21 61.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.568 0.167 . . . . 0.0 110.608 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.99 -23.27 66.81 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -28.59 35.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.415 0.608 . . . . 0.0 110.649 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.81 -39.02 52.84 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.66 61.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -87.32 -25.07 24.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.164 0.438 . . . . 0.0 111.83 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -83.32 -26.35 7.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.519 0.6 . . . . 0.0 110.402 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.93 -16.73 59.97 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.831 0.348 . . . . 0.0 110.243 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.59 -12.42 42.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.333 0.653 . . . . 0.0 110.98 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -171.22 51.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.02 11.37 85.24 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.8 mt -140.08 144.8 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -101.9 -30.41 11.26 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.71 177.14 9.61 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.742 0.417 . . . . 0.0 110.409 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.64 161.98 40.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.66 124.99 72.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.07 124.2 50.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 111.651 -172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.32 136.16 38.45 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 169.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.53 -13.95 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 122.402 0.281 . . . . 0.0 110.94 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 124.27 1.028 . . . . 0.0 112.362 -177.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 67.2 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 51.1 Cg_exo -59.1 -19.56 49.64 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.451 2.101 . . . . 0.0 113.698 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.46 -26.66 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.053 -0.405 . . . . 0.0 111.091 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.92 62.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.34 -17.39 54.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -32.59 63.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.05 -28.15 65.23 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.26 -22.5 59.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.35 -13.64 59.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -100.28 6.19 44.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.792 0.837 . . . . 0.0 110.526 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 57.04 33.83 23.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.419 1.088 . . . . 0.0 112.857 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.46 121.99 41.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.372 0.669 . . . . 0.0 109.542 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.9 153.62 62.07 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.906 3.07 . . . . 0.0 113.332 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -151.8 165.15 35.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.31 159.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 C-N-CA 123.823 0.849 . . . . 0.0 109.311 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 25.4 m-85 -95.21 159.53 14.97 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.143 0.497 . . . . 0.0 111.99 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 136.36 28.47 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -155.6 158.83 39.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.62 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.49 177.81 54.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.9 116.35 7.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t -154.17 156.09 36.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.26 0.624 . . . . 0.0 110.692 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -105.4 -0.35 26.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.216 0.606 . . . . 0.0 111.464 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -134.05 -2.65 2.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 m -88.74 7.92 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.433 0.56 . . . . 0.0 111.658 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 m -134.89 154.15 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.307 0.643 . . . . 0.0 111.15 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.07 -178.44 6.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.925 1.29 . . . . 0.0 108.649 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.5 m -59.43 -16.62 24.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.488 -0.758 . . . . 0.0 112.031 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -65.86 -30.69 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 9.0 m-85 -90.4 -13.51 34.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.545 1.138 . . . . 0.0 109.836 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -88.53 -10.59 48.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.047 0.539 . . . . 0.0 110.426 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.28 -15.04 12.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.34 0.656 . . . . 0.0 111.433 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -126.03 149.82 67.48 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 123.292 0.637 . . . . 0.0 109.481 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.89 147.02 94.27 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.088 2.525 . . . . 0.0 112.561 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -150.61 150.15 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 123.636 0.774 . . . . 0.0 109.102 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.1 tp -144.39 150.38 37.64 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -75.95 165.81 24.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.444 0.298 . . . . 0.0 111.048 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -58.1 -50.42 88.21 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.931 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.29 110.14 2.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.468 1.445 . . . . 0.0 110.063 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -82.18 153.28 26.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.625 0.37 . . . . 0.0 110.771 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.8 p -139.66 159.62 41.74 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.971 0.908 . . . . 0.0 108.997 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -65.11 -26.14 68.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.117 -0.364 . . . . 0.0 110.848 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.55 -36.33 22.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.773 0.261 . . . . 0.0 111.621 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.74 -31.49 49.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.1 t -79.46 -30.4 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.305 0.552 . . . . 0.0 110.078 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.56 69.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.963 0.347 . . . . 0.0 110.728 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.18 -31.57 23.15 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.356 -0.215 . . . . 0.0 111.449 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.21 60.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.9 0.318 . . . . 0.0 110.868 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.49 -20.67 33.55 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.25 -22.5 59.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.823 0.738 . . . . 0.0 110.001 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -19.72 27.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.516 0.327 . . . . 0.0 111.471 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.4 -58.02 2.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.657 0.383 . . . . 0.0 110.958 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.19 -1.31 7.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.788 1.235 . . . . 0.0 113.351 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.226 -1.369 . . . . 0.0 109.971 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.1 mt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.614 0.245 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -4.98 45.15 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.0 mt-30 -125.51 119.1 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mm -122.09 137.22 56.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.978 0.911 . . . . 0.0 111.173 -173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.71 135.27 36.38 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.4 mt -102.59 126.14 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.288 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.6 t -132.27 117.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.69 161.89 36.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.305 0.642 . . . . 0.0 110.455 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -97.11 0.39 48.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.06 0.544 . . . . 0.0 111.638 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.24 132.96 9.34 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.878 -0.514 . . . . 0.0 110.304 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.6 -23.32 70.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.441 2.761 . . . . 0.0 113.615 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.38 -40.45 67.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.99 -29.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.07 69.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.8 ttp -75.81 -27.83 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.7 ttp -73.46 -29.87 62.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.02 -36.7 75.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -73.14 -21.98 60.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.531 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.81 -42.84 63.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.134 -0.354 . . . . 0.0 111.152 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -75.23 -21.21 58.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.365 0.529 . . . . 0.0 111.376 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -82.79 -18.51 40.34 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.184 0.447 . . . . 0.0 111.344 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -85.07 -22.86 28.79 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.57 0.623 . . . . 0.0 110.388 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 -21.2 10.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -93.17 -0.09 57.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.296 0.638 . . . . 0.0 111.149 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t0 52.37 40.96 30.36 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.369 0.605 . . . . 0.0 110.885 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -85.5 165.18 17.34 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.943 0.897 . . . . 0.0 110.784 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.1 m -115.16 74.64 3.89 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.01 0.524 . . . . 0.0 110.151 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.33 156.95 57.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.894 2.396 . . . . 0.0 109.789 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 32.7 m -116.71 -7.75 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.7 171.53 31.05 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.287 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -137.96 139.88 39.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.78 158.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -120.29 -2.65 10.07 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.535 0.734 . . . . 0.0 111.58 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.0 p -138.83 161.04 38.23 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.404 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.55 -26.54 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.045 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.2 -28.33 48.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.68 -27.88 60.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.79 -42.43 73.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.344 0.572 . . . . 0.0 110.175 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.89 -24.58 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.83 61.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.744 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -84.11 -20.87 31.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.978 0.354 . . . . 0.0 111.366 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.84 -31.36 40.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.51 -14.82 54.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.642 0.377 . . . . 0.0 111.791 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -87.75 -13.32 42.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.891 0.477 . . . . 0.0 111.963 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.44 172.58 36.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.4 151.62 43.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -141.87 150.03 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -108.47 -26.81 10.27 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-N 118.045 0.384 . . . . 0.0 111.496 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 171.08 18.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.088 0.555 . . . . 0.0 110.169 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.8 160.4 43.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.145 -0.347 . . . . 0.0 111.097 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.99 127.37 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.88 130.92 56.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.963 0.505 . . . . 0.0 111.188 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -81.53 139.43 35.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.76 -16.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.669 0.271 . . . . 0.0 110.667 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.231 0.11 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.93 -9.15 14.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.592 2.861 . . . . 0.0 111.532 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.28 -29.04 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 O-C-N 122.162 -0.336 . . . . 0.0 110.93 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.48 90.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.293 -0.255 . . . . 0.0 110.622 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.21 -17.54 39.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.374 -0.204 . . . . 0.0 111.35 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.5 70.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.41 -28.08 61.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.6 -22.79 62.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.867 0.303 . . . . 0.0 110.204 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.92 41.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.5 0.32 . . . . 0.0 110.351 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.08 7.95 42.05 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 111.155 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.56 28.81 17.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 112.843 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.4 mt -101.33 128.26 29.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.511 0.724 . . . . 0.0 109.474 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.42 156.1 50.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 111.608 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -147.84 167.14 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.6 t -139.22 145.58 27.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.037 0 C-N-CA 124.108 0.963 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.02 150.91 19.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.522 0.329 . . . . 0.0 110.551 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 119.74 11.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -171.78 163.28 6.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.199 0.6 . . . . 0.0 110.647 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.04 147.34 19.6 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.7 -154.35 25.44 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 117.532 0.666 . . . . 0.0 111.812 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 t -137.81 169.47 17.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.845 0.858 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.44 -11.94 60.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.784 0.434 . . . . 0.0 111.484 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.02 -4.3 27.72 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.398 0.679 . . . . 0.0 111.3 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 m -93.03 2.27 56.87 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.158 0.583 . . . . 0.0 111.337 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.59 154.72 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 123.946 0.898 . . . . 0.0 110.702 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.38 -177.52 5.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.346 0.593 . . . . 0.0 111.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.5 p -61.99 -16.5 51.86 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -73.79 -31.8 63.45 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.332 0.969 . . . . 0.0 110.396 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -82.13 -22.71 36.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -88.44 -5.47 58.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.399 0.279 . . . . 0.0 111.132 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -105.08 -16.81 14.69 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.465 0.706 . . . . 0.0 111.128 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -109.45 158.86 33.43 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.537 0.735 . . . . 0.0 110.09 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.47 152.63 76.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.827 2.352 . . . . 0.0 111.303 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.9 154.49 21.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.159 0.584 . . . . 0.0 110.981 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -145.85 156.53 43.62 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.528 0.731 . . . . 0.0 109.128 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.61 164.48 24.82 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -65.17 -50.19 61.87 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.655 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.26 146.28 35.72 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.238 1.959 . . . . 0.0 109.469 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -105.44 153.72 21.31 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 121.006 0.432 . . . . 0.0 111.139 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.2 p -143.21 160.23 40.84 Favored 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 124.405 1.082 . . . . 0.0 108.739 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.6 mtt -66.55 -23.65 66.25 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.085 -0.384 . . . . 0.0 111.099 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.3 -37.76 21.26 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 122.174 -0.329 . . . . 0.0 111.279 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.97 -34.73 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.92 -29.64 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 117.501 0.651 . . . . 0.0 110.499 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.52 -29.49 63.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.191 -0.318 . . . . 0.0 110.755 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.31 -31.79 22.85 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.088 0.155 . . . . 0.0 111.279 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.13 -34.54 61.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.82 0.282 . . . . 0.0 110.552 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.08 -21.18 33.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.462 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.32 -19.89 59.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.205 0.457 . . . . 0.0 110.219 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.88 23.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.495 0.318 . . . . 0.0 111.464 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 tt -91.6 -59.39 2.14 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.645 0.378 . . . . 0.0 111.473 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.9 mt -70.06 3.72 2.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.271 1.428 . . . . 0.0 113.55 -173.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.783 -1.103 . . . . 0.0 109.94 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.534 0.683 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.82 -6.42 54.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.332 0.653 . . . . 0.0 112.206 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 78.6 mt-30 -128.71 119.05 23.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.5 mm -120.9 131.41 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.609 0.764 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -88.52 140.94 28.95 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.401 ' H ' HD23 ' A' ' 8' ' ' LEU . 89.4 mt -109.99 135.14 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 110.117 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 t -129.07 121.56 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -149.2 159.16 44.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.764 0.426 . . . . 0.0 110.656 -171.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.57 -12.74 12.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.438 0.695 . . . . 0.0 111.526 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -120.16 110.38 36.26 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 123.438 0.695 . . . . 0.0 109.27 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.86 -23.7 35.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.636 2.891 . . . . 0.0 113.955 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.1 tp -73.43 -32.54 64.45 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.3 0.5 . . . . 0.0 110.202 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.77 -28.52 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.63 64.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.594 0.179 . . . . 0.0 110.557 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.0 -33.66 57.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.2 tpt -75.05 -23.95 58.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -38.01 75.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.13 -22.74 57.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.608 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.86 -43.66 68.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.202 -0.311 . . . . 0.0 110.557 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -76.46 -25.5 54.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.936 -0.477 . . . . 0.0 111.416 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 tp -73.0 -32.11 64.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.292 0.497 . . . . 0.0 111.024 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -85.57 -24.07 27.36 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.5 t -76.64 -20.6 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.337 0.517 . . . . 0.0 110.504 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.89 18.38 18.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.709 0.403 . . . . 0.0 111.685 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 54.18 27.66 8.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.9 0.88 . . . . 0.0 113.043 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.9 157.12 20.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.224 0.61 . . . . 0.0 109.518 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.3 m -99.43 120.93 56.62 Favored Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 122.014 -0.429 . . . . 0.0 110.231 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -79.24 162.89 25.4 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.65 2.9 . . . . 0.0 110.696 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -138.7 -27.11 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.69 173.58 33.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -140.73 143.33 34.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.56 154.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 122.584 0.354 . . . . 0.0 110.927 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.19 8.72 28.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.277 0.631 . . . . 0.0 111.634 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -150.63 158.77 44.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 122.826 0.45 . . . . 0.0 110.167 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.1 -22.84 21.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 122.941 0.496 . . . . 0.0 111.101 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.96 62.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 122.271 -0.268 . . . . 0.0 110.716 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.2 -21.58 70.09 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.49 -31.73 42.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.278 0.539 . . . . 0.0 110.498 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.12 -23.76 35.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.759 0.254 . . . . 0.0 110.97 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.18 -30.14 34.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.3 -0.25 . . . . 0.0 111.504 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -87.72 -29.1 21.33 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.18 -28.82 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 118.201 0.455 . . . . 0.0 111.313 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.16 -14.87 59.72 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.794 -0.566 . . . . 0.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.75 -12.54 41.89 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.34 0.656 . . . . 0.0 110.587 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 -173.05 54.28 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.55 74.06 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.203 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -139.17 147.16 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 108.777 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.09 -21.2 10.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.22 -0.419 . . . . 0.0 112.049 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 173.12 14.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.314 0.506 . . . . 0.0 110.532 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.51 164.25 34.0 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.84 133.32 69.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.42 129.11 56.63 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.353 . . . . 0.0 110.996 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -81.44 130.16 34.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.85 -11.28 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.629 0.252 . . . . 0.0 110.542 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 123.704 0.802 . . . . 0.0 110.465 177.281 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 66.3 p . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 118.14 -0.933 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 39.6 Cg_exo -64.96 -24.91 59.9 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.767 1.645 . . . . 0.0 111.889 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.96 -23.88 7.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 C-N-CA 122.333 0.253 . . . . 0.0 110.675 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.17 70.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.49 -17.72 61.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.223 -0.298 . . . . 0.0 110.487 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.78 -29.78 51.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.91 -31.41 69.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.86 61.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.91 -13.87 58.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.588 0.355 . . . . 0.0 110.477 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -102.71 12.27 36.53 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.82 0.848 . . . . 0.0 111.013 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 58.03 33.27 23.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.066 0.947 . . . . 0.0 113.423 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.2 mt -114.37 129.4 24.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 109.457 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.93 159.28 30.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 112.418 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -153.78 168.99 24.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.301 0.641 . . . . 0.0 110.742 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.04 159.76 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 124.006 0.922 . . . . 0.0 108.968 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -99.38 156.21 17.13 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.939 0.4 . . . . 0.0 111.779 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.37 119.53 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -172.61 156.62 3.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.721 0.408 . . . . 0.0 110.604 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.59 143.43 18.47 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.65 -158.09 29.88 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 117.358 0.579 . . . . 0.0 111.916 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.4 t -137.47 170.86 15.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.887 0.875 . . . . 0.0 110.063 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.04 -13.8 62.48 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.101 -0.374 . . . . 0.0 111.302 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.93 3.55 54.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.16 0.584 . . . . 0.0 111.332 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 98.4 p -126.12 20.2 7.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.827 0.451 . . . . 0.0 111.903 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.469 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 16.1 m -132.26 154.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.422 0.689 . . . . 0.0 111.779 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -81.93 170.84 15.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.26 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.5 p -61.09 -21.72 63.95 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.95 -21.42 59.19 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.673 0.669 . . . . 0.0 110.862 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.469 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 3.2 m-85 -80.97 -23.44 38.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -88.21 -8.15 55.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.448 0.699 . . . . 0.0 111.261 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -119.6 -3.96 10.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.199 0.599 . . . . 0.0 112.087 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -140.55 140.8 23.35 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 149.96 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.622 2.881 . . . . 0.0 114.345 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 m -142.75 154.62 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.535 1.134 . . . . 0.0 109.596 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -146.87 155.28 42.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.657 0.383 . . . . 0.0 110.097 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.26 158.12 35.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 44.8 mtpt -66.08 -43.82 57.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.907 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 67.6 Cg_endo -69.39 128.61 16.63 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.676 1.277 . . . . 0.0 108.881 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -100.03 154.08 18.69 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.766 0.426 . . . . 0.0 111.367 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.5 p -141.38 162.39 35.61 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.426 1.09 . . . . 0.0 108.711 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.08 -26.88 68.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.298 -0.251 . . . . 0.0 111.031 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -84.47 -38.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.932 0.333 . . . . 0.0 111.579 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.99 -31.76 59.5 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.18 -27.64 12.02 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.026 0 CA-C-N 117.24 0.52 . . . . 0.0 110.229 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.17 68.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.003 -0.436 . . . . 0.0 110.669 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.24 -33.77 25.99 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 122.321 -0.237 . . . . 0.0 110.939 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.86 66.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.34 -20.33 40.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.63 62.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.777 0.717 . . . . 0.0 109.886 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.41 -23.71 24.44 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.2 mt -91.56 -14.44 30.31 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -107.06 18.04 22.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.376 0.535 . . . . 0.0 111.137 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.442 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.399 0.142 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.434 ' HA ' ' HZ1' ' A' ' 29' ' ' LYS . 1.3 p -70.42 -7.07 40.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.161 -0.337 . . . . 0.0 111.214 -174.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.429 ' HB3' HG13 ' A' ' 32' ' ' VAL . 25.8 mp0 -106.27 114.31 28.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 122.807 0.443 . . . . 0.0 111.457 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 mm -123.88 127.35 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 123.636 0.585 . . . . 0.0 110.225 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.85 136.16 33.49 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.8 mt -103.24 132.78 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.182 0.593 . . . . 0.0 109.937 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.7 t -131.97 118.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 34.8 tp10 -151.24 140.2 21.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.803 0.441 . . . . 0.0 109.945 -176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.66 4.67 48.76 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.524 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 59.0 mt-10 -135.68 138.67 28.8 Favored Pre-proline 0 CA--C 1.529 0.153 0 O-C-N 121.899 -0.5 . . . . 0.0 109.984 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.75 -22.0 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.341 2.694 . . . . 0.0 112.525 -174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -79.42 -36.47 38.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.239 0.472 . . . . 0.0 110.236 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.47 -27.75 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.49 -35.05 78.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.2 ttp -73.63 -30.17 62.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.4 ttp -74.82 -31.43 61.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.382 -0.199 . . . . 0.0 110.485 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.07 -29.97 67.1 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.168 -0.333 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.2 -21.79 56.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.55 -43.79 54.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.089 0.404 . . . . 0.0 110.411 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -74.52 -16.93 60.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.065 0.393 . . . . 0.0 111.167 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -69.05 -30.72 69.12 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -83.2 -23.73 32.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.387 0.275 . . . . 0.0 111.112 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.58 -24.61 23.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.2 tp -93.31 -1.64 55.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.919 0.487 . . . . 0.0 110.544 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.28 35.04 15.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.332 0.653 . . . . 0.0 110.716 -175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HZ1' ' HA ' ' A' ' 5' ' ' THR . 32.6 tptt -85.6 155.57 21.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.217 1.007 . . . . 0.0 109.876 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -90.38 121.56 68.35 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.58 155.26 35.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.473 2.782 . . . . 0.0 110.573 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 6' ' ' GLN . 34.5 m -138.16 -18.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.584 0.354 . . . . 0.0 111.813 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.64 167.52 25.33 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -143.61 138.95 29.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.9 161.31 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.928 0.491 . . . . 0.0 110.501 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -113.34 5.25 16.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.196 0.598 . . . . 0.0 112.486 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 39' ' ' ALA . 29.6 m -137.12 143.79 42.7 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.01 -23.34 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.43 ' H ' HG21 ' A' ' 37' ' ' THR . . . -77.15 -25.68 52.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.42 63.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.42 -34.33 54.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.4 0.6 . . . . 0.0 110.135 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.69 -42.36 67.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.53 -24.8 64.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.437 0.295 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -81.53 -26.51 35.03 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 122.299 -0.25 . . . . 0.0 111.336 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.25 -25.38 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 118.272 0.487 . . . . 0.0 110.267 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -75.12 -14.74 60.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.077 -0.389 . . . . 0.0 110.898 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.32 -12.36 59.93 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 110.484 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.4 -176.12 54.81 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.519 0.58 . . . . 0.0 111.863 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.64 12.73 83.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.164 -0.374 . . . . 0.0 112.164 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.36 145.86 35.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.895 0.848 . . . . 0.0 109.696 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.22 -15.4 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.049 0.539 . . . . 0.0 112.007 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 172.39 12.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.751 0.82 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.09 31.59 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.127 -0.358 . . . . 0.0 111.558 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.03 131.27 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.61 133.84 55.64 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.105 0.478 . . . . 0.0 111.781 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -86.5 137.12 32.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.08 -11.88 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.267 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.69 -7.15 20.32 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.652 2.901 . . . . 0.0 111.589 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.57 -22.77 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 O-C-N 122.142 -0.348 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.72 -28.73 69.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.26 -0.275 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.57 -20.93 61.23 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.338 -0.227 . . . . 0.0 110.614 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -29.82 41.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.24 -32.9 61.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.55 61.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.21 -12.13 55.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 110.395 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -94.31 17.61 12.52 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.871 0.868 . . . . 0.0 110.972 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t0 59.74 31.26 20.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.661 1.184 . . . . 0.0 114.024 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 pt -128.28 143.79 49.39 Favored Pre-proline 0 CA--C 1.532 0.251 0 O-C-N 122.094 -0.379 . . . . 0.0 110.228 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.77 161.61 24.38 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.785 2.99 . . . . 0.0 111.793 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -145.63 165.4 28.8 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.227 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.7 t -137.62 146.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 124.339 1.056 . . . . 0.0 108.542 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.65 155.58 18.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.935 0.397 . . . . 0.0 111.226 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 119.22 11.37 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -174.02 161.09 3.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 109.859 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.02 145.69 25.98 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.48 -159.33 30.78 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 117.455 0.628 . . . . 0.0 112.03 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.9 t -141.05 159.79 41.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.779 0.831 . . . . 0.0 109.972 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -71.8 -5.96 38.08 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.42 4.39 50.62 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.8 m -129.56 22.2 5.52 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.328 0.651 . . . . 0.0 111.696 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.502 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 15.3 m -131.25 154.66 40.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 122.973 0.509 . . . . 0.0 112.072 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.2 168.0 20.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.312 1.045 . . . . 0.0 111.307 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.8 p -62.23 -17.45 58.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -73.61 -25.88 60.52 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.218 0.463 . . . . 0.0 110.167 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.502 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 15.7 m-85 -80.38 -24.39 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.45 -9.33 52.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.997 0.519 . . . . 0.0 111.63 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.02 -18.01 12.72 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -135.16 157.84 75.99 Favored Pre-proline 0 C--O 1.232 0.166 0 C-N-CA 122.847 0.459 . . . . 0.0 110.055 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.33 154.08 25.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.384 3.39 . . . . 0.0 114.082 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.22 154.23 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.381 1.072 . . . . 0.0 109.293 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.7 mt -143.4 156.95 44.8 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.203 0.601 . . . . 0.0 110.754 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -87.05 170.5 11.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.05 -38.84 52.52 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.59 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.78 125.23 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.076 1.85 . . . . 0.0 110.738 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -111.1 152.11 27.32 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.219 0.608 . . . . 0.0 110.187 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.2 p -141.3 159.41 42.27 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.737 0.815 . . . . 0.0 109.147 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -67.55 -26.91 66.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.17 -0.331 . . . . 0.0 111.077 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.66 -35.77 22.38 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.019 0.372 . . . . 0.0 111.676 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.18 -31.21 43.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.66 -28.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.648 0.724 . . . . 0.0 110.578 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.61 66.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.059 -0.401 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.55 -27.94 26.98 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 117.647 0.203 . . . . 0.0 110.966 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.03 -36.5 48.54 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.202 -0.311 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.42 -23.46 40.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.27 -0.269 . . . . 0.0 110.481 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.2 -24.17 60.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.15 -13.86 42.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.089 0.556 . . . . 0.0 111.327 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.33 -33.79 42.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.04 7.3 11.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.37 -179.534 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.269 0.557 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -77.29 -5.68 50.36 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.642 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 67.3 mt-30 -122.39 118.06 27.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -123.42 134.15 67.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.851 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -88.84 138.07 31.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.453 ' H ' HD23 ' A' ' 8' ' ' LEU . 77.2 mt -111.65 126.09 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.806 0.842 . . . . 0.0 109.558 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.8 t -132.18 122.33 48.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 122.775 0.43 . . . . 0.0 110.23 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -141.65 155.32 45.71 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.919 0.488 . . . . 0.0 110.733 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.83 -6.97 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.663 0.385 . . . . 0.0 110.926 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.17 125.93 17.24 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.987 0.515 . . . . 0.0 109.676 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.17 -25.01 76.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.966 2.444 . . . . 0.0 112.804 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.97 -33.14 74.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.099 -0.376 . . . . 0.0 110.525 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.85 -26.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.98 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.807 0.276 . . . . 0.0 110.827 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.64 -31.74 62.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.3 tpt -75.01 -23.73 58.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -39.63 81.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.64 -22.39 60.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.68 -40.14 66.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.904 0.32 . . . . 0.0 111.052 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -74.69 -27.55 60.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.776 -0.577 . . . . 0.0 110.595 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.07 -17.66 58.58 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.917 -0.489 . . . . 0.0 110.606 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -78.58 -28.29 45.85 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.33 -20.74 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.374 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.27 12.22 36.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.296 0.638 . . . . 0.0 111.995 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.89 33.91 15.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.556 0.742 . . . . 0.0 112.291 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.85 163.68 17.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.877 0.871 . . . . 0.0 110.09 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -117.8 74.75 9.7 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 122.698 0.399 . . . . 0.0 110.46 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.94 154.57 65.88 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.941 2.427 . . . . 0.0 109.682 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 33.8 m -115.87 -12.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.337 0.055 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 175.34 35.11 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.248 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -132.49 143.49 49.79 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.737 0.815 . . . . 0.0 108.941 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -146.07 163.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.008 0.523 . . . . 0.0 110.206 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.65 6.92 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.001 0.521 . . . . 0.0 112.065 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -146.12 156.55 43.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.056 0.542 . . . . 0.0 110.183 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.97 -28.31 40.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.98 62.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 -30.77 56.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.36 -38.34 87.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.809 0.805 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.73 -19.32 57.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 -24.97 49.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.088 0.404 . . . . 0.0 111.013 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -77.75 -32.87 52.94 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.05 -26.09 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.464 0.306 . . . . 0.0 110.247 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.39 -15.11 53.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 111.043 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.98 -12.88 20.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.661 0.384 . . . . 0.0 111.582 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.97 172.31 38.47 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.15 154.61 48.14 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.0 mt -141.93 146.04 23.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -103.28 -24.34 13.53 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 174.31 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.695 0.398 . . . . 0.0 110.396 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.11 162.34 40.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.077 -0.39 . . . . 0.0 111.754 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.02 127.97 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.035 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.23 124.63 50.72 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.745 0.418 . . . . 0.0 111.192 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -85.97 124.47 32.46 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.43 -5.31 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.708 0.803 . . . . 0.0 111.95 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 0.0 112.636 -174.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.6 m . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 71.6 Cg_exo -55.41 -19.65 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.685 2.257 . . . . 0.0 114.578 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.95 -26.24 9.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-N 118.858 0.754 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.9 60.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.41 -17.68 53.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.264 0.225 . . . . 0.0 110.533 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.53 -32.66 58.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.8 -26.32 60.56 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.45 61.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.919 0.327 . . . . 0.0 110.357 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.8 -18.83 53.47 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.09 7.7 44.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.554 0.742 . . . . 0.0 111.025 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 58.66 29.53 18.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.408 1.083 . . . . 0.0 113.106 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.8 127.81 29.28 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.5 158.52 44.01 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.759 2.973 . . . . 0.0 111.588 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -150.73 168.29 24.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.873 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.18 146.78 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.113 0.965 . . . . 0.0 108.891 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 21.2 m-85 -89.62 157.79 17.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.101 0.477 . . . . 0.0 111.266 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 144.62 37.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -161.95 174.16 13.46 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.29 117.34 0.76 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.82 -159.27 28.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m -71.09 160.0 33.69 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.887 0.475 . . . . 0.0 110.29 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.82 -11.44 60.38 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.79 -1.82 44.56 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.133 0.424 . . . . 0.0 111.469 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.4 t -78.92 -7.18 57.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.723 0.409 . . . . 0.0 110.92 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 m -135.59 154.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.393 0.677 . . . . 0.0 110.506 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.27 -178.64 3.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.802 0.841 . . . . 0.0 111.351 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.3 p -60.36 -19.68 56.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -70.05 -27.01 64.29 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.194 0.452 . . . . 0.0 110.157 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.405 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 16.0 m-85 -89.17 -18.16 27.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.761 0.824 . . . . 0.0 109.903 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -88.06 -8.81 54.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.511 0.324 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.63 -19.64 13.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.57 0.748 . . . . 0.0 110.842 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -103.61 160.99 24.37 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.997 0.919 . . . . 0.0 110.034 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.02 150.74 82.69 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.859 2.373 . . . . 0.0 110.829 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.48 154.23 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.903 0.881 . . . . 0.0 110.557 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.1 mt -134.56 153.86 51.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.726 0.81 . . . . 0.0 109.886 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -85.37 163.08 18.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.32 -48.04 13.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.348 -0.834 . . . . 0.0 113.221 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.16 138.95 18.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.874 1.716 . . . . 0.0 111.152 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -111.52 157.64 20.1 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.967 0.507 . . . . 0.0 110.506 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.3 p -140.92 165.6 27.07 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.711 1.204 . . . . 0.0 108.039 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.93 -36.68 79.97 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.871 -0.518 . . . . 0.0 111.192 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -84.59 -29.0 26.17 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.281 -0.262 . . . . 0.0 111.306 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.92 -28.16 51.16 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.334 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.01 -25.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 117.898 0.849 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.33 70.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.62 -20.86 30.7 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.478 0.311 . . . . 0.0 110.972 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.9 -40.08 55.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.844 0.293 . . . . 0.0 110.598 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.21 -25.66 42.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.69 62.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.218 0.463 . . . . 0.0 110.378 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.57 -16.58 34.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.044 0.537 . . . . 0.0 111.894 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.27 -33.72 15.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.516 0.326 . . . . 0.0 110.906 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.01 -3.04 58.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.762 0.425 . . . . 0.0 111.987 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.743 -1.122 . . . . 0.0 110.117 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.955 0.407 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.21 -8.7 57.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.534 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -112.22 110.11 20.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.149 0.579 . . . . 0.0 111.905 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.88 139.47 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.401 0.68 . . . . 0.0 110.315 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.85 133.43 47.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.9 mt -98.69 126.47 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.34 109.21 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -143.03 160.18 40.86 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -89.44 -4.54 57.94 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.966 0.506 . . . . 0.0 111.538 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -140.31 140.07 22.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 O-C-N 122.039 -0.413 . . . . 0.0 110.976 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.07 -14.45 10.89 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.767 2.978 . . . . 0.0 112.799 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.33 -45.11 66.85 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.517 0.599 . . . . 0.0 110.703 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.06 -25.4 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.3 66.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.283 -0.261 . . . . 0.0 110.581 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mmt -82.33 -26.25 33.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.5 mmm -75.23 -29.22 60.18 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 122.137 -0.352 . . . . 0.0 110.625 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.47 -30.05 57.15 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.69 -22.21 56.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.882 0.31 . . . . 0.0 110.224 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.39 -45.13 20.1 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.22 -0.3 . . . . 0.0 111.29 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -78.88 -24.04 44.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.558 0.617 . . . . 0.0 112.435 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.34 -22.19 48.42 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.376 0.989 . . . . 0.0 111.066 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -85.23 -23.43 28.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.438 0.563 . . . . 0.0 111.167 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.07 -18.53 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.616 0.366 . . . . 0.0 110.884 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.07 20.22 19.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.867 0.467 . . . . 0.0 111.753 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 53.94 30.29 11.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.931 0.892 . . . . 0.0 113.114 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.5 tmtm? -85.76 164.29 17.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.479 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 23.8 m -123.18 71.8 45.32 Favored Pre-proline 0 CA--C 1.53 0.199 0 O-C-N 122.239 -0.288 . . . . 0.0 111.0 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.19 151.61 81.06 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.725 2.284 . . . . 0.0 109.408 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -112.57 -6.8 11.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.48 174.98 34.84 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -140.75 139.4 34.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.077 0.951 . . . . 0.0 108.684 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 156.02 29.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 122.877 0.471 . . . . 0.0 110.214 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -108.53 2.23 22.04 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 112.048 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.5 p -139.11 158.46 44.14 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 110.311 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.26 -22.93 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.654 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.32 -25.97 58.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.14 71.05 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.31 -30.89 48.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.39 0.595 . . . . 0.0 110.261 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.68 -32.46 53.09 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.51 56.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.172 -0.33 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -87.73 -25.91 23.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.1 -22.01 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.219 0.463 . . . . 0.0 111.293 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.99 -14.74 63.21 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.897 0.317 . . . . 0.0 110.802 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.28 -12.42 37.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.275 0.63 . . . . 0.0 110.81 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 -169.31 53.51 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 12.03 82.06 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.832 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.62 145.88 22.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.76 0.78 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.98 -22.24 5.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.625 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.3 171.07 15.34 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.571 0.748 . . . . 0.0 109.731 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.4 164.87 35.76 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.083 -0.386 . . . . 0.0 110.967 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.9 mt -122.64 133.16 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.25 142.71 45.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.296 0.638 . . . . 0.0 110.691 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -97.51 135.17 39.74 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.566 0.746 . . . . 0.0 109.169 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.35 -16.08 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 122.541 0.336 . . . . 0.0 110.718 177.16 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.1 p . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.8 -13.19 29.35 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.999 2.466 . . . . 0.0 112.245 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.06 -24.04 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.113 0.415 . . . . 0.0 110.326 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.07 65.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.08 -17.62 45.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.452 0.301 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.58 62.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.35 -28.97 64.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.99 -22.83 60.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.57 -19.58 55.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -92.33 10.6 29.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.347 0.659 . . . . 0.0 110.858 172.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t70 59.42 25.18 13.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 113.006 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.48 125.06 46.51 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 157.58 34.42 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.605 2.87 . . . . 0.0 111.113 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -149.39 167.52 25.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.214 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -138.45 141.94 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -82.93 148.46 27.64 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.53 129.68 33.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 169.73 22.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.601 0.36 . . . . 0.0 110.665 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.99 175.87 54.84 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.43 102.37 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -150.39 147.25 27.34 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.701 0.8 . . . . 0.0 109.929 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -105.63 -2.83 22.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 112.29 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.68 0.28 4.38 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.1 m -89.86 5.83 44.5 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.927 -0.483 . . . . 0.0 111.421 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.15 154.46 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.748 0.819 . . . . 0.0 111.118 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -102.86 175.54 5.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.709 0.804 . . . . 0.0 110.563 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -64.98 -11.35 37.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -75.77 -24.21 56.02 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.31 0.505 . . . . 0.0 109.938 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -86.8 -20.12 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -84.02 -12.93 54.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.74 0.416 . . . . 0.0 110.767 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -104.5 -16.69 14.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.355 0.662 . . . . 0.0 111.601 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -109.29 163.14 17.71 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.405 0.682 . . . . 0.0 110.402 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.87 148.2 68.57 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.572 2.848 . . . . 0.0 112.58 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.26 154.75 23.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.762 0.825 . . . . 0.0 110.328 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -145.89 154.26 41.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.744 0.818 . . . . 0.0 109.54 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -80.22 146.29 31.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 34.5 ttmt -72.33 -43.34 9.62 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.019 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 74.3 Cg_endo -69.59 142.26 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.197 1.463 . . . . 0.0 109.74 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.3 150.01 39.52 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 121.376 0.607 . . . . 0.0 111.971 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.6 p -143.7 166.47 24.77 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.028 1.331 . . . . 0.0 107.519 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 55.2 ttm -65.76 -28.19 68.84 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.737 -0.602 . . . . 0.0 110.977 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.32 -31.28 24.93 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.263 -0.273 . . . . 0.0 110.637 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.37 -24.67 67.63 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.648 -0.529 . . . . 0.0 112.129 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.3 p -86.23 -27.51 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 118.155 0.978 . . . . 0.0 110.969 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.09 69.86 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.08 -20.94 29.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.355 0.662 . . . . 0.0 110.584 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.25 61.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.59 -26.41 45.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.02 63.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.923 0.329 . . . . 0.0 110.127 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.82 -17.47 31.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.764 0.425 . . . . 0.0 111.743 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.4 -36.16 13.96 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.599 0.36 . . . . 0.0 111.66 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.72 3.99 54.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.728 0.411 . . . . 0.0 112.055 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.377 -1.297 . . . . 0.0 110.244 179.29 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.654 0.74 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -4.15 42.61 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.075 0.55 . . . . 0.0 110.971 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.414 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 82.5 mt-30 -124.03 115.89 21.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mm -122.26 132.64 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.394 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.458 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 141.3 28.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.458 ' H ' HD21 ' A' ' 8' ' ' LEU . 69.5 mt -105.53 122.45 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.874 0.87 . . . . 0.0 109.251 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.25 113.25 21.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -145.39 163.26 35.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.252 0.548 . . . . 0.0 112.424 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.46 2.45 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.921 1.288 . . . . 0.0 112.153 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -137.8 134.19 18.08 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 123.021 0.528 . . . . 0.0 110.206 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.48 -16.92 14.85 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.344 2.696 . . . . 0.0 111.893 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.88 -41.74 29.02 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.235 -0.29 . . . . 0.0 110.404 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.9 mm -78.25 -30.0 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.46 -29.02 68.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.9 ttt -75.11 -33.86 61.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mtp -73.34 -24.28 60.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.406 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -70.17 -39.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.27 -29.38 66.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.113 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.43 -38.4 65.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -72.77 -23.43 60.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.318 0.508 . . . . 0.0 111.615 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.82 -21.74 54.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.696 0.68 . . . . 0.0 110.872 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.02 -21.47 29.42 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.452 0.569 . . . . 0.0 111.444 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.8 t -85.2 -23.09 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 117.99 0.359 . . . . 0.0 110.42 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.17 13.76 33.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.188 0.595 . . . . 0.0 111.218 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.14 35.44 19.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.75 0.82 . . . . 0.0 112.486 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.79 163.94 17.86 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.81 0.844 . . . . 0.0 109.817 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.4 m -110.4 89.34 8.57 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.293 -0.254 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.15 158.82 55.04 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.84 2.36 . . . . 0.0 110.466 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 30.6 m -130.17 -10.67 2.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.6 169.61 28.43 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 118.198 0.454 . . . . 0.0 112.093 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.9 m -142.12 136.63 30.27 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.27 150.59 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.181 0.515 . . . . 0.0 111.098 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -92.72 -3.73 54.33 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.96 0.904 . . . . 0.0 111.607 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -151.97 158.32 42.95 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.363 0.665 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.1 -23.09 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 121.936 0.094 . . . . 0.0 110.995 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.22 68.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.854 -0.529 . . . . 0.0 109.876 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.53 -22.39 72.86 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.4 -34.48 65.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.967 0.883 . . . . 0.0 109.932 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.49 -27.54 61.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.13 -24.67 59.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -87.16 -26.1 23.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.129 0.422 . . . . 0.0 111.309 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -77.51 -26.49 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.134 0.425 . . . . 0.0 110.12 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -82.45 -14.37 55.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.689 0.396 . . . . 0.0 111.561 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.79 -13.54 16.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.41 41.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.52 145.61 30.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.2 mt -142.85 145.46 23.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -101.17 -25.06 14.15 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 118.093 0.406 . . . . 0.0 111.913 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.21 173.06 10.53 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.946 0.498 . . . . 0.0 110.05 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.48 159.29 44.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.483 0.182 . . . . 0.0 111.161 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.0 123.8 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.28 130.63 56.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.042 0.537 . . . . 0.0 110.019 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.89 152.43 24.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.42 -11.52 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 123.027 0.531 . . . . 0.0 111.4 -177.851 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 24.9 m . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 52.0 Cg_exo -57.63 -5.43 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.652 2.901 . . . . 0.0 114.372 177.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.04 -22.96 32.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.862 0.755 . . . . 0.0 110.845 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.43 -26.64 67.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.189 -0.319 . . . . 0.0 110.154 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' CD ' HH12 ' A' ' 93' ' ' ARG . 50.7 mt-10 -79.03 -17.39 55.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.974 -0.454 . . . . 0.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.3 59.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.13 -34.64 75.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.01 62.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.276 -0.265 . . . . 0.0 110.724 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.34 53.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.54 0.336 . . . . 0.0 110.518 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -99.64 18.49 17.91 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.78 0.832 . . . . 0.0 110.691 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.43 32.22 18.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.367 1.067 . . . . 0.0 113.619 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.47 118.66 24.75 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 160.42 37.24 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.293 3.329 . . . . 0.0 112.615 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.54 166.86 24.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.457 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -141.08 155.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 109.042 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 23.9 m-85 -88.21 159.19 18.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.11 122.22 19.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.1 t -163.78 179.14 7.31 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.886 0.474 . . . . 0.0 110.511 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.19 137.4 5.25 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.15 29.5 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.1 t -76.84 162.41 27.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.004 0.522 . . . . 0.0 110.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.74 -9.65 58.88 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.663 0.385 . . . . 0.0 110.728 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.98 -4.76 59.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.001 0.52 . . . . 0.0 110.612 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -95.37 9.48 39.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.079 0.552 . . . . 0.0 111.938 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.76 154.48 36.86 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.23 0.612 . . . . 0.0 111.131 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -107.47 -176.15 2.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.103 0.961 . . . . 0.0 111.024 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -62.73 -14.46 44.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.524 HH12 ' CD ' ' A' ' 70' ' ' GLU . 85.9 mtt-85 -65.76 -31.87 73.1 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.558 0.343 . . . . 0.0 110.238 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 29.1 m-85 -89.54 -19.47 24.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.605 0.762 . . . . 0.0 109.948 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -88.52 -3.75 58.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.81 0.444 . . . . 0.0 111.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.82 -13.44 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.33 0.652 . . . . 0.0 111.951 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.52 153.45 81.42 Favored Pre-proline 0 C--N 1.34 0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.985 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.74 154.98 51.44 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.36 2.707 . . . . 0.0 113.119 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.28 153.5 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.983 0.913 . . . . 0.0 109.068 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.0 tp -138.09 153.7 49.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.603 0.761 . . . . 0.0 109.755 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -73.68 157.48 36.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.534 0.334 . . . . 0.0 110.512 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -74.56 -50.46 4.54 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.628 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.13 147.55 29.98 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.254 1.969 . . . . 0.0 110.197 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.406 ' CZ ' HD22 ' A' ' 20' ' ' LEU . 4.0 m-30 -111.4 150.82 29.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.106 0.562 . . . . 0.0 110.545 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.7 p -143.26 167.19 22.72 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.093 0.957 . . . . 0.0 108.848 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 83.6 mmm -61.04 -39.48 89.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.036 -0.415 . . . . 0.0 110.791 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.37 -25.46 29.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.297 0.239 . . . . 0.0 111.301 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.71 -25.24 70.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.6 t -85.54 -28.1 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.37 0.585 . . . . 0.0 110.356 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.79 70.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -85.05 -20.69 30.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.797 0.439 . . . . 0.0 110.958 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.48 63.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.152 0.433 . . . . 0.0 110.379 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.12 -26.92 53.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.765 0.257 . . . . 0.0 110.708 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.58 -20.58 26.21 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.509 0.324 . . . . 0.0 111.604 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.25 -36.25 14.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.05 9.17 42.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -173.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.037 -1.458 . . . . 0.0 109.831 178.071 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.489 0.661 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -8.45 57.57 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.244 0.618 . . . . 0.0 111.984 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 66.0 mt-30 -119.37 114.65 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.698 0.681 . . . . 0.0 112.224 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.1 mm -120.24 130.25 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.499 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -87.91 142.86 27.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.499 ' H ' HD21 ' A' ' 8' ' ' LEU . 87.0 mt -110.52 120.89 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.908 0.883 . . . . 0.0 109.05 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.27 120.68 43.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.741 0.417 . . . . 0.0 110.875 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -156.91 158.3 36.42 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -73.84 -7.91 54.01 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.75 0.82 . . . . 0.0 112.132 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.93 132.0 24.09 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.049 0.54 . . . . 0.0 109.901 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.47 -18.79 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.35 2.7 . . . . 0.0 111.405 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.96 -34.73 71.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.082 0.401 . . . . 0.0 110.735 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.1 mm -86.3 -23.74 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.11 78.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.037 -0.414 . . . . 0.0 109.896 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.4 mtt -77.71 -27.29 50.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.0 ttt -69.07 -29.4 67.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.46 -33.02 66.72 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.14 -24.81 64.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.081 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.31 -43.45 60.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.9 0.318 . . . . 0.0 111.338 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -73.54 -22.29 60.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.845 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.18 -18.04 53.78 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.559 0.618 . . . . 0.0 110.838 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -85.31 -22.1 28.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.319 0.509 . . . . 0.0 110.449 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.45 -19.65 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.891 0.476 . . . . 0.0 110.317 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -105.37 16.28 25.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.338 0.655 . . . . 0.0 111.838 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.0 35.0 14.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.734 0.813 . . . . 0.0 112.499 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HZ3' HD12 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -86.07 165.73 16.4 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -115.19 77.83 5.53 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 122.75 0.42 . . . . 0.0 110.284 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.95 157.18 54.16 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.047 2.498 . . . . 0.0 110.203 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 32.8 m -121.59 -14.6 7.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.46 176.47 36.26 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.666 0.666 . . . . 0.0 112.728 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 140.26 46.32 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.34 1.056 . . . . 0.0 108.885 175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.51 154.67 20.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.008 0.432 . . . . 0.0 110.128 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -102.89 -1.49 29.46 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.03 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.9 p -141.42 159.71 41.65 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.794 0.438 . . . . 0.0 110.49 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.82 -22.81 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.682 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.16 54.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.22 -27.63 61.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.18 78.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.16 -26.71 63.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.52 -24.73 62.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.305 0.242 . . . . 0.0 111.316 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -86.57 -23.85 25.66 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.757 0.253 . . . . 0.0 111.293 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.6 -29.66 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 117.923 0.329 . . . . 0.0 111.064 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.54 -14.36 55.03 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.983 -0.448 . . . . 0.0 112.009 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.03 -12.76 15.35 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.123 0.569 . . . . 0.0 112.286 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.92 164.28 37.71 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.69 140.36 24.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.5 mt -144.75 143.98 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -96.7 -32.31 12.24 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.449 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.55 11.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.578 0.351 . . . . 0.0 110.318 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.0 157.83 43.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.668 0.27 . . . . 0.0 111.256 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.0 mt -113.46 123.56 69.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.9 130.8 56.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.455 0.702 . . . . 0.0 110.226 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 170.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.29 -11.88 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 O-C-N 122.034 -0.416 . . . . 0.0 111.968 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.529 0.171 0 O-C-N 121.952 -0.468 . . . . 0.0 110.159 179.438 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.234 0.238 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.82 -11.96 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.561 2.841 . . . . 0.0 111.741 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.38 -17.64 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 122.158 -0.339 . . . . 0.0 111.036 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.92 74.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.847 -0.533 . . . . 0.0 110.156 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.28 -18.26 60.74 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.176 -0.327 . . . . 0.0 111.082 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.46 -29.29 37.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 99.2 mt -72.85 -37.46 67.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.16 -22.37 62.06 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.05 -12.61 54.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.414 0.286 . . . . 0.0 110.721 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -103.91 17.88 23.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.984 0.914 . . . . 0.0 110.779 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 59.06 34.13 23.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.125 0.97 . . . . 0.0 113.264 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.4 mt -120.77 102.2 44.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.849 0.86 . . . . 0.0 108.689 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.57 158.9 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.919 3.079 . . . . 0.0 112.745 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.21 167.13 23.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 111.409 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.4 t -134.74 144.19 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.838 0.855 . . . . 0.0 109.399 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -90.81 151.49 21.15 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 111.124 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.43 143.13 33.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.599 0.76 . . . . 0.0 109.234 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -159.77 158.39 31.09 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 111.007 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.67 95.93 0.96 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 172.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.51 -162.15 33.67 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.3 p -81.48 164.52 21.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.407 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -4.17 49.23 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.585 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.83 -1.3 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.295 0.638 . . . . 0.0 111.05 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.7 m -85.12 7.88 20.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.114 0.566 . . . . 0.0 111.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.439 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.0 m -137.83 154.7 29.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.786 0.834 . . . . 0.0 110.981 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 169.15 17.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.791 0.836 . . . . 0.0 111.917 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 m -61.53 -16.73 50.3 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -75.91 -24.27 55.58 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.7 0.682 . . . . 0.0 110.373 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.439 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 11.8 m-85 -84.24 -20.57 32.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -86.89 -13.01 46.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.086 0.554 . . . . 0.0 110.818 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.73 -27.3 18.14 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.743 0.417 . . . . 0.0 110.354 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -91.46 160.98 35.69 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.96 154.44 61.74 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.873 2.382 . . . . 0.0 111.355 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.9 m -138.9 154.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.152 0.581 . . . . 0.0 110.594 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.9 tp -147.28 146.71 29.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.876 0.471 . . . . 0.0 110.038 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -79.86 163.74 24.13 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.277 0.231 . . . . 0.0 110.585 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.7 -39.12 2.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.11 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.94 133.58 48.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.84 146.13 46.01 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.107 0.563 . . . . 0.0 110.477 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 108' ' ' GLY . 9.8 t -153.34 159.04 42.39 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.787 0.835 . . . . 0.0 109.189 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -63.46 -28.9 70.28 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.62 -39.94 18.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.574 0.625 . . . . 0.0 111.905 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.521 ' H ' HG21 ' A' ' 105' ' ' THR . . . -80.19 -25.7 56.82 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 122.121 -0.362 . . . . 0.0 112.375 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.53 -28.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.685 0.743 . . . . 0.0 110.338 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -29.05 64.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.976 -0.452 . . . . 0.0 110.155 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -83.95 -25.33 30.16 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 110.668 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.32 -32.45 37.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.65 0.204 . . . . 0.0 110.724 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -34.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.44 63.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.059 -0.4 . . . . 0.0 110.567 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 -14.92 39.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.437 0.295 . . . . 0.0 111.345 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.99 -29.52 17.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.271 0.628 . . . . 0.0 110.865 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.465 HD12 ' HZ3' ' A' ' 29' ' ' LYS . 16.3 tp -85.97 10.55 13.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 112.035 -175.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.154 -1.403 . . . . 0.0 110.585 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -8.76 52.13 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 118.392 0.542 . . . . 0.0 111.191 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -118.99 118.88 32.69 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.14 0.427 . . . . 0.0 111.642 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -119.04 131.22 72.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 O-C-N 123.737 0.648 . . . . 0.0 109.881 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.69 130.19 44.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.3 mt -98.67 135.23 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -132.12 125.6 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -149.39 162.85 39.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.231 0.539 . . . . 0.0 112.423 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -123.46 11.86 9.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 109.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -145.03 113.78 4.92 Favored Pre-proline 0 N--CA 1.453 -0.311 0 C-N-CA 124.82 1.248 . . . . 0.0 107.944 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.86 -16.33 11.45 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.06 3.173 . . . . 0.0 114.655 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.47 -23.06 60.03 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.4 -27.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.61 -25.48 61.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.276 -0.265 . . . . 0.0 110.449 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.11 -35.17 28.82 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.448 -0.157 . . . . 0.0 110.779 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 98.1 mmm -75.43 -34.39 60.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.99 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.35 -28.18 42.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.131 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.52 -21.63 55.49 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.798 -0.564 . . . . 0.0 110.088 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.64 -41.32 46.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.194 -0.316 . . . . 0.0 111.447 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -82.08 -21.43 36.81 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.361 0.528 . . . . 0.0 112.368 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.21 -18.09 55.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.075 0.852 . . . . 0.0 110.137 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -85.28 -29.38 24.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.811 0.278 . . . . 0.0 110.774 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -83.28 -19.76 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 122.715 0.406 . . . . 0.0 110.774 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.09 14.53 28.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.793 0.437 . . . . 0.0 111.54 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 51.05 34.72 11.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.652 0.781 . . . . 0.0 111.461 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -85.55 162.7 18.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.849 0.86 . . . . 0.0 110.374 -176.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.415 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 56.8 m -114.42 88.02 14.91 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.951 0.5 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.76 157.94 58.68 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.83 2.354 . . . . 0.0 109.55 176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.46 -16.9 4.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 174.21 33.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 118.329 0.513 . . . . 0.0 112.588 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -137.2 139.65 41.22 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.45 161.04 31.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 110.618 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -131.67 7.43 4.45 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.976 0.51 . . . . 0.0 112.188 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.9 p -136.39 156.69 48.27 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.968 0.507 . . . . 0.0 109.89 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.07 -29.9 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.8 65.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.157 -0.34 . . . . 0.0 110.363 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.33 -24.85 56.14 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.83 -34.99 60.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.614 0.707 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.37 -24.24 32.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.929 0.331 . . . . 0.0 110.393 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.75 57.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.207 0.458 . . . . 0.0 110.728 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -84.37 -31.11 24.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.463 0.705 . . . . 0.0 110.136 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.64 -25.27 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.66 0.384 . . . . 0.0 111.686 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -71.27 -19.08 62.39 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.651 -0.655 . . . . 0.0 111.153 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.91 -12.59 58.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.726 0.298 . . . . 0.0 110.999 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.99 -169.07 53.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.92 81.83 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.634 -0.536 . . . . 0.0 112.577 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.85 147.04 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 117.785 0.793 . . . . 0.0 109.536 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.6 -17.0 5.63 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.38 166.64 28.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.232 0.469 . . . . 0.0 110.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.04 165.53 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.28 -0.263 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.24 133.25 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.36 130.61 56.69 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.086 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -84.39 138.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.93 -12.24 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.443 0.297 . . . . 0.0 110.485 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.551 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.54 -11.83 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.741 2.961 . . . . 0.0 111.812 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -72.44 -13.65 16.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.344 0.258 . . . . 0.0 110.906 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.23 -24.47 63.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 122.221 -0.299 . . . . 0.0 110.388 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.55 -17.39 45.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.342 -0.224 . . . . 0.0 110.466 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.92 61.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.16 -27.02 60.64 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.76 57.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.15 -16.39 56.72 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -91.7 13.67 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.839 0.856 . . . . 0.0 110.026 172.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 60.71 30.5 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.551 1.141 . . . . 0.0 113.646 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.21 124.96 29.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.39 161.04 38.23 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.09 3.193 . . . . 0.0 111.062 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -152.12 171.25 18.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.218 0.533 . . . . 0.0 111.752 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.66 144.7 20.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 124.058 0.943 . . . . 0.0 109.017 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.03 154.46 22.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.408 0.283 . . . . 0.0 110.824 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.52 119.81 22.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -153.41 173.11 16.08 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 111.421 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 135.33 3.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.8 -156.12 26.52 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.1 p -79.26 175.37 10.66 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.954 0.502 . . . . 0.0 110.621 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.02 -6.6 34.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.73 0.412 . . . . 0.0 112.02 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -92.59 -7.64 46.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.021 0.528 . . . . 0.0 111.173 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.4 m -78.92 0.75 26.15 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.008 -0.432 . . . . 0.0 111.547 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 m -140.06 153.16 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.252 0.621 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.9 177.76 4.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.179 0.992 . . . . 0.0 110.485 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -61.63 -18.46 59.54 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.781 -0.575 . . . . 0.0 111.965 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -76.48 -20.74 56.66 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.862 0.755 . . . . 0.0 111.2 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -84.2 -19.29 34.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -88.15 -4.85 58.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.421 0.688 . . . . 0.0 110.264 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.84 -11.19 14.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.695 1.198 . . . . 0.0 111.572 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.75 163.12 41.04 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.92 0.888 . . . . 0.0 110.115 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.61 147.33 92.3 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.625 2.884 . . . . 0.0 112.53 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -140.19 151.36 21.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.603 0.761 . . . . 0.0 110.472 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -146.13 155.2 42.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.012 0.925 . . . . 0.0 108.662 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -85.7 162.03 18.95 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.332 -0.23 . . . . 0.0 110.884 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.68 -41.45 9.55 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.974 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.76 124.52 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.409 2.073 . . . . 0.0 110.875 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -107.33 143.15 36.02 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.3 t -155.7 163.67 39.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.99 -23.64 65.53 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -173.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.44 -38.74 21.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.379 0.536 . . . . 0.0 110.937 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.472 ' H ' HG23 ' A' ' 105' ' ' THR . . . -74.64 -26.75 66.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.6 t -81.44 -21.71 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.734 0.414 . . . . 0.0 109.913 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.18 -30.68 62.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.318 0.508 . . . . 0.0 110.703 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.24 -27.49 38.67 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.52 55.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -72.7 -32.75 66.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.944 0.498 . . . . 0.0 109.812 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.41 -17.97 40.34 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.641 0.376 . . . . 0.0 111.942 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.06 9.88 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -99.11 -58.35 1.96 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.891 0.314 . . . . 0.0 111.791 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.86 -4.21 6.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.972 0.909 . . . . 0.0 112.768 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.244 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.605 0.717 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -2.13 21.11 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.683 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.5 mt-30 -124.03 111.18 15.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.118 0.417 . . . . 0.0 110.786 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.4 mm -119.4 128.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.085 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.99 135.07 33.75 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.5 mt -102.88 134.58 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.02 0.528 . . . . 0.0 109.82 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.07 106.29 10.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -149.85 163.32 38.33 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 123.872 0.869 . . . . 0.0 110.531 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -112.76 -13.73 13.19 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.712 0.405 . . . . 0.0 110.912 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -84.69 127.28 65.98 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.71 -14.01 14.29 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.36 2.706 . . . . 0.0 112.757 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -93.73 -38.47 11.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.602 0.637 . . . . 0.0 111.881 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.25 -28.39 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.82 63.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.852 0.061 . . . . 0.0 110.993 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.4 mtt -84.98 -27.86 26.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.395 -0.191 . . . . 0.0 110.672 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.7 mmm -77.94 -28.42 49.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.728 0.24 . . . . 0.0 110.494 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 21.9 tp -78.95 -30.96 44.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.222 -0.299 . . . . 0.0 110.326 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.65 -26.67 61.73 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.73 -35.19 52.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.361 -0.212 . . . . 0.0 110.485 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -73.35 -27.06 61.29 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.871 -0.518 . . . . 0.0 111.7 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -79.17 -17.8 54.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.613 0.642 . . . . 0.0 110.836 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.14 -29.46 24.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.854 0.297 . . . . 0.0 110.965 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.15 -21.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 122.584 0.353 . . . . 0.0 111.389 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 16.98 17.8 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.882 0.473 . . . . 0.0 111.648 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t0 52.02 34.46 13.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.975 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.79 165.45 16.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.698 0.799 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 77.95 6.52 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.199 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.11 160.55 41.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.54 2.827 . . . . 0.0 110.478 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.7 m -127.37 -25.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.1 176.79 36.29 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 118.527 0.603 . . . . 0.0 112.612 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.8 m -137.61 141.91 41.26 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.96 0.904 . . . . 0.0 108.708 176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.94 159.0 37.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 122.642 0.377 . . . . 0.0 110.152 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.61 -5.98 28.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.853 0.461 . . . . 0.0 111.994 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.7 p -143.06 161.08 39.11 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.085 0.554 . . . . 0.0 110.475 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.17 -22.72 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.787 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.46 -29.67 66.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.51 -27.56 65.23 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.4 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.323 0.562 . . . . 0.0 110.059 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.44 -23.25 50.55 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 177.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.37 45.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.728 0.24 . . . . 0.0 111.386 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -87.35 -21.92 25.4 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.131 -0.356 . . . . 0.0 111.696 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.53 -22.0 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.26 -16.19 60.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.08 -12.42 21.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.403 0.681 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 -167.68 54.03 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.17 24.33 61.63 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.631 -0.538 . . . . 0.0 112.609 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mt -137.22 147.66 26.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.386 0.674 . . . . 0.0 109.306 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -116.28 -26.98 6.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.63 12.49 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.045 0.384 . . . . 0.0 110.582 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.93 34.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.719 0.295 . . . . 0.0 111.388 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.1 mt -122.48 130.44 74.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.81 133.6 54.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.08 155.79 19.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.56 -11.87 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.045 0.538 . . . . 0.0 110.656 177.678 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.446 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 7.9 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 66' ' ' THR . 77.7 Cg_exo -56.84 -12.79 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.908 2.406 . . . . 0.0 114.111 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.45 -13.89 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.47 -24.65 67.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.815 -0.553 . . . . 0.0 109.76 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.26 -17.99 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.457 0.303 . . . . 0.0 110.724 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.16 -27.23 39.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.03 -27.7 61.07 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -25.57 58.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.91 -16.46 56.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -92.67 6.6 46.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.754 0.821 . . . . 0.0 110.136 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.31 35.35 20.74 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.262 1.025 . . . . 0.0 113.199 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.79 129.73 25.18 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.64 157.51 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.602 2.868 . . . . 0.0 111.302 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -145.01 164.79 30.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.609 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -136.12 147.56 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 124.604 1.162 . . . . 0.0 108.837 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 28.9 m-85 -91.98 155.35 18.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.895 0.378 . . . . 0.0 111.682 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.87 128.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -165.28 158.85 16.73 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.657 0.265 . . . . 0.0 111.009 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.61 136.99 13.16 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.04 -151.91 23.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 82.8 p -119.36 176.05 5.53 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.443 0.697 . . . . 0.0 110.55 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.56 -1.92 12.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.833 0.453 . . . . 0.0 111.739 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.66 1.28 14.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.359 0.663 . . . . 0.0 111.187 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -87.16 7.64 27.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.348 0.659 . . . . 0.0 111.609 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.1 m -139.63 155.86 25.65 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 123.748 0.819 . . . . 0.0 111.628 -175.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.57 162.63 20.49 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.949 0.9 . . . . 0.0 111.36 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.8 m -59.1 -19.56 45.56 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -74.12 -25.43 59.76 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.987 0.812 . . . . 0.0 110.743 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 7.1 m-85 -79.98 -19.31 48.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -88.16 -10.22 50.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.827 0.451 . . . . 0.0 110.669 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.91 -11.58 15.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.647 0.779 . . . . 0.0 111.618 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -121.34 160.92 43.75 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.399 0.679 . . . . 0.0 110.118 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.33 148.89 84.37 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.996 2.464 . . . . 0.0 112.242 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.61 154.86 17.97 Favored 'Isoleucine or valine' 0 C--O 1.23 0.046 0 C-N-CA 124.139 0.976 . . . . 0.0 109.909 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.3 tp -138.55 145.16 40.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.821 0.449 . . . . 0.0 109.832 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -76.68 165.27 24.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.774 0.43 . . . . 0.0 110.38 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -79.19 -39.15 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.763 -177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.96 143.81 95.73 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.589 2.192 . . . . 0.0 110.567 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 1.7 m-85 -118.96 133.39 55.86 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.922 0.392 . . . . 0.0 111.348 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -143.33 155.53 44.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.783 1.233 . . . . 0.0 108.923 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.96 -28.6 66.78 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 122.199 -0.313 . . . . 0.0 111.61 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -84.5 -35.24 23.05 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.051 -0.406 . . . . 0.0 111.634 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.0 -38.93 29.09 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.307 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.89 -22.93 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 117.857 0.829 . . . . 0.0 111.162 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.2 64.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.503 -0.748 . . . . 0.0 110.306 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -78.8 -31.96 46.14 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.34 -26.68 46.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.183 0.193 . . . . 0.0 111.038 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.55 -38.7 65.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.25 -23.47 62.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.416 -0.177 . . . . 0.0 110.678 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.08 -13.84 43.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.84 0.456 . . . . 0.0 111.468 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.7 tt -90.89 -29.27 17.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.145 0.578 . . . . 0.0 110.699 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.4 tp -82.91 6.65 17.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.956 0.503 . . . . 0.0 111.887 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.802 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -11.18 36.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.691 -0.631 . . . . 0.0 110.424 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.401 ' HB3' HG12 ' A' ' 32' ' ' VAL . 24.6 mp0 -111.49 104.6 13.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.779 0.432 . . . . 0.0 110.977 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.03 124.11 72.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.981 0.512 . . . . 0.0 110.434 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -86.79 146.99 26.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.502 ' H ' HD23 ' A' ' 8' ' ' LEU . 95.0 mt -110.53 128.1 67.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.922 0.889 . . . . 0.0 109.675 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.3 122.73 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.071 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.97 163.29 33.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.289 0.235 . . . . 0.0 111.262 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.32 -11.32 32.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.53 135.57 13.14 Favored Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.41 -17.32 44.07 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.089 2.526 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -77.87 -37.42 48.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.456 0.571 . . . . 0.0 110.01 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -77.55 -27.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.54 68.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.198 -0.314 . . . . 0.0 110.281 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -76.73 -27.3 55.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -73.22 -33.4 65.32 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.65 -31.65 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.23 -0.294 . . . . 0.0 110.409 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.93 -21.82 43.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.37 -42.96 42.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.094 -0.378 . . . . 0.0 110.15 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.94 -19.36 60.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.641 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.63 -29.29 66.75 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.164 0.438 . . . . 0.0 110.116 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -84.72 -29.58 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.491 0.316 . . . . 0.0 111.385 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -71.55 -24.24 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 6.57 48.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.173 0.589 . . . . 0.0 111.032 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t0 50.73 37.75 17.55 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.584 0.754 . . . . 0.0 111.49 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.6 tmtm? -85.69 158.84 19.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.855 0.862 . . . . 0.0 110.422 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 88.7 m -92.08 124.39 60.07 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.42 153.86 35.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.63 2.886 . . . . 0.0 110.872 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 6' ' ' GLN . 24.8 m -141.77 -21.86 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.409 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.66 163.05 16.92 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -143.96 134.86 25.3 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.57 161.2 24.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.898 0.38 . . . . 0.0 111.117 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -136.08 3.74 2.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.119 0.568 . . . . 0.0 111.546 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -139.3 161.72 36.75 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.357 0.663 . . . . 0.0 110.78 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.41 -32.99 52.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 122.437 0.295 . . . . 0.0 110.239 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.4 -29.51 53.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.347 -0.22 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.89 -33.0 52.04 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 -33.83 74.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.409 0.604 . . . . 0.0 110.511 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.21 -29.02 60.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.26 60.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.47 -26.96 22.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 118.328 0.513 . . . . 0.0 112.15 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -83.28 -21.69 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 118.04 0.382 . . . . 0.0 111.522 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -81.56 -23.05 37.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.41 -13.63 8.4 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.733 0.697 . . . . 0.0 112.316 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.39 -164.94 40.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.51 137.18 5.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.49 164.5 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.74 0.816 . . . . 0.0 110.802 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -124.13 -10.72 7.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.014 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.87 165.85 20.1 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.503 0.721 . . . . 0.0 109.056 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.09 158.0 43.48 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.729 -0.607 . . . . 0.0 111.903 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.7 mm -97.46 121.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.07 124.87 49.13 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.97 118.32 11.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 168.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.56 -29.27 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -171.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.2 t30 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-N 118.197 0.453 . . . . 0.0 110.983 -177.418 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -83.23 -10.33 10.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.625 2.884 . . . . 0.0 111.301 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.6 t -74.24 -29.85 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 117.799 0.272 . . . . 0.0 111.343 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.53 78.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.125 0.42 . . . . 0.0 110.45 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.03 -17.59 39.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.266 -0.272 . . . . 0.0 111.088 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.84 65.97 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.56 -26.49 58.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.49 -24.29 61.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.948 0.34 . . . . 0.0 110.113 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.71 44.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.317 0.247 . . . . 0.0 110.471 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -101.58 8.66 41.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.39 0.676 . . . . 0.0 110.962 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.97 37.12 28.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.652 1.181 . . . . 0.0 113.37 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -110.66 120.98 42.39 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 123.022 0.529 . . . . 0.0 109.767 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.95 154.24 39.83 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.227 3.285 . . . . 0.0 113.663 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.54 168.4 23.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -96.95 152.59 18.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.959 0.409 . . . . 0.0 111.927 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.18 119.61 10.3 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.1 t -172.17 164.48 6.01 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.023 0.929 . . . . 0.0 109.447 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.26 142.61 21.4 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.42 -160.46 32.7 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 117.424 0.612 . . . . 0.0 112.057 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.1 t -143.67 167.69 21.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.303 0.641 . . . . 0.0 110.518 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -3.77 17.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 112.602 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -114.37 10.61 17.1 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.281 0.632 . . . . 0.0 111.874 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.1 p -118.76 9.24 12.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 123.039 0.536 . . . . 0.0 112.017 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.14 154.69 25.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.631 0.773 . . . . 0.0 111.621 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.34 163.8 25.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.288 0.635 . . . . 0.0 111.316 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -59.95 -17.35 37.25 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -71.58 -26.68 62.71 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.852 0.751 . . . . 0.0 110.462 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -83.54 -22.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -88.09 -10.75 49.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.817 0.447 . . . . 0.0 111.319 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.96 -32.23 11.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 110.995 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.3 152.64 50.37 Favored Pre-proline 0 C--N 1.338 0.108 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.67 152.43 56.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.226 2.617 . . . . 0.0 111.413 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.58 153.19 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 122.842 0.457 . . . . 0.0 110.892 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.0 tp -149.06 153.73 38.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -84.85 167.07 16.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.656 0.383 . . . . 0.0 110.677 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -63.6 -46.51 83.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.71 137.05 29.24 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.673 1.582 . . . . 0.0 109.777 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -110.44 148.67 31.58 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.949 0.499 . . . . 0.0 110.331 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.8 p -144.01 161.4 38.87 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.125 0.97 . . . . 0.0 109.21 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.66 -27.14 68.72 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.088 -0.383 . . . . 0.0 111.083 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.78 -36.51 21.65 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.64 -30.42 44.35 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.7 t -82.43 -30.56 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.663 0.731 . . . . 0.0 110.335 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 -26.42 62.74 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.502 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -83.39 -33.75 25.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.401 0.28 . . . . 0.0 110.917 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.84 61.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.319 -0.238 . . . . 0.0 110.703 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.18 -20.61 40.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 119.564 -0.255 . . . . 0.0 110.784 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.43 55.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.37 0.532 . . . . 0.0 110.07 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.57 26.72 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.803 0.441 . . . . 0.0 111.513 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 tt -91.2 -51.88 5.09 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.989 0.515 . . . . 0.0 110.305 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.5 mt -79.13 17.37 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.1 . . . . 0.0 112.147 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.311 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.505 0.669 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -78.04 -6.77 55.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.943 0.497 . . . . 0.0 111.506 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.427 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 64.5 mt-30 -118.73 111.09 18.04 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.09 136.05 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.762 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.0 138.29 33.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.8 mt -102.12 126.2 56.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.867 0.867 . . . . 0.0 109.716 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.37 110.04 15.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 162.67 35.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 111.629 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -98.19 -0.16 44.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.912 0.885 . . . . 0.0 111.32 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.61 105.59 15.72 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.89 -22.47 54.35 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.753 2.969 . . . . 0.0 113.592 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.32 -41.2 73.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.457 0.571 . . . . 0.0 110.427 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.419 HG13 ' HE3' ' A' ' 102' ' ' LYS . 43.6 mm -79.03 -25.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.51 66.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 mmt -80.92 -25.54 37.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mtp -73.33 -30.64 63.49 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.96 -32.11 71.46 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.102 -0.374 . . . . 0.0 110.053 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -74.62 -23.14 58.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.204 -0.31 . . . . 0.0 110.208 175.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.66 -43.3 20.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.301 -0.249 . . . . 0.0 111.14 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -74.35 -27.26 60.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.425 0.557 . . . . 0.0 111.754 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.83 -17.87 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.541 0.61 . . . . 0.0 110.894 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.862 0.301 . . . . 0.0 110.769 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.54 -20.1 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 122.766 0.426 . . . . 0.0 110.793 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -103.13 17.02 25.05 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.97 0.508 . . . . 0.0 111.687 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.88 36.13 17.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.061 0.944 . . . . 0.0 112.76 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.87 164.65 17.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.336 0.654 . . . . 0.0 109.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -117.47 72.18 7.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 O-C-N 122.06 -0.4 . . . . 0.0 110.873 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.92 158.28 48.1 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.845 2.364 . . . . 0.0 110.166 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.4 m -121.58 -9.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -173.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.89 174.03 34.16 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 118.422 0.555 . . . . 0.0 112.374 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.1 m -141.17 137.64 32.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.378 1.071 . . . . 0.0 108.383 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.93 156.88 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.024 0.44 . . . . 0.0 111.077 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.74 -4.26 37.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.982 0.913 . . . . 0.0 111.732 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -151.4 157.5 42.5 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.88 0.472 . . . . 0.0 110.439 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.88 -22.92 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 122.792 0.437 . . . . 0.0 110.567 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.96 -26.09 63.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.949 -0.469 . . . . 0.0 110.245 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.57 -21.17 64.71 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.51 63.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.235 0.518 . . . . 0.0 109.924 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.23 -32.2 66.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.85 -24.68 64.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.443 -0.161 . . . . 0.0 110.919 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -82.94 -25.71 32.11 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.743 0.247 . . . . 0.0 110.949 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.5 t -71.94 -26.55 25.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.78 -14.34 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.674 0.39 . . . . 0.0 110.863 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -98.84 -14.61 19.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.435 0.694 . . . . 0.0 111.994 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.22 169.74 38.76 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.62 148.21 36.59 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.37 149.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.18 -30.66 11.42 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.193 0.452 . . . . 0.0 111.35 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 174.95 11.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.749 0.42 . . . . 0.0 110.582 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.58 161.48 41.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.675 0.274 . . . . 0.0 111.0 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.78 130.86 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.02 136.0 53.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.24 0.616 . . . . 0.0 110.203 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.56 144.99 29.98 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.78 -12.0 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 122.281 -0.262 . . . . 0.0 111.307 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 -179.367 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 28.2 p . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.4 Cg_exo -57.8 -18.72 35.47 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 113.972 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.3 m -82.45 -9.77 11.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 118.061 0.392 . . . . 0.0 111.892 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.61 68.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.983 -0.448 . . . . 0.0 110.458 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -75.18 -17.77 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.291 -0.256 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.81 -25.62 37.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.5 -29.93 61.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 173.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.29 60.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.16 -13.51 57.06 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -95.52 14.76 21.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 110.14 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.17 31.41 19.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.421 1.089 . . . . 0.0 113.489 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.6 mt -122.23 108.69 33.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.9 162.71 38.66 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.628 2.885 . . . . 0.0 111.195 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -150.07 167.54 26.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.248 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.87 144.93 27.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 22.9 m-85 -87.05 153.13 21.78 Favored 'General case' 0 C--N 1.337 0.031 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.83 122.47 13.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -166.99 161.15 14.77 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.732 0.413 . . . . 0.0 110.425 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 134.06 12.13 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.93 -155.61 26.24 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 m -132.52 171.18 14.12 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.923 0.889 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.45 -10.27 54.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.89 2.58 55.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.791 0.436 . . . . 0.0 111.324 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -102.75 7.62 39.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.492 0.717 . . . . 0.0 111.108 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.408 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 5.2 m -139.48 154.83 25.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.972 0.909 . . . . 0.0 111.47 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.98 169.92 14.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.991 0.916 . . . . 0.0 111.547 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.5 p -61.51 -19.12 61.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -70.69 -24.5 62.68 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.379 0.536 . . . . 0.0 110.823 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 49.9 m-85 -89.01 -19.33 25.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.32 -7.87 56.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 111.111 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.92 -18.07 13.47 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.367 0.667 . . . . 0.0 111.229 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -107.35 158.16 33.81 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.235 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.18 151.98 82.27 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.154 2.569 . . . . 0.0 111.58 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.8 154.71 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.952 0.901 . . . . 0.0 110.562 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -139.16 155.09 48.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.566 0.746 . . . . 0.0 109.892 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -79.34 162.95 25.25 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.724 0.41 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.419 ' HE3' HG13 ' A' ' 16' ' ' ILE . 56.9 tptt -78.67 -47.68 1.82 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.591 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.3 144.76 33.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.115 1.876 . . . . 0.0 110.256 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -115.83 147.21 41.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.034 0.533 . . . . 0.0 110.489 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.9 p -144.3 162.48 36.31 Favored 'General case' 0 N--CA 1.46 0.04 0 C-N-CA 124.443 1.097 . . . . 0.0 108.866 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -63.55 -31.87 73.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.91 -0.494 . . . . 0.0 111.207 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -84.62 -33.59 23.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.6 -27.03 57.94 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.9 -25.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.562 0.681 . . . . 0.0 110.527 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.9 -32.37 71.97 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.3 -29.25 38.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.524 0.33 . . . . 0.0 110.429 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.74 60.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 122.302 -0.249 . . . . 0.0 110.97 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.21 -30.2 54.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.83 -26.71 62.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.378 -0.201 . . . . 0.0 110.571 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -18.84 28.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.852 0.461 . . . . 0.0 112.119 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.89 -40.26 11.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.138 0.575 . . . . 0.0 110.92 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.59 18.29 3.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.871 0.469 . . . . 0.0 112.193 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.811 -1.09 . . . . 0.0 110.812 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -72.09 -7.47 49.15 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.712 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.459 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 70.8 mt-30 -119.99 116.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.167 0.44 . . . . 0.0 112.141 -171.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.443 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.0 mm -122.29 128.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 123.932 0.77 . . . . 0.0 111.511 -172.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -86.6 142.24 28.41 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.437 ' H ' HD21 ' A' ' 8' ' ' LEU . 79.3 mt -112.78 130.92 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 t -124.27 125.08 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -152.14 163.63 38.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.693 0.397 . . . . 0.0 111.868 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.77 12.93 13.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.412 0.685 . . . . 0.0 110.601 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -146.87 121.5 5.23 Favored Pre-proline 0 N--CA 1.454 -0.248 0 C-N-CA 123.973 0.909 . . . . 0.0 108.565 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.81 -14.36 44.26 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.24 2.627 . . . . 0.0 112.451 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.7 -31.1 68.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.4 -26.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.02 78.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.027 -0.42 . . . . 0.0 110.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.42 -21.77 30.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.463 -0.148 . . . . 0.0 111.126 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.8 tpt -76.75 -33.93 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.298 -0.251 . . . . 0.0 110.43 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.78 -27.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.229 0.212 . . . . 0.0 110.746 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.96 -21.85 58.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.785 0.266 . . . . 0.0 110.41 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.27 -46.29 28.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.264 -0.272 . . . . 0.0 110.687 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.57 -15.99 58.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.581 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.42 -28.84 64.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -78.84 -23.96 44.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.393 0.277 . . . . 0.0 110.408 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.07 -28.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.31 -1.94 58.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.536 0.335 . . . . 0.0 110.248 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t0 50.11 33.0 6.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.747 1.219 . . . . 0.0 112.96 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HE3' HG12 ' A' ' 7' ' ' ILE . 59.1 pttt -104.47 -165.77 1.18 Allowed 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.285 -0.259 . . . . 0.0 111.664 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -103.2 124.99 36.41 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 112.043 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 164.58 20.27 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.622 2.881 . . . . 0.0 110.067 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 34.8 m -136.07 -28.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.16 178.6 37.8 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.573 0.624 . . . . 0.0 112.616 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -137.35 141.07 41.8 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.39 1.076 . . . . 0.0 108.598 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.15 155.53 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.98 0.419 . . . . 0.0 110.767 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -129.11 7.89 5.54 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.436 0.694 . . . . 0.0 111.749 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 p -132.61 157.73 44.04 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.393 0.677 . . . . 0.0 110.025 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.24 -23.72 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.13 -25.8 42.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.303 -0.248 . . . . 0.0 110.816 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.42 -30.26 58.74 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.6 56.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.332 0.566 . . . . 0.0 110.623 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.13 -24.52 47.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.09 -25.04 40.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.212 -0.305 . . . . 0.0 111.11 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -87.37 -26.7 23.21 Favored 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.96 -22.34 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.687 0.676 . . . . 0.0 110.825 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -79.97 -14.56 58.49 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.33 -0.231 . . . . 0.0 110.468 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.88 -12.74 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.178 0.591 . . . . 0.0 111.137 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.77 53.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.95 62.99 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.052 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mt -140.34 144.73 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.793 0.837 . . . . 0.0 109.217 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.42 -25.71 9.91 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.76 176.99 10.32 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.09 0.405 . . . . 0.0 110.52 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.68 166.73 27.49 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.04 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.39 119.6 29.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.599 0.237 . . . . 0.0 110.759 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -80.41 127.92 32.97 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.613 0.365 . . . . 0.0 110.298 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.8 t -97.19 -11.15 8.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.434 0.694 . . . . 0.0 110.496 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 122.76 0.424 . . . . 0.0 111.85 179.64 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.7 m . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 86.9 Cg_endo -75.12 -13.49 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.174 1.916 . . . . 0.0 111.5 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.39 -29.11 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 122.612 0.365 . . . . 0.0 110.738 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.24 80.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.792 0.329 . . . . 0.0 110.387 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.93 -17.77 45.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.168 -0.332 . . . . 0.0 110.863 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.87 64.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.63 -27.22 62.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.38 -24.74 62.13 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 117.65 0.204 . . . . 0.0 110.49 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.16 52.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.234 -0.292 . . . . 0.0 110.486 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -99.54 8.69 44.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.409 0.684 . . . . 0.0 111.246 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 57.79 35.83 25.87 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.208 1.003 . . . . 0.0 113.026 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.36 131.08 22.23 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.75 156.86 39.76 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.91 3.073 . . . . 0.0 111.502 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.1 167.68 29.03 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.852 0.461 . . . . 0.0 111.132 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -138.89 164.87 25.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.008 0.923 . . . . 0.0 109.625 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' ' CD2' ' A' ' 94' ' ' PHE . 36.5 m-85 -107.51 161.97 14.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.337 0.589 . . . . 0.0 111.921 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.24 17.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.0 m -148.54 150.53 33.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.466 0.306 . . . . 0.0 110.82 -171.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.76 129.99 9.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.2 -171.95 30.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.7 m -83.24 161.29 21.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.688 0.395 . . . . 0.0 110.706 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -76.02 2.53 12.5 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -122.46 11.81 10.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.978 0.511 . . . . 0.0 111.301 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 m -110.61 12.64 22.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.338 0.655 . . . . 0.0 111.849 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.27 154.59 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.404 0.682 . . . . 0.0 109.567 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.54 153.56 23.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.28 0.632 . . . . 0.0 111.979 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.0 m -62.89 -18.92 63.65 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -76.65 -20.5 56.6 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 118.599 0.636 . . . . 0.0 110.459 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.416 ' CD2' ' CD1' ' A' ' 81' ' ' PHE . 9.1 m-85 -85.8 -19.62 30.43 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -83.28 -19.03 37.08 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 122.419 0.288 . . . . 0.0 110.856 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.66 -21.33 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.102 0.561 . . . . 0.0 111.862 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -101.97 157.99 32.64 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 122.799 0.44 . . . . 0.0 110.414 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.12 149.94 76.8 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.43 2.753 . . . . 0.0 111.692 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.66 153.27 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.003 0.521 . . . . 0.0 110.465 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.75 157.48 46.01 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.205 1.002 . . . . 0.0 109.371 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.92 168.64 10.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 37.9 mtmm -60.64 -46.85 97.21 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.116 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 77.7 Cg_endo -71.93 138.16 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.835 1.69 . . . . 0.0 109.628 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -112.51 154.14 26.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.527 0.731 . . . . 0.0 110.325 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.7 p -138.01 160.76 38.48 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.428 0.691 . . . . 0.0 110.363 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.4 tpp -71.15 -28.86 64.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.152 0.426 . . . . 0.0 112.152 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.5 -43.56 14.45 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.968 -0.458 . . . . 0.0 111.931 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -30.18 48.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 119.845 -0.42 . . . . 0.0 112.527 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.0 t -87.22 -30.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 CA-C-N 117.658 0.729 . . . . 0.0 111.01 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.66 68.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.871 -0.518 . . . . 0.0 110.021 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.31 -29.94 38.14 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.121 0.168 . . . . 0.0 110.707 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.6 37.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.295 -0.253 . . . . 0.0 111.417 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.92 -19.95 33.84 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 117.961 0.346 . . . . 0.0 111.115 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.02 -25.65 43.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.61 -25.86 41.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.65 29.92 1.43 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.036 0.935 . . . . 0.0 111.125 173.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.79 -16.47 7.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.425 0.29 . . . . 0.0 111.586 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.22 -177.343 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 ttp . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -133.63 -10.17 2.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.418 0.687 . . . . 0.0 110.6 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.26 -170.48 3.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.463 1.505 . . . . 0.0 107.31 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.6 mt -141.94 30.55 1.63 Allowed 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.365 0.666 . . . . 0.0 109.894 173.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -87.27 -11.56 49.26 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.16 0.584 . . . . 0.0 111.329 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -123.07 113.65 19.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.1 mm -122.47 131.55 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.626 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -89.87 149.81 22.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.53 ' H ' HD23 ' A' ' 8' ' ' LEU . 66.3 mt -115.17 135.59 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 118.115 0.416 . . . . 0.0 110.108 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.58 121.96 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.538 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 12.2 tp10 -150.55 157.49 43.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.806 -173.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.36 -10.49 19.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 112.508 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.538 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 48.0 mt-10 -133.2 132.92 22.44 Favored Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 121.919 -0.488 . . . . 0.0 110.369 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 52.3 Cg_exo -59.41 -21.41 61.1 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.329 2.686 . . . . 0.0 113.2 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.94 -43.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.165 -0.335 . . . . 0.0 110.682 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.0 -25.63 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.76 -30.62 70.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.308 -0.245 . . . . 0.0 110.56 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mmt -82.42 -22.7 35.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.319 -0.238 . . . . 0.0 110.808 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mtp -73.94 -35.44 64.56 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.218 0.463 . . . . 0.0 110.179 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.37 -33.77 74.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.171 -0.331 . . . . 0.0 110.138 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.41 -25.53 60.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.297 -0.252 . . . . 0.0 110.359 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.76 -41.55 23.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.907 0.321 . . . . 0.0 111.136 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.16 -24.89 59.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.872 -0.518 . . . . 0.0 111.937 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.755 0.707 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -85.33 -21.4 28.94 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.554 0.616 . . . . 0.0 112.126 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.2 -26.0 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.25 0.477 . . . . 0.0 111.244 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.03 18.31 13.7 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 122.17 -0.331 . . . . 0.0 111.536 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.87 34.02 18.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.448 0.699 . . . . 0.0 112.388 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -85.64 162.49 18.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.907 0.883 . . . . 0.0 109.102 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m -111.32 85.22 5.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.116 -0.365 . . . . 0.0 110.393 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.27 156.97 62.41 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.732 2.288 . . . . 0.0 110.038 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.15 -9.14 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.18 173.82 33.27 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 119.302 0.955 . . . . 0.0 113.126 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -144.0 141.09 29.96 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.202 1.001 . . . . 0.0 109.014 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.48 162.18 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 122.892 0.477 . . . . 0.0 111.091 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.35 -11.79 29.27 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.524 0.73 . . . . 0.0 111.858 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -149.29 157.99 43.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.947 -0.471 . . . . 0.0 110.491 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -71.55 -22.47 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 122.574 0.35 . . . . 0.0 110.223 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.87 -26.51 66.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.978 -0.451 . . . . 0.0 109.983 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -26.15 55.62 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.49 -30.56 63.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.255 0.527 . . . . 0.0 109.839 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.47 -37.43 68.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.78 64.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.373 -0.204 . . . . 0.0 111.074 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -22.27 29.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.453 0.301 . . . . 0.0 111.062 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.19 -21.85 10.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.75 -14.92 62.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.335 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -100.02 -12.49 19.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.089 0.956 . . . . 0.0 110.681 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.11 -168.49 52.09 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.58 23.36 62.66 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.44 -0.447 . . . . 0.0 112.231 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 mt -135.57 148.01 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.697 0.748 . . . . 0.0 109.343 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -120.0 -30.32 4.73 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.59 178.83 9.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.811 0.444 . . . . 0.0 109.913 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.36 163.1 39.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 mm -113.21 140.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.4 tp -140.71 129.53 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.551 0.215 . . . . 0.0 110.996 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.16 154.08 26.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.421 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.94 -11.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 122.893 0.477 . . . . 0.0 109.903 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -80.2 28.29 0.31 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.159 0.984 . . . . 0.0 111.97 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.17 155.42 14.12 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.333 0.653 . . . . 0.0 110.602 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -81.47 144.7 31.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.11 -174.5 26.16 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 -163.6 42.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -126.3 68.9 1.21 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.977 0.511 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 49.53 29.17 2.82 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.936 0.895 . . . . 0.0 112.639 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -152.05 162.14 41.54 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.864 0.466 . . . . 0.0 109.924 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 t -147.28 133.92 9.89 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 122.958 0.503 . . . . 0.0 110.554 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.45 -11.96 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.601 2.867 . . . . 0.0 111.653 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.25 -22.7 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 122.046 -0.409 . . . . 0.0 110.797 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.29 75.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.06 -17.96 60.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.164 -0.335 . . . . 0.0 111.227 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.33 -29.41 57.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.56 -34.52 72.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.61 -21.06 60.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.053 -0.404 . . . . 0.0 110.81 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.25 -16.59 42.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.514 0.325 . . . . 0.0 111.459 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -104.08 23.81 12.4 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.447 0.699 . . . . 0.0 111.775 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 53.83 41.83 31.93 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.865 0.866 . . . . 0.0 112.662 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.96 87.83 23.67 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.12 164.47 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 124.844 3.696 . . . . 0.0 114.27 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.19 169.3 17.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.975 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.06 141.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.277 1.031 . . . . 0.0 109.27 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.04 150.14 22.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.572 0.225 . . . . 0.0 110.764 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.47 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.89 0.476 . . . . 0.0 110.017 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -160.67 158.73 29.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.212 -0.305 . . . . 0.0 111.112 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.92 113.26 4.14 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.88 -163.52 29.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.8 m -76.88 160.41 29.24 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.237 0.542 . . . . 0.0 110.753 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.99 -3.12 56.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.694 0.398 . . . . 0.0 111.96 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -92.73 -0.46 57.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.584 0.354 . . . . 0.0 111.441 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -84.23 8.35 16.11 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.43 0.692 . . . . 0.0 112.02 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.7 m -136.9 154.68 31.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.752 0.821 . . . . 0.0 110.728 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -72.33 169.27 16.62 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.384 0.673 . . . . 0.0 111.487 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.9 p -61.94 -15.83 46.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -74.82 -24.24 58.59 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.939 0.336 . . . . 0.0 110.268 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 10.1 m-85 -86.01 -22.48 27.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -84.39 -14.53 49.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.801 0.441 . . . . 0.0 110.895 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.69 -33.55 14.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.732 0.413 . . . . 0.0 110.475 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -83.0 160.65 60.07 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.48 152.15 69.9 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.24 2.627 . . . . 0.0 111.181 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.24 154.39 33.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.002 0.521 . . . . 0.0 111.102 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.06 154.63 48.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.711 0.804 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -86.94 165.63 15.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.062 0.545 . . . . 0.0 109.658 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.15 -49.38 12.59 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.33 140.01 21.51 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.052 1.835 . . . . 0.0 111.161 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -110.4 152.34 26.38 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.065 0.46 . . . . 0.0 110.54 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 108' ' ' GLY . 8.8 t -154.26 164.61 38.28 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.028 0.931 . . . . 0.0 108.849 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -58.59 -27.57 64.77 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -84.04 -36.01 23.41 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.084 0.402 . . . . 0.0 111.256 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 105' ' ' THR . . . -79.3 -25.24 59.62 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.12 -30.26 11.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.122 0.461 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.34 69.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.73 -20.81 30.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.684 0.394 . . . . 0.0 111.107 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.24 61.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.477 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.4 mt -77.5 -28.42 52.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.0 -20.28 61.05 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.977 0.353 . . . . 0.0 110.874 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.47 -20.6 26.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.534 0.333 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -91.32 -50.63 5.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.819 0.282 . . . . 0.0 110.546 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.96 2.92 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.328 1.051 . . . . 0.0 112.88 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.173 -1.394 . . . . 0.0 110.0 178.446 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -80.16 -6.58 57.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.505 0.322 . . . . 0.0 111.827 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.88 159.14 43.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.711 0.804 . . . . 0.0 109.941 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.8 68.42 0.66 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.35 0.66 . . . . 0.0 110.697 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -4.14 58.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 175.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.408 ' HB3' HG12 ' A' ' 32' ' ' VAL . 24.0 mp0 -120.37 109.68 15.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.671 0.789 . . . . 0.0 111.438 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 mm -116.62 130.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 O-C-N 123.514 0.509 . . . . 0.0 110.086 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 145.31 25.11 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.541 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.7 mt -113.33 130.57 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.769 0.828 . . . . 0.0 109.237 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.29 117.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -141.26 162.98 34.19 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.626 0.77 . . . . 0.0 110.512 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -84.02 -9.95 58.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.454 0.301 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.6 145.51 40.78 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.839 0.456 . . . . 0.0 109.836 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.07 -14.75 26.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.116 2.544 . . . . 0.0 111.202 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -74.89 -30.32 61.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 117.771 0.26 . . . . 0.0 110.626 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mm -84.91 -30.17 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.77 69.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.8 tpp -78.91 -28.23 43.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.9 ttt -70.39 -29.99 66.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -75.16 -29.48 60.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.499 0.32 . . . . 0.0 110.483 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.88 -23.79 61.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.893 0.315 . . . . 0.0 110.266 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.48 -40.72 42.05 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.438 -0.164 . . . . 0.0 111.432 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.74 -24.66 53.02 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.266 0.484 . . . . 0.0 111.96 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.66 -20.35 56.76 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.704 0.684 . . . . 0.0 110.364 176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.2 -27.66 35.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.875 0.307 . . . . 0.0 110.585 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.4 t -79.76 -22.59 12.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 122.504 0.322 . . . . 0.0 110.859 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.77 13.56 34.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.793 0.437 . . . . 0.0 111.815 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 53.49 29.2 8.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 112.4 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -85.62 161.05 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.629 0.772 . . . . 0.0 109.202 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.8 m -105.83 117.47 57.69 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.6 162.83 27.19 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.322 2.681 . . . . 0.0 110.107 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 6' ' ' GLN . 26.7 m -135.12 -18.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.47 172.75 32.33 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.136 0.425 . . . . 0.0 112.147 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.3 p -139.14 142.02 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 108.464 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.33 152.87 23.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.792 0.329 . . . . 0.0 110.297 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -100.83 1.32 39.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.24 0.616 . . . . 0.0 112.111 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -141.32 157.84 44.67 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 109.812 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.36 -22.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 122.416 -0.177 . . . . 0.0 110.8 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.85 -25.96 61.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.147 -0.346 . . . . 0.0 110.677 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.95 -27.12 60.96 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.24 -34.81 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.34 0.57 . . . . 0.0 110.066 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.36 -36.96 77.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.95 66.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.247 -0.283 . . . . 0.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -84.8 -20.84 30.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.77 0.259 . . . . 0.0 111.332 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.41 -24.2 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.855 0.298 . . . . 0.0 110.45 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -75.83 -14.57 60.29 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.249 -0.282 . . . . 0.0 110.79 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.85 -12.48 22.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.541 0.736 . . . . 0.0 111.035 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.94 53.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.61 11.33 84.17 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.67 147.99 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -121.94 -19.76 6.57 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.13 168.64 26.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.596 0.358 . . . . 0.0 110.097 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.35 34.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 111.49 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.04 129.3 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.68 130.37 56.8 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.806 0.442 . . . . 0.0 111.05 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.47 132.41 34.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.51 -11.26 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.737 0.415 . . . . 0.0 110.782 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -85.08 26.18 0.89 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.074 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.54 148.72 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.724 0.81 . . . . 0.0 111.001 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -62.51 152.97 33.14 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.874 0.87 . . . . 0.0 112.13 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.24 -171.25 22.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.72 1.08 63.36 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.614 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -74.9 145.01 43.05 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.963 0.882 . . . . 0.0 110.829 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -140.47 15.12 2.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.669 0.787 . . . . 0.0 110.832 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -148.08 166.58 27.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.441 0.697 . . . . 0.0 110.045 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m -131.95 71.0 80.63 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.657 0.783 . . . . 0.0 109.364 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -11.69 31.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.669 2.913 . . . . 0.0 111.963 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.2 -19.33 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 O-C-N 122.118 -0.363 . . . . 0.0 110.237 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.75 -26.14 67.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.98 -17.98 59.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.159 -0.338 . . . . 0.0 110.555 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.37 -31.79 48.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.91 -34.12 76.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.06 -21.83 61.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.076 0.15 . . . . 0.0 110.691 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.89 -7.0 59.54 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.895 0.478 . . . . 0.0 110.826 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -114.7 15.01 17.64 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.708 0.803 . . . . 0.0 111.313 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.21 36.8 28.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.251 1.02 . . . . 0.0 112.927 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.7 mt -109.27 108.69 60.34 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.187 0.995 . . . . 0.0 108.366 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.74 154.85 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.733 2.955 . . . . 0.0 112.224 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.54 165.0 31.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.24 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.09 145.35 28.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.371 1.068 . . . . 0.0 108.416 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.14 153.24 18.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 111.308 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.17 148.17 37.8 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -159.95 170.97 20.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.63 0.253 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.77 95.31 0.23 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.71 -160.11 28.45 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.7 t -75.35 157.02 34.88 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.17 -4.43 29.62 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.071 0.549 . . . . 0.0 111.223 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.75 -1.4 34.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.9 11.28 33.8 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.676 0.79 . . . . 0.0 111.461 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 t -126.35 154.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.294 0.638 . . . . 0.0 109.795 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.0 152.46 23.76 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.172 0.589 . . . . 0.0 111.636 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.3 p -63.63 -17.45 62.92 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -77.56 -17.17 58.14 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 118.335 0.516 . . . . 0.0 110.729 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -89.75 -21.35 22.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -88.18 -11.21 47.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.977 0.511 . . . . 0.0 111.327 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.62 -27.26 12.43 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.281 0.632 . . . . 0.0 111.197 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.79 161.17 48.34 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 145.19 80.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.143 2.562 . . . . 0.0 112.608 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.2 m -140.62 154.27 21.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.699 0.8 . . . . 0.0 110.23 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 tp -145.87 146.45 31.12 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.1 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -85.01 158.77 20.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.878 0.471 . . . . 0.0 109.796 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -67.02 -36.22 10.62 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.82 125.32 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.402 2.068 . . . . 0.0 110.202 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -112.29 151.96 29.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.745 0.418 . . . . 0.0 110.854 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.9 p -142.64 159.28 42.53 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.161 0.984 . . . . 0.0 109.087 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -66.04 -26.34 67.46 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.829 -0.544 . . . . 0.0 111.174 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.63 -37.1 21.49 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 117.788 0.267 . . . . 0.0 111.536 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.48 -27.25 59.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.929 -0.373 . . . . 0.0 112.185 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.57 -29.4 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 117.696 0.748 . . . . 0.0 110.464 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.02 69.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.97 -21.16 29.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.365 0.666 . . . . 0.0 110.819 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.39 38.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.66 0.209 . . . . 0.0 110.664 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.62 -28.69 60.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -26.37 63.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.96 41.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.051 0.54 . . . . 0.0 111.752 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -90.98 -33.81 15.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.353 0.261 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -94.08 0.23 55.77 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.901 0.48 . . . . 0.0 111.844 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.22 -1.372 . . . . 0.0 109.767 179.157 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.6 m 56.58 179.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.228 1.011 . . . . 0.0 112.862 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.57 165.21 29.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.386 0.675 . . . . 0.0 110.076 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.82 63.29 1.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 110.463 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.68 -5.47 37.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.39 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.437 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 63.5 mt-30 -119.94 111.77 18.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.803 0.335 . . . . 0.0 111.541 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.21 135.4 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.093 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.38 132.3 36.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 84.0 mt -94.6 128.0 46.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.215 0.606 . . . . 0.0 109.487 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.41 115.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.066 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.89 162.98 32.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.057 0.543 . . . . 0.0 111.622 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.5 4.42 18.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.677 . . . . 0.0 110.374 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -141.11 110.69 6.51 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.804 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -55.75 -21.78 33.88 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.952 3.101 . . . . 0.0 113.875 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 tp -74.31 -33.7 63.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.214 0.461 . . . . 0.0 110.305 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.3 mm -77.73 -31.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.22 65.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.8 tpp -77.76 -31.83 52.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -74.52 -30.41 61.78 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.472 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.16 -29.95 68.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.2 -24.03 54.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.068 0.394 . . . . 0.0 110.193 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.9 -43.13 20.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.241 -0.287 . . . . 0.0 111.279 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.38 -28.33 59.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.188 0.449 . . . . 0.0 111.813 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -79.17 -17.65 54.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.514 0.597 . . . . 0.0 110.865 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.85 -26.16 27.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.039 0.381 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -82.86 -22.59 8.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 122.555 0.342 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.9 mt -101.11 16.35 25.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 51.97 37.36 20.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.862 0.865 . . . . 0.0 112.181 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.61 164.61 17.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.494 0.717 . . . . 0.0 109.528 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.0 m -117.46 71.8 7.02 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 122.537 0.335 . . . . 0.0 110.825 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.3 159.69 42.46 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.986 2.457 . . . . 0.0 110.114 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.2 m -123.81 -10.02 7.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.72 173.77 33.72 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 118.54 0.609 . . . . 0.0 112.291 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.3 m -140.25 139.24 35.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 109.337 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.32 158.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.231 0.612 . . . . 0.0 110.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -137.04 3.63 2.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.655 0.382 . . . . 0.0 111.763 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -139.04 149.71 44.94 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.04 -32.38 55.99 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 122.29 0.236 . . . . 0.0 111.311 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.85 69.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.953 -0.467 . . . . 0.0 110.945 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.49 -29.8 47.5 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.4 63.6 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.516 0.658 . . . . 0.0 110.541 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.92 -27.09 54.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.41 -24.67 61.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.149 -0.344 . . . . 0.0 110.883 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.07 -29.24 22.04 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.09 -21.95 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.564 0.62 . . . . 0.0 111.523 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -81.66 -14.72 56.3 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.07 -0.394 . . . . 0.0 111.021 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -91.9 -13.21 31.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.539 0.336 . . . . 0.0 111.519 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -164.8 42.18 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.61 24.98 61.58 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.306 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -127.79 144.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 117.433 0.616 . . . . 0.0 109.646 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -109.94 -27.87 9.02 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.23 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.06 178.56 7.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.156 0.583 . . . . 0.0 110.389 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.23 162.01 41.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.906 -0.496 . . . . 0.0 111.847 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.4 mt -116.22 126.62 73.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.11 133.06 56.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.876 0.47 . . . . 0.0 111.488 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.83 144.29 30.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -80.37 -11.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -122.7 40.45 3.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.754 0.422 . . . . 0.0 110.696 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.86 153.51 17.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.524 0.73 . . . . 0.0 111.44 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -57.55 152.03 15.71 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.116 0.967 . . . . 0.0 110.98 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 5.64 84.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.98 -0.345 . . . . 0.0 112.471 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.91 176.38 43.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.57 138.32 53.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.828 0.451 . . . . 0.0 110.368 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.1 pttt 47.72 10.97 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.811 2.044 . . . . 0.0 115.402 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -150.39 162.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.666 0.786 . . . . 0.0 109.988 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 t -144.17 135.14 12.4 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.843 0.457 . . . . 0.0 110.263 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.71 -11.72 12.59 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.549 2.833 . . . . 0.0 111.494 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.47 -31.43 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 117.87 0.305 . . . . 0.0 110.775 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.99 86.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.956 -0.465 . . . . 0.0 110.289 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.0 -17.37 40.69 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.263 -0.273 . . . . 0.0 111.274 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -33.25 68.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.1 mt -73.88 -27.54 61.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.24 -23.0 61.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.928 0.331 . . . . 0.0 110.5 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.91 -19.37 40.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.315 0.246 . . . . 0.0 110.375 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -98.12 5.37 48.67 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.43 0.692 . . . . 0.0 111.491 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 57.37 27.6 14.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 112.534 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.6 mt -94.78 124.52 54.43 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.313 0.645 . . . . 0.0 109.327 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -59.89 150.26 78.92 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.894 3.063 . . . . 0.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -151.91 160.39 43.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.672 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.17 156.47 36.66 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.395 0.678 . . . . 0.0 109.498 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.73 160.62 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.35 0.595 . . . . 0.0 111.896 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.46 136.55 36.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.8 p -134.05 161.89 33.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.069 0.461 . . . . 0.0 111.96 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.04 -167.75 36.14 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.11 49.77 2.96 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -153.95 144.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.485 0.714 . . . . 0.0 110.033 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -105.42 -2.32 23.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.456 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.95 -2.87 33.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.042 0.537 . . . . 0.0 111.507 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -85.66 5.63 31.1 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.059 0.544 . . . . 0.0 111.813 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.64 154.73 19.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.137 0.575 . . . . 0.0 111.814 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.66 170.9 15.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.848 0.859 . . . . 0.0 111.179 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -62.85 -17.27 61.21 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -70.73 -29.78 66.12 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.778 -0.576 . . . . 0.0 110.195 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -81.02 -23.94 38.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -84.25 -10.37 57.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.82 0.448 . . . . 0.0 110.885 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -23.58 15.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.981 0.512 . . . . 0.0 110.913 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -97.19 163.86 19.01 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.286 0.634 . . . . 0.0 110.042 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.45 147.53 85.37 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.251 2.634 . . . . 0.0 112.084 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 m -140.36 154.07 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.486 0.714 . . . . 0.0 110.297 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.53 151.65 51.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.528 0.731 . . . . 0.0 109.953 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -74.35 156.76 36.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.502 ' CE ' ' HA ' ' A' ' 102' ' ' LYS . 1.9 tpmt? -71.1 -47.47 14.19 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.723 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.52 142.43 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.902 1.735 . . . . 0.0 109.804 172.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -115.56 157.83 23.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.928 0.891 . . . . 0.0 110.75 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -141.91 162.53 35.24 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 124.058 0.943 . . . . 0.0 109.46 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -64.67 -32.52 74.22 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 122.255 -0.278 . . . . 0.0 111.149 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.45 -34.44 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.712 0.233 . . . . 0.0 111.597 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.03 56.16 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.628 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.27 -27.51 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.954 0.877 . . . . 0.0 110.729 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.02 71.79 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.222 0.465 . . . . 0.0 110.294 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -82.78 -29.62 29.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.327 0.251 . . . . 0.0 110.419 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.65 -31.57 46.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.732 0.242 . . . . 0.0 111.221 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.36 -39.81 58.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.96 -26.8 65.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.497 -0.127 . . . . 0.0 110.802 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.26 -14.41 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.567 0.347 . . . . 0.0 111.566 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -91.25 -35.85 14.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.761 0.424 . . . . 0.0 110.78 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 tp -88.67 -12.15 43.26 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.116 -1.421 . . . . 0.0 110.165 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.324 0.107 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -146.36 166.07 27.44 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.243 0.617 . . . . 0.0 109.856 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.3 175.06 10.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.874 0.469 . . . . 0.0 111.04 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.16 33.11 0.1 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.315 1.046 . . . . 0.0 112.578 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -12.67 40.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.477 0.311 . . . . 0.0 110.774 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.1 116.16 27.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.572 0.349 . . . . 0.0 111.469 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.42 128.76 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.418 0.687 . . . . 0.0 110.366 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -87.82 141.02 28.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.436 ' H ' HD22 ' A' ' 8' ' ' LEU . 90.0 mt -106.0 127.35 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.791 0.836 . . . . 0.0 109.21 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.0 126.87 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -155.07 165.87 35.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.255 0.622 . . . . 0.0 111.181 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -124.21 18.17 9.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.974 0.51 . . . . 0.0 110.242 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -137.77 126.86 14.85 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.727 0.811 . . . . 0.0 108.883 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.77 -18.68 32.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.411 2.741 . . . . 0.0 112.839 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.57 -25.5 35.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.26 0.482 . . . . 0.0 110.512 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.11 -26.05 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.43 84.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.011 -0.431 . . . . 0.0 110.843 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -77.26 -25.12 51.17 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 122.303 -0.248 . . . . 0.0 110.884 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 ttp -75.15 -32.17 61.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.429 -0.169 . . . . 0.0 110.688 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.67 -33.79 69.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.845 0.293 . . . . 0.0 110.68 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.71 -22.01 57.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.885 0.311 . . . . 0.0 110.451 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.75 -38.73 32.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.213 -0.305 . . . . 0.0 111.367 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -78.1 -23.44 47.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.562 0.619 . . . . 0.0 111.297 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.9 -18.54 58.25 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.439 0.563 . . . . 0.0 109.892 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.95 -28.04 35.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.05 0.386 . . . . 0.0 110.019 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -77.74 -23.59 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 122.615 0.366 . . . . 0.0 110.315 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.2 mt -93.04 8.2 40.98 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.793 0.437 . . . . 0.0 111.513 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.23 30.95 8.48 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.25 0.62 . . . . 0.0 111.47 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.0 OUTLIER -85.72 161.12 19.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 -177.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.406 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 94.4 m -107.97 98.99 28.31 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 122.357 0.263 . . . . 0.0 110.321 177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.92 158.76 54.58 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.907 2.405 . . . . 0.0 109.26 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.94 -11.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.31 172.75 32.17 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.313 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -133.97 143.18 48.01 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.968 0.907 . . . . 0.0 108.755 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.69 140.2 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.72 1.53 57.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -140.78 157.06 45.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.119 0.568 . . . . 0.0 109.878 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.3 -22.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 122.47 -0.144 . . . . 0.0 110.779 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.86 63.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -19.58 68.95 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.96 -36.85 48.6 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.738 0.769 . . . . 0.0 110.746 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.76 -30.23 40.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.22 -25.66 59.79 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.187 -0.321 . . . . 0.0 111.266 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -87.39 -26.76 23.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.67 0.388 . . . . 0.0 111.827 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -82.77 -22.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 118.191 0.45 . . . . 0.0 111.604 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.35 -14.66 62.67 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.122 0.419 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.27 -12.52 59.61 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.684 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 -174.8 54.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.82 85.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -133.72 149.38 30.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -129.67 -12.03 4.36 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.57 169.25 20.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.841 0.456 . . . . 0.0 110.101 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 158.63 44.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.581 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.46 127.46 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.43 126.16 55.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.814 0.446 . . . . 0.0 110.888 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -77.85 132.83 38.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.56 -13.26 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.21 -0.306 . . . . 0.0 110.323 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.43 146.19 47.11 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.8 tp -141.44 151.23 43.23 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.119 -0.363 . . . . 0.0 110.53 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.54 151.84 27.55 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.393 0.677 . . . . 0.0 110.973 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.31 -165.62 54.77 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.47 -3.22 82.38 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.408 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.38 156.85 39.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.051 0.926 . . . . 0.0 110.933 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -141.09 173.32 11.6 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.251 0.62 . . . . 0.0 110.838 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t 58.8 -178.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.261 1.024 . . . . 0.0 112.125 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 m -138.87 58.63 13.78 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.074 0.55 . . . . 0.0 110.301 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.35 -10.91 29.12 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.364 2.71 . . . . 0.0 111.401 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.77 -16.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.022 0.529 . . . . 0.0 111.064 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 -23.3 62.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.957 -0.465 . . . . 0.0 109.881 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.19 -19.03 57.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.04 -30.8 39.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.51 -30.13 66.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.31 -20.95 54.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.266 0.226 . . . . 0.0 110.652 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.97 -18.46 59.3 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -90.34 12.83 17.12 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.42 0.688 . . . . 0.0 110.449 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.44 31.93 21.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.812 1.245 . . . . 0.0 112.824 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -113.8 126.17 28.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.68 160.31 38.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.213 3.275 . . . . 0.0 112.338 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.06 171.72 15.94 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.25 149.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.776 0.831 . . . . 0.0 108.967 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.82 154.31 17.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.185 0.517 . . . . 0.0 111.413 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.54 125.03 22.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.6 t -154.69 169.57 23.59 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.64 126.78 1.55 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.56 -164.82 29.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -74.02 159.11 33.15 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 110.307 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.48 -8.68 59.61 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.53 0.332 . . . . 0.0 111.44 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.22 0.76 20.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.215 0.606 . . . . 0.0 112.135 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.0 p -124.1 11.77 8.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.142 0.577 . . . . 0.0 111.948 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.81 160.99 17.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.355 0.597 . . . . 0.0 112.576 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -64.8 -16.2 62.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -78.16 -16.71 57.66 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.717 0.69 . . . . 0.0 111.238 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -85.89 -24.46 26.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -79.02 -15.95 57.54 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.342 0.257 . . . . 0.0 111.012 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.88 -24.69 13.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.045 0.538 . . . . 0.0 111.523 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -90.39 160.32 39.77 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 123.187 0.595 . . . . 0.0 109.53 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -63.71 144.49 89.38 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.83 2.353 . . . . 0.0 110.666 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.17 154.35 20.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.737 0.815 . . . . 0.0 110.806 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -139.96 153.8 47.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -69.41 158.72 34.58 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.403 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 13.8 mmmm -62.33 -47.63 89.04 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.23 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.6 Cg_endo -71.43 135.15 25.95 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.427 1.418 . . . . 0.0 108.849 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.6 156.62 17.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.122 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.6 p -141.11 160.77 39.39 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.382 1.073 . . . . 0.0 108.702 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -62.36 -28.78 70.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.304 -0.248 . . . . 0.0 111.043 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.85 -29.1 27.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.336 -0.228 . . . . 0.0 110.97 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.51 -32.98 49.34 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.052 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -82.28 -24.47 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 117.841 0.82 . . . . 0.0 111.151 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.11 65.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.25 0.477 . . . . 0.0 109.964 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.23 -25.82 27.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.793 0.437 . . . . 0.0 111.549 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.79 -37.35 41.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.781 0.264 . . . . 0.0 110.778 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.37 -27.52 52.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.84 60.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.149 0.431 . . . . 0.0 110.672 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.21 -17.42 32.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.23 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.23 -47.56 7.43 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.16 18.02 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.452 1.101 . . . . 0.0 111.588 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.155 -179.148 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -142.01 161.89 36.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 110.484 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.502 ' C ' ' H ' ' A' ' 5' ' ' THR . . . -148.02 169.76 19.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.672 0.789 . . . . 0.0 109.393 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.67 25.44 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -92.13 -14.28 29.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.043 0.937 . . . . 0.0 109.681 173.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.414 ' HB3' HG13 ' A' ' 32' ' ' VAL . 23.1 mp0 -114.57 111.84 21.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.798 0.439 . . . . 0.0 111.619 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mm -118.41 130.43 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.226 0.61 . . . . 0.0 110.128 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.416 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -90.73 141.18 29.07 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' H ' HD21 ' A' ' 8' ' ' LEU . 96.7 mt -105.31 130.55 56.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.478 0.711 . . . . 0.0 109.78 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 t -127.61 117.97 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.588 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 14.2 tp10 -145.62 156.18 43.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.474 0.71 . . . . 0.0 109.744 -173.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -124.35 15.64 8.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.418 0.687 . . . . 0.0 111.416 -176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.588 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 15.9 tp10 -136.08 107.22 9.58 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.28 -25.02 36.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.626 2.884 . . . . 0.0 114.152 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -77.16 -37.93 52.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.407 0.549 . . . . 0.0 110.465 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.5 mt -79.33 -24.33 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.85 0.296 . . . . 0.0 110.536 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.9 mtt -76.97 -31.3 56.45 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.7 mtp -72.94 -23.77 60.72 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.47 -34.25 63.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.327 -0.233 . . . . 0.0 110.666 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.34 -22.38 51.91 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.42 -37.46 57.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.69 -23.24 56.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.269 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -77.25 -23.46 51.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.926 0.33 . . . . 0.0 110.245 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.07 -32.27 26.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.303 0.241 . . . . 0.0 110.482 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -76.82 -19.77 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.6 tp -82.81 0.22 44.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.583 0.753 . . . . 0.0 110.542 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 53.89 28.8 8.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.861 0.865 . . . . 0.0 111.695 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -91.25 156.84 17.52 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.971 0.908 . . . . 0.0 110.74 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.0 m -92.64 121.61 65.8 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -78.59 161.68 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.168 3.245 . . . . 0.0 111.25 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG13 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -141.7 -18.7 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 173.07 32.58 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.398 0.545 . . . . 0.0 112.548 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.2 p -139.62 142.98 37.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.503 1.121 . . . . 0.0 108.46 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 156.03 21.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.83 -7.66 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.597 0.759 . . . . 0.0 111.563 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -152.61 161.22 42.87 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.668 0.387 . . . . 0.0 110.467 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.65 -22.55 26.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.186 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -27.23 63.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.72 -28.75 56.49 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.32 74.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.563 0.681 . . . . 0.0 109.496 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.94 -31.21 66.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 -24.92 63.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.372 -0.205 . . . . 0.0 111.08 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.348 0.259 . . . . 0.0 111.206 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -76.27 -25.23 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.899 0.318 . . . . 0.0 110.244 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -73.78 -14.78 61.17 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.352 -0.217 . . . . 0.0 110.856 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.4 -12.61 24.06 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.193 0.597 . . . . 0.0 111.007 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.82 -169.04 49.03 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.26 86.35 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.619 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.4 mt -129.16 147.97 33.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.78 -17.47 4.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.99 170.24 22.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.728 0.411 . . . . 0.0 110.43 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.93 162.53 41.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.624 0.249 . . . . 0.0 111.538 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.11 130.97 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.76 125.72 54.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.523 0.329 . . . . 0.0 110.958 -174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.54 129.9 34.85 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.53 -12.93 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.026 0.53 . . . . 0.0 110.9 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -84.44 42.28 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.163 0.585 . . . . 0.0 110.964 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.73 148.85 50.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.877 0.471 . . . . 0.0 110.953 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -81.9 152.39 26.83 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.532 0.733 . . . . 0.0 110.463 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.76 -7.38 27.79 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.168 0.413 . . . . 0.0 112.545 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.74 85.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.878 0.839 . . . . 0.0 113.747 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 173.61 9.18 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.384 1.092 . . . . 0.0 111.301 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -123.38 166.01 16.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.134 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -130.07 22.5 5.3 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.326 0.65 . . . . 0.0 111.318 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.471 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 42.1 p -64.93 -25.86 1.62 Allowed Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.6 Cg_exo -59.05 -16.49 33.15 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.976 1.784 . . . . 0.0 112.99 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.6 -21.67 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.038 0.381 . . . . 0.0 110.291 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.62 65.45 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.026 -0.421 . . . . 0.0 110.064 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.62 -19.66 60.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.339 -0.226 . . . . 0.0 110.66 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.92 51.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.42 -36.88 74.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.17 62.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.276 -0.265 . . . . 0.0 110.748 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 -15.19 54.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.405 0.282 . . . . 0.0 110.432 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -105.29 20.68 18.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.704 0.802 . . . . 0.0 111.403 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 59.02 35.76 24.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.035 0.934 . . . . 0.0 113.444 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.3 mt -118.59 97.62 50.84 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.97 161.14 26.89 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.079 3.186 . . . . 0.0 112.638 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -148.02 170.26 18.12 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.919 0.487 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.5 144.16 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -86.88 155.98 20.03 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.8 0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.05 125.98 18.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -161.93 164.71 28.34 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 110.618 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.45 95.61 0.57 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.43 165.04 12.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.7 m -147.58 28.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.55 0.34 . . . . 0.0 110.873 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -105.62 -50.88 3.11 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.71 -5.42 2.5 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.2 p -88.07 4.18 46.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.879 0.472 . . . . 0.0 112.131 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.43 154.44 30.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.336 0.588 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.98 179.86 7.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.0 108.972 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -57.53 -19.32 24.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.754 -0.591 . . . . 0.0 112.235 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -74.45 -24.63 59.09 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.991 -0.443 . . . . 0.0 110.749 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.56 -17.12 39.89 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.9 0.88 . . . . 0.0 109.396 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -88.26 -11.0 47.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.467 0.707 . . . . 0.0 110.37 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -111.98 -8.46 14.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.628 0.771 . . . . 0.0 111.785 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -137.84 139.56 26.82 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -53.11 154.89 12.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.854 3.036 . . . . 0.0 114.238 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.83 155.14 32.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.136 0.974 . . . . 0.0 110.259 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.3 tp -133.57 149.71 51.65 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -74.08 160.97 30.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -70.45 -42.4 15.05 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.418 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.01 141.15 43.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.5 2.134 . . . . 0.0 109.645 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -103.21 149.08 25.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 110.497 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.4 p -139.08 166.39 24.64 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.955 0.902 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mmm -65.65 -35.77 81.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.185 -0.322 . . . . 0.0 110.808 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.68 -28.38 26.43 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.388 0.275 . . . . 0.0 111.74 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.75 -28.81 64.36 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.6 t -83.91 -30.16 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.344 0.572 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.2 -27.84 60.98 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.39 -24.45 39.71 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.663 0.385 . . . . 0.0 110.244 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.24 64.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.183 -0.323 . . . . 0.0 110.394 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.21 -40.75 74.38 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.49 -18.89 61.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -23.27 24.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tt -91.79 -50.57 5.66 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.163 -0.336 . . . . 0.0 111.13 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.95 -1.12 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.913 -1.518 . . . . 0.0 110.06 178.669 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.591 0.234 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.0 p -148.83 160.39 43.28 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.967 0.507 . . . . 0.0 110.593 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.29 171.8 18.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.135 0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.3 mt -139.69 27.69 2.23 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.769 1.228 . . . . 0.0 110.153 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -79.93 -8.78 59.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.972 0.509 . . . . 0.0 111.585 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.438 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 65.2 mt-30 -121.04 114.62 21.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -119.88 131.98 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.47 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -91.39 145.03 24.97 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.47 ' H ' HD21 ' A' ' 8' ' ' LEU . 74.7 mt -113.34 130.95 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.1 117.71 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.19 163.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -169.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.21 -4.69 5.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.912 0.885 . . . . 0.0 110.538 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -153.75 136.8 10.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -56.74 -18.39 26.65 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.004 3.136 . . . . 0.0 114.52 -176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.62 -21.59 38.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.144 0.429 . . . . 0.0 111.671 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.11 -38.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.15 60.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.312 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.7 ttm -76.26 -32.8 59.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.0 tpt -81.5 -27.83 34.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.274 -0.266 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.48 -36.34 63.28 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -74.59 -21.69 59.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.82 -42.08 61.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.039 -0.413 . . . . 0.0 110.98 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -83.24 -22.78 33.0 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.91 -21.21 40.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.117 0.871 . . . . 0.0 111.076 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -85.58 -29.4 24.16 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.064 0.393 . . . . 0.0 111.314 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.39 -18.66 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 122.386 0.275 . . . . 0.0 111.23 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -99.33 18.15 18.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.119 0.567 . . . . 0.0 111.532 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 53.79 31.3 12.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.673 0.789 . . . . 0.0 112.227 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.51 165.72 16.89 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.639 0.776 . . . . 0.0 109.245 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -118.28 75.21 11.52 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 110.947 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.9 157.34 53.09 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.244 2.629 . . . . 0.0 109.78 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 30.1 m -122.75 -15.19 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.84 178.18 37.98 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.289 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 p -135.37 140.93 45.41 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.524 1.13 . . . . 0.0 108.876 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.51 147.16 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 110.431 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -92.1 2.19 56.73 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.41 0.684 . . . . 0.0 112.255 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -155.01 157.34 37.47 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.099 0.56 . . . . 0.0 110.065 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.48 -22.56 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.137 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.5 -26.04 64.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.36 59.27 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.02 67.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.714 0.757 . . . . 0.0 109.931 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.61 -37.54 68.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.79 -24.94 63.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -86.46 -22.7 26.33 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.314 0.506 . . . . 0.0 111.345 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.53 -28.22 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HB2' HH12 ' A' ' 75' ' ' ARG . 24.4 tt0 -82.52 -14.68 54.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.058 0.543 . . . . 0.0 111.559 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -108.16 -12.54 15.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.043 0.537 . . . . 0.0 112.197 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.71 165.82 38.94 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.15 136.06 18.82 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mt -144.7 146.1 20.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -101.09 -30.93 11.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 173.33 14.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.586 0.355 . . . . 0.0 110.343 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.1 158.23 43.95 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.98 128.27 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.64 119.09 34.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.182 0.593 . . . . 0.0 110.224 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.72 145.21 36.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.3 m -76.78 -11.79 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -84.05 140.43 31.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.3 tp -149.86 149.55 30.64 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.823 0.344 . . . . 0.0 110.391 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -82.21 152.61 26.34 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.668 0.787 . . . . 0.0 111.433 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.61 8.17 87.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.913 -0.382 . . . . 0.0 112.738 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.84 -172.12 38.88 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -126.1 131.42 52.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.781 0.432 . . . . 0.0 110.53 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 50.74 -166.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.699 1.2 . . . . 0.0 112.886 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t 62.42 155.7 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.728 1.611 . . . . 0.0 113.846 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m -146.66 66.41 10.77 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.718 0.807 . . . . 0.0 109.249 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.69 -11.89 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.677 2.918 . . . . 0.0 112.499 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.61 -16.88 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.923 -0.486 . . . . 0.0 110.684 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.3 69.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.823 -0.548 . . . . 0.0 110.048 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.17 -18.07 60.26 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.389 0.276 . . . . 0.0 110.606 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.21 -30.34 38.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.22 -33.77 70.18 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.13 -23.11 61.26 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.063 0.145 . . . . 0.0 110.767 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.67 -16.83 56.82 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.419 HH12 ' HB2' ' A' ' 46' ' ' GLU . 97.6 mtt180 -99.57 16.87 21.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.684 0.794 . . . . 0.0 110.626 173.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.69 26.23 15.3 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 113.65 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.88 122.02 44.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.54 159.58 39.24 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.781 2.988 . . . . 0.0 111.453 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -147.3 164.5 33.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.56 144.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 124.048 0.939 . . . . 0.0 108.688 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -90.93 155.9 18.39 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.23 133.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -155.15 168.81 25.79 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.772 0.429 . . . . 0.0 111.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.95 118.4 0.95 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.57 -154.21 25.49 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -70.86 161.82 30.31 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.684 0.394 . . . . 0.0 110.337 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.99 -1.91 48.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.756 0.422 . . . . 0.0 112.043 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -100.88 0.55 38.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.231 0.612 . . . . 0.0 111.671 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -87.9 5.54 39.98 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.001 0.52 . . . . 0.0 112.12 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.0 m -123.08 154.58 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.488 0.715 . . . . 0.0 111.835 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.5 171.49 15.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.246 1.018 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -61.2 -18.18 56.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.164 0.586 . . . . 0.0 112.567 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -72.73 -24.7 61.01 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.735 0.698 . . . . 0.0 110.989 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.432 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 46.0 m-85 -84.43 -19.18 33.86 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.05 -10.37 50.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.064 0.546 . . . . 0.0 111.176 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.07 -15.06 14.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.349 0.66 . . . . 0.0 111.288 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -108.91 156.1 39.63 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 123.629 0.772 . . . . 0.0 109.585 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.91 151.58 83.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.197 2.598 . . . . 0.0 110.683 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.91 154.37 36.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.761 0.824 . . . . 0.0 110.688 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -135.64 157.2 47.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.821 0.848 . . . . 0.0 110.342 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -81.97 158.79 23.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -67.99 -53.44 20.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.816 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.44 141.71 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.048 1.832 . . . . 0.0 109.585 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -106.49 158.57 16.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.44 0.638 . . . . 0.0 111.681 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 p -137.49 164.25 29.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.768 1.227 . . . . 0.0 107.776 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.9 ttm -65.17 -29.12 69.92 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.001 -0.437 . . . . 0.0 110.883 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.32 -29.95 25.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.076 0.15 . . . . 0.0 110.904 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.95 -28.84 55.8 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.784 -0.453 . . . . 0.0 111.986 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.51 -24.65 8.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-N 117.864 0.832 . . . . 0.0 110.238 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 -28.98 65.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -85.11 -20.96 29.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.575 0.35 . . . . 0.0 110.983 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.89 -41.6 64.48 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.825 0.284 . . . . 0.0 110.314 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -78.92 -27.24 43.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.26 -20.1 60.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.939 0.336 . . . . 0.0 110.556 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.7 24.78 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.349 0.26 . . . . 0.0 111.3 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 tt -91.55 -51.81 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.875 0.307 . . . . 0.0 111.217 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.94 4.11 3.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.09 0.956 . . . . 0.0 113.214 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.828 -1.082 . . . . 0.0 109.966 178.86 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -145.24 158.09 43.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.115 0.566 . . . . 0.0 110.16 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.25 168.98 23.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.244 0.618 . . . . 0.0 110.254 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.9 66.98 1.45 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.347 0.659 . . . . 0.0 110.224 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -74.28 -18.12 60.77 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.099 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.435 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 74.7 mt-30 -102.75 104.07 14.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.829 0.347 . . . . 0.0 110.713 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.23 130.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.573 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.41 129.61 35.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.7 mt -94.34 129.68 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.473 0.709 . . . . 0.0 109.3 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -130.23 103.52 8.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 13' ' ' GLU . 82.0 tt0 -157.61 142.87 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -92.88 -7.48 46.07 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 15.9 tp10 -99.38 104.97 30.16 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.38 -18.32 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.122 2.548 . . . . 0.0 112.061 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.91 -40.17 48.27 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.281 0.491 . . . . 0.0 110.291 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.15 -25.92 6.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.43 -39.47 77.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -74.39 -27.4 60.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.2 ttt -65.8 -33.26 75.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' A' ' 104' ' ' PHE . 7.6 tt -77.21 -30.92 54.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.909 -0.495 . . . . 0.0 110.338 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.12 -21.83 64.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.926 0.33 . . . . 0.0 110.297 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.72 -41.61 62.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 104' ' ' PHE . 67.0 m-85 -73.65 -13.9 61.07 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.452 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.37 -27.17 52.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.309 0.504 . . . . 0.0 110.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -84.29 -24.72 29.75 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -80.49 -19.81 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.21 -6.73 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.186 0.594 . . . . 0.0 110.827 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.46 27.18 6.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.613 ' HG2' ' H ' ' A' ' 30' ' ' THR . 24.5 ttpt -91.07 -175.62 4.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.321 0.648 . . . . 0.0 110.206 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.613 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 89.6 m -109.46 119.53 47.89 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 122.301 -0.249 . . . . 0.0 110.607 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.79 164.48 20.49 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.976 3.117 . . . . 0.0 111.162 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 28.7 m -139.65 -30.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.26 173.85 33.38 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 118.159 0.436 . . . . 0.0 112.532 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.1 m -140.64 142.09 35.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 108.723 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.14 157.46 25.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.207 0.603 . . . . 0.0 110.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -98.32 -3.51 37.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.044 0.538 . . . . 0.0 112.334 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.7 p -142.71 157.58 44.51 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.328 0.651 . . . . 0.0 109.746 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.8 -22.59 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 O-C-N 122.389 -0.194 . . . . 0.0 110.8 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.03 -27.65 67.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.477 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.97 -21.27 74.46 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.66 -30.34 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.249 0.524 . . . . 0.0 110.338 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.4 mt -72.37 -34.1 67.73 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.78 -25.36 49.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -87.35 -31.61 20.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.13 -22.02 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 118.142 0.428 . . . . 0.0 111.752 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.56 -14.84 62.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.233 -0.292 . . . . 0.0 110.502 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.06 -12.43 41.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.59 . . . . 0.0 110.756 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 -167.58 48.22 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 13.89 82.66 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.253 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 mt -135.83 145.58 31.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.774 0.829 . . . . 0.0 109.108 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -106.81 -29.62 9.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 177.68 8.27 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.753 0.421 . . . . 0.0 110.69 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.17 165.34 28.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.01 -0.431 . . . . 0.0 112.06 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.6 mt -125.97 133.33 69.22 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.55 140.34 46.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.507 0.723 . . . . 0.0 109.937 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.94 158.82 16.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.07 -11.47 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -90.96 18.4 6.72 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.886 0.475 . . . . 0.0 112.106 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.89 148.4 49.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.236 0.471 . . . . 0.0 110.53 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -82.24 152.29 26.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.101 0.561 . . . . 0.0 111.958 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 155.29 6.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.51 -13.63 81.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -126.63 155.12 43.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.852 0.861 . . . . 0.0 109.482 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -66.74 145.81 55.13 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.9 p -123.32 3.11 9.16 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.982 0.513 . . . . 0.0 112.211 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 12.4 m -63.32 -35.99 20.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.655 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.1 Cg_exo -58.18 -13.78 17.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 113.753 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.83 -18.58 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 118.299 0.5 . . . . 0.0 110.332 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -25.82 66.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 109.909 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.55 -17.38 54.1 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.859 -0.525 . . . . 0.0 109.979 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.48 -24.05 46.13 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.24 -30.79 63.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 171.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -22.6 59.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.55 -20.18 54.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -91.89 7.62 41.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.95 0.9 . . . . 0.0 110.724 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t70 59.12 32.04 21.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.378 1.071 . . . . 0.0 112.78 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.5 mt -111.94 126.16 28.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.04 161.32 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.429 2.753 . . . . 0.0 111.865 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.37 170.82 19.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.084 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.6 t -138.42 150.32 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.896 0.878 . . . . 0.0 108.92 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 20.2 m-85 -94.26 163.22 13.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.71 127.92 20.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -160.55 170.24 21.32 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.721 0.408 . . . . 0.0 110.534 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.18 132.93 4.26 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.77 -160.49 28.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -72.46 149.18 44.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.997 0.399 . . . . 0.0 110.039 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -75.8 -6.64 51.67 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -110.21 3.94 20.51 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.737 0.415 . . . . 0.0 111.246 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 t -98.48 12.49 34.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.441 0.696 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.01 153.84 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.488 0.715 . . . . 0.0 109.701 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.71 159.86 32.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.243 0.544 . . . . 0.0 112.394 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.1 p -63.2 -17.25 62.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -68.02 -28.02 67.05 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.686 0.675 . . . . 0.0 110.28 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 44.1 m-85 -85.13 -20.87 29.62 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -84.17 -7.99 59.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.905 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -118.62 -9.88 10.16 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.071 0.548 . . . . 0.0 112.14 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -125.29 156.78 69.47 Favored Pre-proline 0 C--N 1.341 0.236 0 C-N-CA 123.022 0.529 . . . . 0.0 110.568 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -54.3 144.18 61.66 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.638 2.892 . . . . 0.0 112.85 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.34 153.9 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.443 0.697 . . . . 0.0 110.077 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -130.69 155.53 46.45 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.927 0.891 . . . . 0.0 109.903 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -74.04 167.32 21.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.063 0.545 . . . . 0.0 110.902 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -75.89 -47.4 3.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.442 -0.789 . . . . 0.0 112.159 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.96 164.27 25.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.618 2.212 . . . . 0.0 110.456 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.456 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 10.9 m-85 -133.94 158.57 43.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.998 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.1 p -142.11 159.12 42.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.3 mtt -65.1 -27.99 69.14 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.137 -0.352 . . . . 0.0 111.126 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.26 -25.63 29.23 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.476 0.179 . . . . 0.0 110.633 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.43 -40.19 28.7 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.8 m -74.64 -21.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.559 0.679 . . . . 0.0 111.066 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.92 -31.43 51.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.12 0.418 . . . . 0.0 110.401 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -81.93 -31.76 31.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.55 60.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.85 -41.37 64.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.64 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.447 -0.158 . . . . 0.0 111.153 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.87 -21.06 25.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 tt -91.96 -38.69 12.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.203 0.601 . . . . 0.0 112.576 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.71 -10.83 59.74 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.935 -179.53 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 119.807 -0.14 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -136.44 163.08 31.31 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.0 0.52 . . . . 0.0 110.657 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.43 -5.13 13.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.158 0.583 . . . . 0.0 112.263 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 76.0 mt 49.2 40.66 18.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.868 0.867 . . . . 0.0 112.069 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.38 -10.87 16.16 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.729 0.812 . . . . 0.0 110.852 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.461 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 80.9 mt-30 -134.16 120.11 19.68 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.93 132.15 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.636 0.585 . . . . 0.0 110.536 -172.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.452 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -88.97 143.49 26.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.452 ' H ' HD21 ' A' ' 8' ' ' LEU . 94.3 mt -112.06 134.2 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.114 0.566 . . . . 0.0 109.845 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 t -132.38 115.7 26.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 22.7 tp10 -145.56 157.69 43.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -106.79 -0.0 23.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.49 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 39.4 tt0 -139.95 129.4 13.68 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 118.307 0.503 . . . . 0.0 110.328 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 53.7 Cg_exo -57.48 -27.43 76.26 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.573 2.849 . . . . 0.0 113.655 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.39 -44.25 71.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.8 -26.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.37 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.623 0.192 . . . . 0.0 111.086 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.5 mtt -75.82 -26.7 57.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 tpt -76.25 -23.91 54.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.15 -35.62 71.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.03 -21.72 56.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.452 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.09 -41.46 70.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.015 -0.428 . . . . 0.0 110.574 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.99 -23.15 62.13 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -85.07 -28.53 25.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.351 0.26 . . . . 0.0 110.677 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.78 -23.57 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.61 5.24 50.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.955 0.502 . . . . 0.0 111.531 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.66 35.9 12.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.544 0.737 . . . . 0.0 111.273 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -85.73 156.85 20.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.018 0.927 . . . . 0.0 111.123 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -91.27 120.23 68.49 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.87 162.49 29.44 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.317 2.678 . . . . 0.0 111.455 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 26.8 m -138.24 -31.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.094 0 C-N-CA 122.443 0.297 . . . . 0.0 111.235 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 176.08 35.79 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -140.26 143.08 35.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.46 155.54 37.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -100.44 1.52 41.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.407 0.683 . . . . 0.0 111.779 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -136.84 154.11 50.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.207 0.603 . . . . 0.0 109.933 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.34 -22.44 11.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.392 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.93 -26.21 61.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.568 0.167 . . . . 0.0 110.608 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.99 -23.27 66.81 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -28.59 35.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.415 0.608 . . . . 0.0 110.649 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.81 -39.02 52.84 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.66 61.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -87.32 -25.07 24.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.164 0.438 . . . . 0.0 111.83 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -83.32 -26.35 7.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.519 0.6 . . . . 0.0 110.402 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.93 -16.73 59.97 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.831 0.348 . . . . 0.0 110.243 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.59 -12.42 42.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.333 0.653 . . . . 0.0 110.98 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -171.22 51.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.02 11.37 85.24 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.8 mt -140.08 144.8 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -101.9 -30.41 11.26 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.71 177.14 9.61 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.742 0.417 . . . . 0.0 110.409 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.64 161.98 40.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.66 124.99 72.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.07 124.2 50.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 111.651 -172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.32 136.16 38.45 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 169.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.53 -13.95 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 122.402 0.281 . . . . 0.0 110.94 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 54.91 -170.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.27 1.028 . . . . 0.0 112.362 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.78 159.37 27.92 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.04 -0.413 . . . . 0.0 110.537 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -81.55 152.42 27.26 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.855 0.462 . . . . 0.0 111.917 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.5 -160.5 13.82 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.58 3.39 34.01 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.746 -0.474 . . . . 0.0 112.832 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -126.32 168.79 13.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.689 0.744 . . . . 0.0 110.965 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -112.77 158.63 19.87 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.319 0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 p -145.86 7.65 1.09 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.109 0.564 . . . . 0.0 112.003 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 67.2 p -101.48 -26.39 0.22 Allowed Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 51.1 Cg_exo -59.1 -19.56 49.64 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.451 2.101 . . . . 0.0 113.698 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.46 -26.66 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.053 -0.405 . . . . 0.0 111.091 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.92 62.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.34 -17.39 54.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -32.59 63.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.05 -28.15 65.23 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.26 -22.5 59.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.35 -13.64 59.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -100.28 6.19 44.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.792 0.837 . . . . 0.0 110.526 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 57.04 33.83 23.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.419 1.088 . . . . 0.0 112.857 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.46 121.99 41.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.372 0.669 . . . . 0.0 109.542 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.9 153.62 62.07 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.906 3.07 . . . . 0.0 113.332 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -151.8 165.15 35.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.31 159.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 C-N-CA 123.823 0.849 . . . . 0.0 109.311 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 25.4 m-85 -95.21 159.53 14.97 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.143 0.497 . . . . 0.0 111.99 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 136.36 28.47 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -155.6 158.83 39.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.62 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.49 177.81 54.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.9 116.35 7.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t -154.17 156.09 36.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.26 0.624 . . . . 0.0 110.692 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -105.4 -0.35 26.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.216 0.606 . . . . 0.0 111.464 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -134.05 -2.65 2.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 m -88.74 7.92 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.433 0.56 . . . . 0.0 111.658 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 m -134.89 154.15 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.307 0.643 . . . . 0.0 111.15 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.07 -178.44 6.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.925 1.29 . . . . 0.0 108.649 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.5 m -59.43 -16.62 24.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.488 -0.758 . . . . 0.0 112.031 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -65.86 -30.69 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 9.0 m-85 -90.4 -13.51 34.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.545 1.138 . . . . 0.0 109.836 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -88.53 -10.59 48.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.047 0.539 . . . . 0.0 110.426 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.28 -15.04 12.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.34 0.656 . . . . 0.0 111.433 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -126.03 149.82 67.48 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 123.292 0.637 . . . . 0.0 109.481 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.89 147.02 94.27 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.088 2.525 . . . . 0.0 112.561 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -150.61 150.15 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 123.636 0.774 . . . . 0.0 109.102 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.1 tp -144.39 150.38 37.64 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -75.95 165.81 24.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.444 0.298 . . . . 0.0 111.048 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -58.1 -50.42 88.21 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.931 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.29 110.14 2.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.468 1.445 . . . . 0.0 110.063 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -82.18 153.28 26.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.625 0.37 . . . . 0.0 110.771 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.8 p -139.66 159.62 41.74 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.971 0.908 . . . . 0.0 108.997 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -65.11 -26.14 68.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.117 -0.364 . . . . 0.0 110.848 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.55 -36.33 22.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.773 0.261 . . . . 0.0 111.621 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.74 -31.49 49.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.1 t -79.46 -30.4 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.305 0.552 . . . . 0.0 110.078 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.56 69.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.963 0.347 . . . . 0.0 110.728 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.18 -31.57 23.15 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.356 -0.215 . . . . 0.0 111.449 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.21 60.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.9 0.318 . . . . 0.0 110.868 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.49 -20.67 33.55 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.25 -22.5 59.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.823 0.738 . . . . 0.0 110.001 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -19.72 27.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.516 0.327 . . . . 0.0 111.471 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.4 -58.02 2.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.657 0.383 . . . . 0.0 110.958 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 73.2 mt -69.19 -1.31 7.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.788 1.235 . . . . 0.0 113.351 -173.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.226 -1.369 . . . . 0.0 109.971 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 t 58.99 167.16 0.05 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.595 1.158 . . . . 0.0 112.121 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.03 -174.36 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 112.466 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 77.1 mt -137.17 29.19 2.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.525 1.13 . . . . 0.0 110.458 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -4.98 45.15 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.0 mt-30 -125.51 119.1 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mm -122.09 137.22 56.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.978 0.911 . . . . 0.0 111.173 -173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.71 135.27 36.38 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 76.4 mt -102.59 126.14 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.288 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.6 t -132.27 117.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.69 161.89 36.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.305 0.642 . . . . 0.0 110.455 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -97.11 0.39 48.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.06 0.544 . . . . 0.0 111.638 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.24 132.96 9.34 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.878 -0.514 . . . . 0.0 110.304 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.6 -23.32 70.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.441 2.761 . . . . 0.0 113.615 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.38 -40.45 67.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.99 -29.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.07 69.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.8 ttp -75.81 -27.83 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.7 ttp -73.46 -29.87 62.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.02 -36.7 75.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -73.14 -21.98 60.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.531 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.81 -42.84 63.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.134 -0.354 . . . . 0.0 111.152 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -75.23 -21.21 58.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.365 0.529 . . . . 0.0 111.376 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -82.79 -18.51 40.34 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.184 0.447 . . . . 0.0 111.344 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -85.07 -22.86 28.79 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.57 0.623 . . . . 0.0 110.388 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 -21.2 10.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -93.17 -0.09 57.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.296 0.638 . . . . 0.0 111.149 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t0 52.37 40.96 30.36 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.369 0.605 . . . . 0.0 110.885 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -85.5 165.18 17.34 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.943 0.897 . . . . 0.0 110.784 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.1 m -115.16 74.64 3.89 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.01 0.524 . . . . 0.0 110.151 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.33 156.95 57.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.894 2.396 . . . . 0.0 109.789 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 32.7 m -116.71 -7.75 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.7 171.53 31.05 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.287 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -137.96 139.88 39.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.78 158.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -120.29 -2.65 10.07 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.535 0.734 . . . . 0.0 111.58 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.0 p -138.83 161.04 38.23 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.404 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.55 -26.54 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.045 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.2 -28.33 48.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.68 -27.88 60.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.79 -42.43 73.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.344 0.572 . . . . 0.0 110.175 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.89 -24.58 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.83 61.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.744 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -84.11 -20.87 31.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.978 0.354 . . . . 0.0 111.366 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.84 -31.36 40.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.51 -14.82 54.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.642 0.377 . . . . 0.0 111.791 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -87.75 -13.32 42.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.891 0.477 . . . . 0.0 111.963 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.44 172.58 36.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.4 151.62 43.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -141.87 150.03 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -108.47 -26.81 10.27 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-N 118.045 0.384 . . . . 0.0 111.496 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 171.08 18.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.088 0.555 . . . . 0.0 110.169 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.8 160.4 43.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.145 -0.347 . . . . 0.0 111.097 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.99 127.37 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.88 130.92 56.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.963 0.505 . . . . 0.0 111.188 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -81.53 139.43 35.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.76 -16.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.669 0.271 . . . . 0.0 110.667 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.99 144.02 37.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.0 tp -154.51 159.55 41.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -67.17 151.95 46.63 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 122.641 0.377 . . . . 0.0 110.307 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -167.15 51.52 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.63 68.61 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.869 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 65' ' ' SER . 9.7 tp10 -73.52 152.62 40.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.08 0.94 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -133.14 15.12 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.073 0.549 . . . . 0.0 111.945 -175.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.433 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 91.9 p -151.06 177.18 10.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.93 0.492 . . . . 0.0 110.571 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -137.46 138.21 24.15 Favored Pre-proline 0 C--O 1.231 0.11 0 C-N-CA 122.625 0.37 . . . . 0.0 110.359 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.93 -9.15 14.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.592 2.861 . . . . 0.0 111.532 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.28 -29.04 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 O-C-N 122.162 -0.336 . . . . 0.0 110.93 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.48 90.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.293 -0.255 . . . . 0.0 110.622 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.21 -17.54 39.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.374 -0.204 . . . . 0.0 111.35 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.5 70.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.41 -28.08 61.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.6 -22.79 62.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.867 0.303 . . . . 0.0 110.204 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.92 41.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.5 0.32 . . . . 0.0 110.351 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.08 7.95 42.05 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 111.155 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.56 28.81 17.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 112.843 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.4 mt -101.33 128.26 29.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.511 0.724 . . . . 0.0 109.474 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.42 156.1 50.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 111.608 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -147.84 167.14 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.6 t -139.22 145.58 27.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.037 0 C-N-CA 124.108 0.963 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.02 150.91 19.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.522 0.329 . . . . 0.0 110.551 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 119.74 11.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -171.78 163.28 6.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.199 0.6 . . . . 0.0 110.647 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.04 147.34 19.6 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.7 -154.35 25.44 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 117.532 0.666 . . . . 0.0 111.812 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 t -137.81 169.47 17.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.845 0.858 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.44 -11.94 60.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.784 0.434 . . . . 0.0 111.484 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.02 -4.3 27.72 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.398 0.679 . . . . 0.0 111.3 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 m -93.03 2.27 56.87 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.158 0.583 . . . . 0.0 111.337 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.59 154.72 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 123.946 0.898 . . . . 0.0 110.702 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.38 -177.52 5.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.346 0.593 . . . . 0.0 111.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.5 p -61.99 -16.5 51.86 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -73.79 -31.8 63.45 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.332 0.969 . . . . 0.0 110.396 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -82.13 -22.71 36.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -88.44 -5.47 58.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.399 0.279 . . . . 0.0 111.132 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -105.08 -16.81 14.69 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.465 0.706 . . . . 0.0 111.128 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -109.45 158.86 33.43 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.537 0.735 . . . . 0.0 110.09 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.47 152.63 76.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.827 2.352 . . . . 0.0 111.303 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.9 154.49 21.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.159 0.584 . . . . 0.0 110.981 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -145.85 156.53 43.62 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.528 0.731 . . . . 0.0 109.128 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.61 164.48 24.82 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -65.17 -50.19 61.87 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.655 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.26 146.28 35.72 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.238 1.959 . . . . 0.0 109.469 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -105.44 153.72 21.31 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 121.006 0.432 . . . . 0.0 111.139 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.2 p -143.21 160.23 40.84 Favored 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 124.405 1.082 . . . . 0.0 108.739 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.6 mtt -66.55 -23.65 66.25 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.085 -0.384 . . . . 0.0 111.099 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.3 -37.76 21.26 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 122.174 -0.329 . . . . 0.0 111.279 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.97 -34.73 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.92 -29.64 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 117.501 0.651 . . . . 0.0 110.499 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.52 -29.49 63.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.191 -0.318 . . . . 0.0 110.755 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.31 -31.79 22.85 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.088 0.155 . . . . 0.0 111.279 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.13 -34.54 61.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.82 0.282 . . . . 0.0 110.552 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.08 -21.18 33.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.462 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.32 -19.89 59.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.205 0.457 . . . . 0.0 110.219 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.88 23.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.495 0.318 . . . . 0.0 111.464 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 tt -91.6 -59.39 2.14 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.645 0.378 . . . . 0.0 111.473 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.9 mt -70.06 3.72 2.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.271 1.428 . . . . 0.0 113.55 -173.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.783 -1.103 . . . . 0.0 109.94 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -144.77 163.61 33.51 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.149 0.58 . . . . 0.0 110.459 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.38 169.15 18.63 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.228 0.611 . . . . 0.0 111.174 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.38 79.6 1.89 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.544 0.738 . . . . 0.0 109.753 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.82 -6.42 54.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.332 0.653 . . . . 0.0 112.206 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 78.6 mt-30 -128.71 119.05 23.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.5 mm -120.9 131.41 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.609 0.764 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -88.52 140.94 28.95 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.401 ' H ' HD23 ' A' ' 8' ' ' LEU . 89.4 mt -109.99 135.14 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 110.117 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 t -129.07 121.56 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -149.2 159.16 44.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.764 0.426 . . . . 0.0 110.656 -171.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.57 -12.74 12.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.438 0.695 . . . . 0.0 111.526 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -120.16 110.38 36.26 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 123.438 0.695 . . . . 0.0 109.27 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.86 -23.7 35.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.636 2.891 . . . . 0.0 113.955 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.1 tp -73.43 -32.54 64.45 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.3 0.5 . . . . 0.0 110.202 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.77 -28.52 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.63 64.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.594 0.179 . . . . 0.0 110.557 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.0 -33.66 57.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.2 tpt -75.05 -23.95 58.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -38.01 75.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.13 -22.74 57.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.608 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.86 -43.66 68.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.202 -0.311 . . . . 0.0 110.557 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -76.46 -25.5 54.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.936 -0.477 . . . . 0.0 111.416 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 tp -73.0 -32.11 64.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.292 0.497 . . . . 0.0 111.024 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -85.57 -24.07 27.36 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.5 t -76.64 -20.6 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.337 0.517 . . . . 0.0 110.504 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.89 18.38 18.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.709 0.403 . . . . 0.0 111.685 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 54.18 27.66 8.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.9 0.88 . . . . 0.0 113.043 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.9 157.12 20.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.224 0.61 . . . . 0.0 109.518 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.3 m -99.43 120.93 56.62 Favored Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 122.014 -0.429 . . . . 0.0 110.231 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -79.24 162.89 25.4 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.65 2.9 . . . . 0.0 110.696 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -138.7 -27.11 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.69 173.58 33.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -140.73 143.33 34.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.56 154.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 122.584 0.354 . . . . 0.0 110.927 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.19 8.72 28.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.277 0.631 . . . . 0.0 111.634 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -150.63 158.77 44.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 122.826 0.45 . . . . 0.0 110.167 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.1 -22.84 21.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 122.941 0.496 . . . . 0.0 111.101 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.96 62.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 122.271 -0.268 . . . . 0.0 110.716 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.2 -21.58 70.09 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.49 -31.73 42.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.278 0.539 . . . . 0.0 110.498 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.12 -23.76 35.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.759 0.254 . . . . 0.0 110.97 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.18 -30.14 34.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.3 -0.25 . . . . 0.0 111.504 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -87.72 -29.1 21.33 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.18 -28.82 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 118.201 0.455 . . . . 0.0 111.313 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.16 -14.87 59.72 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.794 -0.566 . . . . 0.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.75 -12.54 41.89 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.34 0.656 . . . . 0.0 110.587 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 -173.05 54.28 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.55 74.06 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.203 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -139.17 147.16 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 108.777 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.09 -21.2 10.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.22 -0.419 . . . . 0.0 112.049 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 173.12 14.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.314 0.506 . . . . 0.0 110.532 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.51 164.25 34.0 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.84 133.32 69.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.42 129.11 56.63 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.353 . . . . 0.0 110.996 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -81.44 130.16 34.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.85 -11.28 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.629 0.252 . . . . 0.0 110.542 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -87.07 21.7 2.26 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.704 0.802 . . . . 0.0 110.465 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.05 150.25 21.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.802 0.841 . . . . 0.0 111.088 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -65.25 152.25 44.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.067 0.547 . . . . 0.0 111.422 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.95 12.24 82.88 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 -176.37 46.54 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 117.572 0.686 . . . . 0.0 111.605 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.38 116.77 10.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.417 -0.461 . . . . 0.0 110.167 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -151.91 11.06 0.56 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.191 0.596 . . . . 0.0 111.12 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.2 p -105.35 3.66 30.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.416 0.686 . . . . 0.0 112.262 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 66.3 p -93.9 -31.79 0.3 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.14 -0.933 . . . . 0.0 112.253 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 39.6 Cg_exo -64.96 -24.91 59.9 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.767 1.645 . . . . 0.0 111.889 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.96 -23.88 7.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 C-N-CA 122.333 0.253 . . . . 0.0 110.675 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.17 70.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.49 -17.72 61.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.223 -0.298 . . . . 0.0 110.487 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.78 -29.78 51.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.91 -31.41 69.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.86 61.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.91 -13.87 58.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.588 0.355 . . . . 0.0 110.477 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -102.71 12.27 36.53 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.82 0.848 . . . . 0.0 111.013 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 58.03 33.27 23.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.066 0.947 . . . . 0.0 113.423 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.2 mt -114.37 129.4 24.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 109.457 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.93 159.28 30.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 112.418 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -153.78 168.99 24.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.301 0.641 . . . . 0.0 110.742 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.04 159.76 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 124.006 0.922 . . . . 0.0 108.968 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -99.38 156.21 17.13 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.939 0.4 . . . . 0.0 111.779 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.37 119.53 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -172.61 156.62 3.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.721 0.408 . . . . 0.0 110.604 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.59 143.43 18.47 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.65 -158.09 29.88 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 117.358 0.579 . . . . 0.0 111.916 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.4 t -137.47 170.86 15.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.887 0.875 . . . . 0.0 110.063 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.04 -13.8 62.48 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.101 -0.374 . . . . 0.0 111.302 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.93 3.55 54.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.16 0.584 . . . . 0.0 111.332 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 98.4 p -126.12 20.2 7.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.827 0.451 . . . . 0.0 111.903 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.469 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 16.1 m -132.26 154.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.422 0.689 . . . . 0.0 111.779 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -81.93 170.84 15.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.26 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.5 p -61.09 -21.72 63.95 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.95 -21.42 59.19 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.673 0.669 . . . . 0.0 110.862 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.469 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 3.2 m-85 -80.97 -23.44 38.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -88.21 -8.15 55.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.448 0.699 . . . . 0.0 111.261 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -119.6 -3.96 10.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.199 0.599 . . . . 0.0 112.087 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -140.55 140.8 23.35 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 149.96 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.622 2.881 . . . . 0.0 114.345 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 m -142.75 154.62 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.535 1.134 . . . . 0.0 109.596 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -146.87 155.28 42.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.657 0.383 . . . . 0.0 110.097 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.26 158.12 35.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 44.8 mtpt -66.08 -43.82 57.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.907 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 67.6 Cg_endo -69.39 128.61 16.63 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.676 1.277 . . . . 0.0 108.881 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -100.03 154.08 18.69 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.766 0.426 . . . . 0.0 111.367 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.5 p -141.38 162.39 35.61 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.426 1.09 . . . . 0.0 108.711 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.08 -26.88 68.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.298 -0.251 . . . . 0.0 111.031 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -84.47 -38.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.932 0.333 . . . . 0.0 111.579 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.99 -31.76 59.5 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.18 -27.64 12.02 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.026 0 CA-C-N 117.24 0.52 . . . . 0.0 110.229 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.17 68.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.003 -0.436 . . . . 0.0 110.669 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.24 -33.77 25.99 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 122.321 -0.237 . . . . 0.0 110.939 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.86 66.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.34 -20.33 40.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.63 62.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.777 0.717 . . . . 0.0 109.886 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.41 -23.71 24.44 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.2 mt -91.56 -14.44 30.31 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -107.06 18.04 22.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.376 0.535 . . . . 0.0 111.137 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.442 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -137.39 -0.86 2.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.095 0.558 . . . . 0.0 112.104 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.3 14.36 0.76 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.198 0.999 . . . . 0.0 113.018 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.2 56.17 2.62 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.434 ' HA ' ' HZ1' ' A' ' 29' ' ' LYS . 1.3 p -70.42 -7.07 40.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.161 -0.337 . . . . 0.0 111.214 -174.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.429 ' HB3' HG13 ' A' ' 32' ' ' VAL . 25.8 mp0 -106.27 114.31 28.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 122.807 0.443 . . . . 0.0 111.457 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 mm -123.88 127.35 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 123.636 0.585 . . . . 0.0 110.225 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.85 136.16 33.49 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.8 mt -103.24 132.78 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.182 0.593 . . . . 0.0 109.937 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.7 t -131.97 118.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 34.8 tp10 -151.24 140.2 21.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.803 0.441 . . . . 0.0 109.945 -176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.66 4.67 48.76 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 59.0 mt-10 -135.68 138.67 28.8 Favored Pre-proline 0 CA--C 1.529 0.153 0 O-C-N 121.899 -0.5 . . . . 0.0 109.984 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.75 -22.0 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.341 2.694 . . . . 0.0 112.525 -174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -79.42 -36.47 38.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.239 0.472 . . . . 0.0 110.236 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.47 -27.75 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.49 -35.05 78.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.2 ttp -73.63 -30.17 62.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.4 ttp -74.82 -31.43 61.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.382 -0.199 . . . . 0.0 110.485 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.07 -29.97 67.1 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.168 -0.333 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.2 -21.79 56.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.55 -43.79 54.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.089 0.404 . . . . 0.0 110.411 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -74.52 -16.93 60.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.065 0.393 . . . . 0.0 111.167 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -69.05 -30.72 69.12 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -83.2 -23.73 32.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.387 0.275 . . . . 0.0 111.112 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.58 -24.61 23.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.2 tp -93.31 -1.64 55.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.919 0.487 . . . . 0.0 110.544 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.28 35.04 15.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.332 0.653 . . . . 0.0 110.716 -175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HZ1' ' HA ' ' A' ' 5' ' ' THR . 32.6 tptt -85.6 155.57 21.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.217 1.007 . . . . 0.0 109.876 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -90.38 121.56 68.35 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.58 155.26 35.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.473 2.782 . . . . 0.0 110.573 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' HB3' ' A' ' 6' ' ' GLN . 34.5 m -138.16 -18.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.584 0.354 . . . . 0.0 111.813 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.64 167.52 25.33 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -143.61 138.95 29.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.9 161.31 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.928 0.491 . . . . 0.0 110.501 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -113.34 5.25 16.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.196 0.598 . . . . 0.0 112.486 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.43 HG21 ' H ' ' A' ' 39' ' ' ALA . 29.6 m -137.12 143.79 42.7 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.01 -23.34 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.43 ' H ' HG21 ' A' ' 37' ' ' THR . . . -77.15 -25.68 52.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.42 63.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.42 -34.33 54.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.4 0.6 . . . . 0.0 110.135 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.69 -42.36 67.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.53 -24.8 64.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.437 0.295 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -81.53 -26.51 35.03 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 122.299 -0.25 . . . . 0.0 111.336 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.25 -25.38 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 118.272 0.487 . . . . 0.0 110.267 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -75.12 -14.74 60.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.077 -0.389 . . . . 0.0 110.898 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.32 -12.36 59.93 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 110.484 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.4 -176.12 54.81 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.519 0.58 . . . . 0.0 111.863 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.64 12.73 83.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.164 -0.374 . . . . 0.0 112.164 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.36 145.86 35.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.895 0.848 . . . . 0.0 109.696 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.22 -15.4 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.049 0.539 . . . . 0.0 112.007 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 172.39 12.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.751 0.82 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.09 31.59 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.127 -0.358 . . . . 0.0 111.558 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.03 131.27 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.61 133.84 55.64 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.105 0.478 . . . . 0.0 111.781 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -86.5 137.12 32.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.08 -11.88 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -84.17 136.73 33.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 tp -157.66 136.06 11.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.02 152.66 26.56 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 122.675 0.39 . . . . 0.0 110.647 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.99 -161.16 13.57 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.65 -6.38 76.92 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.702 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -83.87 153.58 23.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.944 0.872 . . . . 0.0 110.777 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -148.72 1.13 0.58 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.557 0.343 . . . . 0.0 111.782 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -139.28 167.75 21.36 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.749 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.7 m -134.29 72.47 70.93 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 122.982 0.513 . . . . 0.0 109.74 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.69 -7.15 20.32 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.652 2.901 . . . . 0.0 111.589 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.57 -22.77 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 O-C-N 122.142 -0.348 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.72 -28.73 69.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.26 -0.275 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.57 -20.93 61.23 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.338 -0.227 . . . . 0.0 110.614 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -29.82 41.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.24 -32.9 61.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.55 61.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.21 -12.13 55.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 110.395 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -94.31 17.61 12.52 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.871 0.868 . . . . 0.0 110.972 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t0 59.74 31.26 20.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.661 1.184 . . . . 0.0 114.024 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 pt -128.28 143.79 49.39 Favored Pre-proline 0 CA--C 1.532 0.251 0 O-C-N 122.094 -0.379 . . . . 0.0 110.228 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.77 161.61 24.38 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.785 2.99 . . . . 0.0 111.793 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -145.63 165.4 28.8 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.227 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.7 t -137.62 146.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 124.339 1.056 . . . . 0.0 108.542 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.65 155.58 18.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.935 0.397 . . . . 0.0 111.226 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 119.22 11.37 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -174.02 161.09 3.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 109.859 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.02 145.69 25.98 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.48 -159.33 30.78 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 117.455 0.628 . . . . 0.0 112.03 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.9 t -141.05 159.79 41.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.779 0.831 . . . . 0.0 109.972 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -71.8 -5.96 38.08 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.42 4.39 50.62 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.8 m -129.56 22.2 5.52 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.328 0.651 . . . . 0.0 111.696 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.502 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 15.3 m -131.25 154.66 40.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 122.973 0.509 . . . . 0.0 112.072 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.2 168.0 20.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.312 1.045 . . . . 0.0 111.307 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.8 p -62.23 -17.45 58.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -73.61 -25.88 60.52 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.218 0.463 . . . . 0.0 110.167 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.502 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 15.7 m-85 -80.38 -24.39 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.45 -9.33 52.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.997 0.519 . . . . 0.0 111.63 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.02 -18.01 12.72 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -135.16 157.84 75.99 Favored Pre-proline 0 C--O 1.232 0.166 0 C-N-CA 122.847 0.459 . . . . 0.0 110.055 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.33 154.08 25.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.384 3.39 . . . . 0.0 114.082 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.22 154.23 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.381 1.072 . . . . 0.0 109.293 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.7 mt -143.4 156.95 44.8 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.203 0.601 . . . . 0.0 110.754 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -87.05 170.5 11.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.05 -38.84 52.52 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.59 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.78 125.23 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.076 1.85 . . . . 0.0 110.738 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -111.1 152.11 27.32 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.219 0.608 . . . . 0.0 110.187 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.2 p -141.3 159.41 42.27 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.737 0.815 . . . . 0.0 109.147 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -67.55 -26.91 66.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.17 -0.331 . . . . 0.0 111.077 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.66 -35.77 22.38 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.019 0.372 . . . . 0.0 111.676 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.18 -31.21 43.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.66 -28.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.648 0.724 . . . . 0.0 110.578 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.61 66.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.059 -0.401 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.55 -27.94 26.98 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 117.647 0.203 . . . . 0.0 110.966 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.03 -36.5 48.54 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.202 -0.311 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.42 -23.46 40.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.27 -0.269 . . . . 0.0 110.481 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.2 -24.17 60.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.15 -13.86 42.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.089 0.556 . . . . 0.0 111.327 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.33 -33.79 42.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.04 7.3 11.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.37 -179.534 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.702 -0.11 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 m 53.73 23.3 3.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.012 0.925 . . . . 0.0 113.287 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.0 38.58 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.296 0.638 . . . . 0.0 110.359 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -145.9 74.1 1.36 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.229 0.612 . . . . 0.0 110.382 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -77.29 -5.68 50.36 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.642 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 67.3 mt-30 -122.39 118.06 27.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -123.42 134.15 67.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.851 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -88.84 138.07 31.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.453 ' H ' HD23 ' A' ' 8' ' ' LEU . 77.2 mt -111.65 126.09 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.806 0.842 . . . . 0.0 109.558 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.8 t -132.18 122.33 48.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 122.775 0.43 . . . . 0.0 110.23 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -141.65 155.32 45.71 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.919 0.488 . . . . 0.0 110.733 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.83 -6.97 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.663 0.385 . . . . 0.0 110.926 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.17 125.93 17.24 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.987 0.515 . . . . 0.0 109.676 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.17 -25.01 76.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.966 2.444 . . . . 0.0 112.804 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.97 -33.14 74.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.099 -0.376 . . . . 0.0 110.525 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.85 -26.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.98 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.807 0.276 . . . . 0.0 110.827 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.64 -31.74 62.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.3 tpt -75.01 -23.73 58.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -39.63 81.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.64 -22.39 60.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.68 -40.14 66.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.904 0.32 . . . . 0.0 111.052 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -74.69 -27.55 60.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.776 -0.577 . . . . 0.0 110.595 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.07 -17.66 58.58 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.917 -0.489 . . . . 0.0 110.606 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -78.58 -28.29 45.85 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.33 -20.74 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.374 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.27 12.22 36.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.296 0.638 . . . . 0.0 111.995 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.89 33.91 15.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.556 0.742 . . . . 0.0 112.291 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.85 163.68 17.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.877 0.871 . . . . 0.0 110.09 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -117.8 74.75 9.7 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 122.698 0.399 . . . . 0.0 110.46 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.94 154.57 65.88 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.941 2.427 . . . . 0.0 109.682 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 33.8 m -115.87 -12.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.337 0.055 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 175.34 35.11 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.248 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -132.49 143.49 49.79 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.737 0.815 . . . . 0.0 108.941 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 34.3 m -146.07 163.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.008 0.523 . . . . 0.0 110.206 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.65 6.92 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.001 0.521 . . . . 0.0 112.065 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -146.12 156.55 43.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.056 0.542 . . . . 0.0 110.183 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.97 -28.31 40.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.98 62.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 -30.77 56.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.36 -38.34 87.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.809 0.805 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.73 -19.32 57.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 -24.97 49.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.088 0.404 . . . . 0.0 111.013 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -77.75 -32.87 52.94 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.05 -26.09 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.464 0.306 . . . . 0.0 110.247 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.39 -15.11 53.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 111.043 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.98 -12.88 20.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.661 0.384 . . . . 0.0 111.582 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.97 172.31 38.47 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.15 154.61 48.14 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.0 mt -141.93 146.04 23.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -103.28 -24.34 13.53 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 174.31 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.695 0.398 . . . . 0.0 110.396 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.11 162.34 40.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.077 -0.39 . . . . 0.0 111.754 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.02 127.97 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.035 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.23 124.63 50.72 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.745 0.418 . . . . 0.0 111.192 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -85.97 124.47 32.46 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.43 -5.31 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.708 0.803 . . . . 0.0 111.95 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -75.22 52.17 0.57 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 0.0 112.636 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.09 158.71 32.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.833 -0.542 . . . . 0.0 109.92 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -80.99 152.72 27.83 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 111.087 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.73 6.5 89.0 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.504 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.91 8.16 87.36 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 117.837 0.819 . . . . 0.0 111.992 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.79 167.31 20.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.656 0.728 . . . . 0.0 110.527 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -122.79 166.0 15.68 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 123.019 0.528 . . . . 0.0 110.997 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.4 p -133.89 8.27 3.8 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.992 0.917 . . . . 0.0 110.434 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.6 m -54.56 -35.65 34.45 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 71.6 Cg_exo -55.41 -19.65 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.685 2.257 . . . . 0.0 114.578 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.95 -26.24 9.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-N 118.858 0.754 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.9 60.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.41 -17.68 53.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.264 0.225 . . . . 0.0 110.533 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.53 -32.66 58.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.8 -26.32 60.56 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.45 61.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.919 0.327 . . . . 0.0 110.357 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.8 -18.83 53.47 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.09 7.7 44.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.554 0.742 . . . . 0.0 111.025 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 58.66 29.53 18.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.408 1.083 . . . . 0.0 113.106 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.8 127.81 29.28 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.5 158.52 44.01 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.759 2.973 . . . . 0.0 111.588 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -150.73 168.29 24.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.873 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.18 146.78 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.113 0.965 . . . . 0.0 108.891 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 21.2 m-85 -89.62 157.79 17.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.101 0.477 . . . . 0.0 111.266 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 144.62 37.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -161.95 174.16 13.46 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.29 117.34 0.76 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.82 -159.27 28.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m -71.09 160.0 33.69 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.887 0.475 . . . . 0.0 110.29 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.82 -11.44 60.38 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.79 -1.82 44.56 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.133 0.424 . . . . 0.0 111.469 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.4 t -78.92 -7.18 57.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.723 0.409 . . . . 0.0 110.92 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 m -135.59 154.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.393 0.677 . . . . 0.0 110.506 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.27 -178.64 3.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.802 0.841 . . . . 0.0 111.351 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.3 p -60.36 -19.68 56.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -70.05 -27.01 64.29 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.194 0.452 . . . . 0.0 110.157 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.405 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 16.0 m-85 -89.17 -18.16 27.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.761 0.824 . . . . 0.0 109.903 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -88.06 -8.81 54.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.511 0.324 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.63 -19.64 13.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.57 0.748 . . . . 0.0 110.842 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -103.61 160.99 24.37 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.997 0.919 . . . . 0.0 110.034 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.02 150.74 82.69 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.859 2.373 . . . . 0.0 110.829 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.48 154.23 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.903 0.881 . . . . 0.0 110.557 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.1 mt -134.56 153.86 51.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.726 0.81 . . . . 0.0 109.886 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -85.37 163.08 18.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.32 -48.04 13.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.348 -0.834 . . . . 0.0 113.221 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.16 138.95 18.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.874 1.716 . . . . 0.0 111.152 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -111.52 157.64 20.1 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.967 0.507 . . . . 0.0 110.506 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.3 p -140.92 165.6 27.07 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.711 1.204 . . . . 0.0 108.039 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.93 -36.68 79.97 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.871 -0.518 . . . . 0.0 111.192 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -84.59 -29.0 26.17 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.281 -0.262 . . . . 0.0 111.306 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.92 -28.16 51.16 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.334 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.01 -25.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 117.898 0.849 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.33 70.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.62 -20.86 30.7 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.478 0.311 . . . . 0.0 110.972 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.9 -40.08 55.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.844 0.293 . . . . 0.0 110.598 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.21 -25.66 42.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.69 62.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.218 0.463 . . . . 0.0 110.378 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.57 -16.58 34.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.044 0.537 . . . . 0.0 111.894 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.27 -33.72 15.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.516 0.326 . . . . 0.0 110.906 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.01 -3.04 58.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.762 0.425 . . . . 0.0 111.987 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.743 -1.122 . . . . 0.0 110.117 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.4 p -149.36 160.22 43.61 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.948 0.499 . . . . 0.0 109.917 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.56 22.15 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.697 0.799 . . . . 0.0 112.668 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 42.29 58.13 3.11 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 125.865 1.666 . . . . 0.0 111.817 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.21 -8.7 57.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.534 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -112.22 110.11 20.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.149 0.579 . . . . 0.0 111.905 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.88 139.47 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.401 0.68 . . . . 0.0 110.315 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.85 133.43 47.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.9 mt -98.69 126.47 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.34 109.21 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -143.03 160.18 40.86 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -89.44 -4.54 57.94 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.966 0.506 . . . . 0.0 111.538 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -140.31 140.07 22.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 O-C-N 122.039 -0.413 . . . . 0.0 110.976 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.07 -14.45 10.89 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.767 2.978 . . . . 0.0 112.799 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.33 -45.11 66.85 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.517 0.599 . . . . 0.0 110.703 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.06 -25.4 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.3 66.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.283 -0.261 . . . . 0.0 110.581 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mmt -82.33 -26.25 33.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.5 mmm -75.23 -29.22 60.18 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 122.137 -0.352 . . . . 0.0 110.625 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.47 -30.05 57.15 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.69 -22.21 56.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.882 0.31 . . . . 0.0 110.224 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.39 -45.13 20.1 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.22 -0.3 . . . . 0.0 111.29 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -78.88 -24.04 44.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.558 0.617 . . . . 0.0 112.435 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.34 -22.19 48.42 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.376 0.989 . . . . 0.0 111.066 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -85.23 -23.43 28.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.438 0.563 . . . . 0.0 111.167 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.07 -18.53 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.616 0.366 . . . . 0.0 110.884 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.07 20.22 19.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.867 0.467 . . . . 0.0 111.753 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 53.94 30.29 11.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.931 0.892 . . . . 0.0 113.114 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.5 tmtm? -85.76 164.29 17.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.479 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 23.8 m -123.18 71.8 45.32 Favored Pre-proline 0 CA--C 1.53 0.199 0 O-C-N 122.239 -0.288 . . . . 0.0 111.0 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.19 151.61 81.06 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.725 2.284 . . . . 0.0 109.408 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.1 m -112.57 -6.8 11.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.48 174.98 34.84 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -140.75 139.4 34.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.077 0.951 . . . . 0.0 108.684 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 156.02 29.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 122.877 0.471 . . . . 0.0 110.214 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -108.53 2.23 22.04 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 112.048 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.5 p -139.11 158.46 44.14 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 110.311 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.26 -22.93 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.654 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.32 -25.97 58.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.14 71.05 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.31 -30.89 48.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.39 0.595 . . . . 0.0 110.261 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.68 -32.46 53.09 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.51 56.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.172 -0.33 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -87.73 -25.91 23.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.1 -22.01 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.219 0.463 . . . . 0.0 111.293 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.99 -14.74 63.21 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.897 0.317 . . . . 0.0 110.802 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.28 -12.42 37.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.275 0.63 . . . . 0.0 110.81 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 -169.31 53.51 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 12.03 82.06 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.832 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.62 145.88 22.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.76 0.78 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.98 -22.24 5.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.625 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.3 171.07 15.34 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.571 0.748 . . . . 0.0 109.731 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.4 164.87 35.76 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.083 -0.386 . . . . 0.0 110.967 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.9 mt -122.64 133.16 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.25 142.71 45.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.296 0.638 . . . . 0.0 110.691 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -97.51 135.17 39.74 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.566 0.746 . . . . 0.0 109.169 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.35 -16.08 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -77.65 -2.86 38.05 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.541 0.336 . . . . 0.0 110.718 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.4 tp -108.39 98.72 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -82.34 144.04 30.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.07 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.31 -174.86 48.16 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.57 -24.05 68.69 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 122.119 -0.636 . . . . 0.0 111.552 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -126.66 166.54 17.16 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.869 0.868 . . . . 0.0 110.043 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp 43.98 -115.19 0.4 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.593 0.757 . . . . 0.0 110.947 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -139.62 -46.05 0.45 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.328 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.1 p -143.01 47.15 0.78 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 122.937 0.495 . . . . 0.0 111.831 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.8 -13.19 29.35 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.999 2.466 . . . . 0.0 112.245 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.06 -24.04 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.113 0.415 . . . . 0.0 110.326 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.07 65.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.08 -17.62 45.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.452 0.301 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.58 62.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.35 -28.97 64.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.99 -22.83 60.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.57 -19.58 55.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -92.33 10.6 29.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.347 0.659 . . . . 0.0 110.858 172.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t70 59.42 25.18 13.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 113.006 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.48 125.06 46.51 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 157.58 34.42 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.605 2.87 . . . . 0.0 111.113 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -149.39 167.52 25.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.214 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -138.45 141.94 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -82.93 148.46 27.64 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.53 129.68 33.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 169.73 22.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.601 0.36 . . . . 0.0 110.665 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.99 175.87 54.84 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.43 102.37 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -150.39 147.25 27.34 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.701 0.8 . . . . 0.0 109.929 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -105.63 -2.83 22.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 112.29 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.68 0.28 4.38 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.1 m -89.86 5.83 44.5 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.927 -0.483 . . . . 0.0 111.421 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.15 154.46 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.748 0.819 . . . . 0.0 111.118 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -102.86 175.54 5.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.709 0.804 . . . . 0.0 110.563 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -64.98 -11.35 37.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -75.77 -24.21 56.02 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.31 0.505 . . . . 0.0 109.938 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -86.8 -20.12 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -84.02 -12.93 54.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.74 0.416 . . . . 0.0 110.767 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -104.5 -16.69 14.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.355 0.662 . . . . 0.0 111.601 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -109.29 163.14 17.71 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.405 0.682 . . . . 0.0 110.402 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.87 148.2 68.57 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.572 2.848 . . . . 0.0 112.58 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.26 154.75 23.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.762 0.825 . . . . 0.0 110.328 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -145.89 154.26 41.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.744 0.818 . . . . 0.0 109.54 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -80.22 146.29 31.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.412 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 34.5 ttmt -72.33 -43.34 9.62 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.019 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 74.3 Cg_endo -69.59 142.26 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.197 1.463 . . . . 0.0 109.74 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.3 150.01 39.52 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 121.376 0.607 . . . . 0.0 111.971 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.6 p -143.7 166.47 24.77 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.028 1.331 . . . . 0.0 107.519 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 55.2 ttm -65.76 -28.19 68.84 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.737 -0.602 . . . . 0.0 110.977 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.32 -31.28 24.93 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.263 -0.273 . . . . 0.0 110.637 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.37 -24.67 67.63 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.648 -0.529 . . . . 0.0 112.129 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.3 p -86.23 -27.51 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 118.155 0.978 . . . . 0.0 110.969 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.09 69.86 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.08 -20.94 29.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.355 0.662 . . . . 0.0 110.584 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.25 61.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.59 -26.41 45.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.02 63.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.923 0.329 . . . . 0.0 110.127 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.82 -17.47 31.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.764 0.425 . . . . 0.0 111.743 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.4 -36.16 13.96 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.599 0.36 . . . . 0.0 111.66 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.72 3.99 54.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.728 0.411 . . . . 0.0 112.055 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.377 -1.297 . . . . 0.0 110.244 179.29 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.307 0.098 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t -150.63 165.0 34.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.784 0.434 . . . . 0.0 110.493 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.74 164.08 32.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.38 0.672 . . . . 0.0 110.554 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.28 74.1 1.45 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.654 0.74 . . . . 0.0 110.497 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -4.15 42.61 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.075 0.55 . . . . 0.0 110.971 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.414 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 82.5 mt-30 -124.03 115.89 21.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mm -122.26 132.64 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.394 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.458 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 141.3 28.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.458 ' H ' HD21 ' A' ' 8' ' ' LEU . 69.5 mt -105.53 122.45 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.874 0.87 . . . . 0.0 109.251 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.25 113.25 21.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -145.39 163.26 35.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.252 0.548 . . . . 0.0 112.424 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.46 2.45 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.921 1.288 . . . . 0.0 112.153 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -137.8 134.19 18.08 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 123.021 0.528 . . . . 0.0 110.206 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.48 -16.92 14.85 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.344 2.696 . . . . 0.0 111.893 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.88 -41.74 29.02 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.235 -0.29 . . . . 0.0 110.404 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.9 mm -78.25 -30.0 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.46 -29.02 68.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.9 ttt -75.11 -33.86 61.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mtp -73.34 -24.28 60.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.406 HD22 ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -70.17 -39.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.27 -29.38 66.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.113 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.43 -38.4 65.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -72.77 -23.43 60.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.318 0.508 . . . . 0.0 111.615 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.82 -21.74 54.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.696 0.68 . . . . 0.0 110.872 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.02 -21.47 29.42 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.452 0.569 . . . . 0.0 111.444 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.8 t -85.2 -23.09 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 117.99 0.359 . . . . 0.0 110.42 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.17 13.76 33.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.188 0.595 . . . . 0.0 111.218 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.14 35.44 19.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.75 0.82 . . . . 0.0 112.486 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.79 163.94 17.86 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.81 0.844 . . . . 0.0 109.817 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.4 m -110.4 89.34 8.57 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.293 -0.254 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.15 158.82 55.04 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.84 2.36 . . . . 0.0 110.466 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 30.6 m -130.17 -10.67 2.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.6 169.61 28.43 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 118.198 0.454 . . . . 0.0 112.093 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.9 m -142.12 136.63 30.27 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.27 150.59 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.181 0.515 . . . . 0.0 111.098 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -92.72 -3.73 54.33 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.96 0.904 . . . . 0.0 111.607 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -151.97 158.32 42.95 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.363 0.665 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.1 -23.09 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 121.936 0.094 . . . . 0.0 110.995 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.22 68.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.854 -0.529 . . . . 0.0 109.876 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.53 -22.39 72.86 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.4 -34.48 65.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.967 0.883 . . . . 0.0 109.932 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.49 -27.54 61.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.13 -24.67 59.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -87.16 -26.1 23.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.129 0.422 . . . . 0.0 111.309 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -77.51 -26.49 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.134 0.425 . . . . 0.0 110.12 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -82.45 -14.37 55.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.689 0.396 . . . . 0.0 111.561 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.79 -13.54 16.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.41 41.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.52 145.61 30.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.2 mt -142.85 145.46 23.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -101.17 -25.06 14.15 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 118.093 0.406 . . . . 0.0 111.913 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.21 173.06 10.53 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.946 0.498 . . . . 0.0 110.05 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.48 159.29 44.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.483 0.182 . . . . 0.0 111.161 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.0 123.8 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.28 130.63 56.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.042 0.537 . . . . 0.0 110.019 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.89 152.43 24.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.42 -11.52 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -110.26 151.11 27.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.027 0.531 . . . . 0.0 111.4 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.5 mt -143.38 159.81 41.69 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.662 1.185 . . . . 0.0 109.074 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -81.95 149.02 28.4 Favored 'General case' 0 C--O 1.23 0.072 0 O-C-N 122.347 -0.221 . . . . 0.0 111.407 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.72 -175.72 16.65 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.145 0.402 . . . . 0.0 112.629 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.55 2.19 84.54 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -79.86 163.92 23.99 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.374 0.67 . . . . 0.0 111.333 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 58.22 175.3 0.06 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.827 1.251 . . . . 0.0 112.719 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.1 p -151.75 164.03 37.87 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.26 0.624 . . . . 0.0 109.758 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 24.9 m -63.35 -37.32 29.85 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -175.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 52.0 Cg_exo -57.63 -5.43 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.652 2.901 . . . . 0.0 114.372 177.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.04 -22.96 32.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.862 0.755 . . . . 0.0 110.845 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.43 -26.64 67.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.189 -0.319 . . . . 0.0 110.154 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' CD ' HH12 ' A' ' 93' ' ' ARG . 50.7 mt-10 -79.03 -17.39 55.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.974 -0.454 . . . . 0.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.3 59.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.13 -34.64 75.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.01 62.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.276 -0.265 . . . . 0.0 110.724 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.34 53.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.54 0.336 . . . . 0.0 110.518 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -99.64 18.49 17.91 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.78 0.832 . . . . 0.0 110.691 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.43 32.22 18.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.367 1.067 . . . . 0.0 113.619 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.47 118.66 24.75 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 160.42 37.24 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.293 3.329 . . . . 0.0 112.615 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.54 166.86 24.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.457 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -141.08 155.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 109.042 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 23.9 m-85 -88.21 159.19 18.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.11 122.22 19.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.1 t -163.78 179.14 7.31 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.886 0.474 . . . . 0.0 110.511 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.19 137.4 5.25 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.15 29.5 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.1 t -76.84 162.41 27.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.004 0.522 . . . . 0.0 110.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.74 -9.65 58.88 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.663 0.385 . . . . 0.0 110.728 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.98 -4.76 59.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.001 0.52 . . . . 0.0 110.612 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -95.37 9.48 39.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.079 0.552 . . . . 0.0 111.938 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.76 154.48 36.86 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.23 0.612 . . . . 0.0 111.131 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -107.47 -176.15 2.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.103 0.961 . . . . 0.0 111.024 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -62.73 -14.46 44.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.524 HH12 ' CD ' ' A' ' 70' ' ' GLU . 85.9 mtt-85 -65.76 -31.87 73.1 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.558 0.343 . . . . 0.0 110.238 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 29.1 m-85 -89.54 -19.47 24.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.605 0.762 . . . . 0.0 109.948 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -88.52 -3.75 58.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.81 0.444 . . . . 0.0 111.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.82 -13.44 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.33 0.652 . . . . 0.0 111.951 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.52 153.45 81.42 Favored Pre-proline 0 C--N 1.34 0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.985 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.74 154.98 51.44 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.36 2.707 . . . . 0.0 113.119 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.28 153.5 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.983 0.913 . . . . 0.0 109.068 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.0 tp -138.09 153.7 49.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.603 0.761 . . . . 0.0 109.755 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -73.68 157.48 36.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.534 0.334 . . . . 0.0 110.512 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -74.56 -50.46 4.54 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.628 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.13 147.55 29.98 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.254 1.969 . . . . 0.0 110.197 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.406 ' CZ ' HD22 ' A' ' 20' ' ' LEU . 4.0 m-30 -111.4 150.82 29.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.106 0.562 . . . . 0.0 110.545 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.7 p -143.26 167.19 22.72 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.093 0.957 . . . . 0.0 108.848 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 83.6 mmm -61.04 -39.48 89.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.036 -0.415 . . . . 0.0 110.791 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.37 -25.46 29.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.297 0.239 . . . . 0.0 111.301 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.71 -25.24 70.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.6 t -85.54 -28.1 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.37 0.585 . . . . 0.0 110.356 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.79 70.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -85.05 -20.69 30.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.797 0.439 . . . . 0.0 110.958 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.48 63.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.152 0.433 . . . . 0.0 110.379 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.12 -26.92 53.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.765 0.257 . . . . 0.0 110.708 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.58 -20.58 26.21 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.509 0.324 . . . . 0.0 111.604 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.25 -36.25 14.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.05 9.17 42.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -173.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.037 -1.458 . . . . 0.0 109.831 178.071 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.209 0.052 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m -129.66 16.33 5.88 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.111 0.564 . . . . 0.0 111.614 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.93 164.52 26.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.287 0.565 . . . . 0.0 110.855 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.93 76.64 1.55 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.489 0.661 . . . . 0.0 109.798 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -8.45 57.57 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.244 0.618 . . . . 0.0 111.984 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 66.0 mt-30 -119.37 114.65 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.698 0.681 . . . . 0.0 112.224 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.1 mm -120.24 130.25 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.499 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -87.91 142.86 27.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.499 ' H ' HD21 ' A' ' 8' ' ' LEU . 87.0 mt -110.52 120.89 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.908 0.883 . . . . 0.0 109.05 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.27 120.68 43.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.741 0.417 . . . . 0.0 110.875 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -156.91 158.3 36.42 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -73.84 -7.91 54.01 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.75 0.82 . . . . 0.0 112.132 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.93 132.0 24.09 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.049 0.54 . . . . 0.0 109.901 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.47 -18.79 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.35 2.7 . . . . 0.0 111.405 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.96 -34.73 71.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.082 0.401 . . . . 0.0 110.735 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.1 mm -86.3 -23.74 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.11 78.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.037 -0.414 . . . . 0.0 109.896 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.4 mtt -77.71 -27.29 50.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.0 ttt -69.07 -29.4 67.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.46 -33.02 66.72 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.14 -24.81 64.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.081 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.31 -43.45 60.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.9 0.318 . . . . 0.0 111.338 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -73.54 -22.29 60.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.845 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.18 -18.04 53.78 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.559 0.618 . . . . 0.0 110.838 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -85.31 -22.1 28.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.319 0.509 . . . . 0.0 110.449 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.45 -19.65 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.891 0.476 . . . . 0.0 110.317 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -105.37 16.28 25.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.338 0.655 . . . . 0.0 111.838 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.0 35.0 14.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.734 0.813 . . . . 0.0 112.499 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HZ3' HD12 ' A' ' 117' ' ' LEU . 1.0 OUTLIER -86.07 165.73 16.4 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 -179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -115.19 77.83 5.53 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 122.75 0.42 . . . . 0.0 110.284 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.95 157.18 54.16 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.047 2.498 . . . . 0.0 110.203 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 32.8 m -121.59 -14.6 7.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.46 176.47 36.26 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.666 0.666 . . . . 0.0 112.728 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 140.26 46.32 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.34 1.056 . . . . 0.0 108.885 175.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.51 154.67 20.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.008 0.432 . . . . 0.0 110.128 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -102.89 -1.49 29.46 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.03 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.9 p -141.42 159.71 41.65 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.794 0.438 . . . . 0.0 110.49 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.82 -22.81 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.682 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.16 54.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.22 -27.63 61.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.18 78.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.16 -26.71 63.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.52 -24.73 62.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.305 0.242 . . . . 0.0 111.316 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -86.57 -23.85 25.66 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.757 0.253 . . . . 0.0 111.293 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.6 -29.66 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 117.923 0.329 . . . . 0.0 111.064 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.54 -14.36 55.03 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.983 -0.448 . . . . 0.0 112.009 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.03 -12.76 15.35 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.123 0.569 . . . . 0.0 112.286 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.92 164.28 37.71 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.69 140.36 24.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.5 mt -144.75 143.98 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -96.7 -32.31 12.24 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.449 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.55 11.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.578 0.351 . . . . 0.0 110.318 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.0 157.83 43.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.668 0.27 . . . . 0.0 111.256 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.0 mt -113.46 123.56 69.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.9 130.8 56.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.455 0.702 . . . . 0.0 110.226 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 170.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.29 -11.88 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 O-C-N 122.034 -0.416 . . . . 0.0 111.968 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -104.92 141.49 36.44 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.952 -0.468 . . . . 0.0 110.159 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.2 tp -156.78 133.87 10.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.753 0.821 . . . . 0.0 109.209 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -78.67 137.32 37.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.82 1.7 40.74 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 120.0 -0.333 . . . . 0.0 112.688 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.58 164.08 44.92 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 117.747 0.774 . . . . 0.0 111.668 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.84 147.7 50.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.359 0.663 . . . . 0.0 110.108 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm 49.48 43.04 23.52 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.508 0.723 . . . . 0.0 111.352 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.3 p 49.7 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.352 1.461 . . . . 0.0 112.787 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -133.53 78.57 62.1 Favored Pre-proline 0 C--O 1.234 0.238 0 C-N-CA 123.178 0.591 . . . . 0.0 109.988 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.82 -11.96 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.561 2.841 . . . . 0.0 111.741 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.38 -17.64 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 122.158 -0.339 . . . . 0.0 111.036 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.92 74.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.847 -0.533 . . . . 0.0 110.156 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.28 -18.26 60.74 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.176 -0.327 . . . . 0.0 111.082 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.46 -29.29 37.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 99.2 mt -72.85 -37.46 67.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.16 -22.37 62.06 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.05 -12.61 54.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.414 0.286 . . . . 0.0 110.721 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -103.91 17.88 23.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.984 0.914 . . . . 0.0 110.779 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 59.06 34.13 23.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.125 0.97 . . . . 0.0 113.264 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.4 mt -120.77 102.2 44.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.849 0.86 . . . . 0.0 108.689 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.57 158.9 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.919 3.079 . . . . 0.0 112.745 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.21 167.13 23.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 111.409 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.4 t -134.74 144.19 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.838 0.855 . . . . 0.0 109.399 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -90.81 151.49 21.15 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 111.124 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.43 143.13 33.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.599 0.76 . . . . 0.0 109.234 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -159.77 158.39 31.09 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 111.007 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.67 95.93 0.96 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 172.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.51 -162.15 33.67 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.3 p -81.48 164.52 21.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.407 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -4.17 49.23 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.585 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.83 -1.3 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.295 0.638 . . . . 0.0 111.05 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.7 m -85.12 7.88 20.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.114 0.566 . . . . 0.0 111.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.439 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.0 m -137.83 154.7 29.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.786 0.834 . . . . 0.0 110.981 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 169.15 17.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.791 0.836 . . . . 0.0 111.917 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 m -61.53 -16.73 50.3 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -75.91 -24.27 55.58 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.7 0.682 . . . . 0.0 110.373 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.439 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 11.8 m-85 -84.24 -20.57 32.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -86.89 -13.01 46.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.086 0.554 . . . . 0.0 110.818 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.73 -27.3 18.14 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.743 0.417 . . . . 0.0 110.354 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -91.46 160.98 35.69 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.96 154.44 61.74 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.873 2.382 . . . . 0.0 111.355 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.9 m -138.9 154.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.152 0.581 . . . . 0.0 110.594 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.9 tp -147.28 146.71 29.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.876 0.471 . . . . 0.0 110.038 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -79.86 163.74 24.13 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.277 0.231 . . . . 0.0 110.585 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.7 -39.12 2.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.11 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.94 133.58 48.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.84 146.13 46.01 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.107 0.563 . . . . 0.0 110.477 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.521 HG21 ' H ' ' A' ' 108' ' ' GLY . 9.8 t -153.34 159.04 42.39 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.787 0.835 . . . . 0.0 109.189 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -63.46 -28.9 70.28 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.62 -39.94 18.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.574 0.625 . . . . 0.0 111.905 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.521 ' H ' HG21 ' A' ' 105' ' ' THR . . . -80.19 -25.7 56.82 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 122.121 -0.362 . . . . 0.0 112.375 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.53 -28.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.685 0.743 . . . . 0.0 110.338 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -29.05 64.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.976 -0.452 . . . . 0.0 110.155 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -83.95 -25.33 30.16 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 110.668 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.32 -32.45 37.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.65 0.204 . . . . 0.0 110.724 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -34.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.44 63.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.059 -0.4 . . . . 0.0 110.567 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 -14.92 39.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.437 0.295 . . . . 0.0 111.345 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.99 -29.52 17.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.271 0.628 . . . . 0.0 110.865 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.465 HD12 ' HZ3' ' A' ' 29' ' ' LYS . 16.3 tp -85.97 10.55 13.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 112.035 -175.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.154 -1.403 . . . . 0.0 110.585 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m -141.37 156.59 45.8 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.301 0.64 . . . . 0.0 110.254 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.27 -20.4 0.7 Allowed 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt 50.63 25.1 1.89 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -8.76 52.13 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 118.392 0.542 . . . . 0.0 111.191 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -118.99 118.88 32.69 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.14 0.427 . . . . 0.0 111.642 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -119.04 131.22 72.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 O-C-N 123.737 0.648 . . . . 0.0 109.881 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.69 130.19 44.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 86.3 mt -98.67 135.23 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -132.12 125.6 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -149.39 162.85 39.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.231 0.539 . . . . 0.0 112.423 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -123.46 11.86 9.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 109.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -145.03 113.78 4.92 Favored Pre-proline 0 N--CA 1.453 -0.311 0 C-N-CA 124.82 1.248 . . . . 0.0 107.944 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.86 -16.33 11.45 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.06 3.173 . . . . 0.0 114.655 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.47 -23.06 60.03 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.4 -27.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.61 -25.48 61.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.276 -0.265 . . . . 0.0 110.449 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.11 -35.17 28.82 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.448 -0.157 . . . . 0.0 110.779 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 98.1 mmm -75.43 -34.39 60.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.99 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.35 -28.18 42.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.131 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.52 -21.63 55.49 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.798 -0.564 . . . . 0.0 110.088 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.64 -41.32 46.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.194 -0.316 . . . . 0.0 111.447 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -82.08 -21.43 36.81 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.361 0.528 . . . . 0.0 112.368 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.21 -18.09 55.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.075 0.852 . . . . 0.0 110.137 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -85.28 -29.38 24.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.811 0.278 . . . . 0.0 110.774 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -83.28 -19.76 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 122.715 0.406 . . . . 0.0 110.774 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.09 14.53 28.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.793 0.437 . . . . 0.0 111.54 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 51.05 34.72 11.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.652 0.781 . . . . 0.0 111.461 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HD3' ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -85.55 162.7 18.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.849 0.86 . . . . 0.0 110.374 -176.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.415 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 56.8 m -114.42 88.02 14.91 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.951 0.5 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.76 157.94 58.68 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.83 2.354 . . . . 0.0 109.55 176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.46 -16.9 4.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 174.21 33.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 118.329 0.513 . . . . 0.0 112.588 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -137.2 139.65 41.22 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.45 161.04 31.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 110.618 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -131.67 7.43 4.45 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.976 0.51 . . . . 0.0 112.188 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.9 p -136.39 156.69 48.27 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.968 0.507 . . . . 0.0 109.89 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.07 -29.9 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.8 65.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.157 -0.34 . . . . 0.0 110.363 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.33 -24.85 56.14 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.83 -34.99 60.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.614 0.707 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.37 -24.24 32.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.929 0.331 . . . . 0.0 110.393 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.75 57.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.207 0.458 . . . . 0.0 110.728 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -84.37 -31.11 24.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.463 0.705 . . . . 0.0 110.136 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.64 -25.27 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.66 0.384 . . . . 0.0 111.686 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -71.27 -19.08 62.39 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.651 -0.655 . . . . 0.0 111.153 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.91 -12.59 58.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.726 0.298 . . . . 0.0 110.999 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.99 -169.07 53.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.92 81.83 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.634 -0.536 . . . . 0.0 112.577 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.85 147.04 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 117.785 0.793 . . . . 0.0 109.536 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.6 -17.0 5.63 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.38 166.64 28.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.232 0.469 . . . . 0.0 110.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.04 165.53 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.28 -0.263 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.24 133.25 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.36 130.61 56.69 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.086 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -84.39 138.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.93 -12.24 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.443 0.297 . . . . 0.0 110.485 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.58 134.47 47.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 tp -155.05 152.24 29.35 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.824 0.45 . . . . 0.0 110.107 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -75.31 152.9 38.13 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.055 0.542 . . . . 0.0 111.212 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.83 -172.85 48.54 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 0.62 73.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.377 0.513 . . . . 0.0 113.034 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -68.51 151.39 46.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.915 0.857 . . . . 0.0 110.835 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -144.61 20.97 1.67 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.192 0.597 . . . . 0.0 110.641 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -135.29 163.01 30.96 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.105 0.562 . . . . 0.0 111.088 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 m -136.21 66.28 59.46 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.359 0.664 . . . . 0.0 109.416 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.54 -11.83 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.741 2.961 . . . . 0.0 111.812 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -72.44 -13.65 16.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.344 0.258 . . . . 0.0 110.906 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.23 -24.47 63.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 122.221 -0.299 . . . . 0.0 110.388 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.55 -17.39 45.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.342 -0.224 . . . . 0.0 110.466 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.92 61.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.16 -27.02 60.64 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.76 57.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.15 -16.39 56.72 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -91.7 13.67 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.839 0.856 . . . . 0.0 110.026 172.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 60.71 30.5 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.551 1.141 . . . . 0.0 113.646 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.21 124.96 29.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.39 161.04 38.23 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.09 3.193 . . . . 0.0 111.062 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -152.12 171.25 18.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.218 0.533 . . . . 0.0 111.752 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.66 144.7 20.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 124.058 0.943 . . . . 0.0 109.017 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.03 154.46 22.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.408 0.283 . . . . 0.0 110.824 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.52 119.81 22.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -153.41 173.11 16.08 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 111.421 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 135.33 3.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.8 -156.12 26.52 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.1 p -79.26 175.37 10.66 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.954 0.502 . . . . 0.0 110.621 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.02 -6.6 34.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.73 0.412 . . . . 0.0 112.02 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -92.59 -7.64 46.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.021 0.528 . . . . 0.0 111.173 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.4 m -78.92 0.75 26.15 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.008 -0.432 . . . . 0.0 111.547 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 m -140.06 153.16 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.252 0.621 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.9 177.76 4.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.179 0.992 . . . . 0.0 110.485 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -61.63 -18.46 59.54 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.781 -0.575 . . . . 0.0 111.965 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -76.48 -20.74 56.66 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.862 0.755 . . . . 0.0 111.2 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -84.2 -19.29 34.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -88.15 -4.85 58.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.421 0.688 . . . . 0.0 110.264 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.84 -11.19 14.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.695 1.198 . . . . 0.0 111.572 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.75 163.12 41.04 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.92 0.888 . . . . 0.0 110.115 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.61 147.33 92.3 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.625 2.884 . . . . 0.0 112.53 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -140.19 151.36 21.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.603 0.761 . . . . 0.0 110.472 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -146.13 155.2 42.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.012 0.925 . . . . 0.0 108.662 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -85.7 162.03 18.95 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.332 -0.23 . . . . 0.0 110.884 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.68 -41.45 9.55 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.974 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.76 124.52 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.409 2.073 . . . . 0.0 110.875 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -107.33 143.15 36.02 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.472 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.3 t -155.7 163.67 39.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.99 -23.64 65.53 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -173.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.44 -38.74 21.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.379 0.536 . . . . 0.0 110.937 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.472 ' H ' HG23 ' A' ' 105' ' ' THR . . . -74.64 -26.75 66.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.6 t -81.44 -21.71 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.734 0.414 . . . . 0.0 109.913 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.18 -30.68 62.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.318 0.508 . . . . 0.0 110.703 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.24 -27.49 38.67 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.52 55.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -72.7 -32.75 66.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.944 0.498 . . . . 0.0 109.812 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.41 -17.97 40.34 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.641 0.376 . . . . 0.0 111.942 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.06 9.88 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -99.11 -58.35 1.96 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.891 0.314 . . . . 0.0 111.791 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.86 -4.21 6.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.972 0.909 . . . . 0.0 112.768 -176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.244 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ptm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.422 0.153 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -148.73 154.07 39.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.93 0.492 . . . . 0.0 110.127 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.45 165.51 36.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.088 0.555 . . . . 0.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.1 63.48 1.41 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.605 0.717 . . . . 0.0 110.41 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -2.13 21.11 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.683 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.5 mt-30 -124.03 111.18 15.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.118 0.417 . . . . 0.0 110.786 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.4 mm -119.4 128.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.085 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.99 135.07 33.75 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.5 mt -102.88 134.58 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.02 0.528 . . . . 0.0 109.82 -178.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.07 106.29 10.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -149.85 163.32 38.33 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 123.872 0.869 . . . . 0.0 110.531 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -112.76 -13.73 13.19 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.712 0.405 . . . . 0.0 110.912 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -84.69 127.28 65.98 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.71 -14.01 14.29 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.36 2.706 . . . . 0.0 112.757 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -93.73 -38.47 11.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.602 0.637 . . . . 0.0 111.881 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.25 -28.39 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.82 63.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.852 0.061 . . . . 0.0 110.993 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.4 mtt -84.98 -27.86 26.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.395 -0.191 . . . . 0.0 110.672 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.7 mmm -77.94 -28.42 49.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.728 0.24 . . . . 0.0 110.494 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 21.9 tp -78.95 -30.96 44.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.222 -0.299 . . . . 0.0 110.326 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.65 -26.67 61.73 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.73 -35.19 52.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.361 -0.212 . . . . 0.0 110.485 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -73.35 -27.06 61.29 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.871 -0.518 . . . . 0.0 111.7 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -79.17 -17.8 54.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.613 0.642 . . . . 0.0 110.836 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.14 -29.46 24.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.854 0.297 . . . . 0.0 110.965 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.15 -21.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 122.584 0.353 . . . . 0.0 111.389 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 16.98 17.8 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.882 0.473 . . . . 0.0 111.648 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t0 52.02 34.46 13.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.975 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.79 165.45 16.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.698 0.799 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 77.95 6.52 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.199 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.11 160.55 41.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.54 2.827 . . . . 0.0 110.478 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.7 m -127.37 -25.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.1 176.79 36.29 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 118.527 0.603 . . . . 0.0 112.612 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.8 m -137.61 141.91 41.26 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.96 0.904 . . . . 0.0 108.708 176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.94 159.0 37.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 122.642 0.377 . . . . 0.0 110.152 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.61 -5.98 28.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.853 0.461 . . . . 0.0 111.994 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.7 p -143.06 161.08 39.11 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.085 0.554 . . . . 0.0 110.475 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.17 -22.72 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.787 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.46 -29.67 66.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.51 -27.56 65.23 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.4 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.323 0.562 . . . . 0.0 110.059 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.44 -23.25 50.55 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 177.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.37 45.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.728 0.24 . . . . 0.0 111.386 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -87.35 -21.92 25.4 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.131 -0.356 . . . . 0.0 111.696 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.53 -22.0 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.26 -16.19 60.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.08 -12.42 21.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.403 0.681 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 -167.68 54.03 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.17 24.33 61.63 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.631 -0.538 . . . . 0.0 112.609 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mt -137.22 147.66 26.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.386 0.674 . . . . 0.0 109.306 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -116.28 -26.98 6.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.63 12.49 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.045 0.384 . . . . 0.0 110.582 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.93 34.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.719 0.295 . . . . 0.0 111.388 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.1 mt -122.48 130.44 74.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.81 133.6 54.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.08 155.79 19.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.56 -11.87 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -107.97 141.84 39.0 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.045 0.538 . . . . 0.0 110.656 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.5 mt -143.53 172.6 12.56 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.475 1.11 . . . . 0.0 108.929 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -82.27 134.43 35.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 3.62 72.14 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.777 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.23 157.88 23.03 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 118.786 1.293 . . . . 0.0 112.267 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.52 164.48 22.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.426 0.691 . . . . 0.0 111.26 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.5 tttp 55.85 28.46 12.48 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.576 1.15 . . . . 0.0 113.072 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -82.57 24.44 0.71 Allowed 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.952 -0.468 . . . . 0.0 111.388 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.446 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 7.9 m -56.82 -34.15 23.93 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 66' ' ' THR . 77.7 Cg_exo -56.84 -12.79 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.908 2.406 . . . . 0.0 114.111 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.45 -13.89 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.47 -24.65 67.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.815 -0.553 . . . . 0.0 109.76 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.26 -17.99 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.457 0.303 . . . . 0.0 110.724 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.16 -27.23 39.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.03 -27.7 61.07 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -25.57 58.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.91 -16.46 56.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -92.67 6.6 46.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.754 0.821 . . . . 0.0 110.136 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.31 35.35 20.74 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.262 1.025 . . . . 0.0 113.199 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.79 129.73 25.18 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.64 157.51 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.602 2.868 . . . . 0.0 111.302 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -145.01 164.79 30.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.609 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -136.12 147.56 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 124.604 1.162 . . . . 0.0 108.837 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 28.9 m-85 -91.98 155.35 18.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.895 0.378 . . . . 0.0 111.682 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.87 128.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -165.28 158.85 16.73 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.657 0.265 . . . . 0.0 111.009 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.61 136.99 13.16 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.04 -151.91 23.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 82.8 p -119.36 176.05 5.53 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.443 0.697 . . . . 0.0 110.55 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.56 -1.92 12.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.833 0.453 . . . . 0.0 111.739 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.66 1.28 14.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.359 0.663 . . . . 0.0 111.187 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -87.16 7.64 27.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.348 0.659 . . . . 0.0 111.609 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.1 m -139.63 155.86 25.65 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 123.748 0.819 . . . . 0.0 111.628 -175.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.57 162.63 20.49 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.949 0.9 . . . . 0.0 111.36 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.8 m -59.1 -19.56 45.56 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -74.12 -25.43 59.76 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.987 0.812 . . . . 0.0 110.743 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 7.1 m-85 -79.98 -19.31 48.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -88.16 -10.22 50.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.827 0.451 . . . . 0.0 110.669 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.91 -11.58 15.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.647 0.779 . . . . 0.0 111.618 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -121.34 160.92 43.75 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.399 0.679 . . . . 0.0 110.118 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.33 148.89 84.37 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.996 2.464 . . . . 0.0 112.242 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.61 154.86 17.97 Favored 'Isoleucine or valine' 0 C--O 1.23 0.046 0 C-N-CA 124.139 0.976 . . . . 0.0 109.909 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.3 tp -138.55 145.16 40.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.821 0.449 . . . . 0.0 109.832 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -76.68 165.27 24.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.774 0.43 . . . . 0.0 110.38 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -79.19 -39.15 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.763 -177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.96 143.81 95.73 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.589 2.192 . . . . 0.0 110.567 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 1.7 m-85 -118.96 133.39 55.86 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.922 0.392 . . . . 0.0 111.348 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -143.33 155.53 44.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.783 1.233 . . . . 0.0 108.923 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.96 -28.6 66.78 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 122.199 -0.313 . . . . 0.0 111.61 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -84.5 -35.24 23.05 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.051 -0.406 . . . . 0.0 111.634 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.0 -38.93 29.09 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.307 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.89 -22.93 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 117.857 0.829 . . . . 0.0 111.162 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.2 64.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.503 -0.748 . . . . 0.0 110.306 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -78.8 -31.96 46.14 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.34 -26.68 46.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.183 0.193 . . . . 0.0 111.038 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.55 -38.7 65.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.25 -23.47 62.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.416 -0.177 . . . . 0.0 110.678 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.08 -13.84 43.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.84 0.456 . . . . 0.0 111.468 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.7 tt -90.89 -29.27 17.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.145 0.578 . . . . 0.0 110.699 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.4 tp -82.91 6.65 17.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.956 0.503 . . . . 0.0 111.887 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.802 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -147.53 169.77 18.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.269 0.627 . . . . 0.0 110.222 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' A' ' 5' ' ' THR . . . -147.61 179.13 7.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.985 0.514 . . . . 0.0 110.526 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.35 25.23 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.529 0.731 . . . . 0.0 112.677 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.449 ' H ' ' C ' ' A' ' 3' ' ' ALA . 0.8 OUTLIER -92.03 -11.18 36.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.691 -0.631 . . . . 0.0 110.424 176.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.401 ' HB3' HG12 ' A' ' 32' ' ' VAL . 24.6 mp0 -111.49 104.6 13.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.779 0.432 . . . . 0.0 110.977 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.03 124.11 72.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.981 0.512 . . . . 0.0 110.434 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -86.79 146.99 26.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.502 ' H ' HD23 ' A' ' 8' ' ' LEU . 95.0 mt -110.53 128.1 67.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.922 0.889 . . . . 0.0 109.675 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.3 122.73 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.071 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.97 163.29 33.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.289 0.235 . . . . 0.0 111.262 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.32 -11.32 32.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.53 135.57 13.14 Favored Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.41 -17.32 44.07 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.089 2.526 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -77.87 -37.42 48.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.456 0.571 . . . . 0.0 110.01 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -77.55 -27.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.54 68.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.198 -0.314 . . . . 0.0 110.281 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -76.73 -27.3 55.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -73.22 -33.4 65.32 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.65 -31.65 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.23 -0.294 . . . . 0.0 110.409 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.93 -21.82 43.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.37 -42.96 42.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.094 -0.378 . . . . 0.0 110.15 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.94 -19.36 60.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.641 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.63 -29.29 66.75 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.164 0.438 . . . . 0.0 110.116 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -84.72 -29.58 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.491 0.316 . . . . 0.0 111.385 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -71.55 -24.24 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 6.57 48.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.173 0.589 . . . . 0.0 111.032 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t0 50.73 37.75 17.55 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.584 0.754 . . . . 0.0 111.49 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.6 tmtm? -85.69 158.84 19.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.855 0.862 . . . . 0.0 110.422 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 88.7 m -92.08 124.39 60.07 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.42 153.86 35.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.63 2.886 . . . . 0.0 110.872 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 6' ' ' GLN . 24.8 m -141.77 -21.86 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.409 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.66 163.05 16.92 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -143.96 134.86 25.3 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.57 161.2 24.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.898 0.38 . . . . 0.0 111.117 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -136.08 3.74 2.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.119 0.568 . . . . 0.0 111.546 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -139.3 161.72 36.75 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.357 0.663 . . . . 0.0 110.78 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.41 -32.99 52.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 122.437 0.295 . . . . 0.0 110.239 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.4 -29.51 53.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.347 -0.22 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.89 -33.0 52.04 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 -33.83 74.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.409 0.604 . . . . 0.0 110.511 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.21 -29.02 60.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.26 60.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.47 -26.96 22.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 118.328 0.513 . . . . 0.0 112.15 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -83.28 -21.69 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 118.04 0.382 . . . . 0.0 111.522 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -81.56 -23.05 37.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.41 -13.63 8.4 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.733 0.697 . . . . 0.0 112.316 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.39 -164.94 40.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.51 137.18 5.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.49 164.5 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.74 0.816 . . . . 0.0 110.802 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -124.13 -10.72 7.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.014 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.87 165.85 20.1 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.503 0.721 . . . . 0.0 109.056 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.09 158.0 43.48 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.729 -0.607 . . . . 0.0 111.903 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.7 mm -97.46 121.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.07 124.87 49.13 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.97 118.32 11.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 168.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.56 -29.27 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -171.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -158.53 154.81 27.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.197 0.453 . . . . 0.0 110.983 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.522 ' CD1' ' H ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -151.25 170.35 19.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.203 1.001 . . . . 0.0 108.605 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.522 ' H ' ' CD1' ' A' ' 59' ' ' LEU . 79.9 ttt180 -58.37 135.51 57.22 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.861 -0.525 . . . . 0.0 110.158 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.01 -1.98 45.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.472 -0.627 . . . . 0.0 112.863 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.22 147.29 28.57 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 118.256 1.028 . . . . 0.0 111.304 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.48 154.63 45.9 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.962 0.505 . . . . 0.0 111.17 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 53.15 17.26 0.93 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.966 1.307 . . . . 0.0 114.461 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 m 56.83 -179.26 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.226 1.01 . . . . 0.0 112.878 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -71.09 139.64 85.21 Favored Pre-proline 0 CA--C 1.532 0.255 0 O-C-N 121.9 -0.5 . . . . 0.0 111.188 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -83.23 -10.33 10.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.625 2.884 . . . . 0.0 111.301 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.6 t -74.24 -29.85 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 117.799 0.272 . . . . 0.0 111.343 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.53 78.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.125 0.42 . . . . 0.0 110.45 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.03 -17.59 39.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.266 -0.272 . . . . 0.0 111.088 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.84 65.97 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.56 -26.49 58.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.49 -24.29 61.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.948 0.34 . . . . 0.0 110.113 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.71 44.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.317 0.247 . . . . 0.0 110.471 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -101.58 8.66 41.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.39 0.676 . . . . 0.0 110.962 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.97 37.12 28.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.652 1.181 . . . . 0.0 113.37 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -110.66 120.98 42.39 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 123.022 0.529 . . . . 0.0 109.767 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.95 154.24 39.83 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.227 3.285 . . . . 0.0 113.663 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.54 168.4 23.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -96.95 152.59 18.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.959 0.409 . . . . 0.0 111.927 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.18 119.61 10.3 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.1 t -172.17 164.48 6.01 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.023 0.929 . . . . 0.0 109.447 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.26 142.61 21.4 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.42 -160.46 32.7 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 117.424 0.612 . . . . 0.0 112.057 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.1 t -143.67 167.69 21.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.303 0.641 . . . . 0.0 110.518 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -3.77 17.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 112.602 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -114.37 10.61 17.1 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.281 0.632 . . . . 0.0 111.874 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.1 p -118.76 9.24 12.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 123.039 0.536 . . . . 0.0 112.017 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.14 154.69 25.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.631 0.773 . . . . 0.0 111.621 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.34 163.8 25.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.288 0.635 . . . . 0.0 111.316 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -59.95 -17.35 37.25 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -71.58 -26.68 62.71 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.852 0.751 . . . . 0.0 110.462 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -83.54 -22.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -88.09 -10.75 49.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.817 0.447 . . . . 0.0 111.319 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.96 -32.23 11.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 110.995 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.3 152.64 50.37 Favored Pre-proline 0 C--N 1.338 0.108 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.67 152.43 56.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.226 2.617 . . . . 0.0 111.413 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.58 153.19 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 122.842 0.457 . . . . 0.0 110.892 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.0 tp -149.06 153.73 38.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -84.85 167.07 16.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.656 0.383 . . . . 0.0 110.677 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -63.6 -46.51 83.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.71 137.05 29.24 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.673 1.582 . . . . 0.0 109.777 174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -110.44 148.67 31.58 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.949 0.499 . . . . 0.0 110.331 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.8 p -144.01 161.4 38.87 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.125 0.97 . . . . 0.0 109.21 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.66 -27.14 68.72 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.088 -0.383 . . . . 0.0 111.083 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.78 -36.51 21.65 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.64 -30.42 44.35 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.7 t -82.43 -30.56 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.663 0.731 . . . . 0.0 110.335 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 -26.42 62.74 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.502 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -83.39 -33.75 25.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.401 0.28 . . . . 0.0 110.917 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.84 61.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.319 -0.238 . . . . 0.0 110.703 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.18 -20.61 40.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 119.564 -0.255 . . . . 0.0 110.784 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.43 55.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.37 0.532 . . . . 0.0 110.07 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.57 26.72 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.803 0.441 . . . . 0.0 111.513 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 tt -91.2 -51.88 5.09 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.989 0.515 . . . . 0.0 110.305 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.5 mt -79.13 17.37 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.1 . . . . 0.0 112.147 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.311 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 53.96 21.89 3.09 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.879 0.872 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.61 165.83 33.99 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.352 0.661 . . . . 0.0 110.269 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.56 75.52 1.49 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.505 0.669 . . . . 0.0 109.848 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -78.04 -6.77 55.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.943 0.497 . . . . 0.0 111.506 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.427 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 64.5 mt-30 -118.73 111.09 18.04 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.09 136.05 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.762 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.0 138.29 33.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 79.8 mt -102.12 126.2 56.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.867 0.867 . . . . 0.0 109.716 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.37 110.04 15.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 162.67 35.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 111.629 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -98.19 -0.16 44.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.912 0.885 . . . . 0.0 111.32 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.61 105.59 15.72 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.89 -22.47 54.35 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.753 2.969 . . . . 0.0 113.592 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.32 -41.2 73.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.457 0.571 . . . . 0.0 110.427 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.419 HG13 ' HE3' ' A' ' 102' ' ' LYS . 43.6 mm -79.03 -25.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.51 66.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 mmt -80.92 -25.54 37.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mtp -73.33 -30.64 63.49 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.96 -32.11 71.46 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.102 -0.374 . . . . 0.0 110.053 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -74.62 -23.14 58.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.204 -0.31 . . . . 0.0 110.208 175.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.66 -43.3 20.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.301 -0.249 . . . . 0.0 111.14 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -74.35 -27.26 60.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.425 0.557 . . . . 0.0 111.754 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.83 -17.87 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.541 0.61 . . . . 0.0 110.894 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.862 0.301 . . . . 0.0 110.769 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.54 -20.1 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 122.766 0.426 . . . . 0.0 110.793 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -103.13 17.02 25.05 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.97 0.508 . . . . 0.0 111.687 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.88 36.13 17.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.061 0.944 . . . . 0.0 112.76 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.87 164.65 17.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.336 0.654 . . . . 0.0 109.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -117.47 72.18 7.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 O-C-N 122.06 -0.4 . . . . 0.0 110.873 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.92 158.28 48.1 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.845 2.364 . . . . 0.0 110.166 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.4 m -121.58 -9.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -173.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.89 174.03 34.16 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 118.422 0.555 . . . . 0.0 112.374 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.1 m -141.17 137.64 32.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.378 1.071 . . . . 0.0 108.383 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.93 156.88 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.024 0.44 . . . . 0.0 111.077 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.74 -4.26 37.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.982 0.913 . . . . 0.0 111.732 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -151.4 157.5 42.5 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.88 0.472 . . . . 0.0 110.439 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.88 -22.92 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 122.792 0.437 . . . . 0.0 110.567 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.96 -26.09 63.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.949 -0.469 . . . . 0.0 110.245 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.57 -21.17 64.71 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.51 63.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.235 0.518 . . . . 0.0 109.924 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.23 -32.2 66.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.85 -24.68 64.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.443 -0.161 . . . . 0.0 110.919 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -82.94 -25.71 32.11 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.743 0.247 . . . . 0.0 110.949 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.5 t -71.94 -26.55 25.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.78 -14.34 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.674 0.39 . . . . 0.0 110.863 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -98.84 -14.61 19.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.435 0.694 . . . . 0.0 111.994 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.22 169.74 38.76 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.62 148.21 36.59 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.37 149.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.18 -30.66 11.42 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.193 0.452 . . . . 0.0 111.35 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 174.95 11.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.749 0.42 . . . . 0.0 110.582 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.58 161.48 41.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.675 0.274 . . . . 0.0 111.0 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.78 130.86 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.02 136.0 53.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.24 0.616 . . . . 0.0 110.203 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.56 144.99 29.98 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.78 -12.0 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 122.281 -0.262 . . . . 0.0 111.307 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -123.19 153.46 40.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.2 tp -152.76 141.69 21.18 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -81.93 132.6 35.27 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 117.748 0.249 . . . . 0.0 110.952 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.42 166.02 2.87 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.488 0.566 . . . . 0.0 112.132 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.8 -158.04 29.54 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 122.646 -0.326 . . . . 0.0 112.493 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -86.14 161.37 18.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.42 0.688 . . . . 0.0 110.07 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -62.25 -22.19 65.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.975 0.51 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.8 p 52.93 23.37 2.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 28.2 p -91.84 -24.77 0.27 Allowed Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 175.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.4 Cg_exo -57.8 -18.72 35.47 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 113.972 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.3 m -82.45 -9.77 11.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 118.061 0.392 . . . . 0.0 111.892 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.61 68.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.983 -0.448 . . . . 0.0 110.458 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -75.18 -17.77 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.291 -0.256 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.81 -25.62 37.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.5 -29.93 61.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 173.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.29 60.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.16 -13.51 57.06 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -95.52 14.76 21.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 110.14 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.17 31.41 19.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.421 1.089 . . . . 0.0 113.489 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.6 mt -122.23 108.69 33.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.9 162.71 38.66 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.628 2.885 . . . . 0.0 111.195 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -150.07 167.54 26.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.248 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.87 144.93 27.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 22.9 m-85 -87.05 153.13 21.78 Favored 'General case' 0 C--N 1.337 0.031 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.83 122.47 13.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -166.99 161.15 14.77 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.732 0.413 . . . . 0.0 110.425 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 134.06 12.13 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.93 -155.61 26.24 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 m -132.52 171.18 14.12 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.923 0.889 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.45 -10.27 54.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.89 2.58 55.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.791 0.436 . . . . 0.0 111.324 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -102.75 7.62 39.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.492 0.717 . . . . 0.0 111.108 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.408 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 5.2 m -139.48 154.83 25.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.972 0.909 . . . . 0.0 111.47 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.98 169.92 14.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.991 0.916 . . . . 0.0 111.547 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.5 p -61.51 -19.12 61.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -70.69 -24.5 62.68 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.379 0.536 . . . . 0.0 110.823 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 49.9 m-85 -89.01 -19.33 25.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.32 -7.87 56.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 111.111 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.92 -18.07 13.47 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.367 0.667 . . . . 0.0 111.229 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -107.35 158.16 33.81 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.235 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.18 151.98 82.27 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.154 2.569 . . . . 0.0 111.58 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.8 154.71 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.952 0.901 . . . . 0.0 110.562 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -139.16 155.09 48.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.566 0.746 . . . . 0.0 109.892 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -79.34 162.95 25.25 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.724 0.41 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.419 ' HE3' HG13 ' A' ' 16' ' ' ILE . 56.9 tptt -78.67 -47.68 1.82 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.591 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.3 144.76 33.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.115 1.876 . . . . 0.0 110.256 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -115.83 147.21 41.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.034 0.533 . . . . 0.0 110.489 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.9 p -144.3 162.48 36.31 Favored 'General case' 0 N--CA 1.46 0.04 0 C-N-CA 124.443 1.097 . . . . 0.0 108.866 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -63.55 -31.87 73.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.91 -0.494 . . . . 0.0 111.207 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -84.62 -33.59 23.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.6 -27.03 57.94 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.9 -25.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.562 0.681 . . . . 0.0 110.527 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.9 -32.37 71.97 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.3 -29.25 38.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.524 0.33 . . . . 0.0 110.429 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.74 60.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 122.302 -0.249 . . . . 0.0 110.97 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.21 -30.2 54.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.83 -26.71 62.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.378 -0.201 . . . . 0.0 110.571 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -18.84 28.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.852 0.461 . . . . 0.0 112.119 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.89 -40.26 11.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.138 0.575 . . . . 0.0 110.92 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.59 18.29 3.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.871 0.469 . . . . 0.0 112.193 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.811 -1.09 . . . . 0.0 110.812 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.219 0.056 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m 53.97 25.94 5.89 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.62 155.86 40.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.825 0.45 . . . . 0.0 110.958 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.06 71.23 1.17 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.756 0.822 . . . . 0.0 109.209 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -72.09 -7.47 49.15 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.712 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.459 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 70.8 mt-30 -119.99 116.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.167 0.44 . . . . 0.0 112.141 -171.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.443 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.0 mm -122.29 128.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 123.932 0.77 . . . . 0.0 111.511 -172.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD21 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -86.6 142.24 28.41 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.437 ' H ' HD21 ' A' ' 8' ' ' LEU . 79.3 mt -112.78 130.92 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 t -124.27 125.08 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -152.14 163.63 38.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.693 0.397 . . . . 0.0 111.868 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.77 12.93 13.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.412 0.685 . . . . 0.0 110.601 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -146.87 121.5 5.23 Favored Pre-proline 0 N--CA 1.454 -0.248 0 C-N-CA 123.973 0.909 . . . . 0.0 108.565 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.81 -14.36 44.26 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.24 2.627 . . . . 0.0 112.451 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.7 -31.1 68.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.4 -26.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.02 78.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.027 -0.42 . . . . 0.0 110.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.42 -21.77 30.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.463 -0.148 . . . . 0.0 111.126 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.8 tpt -76.75 -33.93 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.298 -0.251 . . . . 0.0 110.43 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.78 -27.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.229 0.212 . . . . 0.0 110.746 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.96 -21.85 58.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.785 0.266 . . . . 0.0 110.41 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.27 -46.29 28.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.264 -0.272 . . . . 0.0 110.687 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.57 -15.99 58.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.581 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.42 -28.84 64.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -78.84 -23.96 44.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.393 0.277 . . . . 0.0 110.408 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.07 -28.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.31 -1.94 58.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.536 0.335 . . . . 0.0 110.248 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t0 50.11 33.0 6.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.747 1.219 . . . . 0.0 112.96 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HE3' HG12 ' A' ' 7' ' ' ILE . 59.1 pttt -104.47 -165.77 1.18 Allowed 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.285 -0.259 . . . . 0.0 111.664 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -103.2 124.99 36.41 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 112.043 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 164.58 20.27 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.622 2.881 . . . . 0.0 110.067 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.459 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 34.8 m -136.07 -28.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.16 178.6 37.8 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.573 0.624 . . . . 0.0 112.616 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -137.35 141.07 41.8 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.39 1.076 . . . . 0.0 108.598 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.15 155.53 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.98 0.419 . . . . 0.0 110.767 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -129.11 7.89 5.54 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.436 0.694 . . . . 0.0 111.749 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 p -132.61 157.73 44.04 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.393 0.677 . . . . 0.0 110.025 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.24 -23.72 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.13 -25.8 42.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.303 -0.248 . . . . 0.0 110.816 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.42 -30.26 58.74 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.6 56.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.332 0.566 . . . . 0.0 110.623 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.13 -24.52 47.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.09 -25.04 40.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.212 -0.305 . . . . 0.0 111.11 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -87.37 -26.7 23.21 Favored 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.96 -22.34 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.687 0.676 . . . . 0.0 110.825 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -79.97 -14.56 58.49 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.33 -0.231 . . . . 0.0 110.468 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.88 -12.74 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.178 0.591 . . . . 0.0 111.137 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.77 53.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.95 62.99 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.052 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mt -140.34 144.73 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.793 0.837 . . . . 0.0 109.217 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.42 -25.71 9.91 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.76 176.99 10.32 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.09 0.405 . . . . 0.0 110.52 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.68 166.73 27.49 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.04 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.39 119.6 29.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.599 0.237 . . . . 0.0 110.759 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -80.41 127.92 32.97 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.613 0.365 . . . . 0.0 110.298 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.8 t -97.19 -11.15 8.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.434 0.694 . . . . 0.0 110.496 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -71.48 9.16 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.76 0.424 . . . . 0.0 111.85 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 158.54 21.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.506 0.722 . . . . 0.0 109.927 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -62.49 146.54 51.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.98 0.512 . . . . 0.0 111.101 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.68 145.14 4.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.871 0.748 . . . . 0.0 112.11 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.83 -9.8 57.03 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.661 -0.522 . . . . 0.0 111.818 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -126.63 149.31 49.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.705 0.753 . . . . 0.0 110.147 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 50.74 29.27 4.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.006 0.923 . . . . 0.0 112.094 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.4 p -102.13 -3.36 27.62 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.346 0.659 . . . . 0.0 111.935 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.7 m -137.32 33.85 0.23 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 86.9 Cg_endo -75.12 -13.49 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.174 1.916 . . . . 0.0 111.5 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.39 -29.11 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 122.612 0.365 . . . . 0.0 110.738 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.24 80.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.792 0.329 . . . . 0.0 110.387 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.93 -17.77 45.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.168 -0.332 . . . . 0.0 110.863 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.87 64.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.63 -27.22 62.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.38 -24.74 62.13 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 117.65 0.204 . . . . 0.0 110.49 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.16 52.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.234 -0.292 . . . . 0.0 110.486 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -99.54 8.69 44.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.409 0.684 . . . . 0.0 111.246 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 57.79 35.83 25.87 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.208 1.003 . . . . 0.0 113.026 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.36 131.08 22.23 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.75 156.86 39.76 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.91 3.073 . . . . 0.0 111.502 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.1 167.68 29.03 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.852 0.461 . . . . 0.0 111.132 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -138.89 164.87 25.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.008 0.923 . . . . 0.0 109.625 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' ' CD2' ' A' ' 94' ' ' PHE . 36.5 m-85 -107.51 161.97 14.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.337 0.589 . . . . 0.0 111.921 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.24 17.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.0 m -148.54 150.53 33.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.466 0.306 . . . . 0.0 110.82 -171.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.76 129.99 9.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.2 -171.95 30.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.7 m -83.24 161.29 21.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.688 0.395 . . . . 0.0 110.706 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -76.02 2.53 12.5 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -122.46 11.81 10.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.978 0.511 . . . . 0.0 111.301 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 m -110.61 12.64 22.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.338 0.655 . . . . 0.0 111.849 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.27 154.59 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.404 0.682 . . . . 0.0 109.567 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.54 153.56 23.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.28 0.632 . . . . 0.0 111.979 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.0 m -62.89 -18.92 63.65 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -76.65 -20.5 56.6 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 118.599 0.636 . . . . 0.0 110.459 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.416 ' CD2' ' CD1' ' A' ' 81' ' ' PHE . 9.1 m-85 -85.8 -19.62 30.43 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -83.28 -19.03 37.08 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 122.419 0.288 . . . . 0.0 110.856 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.66 -21.33 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.102 0.561 . . . . 0.0 111.862 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -101.97 157.99 32.64 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 122.799 0.44 . . . . 0.0 110.414 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.12 149.94 76.8 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.43 2.753 . . . . 0.0 111.692 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.66 153.27 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.003 0.521 . . . . 0.0 110.465 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.75 157.48 46.01 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.205 1.002 . . . . 0.0 109.371 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.92 168.64 10.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 37.9 mtmm -60.64 -46.85 97.21 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.116 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 77.7 Cg_endo -71.93 138.16 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.835 1.69 . . . . 0.0 109.628 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -112.51 154.14 26.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.527 0.731 . . . . 0.0 110.325 -177.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.7 p -138.01 160.76 38.48 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.428 0.691 . . . . 0.0 110.363 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.4 tpp -71.15 -28.86 64.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.152 0.426 . . . . 0.0 112.152 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.5 -43.56 14.45 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.968 -0.458 . . . . 0.0 111.931 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -30.18 48.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 119.845 -0.42 . . . . 0.0 112.527 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.0 t -87.22 -30.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 CA-C-N 117.658 0.729 . . . . 0.0 111.01 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.66 68.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.871 -0.518 . . . . 0.0 110.021 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.31 -29.94 38.14 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.121 0.168 . . . . 0.0 110.707 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.6 37.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.295 -0.253 . . . . 0.0 111.417 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.92 -19.95 33.84 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 117.961 0.346 . . . . 0.0 111.115 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.02 -25.65 43.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.61 -25.86 41.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.65 29.92 1.43 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.036 0.935 . . . . 0.0 111.125 173.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.79 -16.47 7.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.425 0.29 . . . . 0.0 111.586 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.22 -177.343 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 4' ' ' LEU . 29.6 mt . . . . . 0 N--CA 1.458 -0.058 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -87.27 -11.56 49.26 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.16 0.584 . . . . 0.0 111.329 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.568 ' HB3' HG11 ' A' ' 32' ' ' VAL . 81.4 mt-30 -123.07 113.65 19.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.1 mm -122.47 131.55 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.626 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -89.87 149.81 22.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.635 ' H ' HD23 ' A' ' 8' ' ' LEU . 66.3 mt -115.17 135.59 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 118.115 0.416 . . . . 0.0 110.108 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.58 121.96 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 12.2 tp10 -150.55 157.49 43.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.806 -173.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.36 -10.49 19.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 112.508 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.552 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 48.0 mt-10 -133.2 132.92 22.44 Favored Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 121.919 -0.488 . . . . 0.0 110.369 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.41 -21.41 61.1 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.329 2.686 . . . . 0.0 113.2 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.94 -43.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.165 -0.335 . . . . 0.0 110.682 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.0 -25.63 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.76 -30.62 70.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.308 -0.245 . . . . 0.0 110.56 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mmt -82.42 -22.7 35.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.319 -0.238 . . . . 0.0 110.808 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mtp -73.94 -35.44 64.56 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.218 0.463 . . . . 0.0 110.179 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.37 -33.77 74.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.171 -0.331 . . . . 0.0 110.138 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.41 -25.53 60.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.297 -0.252 . . . . 0.0 110.359 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.76 -41.55 23.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.907 0.321 . . . . 0.0 111.136 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.16 -24.89 59.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.872 -0.518 . . . . 0.0 111.937 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.755 0.707 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -85.33 -21.4 28.94 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.554 0.616 . . . . 0.0 112.126 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.2 -26.0 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.25 0.477 . . . . 0.0 111.244 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.03 18.31 13.7 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 122.17 -0.331 . . . . 0.0 111.536 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.87 34.02 18.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.448 0.699 . . . . 0.0 112.388 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -85.64 162.49 18.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.907 0.883 . . . . 0.0 109.102 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m -111.32 85.22 5.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.116 -0.365 . . . . 0.0 110.393 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.27 156.97 62.41 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.732 2.288 . . . . 0.0 110.038 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.7 m -131.15 -9.14 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.18 173.82 33.27 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 119.302 0.955 . . . . 0.0 113.126 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -144.0 141.09 29.96 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.202 1.001 . . . . 0.0 109.014 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.48 162.18 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 122.892 0.477 . . . . 0.0 111.091 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.35 -11.79 29.27 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.524 0.73 . . . . 0.0 111.858 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -149.29 157.99 43.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.947 -0.471 . . . . 0.0 110.491 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -71.55 -22.47 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 122.574 0.35 . . . . 0.0 110.223 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.87 -26.51 66.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.978 -0.451 . . . . 0.0 109.983 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -26.15 55.62 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.49 -30.56 63.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.255 0.527 . . . . 0.0 109.839 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.47 -37.43 68.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.78 64.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.373 -0.204 . . . . 0.0 111.074 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -22.27 29.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.453 0.301 . . . . 0.0 111.062 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.19 -21.85 10.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.75 -14.92 62.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.335 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -100.02 -12.49 19.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.089 0.956 . . . . 0.0 110.681 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.11 -168.49 52.09 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.58 23.36 62.66 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.44 -0.447 . . . . 0.0 112.231 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 mt -135.57 148.01 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.697 0.748 . . . . 0.0 109.343 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -120.0 -30.32 4.73 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.59 178.83 9.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.811 0.444 . . . . 0.0 109.913 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.36 163.1 39.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 mm -113.21 140.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.4 tp -140.71 129.53 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.551 0.215 . . . . 0.0 110.996 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.16 154.08 26.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.421 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.94 -11.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 122.893 0.477 . . . . 0.0 109.903 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 124.159 0.984 . . . . 0.0 111.97 -177.421 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.529 0.15 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.45 -11.96 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.601 2.867 . . . . 0.0 111.653 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.25 -22.7 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 122.046 -0.409 . . . . 0.0 110.797 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.29 75.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.06 -17.96 60.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.164 -0.335 . . . . 0.0 111.227 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.33 -29.41 57.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.56 -34.52 72.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.61 -21.06 60.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.053 -0.404 . . . . 0.0 110.81 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.25 -16.59 42.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.514 0.325 . . . . 0.0 111.459 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -104.08 23.81 12.4 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.447 0.699 . . . . 0.0 111.775 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 53.83 41.83 31.93 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.865 0.866 . . . . 0.0 112.662 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.96 87.83 23.67 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.12 164.47 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 124.844 3.696 . . . . 0.0 114.27 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.19 169.3 17.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.975 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.06 141.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.277 1.031 . . . . 0.0 109.27 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.04 150.14 22.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.572 0.225 . . . . 0.0 110.764 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.47 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.89 0.476 . . . . 0.0 110.017 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -160.67 158.73 29.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.212 -0.305 . . . . 0.0 111.112 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.92 113.26 4.14 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.88 -163.52 29.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.8 m -76.88 160.41 29.24 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.237 0.542 . . . . 0.0 110.753 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.99 -3.12 56.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.694 0.398 . . . . 0.0 111.96 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -92.73 -0.46 57.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.584 0.354 . . . . 0.0 111.441 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -84.23 8.35 16.11 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.43 0.692 . . . . 0.0 112.02 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.7 m -136.9 154.68 31.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.752 0.821 . . . . 0.0 110.728 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -72.33 169.27 16.62 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.384 0.673 . . . . 0.0 111.487 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.9 p -61.94 -15.83 46.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -74.82 -24.24 58.59 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.939 0.336 . . . . 0.0 110.268 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 10.1 m-85 -86.01 -22.48 27.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -84.39 -14.53 49.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.801 0.441 . . . . 0.0 110.895 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.69 -33.55 14.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.732 0.413 . . . . 0.0 110.475 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -83.0 160.65 60.07 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.48 152.15 69.9 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.24 2.627 . . . . 0.0 111.181 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.24 154.39 33.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.002 0.521 . . . . 0.0 111.102 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.06 154.63 48.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.711 0.804 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -86.94 165.63 15.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.062 0.545 . . . . 0.0 109.658 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.15 -49.38 12.59 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.33 140.01 21.51 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.052 1.835 . . . . 0.0 111.161 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -110.4 152.34 26.38 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.065 0.46 . . . . 0.0 110.54 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 108' ' ' GLY . 8.8 t -154.26 164.61 38.28 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.028 0.931 . . . . 0.0 108.849 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -58.59 -27.57 64.77 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -84.04 -36.01 23.41 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.084 0.402 . . . . 0.0 111.256 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.456 ' H ' HG23 ' A' ' 105' ' ' THR . . . -79.3 -25.24 59.62 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.12 -30.26 11.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.122 0.461 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.34 69.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.73 -20.81 30.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.684 0.394 . . . . 0.0 111.107 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.24 61.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.477 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.4 mt -77.5 -28.42 52.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.0 -20.28 61.05 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.977 0.353 . . . . 0.0 110.874 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.47 -20.6 26.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.534 0.333 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -91.32 -50.63 5.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.819 0.282 . . . . 0.0 110.546 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.96 2.92 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.328 1.051 . . . . 0.0 112.88 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.173 -1.394 . . . . 0.0 110.0 178.446 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.419 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -4.14 58.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 175.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.649 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.0 mp0 -120.37 109.68 15.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.671 0.789 . . . . 0.0 111.438 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 mm -116.62 130.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 O-C-N 123.514 0.509 . . . . 0.0 110.086 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 145.31 25.11 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.656 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.7 mt -113.33 130.57 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.769 0.828 . . . . 0.0 109.237 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.29 117.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -141.26 162.98 34.19 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.626 0.77 . . . . 0.0 110.512 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -84.02 -9.95 58.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.454 0.301 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.6 145.51 40.78 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.839 0.456 . . . . 0.0 109.836 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.07 -14.75 26.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.116 2.544 . . . . 0.0 111.202 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -74.89 -30.32 61.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 117.771 0.26 . . . . 0.0 110.626 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mm -84.91 -30.17 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.77 69.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.8 tpp -78.91 -28.23 43.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.9 ttt -70.39 -29.99 66.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 2.1 mm? -75.16 -29.48 60.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.499 0.32 . . . . 0.0 110.483 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.88 -23.79 61.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.893 0.315 . . . . 0.0 110.266 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.48 -40.72 42.05 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.438 -0.164 . . . . 0.0 111.432 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.74 -24.66 53.02 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.266 0.484 . . . . 0.0 111.96 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.66 -20.35 56.76 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.704 0.684 . . . . 0.0 110.364 176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.2 -27.66 35.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.875 0.307 . . . . 0.0 110.585 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.4 t -79.76 -22.59 12.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 122.504 0.322 . . . . 0.0 110.859 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.77 13.56 34.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.793 0.437 . . . . 0.0 111.815 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 53.49 29.2 8.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 112.4 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -85.62 161.05 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.629 0.772 . . . . 0.0 109.202 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.8 m -105.83 117.47 57.69 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.6 162.83 27.19 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.322 2.681 . . . . 0.0 110.107 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 6' ' ' GLN . 26.7 m -135.12 -18.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.47 172.75 32.33 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.136 0.425 . . . . 0.0 112.147 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.3 p -139.14 142.02 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 108.464 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.33 152.87 23.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.792 0.329 . . . . 0.0 110.297 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -100.83 1.32 39.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.24 0.616 . . . . 0.0 112.111 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -141.32 157.84 44.67 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 109.812 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.36 -22.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 122.416 -0.177 . . . . 0.0 110.8 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.85 -25.96 61.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.147 -0.346 . . . . 0.0 110.677 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.95 -27.12 60.96 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.24 -34.81 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.34 0.57 . . . . 0.0 110.066 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -69.36 -36.96 77.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.95 66.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.247 -0.283 . . . . 0.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -84.8 -20.84 30.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.77 0.259 . . . . 0.0 111.332 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.41 -24.2 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.855 0.298 . . . . 0.0 110.45 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -75.83 -14.57 60.29 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.249 -0.282 . . . . 0.0 110.79 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.85 -12.48 22.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.541 0.736 . . . . 0.0 111.035 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.94 53.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.61 11.33 84.17 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.67 147.99 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -121.94 -19.76 6.57 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.13 168.64 26.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.596 0.358 . . . . 0.0 110.097 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.35 34.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 111.49 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.04 129.3 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.68 130.37 56.8 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.806 0.442 . . . . 0.0 111.05 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.47 132.41 34.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.51 -11.26 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.737 0.415 . . . . 0.0 110.782 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.074 -179.847 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -11.69 31.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.669 2.913 . . . . 0.0 111.963 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.2 -19.33 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 O-C-N 122.118 -0.363 . . . . 0.0 110.237 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.75 -26.14 67.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.98 -17.98 59.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.159 -0.338 . . . . 0.0 110.555 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.37 -31.79 48.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.91 -34.12 76.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.06 -21.83 61.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.076 0.15 . . . . 0.0 110.691 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.89 -7.0 59.54 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.895 0.478 . . . . 0.0 110.826 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -114.7 15.01 17.64 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.708 0.803 . . . . 0.0 111.313 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.21 36.8 28.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.251 1.02 . . . . 0.0 112.927 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.7 mt -109.27 108.69 60.34 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.187 0.995 . . . . 0.0 108.366 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.74 154.85 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.733 2.955 . . . . 0.0 112.224 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.54 165.0 31.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.24 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.09 145.35 28.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.371 1.068 . . . . 0.0 108.416 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.14 153.24 18.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 111.308 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.17 148.17 37.8 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -159.95 170.97 20.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.63 0.253 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.77 95.31 0.23 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.71 -160.11 28.45 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.7 t -75.35 157.02 34.88 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.17 -4.43 29.62 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.071 0.549 . . . . 0.0 111.223 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.75 -1.4 34.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.9 11.28 33.8 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.676 0.79 . . . . 0.0 111.461 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 t -126.35 154.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.294 0.638 . . . . 0.0 109.795 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.0 152.46 23.76 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.172 0.589 . . . . 0.0 111.636 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.3 p -63.63 -17.45 62.92 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -77.56 -17.17 58.14 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 118.335 0.516 . . . . 0.0 110.729 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -89.75 -21.35 22.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -88.18 -11.21 47.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.977 0.511 . . . . 0.0 111.327 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.62 -27.26 12.43 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.281 0.632 . . . . 0.0 111.197 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.79 161.17 48.34 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 145.19 80.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.143 2.562 . . . . 0.0 112.608 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.2 m -140.62 154.27 21.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.699 0.8 . . . . 0.0 110.23 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 tp -145.87 146.45 31.12 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.1 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -85.01 158.77 20.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.878 0.471 . . . . 0.0 109.796 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -67.02 -36.22 10.62 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.82 125.32 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.402 2.068 . . . . 0.0 110.202 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 3.8 m-30 -112.29 151.96 29.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.745 0.418 . . . . 0.0 110.854 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.9 p -142.64 159.28 42.53 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.161 0.984 . . . . 0.0 109.087 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -66.04 -26.34 67.46 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.829 -0.544 . . . . 0.0 111.174 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.63 -37.1 21.49 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 117.788 0.267 . . . . 0.0 111.536 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.48 -27.25 59.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.929 -0.373 . . . . 0.0 112.185 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.57 -29.4 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 117.696 0.748 . . . . 0.0 110.464 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.02 69.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.97 -21.16 29.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.365 0.666 . . . . 0.0 110.819 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.39 38.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.66 0.209 . . . . 0.0 110.664 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.62 -28.69 60.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -26.37 63.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.96 41.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.051 0.54 . . . . 0.0 111.752 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -90.98 -33.81 15.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.353 0.261 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -94.08 0.23 55.77 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.901 0.48 . . . . 0.0 111.844 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.22 -1.372 . . . . 0.0 109.767 179.157 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.68 -5.47 37.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.39 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 63.5 mt-30 -119.94 111.77 18.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.803 0.335 . . . . 0.0 111.541 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.21 135.4 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.093 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -92.38 132.3 36.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' N ' HD23 ' A' ' 8' ' ' LEU . 84.0 mt -94.6 128.0 46.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.215 0.606 . . . . 0.0 109.487 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.41 115.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.066 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.89 162.98 32.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.057 0.543 . . . . 0.0 111.622 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.5 4.42 18.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.677 . . . . 0.0 110.374 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -141.11 110.69 6.51 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.804 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -55.75 -21.78 33.88 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.952 3.101 . . . . 0.0 113.875 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 tp -74.31 -33.7 63.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.214 0.461 . . . . 0.0 110.305 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.3 mm -77.73 -31.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.22 65.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.8 tpp -77.76 -31.83 52.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -74.52 -30.41 61.78 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.472 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.16 -29.95 68.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.2 -24.03 54.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.068 0.394 . . . . 0.0 110.193 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.9 -43.13 20.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.241 -0.287 . . . . 0.0 111.279 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.38 -28.33 59.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.188 0.449 . . . . 0.0 111.813 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -79.17 -17.65 54.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.514 0.597 . . . . 0.0 110.865 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.85 -26.16 27.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.039 0.381 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -82.86 -22.59 8.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 122.555 0.342 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.9 mt -101.11 16.35 25.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 51.97 37.36 20.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.862 0.865 . . . . 0.0 112.181 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.61 164.61 17.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.494 0.717 . . . . 0.0 109.528 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.0 m -117.46 71.8 7.02 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 122.537 0.335 . . . . 0.0 110.825 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.3 159.69 42.46 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.986 2.457 . . . . 0.0 110.114 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.2 m -123.81 -10.02 7.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.72 173.77 33.72 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 118.54 0.609 . . . . 0.0 112.291 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.3 m -140.25 139.24 35.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 109.337 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.32 158.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.231 0.612 . . . . 0.0 110.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -137.04 3.63 2.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.655 0.382 . . . . 0.0 111.763 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -139.04 149.71 44.94 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.04 -32.38 55.99 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 122.29 0.236 . . . . 0.0 111.311 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.85 69.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.953 -0.467 . . . . 0.0 110.945 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.49 -29.8 47.5 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.4 63.6 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.516 0.658 . . . . 0.0 110.541 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.92 -27.09 54.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.41 -24.67 61.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.149 -0.344 . . . . 0.0 110.883 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.07 -29.24 22.04 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.09 -21.95 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.564 0.62 . . . . 0.0 111.523 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -81.66 -14.72 56.3 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.07 -0.394 . . . . 0.0 111.021 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -91.9 -13.21 31.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.539 0.336 . . . . 0.0 111.519 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -164.8 42.18 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.61 24.98 61.58 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.306 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -127.79 144.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 117.433 0.616 . . . . 0.0 109.646 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -109.94 -27.87 9.02 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.23 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.06 178.56 7.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.156 0.583 . . . . 0.0 110.389 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.23 162.01 41.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.906 -0.496 . . . . 0.0 111.847 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.4 mt -116.22 126.62 73.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.11 133.06 56.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.876 0.47 . . . . 0.0 111.488 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.83 144.29 30.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -80.37 -11.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 122.754 0.422 . . . . 0.0 110.696 -176.955 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.71 -11.72 12.59 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.549 2.833 . . . . 0.0 111.494 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.47 -31.43 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 117.87 0.305 . . . . 0.0 110.775 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.99 86.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.956 -0.465 . . . . 0.0 110.289 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.0 -17.37 40.69 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.263 -0.273 . . . . 0.0 111.274 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -33.25 68.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.1 mt -73.88 -27.54 61.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.24 -23.0 61.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.928 0.331 . . . . 0.0 110.5 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.91 -19.37 40.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.315 0.246 . . . . 0.0 110.375 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -98.12 5.37 48.67 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.43 0.692 . . . . 0.0 111.491 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 57.37 27.6 14.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 112.534 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.6 mt -94.78 124.52 54.43 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.313 0.645 . . . . 0.0 109.327 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -59.89 150.26 78.92 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.894 3.063 . . . . 0.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -151.91 160.39 43.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.672 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.17 156.47 36.66 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.395 0.678 . . . . 0.0 109.498 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.73 160.62 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.35 0.595 . . . . 0.0 111.896 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.46 136.55 36.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.8 p -134.05 161.89 33.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.069 0.461 . . . . 0.0 111.96 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.04 -167.75 36.14 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.11 49.77 2.96 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -153.95 144.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.485 0.714 . . . . 0.0 110.033 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -105.42 -2.32 23.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.456 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.95 -2.87 33.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.042 0.537 . . . . 0.0 111.507 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -85.66 5.63 31.1 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.059 0.544 . . . . 0.0 111.813 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.64 154.73 19.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.137 0.575 . . . . 0.0 111.814 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.66 170.9 15.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.848 0.859 . . . . 0.0 111.179 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -62.85 -17.27 61.21 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -70.73 -29.78 66.12 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.778 -0.576 . . . . 0.0 110.195 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -81.02 -23.94 38.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -84.25 -10.37 57.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.82 0.448 . . . . 0.0 110.885 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -23.58 15.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.981 0.512 . . . . 0.0 110.913 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -97.19 163.86 19.01 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.286 0.634 . . . . 0.0 110.042 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.45 147.53 85.37 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.251 2.634 . . . . 0.0 112.084 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 m -140.36 154.07 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.486 0.714 . . . . 0.0 110.297 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.53 151.65 51.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.528 0.731 . . . . 0.0 109.953 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -74.35 156.76 36.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.53 ' HA ' ' CE ' ' A' ' 102' ' ' LYS . 1.9 tpmt? -71.1 -47.47 14.19 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.723 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 92.3 Cg_endo -73.52 142.43 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.902 1.735 . . . . 0.0 109.804 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -115.56 157.83 23.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.928 0.891 . . . . 0.0 110.75 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -141.91 162.53 35.24 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 124.058 0.943 . . . . 0.0 109.46 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -64.67 -32.52 74.22 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 122.255 -0.278 . . . . 0.0 111.149 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.45 -34.44 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.712 0.233 . . . . 0.0 111.597 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.03 56.16 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.628 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.27 -27.51 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.954 0.877 . . . . 0.0 110.729 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.02 71.79 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.222 0.465 . . . . 0.0 110.294 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -82.78 -29.62 29.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.327 0.251 . . . . 0.0 110.419 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.65 -31.57 46.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.732 0.242 . . . . 0.0 111.221 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.36 -39.81 58.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.96 -26.8 65.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.497 -0.127 . . . . 0.0 110.802 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.26 -14.41 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.567 0.347 . . . . 0.0 111.566 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -91.25 -35.85 14.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.761 0.424 . . . . 0.0 110.78 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 tp -88.67 -12.15 43.26 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.116 -1.421 . . . . 0.0 110.165 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -12.67 40.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.477 0.311 . . . . 0.0 110.774 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.577 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.7 mp0 -115.1 116.16 27.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.572 0.349 . . . . 0.0 111.469 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.42 128.76 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.418 0.687 . . . . 0.0 110.366 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -87.82 141.02 28.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.556 ' H ' HD23 ' A' ' 8' ' ' LEU . 90.0 mt -106.0 127.35 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.791 0.836 . . . . 0.0 109.21 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.0 126.87 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -155.07 165.87 35.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.255 0.622 . . . . 0.0 111.181 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -124.21 18.17 9.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.974 0.51 . . . . 0.0 110.242 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -137.77 126.86 14.85 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.727 0.811 . . . . 0.0 108.883 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.77 -18.68 32.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.411 2.741 . . . . 0.0 112.839 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.57 -25.5 35.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.26 0.482 . . . . 0.0 110.512 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.11 -26.05 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.43 84.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.011 -0.431 . . . . 0.0 110.843 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -77.26 -25.12 51.17 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 122.303 -0.248 . . . . 0.0 110.884 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 ttp -75.15 -32.17 61.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.429 -0.169 . . . . 0.0 110.688 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.67 -33.79 69.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.845 0.293 . . . . 0.0 110.68 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.71 -22.01 57.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.885 0.311 . . . . 0.0 110.451 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.75 -38.73 32.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.213 -0.305 . . . . 0.0 111.367 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -78.1 -23.44 47.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.562 0.619 . . . . 0.0 111.297 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.9 -18.54 58.25 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.439 0.563 . . . . 0.0 109.892 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.95 -28.04 35.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.05 0.386 . . . . 0.0 110.019 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -77.74 -23.59 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 122.615 0.366 . . . . 0.0 110.315 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.2 mt -93.04 8.2 40.98 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.793 0.437 . . . . 0.0 111.513 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.23 30.95 8.48 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.25 0.62 . . . . 0.0 111.47 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.72 161.12 19.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.4 m -107.97 98.99 28.31 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 122.357 0.263 . . . . 0.0 110.321 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.92 158.76 54.58 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.907 2.405 . . . . 0.0 109.26 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.577 HG11 ' HB3' ' A' ' 6' ' ' GLN . 34.2 m -127.94 -11.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.31 172.75 32.17 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.313 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -133.97 143.18 48.01 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.968 0.907 . . . . 0.0 108.755 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.69 140.2 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.72 1.53 57.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -140.78 157.06 45.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.119 0.568 . . . . 0.0 109.878 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.3 -22.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 122.47 -0.144 . . . . 0.0 110.779 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.86 63.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -19.58 68.95 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.96 -36.85 48.6 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.738 0.769 . . . . 0.0 110.746 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.76 -30.23 40.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.22 -25.66 59.79 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.187 -0.321 . . . . 0.0 111.266 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -87.39 -26.76 23.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.67 0.388 . . . . 0.0 111.827 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -82.77 -22.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 118.191 0.45 . . . . 0.0 111.604 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.35 -14.66 62.67 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.122 0.419 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.27 -12.52 59.61 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.684 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 -174.8 54.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.82 85.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -133.72 149.38 30.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -129.67 -12.03 4.36 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.57 169.25 20.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.841 0.456 . . . . 0.0 110.101 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 158.63 44.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.581 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.46 127.46 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.43 126.16 55.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.814 0.446 . . . . 0.0 110.888 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -77.85 132.83 38.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.56 -13.26 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.21 -0.306 . . . . 0.0 110.323 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.241 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.35 -10.91 29.12 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.364 2.71 . . . . 0.0 111.401 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.77 -16.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.022 0.529 . . . . 0.0 111.064 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 -23.3 62.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.957 -0.465 . . . . 0.0 109.881 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.19 -19.03 57.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.04 -30.8 39.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.51 -30.13 66.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.31 -20.95 54.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.266 0.226 . . . . 0.0 110.652 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.97 -18.46 59.3 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -90.34 12.83 17.12 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.42 0.688 . . . . 0.0 110.449 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.44 31.93 21.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.812 1.245 . . . . 0.0 112.824 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -113.8 126.17 28.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.68 160.31 38.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.213 3.275 . . . . 0.0 112.338 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.06 171.72 15.94 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.25 149.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.776 0.831 . . . . 0.0 108.967 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.82 154.31 17.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.185 0.517 . . . . 0.0 111.413 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.54 125.03 22.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.6 t -154.69 169.57 23.59 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.64 126.78 1.55 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.56 -164.82 29.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -74.02 159.11 33.15 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 110.307 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.48 -8.68 59.61 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.53 0.332 . . . . 0.0 111.44 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.22 0.76 20.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.215 0.606 . . . . 0.0 112.135 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.0 p -124.1 11.77 8.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.142 0.577 . . . . 0.0 111.948 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.81 160.99 17.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.355 0.597 . . . . 0.0 112.576 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -64.8 -16.2 62.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -78.16 -16.71 57.66 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.717 0.69 . . . . 0.0 111.238 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -85.89 -24.46 26.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -79.02 -15.95 57.54 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.342 0.257 . . . . 0.0 111.012 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.88 -24.69 13.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.045 0.538 . . . . 0.0 111.523 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -90.39 160.32 39.77 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 123.187 0.595 . . . . 0.0 109.53 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -63.71 144.49 89.38 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.83 2.353 . . . . 0.0 110.666 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.17 154.35 20.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.737 0.815 . . . . 0.0 110.806 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -139.96 153.8 47.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -69.41 158.72 34.58 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.438 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 13.8 mmmm -62.33 -47.63 89.04 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.23 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.6 Cg_endo -71.43 135.15 25.95 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.427 1.418 . . . . 0.0 108.849 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.6 156.62 17.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.122 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.6 p -141.11 160.77 39.39 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.382 1.073 . . . . 0.0 108.702 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -62.36 -28.78 70.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.304 -0.248 . . . . 0.0 111.043 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.85 -29.1 27.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.336 -0.228 . . . . 0.0 110.97 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.51 -32.98 49.34 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.052 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -82.28 -24.47 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 117.841 0.82 . . . . 0.0 111.151 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.11 65.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.25 0.477 . . . . 0.0 109.964 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.23 -25.82 27.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.793 0.437 . . . . 0.0 111.549 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.79 -37.35 41.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.781 0.264 . . . . 0.0 110.778 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.37 -27.52 52.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.84 60.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.149 0.431 . . . . 0.0 110.672 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.21 -17.42 32.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.23 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.23 -47.56 7.43 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.16 18.02 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.452 1.101 . . . . 0.0 111.588 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.155 -179.148 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.13 -14.28 29.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.043 0.937 . . . . 0.0 109.681 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.652 ' HB3' HG11 ' A' ' 32' ' ' VAL . 23.1 mp0 -114.57 111.84 21.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.798 0.439 . . . . 0.0 111.619 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mm -118.41 130.43 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.226 0.61 . . . . 0.0 110.128 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -90.73 141.18 29.07 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.087 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.524 ' H ' HD23 ' A' ' 8' ' ' LEU . 96.7 mt -105.31 130.55 56.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.478 0.711 . . . . 0.0 109.78 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 t -127.61 117.97 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.605 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 14.2 tp10 -145.62 156.18 43.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.474 0.71 . . . . 0.0 109.744 -173.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -124.35 15.64 8.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.418 0.687 . . . . 0.0 111.416 -176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.605 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 15.9 tp10 -136.08 107.22 9.58 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.28 -25.02 36.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.626 2.884 . . . . 0.0 114.152 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -77.16 -37.93 52.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.407 0.549 . . . . 0.0 110.465 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.5 mt -79.33 -24.33 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.85 0.296 . . . . 0.0 110.536 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.9 mtt -76.97 -31.3 56.45 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.7 mtp -72.94 -23.77 60.72 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -74.47 -34.25 63.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.327 -0.233 . . . . 0.0 110.666 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.34 -22.38 51.91 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.42 -37.46 57.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.69 -23.24 56.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.269 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -77.25 -23.46 51.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.926 0.33 . . . . 0.0 110.245 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.07 -32.27 26.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.303 0.241 . . . . 0.0 110.482 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -76.82 -19.77 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.6 tp -82.81 0.22 44.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.583 0.753 . . . . 0.0 110.542 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 53.89 28.8 8.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.861 0.865 . . . . 0.0 111.695 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -91.25 156.84 17.52 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.971 0.908 . . . . 0.0 110.74 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.0 m -92.64 121.61 65.8 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -78.59 161.68 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.168 3.245 . . . . 0.0 111.25 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -141.7 -18.7 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 173.07 32.58 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.398 0.545 . . . . 0.0 112.548 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.2 p -139.62 142.98 37.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.503 1.121 . . . . 0.0 108.46 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 156.03 21.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.83 -7.66 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.597 0.759 . . . . 0.0 111.563 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -152.61 161.22 42.87 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.668 0.387 . . . . 0.0 110.467 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.65 -22.55 26.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.186 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -27.23 63.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.72 -28.75 56.49 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.32 74.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.563 0.681 . . . . 0.0 109.496 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.94 -31.21 66.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 -24.92 63.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.372 -0.205 . . . . 0.0 111.08 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.348 0.259 . . . . 0.0 111.206 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -76.27 -25.23 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.899 0.318 . . . . 0.0 110.244 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -73.78 -14.78 61.17 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.352 -0.217 . . . . 0.0 110.856 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.4 -12.61 24.06 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.193 0.597 . . . . 0.0 111.007 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.82 -169.04 49.03 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.26 86.35 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.619 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.4 mt -129.16 147.97 33.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.78 -17.47 4.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.99 170.24 22.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.728 0.411 . . . . 0.0 110.43 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.93 162.53 41.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.624 0.249 . . . . 0.0 111.538 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.11 130.97 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.76 125.72 54.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.523 0.329 . . . . 0.0 110.958 -174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.54 129.9 34.85 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.53 -12.93 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.026 0.53 . . . . 0.0 110.9 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 123.163 0.585 . . . . 0.0 110.964 -177.218 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.471 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 42.1 p . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.6 Cg_exo -59.05 -16.49 33.15 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.976 1.784 . . . . 0.0 112.99 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.6 -21.67 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.038 0.381 . . . . 0.0 110.291 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.62 65.45 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.026 -0.421 . . . . 0.0 110.064 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.62 -19.66 60.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.339 -0.226 . . . . 0.0 110.66 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.92 51.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.42 -36.88 74.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.17 62.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.276 -0.265 . . . . 0.0 110.748 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 -15.19 54.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.405 0.282 . . . . 0.0 110.432 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -105.29 20.68 18.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.704 0.802 . . . . 0.0 111.403 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 59.02 35.76 24.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.035 0.934 . . . . 0.0 113.444 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.3 mt -118.59 97.62 50.84 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.97 161.14 26.89 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.079 3.186 . . . . 0.0 112.638 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -148.02 170.26 18.12 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.919 0.487 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.5 144.16 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -86.88 155.98 20.03 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.8 0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.05 125.98 18.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -161.93 164.71 28.34 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 110.618 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.45 95.61 0.57 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.43 165.04 12.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.7 m -147.58 28.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.55 0.34 . . . . 0.0 110.873 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -105.62 -50.88 3.11 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.71 -5.42 2.5 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.2 p -88.07 4.18 46.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.879 0.472 . . . . 0.0 112.131 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.43 154.44 30.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.336 0.588 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.98 179.86 7.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.0 108.972 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -57.53 -19.32 24.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.754 -0.591 . . . . 0.0 112.235 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -74.45 -24.63 59.09 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.991 -0.443 . . . . 0.0 110.749 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.56 -17.12 39.89 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.9 0.88 . . . . 0.0 109.396 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -88.26 -11.0 47.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.467 0.707 . . . . 0.0 110.37 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -111.98 -8.46 14.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.628 0.771 . . . . 0.0 111.785 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 26.1 tpt180 -137.84 139.56 26.82 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 79.0 Cg_exo -53.11 154.89 12.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.854 3.036 . . . . 0.0 114.238 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.83 155.14 32.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.136 0.974 . . . . 0.0 110.259 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.3 tp -133.57 149.71 51.65 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -74.08 160.97 30.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -70.45 -42.4 15.05 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.418 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.01 141.15 43.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.5 2.134 . . . . 0.0 109.645 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 4.6 m-30 -103.21 149.08 25.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 110.497 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.4 p -139.08 166.39 24.64 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.955 0.902 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mmm -65.65 -35.77 81.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.185 -0.322 . . . . 0.0 110.808 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.68 -28.38 26.43 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.388 0.275 . . . . 0.0 111.74 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.75 -28.81 64.36 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.6 t -83.91 -30.16 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.344 0.572 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.2 -27.84 60.98 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.39 -24.45 39.71 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.663 0.385 . . . . 0.0 110.244 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.24 64.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.183 -0.323 . . . . 0.0 110.394 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.21 -40.75 74.38 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.49 -18.89 61.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -23.27 24.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tt -91.79 -50.57 5.66 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.163 -0.336 . . . . 0.0 111.13 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.95 -1.12 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.913 -1.518 . . . . 0.0 110.06 178.669 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -79.93 -8.78 59.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.972 0.509 . . . . 0.0 111.585 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.438 ' HB3' HG11 ' A' ' 32' ' ' VAL . 65.2 mt-30 -121.04 114.62 21.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -119.88 131.98 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -91.39 145.03 24.97 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.559 ' H ' HD23 ' A' ' 8' ' ' LEU . 74.7 mt -113.34 130.95 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.1 117.71 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.19 163.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.21 -4.69 5.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.912 0.885 . . . . 0.0 110.538 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 44.5 tt0 -153.75 136.8 10.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 61.8 Cg_exo -56.74 -18.39 26.65 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.004 3.136 . . . . 0.0 114.52 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.62 -21.59 38.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.144 0.429 . . . . 0.0 111.671 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.11 -38.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.15 60.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.312 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.7 ttm -76.26 -32.8 59.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.0 tpt -81.5 -27.83 34.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.274 -0.266 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.48 -36.34 63.28 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -74.59 -21.69 59.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.82 -42.08 61.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.039 -0.413 . . . . 0.0 110.98 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -83.24 -22.78 33.0 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.91 -21.21 40.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.117 0.871 . . . . 0.0 111.076 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -85.58 -29.4 24.16 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.064 0.393 . . . . 0.0 111.314 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.39 -18.66 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 122.386 0.275 . . . . 0.0 111.23 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -99.33 18.15 18.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.119 0.567 . . . . 0.0 111.532 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 53.79 31.3 12.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.673 0.789 . . . . 0.0 112.227 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.51 165.72 16.89 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.639 0.776 . . . . 0.0 109.245 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -118.28 75.21 11.52 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 110.947 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.9 157.34 53.09 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.244 2.629 . . . . 0.0 109.78 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.1 m -122.75 -15.19 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.84 178.18 37.98 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.289 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 p -135.37 140.93 45.41 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.524 1.13 . . . . 0.0 108.876 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.51 147.16 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 110.431 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -92.1 2.19 56.73 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.41 0.684 . . . . 0.0 112.255 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -155.01 157.34 37.47 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.099 0.56 . . . . 0.0 110.065 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.48 -22.56 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.137 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.5 -26.04 64.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.36 59.27 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.02 67.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.714 0.757 . . . . 0.0 109.931 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.61 -37.54 68.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.79 -24.94 63.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -86.46 -22.7 26.33 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.314 0.506 . . . . 0.0 111.345 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.53 -28.22 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.52 -14.68 54.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.058 0.543 . . . . 0.0 111.559 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -108.16 -12.54 15.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.043 0.537 . . . . 0.0 112.197 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.71 165.82 38.94 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.15 136.06 18.82 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mt -144.7 146.1 20.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -101.09 -30.93 11.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 173.33 14.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.586 0.355 . . . . 0.0 110.343 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.1 158.23 43.95 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.98 128.27 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.64 119.09 34.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.182 0.593 . . . . 0.0 110.224 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.72 145.21 36.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.3 m -76.78 -11.79 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.879 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.69 -11.89 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.677 2.918 . . . . 0.0 112.499 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.61 -16.88 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.923 -0.486 . . . . 0.0 110.684 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.3 69.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.823 -0.548 . . . . 0.0 110.048 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.17 -18.07 60.26 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.389 0.276 . . . . 0.0 110.606 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.21 -30.34 38.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.22 -33.77 70.18 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.13 -23.11 61.26 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.063 0.145 . . . . 0.0 110.767 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.67 -16.83 56.82 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -99.57 16.87 21.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.684 0.794 . . . . 0.0 110.626 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.69 26.23 15.3 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 113.65 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.88 122.02 44.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.54 159.58 39.24 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.781 2.988 . . . . 0.0 111.453 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -147.3 164.5 33.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.56 144.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 124.048 0.939 . . . . 0.0 108.688 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -90.93 155.9 18.39 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.23 133.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -155.15 168.81 25.79 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.772 0.429 . . . . 0.0 111.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.95 118.4 0.95 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.57 -154.21 25.49 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -70.86 161.82 30.31 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.684 0.394 . . . . 0.0 110.337 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.99 -1.91 48.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.756 0.422 . . . . 0.0 112.043 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -100.88 0.55 38.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.231 0.612 . . . . 0.0 111.671 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -87.9 5.54 39.98 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.001 0.52 . . . . 0.0 112.12 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.0 m -123.08 154.58 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.488 0.715 . . . . 0.0 111.835 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.5 171.49 15.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.246 1.018 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -61.2 -18.18 56.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.164 0.586 . . . . 0.0 112.567 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -72.73 -24.7 61.01 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.735 0.698 . . . . 0.0 110.989 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 46.0 m-85 -84.43 -19.18 33.86 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.05 -10.37 50.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.064 0.546 . . . . 0.0 111.176 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.07 -15.06 14.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.349 0.66 . . . . 0.0 111.288 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -108.91 156.1 39.63 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 123.629 0.772 . . . . 0.0 109.585 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.91 151.58 83.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.197 2.598 . . . . 0.0 110.683 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.91 154.37 36.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.761 0.824 . . . . 0.0 110.688 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -135.64 157.2 47.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.821 0.848 . . . . 0.0 110.342 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -81.97 158.79 23.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -67.99 -53.44 20.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.816 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.44 141.71 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.048 1.832 . . . . 0.0 109.585 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -106.49 158.57 16.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.44 0.638 . . . . 0.0 111.681 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 p -137.49 164.25 29.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.768 1.227 . . . . 0.0 107.776 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.9 ttm -65.17 -29.12 69.92 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.001 -0.437 . . . . 0.0 110.883 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.32 -29.95 25.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.076 0.15 . . . . 0.0 110.904 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.95 -28.84 55.8 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.784 -0.453 . . . . 0.0 111.986 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.51 -24.65 8.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-N 117.864 0.832 . . . . 0.0 110.238 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 -28.98 65.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -85.11 -20.96 29.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.575 0.35 . . . . 0.0 110.983 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.89 -41.6 64.48 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.825 0.284 . . . . 0.0 110.314 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -78.92 -27.24 43.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.26 -20.1 60.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.939 0.336 . . . . 0.0 110.556 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.7 24.78 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.349 0.26 . . . . 0.0 111.3 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 tt -91.55 -51.81 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.875 0.307 . . . . 0.0 111.217 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.94 4.11 3.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.09 0.956 . . . . 0.0 113.214 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.828 -1.082 . . . . 0.0 109.966 178.86 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.375 0.607 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -74.28 -18.12 60.77 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.099 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 74.7 mt-30 -102.75 104.07 14.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.829 0.347 . . . . 0.0 110.713 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.23 130.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.573 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -89.41 129.61 35.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.354 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.406 ' N ' HD23 ' A' ' 8' ' ' LEU . 79.7 mt -94.34 129.68 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.473 0.709 . . . . 0.0 109.3 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -130.23 103.52 8.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 13' ' ' GLU . 82.0 tt0 -157.61 142.87 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -92.88 -7.48 46.07 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 15.9 tp10 -99.38 104.97 30.16 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.38 -18.32 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.122 2.548 . . . . 0.0 112.061 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.91 -40.17 48.27 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.281 0.491 . . . . 0.0 110.291 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.15 -25.92 6.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.43 -39.47 77.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -74.39 -27.4 60.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.2 ttt -65.8 -33.26 75.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.431 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 7.6 tt -77.21 -30.92 54.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.909 -0.495 . . . . 0.0 110.338 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.12 -21.83 64.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.926 0.33 . . . . 0.0 110.297 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.72 -41.61 62.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 104' ' ' PHE . 67.0 m-85 -73.65 -13.9 61.07 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.452 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.37 -27.17 52.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.309 0.504 . . . . 0.0 110.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -84.29 -24.72 29.75 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -80.49 -19.81 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.21 -6.73 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.186 0.594 . . . . 0.0 110.827 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.46 27.18 6.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.581 ' HG2' ' H ' ' A' ' 30' ' ' THR . 24.5 ttpt -91.07 -175.62 4.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.321 0.648 . . . . 0.0 110.206 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.581 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 89.6 m -109.46 119.53 47.89 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 122.301 -0.249 . . . . 0.0 110.607 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.79 164.48 20.49 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.976 3.117 . . . . 0.0 111.162 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 28.7 m -139.65 -30.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.26 173.85 33.38 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 118.159 0.436 . . . . 0.0 112.532 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.1 m -140.64 142.09 35.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 108.723 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.14 157.46 25.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.207 0.603 . . . . 0.0 110.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -98.32 -3.51 37.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.044 0.538 . . . . 0.0 112.334 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.7 p -142.71 157.58 44.51 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.328 0.651 . . . . 0.0 109.746 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.8 -22.59 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 O-C-N 122.389 -0.194 . . . . 0.0 110.8 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.03 -27.65 67.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.477 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.97 -21.27 74.46 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.66 -30.34 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.249 0.524 . . . . 0.0 110.338 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.4 mt -72.37 -34.1 67.73 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.78 -25.36 49.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -87.35 -31.61 20.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.13 -22.02 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 118.142 0.428 . . . . 0.0 111.752 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.56 -14.84 62.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.233 -0.292 . . . . 0.0 110.502 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.06 -12.43 41.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.59 . . . . 0.0 110.756 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 -167.58 48.22 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 13.89 82.66 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.253 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 mt -135.83 145.58 31.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.774 0.829 . . . . 0.0 109.108 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -106.81 -29.62 9.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 177.68 8.27 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.753 0.421 . . . . 0.0 110.69 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.17 165.34 28.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.01 -0.431 . . . . 0.0 112.06 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.6 mt -125.97 133.33 69.22 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.55 140.34 46.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.507 0.723 . . . . 0.0 109.937 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.94 158.82 16.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.07 -11.47 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 122.886 0.475 . . . . 0.0 112.106 -175.779 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 12.4 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.655 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.1 Cg_exo -58.18 -13.78 17.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 113.753 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.83 -18.58 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 118.299 0.5 . . . . 0.0 110.332 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -25.82 66.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 109.909 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.55 -17.38 54.1 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.859 -0.525 . . . . 0.0 109.979 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.48 -24.05 46.13 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.24 -30.79 63.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 171.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -22.6 59.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.55 -20.18 54.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -91.89 7.62 41.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.95 0.9 . . . . 0.0 110.724 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t70 59.12 32.04 21.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.378 1.071 . . . . 0.0 112.78 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.5 mt -111.94 126.16 28.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.04 161.32 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.429 2.753 . . . . 0.0 111.865 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.37 170.82 19.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.084 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.6 t -138.42 150.32 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.896 0.878 . . . . 0.0 108.92 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 20.2 m-85 -94.26 163.22 13.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.71 127.92 20.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -160.55 170.24 21.32 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.721 0.408 . . . . 0.0 110.534 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.18 132.93 4.26 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.77 -160.49 28.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -72.46 149.18 44.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.997 0.399 . . . . 0.0 110.039 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -75.8 -6.64 51.67 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -110.21 3.94 20.51 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.737 0.415 . . . . 0.0 111.246 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 t -98.48 12.49 34.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.441 0.696 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.01 153.84 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.488 0.715 . . . . 0.0 109.701 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.71 159.86 32.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.243 0.544 . . . . 0.0 112.394 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.1 p -63.2 -17.25 62.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -68.02 -28.02 67.05 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.686 0.675 . . . . 0.0 110.28 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 44.1 m-85 -85.13 -20.87 29.62 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -84.17 -7.99 59.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.905 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -118.62 -9.88 10.16 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.071 0.548 . . . . 0.0 112.14 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -125.29 156.78 69.47 Favored Pre-proline 0 C--N 1.341 0.236 0 C-N-CA 123.022 0.529 . . . . 0.0 110.568 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -54.3 144.18 61.66 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.638 2.892 . . . . 0.0 112.85 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.34 153.9 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.443 0.697 . . . . 0.0 110.077 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -130.69 155.53 46.45 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.927 0.891 . . . . 0.0 109.903 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -74.04 167.32 21.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.063 0.545 . . . . 0.0 110.902 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -75.89 -47.4 3.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.442 -0.789 . . . . 0.0 112.159 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.96 164.27 25.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.618 2.212 . . . . 0.0 110.456 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 10.9 m-85 -133.94 158.57 43.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.998 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.1 p -142.11 159.12 42.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.3 mtt -65.1 -27.99 69.14 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.137 -0.352 . . . . 0.0 111.126 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.26 -25.63 29.23 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.476 0.179 . . . . 0.0 110.633 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.43 -40.19 28.7 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.8 m -74.64 -21.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.559 0.679 . . . . 0.0 111.066 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.92 -31.43 51.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.12 0.418 . . . . 0.0 110.401 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -81.93 -31.76 31.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.55 60.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.85 -41.37 64.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.64 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.447 -0.158 . . . . 0.0 111.153 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.87 -21.06 25.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 tt -91.96 -38.69 12.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.203 0.601 . . . . 0.0 112.576 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.71 -10.83 59.74 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.935 -179.53 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 117' ' ' LEU . 76.0 mt . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.38 -10.87 16.16 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.729 0.812 . . . . 0.0 110.852 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.489 ' HB3' HG11 ' A' ' 32' ' ' VAL . 80.9 mt-30 -134.16 120.11 19.68 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.93 132.15 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.636 0.585 . . . . 0.0 110.536 -172.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -88.97 143.49 26.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.559 ' H ' HD23 ' A' ' 8' ' ' LEU . 94.3 mt -112.06 134.2 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.114 0.566 . . . . 0.0 109.845 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 t -132.38 115.7 26.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 22.7 tp10 -145.56 157.69 43.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -106.79 -0.0 23.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.495 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 39.4 tt0 -139.95 129.4 13.68 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 118.307 0.503 . . . . 0.0 110.328 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 53.7 Cg_exo -57.48 -27.43 76.26 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.573 2.849 . . . . 0.0 113.655 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.39 -44.25 71.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.8 -26.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.37 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.623 0.192 . . . . 0.0 111.086 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.5 mtt -75.82 -26.7 57.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 tpt -76.25 -23.91 54.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -71.15 -35.62 71.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.03 -21.72 56.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.452 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.09 -41.46 70.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.015 -0.428 . . . . 0.0 110.574 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.99 -23.15 62.13 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -85.07 -28.53 25.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.351 0.26 . . . . 0.0 110.677 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.78 -23.57 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.61 5.24 50.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.955 0.502 . . . . 0.0 111.531 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.66 35.9 12.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.544 0.737 . . . . 0.0 111.273 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -85.73 156.85 20.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.018 0.927 . . . . 0.0 111.123 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -91.27 120.23 68.49 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.87 162.49 29.44 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.317 2.678 . . . . 0.0 111.455 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 6' ' ' GLN . 26.8 m -138.24 -31.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.094 0 C-N-CA 122.443 0.297 . . . . 0.0 111.235 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 176.08 35.79 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -140.26 143.08 35.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.46 155.54 37.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -100.44 1.52 41.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.407 0.683 . . . . 0.0 111.779 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -136.84 154.11 50.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.207 0.603 . . . . 0.0 109.933 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.34 -22.44 11.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.392 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.93 -26.21 61.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.568 0.167 . . . . 0.0 110.608 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.99 -23.27 66.81 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -28.59 35.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.415 0.608 . . . . 0.0 110.649 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.81 -39.02 52.84 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.66 61.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -87.32 -25.07 24.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.164 0.438 . . . . 0.0 111.83 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -83.32 -26.35 7.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.519 0.6 . . . . 0.0 110.402 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.93 -16.73 59.97 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.831 0.348 . . . . 0.0 110.243 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.59 -12.42 42.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.333 0.653 . . . . 0.0 110.98 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -171.22 51.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.02 11.37 85.24 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.8 mt -140.08 144.8 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -101.9 -30.41 11.26 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.71 177.14 9.61 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.742 0.417 . . . . 0.0 110.409 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.64 161.98 40.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.66 124.99 72.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.07 124.2 50.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 111.651 -172.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.32 136.16 38.45 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 169.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.53 -13.95 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 122.402 0.281 . . . . 0.0 110.94 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 124.27 1.028 . . . . 0.0 112.362 -177.969 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 67.2 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 51.1 Cg_exo -59.1 -19.56 49.64 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.451 2.101 . . . . 0.0 113.698 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.46 -26.66 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.053 -0.405 . . . . 0.0 111.091 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.92 62.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.34 -17.39 54.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -32.59 63.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.05 -28.15 65.23 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.26 -22.5 59.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.35 -13.64 59.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -100.28 6.19 44.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.792 0.837 . . . . 0.0 110.526 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 57.04 33.83 23.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.419 1.088 . . . . 0.0 112.857 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.46 121.99 41.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.372 0.669 . . . . 0.0 109.542 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.9 153.62 62.07 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.906 3.07 . . . . 0.0 113.332 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -151.8 165.15 35.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.31 159.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 C-N-CA 123.823 0.849 . . . . 0.0 109.311 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 25.4 m-85 -95.21 159.53 14.97 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.143 0.497 . . . . 0.0 111.99 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 136.36 28.47 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -155.6 158.83 39.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.62 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.49 177.81 54.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.9 116.35 7.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t -154.17 156.09 36.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.26 0.624 . . . . 0.0 110.692 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -105.4 -0.35 26.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.216 0.606 . . . . 0.0 111.464 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -134.05 -2.65 2.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 m -88.74 7.92 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.433 0.56 . . . . 0.0 111.658 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 m -134.89 154.15 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.307 0.643 . . . . 0.0 111.15 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.07 -178.44 6.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.925 1.29 . . . . 0.0 108.649 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.5 m -59.43 -16.62 24.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.488 -0.758 . . . . 0.0 112.031 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -65.86 -30.69 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 9.0 m-85 -90.4 -13.51 34.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.545 1.138 . . . . 0.0 109.836 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -88.53 -10.59 48.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.047 0.539 . . . . 0.0 110.426 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.28 -15.04 12.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.34 0.656 . . . . 0.0 111.433 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -126.03 149.82 67.48 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 123.292 0.637 . . . . 0.0 109.481 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.89 147.02 94.27 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.088 2.525 . . . . 0.0 112.561 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -150.61 150.15 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 123.636 0.774 . . . . 0.0 109.102 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.1 tp -144.39 150.38 37.64 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -75.95 165.81 24.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.444 0.298 . . . . 0.0 111.048 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -58.1 -50.42 88.21 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.931 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.29 110.14 2.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.468 1.445 . . . . 0.0 110.063 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 5.4 m-30 -82.18 153.28 26.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.625 0.37 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.8 p -139.66 159.62 41.74 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.971 0.908 . . . . 0.0 108.997 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -65.11 -26.14 68.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.117 -0.364 . . . . 0.0 110.848 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.55 -36.33 22.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.773 0.261 . . . . 0.0 111.621 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.74 -31.49 49.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.1 t -79.46 -30.4 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.305 0.552 . . . . 0.0 110.078 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.56 69.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.963 0.347 . . . . 0.0 110.728 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.18 -31.57 23.15 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.356 -0.215 . . . . 0.0 111.449 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.21 60.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.9 0.318 . . . . 0.0 110.868 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.49 -20.67 33.55 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.25 -22.5 59.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.823 0.738 . . . . 0.0 110.001 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -19.72 27.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.516 0.327 . . . . 0.0 111.471 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.4 -58.02 2.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.657 0.383 . . . . 0.0 110.958 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 4' ' ' LEU . 73.2 mt -69.19 -1.31 7.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.788 1.235 . . . . 0.0 113.351 -173.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.226 -1.369 . . . . 0.0 109.971 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 117' ' ' LEU . 77.1 mt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.614 0.245 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -4.98 45.15 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.456 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.0 mt-30 -125.51 119.1 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mm -122.09 137.22 56.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.978 0.911 . . . . 0.0 111.173 -173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -94.71 135.27 36.38 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' H ' HD23 ' A' ' 8' ' ' LEU . 76.4 mt -102.59 126.14 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.288 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.6 t -132.27 117.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.69 161.89 36.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.305 0.642 . . . . 0.0 110.455 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -97.11 0.39 48.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.06 0.544 . . . . 0.0 111.638 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' A' ' 15' ' ' LEU . 42.3 tt0 -147.24 132.96 9.34 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.878 -0.514 . . . . 0.0 110.304 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.6 -23.32 70.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.441 2.761 . . . . 0.0 113.615 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 9.3 tt -72.38 -40.45 67.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.99 -29.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.07 69.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.8 ttp -75.81 -27.83 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.7 ttp -73.46 -29.87 62.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.02 -36.7 75.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -73.14 -21.98 60.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.531 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.81 -42.84 63.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.134 -0.354 . . . . 0.0 111.152 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -75.23 -21.21 58.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.365 0.529 . . . . 0.0 111.376 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -82.79 -18.51 40.34 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.184 0.447 . . . . 0.0 111.344 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -85.07 -22.86 28.79 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.57 0.623 . . . . 0.0 110.388 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 -21.2 10.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -93.17 -0.09 57.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.296 0.638 . . . . 0.0 111.149 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t0 52.37 40.96 30.36 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.369 0.605 . . . . 0.0 110.885 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -85.5 165.18 17.34 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.943 0.897 . . . . 0.0 110.784 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.1 m -115.16 74.64 3.89 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.01 0.524 . . . . 0.0 110.151 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.33 156.95 57.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.894 2.396 . . . . 0.0 109.789 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 32.7 m -116.71 -7.75 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.7 171.53 31.05 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.287 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -137.96 139.88 39.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.78 158.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -120.29 -2.65 10.07 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.535 0.734 . . . . 0.0 111.58 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.0 p -138.83 161.04 38.23 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.404 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.55 -26.54 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.045 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.2 -28.33 48.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.68 -27.88 60.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.79 -42.43 73.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.344 0.572 . . . . 0.0 110.175 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.89 -24.58 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.83 61.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.744 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -84.11 -20.87 31.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.978 0.354 . . . . 0.0 111.366 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.84 -31.36 40.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.51 -14.82 54.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.642 0.377 . . . . 0.0 111.791 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -87.75 -13.32 42.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.891 0.477 . . . . 0.0 111.963 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.44 172.58 36.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.4 151.62 43.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -141.87 150.03 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -108.47 -26.81 10.27 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-N 118.045 0.384 . . . . 0.0 111.496 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 171.08 18.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.088 0.555 . . . . 0.0 110.169 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.8 160.4 43.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.145 -0.347 . . . . 0.0 111.097 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.99 127.37 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.88 130.92 56.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.963 0.505 . . . . 0.0 111.188 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -81.53 139.43 35.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.76 -16.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.669 0.271 . . . . 0.0 110.667 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.889 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.231 0.11 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.93 -9.15 14.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.592 2.861 . . . . 0.0 111.532 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.28 -29.04 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 O-C-N 122.162 -0.336 . . . . 0.0 110.93 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.48 90.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.293 -0.255 . . . . 0.0 110.622 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.21 -17.54 39.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.374 -0.204 . . . . 0.0 111.35 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.5 70.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.41 -28.08 61.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.6 -22.79 62.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.867 0.303 . . . . 0.0 110.204 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.92 41.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.5 0.32 . . . . 0.0 110.351 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.08 7.95 42.05 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 111.155 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.56 28.81 17.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 112.843 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.4 mt -101.33 128.26 29.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.511 0.724 . . . . 0.0 109.474 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.42 156.1 50.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 111.608 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -147.84 167.14 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.6 t -139.22 145.58 27.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.037 0 C-N-CA 124.108 0.963 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.02 150.91 19.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.522 0.329 . . . . 0.0 110.551 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 119.74 11.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -171.78 163.28 6.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.199 0.6 . . . . 0.0 110.647 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.04 147.34 19.6 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.7 -154.35 25.44 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 117.532 0.666 . . . . 0.0 111.812 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 t -137.81 169.47 17.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.845 0.858 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.44 -11.94 60.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.784 0.434 . . . . 0.0 111.484 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.02 -4.3 27.72 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.398 0.679 . . . . 0.0 111.3 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 m -93.03 2.27 56.87 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.158 0.583 . . . . 0.0 111.337 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.59 154.72 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 123.946 0.898 . . . . 0.0 110.702 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.38 -177.52 5.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.346 0.593 . . . . 0.0 111.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.5 p -61.99 -16.5 51.86 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -73.79 -31.8 63.45 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.332 0.969 . . . . 0.0 110.396 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -82.13 -22.71 36.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -88.44 -5.47 58.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.399 0.279 . . . . 0.0 111.132 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -105.08 -16.81 14.69 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.465 0.706 . . . . 0.0 111.128 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -109.45 158.86 33.43 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.537 0.735 . . . . 0.0 110.09 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.47 152.63 76.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.827 2.352 . . . . 0.0 111.303 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.9 154.49 21.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.159 0.584 . . . . 0.0 110.981 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -145.85 156.53 43.62 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.528 0.731 . . . . 0.0 109.128 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.61 164.48 24.82 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -65.17 -50.19 61.87 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.655 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.26 146.28 35.72 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.238 1.959 . . . . 0.0 109.469 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -105.44 153.72 21.31 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 121.006 0.432 . . . . 0.0 111.139 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.2 p -143.21 160.23 40.84 Favored 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 124.405 1.082 . . . . 0.0 108.739 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.6 mtt -66.55 -23.65 66.25 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.085 -0.384 . . . . 0.0 111.099 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.3 -37.76 21.26 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 122.174 -0.329 . . . . 0.0 111.279 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.97 -34.73 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.92 -29.64 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 117.501 0.651 . . . . 0.0 110.499 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.52 -29.49 63.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.191 -0.318 . . . . 0.0 110.755 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.31 -31.79 22.85 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.088 0.155 . . . . 0.0 111.279 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.13 -34.54 61.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.82 0.282 . . . . 0.0 110.552 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.08 -21.18 33.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.462 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.32 -19.89 59.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.205 0.457 . . . . 0.0 110.219 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.88 23.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.495 0.318 . . . . 0.0 111.464 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 tt -91.6 -59.39 2.14 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.645 0.378 . . . . 0.0 111.473 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 4' ' ' LEU . 48.9 mt -70.06 3.72 2.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.271 1.428 . . . . 0.0 113.55 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.783 -1.103 . . . . 0.0 109.94 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.534 0.683 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.82 -6.42 54.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.332 0.653 . . . . 0.0 112.206 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.587 ' HB3' HG11 ' A' ' 32' ' ' VAL . 78.6 mt-30 -128.71 119.05 23.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.5 mm -120.9 131.41 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.609 0.764 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -88.52 140.94 28.95 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 8' ' ' LEU . 89.4 mt -109.99 135.14 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 110.117 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 t -129.07 121.56 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 16.9 tp10 -149.2 159.16 44.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.764 0.426 . . . . 0.0 110.656 -171.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.57 -12.74 12.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.438 0.695 . . . . 0.0 111.526 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 18.1 tp10 -120.16 110.38 36.26 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 123.438 0.695 . . . . 0.0 109.27 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.86 -23.7 35.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.636 2.891 . . . . 0.0 113.955 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.1 tp -73.43 -32.54 64.45 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.3 0.5 . . . . 0.0 110.202 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.77 -28.52 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.63 64.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.594 0.179 . . . . 0.0 110.557 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.0 -33.66 57.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.2 tpt -75.05 -23.95 58.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -38.01 75.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.13 -22.74 57.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.608 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.86 -43.66 68.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.202 -0.311 . . . . 0.0 110.557 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -76.46 -25.5 54.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.936 -0.477 . . . . 0.0 111.416 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 tp -73.0 -32.11 64.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.292 0.497 . . . . 0.0 111.024 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -85.57 -24.07 27.36 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.5 t -76.64 -20.6 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.337 0.517 . . . . 0.0 110.504 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.89 18.38 18.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.709 0.403 . . . . 0.0 111.685 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 54.18 27.66 8.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.9 0.88 . . . . 0.0 113.043 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.9 157.12 20.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.224 0.61 . . . . 0.0 109.518 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.3 m -99.43 120.93 56.62 Favored Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 122.014 -0.429 . . . . 0.0 110.231 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -79.24 162.89 25.4 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.65 2.9 . . . . 0.0 110.696 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -138.7 -27.11 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.69 173.58 33.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -140.73 143.33 34.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.56 154.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 122.584 0.354 . . . . 0.0 110.927 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.19 8.72 28.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.277 0.631 . . . . 0.0 111.634 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -150.63 158.77 44.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 122.826 0.45 . . . . 0.0 110.167 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.1 -22.84 21.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 122.941 0.496 . . . . 0.0 111.101 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.96 62.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 122.271 -0.268 . . . . 0.0 110.716 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.2 -21.58 70.09 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.49 -31.73 42.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.278 0.539 . . . . 0.0 110.498 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.12 -23.76 35.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.759 0.254 . . . . 0.0 110.97 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.18 -30.14 34.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.3 -0.25 . . . . 0.0 111.504 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -87.72 -29.1 21.33 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.18 -28.82 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 118.201 0.455 . . . . 0.0 111.313 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.16 -14.87 59.72 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.794 -0.566 . . . . 0.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.75 -12.54 41.89 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.34 0.656 . . . . 0.0 110.587 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 -173.05 54.28 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.55 74.06 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.203 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -139.17 147.16 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 108.777 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.09 -21.2 10.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.22 -0.419 . . . . 0.0 112.049 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 173.12 14.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.314 0.506 . . . . 0.0 110.532 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.51 164.25 34.0 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.84 133.32 69.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.42 129.11 56.63 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.353 . . . . 0.0 110.996 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -81.44 130.16 34.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.85 -11.28 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.629 0.252 . . . . 0.0 110.542 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 123.704 0.802 . . . . 0.0 110.465 177.281 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 66.3 p . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 118.14 -0.933 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 39.6 Cg_exo -64.96 -24.91 59.9 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.767 1.645 . . . . 0.0 111.889 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.96 -23.88 7.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 C-N-CA 122.333 0.253 . . . . 0.0 110.675 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.17 70.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.49 -17.72 61.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.223 -0.298 . . . . 0.0 110.487 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.78 -29.78 51.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.91 -31.41 69.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.86 61.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.91 -13.87 58.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.588 0.355 . . . . 0.0 110.477 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -102.71 12.27 36.53 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.82 0.848 . . . . 0.0 111.013 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 58.03 33.27 23.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.066 0.947 . . . . 0.0 113.423 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.2 mt -114.37 129.4 24.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 109.457 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.93 159.28 30.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 112.418 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -153.78 168.99 24.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.301 0.641 . . . . 0.0 110.742 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.04 159.76 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 124.006 0.922 . . . . 0.0 108.968 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -99.38 156.21 17.13 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.939 0.4 . . . . 0.0 111.779 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.37 119.53 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -172.61 156.62 3.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.721 0.408 . . . . 0.0 110.604 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.59 143.43 18.47 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.65 -158.09 29.88 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 117.358 0.579 . . . . 0.0 111.916 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.4 t -137.47 170.86 15.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.887 0.875 . . . . 0.0 110.063 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.04 -13.8 62.48 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.101 -0.374 . . . . 0.0 111.302 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.93 3.55 54.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.16 0.584 . . . . 0.0 111.332 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 98.4 p -126.12 20.2 7.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.827 0.451 . . . . 0.0 111.903 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 16.1 m -132.26 154.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.422 0.689 . . . . 0.0 111.779 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -81.93 170.84 15.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.26 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.5 p -61.09 -21.72 63.95 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.95 -21.42 59.19 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.673 0.669 . . . . 0.0 110.862 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.465 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 3.2 m-85 -80.97 -23.44 38.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -88.21 -8.15 55.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.448 0.699 . . . . 0.0 111.261 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -119.6 -3.96 10.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.199 0.599 . . . . 0.0 112.087 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -140.55 140.8 23.35 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 149.96 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.622 2.881 . . . . 0.0 114.345 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 m -142.75 154.62 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.535 1.134 . . . . 0.0 109.596 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -146.87 155.28 42.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.657 0.383 . . . . 0.0 110.097 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.26 158.12 35.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 44.8 mtpt -66.08 -43.82 57.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.907 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 67.6 Cg_endo -69.39 128.61 16.63 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.676 1.277 . . . . 0.0 108.881 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -100.03 154.08 18.69 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.766 0.426 . . . . 0.0 111.367 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.5 p -141.38 162.39 35.61 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.426 1.09 . . . . 0.0 108.711 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.08 -26.88 68.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.298 -0.251 . . . . 0.0 111.031 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -84.47 -38.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.932 0.333 . . . . 0.0 111.579 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.99 -31.76 59.5 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.18 -27.64 12.02 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.026 0 CA-C-N 117.24 0.52 . . . . 0.0 110.229 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.17 68.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.003 -0.436 . . . . 0.0 110.669 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.24 -33.77 25.99 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 122.321 -0.237 . . . . 0.0 110.939 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.86 66.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.34 -20.33 40.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.63 62.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.777 0.717 . . . . 0.0 109.886 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.41 -23.71 24.44 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.2 mt -91.56 -14.44 30.31 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -107.06 18.04 22.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.376 0.535 . . . . 0.0 111.137 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.442 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.399 0.142 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -70.42 -7.07 40.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.161 -0.337 . . . . 0.0 111.214 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.674 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.8 mp0 -106.27 114.31 28.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 122.807 0.443 . . . . 0.0 111.457 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 mm -123.88 127.35 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 123.636 0.585 . . . . 0.0 110.225 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -92.85 136.16 33.49 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.434 ' N ' HD23 ' A' ' 8' ' ' LEU . 96.8 mt -103.24 132.78 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.182 0.593 . . . . 0.0 109.937 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.7 t -131.97 118.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 34.8 tp10 -151.24 140.2 21.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.803 0.441 . . . . 0.0 109.945 -176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.66 4.67 48.76 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.561 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 59.0 mt-10 -135.68 138.67 28.8 Favored Pre-proline 0 CA--C 1.529 0.153 0 O-C-N 121.899 -0.5 . . . . 0.0 109.984 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.75 -22.0 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.341 2.694 . . . . 0.0 112.525 -174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -79.42 -36.47 38.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.239 0.472 . . . . 0.0 110.236 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.47 -27.75 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.49 -35.05 78.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.2 ttp -73.63 -30.17 62.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.4 ttp -74.82 -31.43 61.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.382 -0.199 . . . . 0.0 110.485 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.07 -29.97 67.1 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.168 -0.333 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.2 -21.79 56.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.55 -43.79 54.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.089 0.404 . . . . 0.0 110.411 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -74.52 -16.93 60.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.065 0.393 . . . . 0.0 111.167 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -69.05 -30.72 69.12 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -83.2 -23.73 32.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.387 0.275 . . . . 0.0 111.112 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.58 -24.61 23.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.2 tp -93.31 -1.64 55.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.919 0.487 . . . . 0.0 110.544 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.28 35.04 15.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.332 0.653 . . . . 0.0 110.716 -175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -85.6 155.57 21.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.217 1.007 . . . . 0.0 109.876 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -90.38 121.56 68.35 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.58 155.26 35.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.473 2.782 . . . . 0.0 110.573 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 6' ' ' GLN . 34.5 m -138.16 -18.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.584 0.354 . . . . 0.0 111.813 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.64 167.52 25.33 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -143.61 138.95 29.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.9 161.31 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.928 0.491 . . . . 0.0 110.501 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -113.34 5.25 16.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.196 0.598 . . . . 0.0 112.486 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 39' ' ' ALA . 29.6 m -137.12 143.79 42.7 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.01 -23.34 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 37' ' ' THR . . . -77.15 -25.68 52.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.42 63.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.42 -34.33 54.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.4 0.6 . . . . 0.0 110.135 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.69 -42.36 67.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.53 -24.8 64.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.437 0.295 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -81.53 -26.51 35.03 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 122.299 -0.25 . . . . 0.0 111.336 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.25 -25.38 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 118.272 0.487 . . . . 0.0 110.267 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -75.12 -14.74 60.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.077 -0.389 . . . . 0.0 110.898 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.32 -12.36 59.93 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 110.484 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.4 -176.12 54.81 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.519 0.58 . . . . 0.0 111.863 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.64 12.73 83.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.164 -0.374 . . . . 0.0 112.164 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.36 145.86 35.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.895 0.848 . . . . 0.0 109.696 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.22 -15.4 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.049 0.539 . . . . 0.0 112.007 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 172.39 12.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.751 0.82 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.09 31.59 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.127 -0.358 . . . . 0.0 111.558 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.03 131.27 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.61 133.84 55.64 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.105 0.478 . . . . 0.0 111.781 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -86.5 137.12 32.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.08 -11.88 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.267 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.69 -7.15 20.32 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.652 2.901 . . . . 0.0 111.589 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.57 -22.77 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 O-C-N 122.142 -0.348 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.72 -28.73 69.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.26 -0.275 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.57 -20.93 61.23 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.338 -0.227 . . . . 0.0 110.614 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -29.82 41.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.24 -32.9 61.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.55 61.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.21 -12.13 55.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 110.395 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -94.31 17.61 12.52 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.871 0.868 . . . . 0.0 110.972 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t0 59.74 31.26 20.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.661 1.184 . . . . 0.0 114.024 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 pt -128.28 143.79 49.39 Favored Pre-proline 0 CA--C 1.532 0.251 0 O-C-N 122.094 -0.379 . . . . 0.0 110.228 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.77 161.61 24.38 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.785 2.99 . . . . 0.0 111.793 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -145.63 165.4 28.8 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.227 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.7 t -137.62 146.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 124.339 1.056 . . . . 0.0 108.542 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.65 155.58 18.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.935 0.397 . . . . 0.0 111.226 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 119.22 11.37 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -174.02 161.09 3.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 109.859 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.02 145.69 25.98 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.48 -159.33 30.78 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 117.455 0.628 . . . . 0.0 112.03 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.9 t -141.05 159.79 41.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.779 0.831 . . . . 0.0 109.972 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -71.8 -5.96 38.08 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.42 4.39 50.62 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.8 m -129.56 22.2 5.52 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.328 0.651 . . . . 0.0 111.696 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 15.3 m -131.25 154.66 40.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 122.973 0.509 . . . . 0.0 112.072 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.2 168.0 20.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.312 1.045 . . . . 0.0 111.307 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.8 p -62.23 -17.45 58.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -73.61 -25.88 60.52 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.218 0.463 . . . . 0.0 110.167 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.495 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 15.7 m-85 -80.38 -24.39 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.45 -9.33 52.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.997 0.519 . . . . 0.0 111.63 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.02 -18.01 12.72 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -135.16 157.84 75.99 Favored Pre-proline 0 C--O 1.232 0.166 0 C-N-CA 122.847 0.459 . . . . 0.0 110.055 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.33 154.08 25.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.384 3.39 . . . . 0.0 114.082 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.22 154.23 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.381 1.072 . . . . 0.0 109.293 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.7 mt -143.4 156.95 44.8 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.203 0.601 . . . . 0.0 110.754 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -87.05 170.5 11.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.05 -38.84 52.52 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.59 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.78 125.23 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.076 1.85 . . . . 0.0 110.738 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -111.1 152.11 27.32 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.219 0.608 . . . . 0.0 110.187 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.2 p -141.3 159.41 42.27 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.737 0.815 . . . . 0.0 109.147 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -67.55 -26.91 66.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.17 -0.331 . . . . 0.0 111.077 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.66 -35.77 22.38 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.019 0.372 . . . . 0.0 111.676 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.18 -31.21 43.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.66 -28.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.648 0.724 . . . . 0.0 110.578 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.61 66.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.059 -0.401 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.55 -27.94 26.98 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 117.647 0.203 . . . . 0.0 110.966 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.03 -36.5 48.54 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.202 -0.311 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.42 -23.46 40.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.27 -0.269 . . . . 0.0 110.481 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.2 -24.17 60.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.15 -13.86 42.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.089 0.556 . . . . 0.0 111.327 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.33 -33.79 42.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.04 7.3 11.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.37 -179.534 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 4' ' ' LEU . 1.1 pt? . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.269 0.557 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -77.29 -5.68 50.36 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.642 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 67.3 mt-30 -122.39 118.06 27.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -123.42 134.15 67.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.851 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -88.84 138.07 31.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.57 ' H ' HD23 ' A' ' 8' ' ' LEU . 77.2 mt -111.65 126.09 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.806 0.842 . . . . 0.0 109.558 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 35' ' ' VAL . 19.8 t -132.18 122.33 48.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 122.775 0.43 . . . . 0.0 110.23 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -141.65 155.32 45.71 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.919 0.488 . . . . 0.0 110.733 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.83 -6.97 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.663 0.385 . . . . 0.0 110.926 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.17 125.93 17.24 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.987 0.515 . . . . 0.0 109.676 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.17 -25.01 76.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.966 2.444 . . . . 0.0 112.804 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.97 -33.14 74.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.099 -0.376 . . . . 0.0 110.525 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.85 -26.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.98 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.807 0.276 . . . . 0.0 110.827 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.64 -31.74 62.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.3 tpt -75.01 -23.73 58.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -39.63 81.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.64 -22.39 60.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.68 -40.14 66.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.904 0.32 . . . . 0.0 111.052 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -74.69 -27.55 60.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.776 -0.577 . . . . 0.0 110.595 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.07 -17.66 58.58 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.917 -0.489 . . . . 0.0 110.606 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -78.58 -28.29 45.85 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.33 -20.74 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.374 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.27 12.22 36.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.296 0.638 . . . . 0.0 111.995 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.89 33.91 15.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.556 0.742 . . . . 0.0 112.291 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.85 163.68 17.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.877 0.871 . . . . 0.0 110.09 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -117.8 74.75 9.7 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 122.698 0.399 . . . . 0.0 110.46 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.94 154.57 65.88 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.941 2.427 . . . . 0.0 109.682 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 33.8 m -115.87 -12.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.337 0.055 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 175.34 35.11 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.248 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -132.49 143.49 49.79 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.737 0.815 . . . . 0.0 108.941 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.411 ' CG2' HG22 ' A' ' 10' ' ' VAL . 34.3 m -146.07 163.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.008 0.523 . . . . 0.0 110.206 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.65 6.92 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.001 0.521 . . . . 0.0 112.065 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -146.12 156.55 43.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.056 0.542 . . . . 0.0 110.183 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.97 -28.31 40.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.98 62.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 -30.77 56.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.36 -38.34 87.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.809 0.805 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.73 -19.32 57.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 -24.97 49.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.088 0.404 . . . . 0.0 111.013 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -77.75 -32.87 52.94 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.05 -26.09 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.464 0.306 . . . . 0.0 110.247 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.39 -15.11 53.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 111.043 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.98 -12.88 20.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.661 0.384 . . . . 0.0 111.582 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.97 172.31 38.47 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.15 154.61 48.14 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.0 mt -141.93 146.04 23.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -103.28 -24.34 13.53 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 174.31 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.695 0.398 . . . . 0.0 110.396 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.11 162.34 40.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.077 -0.39 . . . . 0.0 111.754 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.02 127.97 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.035 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.23 124.63 50.72 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.745 0.418 . . . . 0.0 111.192 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -85.97 124.47 32.46 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.43 -5.31 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.708 0.803 . . . . 0.0 111.95 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 0.0 112.636 -174.997 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.6 m . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 71.6 Cg_exo -55.41 -19.65 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.685 2.257 . . . . 0.0 114.578 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.95 -26.24 9.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-N 118.858 0.754 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.9 60.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.41 -17.68 53.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.264 0.225 . . . . 0.0 110.533 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.53 -32.66 58.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.8 -26.32 60.56 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.45 61.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.919 0.327 . . . . 0.0 110.357 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.8 -18.83 53.47 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.09 7.7 44.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.554 0.742 . . . . 0.0 111.025 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 58.66 29.53 18.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.408 1.083 . . . . 0.0 113.106 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.8 127.81 29.28 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.5 158.52 44.01 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.759 2.973 . . . . 0.0 111.588 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -150.73 168.29 24.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.873 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.18 146.78 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.113 0.965 . . . . 0.0 108.891 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 21.2 m-85 -89.62 157.79 17.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.101 0.477 . . . . 0.0 111.266 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 144.62 37.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -161.95 174.16 13.46 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.29 117.34 0.76 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.82 -159.27 28.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m -71.09 160.0 33.69 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.887 0.475 . . . . 0.0 110.29 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.82 -11.44 60.38 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.79 -1.82 44.56 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.133 0.424 . . . . 0.0 111.469 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.4 t -78.92 -7.18 57.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.723 0.409 . . . . 0.0 110.92 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 m -135.59 154.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.393 0.677 . . . . 0.0 110.506 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.27 -178.64 3.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.802 0.841 . . . . 0.0 111.351 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.3 p -60.36 -19.68 56.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -70.05 -27.01 64.29 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.194 0.452 . . . . 0.0 110.157 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.405 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 16.0 m-85 -89.17 -18.16 27.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.761 0.824 . . . . 0.0 109.903 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -88.06 -8.81 54.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.511 0.324 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.63 -19.64 13.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.57 0.748 . . . . 0.0 110.842 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -103.61 160.99 24.37 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.997 0.919 . . . . 0.0 110.034 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.02 150.74 82.69 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.859 2.373 . . . . 0.0 110.829 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.48 154.23 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.903 0.881 . . . . 0.0 110.557 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.1 mt -134.56 153.86 51.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.726 0.81 . . . . 0.0 109.886 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -85.37 163.08 18.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.32 -48.04 13.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.348 -0.834 . . . . 0.0 113.221 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.16 138.95 18.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.874 1.716 . . . . 0.0 111.152 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -111.52 157.64 20.1 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.967 0.507 . . . . 0.0 110.506 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.3 p -140.92 165.6 27.07 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.711 1.204 . . . . 0.0 108.039 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.93 -36.68 79.97 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.871 -0.518 . . . . 0.0 111.192 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -84.59 -29.0 26.17 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.281 -0.262 . . . . 0.0 111.306 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.92 -28.16 51.16 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.334 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.01 -25.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 117.898 0.849 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.33 70.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.62 -20.86 30.7 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.478 0.311 . . . . 0.0 110.972 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.9 -40.08 55.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.844 0.293 . . . . 0.0 110.598 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.21 -25.66 42.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.69 62.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.218 0.463 . . . . 0.0 110.378 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.57 -16.58 34.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.044 0.537 . . . . 0.0 111.894 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.27 -33.72 15.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.516 0.326 . . . . 0.0 110.906 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.01 -3.04 58.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.762 0.425 . . . . 0.0 111.987 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.743 -1.122 . . . . 0.0 110.117 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.955 0.407 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.21 -8.7 57.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.534 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.462 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.6 mp0 -112.22 110.11 20.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.149 0.579 . . . . 0.0 111.905 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.88 139.47 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.401 0.68 . . . . 0.0 110.315 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.85 133.43 47.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.9 mt -98.69 126.47 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.34 109.21 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -143.03 160.18 40.86 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -89.44 -4.54 57.94 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.966 0.506 . . . . 0.0 111.538 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -140.31 140.07 22.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 O-C-N 122.039 -0.413 . . . . 0.0 110.976 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.07 -14.45 10.89 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.767 2.978 . . . . 0.0 112.799 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.33 -45.11 66.85 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.517 0.599 . . . . 0.0 110.703 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.06 -25.4 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.3 66.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.283 -0.261 . . . . 0.0 110.581 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mmt -82.33 -26.25 33.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.5 mmm -75.23 -29.22 60.18 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 122.137 -0.352 . . . . 0.0 110.625 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.403 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 3.1 mm? -76.47 -30.05 57.15 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.69 -22.21 56.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.882 0.31 . . . . 0.0 110.224 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.39 -45.13 20.1 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.22 -0.3 . . . . 0.0 111.29 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -78.88 -24.04 44.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.558 0.617 . . . . 0.0 112.435 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.34 -22.19 48.42 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.376 0.989 . . . . 0.0 111.066 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -85.23 -23.43 28.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.438 0.563 . . . . 0.0 111.167 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.07 -18.53 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.616 0.366 . . . . 0.0 110.884 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.07 20.22 19.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.867 0.467 . . . . 0.0 111.753 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 53.94 30.29 11.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.931 0.892 . . . . 0.0 113.114 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.5 tmtm? -85.76 164.29 17.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.464 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 23.8 m -123.18 71.8 45.32 Favored Pre-proline 0 CA--C 1.53 0.199 0 O-C-N 122.239 -0.288 . . . . 0.0 111.0 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.19 151.61 81.06 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.725 2.284 . . . . 0.0 109.408 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 6' ' ' GLN . 33.1 m -112.57 -6.8 11.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.48 174.98 34.84 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -140.75 139.4 34.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.077 0.951 . . . . 0.0 108.684 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 156.02 29.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 122.877 0.471 . . . . 0.0 110.214 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -108.53 2.23 22.04 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 112.048 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.5 p -139.11 158.46 44.14 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 110.311 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.26 -22.93 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.654 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.32 -25.97 58.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.14 71.05 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.31 -30.89 48.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.39 0.595 . . . . 0.0 110.261 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.68 -32.46 53.09 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.51 56.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.172 -0.33 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -87.73 -25.91 23.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.1 -22.01 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.219 0.463 . . . . 0.0 111.293 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.99 -14.74 63.21 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.897 0.317 . . . . 0.0 110.802 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.28 -12.42 37.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.275 0.63 . . . . 0.0 110.81 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 -169.31 53.51 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 12.03 82.06 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.832 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.62 145.88 22.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.76 0.78 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.98 -22.24 5.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.625 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.3 171.07 15.34 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.571 0.748 . . . . 0.0 109.731 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.4 164.87 35.76 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.083 -0.386 . . . . 0.0 110.967 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.9 mt -122.64 133.16 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.25 142.71 45.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.296 0.638 . . . . 0.0 110.691 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -97.51 135.17 39.74 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.566 0.746 . . . . 0.0 109.169 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.35 -16.08 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 122.541 0.336 . . . . 0.0 110.718 177.16 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.1 p . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.8 -13.19 29.35 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.999 2.466 . . . . 0.0 112.245 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.06 -24.04 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.113 0.415 . . . . 0.0 110.326 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.07 65.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.08 -17.62 45.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.452 0.301 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.58 62.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.35 -28.97 64.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.99 -22.83 60.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.57 -19.58 55.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -92.33 10.6 29.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.347 0.659 . . . . 0.0 110.858 172.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t70 59.42 25.18 13.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 113.006 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.48 125.06 46.51 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 157.58 34.42 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.605 2.87 . . . . 0.0 111.113 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -149.39 167.52 25.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.214 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -138.45 141.94 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -82.93 148.46 27.64 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.53 129.68 33.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 169.73 22.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.601 0.36 . . . . 0.0 110.665 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.99 175.87 54.84 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.43 102.37 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -150.39 147.25 27.34 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.701 0.8 . . . . 0.0 109.929 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -105.63 -2.83 22.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 112.29 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.68 0.28 4.38 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.1 m -89.86 5.83 44.5 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.927 -0.483 . . . . 0.0 111.421 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.15 154.46 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.748 0.819 . . . . 0.0 111.118 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -102.86 175.54 5.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.709 0.804 . . . . 0.0 110.563 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -64.98 -11.35 37.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -75.77 -24.21 56.02 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.31 0.505 . . . . 0.0 109.938 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -86.8 -20.12 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -84.02 -12.93 54.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.74 0.416 . . . . 0.0 110.767 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -104.5 -16.69 14.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.355 0.662 . . . . 0.0 111.601 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -109.29 163.14 17.71 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.405 0.682 . . . . 0.0 110.402 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.87 148.2 68.57 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.572 2.848 . . . . 0.0 112.58 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.26 154.75 23.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.762 0.825 . . . . 0.0 110.328 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -145.89 154.26 41.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.744 0.818 . . . . 0.0 109.54 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -80.22 146.29 31.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 34.5 ttmt -72.33 -43.34 9.62 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.019 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 74.3 Cg_endo -69.59 142.26 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.197 1.463 . . . . 0.0 109.74 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.4 m-85 -117.3 150.01 39.52 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 121.376 0.607 . . . . 0.0 111.971 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.6 p -143.7 166.47 24.77 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.028 1.331 . . . . 0.0 107.519 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 55.2 ttm -65.76 -28.19 68.84 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.737 -0.602 . . . . 0.0 110.977 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.32 -31.28 24.93 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.263 -0.273 . . . . 0.0 110.637 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.37 -24.67 67.63 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.648 -0.529 . . . . 0.0 112.129 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.3 p -86.23 -27.51 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 118.155 0.978 . . . . 0.0 110.969 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.09 69.86 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.08 -20.94 29.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.355 0.662 . . . . 0.0 110.584 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.25 61.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.59 -26.41 45.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.02 63.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.923 0.329 . . . . 0.0 110.127 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.82 -17.47 31.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.764 0.425 . . . . 0.0 111.743 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.4 -36.16 13.96 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.599 0.36 . . . . 0.0 111.66 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.72 3.99 54.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.728 0.411 . . . . 0.0 112.055 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.377 -1.297 . . . . 0.0 110.244 179.29 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.654 0.74 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -4.15 42.61 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.075 0.55 . . . . 0.0 110.971 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.536 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.5 mt-30 -124.03 115.89 21.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mm -122.26 132.64 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.394 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 141.3 28.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.558 ' H ' HD23 ' A' ' 8' ' ' LEU . 69.5 mt -105.53 122.45 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.874 0.87 . . . . 0.0 109.251 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.25 113.25 21.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -145.39 163.26 35.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.252 0.548 . . . . 0.0 112.424 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.46 2.45 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.921 1.288 . . . . 0.0 112.153 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -137.8 134.19 18.08 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 123.021 0.528 . . . . 0.0 110.206 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.48 -16.92 14.85 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.344 2.696 . . . . 0.0 111.893 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.88 -41.74 29.02 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.235 -0.29 . . . . 0.0 110.404 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.9 mm -78.25 -30.0 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.46 -29.02 68.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.9 ttt -75.11 -33.86 61.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mtp -73.34 -24.28 60.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -70.17 -39.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.27 -29.38 66.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.113 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.43 -38.4 65.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -72.77 -23.43 60.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.318 0.508 . . . . 0.0 111.615 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.82 -21.74 54.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.696 0.68 . . . . 0.0 110.872 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.02 -21.47 29.42 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.452 0.569 . . . . 0.0 111.444 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.8 t -85.2 -23.09 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 117.99 0.359 . . . . 0.0 110.42 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.17 13.76 33.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.188 0.595 . . . . 0.0 111.218 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.14 35.44 19.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.75 0.82 . . . . 0.0 112.486 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.79 163.94 17.86 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.81 0.844 . . . . 0.0 109.817 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.4 m -110.4 89.34 8.57 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.293 -0.254 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.15 158.82 55.04 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.84 2.36 . . . . 0.0 110.466 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.6 m -130.17 -10.67 2.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.6 169.61 28.43 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 118.198 0.454 . . . . 0.0 112.093 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.9 m -142.12 136.63 30.27 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.27 150.59 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.181 0.515 . . . . 0.0 111.098 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -92.72 -3.73 54.33 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.96 0.904 . . . . 0.0 111.607 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -151.97 158.32 42.95 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.363 0.665 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.1 -23.09 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 121.936 0.094 . . . . 0.0 110.995 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.22 68.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.854 -0.529 . . . . 0.0 109.876 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.53 -22.39 72.86 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.4 -34.48 65.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.967 0.883 . . . . 0.0 109.932 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.49 -27.54 61.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.13 -24.67 59.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -87.16 -26.1 23.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.129 0.422 . . . . 0.0 111.309 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -77.51 -26.49 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.134 0.425 . . . . 0.0 110.12 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -82.45 -14.37 55.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.689 0.396 . . . . 0.0 111.561 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.79 -13.54 16.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.41 41.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.52 145.61 30.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.2 mt -142.85 145.46 23.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -101.17 -25.06 14.15 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 118.093 0.406 . . . . 0.0 111.913 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.21 173.06 10.53 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.946 0.498 . . . . 0.0 110.05 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.48 159.29 44.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.483 0.182 . . . . 0.0 111.161 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.0 123.8 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.28 130.63 56.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.042 0.537 . . . . 0.0 110.019 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.89 152.43 24.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.42 -11.52 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 123.027 0.531 . . . . 0.0 111.4 -177.851 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 24.9 m . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 52.0 Cg_exo -57.63 -5.43 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.652 2.901 . . . . 0.0 114.372 177.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.04 -22.96 32.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.862 0.755 . . . . 0.0 110.845 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.43 -26.64 67.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.189 -0.319 . . . . 0.0 110.154 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.53 ' CD ' HH12 ' A' ' 93' ' ' ARG . 50.7 mt-10 -79.03 -17.39 55.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.974 -0.454 . . . . 0.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.3 59.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.13 -34.64 75.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.01 62.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.276 -0.265 . . . . 0.0 110.724 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.34 53.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.54 0.336 . . . . 0.0 110.518 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -99.64 18.49 17.91 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.78 0.832 . . . . 0.0 110.691 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.43 32.22 18.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.367 1.067 . . . . 0.0 113.619 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.47 118.66 24.75 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 160.42 37.24 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.293 3.329 . . . . 0.0 112.615 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.54 166.86 24.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.457 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -141.08 155.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 109.042 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 23.9 m-85 -88.21 159.19 18.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.11 122.22 19.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.1 t -163.78 179.14 7.31 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.886 0.474 . . . . 0.0 110.511 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.19 137.4 5.25 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.15 29.5 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.1 t -76.84 162.41 27.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.004 0.522 . . . . 0.0 110.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.74 -9.65 58.88 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.663 0.385 . . . . 0.0 110.728 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.98 -4.76 59.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.001 0.52 . . . . 0.0 110.612 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -95.37 9.48 39.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.079 0.552 . . . . 0.0 111.938 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.76 154.48 36.86 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.23 0.612 . . . . 0.0 111.131 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -107.47 -176.15 2.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.103 0.961 . . . . 0.0 111.024 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -62.73 -14.46 44.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.53 HH12 ' CD ' ' A' ' 70' ' ' GLU . 85.9 mtt-85 -65.76 -31.87 73.1 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.558 0.343 . . . . 0.0 110.238 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 29.1 m-85 -89.54 -19.47 24.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.605 0.762 . . . . 0.0 109.948 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -88.52 -3.75 58.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.81 0.444 . . . . 0.0 111.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.82 -13.44 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.33 0.652 . . . . 0.0 111.951 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.52 153.45 81.42 Favored Pre-proline 0 C--N 1.34 0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.985 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.74 154.98 51.44 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.36 2.707 . . . . 0.0 113.119 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.28 153.5 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.983 0.913 . . . . 0.0 109.068 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.0 tp -138.09 153.7 49.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.603 0.761 . . . . 0.0 109.755 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -73.68 157.48 36.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.534 0.334 . . . . 0.0 110.512 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -74.56 -50.46 4.54 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.628 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.13 147.55 29.98 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.254 1.969 . . . . 0.0 110.197 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.502 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 4.0 m-30 -111.4 150.82 29.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.106 0.562 . . . . 0.0 110.545 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.7 p -143.26 167.19 22.72 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.093 0.957 . . . . 0.0 108.848 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 83.6 mmm -61.04 -39.48 89.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.036 -0.415 . . . . 0.0 110.791 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.37 -25.46 29.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.297 0.239 . . . . 0.0 111.301 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.71 -25.24 70.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.6 t -85.54 -28.1 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.37 0.585 . . . . 0.0 110.356 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.79 70.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -85.05 -20.69 30.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.797 0.439 . . . . 0.0 110.958 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.48 63.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.152 0.433 . . . . 0.0 110.379 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.12 -26.92 53.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.765 0.257 . . . . 0.0 110.708 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.58 -20.58 26.21 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.509 0.324 . . . . 0.0 111.604 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.25 -36.25 14.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.05 9.17 42.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -173.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.037 -1.458 . . . . 0.0 109.831 178.071 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.489 0.661 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -8.45 57.57 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.244 0.618 . . . . 0.0 111.984 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.0 mt-30 -119.37 114.65 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.698 0.681 . . . . 0.0 112.224 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.1 mm -120.24 130.25 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -87.91 142.86 27.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.617 ' H ' HD23 ' A' ' 8' ' ' LEU . 87.0 mt -110.52 120.89 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.908 0.883 . . . . 0.0 109.05 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.27 120.68 43.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.741 0.417 . . . . 0.0 110.875 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -156.91 158.3 36.42 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -73.84 -7.91 54.01 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.75 0.82 . . . . 0.0 112.132 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.93 132.0 24.09 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.049 0.54 . . . . 0.0 109.901 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.47 -18.79 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.35 2.7 . . . . 0.0 111.405 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.96 -34.73 71.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.082 0.401 . . . . 0.0 110.735 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.1 mm -86.3 -23.74 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.11 78.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.037 -0.414 . . . . 0.0 109.896 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.4 mtt -77.71 -27.29 50.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.0 ttt -69.07 -29.4 67.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 1.1 mm? -72.46 -33.02 66.72 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.14 -24.81 64.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.081 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.31 -43.45 60.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.9 0.318 . . . . 0.0 111.338 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -73.54 -22.29 60.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.845 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.18 -18.04 53.78 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.559 0.618 . . . . 0.0 110.838 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -85.31 -22.1 28.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.319 0.509 . . . . 0.0 110.449 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.45 -19.65 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.891 0.476 . . . . 0.0 110.317 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -105.37 16.28 25.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.338 0.655 . . . . 0.0 111.838 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.0 35.0 14.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.734 0.813 . . . . 0.0 112.499 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.07 165.73 16.4 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -115.19 77.83 5.53 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 122.75 0.42 . . . . 0.0 110.284 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.95 157.18 54.16 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.047 2.498 . . . . 0.0 110.203 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 6' ' ' GLN . 32.8 m -121.59 -14.6 7.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.46 176.47 36.26 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.666 0.666 . . . . 0.0 112.728 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 140.26 46.32 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.34 1.056 . . . . 0.0 108.885 175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.51 154.67 20.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.008 0.432 . . . . 0.0 110.128 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -102.89 -1.49 29.46 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.03 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.9 p -141.42 159.71 41.65 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.794 0.438 . . . . 0.0 110.49 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.82 -22.81 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.682 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.16 54.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.22 -27.63 61.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.18 78.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.16 -26.71 63.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.52 -24.73 62.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.305 0.242 . . . . 0.0 111.316 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -86.57 -23.85 25.66 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.757 0.253 . . . . 0.0 111.293 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.6 -29.66 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 117.923 0.329 . . . . 0.0 111.064 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.54 -14.36 55.03 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.983 -0.448 . . . . 0.0 112.009 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.03 -12.76 15.35 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.123 0.569 . . . . 0.0 112.286 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.92 164.28 37.71 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.69 140.36 24.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.5 mt -144.75 143.98 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -96.7 -32.31 12.24 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.449 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.55 11.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.578 0.351 . . . . 0.0 110.318 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.0 157.83 43.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.668 0.27 . . . . 0.0 111.256 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.0 mt -113.46 123.56 69.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.9 130.8 56.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.455 0.702 . . . . 0.0 110.226 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 170.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.29 -11.88 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 O-C-N 122.034 -0.416 . . . . 0.0 111.968 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.529 0.171 0 O-C-N 121.952 -0.468 . . . . 0.0 110.159 179.438 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.234 0.238 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.82 -11.96 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.561 2.841 . . . . 0.0 111.741 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.38 -17.64 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 122.158 -0.339 . . . . 0.0 111.036 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.92 74.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.847 -0.533 . . . . 0.0 110.156 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.28 -18.26 60.74 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.176 -0.327 . . . . 0.0 111.082 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.46 -29.29 37.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 99.2 mt -72.85 -37.46 67.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.16 -22.37 62.06 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.05 -12.61 54.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.414 0.286 . . . . 0.0 110.721 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -103.91 17.88 23.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.984 0.914 . . . . 0.0 110.779 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 59.06 34.13 23.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.125 0.97 . . . . 0.0 113.264 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.4 mt -120.77 102.2 44.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.849 0.86 . . . . 0.0 108.689 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.57 158.9 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.919 3.079 . . . . 0.0 112.745 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.21 167.13 23.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 111.409 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.4 t -134.74 144.19 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.838 0.855 . . . . 0.0 109.399 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -90.81 151.49 21.15 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 111.124 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.43 143.13 33.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.599 0.76 . . . . 0.0 109.234 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -159.77 158.39 31.09 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 111.007 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.67 95.93 0.96 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 172.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.51 -162.15 33.67 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.3 p -81.48 164.52 21.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.407 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -4.17 49.23 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.585 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.83 -1.3 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.295 0.638 . . . . 0.0 111.05 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.7 m -85.12 7.88 20.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.114 0.566 . . . . 0.0 111.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.0 m -137.83 154.7 29.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.786 0.834 . . . . 0.0 110.981 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 169.15 17.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.791 0.836 . . . . 0.0 111.917 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 m -61.53 -16.73 50.3 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -75.91 -24.27 55.58 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.7 0.682 . . . . 0.0 110.373 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.427 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 11.8 m-85 -84.24 -20.57 32.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -86.89 -13.01 46.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.086 0.554 . . . . 0.0 110.818 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.73 -27.3 18.14 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.743 0.417 . . . . 0.0 110.354 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -91.46 160.98 35.69 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.96 154.44 61.74 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.873 2.382 . . . . 0.0 111.355 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.9 m -138.9 154.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.152 0.581 . . . . 0.0 110.594 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.9 tp -147.28 146.71 29.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.876 0.471 . . . . 0.0 110.038 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -79.86 163.74 24.13 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.277 0.231 . . . . 0.0 110.585 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.7 -39.12 2.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.11 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.94 133.58 48.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.9 m-85 -119.84 146.13 46.01 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.107 0.563 . . . . 0.0 110.477 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.8 t -153.34 159.04 42.39 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.787 0.835 . . . . 0.0 109.189 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -63.46 -28.9 70.28 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.62 -39.94 18.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.574 0.625 . . . . 0.0 111.905 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.547 ' H ' HG23 ' A' ' 105' ' ' THR . . . -80.19 -25.7 56.82 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 122.121 -0.362 . . . . 0.0 112.375 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.53 -28.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.685 0.743 . . . . 0.0 110.338 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -29.05 64.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.976 -0.452 . . . . 0.0 110.155 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -83.95 -25.33 30.16 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 110.668 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.32 -32.45 37.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.65 0.204 . . . . 0.0 110.724 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -34.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.44 63.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.059 -0.4 . . . . 0.0 110.567 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 -14.92 39.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.437 0.295 . . . . 0.0 111.345 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.99 -29.52 17.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.271 0.628 . . . . 0.0 110.865 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.3 tp -85.97 10.55 13.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 112.035 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.154 -1.403 . . . . 0.0 110.585 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 117' ' ' LEU . 88.4 mt . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -8.76 52.13 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 118.392 0.542 . . . . 0.0 111.191 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.503 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.8 mp0 -118.99 118.88 32.69 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.14 0.427 . . . . 0.0 111.642 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -119.04 131.22 72.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 O-C-N 123.737 0.648 . . . . 0.0 109.881 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -97.69 130.19 44.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 8' ' ' LEU . 86.3 mt -98.67 135.23 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -132.12 125.6 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -149.39 162.85 39.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.231 0.539 . . . . 0.0 112.423 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -123.46 11.86 9.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 109.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -145.03 113.78 4.92 Favored Pre-proline 0 N--CA 1.453 -0.311 0 C-N-CA 124.82 1.248 . . . . 0.0 107.944 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.86 -16.33 11.45 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.06 3.173 . . . . 0.0 114.655 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.47 -23.06 60.03 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.4 -27.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.61 -25.48 61.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.276 -0.265 . . . . 0.0 110.449 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.11 -35.17 28.82 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.448 -0.157 . . . . 0.0 110.779 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 98.1 mmm -75.43 -34.39 60.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.99 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.35 -28.18 42.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.131 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.52 -21.63 55.49 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.798 -0.564 . . . . 0.0 110.088 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.64 -41.32 46.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.194 -0.316 . . . . 0.0 111.447 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -82.08 -21.43 36.81 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.361 0.528 . . . . 0.0 112.368 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.21 -18.09 55.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.075 0.852 . . . . 0.0 110.137 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -85.28 -29.38 24.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.811 0.278 . . . . 0.0 110.774 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -83.28 -19.76 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 122.715 0.406 . . . . 0.0 110.774 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.09 14.53 28.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.793 0.437 . . . . 0.0 111.54 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 51.05 34.72 11.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.652 0.781 . . . . 0.0 111.461 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HD3' ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -85.55 162.7 18.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.849 0.86 . . . . 0.0 110.374 -176.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.4 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 56.8 m -114.42 88.02 14.91 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.951 0.5 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.76 157.94 58.68 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.83 2.354 . . . . 0.0 109.55 176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 6' ' ' GLN . 33.0 m -123.46 -16.9 4.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 174.21 33.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 118.329 0.513 . . . . 0.0 112.588 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -137.2 139.65 41.22 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.45 161.04 31.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 110.618 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -131.67 7.43 4.45 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.976 0.51 . . . . 0.0 112.188 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.9 p -136.39 156.69 48.27 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.968 0.507 . . . . 0.0 109.89 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.07 -29.9 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.8 65.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.157 -0.34 . . . . 0.0 110.363 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.33 -24.85 56.14 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.83 -34.99 60.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.614 0.707 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.37 -24.24 32.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.929 0.331 . . . . 0.0 110.393 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.75 57.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.207 0.458 . . . . 0.0 110.728 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -84.37 -31.11 24.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.463 0.705 . . . . 0.0 110.136 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.64 -25.27 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.66 0.384 . . . . 0.0 111.686 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -71.27 -19.08 62.39 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.651 -0.655 . . . . 0.0 111.153 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.91 -12.59 58.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.726 0.298 . . . . 0.0 110.999 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.99 -169.07 53.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.92 81.83 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.634 -0.536 . . . . 0.0 112.577 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.85 147.04 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 117.785 0.793 . . . . 0.0 109.536 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.6 -17.0 5.63 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.38 166.64 28.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.232 0.469 . . . . 0.0 110.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.04 165.53 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.28 -0.263 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.24 133.25 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.36 130.61 56.69 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.086 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -84.39 138.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.93 -12.24 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.443 0.297 . . . . 0.0 110.485 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.551 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.54 -11.83 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.741 2.961 . . . . 0.0 111.812 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -72.44 -13.65 16.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.344 0.258 . . . . 0.0 110.906 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.23 -24.47 63.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 122.221 -0.299 . . . . 0.0 110.388 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.55 -17.39 45.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.342 -0.224 . . . . 0.0 110.466 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.92 61.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.16 -27.02 60.64 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.76 57.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.15 -16.39 56.72 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -91.7 13.67 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.839 0.856 . . . . 0.0 110.026 172.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 60.71 30.5 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.551 1.141 . . . . 0.0 113.646 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.21 124.96 29.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.39 161.04 38.23 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.09 3.193 . . . . 0.0 111.062 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -152.12 171.25 18.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.218 0.533 . . . . 0.0 111.752 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.66 144.7 20.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 124.058 0.943 . . . . 0.0 109.017 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.03 154.46 22.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.408 0.283 . . . . 0.0 110.824 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.52 119.81 22.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -153.41 173.11 16.08 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 111.421 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 135.33 3.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.8 -156.12 26.52 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.1 p -79.26 175.37 10.66 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.954 0.502 . . . . 0.0 110.621 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.02 -6.6 34.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.73 0.412 . . . . 0.0 112.02 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -92.59 -7.64 46.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.021 0.528 . . . . 0.0 111.173 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.4 m -78.92 0.75 26.15 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.008 -0.432 . . . . 0.0 111.547 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 m -140.06 153.16 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.252 0.621 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.9 177.76 4.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.179 0.992 . . . . 0.0 110.485 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -61.63 -18.46 59.54 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.781 -0.575 . . . . 0.0 111.965 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -76.48 -20.74 56.66 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.862 0.755 . . . . 0.0 111.2 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -84.2 -19.29 34.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -88.15 -4.85 58.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.421 0.688 . . . . 0.0 110.264 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.84 -11.19 14.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.695 1.198 . . . . 0.0 111.572 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.75 163.12 41.04 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.92 0.888 . . . . 0.0 110.115 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.61 147.33 92.3 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.625 2.884 . . . . 0.0 112.53 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -140.19 151.36 21.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.603 0.761 . . . . 0.0 110.472 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -146.13 155.2 42.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.012 0.925 . . . . 0.0 108.662 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -85.7 162.03 18.95 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.332 -0.23 . . . . 0.0 110.884 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.68 -41.45 9.55 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.974 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.76 124.52 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.409 2.073 . . . . 0.0 110.875 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -107.33 143.15 36.02 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.3 t -155.7 163.67 39.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.99 -23.64 65.53 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -173.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.44 -38.74 21.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.379 0.536 . . . . 0.0 110.937 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' H ' HG23 ' A' ' 105' ' ' THR . . . -74.64 -26.75 66.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.6 t -81.44 -21.71 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.734 0.414 . . . . 0.0 109.913 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.18 -30.68 62.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.318 0.508 . . . . 0.0 110.703 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.24 -27.49 38.67 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.52 55.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -72.7 -32.75 66.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.944 0.498 . . . . 0.0 109.812 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.41 -17.97 40.34 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.641 0.376 . . . . 0.0 111.942 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.06 9.88 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -99.11 -58.35 1.96 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.891 0.314 . . . . 0.0 111.791 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 4' ' ' LEU . 3.2 mm? -65.86 -4.21 6.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.972 0.909 . . . . 0.0 112.768 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.244 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.605 0.717 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -2.13 21.11 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.683 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.5 mt-30 -124.03 111.18 15.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.118 0.417 . . . . 0.0 110.786 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.4 mm -119.4 128.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.085 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -88.99 135.07 33.75 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' N ' HD23 ' A' ' 8' ' ' LEU . 67.5 mt -102.88 134.58 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.02 0.528 . . . . 0.0 109.82 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.07 106.29 10.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -149.85 163.32 38.33 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 123.872 0.869 . . . . 0.0 110.531 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -112.76 -13.73 13.19 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.712 0.405 . . . . 0.0 110.912 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -84.69 127.28 65.98 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.71 -14.01 14.29 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.36 2.706 . . . . 0.0 112.757 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -93.73 -38.47 11.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.602 0.637 . . . . 0.0 111.881 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.8 mp -76.25 -28.39 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.82 63.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.852 0.061 . . . . 0.0 110.993 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.4 mtt -84.98 -27.86 26.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.395 -0.191 . . . . 0.0 110.672 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.7 mmm -77.94 -28.42 49.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.728 0.24 . . . . 0.0 110.494 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 21.9 tp -78.95 -30.96 44.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.222 -0.299 . . . . 0.0 110.326 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.65 -26.67 61.73 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.73 -35.19 52.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.361 -0.212 . . . . 0.0 110.485 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -73.35 -27.06 61.29 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.871 -0.518 . . . . 0.0 111.7 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -79.17 -17.8 54.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.613 0.642 . . . . 0.0 110.836 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.14 -29.46 24.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.854 0.297 . . . . 0.0 110.965 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.15 -21.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 122.584 0.353 . . . . 0.0 111.389 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 16.98 17.8 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.882 0.473 . . . . 0.0 111.648 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t0 52.02 34.46 13.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.975 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.79 165.45 16.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.698 0.799 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 77.95 6.52 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.199 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.11 160.55 41.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.54 2.827 . . . . 0.0 110.478 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.7 m -127.37 -25.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.1 176.79 36.29 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 118.527 0.603 . . . . 0.0 112.612 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.8 m -137.61 141.91 41.26 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.96 0.904 . . . . 0.0 108.708 176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.94 159.0 37.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 122.642 0.377 . . . . 0.0 110.152 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.61 -5.98 28.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.853 0.461 . . . . 0.0 111.994 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.7 p -143.06 161.08 39.11 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.085 0.554 . . . . 0.0 110.475 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.17 -22.72 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.787 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.46 -29.67 66.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.51 -27.56 65.23 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.4 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.323 0.562 . . . . 0.0 110.059 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.44 -23.25 50.55 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 177.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.37 45.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.728 0.24 . . . . 0.0 111.386 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 5.1 mmp_? -87.35 -21.92 25.4 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.131 -0.356 . . . . 0.0 111.696 175.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.53 -22.0 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.26 -16.19 60.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.08 -12.42 21.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.403 0.681 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 -167.68 54.03 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.17 24.33 61.63 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.631 -0.538 . . . . 0.0 112.609 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mt -137.22 147.66 26.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.386 0.674 . . . . 0.0 109.306 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -116.28 -26.98 6.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.63 12.49 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.045 0.384 . . . . 0.0 110.582 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.93 34.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.719 0.295 . . . . 0.0 111.388 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.1 mt -122.48 130.44 74.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.81 133.6 54.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.08 155.79 19.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.56 -11.87 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.045 0.538 . . . . 0.0 110.656 177.678 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.446 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 7.9 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 66' ' ' THR . 77.7 Cg_exo -56.84 -12.79 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.908 2.406 . . . . 0.0 114.111 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.45 -13.89 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.47 -24.65 67.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.815 -0.553 . . . . 0.0 109.76 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.26 -17.99 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.457 0.303 . . . . 0.0 110.724 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.16 -27.23 39.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.03 -27.7 61.07 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -25.57 58.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.91 -16.46 56.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -92.67 6.6 46.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.754 0.821 . . . . 0.0 110.136 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.31 35.35 20.74 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.262 1.025 . . . . 0.0 113.199 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.79 129.73 25.18 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.64 157.51 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.602 2.868 . . . . 0.0 111.302 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -145.01 164.79 30.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.609 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -136.12 147.56 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 124.604 1.162 . . . . 0.0 108.837 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 28.9 m-85 -91.98 155.35 18.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.895 0.378 . . . . 0.0 111.682 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.87 128.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -165.28 158.85 16.73 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.657 0.265 . . . . 0.0 111.009 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.61 136.99 13.16 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.04 -151.91 23.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 82.8 p -119.36 176.05 5.53 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.443 0.697 . . . . 0.0 110.55 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.56 -1.92 12.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.833 0.453 . . . . 0.0 111.739 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.66 1.28 14.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.359 0.663 . . . . 0.0 111.187 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -87.16 7.64 27.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.348 0.659 . . . . 0.0 111.609 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.1 m -139.63 155.86 25.65 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 123.748 0.819 . . . . 0.0 111.628 -175.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.57 162.63 20.49 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.949 0.9 . . . . 0.0 111.36 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.8 m -59.1 -19.56 45.56 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -74.12 -25.43 59.76 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.987 0.812 . . . . 0.0 110.743 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 7.1 m-85 -79.98 -19.31 48.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -88.16 -10.22 50.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.827 0.451 . . . . 0.0 110.669 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.91 -11.58 15.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.647 0.779 . . . . 0.0 111.618 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -121.34 160.92 43.75 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.399 0.679 . . . . 0.0 110.118 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.33 148.89 84.37 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.996 2.464 . . . . 0.0 112.242 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.61 154.86 17.97 Favored 'Isoleucine or valine' 0 C--O 1.23 0.046 0 C-N-CA 124.139 0.976 . . . . 0.0 109.909 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.3 tp -138.55 145.16 40.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.821 0.449 . . . . 0.0 109.832 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -76.68 165.27 24.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.774 0.43 . . . . 0.0 110.38 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -79.19 -39.15 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.763 -177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.96 143.81 95.73 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.589 2.192 . . . . 0.0 110.567 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 1.7 m-85 -118.96 133.39 55.86 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.922 0.392 . . . . 0.0 111.348 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -143.33 155.53 44.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.783 1.233 . . . . 0.0 108.923 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.96 -28.6 66.78 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 122.199 -0.313 . . . . 0.0 111.61 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -84.5 -35.24 23.05 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.051 -0.406 . . . . 0.0 111.634 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.0 -38.93 29.09 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.307 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.89 -22.93 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 117.857 0.829 . . . . 0.0 111.162 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.2 64.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.503 -0.748 . . . . 0.0 110.306 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -78.8 -31.96 46.14 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.34 -26.68 46.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.183 0.193 . . . . 0.0 111.038 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.55 -38.7 65.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.25 -23.47 62.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.416 -0.177 . . . . 0.0 110.678 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.08 -13.84 43.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.84 0.456 . . . . 0.0 111.468 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.7 tt -90.89 -29.27 17.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.145 0.578 . . . . 0.0 110.699 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.4 tp -82.91 6.65 17.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.956 0.503 . . . . 0.0 111.887 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.802 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -11.18 36.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.691 -0.631 . . . . 0.0 110.424 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.41 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.6 mp0 -111.49 104.6 13.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.779 0.432 . . . . 0.0 110.977 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.03 124.11 72.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.981 0.512 . . . . 0.0 110.434 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -86.79 146.99 26.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.434 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.618 ' H ' HD23 ' A' ' 8' ' ' LEU . 95.0 mt -110.53 128.1 67.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.922 0.889 . . . . 0.0 109.675 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.3 122.73 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.071 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.97 163.29 33.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.289 0.235 . . . . 0.0 111.262 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.32 -11.32 32.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.53 135.57 13.14 Favored Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.41 -17.32 44.07 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.089 2.526 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -77.87 -37.42 48.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.456 0.571 . . . . 0.0 110.01 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -77.55 -27.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.54 68.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.198 -0.314 . . . . 0.0 110.281 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -76.73 -27.3 55.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -73.22 -33.4 65.32 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.65 -31.65 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.23 -0.294 . . . . 0.0 110.409 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.93 -21.82 43.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.37 -42.96 42.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.094 -0.378 . . . . 0.0 110.15 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.94 -19.36 60.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.641 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.63 -29.29 66.75 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.164 0.438 . . . . 0.0 110.116 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -84.72 -29.58 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.491 0.316 . . . . 0.0 111.385 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -71.55 -24.24 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 6.57 48.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.173 0.589 . . . . 0.0 111.032 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t0 50.73 37.75 17.55 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.584 0.754 . . . . 0.0 111.49 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.6 tmtm? -85.69 158.84 19.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.855 0.862 . . . . 0.0 110.422 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.444 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 88.7 m -92.08 124.39 60.07 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.42 153.86 35.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.63 2.886 . . . . 0.0 110.872 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 6' ' ' GLN . 24.8 m -141.77 -21.86 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.409 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.66 163.05 16.92 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -143.96 134.86 25.3 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.57 161.2 24.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.898 0.38 . . . . 0.0 111.117 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -136.08 3.74 2.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.119 0.568 . . . . 0.0 111.546 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -139.3 161.72 36.75 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.357 0.663 . . . . 0.0 110.78 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.41 -32.99 52.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 122.437 0.295 . . . . 0.0 110.239 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.4 -29.51 53.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.347 -0.22 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.89 -33.0 52.04 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 -33.83 74.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.409 0.604 . . . . 0.0 110.511 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.21 -29.02 60.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.26 60.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.47 -26.96 22.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 118.328 0.513 . . . . 0.0 112.15 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -83.28 -21.69 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 118.04 0.382 . . . . 0.0 111.522 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -81.56 -23.05 37.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.41 -13.63 8.4 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.733 0.697 . . . . 0.0 112.316 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.39 -164.94 40.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.51 137.18 5.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.49 164.5 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.74 0.816 . . . . 0.0 110.802 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -124.13 -10.72 7.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.014 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.87 165.85 20.1 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.503 0.721 . . . . 0.0 109.056 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.09 158.0 43.48 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.729 -0.607 . . . . 0.0 111.903 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.7 mm -97.46 121.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.07 124.87 49.13 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.97 118.32 11.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 168.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.56 -29.27 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -171.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.2 t30 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-N 118.197 0.453 . . . . 0.0 110.983 -177.418 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -83.23 -10.33 10.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.625 2.884 . . . . 0.0 111.301 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.6 t -74.24 -29.85 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 117.799 0.272 . . . . 0.0 111.343 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.53 78.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.125 0.42 . . . . 0.0 110.45 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.03 -17.59 39.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.266 -0.272 . . . . 0.0 111.088 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.84 65.97 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.56 -26.49 58.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.49 -24.29 61.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.948 0.34 . . . . 0.0 110.113 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.71 44.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.317 0.247 . . . . 0.0 110.471 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -101.58 8.66 41.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.39 0.676 . . . . 0.0 110.962 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.97 37.12 28.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.652 1.181 . . . . 0.0 113.37 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -110.66 120.98 42.39 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 123.022 0.529 . . . . 0.0 109.767 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.95 154.24 39.83 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.227 3.285 . . . . 0.0 113.663 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.54 168.4 23.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -96.95 152.59 18.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.959 0.409 . . . . 0.0 111.927 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.18 119.61 10.3 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.1 t -172.17 164.48 6.01 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.023 0.929 . . . . 0.0 109.447 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.26 142.61 21.4 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.42 -160.46 32.7 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 117.424 0.612 . . . . 0.0 112.057 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.1 t -143.67 167.69 21.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.303 0.641 . . . . 0.0 110.518 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -3.77 17.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 112.602 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -114.37 10.61 17.1 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.281 0.632 . . . . 0.0 111.874 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.1 p -118.76 9.24 12.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 123.039 0.536 . . . . 0.0 112.017 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.14 154.69 25.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.631 0.773 . . . . 0.0 111.621 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.34 163.8 25.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.288 0.635 . . . . 0.0 111.316 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -59.95 -17.35 37.25 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -71.58 -26.68 62.71 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.852 0.751 . . . . 0.0 110.462 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -83.54 -22.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -88.09 -10.75 49.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.817 0.447 . . . . 0.0 111.319 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.96 -32.23 11.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 110.995 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.3 152.64 50.37 Favored Pre-proline 0 C--N 1.338 0.108 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.67 152.43 56.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.226 2.617 . . . . 0.0 111.413 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.58 153.19 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 122.842 0.457 . . . . 0.0 110.892 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.0 tp -149.06 153.73 38.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -84.85 167.07 16.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.656 0.383 . . . . 0.0 110.677 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 69.5 mmtt -63.6 -46.51 83.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.3 Cg_endo -71.71 137.05 29.24 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.673 1.582 . . . . 0.0 109.777 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -110.44 148.67 31.58 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.949 0.499 . . . . 0.0 110.331 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.8 p -144.01 161.4 38.87 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.125 0.97 . . . . 0.0 109.21 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.66 -27.14 68.72 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.088 -0.383 . . . . 0.0 111.083 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.78 -36.51 21.65 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.64 -30.42 44.35 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.7 t -82.43 -30.56 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.663 0.731 . . . . 0.0 110.335 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 -26.42 62.74 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.502 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -83.39 -33.75 25.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.401 0.28 . . . . 0.0 110.917 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.84 61.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.319 -0.238 . . . . 0.0 110.703 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.18 -20.61 40.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 119.564 -0.255 . . . . 0.0 110.784 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.43 55.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.37 0.532 . . . . 0.0 110.07 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.57 26.72 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.803 0.441 . . . . 0.0 111.513 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 tt -91.2 -51.88 5.09 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.989 0.515 . . . . 0.0 110.305 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.5 mt -79.13 17.37 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.1 . . . . 0.0 112.147 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.311 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.505 0.669 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -78.04 -6.77 55.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.943 0.497 . . . . 0.0 111.506 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.451 ' HB3' HG11 ' A' ' 32' ' ' VAL . 64.5 mt-30 -118.73 111.09 18.04 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.09 136.05 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.762 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -96.0 138.29 33.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.48 ' H ' HD23 ' A' ' 8' ' ' LEU . 79.8 mt -102.12 126.2 56.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.867 0.867 . . . . 0.0 109.716 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.37 110.04 15.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 162.67 35.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 111.629 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -98.19 -0.16 44.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.912 0.885 . . . . 0.0 111.32 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.61 105.59 15.72 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.89 -22.47 54.35 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.753 2.969 . . . . 0.0 113.592 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.32 -41.2 73.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.457 0.571 . . . . 0.0 110.427 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.418 HG13 ' HE3' ' A' ' 102' ' ' LYS . 43.6 mm -79.03 -25.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.51 66.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 mmt -80.92 -25.54 37.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mtp -73.33 -30.64 63.49 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.96 -32.11 71.46 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.102 -0.374 . . . . 0.0 110.053 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -74.62 -23.14 58.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.204 -0.31 . . . . 0.0 110.208 175.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.66 -43.3 20.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.301 -0.249 . . . . 0.0 111.14 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -74.35 -27.26 60.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.425 0.557 . . . . 0.0 111.754 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.83 -17.87 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.541 0.61 . . . . 0.0 110.894 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.862 0.301 . . . . 0.0 110.769 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.54 -20.1 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 122.766 0.426 . . . . 0.0 110.793 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -103.13 17.02 25.05 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.97 0.508 . . . . 0.0 111.687 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.88 36.13 17.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.061 0.944 . . . . 0.0 112.76 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.87 164.65 17.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.336 0.654 . . . . 0.0 109.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -117.47 72.18 7.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 O-C-N 122.06 -0.4 . . . . 0.0 110.873 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.92 158.28 48.1 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.845 2.364 . . . . 0.0 110.166 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 6' ' ' GLN . 31.4 m -121.58 -9.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -173.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.89 174.03 34.16 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 118.422 0.555 . . . . 0.0 112.374 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.1 m -141.17 137.64 32.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.378 1.071 . . . . 0.0 108.383 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.93 156.88 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.024 0.44 . . . . 0.0 111.077 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.74 -4.26 37.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.982 0.913 . . . . 0.0 111.732 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -151.4 157.5 42.5 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.88 0.472 . . . . 0.0 110.439 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.88 -22.92 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 122.792 0.437 . . . . 0.0 110.567 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.96 -26.09 63.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.949 -0.469 . . . . 0.0 110.245 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.57 -21.17 64.71 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.51 63.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.235 0.518 . . . . 0.0 109.924 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.23 -32.2 66.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.85 -24.68 64.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.443 -0.161 . . . . 0.0 110.919 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -82.94 -25.71 32.11 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.743 0.247 . . . . 0.0 110.949 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.5 t -71.94 -26.55 25.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.78 -14.34 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.674 0.39 . . . . 0.0 110.863 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -98.84 -14.61 19.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.435 0.694 . . . . 0.0 111.994 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.22 169.74 38.76 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.62 148.21 36.59 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.37 149.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.18 -30.66 11.42 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.193 0.452 . . . . 0.0 111.35 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 174.95 11.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.749 0.42 . . . . 0.0 110.582 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.58 161.48 41.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.675 0.274 . . . . 0.0 111.0 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.78 130.86 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.02 136.0 53.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.24 0.616 . . . . 0.0 110.203 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.56 144.99 29.98 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.78 -12.0 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 122.281 -0.262 . . . . 0.0 111.307 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 -179.367 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 28.2 p . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.4 Cg_exo -57.8 -18.72 35.47 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 113.972 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.3 m -82.45 -9.77 11.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 118.061 0.392 . . . . 0.0 111.892 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.61 68.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.983 -0.448 . . . . 0.0 110.458 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -75.18 -17.77 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.291 -0.256 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.81 -25.62 37.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.5 -29.93 61.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 173.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.29 60.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.16 -13.51 57.06 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -95.52 14.76 21.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 110.14 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.17 31.41 19.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.421 1.089 . . . . 0.0 113.489 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.6 mt -122.23 108.69 33.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.9 162.71 38.66 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.628 2.885 . . . . 0.0 111.195 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -150.07 167.54 26.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.248 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.87 144.93 27.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 22.9 m-85 -87.05 153.13 21.78 Favored 'General case' 0 C--N 1.337 0.031 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.83 122.47 13.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -166.99 161.15 14.77 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.732 0.413 . . . . 0.0 110.425 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 134.06 12.13 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.93 -155.61 26.24 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 m -132.52 171.18 14.12 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.923 0.889 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.45 -10.27 54.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.89 2.58 55.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.791 0.436 . . . . 0.0 111.324 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -102.75 7.62 39.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.492 0.717 . . . . 0.0 111.108 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.4 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 5.2 m -139.48 154.83 25.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.972 0.909 . . . . 0.0 111.47 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.98 169.92 14.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.991 0.916 . . . . 0.0 111.547 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.5 p -61.51 -19.12 61.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -70.69 -24.5 62.68 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.379 0.536 . . . . 0.0 110.823 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 49.9 m-85 -89.01 -19.33 25.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.32 -7.87 56.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 111.111 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.92 -18.07 13.47 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.367 0.667 . . . . 0.0 111.229 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -107.35 158.16 33.81 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.235 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.18 151.98 82.27 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.154 2.569 . . . . 0.0 111.58 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.8 154.71 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.952 0.901 . . . . 0.0 110.562 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -139.16 155.09 48.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.566 0.746 . . . . 0.0 109.892 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -79.34 162.95 25.25 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.724 0.41 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 56.9 tptt -78.67 -47.68 1.82 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.591 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 88.7 Cg_endo -74.3 144.76 33.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.115 1.876 . . . . 0.0 110.256 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -115.83 147.21 41.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.034 0.533 . . . . 0.0 110.489 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.9 p -144.3 162.48 36.31 Favored 'General case' 0 N--CA 1.46 0.04 0 C-N-CA 124.443 1.097 . . . . 0.0 108.866 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -63.55 -31.87 73.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.91 -0.494 . . . . 0.0 111.207 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -84.62 -33.59 23.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.6 -27.03 57.94 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.9 -25.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.562 0.681 . . . . 0.0 110.527 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.9 -32.37 71.97 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.3 -29.25 38.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.524 0.33 . . . . 0.0 110.429 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.74 60.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 122.302 -0.249 . . . . 0.0 110.97 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.21 -30.2 54.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.83 -26.71 62.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.378 -0.201 . . . . 0.0 110.571 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -18.84 28.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.852 0.461 . . . . 0.0 112.119 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.89 -40.26 11.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.138 0.575 . . . . 0.0 110.92 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.59 18.29 3.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.871 0.469 . . . . 0.0 112.193 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.811 -1.09 . . . . 0.0 110.812 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -72.09 -7.47 49.15 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.712 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.457 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 70.8 mt-30 -119.99 116.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.167 0.44 . . . . 0.0 112.141 -171.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.451 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.0 mm -122.29 128.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 123.932 0.77 . . . . 0.0 111.511 -172.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -86.6 142.24 28.41 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' H ' HD23 ' A' ' 8' ' ' LEU . 79.3 mt -112.78 130.92 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 t -124.27 125.08 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -152.14 163.63 38.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.693 0.397 . . . . 0.0 111.868 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.77 12.93 13.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.412 0.685 . . . . 0.0 110.601 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -146.87 121.5 5.23 Favored Pre-proline 0 N--CA 1.454 -0.248 0 C-N-CA 123.973 0.909 . . . . 0.0 108.565 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.81 -14.36 44.26 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.24 2.627 . . . . 0.0 112.451 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.7 -31.1 68.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.4 -26.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.02 78.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.027 -0.42 . . . . 0.0 110.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.42 -21.77 30.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.463 -0.148 . . . . 0.0 111.126 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.8 tpt -76.75 -33.93 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.298 -0.251 . . . . 0.0 110.43 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.78 -27.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.229 0.212 . . . . 0.0 110.746 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.96 -21.85 58.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.785 0.266 . . . . 0.0 110.41 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.27 -46.29 28.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.264 -0.272 . . . . 0.0 110.687 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.57 -15.99 58.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.581 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.42 -28.84 64.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -78.84 -23.96 44.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.393 0.277 . . . . 0.0 110.408 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.07 -28.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.31 -1.94 58.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.536 0.335 . . . . 0.0 110.248 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t0 50.11 33.0 6.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.747 1.219 . . . . 0.0 112.96 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HE3' HG12 ' A' ' 7' ' ' ILE . 59.1 pttt -104.47 -165.77 1.18 Allowed 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.285 -0.259 . . . . 0.0 111.664 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -103.2 124.99 36.41 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 112.043 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 164.58 20.27 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.622 2.881 . . . . 0.0 110.067 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 34.8 m -136.07 -28.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.16 178.6 37.8 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.573 0.624 . . . . 0.0 112.616 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -137.35 141.07 41.8 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.39 1.076 . . . . 0.0 108.598 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.15 155.53 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.98 0.419 . . . . 0.0 110.767 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -129.11 7.89 5.54 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.436 0.694 . . . . 0.0 111.749 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 p -132.61 157.73 44.04 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.393 0.677 . . . . 0.0 110.025 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.24 -23.72 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.13 -25.8 42.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.303 -0.248 . . . . 0.0 110.816 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.42 -30.26 58.74 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.6 56.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.332 0.566 . . . . 0.0 110.623 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.13 -24.52 47.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.09 -25.04 40.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.212 -0.305 . . . . 0.0 111.11 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -87.37 -26.7 23.21 Favored 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.96 -22.34 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.687 0.676 . . . . 0.0 110.825 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -79.97 -14.56 58.49 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.33 -0.231 . . . . 0.0 110.468 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.88 -12.74 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.178 0.591 . . . . 0.0 111.137 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.77 53.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.95 62.99 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.052 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mt -140.34 144.73 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.793 0.837 . . . . 0.0 109.217 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.42 -25.71 9.91 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.76 176.99 10.32 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.09 0.405 . . . . 0.0 110.52 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.68 166.73 27.49 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.04 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.39 119.6 29.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.599 0.237 . . . . 0.0 110.759 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -80.41 127.92 32.97 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.613 0.365 . . . . 0.0 110.298 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.8 t -97.19 -11.15 8.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.434 0.694 . . . . 0.0 110.496 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 122.76 0.424 . . . . 0.0 111.85 179.64 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.7 m . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 86.9 Cg_endo -75.12 -13.49 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.174 1.916 . . . . 0.0 111.5 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.39 -29.11 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 122.612 0.365 . . . . 0.0 110.738 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.24 80.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.792 0.329 . . . . 0.0 110.387 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.93 -17.77 45.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.168 -0.332 . . . . 0.0 110.863 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.87 64.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.63 -27.22 62.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.38 -24.74 62.13 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 117.65 0.204 . . . . 0.0 110.49 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.16 52.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.234 -0.292 . . . . 0.0 110.486 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -99.54 8.69 44.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.409 0.684 . . . . 0.0 111.246 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 57.79 35.83 25.87 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.208 1.003 . . . . 0.0 113.026 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.36 131.08 22.23 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.75 156.86 39.76 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.91 3.073 . . . . 0.0 111.502 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.1 167.68 29.03 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.852 0.461 . . . . 0.0 111.132 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -138.89 164.87 25.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.008 0.923 . . . . 0.0 109.625 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' ' CD2' ' A' ' 94' ' ' PHE . 36.5 m-85 -107.51 161.97 14.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.337 0.589 . . . . 0.0 111.921 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.24 17.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.0 m -148.54 150.53 33.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.466 0.306 . . . . 0.0 110.82 -171.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.76 129.99 9.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.2 -171.95 30.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.7 m -83.24 161.29 21.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.688 0.395 . . . . 0.0 110.706 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -76.02 2.53 12.5 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -122.46 11.81 10.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.978 0.511 . . . . 0.0 111.301 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 m -110.61 12.64 22.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.338 0.655 . . . . 0.0 111.849 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.27 154.59 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.404 0.682 . . . . 0.0 109.567 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.54 153.56 23.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.28 0.632 . . . . 0.0 111.979 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.0 m -62.89 -18.92 63.65 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -76.65 -20.5 56.6 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 118.599 0.636 . . . . 0.0 110.459 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.416 ' CD2' ' CD1' ' A' ' 81' ' ' PHE . 9.1 m-85 -85.8 -19.62 30.43 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -83.28 -19.03 37.08 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 122.419 0.288 . . . . 0.0 110.856 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.66 -21.33 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.102 0.561 . . . . 0.0 111.862 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -101.97 157.99 32.64 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 122.799 0.44 . . . . 0.0 110.414 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.12 149.94 76.8 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.43 2.753 . . . . 0.0 111.692 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.66 153.27 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.003 0.521 . . . . 0.0 110.465 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.75 157.48 46.01 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.205 1.002 . . . . 0.0 109.371 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.92 168.64 10.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 37.9 mtmm -60.64 -46.85 97.21 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.116 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 77.7 Cg_endo -71.93 138.16 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.835 1.69 . . . . 0.0 109.628 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 109' ' ' VAL . 2.2 m-30 -112.51 154.14 26.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.527 0.731 . . . . 0.0 110.325 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.7 p -138.01 160.76 38.48 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.428 0.691 . . . . 0.0 110.363 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.4 tpp -71.15 -28.86 64.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.152 0.426 . . . . 0.0 112.152 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.5 -43.56 14.45 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.968 -0.458 . . . . 0.0 111.931 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -30.18 48.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 119.845 -0.42 . . . . 0.0 112.527 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 104' ' ' PHE . 47.0 t -87.22 -30.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 CA-C-N 117.658 0.729 . . . . 0.0 111.01 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.66 68.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.871 -0.518 . . . . 0.0 110.021 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.31 -29.94 38.14 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.121 0.168 . . . . 0.0 110.707 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.6 37.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.295 -0.253 . . . . 0.0 111.417 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.92 -19.95 33.84 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 117.961 0.346 . . . . 0.0 111.115 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.02 -25.65 43.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.61 -25.86 41.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.65 29.92 1.43 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.036 0.935 . . . . 0.0 111.125 173.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.79 -16.47 7.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.425 0.29 . . . . 0.0 111.586 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.22 -177.343 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 ttp . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -133.63 -10.17 2.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.418 0.687 . . . . 0.0 110.6 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.26 -170.48 3.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.463 1.505 . . . . 0.0 107.31 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 4' ' ' LEU . 29.6 mt -141.94 30.55 1.63 Allowed 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.365 0.666 . . . . 0.0 109.894 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -87.27 -11.56 49.26 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.16 0.584 . . . . 0.0 111.329 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.568 ' HB3' HG11 ' A' ' 32' ' ' VAL . 81.4 mt-30 -123.07 113.65 19.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.1 mm -122.47 131.55 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.626 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -89.87 149.81 22.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.635 ' H ' HD23 ' A' ' 8' ' ' LEU . 66.3 mt -115.17 135.59 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 118.115 0.416 . . . . 0.0 110.108 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.58 121.96 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 12.2 tp10 -150.55 157.49 43.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.806 -173.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.36 -10.49 19.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 112.508 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.552 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 48.0 mt-10 -133.2 132.92 22.44 Favored Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 121.919 -0.488 . . . . 0.0 110.369 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.41 -21.41 61.1 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.329 2.686 . . . . 0.0 113.2 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.94 -43.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.165 -0.335 . . . . 0.0 110.682 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.0 -25.63 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.76 -30.62 70.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.308 -0.245 . . . . 0.0 110.56 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mmt -82.42 -22.7 35.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.319 -0.238 . . . . 0.0 110.808 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mtp -73.94 -35.44 64.56 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.218 0.463 . . . . 0.0 110.179 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.37 -33.77 74.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.171 -0.331 . . . . 0.0 110.138 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.41 -25.53 60.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.297 -0.252 . . . . 0.0 110.359 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.76 -41.55 23.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.907 0.321 . . . . 0.0 111.136 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.16 -24.89 59.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.872 -0.518 . . . . 0.0 111.937 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.755 0.707 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -85.33 -21.4 28.94 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.554 0.616 . . . . 0.0 112.126 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.2 -26.0 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.25 0.477 . . . . 0.0 111.244 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.03 18.31 13.7 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 122.17 -0.331 . . . . 0.0 111.536 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.87 34.02 18.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.448 0.699 . . . . 0.0 112.388 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -85.64 162.49 18.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.907 0.883 . . . . 0.0 109.102 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m -111.32 85.22 5.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.116 -0.365 . . . . 0.0 110.393 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.27 156.97 62.41 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.732 2.288 . . . . 0.0 110.038 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.7 m -131.15 -9.14 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.18 173.82 33.27 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 119.302 0.955 . . . . 0.0 113.126 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -144.0 141.09 29.96 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.202 1.001 . . . . 0.0 109.014 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.48 162.18 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 122.892 0.477 . . . . 0.0 111.091 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.35 -11.79 29.27 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.524 0.73 . . . . 0.0 111.858 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -149.29 157.99 43.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.947 -0.471 . . . . 0.0 110.491 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -71.55 -22.47 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 122.574 0.35 . . . . 0.0 110.223 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.87 -26.51 66.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.978 -0.451 . . . . 0.0 109.983 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -26.15 55.62 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.49 -30.56 63.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.255 0.527 . . . . 0.0 109.839 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.47 -37.43 68.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.78 64.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.373 -0.204 . . . . 0.0 111.074 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -22.27 29.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.453 0.301 . . . . 0.0 111.062 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.19 -21.85 10.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.75 -14.92 62.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.335 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -100.02 -12.49 19.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.089 0.956 . . . . 0.0 110.681 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.11 -168.49 52.09 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.58 23.36 62.66 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.44 -0.447 . . . . 0.0 112.231 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 mt -135.57 148.01 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.697 0.748 . . . . 0.0 109.343 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -120.0 -30.32 4.73 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.59 178.83 9.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.811 0.444 . . . . 0.0 109.913 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.36 163.1 39.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 mm -113.21 140.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.4 tp -140.71 129.53 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.551 0.215 . . . . 0.0 110.996 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.16 154.08 26.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.421 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.94 -11.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 122.893 0.477 . . . . 0.0 109.903 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -80.2 28.29 0.31 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.159 0.984 . . . . 0.0 111.97 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.17 155.42 14.12 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.333 0.653 . . . . 0.0 110.602 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -81.47 144.7 31.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.11 -174.5 26.16 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 -163.6 42.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -126.3 68.9 1.21 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.977 0.511 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 49.53 29.17 2.82 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.936 0.895 . . . . 0.0 112.639 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -152.05 162.14 41.54 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.864 0.466 . . . . 0.0 109.924 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 t -147.28 133.92 9.89 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 122.958 0.503 . . . . 0.0 110.554 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.45 -11.96 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.601 2.867 . . . . 0.0 111.653 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.25 -22.7 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 122.046 -0.409 . . . . 0.0 110.797 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.29 75.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.06 -17.96 60.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.164 -0.335 . . . . 0.0 111.227 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.33 -29.41 57.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.56 -34.52 72.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.61 -21.06 60.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.053 -0.404 . . . . 0.0 110.81 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.25 -16.59 42.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.514 0.325 . . . . 0.0 111.459 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -104.08 23.81 12.4 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.447 0.699 . . . . 0.0 111.775 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 53.83 41.83 31.93 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.865 0.866 . . . . 0.0 112.662 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.96 87.83 23.67 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.12 164.47 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 124.844 3.696 . . . . 0.0 114.27 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.19 169.3 17.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.975 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.06 141.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.277 1.031 . . . . 0.0 109.27 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.04 150.14 22.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.572 0.225 . . . . 0.0 110.764 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.47 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.89 0.476 . . . . 0.0 110.017 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -160.67 158.73 29.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.212 -0.305 . . . . 0.0 111.112 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.92 113.26 4.14 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.88 -163.52 29.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.8 m -76.88 160.41 29.24 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.237 0.542 . . . . 0.0 110.753 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.99 -3.12 56.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.694 0.398 . . . . 0.0 111.96 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -92.73 -0.46 57.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.584 0.354 . . . . 0.0 111.441 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -84.23 8.35 16.11 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.43 0.692 . . . . 0.0 112.02 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.7 m -136.9 154.68 31.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.752 0.821 . . . . 0.0 110.728 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -72.33 169.27 16.62 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.384 0.673 . . . . 0.0 111.487 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.9 p -61.94 -15.83 46.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -74.82 -24.24 58.59 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.939 0.336 . . . . 0.0 110.268 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 10.1 m-85 -86.01 -22.48 27.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -84.39 -14.53 49.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.801 0.441 . . . . 0.0 110.895 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.69 -33.55 14.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.732 0.413 . . . . 0.0 110.475 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -83.0 160.65 60.07 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.48 152.15 69.9 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.24 2.627 . . . . 0.0 111.181 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.24 154.39 33.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.002 0.521 . . . . 0.0 111.102 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.06 154.63 48.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.711 0.804 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -86.94 165.63 15.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.062 0.545 . . . . 0.0 109.658 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.15 -49.38 12.59 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.33 140.01 21.51 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.052 1.835 . . . . 0.0 111.161 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -110.4 152.34 26.38 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.065 0.46 . . . . 0.0 110.54 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 108' ' ' GLY . 8.8 t -154.26 164.61 38.28 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.028 0.931 . . . . 0.0 108.849 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -58.59 -27.57 64.77 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -84.04 -36.01 23.41 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.084 0.402 . . . . 0.0 111.256 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.456 ' H ' HG23 ' A' ' 105' ' ' THR . . . -79.3 -25.24 59.62 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.12 -30.26 11.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.122 0.461 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.34 69.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.73 -20.81 30.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.684 0.394 . . . . 0.0 111.107 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.24 61.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.477 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.4 mt -77.5 -28.42 52.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.0 -20.28 61.05 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.977 0.353 . . . . 0.0 110.874 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.47 -20.6 26.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.534 0.333 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -91.32 -50.63 5.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.819 0.282 . . . . 0.0 110.546 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.96 2.92 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.328 1.051 . . . . 0.0 112.88 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.173 -1.394 . . . . 0.0 110.0 178.446 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -80.16 -6.58 57.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.505 0.322 . . . . 0.0 111.827 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.88 159.14 43.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.711 0.804 . . . . 0.0 109.941 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.8 68.42 0.66 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.35 0.66 . . . . 0.0 110.697 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -4.14 58.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 175.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.649 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.0 mp0 -120.37 109.68 15.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.671 0.789 . . . . 0.0 111.438 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 mm -116.62 130.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 O-C-N 123.514 0.509 . . . . 0.0 110.086 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 145.31 25.11 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.656 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.7 mt -113.33 130.57 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.769 0.828 . . . . 0.0 109.237 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.29 117.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -141.26 162.98 34.19 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.626 0.77 . . . . 0.0 110.512 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -84.02 -9.95 58.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.454 0.301 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.6 145.51 40.78 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.839 0.456 . . . . 0.0 109.836 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.07 -14.75 26.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.116 2.544 . . . . 0.0 111.202 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -74.89 -30.32 61.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 117.771 0.26 . . . . 0.0 110.626 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mm -84.91 -30.17 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.77 69.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.8 tpp -78.91 -28.23 43.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.9 ttt -70.39 -29.99 66.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 2.1 mm? -75.16 -29.48 60.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.499 0.32 . . . . 0.0 110.483 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.88 -23.79 61.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.893 0.315 . . . . 0.0 110.266 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.48 -40.72 42.05 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.438 -0.164 . . . . 0.0 111.432 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.74 -24.66 53.02 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.266 0.484 . . . . 0.0 111.96 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.66 -20.35 56.76 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.704 0.684 . . . . 0.0 110.364 176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.2 -27.66 35.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.875 0.307 . . . . 0.0 110.585 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.4 t -79.76 -22.59 12.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 122.504 0.322 . . . . 0.0 110.859 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.77 13.56 34.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.793 0.437 . . . . 0.0 111.815 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 53.49 29.2 8.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 112.4 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -85.62 161.05 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.629 0.772 . . . . 0.0 109.202 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.8 m -105.83 117.47 57.69 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.6 162.83 27.19 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.322 2.681 . . . . 0.0 110.107 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 6' ' ' GLN . 26.7 m -135.12 -18.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.47 172.75 32.33 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.136 0.425 . . . . 0.0 112.147 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.3 p -139.14 142.02 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 108.464 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.33 152.87 23.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.792 0.329 . . . . 0.0 110.297 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -100.83 1.32 39.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.24 0.616 . . . . 0.0 112.111 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -141.32 157.84 44.67 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 109.812 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.36 -22.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 122.416 -0.177 . . . . 0.0 110.8 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.85 -25.96 61.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.147 -0.346 . . . . 0.0 110.677 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.95 -27.12 60.96 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.24 -34.81 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.34 0.57 . . . . 0.0 110.066 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -69.36 -36.96 77.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.95 66.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.247 -0.283 . . . . 0.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -84.8 -20.84 30.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.77 0.259 . . . . 0.0 111.332 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.41 -24.2 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.855 0.298 . . . . 0.0 110.45 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -75.83 -14.57 60.29 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.249 -0.282 . . . . 0.0 110.79 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.85 -12.48 22.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.541 0.736 . . . . 0.0 111.035 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.94 53.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.61 11.33 84.17 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.67 147.99 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -121.94 -19.76 6.57 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.13 168.64 26.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.596 0.358 . . . . 0.0 110.097 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.35 34.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 111.49 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.04 129.3 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.68 130.37 56.8 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.806 0.442 . . . . 0.0 111.05 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.47 132.41 34.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.51 -11.26 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.737 0.415 . . . . 0.0 110.782 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -85.08 26.18 0.89 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.074 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.54 148.72 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.724 0.81 . . . . 0.0 111.001 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -62.51 152.97 33.14 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.874 0.87 . . . . 0.0 112.13 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.24 -171.25 22.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.72 1.08 63.36 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.614 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -74.9 145.01 43.05 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.963 0.882 . . . . 0.0 110.829 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -140.47 15.12 2.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.669 0.787 . . . . 0.0 110.832 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -148.08 166.58 27.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.441 0.697 . . . . 0.0 110.045 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m -131.95 71.0 80.63 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.657 0.783 . . . . 0.0 109.364 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -11.69 31.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.669 2.913 . . . . 0.0 111.963 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.2 -19.33 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 O-C-N 122.118 -0.363 . . . . 0.0 110.237 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.75 -26.14 67.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.98 -17.98 59.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.159 -0.338 . . . . 0.0 110.555 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.37 -31.79 48.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.91 -34.12 76.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.06 -21.83 61.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.076 0.15 . . . . 0.0 110.691 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.89 -7.0 59.54 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.895 0.478 . . . . 0.0 110.826 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -114.7 15.01 17.64 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.708 0.803 . . . . 0.0 111.313 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.21 36.8 28.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.251 1.02 . . . . 0.0 112.927 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.7 mt -109.27 108.69 60.34 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.187 0.995 . . . . 0.0 108.366 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.74 154.85 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.733 2.955 . . . . 0.0 112.224 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.54 165.0 31.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.24 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.09 145.35 28.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.371 1.068 . . . . 0.0 108.416 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.14 153.24 18.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 111.308 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.17 148.17 37.8 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -159.95 170.97 20.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.63 0.253 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.77 95.31 0.23 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.71 -160.11 28.45 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.7 t -75.35 157.02 34.88 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.17 -4.43 29.62 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.071 0.549 . . . . 0.0 111.223 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.75 -1.4 34.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.9 11.28 33.8 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.676 0.79 . . . . 0.0 111.461 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 t -126.35 154.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.294 0.638 . . . . 0.0 109.795 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.0 152.46 23.76 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.172 0.589 . . . . 0.0 111.636 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.3 p -63.63 -17.45 62.92 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -77.56 -17.17 58.14 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 118.335 0.516 . . . . 0.0 110.729 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -89.75 -21.35 22.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -88.18 -11.21 47.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.977 0.511 . . . . 0.0 111.327 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.62 -27.26 12.43 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.281 0.632 . . . . 0.0 111.197 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.79 161.17 48.34 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 145.19 80.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.143 2.562 . . . . 0.0 112.608 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.2 m -140.62 154.27 21.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.699 0.8 . . . . 0.0 110.23 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 tp -145.87 146.45 31.12 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.1 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -85.01 158.77 20.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.878 0.471 . . . . 0.0 109.796 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -67.02 -36.22 10.62 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.82 125.32 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.402 2.068 . . . . 0.0 110.202 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 3.8 m-30 -112.29 151.96 29.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.745 0.418 . . . . 0.0 110.854 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.9 p -142.64 159.28 42.53 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.161 0.984 . . . . 0.0 109.087 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -66.04 -26.34 67.46 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.829 -0.544 . . . . 0.0 111.174 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.63 -37.1 21.49 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 117.788 0.267 . . . . 0.0 111.536 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.48 -27.25 59.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.929 -0.373 . . . . 0.0 112.185 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.57 -29.4 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 117.696 0.748 . . . . 0.0 110.464 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.02 69.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.97 -21.16 29.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.365 0.666 . . . . 0.0 110.819 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.39 38.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.66 0.209 . . . . 0.0 110.664 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.62 -28.69 60.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -26.37 63.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.96 41.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.051 0.54 . . . . 0.0 111.752 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -90.98 -33.81 15.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.353 0.261 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -94.08 0.23 55.77 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.901 0.48 . . . . 0.0 111.844 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.22 -1.372 . . . . 0.0 109.767 179.157 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.6 m 56.58 179.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.228 1.011 . . . . 0.0 112.862 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.57 165.21 29.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.386 0.675 . . . . 0.0 110.076 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.82 63.29 1.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 110.463 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.68 -5.47 37.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.39 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 63.5 mt-30 -119.94 111.77 18.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.803 0.335 . . . . 0.0 111.541 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.21 135.4 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.093 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -92.38 132.3 36.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' N ' HD23 ' A' ' 8' ' ' LEU . 84.0 mt -94.6 128.0 46.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.215 0.606 . . . . 0.0 109.487 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.41 115.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.066 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.89 162.98 32.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.057 0.543 . . . . 0.0 111.622 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.5 4.42 18.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.677 . . . . 0.0 110.374 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -141.11 110.69 6.51 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.804 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -55.75 -21.78 33.88 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.952 3.101 . . . . 0.0 113.875 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 tp -74.31 -33.7 63.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.214 0.461 . . . . 0.0 110.305 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.3 mm -77.73 -31.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.22 65.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.8 tpp -77.76 -31.83 52.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -74.52 -30.41 61.78 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.472 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.16 -29.95 68.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.2 -24.03 54.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.068 0.394 . . . . 0.0 110.193 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.9 -43.13 20.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.241 -0.287 . . . . 0.0 111.279 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.38 -28.33 59.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.188 0.449 . . . . 0.0 111.813 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -79.17 -17.65 54.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.514 0.597 . . . . 0.0 110.865 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.85 -26.16 27.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.039 0.381 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -82.86 -22.59 8.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 122.555 0.342 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.9 mt -101.11 16.35 25.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 51.97 37.36 20.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.862 0.865 . . . . 0.0 112.181 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.61 164.61 17.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.494 0.717 . . . . 0.0 109.528 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.0 m -117.46 71.8 7.02 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 122.537 0.335 . . . . 0.0 110.825 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.3 159.69 42.46 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.986 2.457 . . . . 0.0 110.114 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.2 m -123.81 -10.02 7.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.72 173.77 33.72 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 118.54 0.609 . . . . 0.0 112.291 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.3 m -140.25 139.24 35.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 109.337 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.32 158.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.231 0.612 . . . . 0.0 110.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -137.04 3.63 2.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.655 0.382 . . . . 0.0 111.763 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -139.04 149.71 44.94 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.04 -32.38 55.99 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 122.29 0.236 . . . . 0.0 111.311 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.85 69.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.953 -0.467 . . . . 0.0 110.945 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.49 -29.8 47.5 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.4 63.6 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.516 0.658 . . . . 0.0 110.541 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.92 -27.09 54.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.41 -24.67 61.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.149 -0.344 . . . . 0.0 110.883 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.07 -29.24 22.04 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.09 -21.95 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.564 0.62 . . . . 0.0 111.523 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -81.66 -14.72 56.3 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.07 -0.394 . . . . 0.0 111.021 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -91.9 -13.21 31.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.539 0.336 . . . . 0.0 111.519 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -164.8 42.18 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.61 24.98 61.58 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.306 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -127.79 144.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 117.433 0.616 . . . . 0.0 109.646 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -109.94 -27.87 9.02 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.23 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.06 178.56 7.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.156 0.583 . . . . 0.0 110.389 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.23 162.01 41.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.906 -0.496 . . . . 0.0 111.847 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.4 mt -116.22 126.62 73.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.11 133.06 56.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.876 0.47 . . . . 0.0 111.488 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.83 144.29 30.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -80.37 -11.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -122.7 40.45 3.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.754 0.422 . . . . 0.0 110.696 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.86 153.51 17.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.524 0.73 . . . . 0.0 111.44 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -57.55 152.03 15.71 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.116 0.967 . . . . 0.0 110.98 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 5.64 84.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.98 -0.345 . . . . 0.0 112.471 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.91 176.38 43.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.57 138.32 53.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.828 0.451 . . . . 0.0 110.368 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.1 pttt 47.72 10.97 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.811 2.044 . . . . 0.0 115.402 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -150.39 162.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.666 0.786 . . . . 0.0 109.988 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 t -144.17 135.14 12.4 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.843 0.457 . . . . 0.0 110.263 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.71 -11.72 12.59 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.549 2.833 . . . . 0.0 111.494 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.47 -31.43 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 117.87 0.305 . . . . 0.0 110.775 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.99 86.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.956 -0.465 . . . . 0.0 110.289 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.0 -17.37 40.69 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.263 -0.273 . . . . 0.0 111.274 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -33.25 68.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.1 mt -73.88 -27.54 61.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.24 -23.0 61.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.928 0.331 . . . . 0.0 110.5 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.91 -19.37 40.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.315 0.246 . . . . 0.0 110.375 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -98.12 5.37 48.67 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.43 0.692 . . . . 0.0 111.491 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 57.37 27.6 14.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 112.534 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.6 mt -94.78 124.52 54.43 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.313 0.645 . . . . 0.0 109.327 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -59.89 150.26 78.92 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.894 3.063 . . . . 0.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -151.91 160.39 43.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.672 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.17 156.47 36.66 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.395 0.678 . . . . 0.0 109.498 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.73 160.62 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.35 0.595 . . . . 0.0 111.896 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.46 136.55 36.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.8 p -134.05 161.89 33.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.069 0.461 . . . . 0.0 111.96 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.04 -167.75 36.14 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.11 49.77 2.96 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -153.95 144.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.485 0.714 . . . . 0.0 110.033 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -105.42 -2.32 23.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.456 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.95 -2.87 33.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.042 0.537 . . . . 0.0 111.507 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -85.66 5.63 31.1 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.059 0.544 . . . . 0.0 111.813 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.64 154.73 19.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.137 0.575 . . . . 0.0 111.814 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.66 170.9 15.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.848 0.859 . . . . 0.0 111.179 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -62.85 -17.27 61.21 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -70.73 -29.78 66.12 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.778 -0.576 . . . . 0.0 110.195 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -81.02 -23.94 38.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -84.25 -10.37 57.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.82 0.448 . . . . 0.0 110.885 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -23.58 15.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.981 0.512 . . . . 0.0 110.913 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -97.19 163.86 19.01 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.286 0.634 . . . . 0.0 110.042 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.45 147.53 85.37 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.251 2.634 . . . . 0.0 112.084 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 m -140.36 154.07 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.486 0.714 . . . . 0.0 110.297 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.53 151.65 51.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.528 0.731 . . . . 0.0 109.953 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -74.35 156.76 36.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.53 ' HA ' ' CE ' ' A' ' 102' ' ' LYS . 1.9 tpmt? -71.1 -47.47 14.19 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.723 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 92.3 Cg_endo -73.52 142.43 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.902 1.735 . . . . 0.0 109.804 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -115.56 157.83 23.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.928 0.891 . . . . 0.0 110.75 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -141.91 162.53 35.24 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 124.058 0.943 . . . . 0.0 109.46 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -64.67 -32.52 74.22 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 122.255 -0.278 . . . . 0.0 111.149 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.45 -34.44 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.712 0.233 . . . . 0.0 111.597 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.03 56.16 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.628 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.27 -27.51 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.954 0.877 . . . . 0.0 110.729 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.02 71.79 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.222 0.465 . . . . 0.0 110.294 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -82.78 -29.62 29.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.327 0.251 . . . . 0.0 110.419 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.65 -31.57 46.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.732 0.242 . . . . 0.0 111.221 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.36 -39.81 58.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.96 -26.8 65.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.497 -0.127 . . . . 0.0 110.802 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.26 -14.41 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.567 0.347 . . . . 0.0 111.566 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -91.25 -35.85 14.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.761 0.424 . . . . 0.0 110.78 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 tp -88.67 -12.15 43.26 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.116 -1.421 . . . . 0.0 110.165 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.324 0.107 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -146.36 166.07 27.44 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.243 0.617 . . . . 0.0 109.856 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.3 175.06 10.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.874 0.469 . . . . 0.0 111.04 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.16 33.11 0.1 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.315 1.046 . . . . 0.0 112.578 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -12.67 40.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.477 0.311 . . . . 0.0 110.774 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.577 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.7 mp0 -115.1 116.16 27.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.572 0.349 . . . . 0.0 111.469 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.42 128.76 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.418 0.687 . . . . 0.0 110.366 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -87.82 141.02 28.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.556 ' H ' HD23 ' A' ' 8' ' ' LEU . 90.0 mt -106.0 127.35 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.791 0.836 . . . . 0.0 109.21 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.0 126.87 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -155.07 165.87 35.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.255 0.622 . . . . 0.0 111.181 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -124.21 18.17 9.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.974 0.51 . . . . 0.0 110.242 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -137.77 126.86 14.85 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.727 0.811 . . . . 0.0 108.883 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.77 -18.68 32.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.411 2.741 . . . . 0.0 112.839 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.57 -25.5 35.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.26 0.482 . . . . 0.0 110.512 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.11 -26.05 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.43 84.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.011 -0.431 . . . . 0.0 110.843 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -77.26 -25.12 51.17 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 122.303 -0.248 . . . . 0.0 110.884 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 ttp -75.15 -32.17 61.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.429 -0.169 . . . . 0.0 110.688 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.67 -33.79 69.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.845 0.293 . . . . 0.0 110.68 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.71 -22.01 57.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.885 0.311 . . . . 0.0 110.451 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.75 -38.73 32.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.213 -0.305 . . . . 0.0 111.367 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -78.1 -23.44 47.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.562 0.619 . . . . 0.0 111.297 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.9 -18.54 58.25 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.439 0.563 . . . . 0.0 109.892 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.95 -28.04 35.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.05 0.386 . . . . 0.0 110.019 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -77.74 -23.59 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 122.615 0.366 . . . . 0.0 110.315 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.2 mt -93.04 8.2 40.98 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.793 0.437 . . . . 0.0 111.513 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.23 30.95 8.48 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.25 0.62 . . . . 0.0 111.47 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.72 161.12 19.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.4 m -107.97 98.99 28.31 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 122.357 0.263 . . . . 0.0 110.321 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.92 158.76 54.58 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.907 2.405 . . . . 0.0 109.26 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.577 HG11 ' HB3' ' A' ' 6' ' ' GLN . 34.2 m -127.94 -11.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.31 172.75 32.17 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.313 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -133.97 143.18 48.01 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.968 0.907 . . . . 0.0 108.755 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.69 140.2 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.72 1.53 57.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -140.78 157.06 45.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.119 0.568 . . . . 0.0 109.878 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.3 -22.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 122.47 -0.144 . . . . 0.0 110.779 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.86 63.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -19.58 68.95 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.96 -36.85 48.6 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.738 0.769 . . . . 0.0 110.746 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.76 -30.23 40.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.22 -25.66 59.79 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.187 -0.321 . . . . 0.0 111.266 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -87.39 -26.76 23.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.67 0.388 . . . . 0.0 111.827 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -82.77 -22.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 118.191 0.45 . . . . 0.0 111.604 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.35 -14.66 62.67 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.122 0.419 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.27 -12.52 59.61 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.684 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 -174.8 54.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.82 85.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -133.72 149.38 30.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -129.67 -12.03 4.36 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.57 169.25 20.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.841 0.456 . . . . 0.0 110.101 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 158.63 44.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.581 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.46 127.46 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.43 126.16 55.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.814 0.446 . . . . 0.0 110.888 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -77.85 132.83 38.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.56 -13.26 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.21 -0.306 . . . . 0.0 110.323 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.43 146.19 47.11 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.8 tp -141.44 151.23 43.23 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.119 -0.363 . . . . 0.0 110.53 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.54 151.84 27.55 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.393 0.677 . . . . 0.0 110.973 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.31 -165.62 54.77 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.47 -3.22 82.38 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.408 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.38 156.85 39.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.051 0.926 . . . . 0.0 110.933 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -141.09 173.32 11.6 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.251 0.62 . . . . 0.0 110.838 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t 58.8 -178.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.261 1.024 . . . . 0.0 112.125 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 m -138.87 58.63 13.78 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.074 0.55 . . . . 0.0 110.301 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.35 -10.91 29.12 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.364 2.71 . . . . 0.0 111.401 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.77 -16.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.022 0.529 . . . . 0.0 111.064 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 -23.3 62.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.957 -0.465 . . . . 0.0 109.881 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.19 -19.03 57.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.04 -30.8 39.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.51 -30.13 66.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.31 -20.95 54.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.266 0.226 . . . . 0.0 110.652 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.97 -18.46 59.3 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -90.34 12.83 17.12 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.42 0.688 . . . . 0.0 110.449 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.44 31.93 21.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.812 1.245 . . . . 0.0 112.824 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -113.8 126.17 28.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.68 160.31 38.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.213 3.275 . . . . 0.0 112.338 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.06 171.72 15.94 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.25 149.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.776 0.831 . . . . 0.0 108.967 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.82 154.31 17.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.185 0.517 . . . . 0.0 111.413 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.54 125.03 22.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.6 t -154.69 169.57 23.59 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.64 126.78 1.55 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.56 -164.82 29.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -74.02 159.11 33.15 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 110.307 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.48 -8.68 59.61 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.53 0.332 . . . . 0.0 111.44 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.22 0.76 20.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.215 0.606 . . . . 0.0 112.135 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.0 p -124.1 11.77 8.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.142 0.577 . . . . 0.0 111.948 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.81 160.99 17.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.355 0.597 . . . . 0.0 112.576 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -64.8 -16.2 62.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -78.16 -16.71 57.66 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.717 0.69 . . . . 0.0 111.238 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -85.89 -24.46 26.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -79.02 -15.95 57.54 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.342 0.257 . . . . 0.0 111.012 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.88 -24.69 13.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.045 0.538 . . . . 0.0 111.523 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -90.39 160.32 39.77 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 123.187 0.595 . . . . 0.0 109.53 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -63.71 144.49 89.38 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.83 2.353 . . . . 0.0 110.666 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.17 154.35 20.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.737 0.815 . . . . 0.0 110.806 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -139.96 153.8 47.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -69.41 158.72 34.58 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.438 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 13.8 mmmm -62.33 -47.63 89.04 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.23 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.6 Cg_endo -71.43 135.15 25.95 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.427 1.418 . . . . 0.0 108.849 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.6 156.62 17.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.122 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.6 p -141.11 160.77 39.39 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.382 1.073 . . . . 0.0 108.702 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -62.36 -28.78 70.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.304 -0.248 . . . . 0.0 111.043 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.85 -29.1 27.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.336 -0.228 . . . . 0.0 110.97 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.51 -32.98 49.34 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.052 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -82.28 -24.47 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 117.841 0.82 . . . . 0.0 111.151 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.11 65.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.25 0.477 . . . . 0.0 109.964 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.23 -25.82 27.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.793 0.437 . . . . 0.0 111.549 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.79 -37.35 41.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.781 0.264 . . . . 0.0 110.778 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.37 -27.52 52.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.84 60.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.149 0.431 . . . . 0.0 110.672 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.21 -17.42 32.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.23 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.23 -47.56 7.43 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.16 18.02 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.452 1.101 . . . . 0.0 111.588 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.155 -179.148 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -142.01 161.89 36.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 110.484 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 5' ' ' THR . . . -148.02 169.76 19.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.672 0.789 . . . . 0.0 109.393 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.67 25.44 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -92.13 -14.28 29.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.043 0.937 . . . . 0.0 109.681 173.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.652 ' HB3' HG11 ' A' ' 32' ' ' VAL . 23.1 mp0 -114.57 111.84 21.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.798 0.439 . . . . 0.0 111.619 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mm -118.41 130.43 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.226 0.61 . . . . 0.0 110.128 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -90.73 141.18 29.07 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.087 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.524 ' H ' HD23 ' A' ' 8' ' ' LEU . 96.7 mt -105.31 130.55 56.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.478 0.711 . . . . 0.0 109.78 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 t -127.61 117.97 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.605 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 14.2 tp10 -145.62 156.18 43.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.474 0.71 . . . . 0.0 109.744 -173.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -124.35 15.64 8.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.418 0.687 . . . . 0.0 111.416 -176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.605 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 15.9 tp10 -136.08 107.22 9.58 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.28 -25.02 36.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.626 2.884 . . . . 0.0 114.152 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -77.16 -37.93 52.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.407 0.549 . . . . 0.0 110.465 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.5 mt -79.33 -24.33 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.85 0.296 . . . . 0.0 110.536 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.9 mtt -76.97 -31.3 56.45 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.7 mtp -72.94 -23.77 60.72 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -74.47 -34.25 63.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.327 -0.233 . . . . 0.0 110.666 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.34 -22.38 51.91 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.42 -37.46 57.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.69 -23.24 56.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.269 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -77.25 -23.46 51.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.926 0.33 . . . . 0.0 110.245 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.07 -32.27 26.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.303 0.241 . . . . 0.0 110.482 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -76.82 -19.77 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.6 tp -82.81 0.22 44.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.583 0.753 . . . . 0.0 110.542 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 53.89 28.8 8.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.861 0.865 . . . . 0.0 111.695 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -91.25 156.84 17.52 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.971 0.908 . . . . 0.0 110.74 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.0 m -92.64 121.61 65.8 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -78.59 161.68 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.168 3.245 . . . . 0.0 111.25 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -141.7 -18.7 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 173.07 32.58 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.398 0.545 . . . . 0.0 112.548 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.2 p -139.62 142.98 37.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.503 1.121 . . . . 0.0 108.46 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 156.03 21.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.83 -7.66 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.597 0.759 . . . . 0.0 111.563 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -152.61 161.22 42.87 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.668 0.387 . . . . 0.0 110.467 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.65 -22.55 26.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.186 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -27.23 63.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.72 -28.75 56.49 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.32 74.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.563 0.681 . . . . 0.0 109.496 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.94 -31.21 66.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 -24.92 63.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.372 -0.205 . . . . 0.0 111.08 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.348 0.259 . . . . 0.0 111.206 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -76.27 -25.23 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.899 0.318 . . . . 0.0 110.244 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -73.78 -14.78 61.17 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.352 -0.217 . . . . 0.0 110.856 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.4 -12.61 24.06 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.193 0.597 . . . . 0.0 111.007 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.82 -169.04 49.03 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.26 86.35 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.619 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.4 mt -129.16 147.97 33.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.78 -17.47 4.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.99 170.24 22.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.728 0.411 . . . . 0.0 110.43 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.93 162.53 41.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.624 0.249 . . . . 0.0 111.538 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.11 130.97 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.76 125.72 54.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.523 0.329 . . . . 0.0 110.958 -174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.54 129.9 34.85 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.53 -12.93 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.026 0.53 . . . . 0.0 110.9 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -84.44 42.28 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.163 0.585 . . . . 0.0 110.964 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.73 148.85 50.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.877 0.471 . . . . 0.0 110.953 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -81.9 152.39 26.83 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.532 0.733 . . . . 0.0 110.463 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.76 -7.38 27.79 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.168 0.413 . . . . 0.0 112.545 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.74 85.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.878 0.839 . . . . 0.0 113.747 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 173.61 9.18 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.384 1.092 . . . . 0.0 111.301 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -123.38 166.01 16.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.134 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -130.07 22.5 5.3 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.326 0.65 . . . . 0.0 111.318 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.471 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 42.1 p -64.93 -25.86 1.62 Allowed Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.6 Cg_exo -59.05 -16.49 33.15 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.976 1.784 . . . . 0.0 112.99 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.6 -21.67 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.038 0.381 . . . . 0.0 110.291 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.62 65.45 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.026 -0.421 . . . . 0.0 110.064 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.62 -19.66 60.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.339 -0.226 . . . . 0.0 110.66 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.92 51.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.42 -36.88 74.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.17 62.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.276 -0.265 . . . . 0.0 110.748 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 -15.19 54.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.405 0.282 . . . . 0.0 110.432 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -105.29 20.68 18.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.704 0.802 . . . . 0.0 111.403 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 59.02 35.76 24.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.035 0.934 . . . . 0.0 113.444 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.3 mt -118.59 97.62 50.84 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.97 161.14 26.89 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.079 3.186 . . . . 0.0 112.638 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -148.02 170.26 18.12 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.919 0.487 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.5 144.16 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -86.88 155.98 20.03 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.8 0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.05 125.98 18.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -161.93 164.71 28.34 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 110.618 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.45 95.61 0.57 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.43 165.04 12.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.7 m -147.58 28.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.55 0.34 . . . . 0.0 110.873 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -105.62 -50.88 3.11 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.71 -5.42 2.5 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.2 p -88.07 4.18 46.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.879 0.472 . . . . 0.0 112.131 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.43 154.44 30.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.336 0.588 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.98 179.86 7.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.0 108.972 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -57.53 -19.32 24.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.754 -0.591 . . . . 0.0 112.235 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -74.45 -24.63 59.09 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.991 -0.443 . . . . 0.0 110.749 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.56 -17.12 39.89 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.9 0.88 . . . . 0.0 109.396 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -88.26 -11.0 47.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.467 0.707 . . . . 0.0 110.37 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -111.98 -8.46 14.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.628 0.771 . . . . 0.0 111.785 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 26.1 tpt180 -137.84 139.56 26.82 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 79.0 Cg_exo -53.11 154.89 12.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.854 3.036 . . . . 0.0 114.238 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.83 155.14 32.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.136 0.974 . . . . 0.0 110.259 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.3 tp -133.57 149.71 51.65 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -74.08 160.97 30.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -70.45 -42.4 15.05 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.418 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.01 141.15 43.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.5 2.134 . . . . 0.0 109.645 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 4.6 m-30 -103.21 149.08 25.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 110.497 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.4 p -139.08 166.39 24.64 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.955 0.902 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mmm -65.65 -35.77 81.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.185 -0.322 . . . . 0.0 110.808 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.68 -28.38 26.43 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.388 0.275 . . . . 0.0 111.74 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.75 -28.81 64.36 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.6 t -83.91 -30.16 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.344 0.572 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.2 -27.84 60.98 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.39 -24.45 39.71 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.663 0.385 . . . . 0.0 110.244 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.24 64.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.183 -0.323 . . . . 0.0 110.394 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.21 -40.75 74.38 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.49 -18.89 61.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -23.27 24.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tt -91.79 -50.57 5.66 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.163 -0.336 . . . . 0.0 111.13 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.95 -1.12 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.913 -1.518 . . . . 0.0 110.06 178.669 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.591 0.234 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.0 p -148.83 160.39 43.28 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.967 0.507 . . . . 0.0 110.593 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.29 171.8 18.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.135 0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.3 mt -139.69 27.69 2.23 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.769 1.228 . . . . 0.0 110.153 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -79.93 -8.78 59.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.972 0.509 . . . . 0.0 111.585 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.438 ' HB3' HG11 ' A' ' 32' ' ' VAL . 65.2 mt-30 -121.04 114.62 21.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -119.88 131.98 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -91.39 145.03 24.97 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.559 ' H ' HD23 ' A' ' 8' ' ' LEU . 74.7 mt -113.34 130.95 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.1 117.71 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.19 163.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -169.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.21 -4.69 5.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.912 0.885 . . . . 0.0 110.538 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 44.5 tt0 -153.75 136.8 10.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 61.8 Cg_exo -56.74 -18.39 26.65 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.004 3.136 . . . . 0.0 114.52 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.62 -21.59 38.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.144 0.429 . . . . 0.0 111.671 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.11 -38.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.15 60.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.312 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.7 ttm -76.26 -32.8 59.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.0 tpt -81.5 -27.83 34.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.274 -0.266 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.48 -36.34 63.28 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -74.59 -21.69 59.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.82 -42.08 61.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.039 -0.413 . . . . 0.0 110.98 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -83.24 -22.78 33.0 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.91 -21.21 40.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.117 0.871 . . . . 0.0 111.076 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -85.58 -29.4 24.16 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.064 0.393 . . . . 0.0 111.314 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.39 -18.66 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 122.386 0.275 . . . . 0.0 111.23 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -99.33 18.15 18.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.119 0.567 . . . . 0.0 111.532 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 53.79 31.3 12.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.673 0.789 . . . . 0.0 112.227 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.51 165.72 16.89 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.639 0.776 . . . . 0.0 109.245 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -118.28 75.21 11.52 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 110.947 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.9 157.34 53.09 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.244 2.629 . . . . 0.0 109.78 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.1 m -122.75 -15.19 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.84 178.18 37.98 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.289 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 p -135.37 140.93 45.41 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.524 1.13 . . . . 0.0 108.876 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.51 147.16 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 110.431 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -92.1 2.19 56.73 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.41 0.684 . . . . 0.0 112.255 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -155.01 157.34 37.47 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.099 0.56 . . . . 0.0 110.065 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.48 -22.56 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.137 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.5 -26.04 64.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.36 59.27 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.02 67.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.714 0.757 . . . . 0.0 109.931 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.61 -37.54 68.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.79 -24.94 63.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -86.46 -22.7 26.33 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.314 0.506 . . . . 0.0 111.345 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.53 -28.22 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.52 -14.68 54.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.058 0.543 . . . . 0.0 111.559 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -108.16 -12.54 15.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.043 0.537 . . . . 0.0 112.197 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.71 165.82 38.94 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.15 136.06 18.82 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mt -144.7 146.1 20.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -101.09 -30.93 11.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 173.33 14.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.586 0.355 . . . . 0.0 110.343 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.1 158.23 43.95 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.98 128.27 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.64 119.09 34.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.182 0.593 . . . . 0.0 110.224 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.72 145.21 36.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.3 m -76.78 -11.79 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -84.05 140.43 31.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.3 tp -149.86 149.55 30.64 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.823 0.344 . . . . 0.0 110.391 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -82.21 152.61 26.34 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.668 0.787 . . . . 0.0 111.433 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.61 8.17 87.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.913 -0.382 . . . . 0.0 112.738 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.84 -172.12 38.88 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -126.1 131.42 52.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.781 0.432 . . . . 0.0 110.53 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 50.74 -166.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.699 1.2 . . . . 0.0 112.886 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t 62.42 155.7 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.728 1.611 . . . . 0.0 113.846 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m -146.66 66.41 10.77 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.718 0.807 . . . . 0.0 109.249 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.69 -11.89 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.677 2.918 . . . . 0.0 112.499 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.61 -16.88 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.923 -0.486 . . . . 0.0 110.684 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.3 69.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.823 -0.548 . . . . 0.0 110.048 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.17 -18.07 60.26 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.389 0.276 . . . . 0.0 110.606 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.21 -30.34 38.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.22 -33.77 70.18 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.13 -23.11 61.26 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.063 0.145 . . . . 0.0 110.767 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.67 -16.83 56.82 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -99.57 16.87 21.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.684 0.794 . . . . 0.0 110.626 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.69 26.23 15.3 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 113.65 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.88 122.02 44.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.54 159.58 39.24 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.781 2.988 . . . . 0.0 111.453 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -147.3 164.5 33.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.56 144.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 124.048 0.939 . . . . 0.0 108.688 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -90.93 155.9 18.39 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.23 133.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -155.15 168.81 25.79 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.772 0.429 . . . . 0.0 111.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.95 118.4 0.95 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.57 -154.21 25.49 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -70.86 161.82 30.31 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.684 0.394 . . . . 0.0 110.337 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.99 -1.91 48.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.756 0.422 . . . . 0.0 112.043 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -100.88 0.55 38.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.231 0.612 . . . . 0.0 111.671 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -87.9 5.54 39.98 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.001 0.52 . . . . 0.0 112.12 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.0 m -123.08 154.58 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.488 0.715 . . . . 0.0 111.835 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.5 171.49 15.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.246 1.018 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -61.2 -18.18 56.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.164 0.586 . . . . 0.0 112.567 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -72.73 -24.7 61.01 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.735 0.698 . . . . 0.0 110.989 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 46.0 m-85 -84.43 -19.18 33.86 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.05 -10.37 50.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.064 0.546 . . . . 0.0 111.176 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.07 -15.06 14.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.349 0.66 . . . . 0.0 111.288 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -108.91 156.1 39.63 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 123.629 0.772 . . . . 0.0 109.585 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.91 151.58 83.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.197 2.598 . . . . 0.0 110.683 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.91 154.37 36.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.761 0.824 . . . . 0.0 110.688 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -135.64 157.2 47.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.821 0.848 . . . . 0.0 110.342 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -81.97 158.79 23.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -67.99 -53.44 20.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.816 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.44 141.71 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.048 1.832 . . . . 0.0 109.585 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -106.49 158.57 16.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.44 0.638 . . . . 0.0 111.681 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 p -137.49 164.25 29.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.768 1.227 . . . . 0.0 107.776 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.9 ttm -65.17 -29.12 69.92 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.001 -0.437 . . . . 0.0 110.883 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.32 -29.95 25.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.076 0.15 . . . . 0.0 110.904 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.95 -28.84 55.8 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.784 -0.453 . . . . 0.0 111.986 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.51 -24.65 8.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-N 117.864 0.832 . . . . 0.0 110.238 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 -28.98 65.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -85.11 -20.96 29.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.575 0.35 . . . . 0.0 110.983 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.89 -41.6 64.48 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.825 0.284 . . . . 0.0 110.314 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -78.92 -27.24 43.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.26 -20.1 60.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.939 0.336 . . . . 0.0 110.556 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.7 24.78 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.349 0.26 . . . . 0.0 111.3 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 tt -91.55 -51.81 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.875 0.307 . . . . 0.0 111.217 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.94 4.11 3.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.09 0.956 . . . . 0.0 113.214 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.828 -1.082 . . . . 0.0 109.966 178.86 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -145.24 158.09 43.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.115 0.566 . . . . 0.0 110.16 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.25 168.98 23.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.244 0.618 . . . . 0.0 110.254 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.9 66.98 1.45 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.347 0.659 . . . . 0.0 110.224 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -74.28 -18.12 60.77 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.099 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 74.7 mt-30 -102.75 104.07 14.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.829 0.347 . . . . 0.0 110.713 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.23 130.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.573 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -89.41 129.61 35.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.354 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.406 ' N ' HD23 ' A' ' 8' ' ' LEU . 79.7 mt -94.34 129.68 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.473 0.709 . . . . 0.0 109.3 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -130.23 103.52 8.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 13' ' ' GLU . 82.0 tt0 -157.61 142.87 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -92.88 -7.48 46.07 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 15.9 tp10 -99.38 104.97 30.16 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.38 -18.32 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.122 2.548 . . . . 0.0 112.061 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.91 -40.17 48.27 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.281 0.491 . . . . 0.0 110.291 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.15 -25.92 6.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.43 -39.47 77.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -74.39 -27.4 60.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.2 ttt -65.8 -33.26 75.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 7.6 tt -77.21 -30.92 54.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.909 -0.495 . . . . 0.0 110.338 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.12 -21.83 64.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.926 0.33 . . . . 0.0 110.297 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.72 -41.61 62.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 104' ' ' PHE . 67.0 m-85 -73.65 -13.9 61.07 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.452 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.37 -27.17 52.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.309 0.504 . . . . 0.0 110.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -84.29 -24.72 29.75 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -80.49 -19.81 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.21 -6.73 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.186 0.594 . . . . 0.0 110.827 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.46 27.18 6.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.581 ' HG2' ' H ' ' A' ' 30' ' ' THR . 24.5 ttpt -91.07 -175.62 4.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.321 0.648 . . . . 0.0 110.206 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.581 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 89.6 m -109.46 119.53 47.89 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 122.301 -0.249 . . . . 0.0 110.607 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.79 164.48 20.49 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.976 3.117 . . . . 0.0 111.162 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 28.7 m -139.65 -30.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.26 173.85 33.38 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 118.159 0.436 . . . . 0.0 112.532 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.1 m -140.64 142.09 35.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 108.723 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.14 157.46 25.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.207 0.603 . . . . 0.0 110.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -98.32 -3.51 37.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.044 0.538 . . . . 0.0 112.334 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.7 p -142.71 157.58 44.51 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.328 0.651 . . . . 0.0 109.746 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.8 -22.59 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 O-C-N 122.389 -0.194 . . . . 0.0 110.8 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.03 -27.65 67.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.477 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.97 -21.27 74.46 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.66 -30.34 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.249 0.524 . . . . 0.0 110.338 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.4 mt -72.37 -34.1 67.73 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.78 -25.36 49.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -87.35 -31.61 20.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.13 -22.02 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 118.142 0.428 . . . . 0.0 111.752 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.56 -14.84 62.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.233 -0.292 . . . . 0.0 110.502 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.06 -12.43 41.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.59 . . . . 0.0 110.756 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 -167.58 48.22 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 13.89 82.66 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.253 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 mt -135.83 145.58 31.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.774 0.829 . . . . 0.0 109.108 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -106.81 -29.62 9.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 177.68 8.27 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.753 0.421 . . . . 0.0 110.69 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.17 165.34 28.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.01 -0.431 . . . . 0.0 112.06 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.6 mt -125.97 133.33 69.22 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.55 140.34 46.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.507 0.723 . . . . 0.0 109.937 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.94 158.82 16.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.07 -11.47 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -90.96 18.4 6.72 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.886 0.475 . . . . 0.0 112.106 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.89 148.4 49.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.236 0.471 . . . . 0.0 110.53 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -82.24 152.29 26.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.101 0.561 . . . . 0.0 111.958 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 155.29 6.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.51 -13.63 81.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -126.63 155.12 43.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.852 0.861 . . . . 0.0 109.482 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -66.74 145.81 55.13 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.9 p -123.32 3.11 9.16 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.982 0.513 . . . . 0.0 112.211 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 12.4 m -63.32 -35.99 20.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.655 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.1 Cg_exo -58.18 -13.78 17.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 113.753 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.83 -18.58 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 118.299 0.5 . . . . 0.0 110.332 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -25.82 66.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 109.909 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.55 -17.38 54.1 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.859 -0.525 . . . . 0.0 109.979 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.48 -24.05 46.13 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.24 -30.79 63.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 171.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -22.6 59.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.55 -20.18 54.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -91.89 7.62 41.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.95 0.9 . . . . 0.0 110.724 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t70 59.12 32.04 21.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.378 1.071 . . . . 0.0 112.78 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.5 mt -111.94 126.16 28.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.04 161.32 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.429 2.753 . . . . 0.0 111.865 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.37 170.82 19.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.084 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.6 t -138.42 150.32 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.896 0.878 . . . . 0.0 108.92 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 20.2 m-85 -94.26 163.22 13.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.71 127.92 20.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -160.55 170.24 21.32 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.721 0.408 . . . . 0.0 110.534 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.18 132.93 4.26 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.77 -160.49 28.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -72.46 149.18 44.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.997 0.399 . . . . 0.0 110.039 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -75.8 -6.64 51.67 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -110.21 3.94 20.51 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.737 0.415 . . . . 0.0 111.246 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 t -98.48 12.49 34.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.441 0.696 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.01 153.84 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.488 0.715 . . . . 0.0 109.701 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.71 159.86 32.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.243 0.544 . . . . 0.0 112.394 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.1 p -63.2 -17.25 62.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -68.02 -28.02 67.05 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.686 0.675 . . . . 0.0 110.28 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 44.1 m-85 -85.13 -20.87 29.62 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -84.17 -7.99 59.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.905 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -118.62 -9.88 10.16 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.071 0.548 . . . . 0.0 112.14 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -125.29 156.78 69.47 Favored Pre-proline 0 C--N 1.341 0.236 0 C-N-CA 123.022 0.529 . . . . 0.0 110.568 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -54.3 144.18 61.66 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.638 2.892 . . . . 0.0 112.85 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.34 153.9 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.443 0.697 . . . . 0.0 110.077 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -130.69 155.53 46.45 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.927 0.891 . . . . 0.0 109.903 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -74.04 167.32 21.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.063 0.545 . . . . 0.0 110.902 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -75.89 -47.4 3.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.442 -0.789 . . . . 0.0 112.159 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.96 164.27 25.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.618 2.212 . . . . 0.0 110.456 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 10.9 m-85 -133.94 158.57 43.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.998 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.1 p -142.11 159.12 42.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.3 mtt -65.1 -27.99 69.14 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.137 -0.352 . . . . 0.0 111.126 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.26 -25.63 29.23 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.476 0.179 . . . . 0.0 110.633 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.43 -40.19 28.7 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.8 m -74.64 -21.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.559 0.679 . . . . 0.0 111.066 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.92 -31.43 51.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.12 0.418 . . . . 0.0 110.401 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -81.93 -31.76 31.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.55 60.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.85 -41.37 64.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.64 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.447 -0.158 . . . . 0.0 111.153 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.87 -21.06 25.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 tt -91.96 -38.69 12.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.203 0.601 . . . . 0.0 112.576 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.71 -10.83 59.74 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.935 -179.53 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 119.807 -0.14 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -136.44 163.08 31.31 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.0 0.52 . . . . 0.0 110.657 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.43 -5.13 13.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.158 0.583 . . . . 0.0 112.263 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.433 ' H ' ' HB3' ' A' ' 51' ' ' ASP . 76.0 mt 49.2 40.66 18.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.868 0.867 . . . . 0.0 112.069 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.38 -10.87 16.16 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.729 0.812 . . . . 0.0 110.852 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.489 ' HB3' HG11 ' A' ' 32' ' ' VAL . 80.9 mt-30 -134.16 120.11 19.68 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.93 132.15 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.636 0.585 . . . . 0.0 110.536 -172.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -88.97 143.49 26.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.559 ' H ' HD23 ' A' ' 8' ' ' LEU . 94.3 mt -112.06 134.2 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.114 0.566 . . . . 0.0 109.845 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 t -132.38 115.7 26.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 22.7 tp10 -145.56 157.69 43.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -106.79 -0.0 23.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.495 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 39.4 tt0 -139.95 129.4 13.68 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 118.307 0.503 . . . . 0.0 110.328 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 53.7 Cg_exo -57.48 -27.43 76.26 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.573 2.849 . . . . 0.0 113.655 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.39 -44.25 71.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.8 -26.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.37 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.623 0.192 . . . . 0.0 111.086 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.5 mtt -75.82 -26.7 57.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 tpt -76.25 -23.91 54.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -71.15 -35.62 71.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.03 -21.72 56.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.452 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.09 -41.46 70.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.015 -0.428 . . . . 0.0 110.574 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.99 -23.15 62.13 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -85.07 -28.53 25.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.351 0.26 . . . . 0.0 110.677 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.78 -23.57 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.61 5.24 50.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.955 0.502 . . . . 0.0 111.531 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.66 35.9 12.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.544 0.737 . . . . 0.0 111.273 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -85.73 156.85 20.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.018 0.927 . . . . 0.0 111.123 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -91.27 120.23 68.49 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.87 162.49 29.44 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.317 2.678 . . . . 0.0 111.455 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 6' ' ' GLN . 26.8 m -138.24 -31.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.094 0 C-N-CA 122.443 0.297 . . . . 0.0 111.235 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 176.08 35.79 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -140.26 143.08 35.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.46 155.54 37.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -100.44 1.52 41.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.407 0.683 . . . . 0.0 111.779 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -136.84 154.11 50.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.207 0.603 . . . . 0.0 109.933 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.34 -22.44 11.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.392 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.93 -26.21 61.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.568 0.167 . . . . 0.0 110.608 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.99 -23.27 66.81 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -28.59 35.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.415 0.608 . . . . 0.0 110.649 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.81 -39.02 52.84 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.66 61.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -87.32 -25.07 24.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.164 0.438 . . . . 0.0 111.83 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -83.32 -26.35 7.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.519 0.6 . . . . 0.0 110.402 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.93 -16.73 59.97 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.831 0.348 . . . . 0.0 110.243 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.59 -12.42 42.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.333 0.653 . . . . 0.0 110.98 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -171.22 51.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.02 11.37 85.24 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.8 mt -140.08 144.8 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 4' ' ' LEU . 68.2 m-20 -101.9 -30.41 11.26 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.71 177.14 9.61 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.742 0.417 . . . . 0.0 110.409 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.64 161.98 40.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.66 124.99 72.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.07 124.2 50.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 111.651 -172.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.32 136.16 38.45 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 169.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.53 -13.95 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 122.402 0.281 . . . . 0.0 110.94 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 54.91 -170.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.27 1.028 . . . . 0.0 112.362 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.78 159.37 27.92 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.04 -0.413 . . . . 0.0 110.537 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -81.55 152.42 27.26 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.855 0.462 . . . . 0.0 111.917 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.5 -160.5 13.82 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.58 3.39 34.01 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.746 -0.474 . . . . 0.0 112.832 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -126.32 168.79 13.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.689 0.744 . . . . 0.0 110.965 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -112.77 158.63 19.87 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.319 0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 p -145.86 7.65 1.09 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.109 0.564 . . . . 0.0 112.003 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 67.2 p -101.48 -26.39 0.22 Allowed Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 51.1 Cg_exo -59.1 -19.56 49.64 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.451 2.101 . . . . 0.0 113.698 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.46 -26.66 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.053 -0.405 . . . . 0.0 111.091 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.92 62.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.34 -17.39 54.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -32.59 63.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.05 -28.15 65.23 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.26 -22.5 59.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.35 -13.64 59.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -100.28 6.19 44.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.792 0.837 . . . . 0.0 110.526 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 57.04 33.83 23.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.419 1.088 . . . . 0.0 112.857 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.46 121.99 41.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.372 0.669 . . . . 0.0 109.542 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.9 153.62 62.07 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.906 3.07 . . . . 0.0 113.332 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -151.8 165.15 35.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.31 159.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 C-N-CA 123.823 0.849 . . . . 0.0 109.311 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 25.4 m-85 -95.21 159.53 14.97 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.143 0.497 . . . . 0.0 111.99 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 136.36 28.47 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -155.6 158.83 39.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.62 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.49 177.81 54.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.9 116.35 7.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t -154.17 156.09 36.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.26 0.624 . . . . 0.0 110.692 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -105.4 -0.35 26.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.216 0.606 . . . . 0.0 111.464 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -134.05 -2.65 2.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 m -88.74 7.92 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.433 0.56 . . . . 0.0 111.658 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 m -134.89 154.15 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.307 0.643 . . . . 0.0 111.15 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.07 -178.44 6.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.925 1.29 . . . . 0.0 108.649 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.5 m -59.43 -16.62 24.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.488 -0.758 . . . . 0.0 112.031 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -65.86 -30.69 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 9.0 m-85 -90.4 -13.51 34.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.545 1.138 . . . . 0.0 109.836 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -88.53 -10.59 48.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.047 0.539 . . . . 0.0 110.426 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.28 -15.04 12.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.34 0.656 . . . . 0.0 111.433 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -126.03 149.82 67.48 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 123.292 0.637 . . . . 0.0 109.481 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.89 147.02 94.27 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.088 2.525 . . . . 0.0 112.561 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -150.61 150.15 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 123.636 0.774 . . . . 0.0 109.102 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.1 tp -144.39 150.38 37.64 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -75.95 165.81 24.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.444 0.298 . . . . 0.0 111.048 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -58.1 -50.42 88.21 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.931 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.29 110.14 2.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.468 1.445 . . . . 0.0 110.063 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 5.4 m-30 -82.18 153.28 26.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.625 0.37 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.8 p -139.66 159.62 41.74 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.971 0.908 . . . . 0.0 108.997 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -65.11 -26.14 68.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.117 -0.364 . . . . 0.0 110.848 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.55 -36.33 22.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.773 0.261 . . . . 0.0 111.621 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.74 -31.49 49.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.1 t -79.46 -30.4 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.305 0.552 . . . . 0.0 110.078 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.56 69.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.963 0.347 . . . . 0.0 110.728 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.18 -31.57 23.15 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.356 -0.215 . . . . 0.0 111.449 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.21 60.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.9 0.318 . . . . 0.0 110.868 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.49 -20.67 33.55 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.25 -22.5 59.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.823 0.738 . . . . 0.0 110.001 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -19.72 27.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.516 0.327 . . . . 0.0 111.471 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.4 -58.02 2.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.657 0.383 . . . . 0.0 110.958 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 4' ' ' LEU . 73.2 mt -69.19 -1.31 7.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.788 1.235 . . . . 0.0 113.351 -173.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.226 -1.369 . . . . 0.0 109.971 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 t 58.99 167.16 0.05 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.595 1.158 . . . . 0.0 112.121 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.03 -174.36 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 112.466 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 117' ' ' LEU . 77.1 mt -137.17 29.19 2.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.525 1.13 . . . . 0.0 110.458 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -4.98 45.15 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.456 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.0 mt-30 -125.51 119.1 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mm -122.09 137.22 56.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.978 0.911 . . . . 0.0 111.173 -173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -94.71 135.27 36.38 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' H ' HD23 ' A' ' 8' ' ' LEU . 76.4 mt -102.59 126.14 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.288 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.6 t -132.27 117.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.69 161.89 36.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.305 0.642 . . . . 0.0 110.455 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -97.11 0.39 48.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.06 0.544 . . . . 0.0 111.638 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' A' ' 15' ' ' LEU . 42.3 tt0 -147.24 132.96 9.34 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.878 -0.514 . . . . 0.0 110.304 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.6 -23.32 70.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.441 2.761 . . . . 0.0 113.615 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 9.3 tt -72.38 -40.45 67.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.99 -29.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.07 69.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.8 ttp -75.81 -27.83 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.7 ttp -73.46 -29.87 62.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.02 -36.7 75.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -73.14 -21.98 60.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.531 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.81 -42.84 63.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.134 -0.354 . . . . 0.0 111.152 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -75.23 -21.21 58.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.365 0.529 . . . . 0.0 111.376 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -82.79 -18.51 40.34 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.184 0.447 . . . . 0.0 111.344 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -85.07 -22.86 28.79 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.57 0.623 . . . . 0.0 110.388 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 -21.2 10.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -93.17 -0.09 57.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.296 0.638 . . . . 0.0 111.149 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t0 52.37 40.96 30.36 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.369 0.605 . . . . 0.0 110.885 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -85.5 165.18 17.34 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.943 0.897 . . . . 0.0 110.784 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.1 m -115.16 74.64 3.89 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.01 0.524 . . . . 0.0 110.151 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.33 156.95 57.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.894 2.396 . . . . 0.0 109.789 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 32.7 m -116.71 -7.75 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.7 171.53 31.05 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.287 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -137.96 139.88 39.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.78 158.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -120.29 -2.65 10.07 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.535 0.734 . . . . 0.0 111.58 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.0 p -138.83 161.04 38.23 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.404 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.55 -26.54 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.045 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.2 -28.33 48.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.68 -27.88 60.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.79 -42.43 73.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.344 0.572 . . . . 0.0 110.175 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.89 -24.58 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.83 61.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.744 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -84.11 -20.87 31.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.978 0.354 . . . . 0.0 111.366 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.84 -31.36 40.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.51 -14.82 54.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.642 0.377 . . . . 0.0 111.791 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -87.75 -13.32 42.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.891 0.477 . . . . 0.0 111.963 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.44 172.58 36.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.4 151.62 43.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -141.87 150.03 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -108.47 -26.81 10.27 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-N 118.045 0.384 . . . . 0.0 111.496 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 171.08 18.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.088 0.555 . . . . 0.0 110.169 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.8 160.4 43.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.145 -0.347 . . . . 0.0 111.097 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.99 127.37 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.88 130.92 56.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.963 0.505 . . . . 0.0 111.188 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -81.53 139.43 35.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.76 -16.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.669 0.271 . . . . 0.0 110.667 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.99 144.02 37.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.0 tp -154.51 159.55 41.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -67.17 151.95 46.63 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 122.641 0.377 . . . . 0.0 110.307 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -167.15 51.52 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.63 68.61 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.869 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 65' ' ' SER . 9.7 tp10 -73.52 152.62 40.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.08 0.94 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -133.14 15.12 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.073 0.549 . . . . 0.0 111.945 -175.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.443 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 91.9 p -151.06 177.18 10.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.93 0.492 . . . . 0.0 110.571 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -137.46 138.21 24.15 Favored Pre-proline 0 C--O 1.231 0.11 0 C-N-CA 122.625 0.37 . . . . 0.0 110.359 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.93 -9.15 14.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.592 2.861 . . . . 0.0 111.532 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.28 -29.04 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 O-C-N 122.162 -0.336 . . . . 0.0 110.93 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.48 90.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.293 -0.255 . . . . 0.0 110.622 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.21 -17.54 39.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.374 -0.204 . . . . 0.0 111.35 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.5 70.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.41 -28.08 61.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.6 -22.79 62.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.867 0.303 . . . . 0.0 110.204 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.92 41.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.5 0.32 . . . . 0.0 110.351 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.08 7.95 42.05 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 111.155 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.56 28.81 17.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 112.843 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.4 mt -101.33 128.26 29.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.511 0.724 . . . . 0.0 109.474 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.42 156.1 50.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 111.608 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -147.84 167.14 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.6 t -139.22 145.58 27.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.037 0 C-N-CA 124.108 0.963 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.02 150.91 19.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.522 0.329 . . . . 0.0 110.551 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 119.74 11.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -171.78 163.28 6.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.199 0.6 . . . . 0.0 110.647 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.04 147.34 19.6 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.7 -154.35 25.44 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 117.532 0.666 . . . . 0.0 111.812 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 t -137.81 169.47 17.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.845 0.858 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.44 -11.94 60.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.784 0.434 . . . . 0.0 111.484 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.02 -4.3 27.72 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.398 0.679 . . . . 0.0 111.3 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 m -93.03 2.27 56.87 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.158 0.583 . . . . 0.0 111.337 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.59 154.72 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 123.946 0.898 . . . . 0.0 110.702 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.38 -177.52 5.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.346 0.593 . . . . 0.0 111.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.5 p -61.99 -16.5 51.86 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -73.79 -31.8 63.45 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.332 0.969 . . . . 0.0 110.396 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -82.13 -22.71 36.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -88.44 -5.47 58.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.399 0.279 . . . . 0.0 111.132 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -105.08 -16.81 14.69 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.465 0.706 . . . . 0.0 111.128 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -109.45 158.86 33.43 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.537 0.735 . . . . 0.0 110.09 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.47 152.63 76.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.827 2.352 . . . . 0.0 111.303 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.9 154.49 21.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.159 0.584 . . . . 0.0 110.981 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -145.85 156.53 43.62 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.528 0.731 . . . . 0.0 109.128 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.61 164.48 24.82 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -65.17 -50.19 61.87 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.655 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.26 146.28 35.72 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.238 1.959 . . . . 0.0 109.469 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -105.44 153.72 21.31 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 121.006 0.432 . . . . 0.0 111.139 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.2 p -143.21 160.23 40.84 Favored 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 124.405 1.082 . . . . 0.0 108.739 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.6 mtt -66.55 -23.65 66.25 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.085 -0.384 . . . . 0.0 111.099 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.3 -37.76 21.26 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 122.174 -0.329 . . . . 0.0 111.279 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.97 -34.73 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.92 -29.64 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 117.501 0.651 . . . . 0.0 110.499 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.52 -29.49 63.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.191 -0.318 . . . . 0.0 110.755 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.31 -31.79 22.85 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.088 0.155 . . . . 0.0 111.279 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.13 -34.54 61.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.82 0.282 . . . . 0.0 110.552 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.08 -21.18 33.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.462 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.32 -19.89 59.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.205 0.457 . . . . 0.0 110.219 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.88 23.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.495 0.318 . . . . 0.0 111.464 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 tt -91.6 -59.39 2.14 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.645 0.378 . . . . 0.0 111.473 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 4' ' ' LEU . 48.9 mt -70.06 3.72 2.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.271 1.428 . . . . 0.0 113.55 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.783 -1.103 . . . . 0.0 109.94 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -144.77 163.61 33.51 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.149 0.58 . . . . 0.0 110.459 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.38 169.15 18.63 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.228 0.611 . . . . 0.0 111.174 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.38 79.6 1.89 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.544 0.738 . . . . 0.0 109.753 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.82 -6.42 54.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.332 0.653 . . . . 0.0 112.206 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.587 ' HB3' HG11 ' A' ' 32' ' ' VAL . 78.6 mt-30 -128.71 119.05 23.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.5 mm -120.9 131.41 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.609 0.764 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -88.52 140.94 28.95 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 8' ' ' LEU . 89.4 mt -109.99 135.14 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 110.117 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 t -129.07 121.56 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 16.9 tp10 -149.2 159.16 44.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.764 0.426 . . . . 0.0 110.656 -171.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.57 -12.74 12.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.438 0.695 . . . . 0.0 111.526 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 18.1 tp10 -120.16 110.38 36.26 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 123.438 0.695 . . . . 0.0 109.27 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.86 -23.7 35.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.636 2.891 . . . . 0.0 113.955 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.1 tp -73.43 -32.54 64.45 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.3 0.5 . . . . 0.0 110.202 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.77 -28.52 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.63 64.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.594 0.179 . . . . 0.0 110.557 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.0 -33.66 57.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.2 tpt -75.05 -23.95 58.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -38.01 75.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.13 -22.74 57.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.608 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.86 -43.66 68.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.202 -0.311 . . . . 0.0 110.557 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -76.46 -25.5 54.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.936 -0.477 . . . . 0.0 111.416 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 tp -73.0 -32.11 64.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.292 0.497 . . . . 0.0 111.024 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -85.57 -24.07 27.36 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.5 t -76.64 -20.6 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.337 0.517 . . . . 0.0 110.504 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.89 18.38 18.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.709 0.403 . . . . 0.0 111.685 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 54.18 27.66 8.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.9 0.88 . . . . 0.0 113.043 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.9 157.12 20.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.224 0.61 . . . . 0.0 109.518 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.3 m -99.43 120.93 56.62 Favored Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 122.014 -0.429 . . . . 0.0 110.231 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -79.24 162.89 25.4 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.65 2.9 . . . . 0.0 110.696 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -138.7 -27.11 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.69 173.58 33.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -140.73 143.33 34.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.56 154.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 122.584 0.354 . . . . 0.0 110.927 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.19 8.72 28.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.277 0.631 . . . . 0.0 111.634 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -150.63 158.77 44.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 122.826 0.45 . . . . 0.0 110.167 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.1 -22.84 21.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 122.941 0.496 . . . . 0.0 111.101 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.96 62.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 122.271 -0.268 . . . . 0.0 110.716 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.2 -21.58 70.09 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.49 -31.73 42.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.278 0.539 . . . . 0.0 110.498 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.12 -23.76 35.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.759 0.254 . . . . 0.0 110.97 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.18 -30.14 34.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.3 -0.25 . . . . 0.0 111.504 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -87.72 -29.1 21.33 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.18 -28.82 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 118.201 0.455 . . . . 0.0 111.313 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.16 -14.87 59.72 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.794 -0.566 . . . . 0.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.75 -12.54 41.89 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.34 0.656 . . . . 0.0 110.587 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 -173.05 54.28 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.55 74.06 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.203 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -139.17 147.16 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 108.777 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.09 -21.2 10.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.22 -0.419 . . . . 0.0 112.049 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 173.12 14.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.314 0.506 . . . . 0.0 110.532 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.51 164.25 34.0 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.84 133.32 69.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.42 129.11 56.63 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.353 . . . . 0.0 110.996 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -81.44 130.16 34.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.85 -11.28 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.629 0.252 . . . . 0.0 110.542 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -87.07 21.7 2.26 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.704 0.802 . . . . 0.0 110.465 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.05 150.25 21.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.802 0.841 . . . . 0.0 111.088 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -65.25 152.25 44.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.067 0.547 . . . . 0.0 111.422 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.95 12.24 82.88 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 -176.37 46.54 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 117.572 0.686 . . . . 0.0 111.605 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.38 116.77 10.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.417 -0.461 . . . . 0.0 110.167 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -151.91 11.06 0.56 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.191 0.596 . . . . 0.0 111.12 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.2 p -105.35 3.66 30.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.416 0.686 . . . . 0.0 112.262 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 66.3 p -93.9 -31.79 0.3 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.14 -0.933 . . . . 0.0 112.253 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 39.6 Cg_exo -64.96 -24.91 59.9 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.767 1.645 . . . . 0.0 111.889 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.96 -23.88 7.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 C-N-CA 122.333 0.253 . . . . 0.0 110.675 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.17 70.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.49 -17.72 61.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.223 -0.298 . . . . 0.0 110.487 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.78 -29.78 51.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.91 -31.41 69.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.86 61.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.91 -13.87 58.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.588 0.355 . . . . 0.0 110.477 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -102.71 12.27 36.53 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.82 0.848 . . . . 0.0 111.013 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 58.03 33.27 23.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.066 0.947 . . . . 0.0 113.423 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.2 mt -114.37 129.4 24.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 109.457 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.93 159.28 30.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 112.418 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -153.78 168.99 24.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.301 0.641 . . . . 0.0 110.742 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.04 159.76 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 124.006 0.922 . . . . 0.0 108.968 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -99.38 156.21 17.13 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.939 0.4 . . . . 0.0 111.779 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.37 119.53 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -172.61 156.62 3.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.721 0.408 . . . . 0.0 110.604 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.59 143.43 18.47 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.65 -158.09 29.88 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 117.358 0.579 . . . . 0.0 111.916 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.4 t -137.47 170.86 15.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.887 0.875 . . . . 0.0 110.063 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.04 -13.8 62.48 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.101 -0.374 . . . . 0.0 111.302 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.93 3.55 54.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.16 0.584 . . . . 0.0 111.332 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 98.4 p -126.12 20.2 7.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.827 0.451 . . . . 0.0 111.903 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 16.1 m -132.26 154.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.422 0.689 . . . . 0.0 111.779 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -81.93 170.84 15.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.26 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.5 p -61.09 -21.72 63.95 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.95 -21.42 59.19 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.673 0.669 . . . . 0.0 110.862 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.465 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 3.2 m-85 -80.97 -23.44 38.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -88.21 -8.15 55.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.448 0.699 . . . . 0.0 111.261 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -119.6 -3.96 10.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.199 0.599 . . . . 0.0 112.087 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -140.55 140.8 23.35 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 149.96 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.622 2.881 . . . . 0.0 114.345 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 m -142.75 154.62 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.535 1.134 . . . . 0.0 109.596 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -146.87 155.28 42.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.657 0.383 . . . . 0.0 110.097 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.26 158.12 35.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 44.8 mtpt -66.08 -43.82 57.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.907 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 67.6 Cg_endo -69.39 128.61 16.63 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.676 1.277 . . . . 0.0 108.881 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -100.03 154.08 18.69 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.766 0.426 . . . . 0.0 111.367 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.5 p -141.38 162.39 35.61 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.426 1.09 . . . . 0.0 108.711 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.08 -26.88 68.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.298 -0.251 . . . . 0.0 111.031 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -84.47 -38.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.932 0.333 . . . . 0.0 111.579 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.99 -31.76 59.5 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.18 -27.64 12.02 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.026 0 CA-C-N 117.24 0.52 . . . . 0.0 110.229 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.17 68.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.003 -0.436 . . . . 0.0 110.669 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.24 -33.77 25.99 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 122.321 -0.237 . . . . 0.0 110.939 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.86 66.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.34 -20.33 40.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.63 62.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.777 0.717 . . . . 0.0 109.886 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.41 -23.71 24.44 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.2 mt -91.56 -14.44 30.31 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -107.06 18.04 22.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.376 0.535 . . . . 0.0 111.137 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.442 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -137.39 -0.86 2.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.095 0.558 . . . . 0.0 112.104 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.3 14.36 0.76 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.198 0.999 . . . . 0.0 113.018 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.2 56.17 2.62 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -70.42 -7.07 40.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.161 -0.337 . . . . 0.0 111.214 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.674 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.8 mp0 -106.27 114.31 28.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 122.807 0.443 . . . . 0.0 111.457 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 mm -123.88 127.35 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 123.636 0.585 . . . . 0.0 110.225 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -92.85 136.16 33.49 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.434 ' N ' HD23 ' A' ' 8' ' ' LEU . 96.8 mt -103.24 132.78 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.182 0.593 . . . . 0.0 109.937 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.7 t -131.97 118.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 34.8 tp10 -151.24 140.2 21.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.803 0.441 . . . . 0.0 109.945 -176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.66 4.67 48.76 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.561 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 59.0 mt-10 -135.68 138.67 28.8 Favored Pre-proline 0 CA--C 1.529 0.153 0 O-C-N 121.899 -0.5 . . . . 0.0 109.984 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.75 -22.0 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.341 2.694 . . . . 0.0 112.525 -174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -79.42 -36.47 38.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.239 0.472 . . . . 0.0 110.236 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.47 -27.75 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.49 -35.05 78.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.2 ttp -73.63 -30.17 62.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.4 ttp -74.82 -31.43 61.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.382 -0.199 . . . . 0.0 110.485 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.07 -29.97 67.1 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.168 -0.333 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.2 -21.79 56.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.55 -43.79 54.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.089 0.404 . . . . 0.0 110.411 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -74.52 -16.93 60.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.065 0.393 . . . . 0.0 111.167 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -69.05 -30.72 69.12 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -83.2 -23.73 32.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.387 0.275 . . . . 0.0 111.112 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.58 -24.61 23.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.2 tp -93.31 -1.64 55.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.919 0.487 . . . . 0.0 110.544 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.28 35.04 15.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.332 0.653 . . . . 0.0 110.716 -175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -85.6 155.57 21.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.217 1.007 . . . . 0.0 109.876 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -90.38 121.56 68.35 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.58 155.26 35.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.473 2.782 . . . . 0.0 110.573 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 6' ' ' GLN . 34.5 m -138.16 -18.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.584 0.354 . . . . 0.0 111.813 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.64 167.52 25.33 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -143.61 138.95 29.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.9 161.31 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.928 0.491 . . . . 0.0 110.501 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -113.34 5.25 16.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.196 0.598 . . . . 0.0 112.486 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 39' ' ' ALA . 29.6 m -137.12 143.79 42.7 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.01 -23.34 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 37' ' ' THR . . . -77.15 -25.68 52.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.42 63.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.42 -34.33 54.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.4 0.6 . . . . 0.0 110.135 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.69 -42.36 67.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.53 -24.8 64.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.437 0.295 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -81.53 -26.51 35.03 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 122.299 -0.25 . . . . 0.0 111.336 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.25 -25.38 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 118.272 0.487 . . . . 0.0 110.267 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -75.12 -14.74 60.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.077 -0.389 . . . . 0.0 110.898 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.32 -12.36 59.93 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 110.484 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.4 -176.12 54.81 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.519 0.58 . . . . 0.0 111.863 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.64 12.73 83.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.164 -0.374 . . . . 0.0 112.164 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.36 145.86 35.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.895 0.848 . . . . 0.0 109.696 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.22 -15.4 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.049 0.539 . . . . 0.0 112.007 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 172.39 12.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.751 0.82 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.09 31.59 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.127 -0.358 . . . . 0.0 111.558 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.03 131.27 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.61 133.84 55.64 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.105 0.478 . . . . 0.0 111.781 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -86.5 137.12 32.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.08 -11.88 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -84.17 136.73 33.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 tp -157.66 136.06 11.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.02 152.66 26.56 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 122.675 0.39 . . . . 0.0 110.647 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.99 -161.16 13.57 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.65 -6.38 76.92 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.702 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -83.87 153.58 23.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.944 0.872 . . . . 0.0 110.777 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -148.72 1.13 0.58 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.557 0.343 . . . . 0.0 111.782 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -139.28 167.75 21.36 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.749 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.7 m -134.29 72.47 70.93 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 122.982 0.513 . . . . 0.0 109.74 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.69 -7.15 20.32 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.652 2.901 . . . . 0.0 111.589 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.57 -22.77 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 O-C-N 122.142 -0.348 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.72 -28.73 69.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.26 -0.275 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.57 -20.93 61.23 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.338 -0.227 . . . . 0.0 110.614 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -29.82 41.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.24 -32.9 61.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.55 61.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.21 -12.13 55.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 110.395 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -94.31 17.61 12.52 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.871 0.868 . . . . 0.0 110.972 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t0 59.74 31.26 20.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.661 1.184 . . . . 0.0 114.024 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 pt -128.28 143.79 49.39 Favored Pre-proline 0 CA--C 1.532 0.251 0 O-C-N 122.094 -0.379 . . . . 0.0 110.228 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.77 161.61 24.38 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.785 2.99 . . . . 0.0 111.793 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -145.63 165.4 28.8 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.227 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.7 t -137.62 146.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 124.339 1.056 . . . . 0.0 108.542 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.65 155.58 18.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.935 0.397 . . . . 0.0 111.226 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 119.22 11.37 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -174.02 161.09 3.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 109.859 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.02 145.69 25.98 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.48 -159.33 30.78 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 117.455 0.628 . . . . 0.0 112.03 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.9 t -141.05 159.79 41.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.779 0.831 . . . . 0.0 109.972 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -71.8 -5.96 38.08 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.42 4.39 50.62 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.8 m -129.56 22.2 5.52 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.328 0.651 . . . . 0.0 111.696 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 15.3 m -131.25 154.66 40.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 122.973 0.509 . . . . 0.0 112.072 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.2 168.0 20.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.312 1.045 . . . . 0.0 111.307 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.8 p -62.23 -17.45 58.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -73.61 -25.88 60.52 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.218 0.463 . . . . 0.0 110.167 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.495 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 15.7 m-85 -80.38 -24.39 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.45 -9.33 52.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.997 0.519 . . . . 0.0 111.63 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.02 -18.01 12.72 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -135.16 157.84 75.99 Favored Pre-proline 0 C--O 1.232 0.166 0 C-N-CA 122.847 0.459 . . . . 0.0 110.055 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.33 154.08 25.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.384 3.39 . . . . 0.0 114.082 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.22 154.23 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.381 1.072 . . . . 0.0 109.293 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.7 mt -143.4 156.95 44.8 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.203 0.601 . . . . 0.0 110.754 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -87.05 170.5 11.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.05 -38.84 52.52 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.59 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.78 125.23 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.076 1.85 . . . . 0.0 110.738 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -111.1 152.11 27.32 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.219 0.608 . . . . 0.0 110.187 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.2 p -141.3 159.41 42.27 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.737 0.815 . . . . 0.0 109.147 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -67.55 -26.91 66.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.17 -0.331 . . . . 0.0 111.077 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.66 -35.77 22.38 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.019 0.372 . . . . 0.0 111.676 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.18 -31.21 43.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.66 -28.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.648 0.724 . . . . 0.0 110.578 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.61 66.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.059 -0.401 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.55 -27.94 26.98 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 117.647 0.203 . . . . 0.0 110.966 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.03 -36.5 48.54 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.202 -0.311 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.42 -23.46 40.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.27 -0.269 . . . . 0.0 110.481 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.2 -24.17 60.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.15 -13.86 42.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.089 0.556 . . . . 0.0 111.327 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.33 -33.79 42.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.04 7.3 11.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.37 -179.534 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.702 -0.11 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 m 53.73 23.3 3.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.012 0.925 . . . . 0.0 113.287 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.0 38.58 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.296 0.638 . . . . 0.0 110.359 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 4' ' ' LEU . 1.1 pt? -145.9 74.1 1.36 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.229 0.612 . . . . 0.0 110.382 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -77.29 -5.68 50.36 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.642 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 67.3 mt-30 -122.39 118.06 27.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -123.42 134.15 67.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.851 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -88.84 138.07 31.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.57 ' H ' HD23 ' A' ' 8' ' ' LEU . 77.2 mt -111.65 126.09 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.806 0.842 . . . . 0.0 109.558 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 35' ' ' VAL . 19.8 t -132.18 122.33 48.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 122.775 0.43 . . . . 0.0 110.23 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -141.65 155.32 45.71 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.919 0.488 . . . . 0.0 110.733 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.83 -6.97 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.663 0.385 . . . . 0.0 110.926 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.17 125.93 17.24 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.987 0.515 . . . . 0.0 109.676 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.17 -25.01 76.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.966 2.444 . . . . 0.0 112.804 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.97 -33.14 74.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.099 -0.376 . . . . 0.0 110.525 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.85 -26.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.98 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.807 0.276 . . . . 0.0 110.827 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.64 -31.74 62.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.3 tpt -75.01 -23.73 58.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -39.63 81.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.64 -22.39 60.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.68 -40.14 66.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.904 0.32 . . . . 0.0 111.052 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -74.69 -27.55 60.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.776 -0.577 . . . . 0.0 110.595 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.07 -17.66 58.58 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.917 -0.489 . . . . 0.0 110.606 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -78.58 -28.29 45.85 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.33 -20.74 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.374 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.27 12.22 36.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.296 0.638 . . . . 0.0 111.995 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.89 33.91 15.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.556 0.742 . . . . 0.0 112.291 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.85 163.68 17.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.877 0.871 . . . . 0.0 110.09 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -117.8 74.75 9.7 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 122.698 0.399 . . . . 0.0 110.46 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.94 154.57 65.88 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.941 2.427 . . . . 0.0 109.682 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 33.8 m -115.87 -12.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.337 0.055 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 175.34 35.11 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.248 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -132.49 143.49 49.79 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.737 0.815 . . . . 0.0 108.941 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.411 ' CG2' HG22 ' A' ' 10' ' ' VAL . 34.3 m -146.07 163.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.008 0.523 . . . . 0.0 110.206 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.65 6.92 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.001 0.521 . . . . 0.0 112.065 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -146.12 156.55 43.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.056 0.542 . . . . 0.0 110.183 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.97 -28.31 40.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.98 62.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 -30.77 56.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.36 -38.34 87.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.809 0.805 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.73 -19.32 57.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 -24.97 49.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.088 0.404 . . . . 0.0 111.013 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -77.75 -32.87 52.94 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.05 -26.09 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.464 0.306 . . . . 0.0 110.247 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.39 -15.11 53.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 111.043 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.98 -12.88 20.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.661 0.384 . . . . 0.0 111.582 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.97 172.31 38.47 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.15 154.61 48.14 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.0 mt -141.93 146.04 23.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -103.28 -24.34 13.53 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 174.31 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.695 0.398 . . . . 0.0 110.396 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.11 162.34 40.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.077 -0.39 . . . . 0.0 111.754 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.02 127.97 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.035 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.23 124.63 50.72 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.745 0.418 . . . . 0.0 111.192 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -85.97 124.47 32.46 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.43 -5.31 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.708 0.803 . . . . 0.0 111.95 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -75.22 52.17 0.57 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 0.0 112.636 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.09 158.71 32.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.833 -0.542 . . . . 0.0 109.92 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -80.99 152.72 27.83 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 111.087 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.73 6.5 89.0 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.504 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.91 8.16 87.36 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 117.837 0.819 . . . . 0.0 111.992 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.79 167.31 20.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.656 0.728 . . . . 0.0 110.527 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -122.79 166.0 15.68 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 123.019 0.528 . . . . 0.0 110.997 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.4 p -133.89 8.27 3.8 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.992 0.917 . . . . 0.0 110.434 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.6 m -54.56 -35.65 34.45 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 71.6 Cg_exo -55.41 -19.65 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.685 2.257 . . . . 0.0 114.578 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.95 -26.24 9.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-N 118.858 0.754 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.9 60.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.41 -17.68 53.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.264 0.225 . . . . 0.0 110.533 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.53 -32.66 58.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.8 -26.32 60.56 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.45 61.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.919 0.327 . . . . 0.0 110.357 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.8 -18.83 53.47 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.09 7.7 44.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.554 0.742 . . . . 0.0 111.025 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 58.66 29.53 18.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.408 1.083 . . . . 0.0 113.106 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.8 127.81 29.28 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.5 158.52 44.01 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.759 2.973 . . . . 0.0 111.588 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -150.73 168.29 24.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.873 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.18 146.78 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.113 0.965 . . . . 0.0 108.891 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 21.2 m-85 -89.62 157.79 17.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.101 0.477 . . . . 0.0 111.266 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 144.62 37.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -161.95 174.16 13.46 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.29 117.34 0.76 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.82 -159.27 28.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m -71.09 160.0 33.69 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.887 0.475 . . . . 0.0 110.29 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.82 -11.44 60.38 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.79 -1.82 44.56 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.133 0.424 . . . . 0.0 111.469 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.4 t -78.92 -7.18 57.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.723 0.409 . . . . 0.0 110.92 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 m -135.59 154.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.393 0.677 . . . . 0.0 110.506 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.27 -178.64 3.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.802 0.841 . . . . 0.0 111.351 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.3 p -60.36 -19.68 56.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -70.05 -27.01 64.29 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.194 0.452 . . . . 0.0 110.157 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.405 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 16.0 m-85 -89.17 -18.16 27.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.761 0.824 . . . . 0.0 109.903 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -88.06 -8.81 54.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.511 0.324 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.63 -19.64 13.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.57 0.748 . . . . 0.0 110.842 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -103.61 160.99 24.37 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.997 0.919 . . . . 0.0 110.034 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.02 150.74 82.69 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.859 2.373 . . . . 0.0 110.829 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.48 154.23 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.903 0.881 . . . . 0.0 110.557 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.1 mt -134.56 153.86 51.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.726 0.81 . . . . 0.0 109.886 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -85.37 163.08 18.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.32 -48.04 13.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.348 -0.834 . . . . 0.0 113.221 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.16 138.95 18.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.874 1.716 . . . . 0.0 111.152 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -111.52 157.64 20.1 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.967 0.507 . . . . 0.0 110.506 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.3 p -140.92 165.6 27.07 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.711 1.204 . . . . 0.0 108.039 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.93 -36.68 79.97 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.871 -0.518 . . . . 0.0 111.192 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -84.59 -29.0 26.17 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.281 -0.262 . . . . 0.0 111.306 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.92 -28.16 51.16 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.334 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.01 -25.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 117.898 0.849 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.33 70.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.62 -20.86 30.7 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.478 0.311 . . . . 0.0 110.972 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.9 -40.08 55.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.844 0.293 . . . . 0.0 110.598 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.21 -25.66 42.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.69 62.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.218 0.463 . . . . 0.0 110.378 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.57 -16.58 34.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.044 0.537 . . . . 0.0 111.894 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.27 -33.72 15.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.516 0.326 . . . . 0.0 110.906 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.01 -3.04 58.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.762 0.425 . . . . 0.0 111.987 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.743 -1.122 . . . . 0.0 110.117 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.4 p -149.36 160.22 43.61 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.948 0.499 . . . . 0.0 109.917 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.56 22.15 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.697 0.799 . . . . 0.0 112.668 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 42.29 58.13 3.11 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 125.865 1.666 . . . . 0.0 111.817 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.21 -8.7 57.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.534 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.462 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.6 mp0 -112.22 110.11 20.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.149 0.579 . . . . 0.0 111.905 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.88 139.47 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.401 0.68 . . . . 0.0 110.315 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.85 133.43 47.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.9 mt -98.69 126.47 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.34 109.21 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -143.03 160.18 40.86 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -89.44 -4.54 57.94 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.966 0.506 . . . . 0.0 111.538 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -140.31 140.07 22.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 O-C-N 122.039 -0.413 . . . . 0.0 110.976 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.07 -14.45 10.89 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.767 2.978 . . . . 0.0 112.799 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.33 -45.11 66.85 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.517 0.599 . . . . 0.0 110.703 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.06 -25.4 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.3 66.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.283 -0.261 . . . . 0.0 110.581 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mmt -82.33 -26.25 33.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.5 mmm -75.23 -29.22 60.18 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 122.137 -0.352 . . . . 0.0 110.625 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.403 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 3.1 mm? -76.47 -30.05 57.15 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.69 -22.21 56.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.882 0.31 . . . . 0.0 110.224 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.39 -45.13 20.1 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.22 -0.3 . . . . 0.0 111.29 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -78.88 -24.04 44.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.558 0.617 . . . . 0.0 112.435 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.34 -22.19 48.42 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.376 0.989 . . . . 0.0 111.066 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -85.23 -23.43 28.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.438 0.563 . . . . 0.0 111.167 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.07 -18.53 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.616 0.366 . . . . 0.0 110.884 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.07 20.22 19.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.867 0.467 . . . . 0.0 111.753 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 53.94 30.29 11.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.931 0.892 . . . . 0.0 113.114 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.5 tmtm? -85.76 164.29 17.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.464 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 23.8 m -123.18 71.8 45.32 Favored Pre-proline 0 CA--C 1.53 0.199 0 O-C-N 122.239 -0.288 . . . . 0.0 111.0 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.19 151.61 81.06 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.725 2.284 . . . . 0.0 109.408 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 6' ' ' GLN . 33.1 m -112.57 -6.8 11.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.48 174.98 34.84 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -140.75 139.4 34.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.077 0.951 . . . . 0.0 108.684 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 156.02 29.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 122.877 0.471 . . . . 0.0 110.214 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -108.53 2.23 22.04 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 112.048 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.5 p -139.11 158.46 44.14 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 110.311 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.26 -22.93 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.654 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.32 -25.97 58.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.14 71.05 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.31 -30.89 48.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.39 0.595 . . . . 0.0 110.261 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.68 -32.46 53.09 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.51 56.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.172 -0.33 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -87.73 -25.91 23.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.1 -22.01 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.219 0.463 . . . . 0.0 111.293 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.99 -14.74 63.21 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.897 0.317 . . . . 0.0 110.802 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.28 -12.42 37.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.275 0.63 . . . . 0.0 110.81 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 -169.31 53.51 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 12.03 82.06 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.832 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.62 145.88 22.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.76 0.78 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.98 -22.24 5.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.625 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.3 171.07 15.34 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.571 0.748 . . . . 0.0 109.731 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.4 164.87 35.76 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.083 -0.386 . . . . 0.0 110.967 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.9 mt -122.64 133.16 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.25 142.71 45.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.296 0.638 . . . . 0.0 110.691 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -97.51 135.17 39.74 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.566 0.746 . . . . 0.0 109.169 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.35 -16.08 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -77.65 -2.86 38.05 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.541 0.336 . . . . 0.0 110.718 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.4 tp -108.39 98.72 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -82.34 144.04 30.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.07 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.31 -174.86 48.16 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.57 -24.05 68.69 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 122.119 -0.636 . . . . 0.0 111.552 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -126.66 166.54 17.16 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.869 0.868 . . . . 0.0 110.043 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp 43.98 -115.19 0.4 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.593 0.757 . . . . 0.0 110.947 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -139.62 -46.05 0.45 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.328 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.1 p -143.01 47.15 0.78 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 122.937 0.495 . . . . 0.0 111.831 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.8 -13.19 29.35 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.999 2.466 . . . . 0.0 112.245 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.06 -24.04 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.113 0.415 . . . . 0.0 110.326 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.07 65.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.08 -17.62 45.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.452 0.301 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.58 62.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.35 -28.97 64.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.99 -22.83 60.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.57 -19.58 55.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -92.33 10.6 29.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.347 0.659 . . . . 0.0 110.858 172.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t70 59.42 25.18 13.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 113.006 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.48 125.06 46.51 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 157.58 34.42 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.605 2.87 . . . . 0.0 111.113 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -149.39 167.52 25.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.214 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -138.45 141.94 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -82.93 148.46 27.64 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.53 129.68 33.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 169.73 22.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.601 0.36 . . . . 0.0 110.665 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.99 175.87 54.84 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.43 102.37 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -150.39 147.25 27.34 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.701 0.8 . . . . 0.0 109.929 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -105.63 -2.83 22.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 112.29 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.68 0.28 4.38 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.1 m -89.86 5.83 44.5 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.927 -0.483 . . . . 0.0 111.421 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.15 154.46 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.748 0.819 . . . . 0.0 111.118 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -102.86 175.54 5.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.709 0.804 . . . . 0.0 110.563 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -64.98 -11.35 37.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -75.77 -24.21 56.02 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.31 0.505 . . . . 0.0 109.938 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -86.8 -20.12 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -84.02 -12.93 54.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.74 0.416 . . . . 0.0 110.767 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -104.5 -16.69 14.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.355 0.662 . . . . 0.0 111.601 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -109.29 163.14 17.71 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.405 0.682 . . . . 0.0 110.402 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.87 148.2 68.57 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.572 2.848 . . . . 0.0 112.58 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.26 154.75 23.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.762 0.825 . . . . 0.0 110.328 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -145.89 154.26 41.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.744 0.818 . . . . 0.0 109.54 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -80.22 146.29 31.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 34.5 ttmt -72.33 -43.34 9.62 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.019 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 74.3 Cg_endo -69.59 142.26 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.197 1.463 . . . . 0.0 109.74 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.4 m-85 -117.3 150.01 39.52 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 121.376 0.607 . . . . 0.0 111.971 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.6 p -143.7 166.47 24.77 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.028 1.331 . . . . 0.0 107.519 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 55.2 ttm -65.76 -28.19 68.84 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.737 -0.602 . . . . 0.0 110.977 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.32 -31.28 24.93 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.263 -0.273 . . . . 0.0 110.637 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.37 -24.67 67.63 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.648 -0.529 . . . . 0.0 112.129 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.3 p -86.23 -27.51 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 118.155 0.978 . . . . 0.0 110.969 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.09 69.86 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.08 -20.94 29.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.355 0.662 . . . . 0.0 110.584 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.25 61.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.59 -26.41 45.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.02 63.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.923 0.329 . . . . 0.0 110.127 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.82 -17.47 31.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.764 0.425 . . . . 0.0 111.743 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.4 -36.16 13.96 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.599 0.36 . . . . 0.0 111.66 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.72 3.99 54.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.728 0.411 . . . . 0.0 112.055 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.377 -1.297 . . . . 0.0 110.244 179.29 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.307 0.098 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t -150.63 165.0 34.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.784 0.434 . . . . 0.0 110.493 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.74 164.08 32.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.38 0.672 . . . . 0.0 110.554 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.28 74.1 1.45 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.654 0.74 . . . . 0.0 110.497 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -4.15 42.61 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.075 0.55 . . . . 0.0 110.971 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.536 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.5 mt-30 -124.03 115.89 21.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mm -122.26 132.64 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.394 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 141.3 28.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.558 ' H ' HD23 ' A' ' 8' ' ' LEU . 69.5 mt -105.53 122.45 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.874 0.87 . . . . 0.0 109.251 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.25 113.25 21.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -145.39 163.26 35.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.252 0.548 . . . . 0.0 112.424 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.46 2.45 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.921 1.288 . . . . 0.0 112.153 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -137.8 134.19 18.08 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 123.021 0.528 . . . . 0.0 110.206 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.48 -16.92 14.85 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.344 2.696 . . . . 0.0 111.893 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.88 -41.74 29.02 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.235 -0.29 . . . . 0.0 110.404 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.9 mm -78.25 -30.0 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.46 -29.02 68.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.9 ttt -75.11 -33.86 61.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mtp -73.34 -24.28 60.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -70.17 -39.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.27 -29.38 66.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.113 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.43 -38.4 65.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -72.77 -23.43 60.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.318 0.508 . . . . 0.0 111.615 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.82 -21.74 54.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.696 0.68 . . . . 0.0 110.872 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.02 -21.47 29.42 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.452 0.569 . . . . 0.0 111.444 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.8 t -85.2 -23.09 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 117.99 0.359 . . . . 0.0 110.42 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.17 13.76 33.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.188 0.595 . . . . 0.0 111.218 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.14 35.44 19.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.75 0.82 . . . . 0.0 112.486 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.79 163.94 17.86 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.81 0.844 . . . . 0.0 109.817 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.4 m -110.4 89.34 8.57 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.293 -0.254 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.15 158.82 55.04 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.84 2.36 . . . . 0.0 110.466 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.6 m -130.17 -10.67 2.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.6 169.61 28.43 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 118.198 0.454 . . . . 0.0 112.093 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.9 m -142.12 136.63 30.27 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.27 150.59 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.181 0.515 . . . . 0.0 111.098 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -92.72 -3.73 54.33 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.96 0.904 . . . . 0.0 111.607 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -151.97 158.32 42.95 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.363 0.665 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.1 -23.09 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 121.936 0.094 . . . . 0.0 110.995 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.22 68.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.854 -0.529 . . . . 0.0 109.876 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.53 -22.39 72.86 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.4 -34.48 65.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.967 0.883 . . . . 0.0 109.932 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.49 -27.54 61.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.13 -24.67 59.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -87.16 -26.1 23.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.129 0.422 . . . . 0.0 111.309 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -77.51 -26.49 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.134 0.425 . . . . 0.0 110.12 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -82.45 -14.37 55.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.689 0.396 . . . . 0.0 111.561 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.79 -13.54 16.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.41 41.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.52 145.61 30.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.2 mt -142.85 145.46 23.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -101.17 -25.06 14.15 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 118.093 0.406 . . . . 0.0 111.913 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.21 173.06 10.53 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.946 0.498 . . . . 0.0 110.05 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.48 159.29 44.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.483 0.182 . . . . 0.0 111.161 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.0 123.8 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.28 130.63 56.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.042 0.537 . . . . 0.0 110.019 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.89 152.43 24.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.42 -11.52 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -110.26 151.11 27.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.027 0.531 . . . . 0.0 111.4 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.5 mt -143.38 159.81 41.69 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.662 1.185 . . . . 0.0 109.074 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -81.95 149.02 28.4 Favored 'General case' 0 C--O 1.23 0.072 0 O-C-N 122.347 -0.221 . . . . 0.0 111.407 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.72 -175.72 16.65 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.145 0.402 . . . . 0.0 112.629 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.55 2.19 84.54 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -79.86 163.92 23.99 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.374 0.67 . . . . 0.0 111.333 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 58.22 175.3 0.06 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.827 1.251 . . . . 0.0 112.719 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.1 p -151.75 164.03 37.87 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.26 0.624 . . . . 0.0 109.758 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 24.9 m -63.35 -37.32 29.85 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -175.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 52.0 Cg_exo -57.63 -5.43 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.652 2.901 . . . . 0.0 114.372 177.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.04 -22.96 32.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.862 0.755 . . . . 0.0 110.845 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.43 -26.64 67.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.189 -0.319 . . . . 0.0 110.154 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.53 ' CD ' HH12 ' A' ' 93' ' ' ARG . 50.7 mt-10 -79.03 -17.39 55.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.974 -0.454 . . . . 0.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.3 59.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.13 -34.64 75.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.01 62.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.276 -0.265 . . . . 0.0 110.724 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.34 53.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.54 0.336 . . . . 0.0 110.518 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -99.64 18.49 17.91 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.78 0.832 . . . . 0.0 110.691 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.43 32.22 18.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.367 1.067 . . . . 0.0 113.619 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.47 118.66 24.75 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 160.42 37.24 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.293 3.329 . . . . 0.0 112.615 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.54 166.86 24.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.457 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -141.08 155.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 109.042 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 23.9 m-85 -88.21 159.19 18.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.11 122.22 19.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.1 t -163.78 179.14 7.31 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.886 0.474 . . . . 0.0 110.511 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.19 137.4 5.25 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.15 29.5 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.1 t -76.84 162.41 27.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.004 0.522 . . . . 0.0 110.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.74 -9.65 58.88 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.663 0.385 . . . . 0.0 110.728 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.98 -4.76 59.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.001 0.52 . . . . 0.0 110.612 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -95.37 9.48 39.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.079 0.552 . . . . 0.0 111.938 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.76 154.48 36.86 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.23 0.612 . . . . 0.0 111.131 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -107.47 -176.15 2.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.103 0.961 . . . . 0.0 111.024 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -62.73 -14.46 44.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.53 HH12 ' CD ' ' A' ' 70' ' ' GLU . 85.9 mtt-85 -65.76 -31.87 73.1 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.558 0.343 . . . . 0.0 110.238 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 29.1 m-85 -89.54 -19.47 24.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.605 0.762 . . . . 0.0 109.948 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -88.52 -3.75 58.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.81 0.444 . . . . 0.0 111.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.82 -13.44 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.33 0.652 . . . . 0.0 111.951 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.52 153.45 81.42 Favored Pre-proline 0 C--N 1.34 0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.985 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.74 154.98 51.44 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.36 2.707 . . . . 0.0 113.119 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.28 153.5 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.983 0.913 . . . . 0.0 109.068 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.0 tp -138.09 153.7 49.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.603 0.761 . . . . 0.0 109.755 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -73.68 157.48 36.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.534 0.334 . . . . 0.0 110.512 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -74.56 -50.46 4.54 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.628 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.13 147.55 29.98 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.254 1.969 . . . . 0.0 110.197 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.502 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 4.0 m-30 -111.4 150.82 29.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.106 0.562 . . . . 0.0 110.545 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.7 p -143.26 167.19 22.72 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.093 0.957 . . . . 0.0 108.848 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 83.6 mmm -61.04 -39.48 89.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.036 -0.415 . . . . 0.0 110.791 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.37 -25.46 29.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.297 0.239 . . . . 0.0 111.301 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.71 -25.24 70.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.6 t -85.54 -28.1 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.37 0.585 . . . . 0.0 110.356 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.79 70.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -85.05 -20.69 30.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.797 0.439 . . . . 0.0 110.958 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.48 63.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.152 0.433 . . . . 0.0 110.379 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.12 -26.92 53.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.765 0.257 . . . . 0.0 110.708 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.58 -20.58 26.21 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.509 0.324 . . . . 0.0 111.604 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.25 -36.25 14.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.05 9.17 42.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -173.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.037 -1.458 . . . . 0.0 109.831 178.071 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.209 0.052 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m -129.66 16.33 5.88 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.111 0.564 . . . . 0.0 111.614 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.93 164.52 26.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.287 0.565 . . . . 0.0 110.855 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.93 76.64 1.55 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.489 0.661 . . . . 0.0 109.798 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -8.45 57.57 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.244 0.618 . . . . 0.0 111.984 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.0 mt-30 -119.37 114.65 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.698 0.681 . . . . 0.0 112.224 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.1 mm -120.24 130.25 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -87.91 142.86 27.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.617 ' H ' HD23 ' A' ' 8' ' ' LEU . 87.0 mt -110.52 120.89 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.908 0.883 . . . . 0.0 109.05 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.27 120.68 43.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.741 0.417 . . . . 0.0 110.875 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -156.91 158.3 36.42 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -73.84 -7.91 54.01 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.75 0.82 . . . . 0.0 112.132 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.93 132.0 24.09 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.049 0.54 . . . . 0.0 109.901 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.47 -18.79 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.35 2.7 . . . . 0.0 111.405 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.96 -34.73 71.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.082 0.401 . . . . 0.0 110.735 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.1 mm -86.3 -23.74 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.11 78.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.037 -0.414 . . . . 0.0 109.896 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.4 mtt -77.71 -27.29 50.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.0 ttt -69.07 -29.4 67.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 1.1 mm? -72.46 -33.02 66.72 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.14 -24.81 64.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.081 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.31 -43.45 60.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.9 0.318 . . . . 0.0 111.338 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -73.54 -22.29 60.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.845 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.18 -18.04 53.78 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.559 0.618 . . . . 0.0 110.838 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -85.31 -22.1 28.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.319 0.509 . . . . 0.0 110.449 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.45 -19.65 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.891 0.476 . . . . 0.0 110.317 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -105.37 16.28 25.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.338 0.655 . . . . 0.0 111.838 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.0 35.0 14.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.734 0.813 . . . . 0.0 112.499 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.07 165.73 16.4 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -115.19 77.83 5.53 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 122.75 0.42 . . . . 0.0 110.284 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.95 157.18 54.16 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.047 2.498 . . . . 0.0 110.203 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 6' ' ' GLN . 32.8 m -121.59 -14.6 7.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.46 176.47 36.26 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.666 0.666 . . . . 0.0 112.728 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 140.26 46.32 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.34 1.056 . . . . 0.0 108.885 175.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.51 154.67 20.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.008 0.432 . . . . 0.0 110.128 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -102.89 -1.49 29.46 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.03 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.9 p -141.42 159.71 41.65 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.794 0.438 . . . . 0.0 110.49 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.82 -22.81 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.682 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.16 54.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.22 -27.63 61.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.18 78.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.16 -26.71 63.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.52 -24.73 62.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.305 0.242 . . . . 0.0 111.316 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -86.57 -23.85 25.66 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.757 0.253 . . . . 0.0 111.293 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.6 -29.66 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 117.923 0.329 . . . . 0.0 111.064 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.54 -14.36 55.03 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.983 -0.448 . . . . 0.0 112.009 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.03 -12.76 15.35 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.123 0.569 . . . . 0.0 112.286 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.92 164.28 37.71 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.69 140.36 24.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.5 mt -144.75 143.98 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -96.7 -32.31 12.24 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.449 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.55 11.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.578 0.351 . . . . 0.0 110.318 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.0 157.83 43.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.668 0.27 . . . . 0.0 111.256 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.0 mt -113.46 123.56 69.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.9 130.8 56.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.455 0.702 . . . . 0.0 110.226 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 170.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.29 -11.88 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 O-C-N 122.034 -0.416 . . . . 0.0 111.968 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -104.92 141.49 36.44 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.952 -0.468 . . . . 0.0 110.159 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.2 tp -156.78 133.87 10.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.753 0.821 . . . . 0.0 109.209 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -78.67 137.32 37.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.82 1.7 40.74 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 120.0 -0.333 . . . . 0.0 112.688 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.58 164.08 44.92 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 117.747 0.774 . . . . 0.0 111.668 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.84 147.7 50.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.359 0.663 . . . . 0.0 110.108 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm 49.48 43.04 23.52 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.508 0.723 . . . . 0.0 111.352 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.3 p 49.7 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.352 1.461 . . . . 0.0 112.787 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -133.53 78.57 62.1 Favored Pre-proline 0 C--O 1.234 0.238 0 C-N-CA 123.178 0.591 . . . . 0.0 109.988 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.82 -11.96 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.561 2.841 . . . . 0.0 111.741 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.38 -17.64 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 122.158 -0.339 . . . . 0.0 111.036 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.92 74.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.847 -0.533 . . . . 0.0 110.156 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.28 -18.26 60.74 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.176 -0.327 . . . . 0.0 111.082 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.46 -29.29 37.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 99.2 mt -72.85 -37.46 67.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.16 -22.37 62.06 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.05 -12.61 54.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.414 0.286 . . . . 0.0 110.721 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -103.91 17.88 23.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.984 0.914 . . . . 0.0 110.779 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 59.06 34.13 23.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.125 0.97 . . . . 0.0 113.264 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.4 mt -120.77 102.2 44.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.849 0.86 . . . . 0.0 108.689 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.57 158.9 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.919 3.079 . . . . 0.0 112.745 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.21 167.13 23.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 111.409 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.4 t -134.74 144.19 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.838 0.855 . . . . 0.0 109.399 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -90.81 151.49 21.15 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 111.124 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.43 143.13 33.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.599 0.76 . . . . 0.0 109.234 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -159.77 158.39 31.09 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 111.007 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.67 95.93 0.96 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 172.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.51 -162.15 33.67 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.3 p -81.48 164.52 21.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.407 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -4.17 49.23 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.585 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.83 -1.3 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.295 0.638 . . . . 0.0 111.05 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.7 m -85.12 7.88 20.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.114 0.566 . . . . 0.0 111.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.0 m -137.83 154.7 29.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.786 0.834 . . . . 0.0 110.981 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 169.15 17.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.791 0.836 . . . . 0.0 111.917 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 m -61.53 -16.73 50.3 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -75.91 -24.27 55.58 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.7 0.682 . . . . 0.0 110.373 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.427 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 11.8 m-85 -84.24 -20.57 32.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -86.89 -13.01 46.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.086 0.554 . . . . 0.0 110.818 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.73 -27.3 18.14 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.743 0.417 . . . . 0.0 110.354 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -91.46 160.98 35.69 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.96 154.44 61.74 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.873 2.382 . . . . 0.0 111.355 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.9 m -138.9 154.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.152 0.581 . . . . 0.0 110.594 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.9 tp -147.28 146.71 29.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.876 0.471 . . . . 0.0 110.038 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -79.86 163.74 24.13 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.277 0.231 . . . . 0.0 110.585 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.7 -39.12 2.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.11 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.94 133.58 48.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.9 m-85 -119.84 146.13 46.01 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.107 0.563 . . . . 0.0 110.477 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.8 t -153.34 159.04 42.39 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.787 0.835 . . . . 0.0 109.189 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -63.46 -28.9 70.28 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.62 -39.94 18.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.574 0.625 . . . . 0.0 111.905 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.547 ' H ' HG23 ' A' ' 105' ' ' THR . . . -80.19 -25.7 56.82 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 122.121 -0.362 . . . . 0.0 112.375 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.53 -28.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.685 0.743 . . . . 0.0 110.338 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -29.05 64.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.976 -0.452 . . . . 0.0 110.155 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -83.95 -25.33 30.16 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 110.668 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.32 -32.45 37.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.65 0.204 . . . . 0.0 110.724 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -34.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.44 63.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.059 -0.4 . . . . 0.0 110.567 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 -14.92 39.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.437 0.295 . . . . 0.0 111.345 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.99 -29.52 17.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.271 0.628 . . . . 0.0 110.865 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.3 tp -85.97 10.55 13.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 112.035 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.154 -1.403 . . . . 0.0 110.585 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m -141.37 156.59 45.8 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.301 0.64 . . . . 0.0 110.254 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.27 -20.4 0.7 Allowed 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 117' ' ' LEU . 88.4 mt 50.63 25.1 1.89 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -8.76 52.13 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 118.392 0.542 . . . . 0.0 111.191 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.503 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.8 mp0 -118.99 118.88 32.69 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.14 0.427 . . . . 0.0 111.642 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -119.04 131.22 72.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 O-C-N 123.737 0.648 . . . . 0.0 109.881 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -97.69 130.19 44.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 8' ' ' LEU . 86.3 mt -98.67 135.23 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -132.12 125.6 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -149.39 162.85 39.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.231 0.539 . . . . 0.0 112.423 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -123.46 11.86 9.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 109.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -145.03 113.78 4.92 Favored Pre-proline 0 N--CA 1.453 -0.311 0 C-N-CA 124.82 1.248 . . . . 0.0 107.944 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.86 -16.33 11.45 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.06 3.173 . . . . 0.0 114.655 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.47 -23.06 60.03 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.4 -27.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.61 -25.48 61.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.276 -0.265 . . . . 0.0 110.449 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.11 -35.17 28.82 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.448 -0.157 . . . . 0.0 110.779 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 98.1 mmm -75.43 -34.39 60.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.99 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.35 -28.18 42.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.131 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.52 -21.63 55.49 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.798 -0.564 . . . . 0.0 110.088 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.64 -41.32 46.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.194 -0.316 . . . . 0.0 111.447 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -82.08 -21.43 36.81 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.361 0.528 . . . . 0.0 112.368 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.21 -18.09 55.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.075 0.852 . . . . 0.0 110.137 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -85.28 -29.38 24.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.811 0.278 . . . . 0.0 110.774 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -83.28 -19.76 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 122.715 0.406 . . . . 0.0 110.774 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.09 14.53 28.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.793 0.437 . . . . 0.0 111.54 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 51.05 34.72 11.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.652 0.781 . . . . 0.0 111.461 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HD3' ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -85.55 162.7 18.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.849 0.86 . . . . 0.0 110.374 -176.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.4 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 56.8 m -114.42 88.02 14.91 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.951 0.5 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.76 157.94 58.68 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.83 2.354 . . . . 0.0 109.55 176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 6' ' ' GLN . 33.0 m -123.46 -16.9 4.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 174.21 33.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 118.329 0.513 . . . . 0.0 112.588 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -137.2 139.65 41.22 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.45 161.04 31.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 110.618 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -131.67 7.43 4.45 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.976 0.51 . . . . 0.0 112.188 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.9 p -136.39 156.69 48.27 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.968 0.507 . . . . 0.0 109.89 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.07 -29.9 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.8 65.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.157 -0.34 . . . . 0.0 110.363 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.33 -24.85 56.14 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.83 -34.99 60.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.614 0.707 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.37 -24.24 32.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.929 0.331 . . . . 0.0 110.393 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.75 57.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.207 0.458 . . . . 0.0 110.728 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -84.37 -31.11 24.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.463 0.705 . . . . 0.0 110.136 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.64 -25.27 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.66 0.384 . . . . 0.0 111.686 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -71.27 -19.08 62.39 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.651 -0.655 . . . . 0.0 111.153 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.91 -12.59 58.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.726 0.298 . . . . 0.0 110.999 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.99 -169.07 53.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.92 81.83 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.634 -0.536 . . . . 0.0 112.577 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.85 147.04 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 117.785 0.793 . . . . 0.0 109.536 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.6 -17.0 5.63 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.38 166.64 28.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.232 0.469 . . . . 0.0 110.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.04 165.53 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.28 -0.263 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.24 133.25 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.36 130.61 56.69 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.086 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -84.39 138.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.93 -12.24 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.443 0.297 . . . . 0.0 110.485 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.58 134.47 47.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 tp -155.05 152.24 29.35 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.824 0.45 . . . . 0.0 110.107 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -75.31 152.9 38.13 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.055 0.542 . . . . 0.0 111.212 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.83 -172.85 48.54 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 0.62 73.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.377 0.513 . . . . 0.0 113.034 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -68.51 151.39 46.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.915 0.857 . . . . 0.0 110.835 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -144.61 20.97 1.67 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.192 0.597 . . . . 0.0 110.641 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -135.29 163.01 30.96 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.105 0.562 . . . . 0.0 111.088 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 m -136.21 66.28 59.46 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.359 0.664 . . . . 0.0 109.416 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.54 -11.83 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.741 2.961 . . . . 0.0 111.812 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -72.44 -13.65 16.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.344 0.258 . . . . 0.0 110.906 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.23 -24.47 63.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 122.221 -0.299 . . . . 0.0 110.388 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.55 -17.39 45.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.342 -0.224 . . . . 0.0 110.466 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.92 61.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.16 -27.02 60.64 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.76 57.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.15 -16.39 56.72 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -91.7 13.67 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.839 0.856 . . . . 0.0 110.026 172.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 60.71 30.5 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.551 1.141 . . . . 0.0 113.646 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.21 124.96 29.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.39 161.04 38.23 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.09 3.193 . . . . 0.0 111.062 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -152.12 171.25 18.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.218 0.533 . . . . 0.0 111.752 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.66 144.7 20.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 124.058 0.943 . . . . 0.0 109.017 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.03 154.46 22.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.408 0.283 . . . . 0.0 110.824 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.52 119.81 22.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -153.41 173.11 16.08 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 111.421 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 135.33 3.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.8 -156.12 26.52 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.1 p -79.26 175.37 10.66 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.954 0.502 . . . . 0.0 110.621 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.02 -6.6 34.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.73 0.412 . . . . 0.0 112.02 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -92.59 -7.64 46.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.021 0.528 . . . . 0.0 111.173 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.4 m -78.92 0.75 26.15 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.008 -0.432 . . . . 0.0 111.547 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 m -140.06 153.16 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.252 0.621 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.9 177.76 4.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.179 0.992 . . . . 0.0 110.485 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -61.63 -18.46 59.54 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.781 -0.575 . . . . 0.0 111.965 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -76.48 -20.74 56.66 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.862 0.755 . . . . 0.0 111.2 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -84.2 -19.29 34.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -88.15 -4.85 58.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.421 0.688 . . . . 0.0 110.264 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.84 -11.19 14.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.695 1.198 . . . . 0.0 111.572 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.75 163.12 41.04 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.92 0.888 . . . . 0.0 110.115 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.61 147.33 92.3 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.625 2.884 . . . . 0.0 112.53 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -140.19 151.36 21.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.603 0.761 . . . . 0.0 110.472 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -146.13 155.2 42.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.012 0.925 . . . . 0.0 108.662 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -85.7 162.03 18.95 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.332 -0.23 . . . . 0.0 110.884 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.68 -41.45 9.55 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.974 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.76 124.52 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.409 2.073 . . . . 0.0 110.875 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -107.33 143.15 36.02 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.3 t -155.7 163.67 39.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.99 -23.64 65.53 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -173.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.44 -38.74 21.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.379 0.536 . . . . 0.0 110.937 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' H ' HG23 ' A' ' 105' ' ' THR . . . -74.64 -26.75 66.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.6 t -81.44 -21.71 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.734 0.414 . . . . 0.0 109.913 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.18 -30.68 62.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.318 0.508 . . . . 0.0 110.703 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.24 -27.49 38.67 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.52 55.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -72.7 -32.75 66.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.944 0.498 . . . . 0.0 109.812 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.41 -17.97 40.34 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.641 0.376 . . . . 0.0 111.942 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.06 9.88 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -99.11 -58.35 1.96 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.891 0.314 . . . . 0.0 111.791 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 4' ' ' LEU . 3.2 mm? -65.86 -4.21 6.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.972 0.909 . . . . 0.0 112.768 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.244 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ptm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.422 0.153 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -148.73 154.07 39.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.93 0.492 . . . . 0.0 110.127 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.45 165.51 36.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.088 0.555 . . . . 0.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.1 63.48 1.41 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.605 0.717 . . . . 0.0 110.41 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -2.13 21.11 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.683 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.5 mt-30 -124.03 111.18 15.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.118 0.417 . . . . 0.0 110.786 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.4 mm -119.4 128.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.085 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -88.99 135.07 33.75 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' N ' HD23 ' A' ' 8' ' ' LEU . 67.5 mt -102.88 134.58 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.02 0.528 . . . . 0.0 109.82 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.07 106.29 10.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -149.85 163.32 38.33 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 123.872 0.869 . . . . 0.0 110.531 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -112.76 -13.73 13.19 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.712 0.405 . . . . 0.0 110.912 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -84.69 127.28 65.98 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.71 -14.01 14.29 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.36 2.706 . . . . 0.0 112.757 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -93.73 -38.47 11.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.602 0.637 . . . . 0.0 111.881 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.8 mp -76.25 -28.39 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.82 63.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.852 0.061 . . . . 0.0 110.993 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.4 mtt -84.98 -27.86 26.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.395 -0.191 . . . . 0.0 110.672 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.7 mmm -77.94 -28.42 49.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.728 0.24 . . . . 0.0 110.494 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 21.9 tp -78.95 -30.96 44.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.222 -0.299 . . . . 0.0 110.326 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.65 -26.67 61.73 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.73 -35.19 52.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.361 -0.212 . . . . 0.0 110.485 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -73.35 -27.06 61.29 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.871 -0.518 . . . . 0.0 111.7 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -79.17 -17.8 54.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.613 0.642 . . . . 0.0 110.836 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.14 -29.46 24.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.854 0.297 . . . . 0.0 110.965 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.15 -21.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 122.584 0.353 . . . . 0.0 111.389 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 16.98 17.8 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.882 0.473 . . . . 0.0 111.648 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t0 52.02 34.46 13.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.975 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.79 165.45 16.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.698 0.799 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 77.95 6.52 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.199 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.11 160.55 41.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.54 2.827 . . . . 0.0 110.478 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.7 m -127.37 -25.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.1 176.79 36.29 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 118.527 0.603 . . . . 0.0 112.612 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.8 m -137.61 141.91 41.26 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.96 0.904 . . . . 0.0 108.708 176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.94 159.0 37.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 122.642 0.377 . . . . 0.0 110.152 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.61 -5.98 28.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.853 0.461 . . . . 0.0 111.994 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.7 p -143.06 161.08 39.11 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.085 0.554 . . . . 0.0 110.475 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.17 -22.72 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.787 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.46 -29.67 66.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.51 -27.56 65.23 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.4 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.323 0.562 . . . . 0.0 110.059 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.44 -23.25 50.55 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 177.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.37 45.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.728 0.24 . . . . 0.0 111.386 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 5.1 mmp_? -87.35 -21.92 25.4 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.131 -0.356 . . . . 0.0 111.696 175.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.53 -22.0 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.26 -16.19 60.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.08 -12.42 21.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.403 0.681 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 -167.68 54.03 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.17 24.33 61.63 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.631 -0.538 . . . . 0.0 112.609 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mt -137.22 147.66 26.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.386 0.674 . . . . 0.0 109.306 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -116.28 -26.98 6.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.63 12.49 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.045 0.384 . . . . 0.0 110.582 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.93 34.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.719 0.295 . . . . 0.0 111.388 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.1 mt -122.48 130.44 74.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.81 133.6 54.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.08 155.79 19.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.56 -11.87 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -107.97 141.84 39.0 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.045 0.538 . . . . 0.0 110.656 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.5 mt -143.53 172.6 12.56 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.475 1.11 . . . . 0.0 108.929 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -82.27 134.43 35.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 3.62 72.14 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.777 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.23 157.88 23.03 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 118.786 1.293 . . . . 0.0 112.267 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.52 164.48 22.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.426 0.691 . . . . 0.0 111.26 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.5 tttp 55.85 28.46 12.48 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.576 1.15 . . . . 0.0 113.072 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -82.57 24.44 0.71 Allowed 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.952 -0.468 . . . . 0.0 111.388 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.446 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 7.9 m -56.82 -34.15 23.93 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 66' ' ' THR . 77.7 Cg_exo -56.84 -12.79 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.908 2.406 . . . . 0.0 114.111 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.45 -13.89 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.47 -24.65 67.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.815 -0.553 . . . . 0.0 109.76 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.26 -17.99 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.457 0.303 . . . . 0.0 110.724 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.16 -27.23 39.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.03 -27.7 61.07 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -25.57 58.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.91 -16.46 56.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -92.67 6.6 46.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.754 0.821 . . . . 0.0 110.136 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.31 35.35 20.74 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.262 1.025 . . . . 0.0 113.199 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.79 129.73 25.18 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.64 157.51 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.602 2.868 . . . . 0.0 111.302 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -145.01 164.79 30.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.609 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -136.12 147.56 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 124.604 1.162 . . . . 0.0 108.837 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 28.9 m-85 -91.98 155.35 18.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.895 0.378 . . . . 0.0 111.682 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.87 128.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -165.28 158.85 16.73 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.657 0.265 . . . . 0.0 111.009 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.61 136.99 13.16 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.04 -151.91 23.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 82.8 p -119.36 176.05 5.53 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.443 0.697 . . . . 0.0 110.55 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.56 -1.92 12.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.833 0.453 . . . . 0.0 111.739 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.66 1.28 14.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.359 0.663 . . . . 0.0 111.187 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -87.16 7.64 27.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.348 0.659 . . . . 0.0 111.609 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.1 m -139.63 155.86 25.65 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 123.748 0.819 . . . . 0.0 111.628 -175.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.57 162.63 20.49 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.949 0.9 . . . . 0.0 111.36 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.8 m -59.1 -19.56 45.56 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -74.12 -25.43 59.76 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.987 0.812 . . . . 0.0 110.743 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 7.1 m-85 -79.98 -19.31 48.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -88.16 -10.22 50.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.827 0.451 . . . . 0.0 110.669 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.91 -11.58 15.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.647 0.779 . . . . 0.0 111.618 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -121.34 160.92 43.75 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.399 0.679 . . . . 0.0 110.118 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.33 148.89 84.37 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.996 2.464 . . . . 0.0 112.242 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.61 154.86 17.97 Favored 'Isoleucine or valine' 0 C--O 1.23 0.046 0 C-N-CA 124.139 0.976 . . . . 0.0 109.909 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.3 tp -138.55 145.16 40.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.821 0.449 . . . . 0.0 109.832 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -76.68 165.27 24.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.774 0.43 . . . . 0.0 110.38 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -79.19 -39.15 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.763 -177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.96 143.81 95.73 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.589 2.192 . . . . 0.0 110.567 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 1.7 m-85 -118.96 133.39 55.86 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.922 0.392 . . . . 0.0 111.348 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -143.33 155.53 44.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.783 1.233 . . . . 0.0 108.923 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.96 -28.6 66.78 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 122.199 -0.313 . . . . 0.0 111.61 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -84.5 -35.24 23.05 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.051 -0.406 . . . . 0.0 111.634 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.0 -38.93 29.09 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.307 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.89 -22.93 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 117.857 0.829 . . . . 0.0 111.162 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.2 64.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.503 -0.748 . . . . 0.0 110.306 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -78.8 -31.96 46.14 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.34 -26.68 46.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.183 0.193 . . . . 0.0 111.038 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.55 -38.7 65.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.25 -23.47 62.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.416 -0.177 . . . . 0.0 110.678 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.08 -13.84 43.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.84 0.456 . . . . 0.0 111.468 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.7 tt -90.89 -29.27 17.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.145 0.578 . . . . 0.0 110.699 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.4 tp -82.91 6.65 17.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.956 0.503 . . . . 0.0 111.887 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.802 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -147.53 169.77 18.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.269 0.627 . . . . 0.0 110.222 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 5' ' ' THR . . . -147.61 179.13 7.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.985 0.514 . . . . 0.0 110.526 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.35 25.23 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.529 0.731 . . . . 0.0 112.677 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 3' ' ' ALA . 0.8 OUTLIER -92.03 -11.18 36.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.691 -0.631 . . . . 0.0 110.424 176.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.41 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.6 mp0 -111.49 104.6 13.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.779 0.432 . . . . 0.0 110.977 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.03 124.11 72.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.981 0.512 . . . . 0.0 110.434 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -86.79 146.99 26.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.434 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.618 ' H ' HD23 ' A' ' 8' ' ' LEU . 95.0 mt -110.53 128.1 67.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.922 0.889 . . . . 0.0 109.675 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.3 122.73 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.071 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.97 163.29 33.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.289 0.235 . . . . 0.0 111.262 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.32 -11.32 32.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.53 135.57 13.14 Favored Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.41 -17.32 44.07 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.089 2.526 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -77.87 -37.42 48.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.456 0.571 . . . . 0.0 110.01 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -77.55 -27.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.54 68.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.198 -0.314 . . . . 0.0 110.281 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -76.73 -27.3 55.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -73.22 -33.4 65.32 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.65 -31.65 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.23 -0.294 . . . . 0.0 110.409 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.93 -21.82 43.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.37 -42.96 42.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.094 -0.378 . . . . 0.0 110.15 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.94 -19.36 60.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.641 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.63 -29.29 66.75 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.164 0.438 . . . . 0.0 110.116 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -84.72 -29.58 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.491 0.316 . . . . 0.0 111.385 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -71.55 -24.24 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 6.57 48.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.173 0.589 . . . . 0.0 111.032 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t0 50.73 37.75 17.55 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.584 0.754 . . . . 0.0 111.49 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.6 tmtm? -85.69 158.84 19.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.855 0.862 . . . . 0.0 110.422 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.444 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 88.7 m -92.08 124.39 60.07 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.42 153.86 35.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.63 2.886 . . . . 0.0 110.872 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 6' ' ' GLN . 24.8 m -141.77 -21.86 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.409 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.66 163.05 16.92 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -143.96 134.86 25.3 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.57 161.2 24.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.898 0.38 . . . . 0.0 111.117 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -136.08 3.74 2.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.119 0.568 . . . . 0.0 111.546 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -139.3 161.72 36.75 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.357 0.663 . . . . 0.0 110.78 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.41 -32.99 52.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 122.437 0.295 . . . . 0.0 110.239 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.4 -29.51 53.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.347 -0.22 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.89 -33.0 52.04 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 -33.83 74.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.409 0.604 . . . . 0.0 110.511 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.21 -29.02 60.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.26 60.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.47 -26.96 22.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 118.328 0.513 . . . . 0.0 112.15 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -83.28 -21.69 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 118.04 0.382 . . . . 0.0 111.522 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -81.56 -23.05 37.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.41 -13.63 8.4 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.733 0.697 . . . . 0.0 112.316 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.39 -164.94 40.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.51 137.18 5.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.49 164.5 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.74 0.816 . . . . 0.0 110.802 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -124.13 -10.72 7.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.014 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.87 165.85 20.1 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.503 0.721 . . . . 0.0 109.056 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.09 158.0 43.48 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.729 -0.607 . . . . 0.0 111.903 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.7 mm -97.46 121.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.07 124.87 49.13 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.97 118.32 11.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 168.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.56 -29.27 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -171.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -158.53 154.81 27.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.197 0.453 . . . . 0.0 110.983 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.556 HD13 ' H ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -151.25 170.35 19.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.203 1.001 . . . . 0.0 108.605 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.556 ' H ' HD13 ' A' ' 59' ' ' LEU . 79.9 ttt180 -58.37 135.51 57.22 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.861 -0.525 . . . . 0.0 110.158 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.01 -1.98 45.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.472 -0.627 . . . . 0.0 112.863 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.22 147.29 28.57 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 118.256 1.028 . . . . 0.0 111.304 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.48 154.63 45.9 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.962 0.505 . . . . 0.0 111.17 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 53.15 17.26 0.93 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.966 1.307 . . . . 0.0 114.461 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 m 56.83 -179.26 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.226 1.01 . . . . 0.0 112.878 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -71.09 139.64 85.21 Favored Pre-proline 0 CA--C 1.532 0.255 0 O-C-N 121.9 -0.5 . . . . 0.0 111.188 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -83.23 -10.33 10.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.625 2.884 . . . . 0.0 111.301 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.6 t -74.24 -29.85 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 117.799 0.272 . . . . 0.0 111.343 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.53 78.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.125 0.42 . . . . 0.0 110.45 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.03 -17.59 39.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.266 -0.272 . . . . 0.0 111.088 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.84 65.97 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.56 -26.49 58.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.49 -24.29 61.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.948 0.34 . . . . 0.0 110.113 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.71 44.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.317 0.247 . . . . 0.0 110.471 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -101.58 8.66 41.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.39 0.676 . . . . 0.0 110.962 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.97 37.12 28.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.652 1.181 . . . . 0.0 113.37 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -110.66 120.98 42.39 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 123.022 0.529 . . . . 0.0 109.767 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.95 154.24 39.83 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.227 3.285 . . . . 0.0 113.663 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.54 168.4 23.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -96.95 152.59 18.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.959 0.409 . . . . 0.0 111.927 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.18 119.61 10.3 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.1 t -172.17 164.48 6.01 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.023 0.929 . . . . 0.0 109.447 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.26 142.61 21.4 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.42 -160.46 32.7 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 117.424 0.612 . . . . 0.0 112.057 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.1 t -143.67 167.69 21.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.303 0.641 . . . . 0.0 110.518 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -3.77 17.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 112.602 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -114.37 10.61 17.1 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.281 0.632 . . . . 0.0 111.874 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.1 p -118.76 9.24 12.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 123.039 0.536 . . . . 0.0 112.017 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.14 154.69 25.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.631 0.773 . . . . 0.0 111.621 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.34 163.8 25.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.288 0.635 . . . . 0.0 111.316 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -59.95 -17.35 37.25 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -71.58 -26.68 62.71 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.852 0.751 . . . . 0.0 110.462 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -83.54 -22.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -88.09 -10.75 49.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.817 0.447 . . . . 0.0 111.319 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.96 -32.23 11.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 110.995 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.3 152.64 50.37 Favored Pre-proline 0 C--N 1.338 0.108 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.67 152.43 56.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.226 2.617 . . . . 0.0 111.413 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.58 153.19 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 122.842 0.457 . . . . 0.0 110.892 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.0 tp -149.06 153.73 38.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -84.85 167.07 16.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.656 0.383 . . . . 0.0 110.677 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 69.5 mmtt -63.6 -46.51 83.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.3 Cg_endo -71.71 137.05 29.24 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.673 1.582 . . . . 0.0 109.777 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -110.44 148.67 31.58 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.949 0.499 . . . . 0.0 110.331 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.8 p -144.01 161.4 38.87 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.125 0.97 . . . . 0.0 109.21 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.66 -27.14 68.72 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.088 -0.383 . . . . 0.0 111.083 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.78 -36.51 21.65 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.64 -30.42 44.35 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.7 t -82.43 -30.56 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.663 0.731 . . . . 0.0 110.335 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 -26.42 62.74 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.502 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -83.39 -33.75 25.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.401 0.28 . . . . 0.0 110.917 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.84 61.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.319 -0.238 . . . . 0.0 110.703 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.18 -20.61 40.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 119.564 -0.255 . . . . 0.0 110.784 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.43 55.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.37 0.532 . . . . 0.0 110.07 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.57 26.72 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.803 0.441 . . . . 0.0 111.513 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 tt -91.2 -51.88 5.09 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.989 0.515 . . . . 0.0 110.305 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.5 mt -79.13 17.37 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.1 . . . . 0.0 112.147 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.311 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 53.96 21.89 3.09 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.879 0.872 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.61 165.83 33.99 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.352 0.661 . . . . 0.0 110.269 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.56 75.52 1.49 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.505 0.669 . . . . 0.0 109.848 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -78.04 -6.77 55.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.943 0.497 . . . . 0.0 111.506 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.451 ' HB3' HG11 ' A' ' 32' ' ' VAL . 64.5 mt-30 -118.73 111.09 18.04 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.09 136.05 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.762 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -96.0 138.29 33.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.48 ' H ' HD23 ' A' ' 8' ' ' LEU . 79.8 mt -102.12 126.2 56.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.867 0.867 . . . . 0.0 109.716 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.37 110.04 15.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 162.67 35.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 111.629 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -98.19 -0.16 44.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.912 0.885 . . . . 0.0 111.32 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.61 105.59 15.72 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.89 -22.47 54.35 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.753 2.969 . . . . 0.0 113.592 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.32 -41.2 73.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.457 0.571 . . . . 0.0 110.427 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.418 HG13 ' HE3' ' A' ' 102' ' ' LYS . 43.6 mm -79.03 -25.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.51 66.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 mmt -80.92 -25.54 37.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mtp -73.33 -30.64 63.49 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.96 -32.11 71.46 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.102 -0.374 . . . . 0.0 110.053 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -74.62 -23.14 58.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.204 -0.31 . . . . 0.0 110.208 175.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.66 -43.3 20.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.301 -0.249 . . . . 0.0 111.14 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -74.35 -27.26 60.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.425 0.557 . . . . 0.0 111.754 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.83 -17.87 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.541 0.61 . . . . 0.0 110.894 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.862 0.301 . . . . 0.0 110.769 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.54 -20.1 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 122.766 0.426 . . . . 0.0 110.793 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -103.13 17.02 25.05 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.97 0.508 . . . . 0.0 111.687 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.88 36.13 17.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.061 0.944 . . . . 0.0 112.76 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.87 164.65 17.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.336 0.654 . . . . 0.0 109.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -117.47 72.18 7.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 O-C-N 122.06 -0.4 . . . . 0.0 110.873 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.92 158.28 48.1 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.845 2.364 . . . . 0.0 110.166 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 6' ' ' GLN . 31.4 m -121.58 -9.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -173.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.89 174.03 34.16 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 118.422 0.555 . . . . 0.0 112.374 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.1 m -141.17 137.64 32.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.378 1.071 . . . . 0.0 108.383 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.93 156.88 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.024 0.44 . . . . 0.0 111.077 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.74 -4.26 37.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.982 0.913 . . . . 0.0 111.732 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -151.4 157.5 42.5 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.88 0.472 . . . . 0.0 110.439 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.88 -22.92 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 122.792 0.437 . . . . 0.0 110.567 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.96 -26.09 63.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.949 -0.469 . . . . 0.0 110.245 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.57 -21.17 64.71 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.51 63.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.235 0.518 . . . . 0.0 109.924 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.23 -32.2 66.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.85 -24.68 64.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.443 -0.161 . . . . 0.0 110.919 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -82.94 -25.71 32.11 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.743 0.247 . . . . 0.0 110.949 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.5 t -71.94 -26.55 25.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.78 -14.34 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.674 0.39 . . . . 0.0 110.863 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -98.84 -14.61 19.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.435 0.694 . . . . 0.0 111.994 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.22 169.74 38.76 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.62 148.21 36.59 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.37 149.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.18 -30.66 11.42 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.193 0.452 . . . . 0.0 111.35 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 174.95 11.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.749 0.42 . . . . 0.0 110.582 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.58 161.48 41.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.675 0.274 . . . . 0.0 111.0 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.78 130.86 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.02 136.0 53.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.24 0.616 . . . . 0.0 110.203 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.56 144.99 29.98 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.78 -12.0 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 122.281 -0.262 . . . . 0.0 111.307 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -123.19 153.46 40.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.2 tp -152.76 141.69 21.18 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -81.93 132.6 35.27 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 117.748 0.249 . . . . 0.0 110.952 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.42 166.02 2.87 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.488 0.566 . . . . 0.0 112.132 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.8 -158.04 29.54 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 122.646 -0.326 . . . . 0.0 112.493 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -86.14 161.37 18.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.42 0.688 . . . . 0.0 110.07 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -62.25 -22.19 65.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.975 0.51 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.8 p 52.93 23.37 2.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 28.2 p -91.84 -24.77 0.27 Allowed Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 175.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.4 Cg_exo -57.8 -18.72 35.47 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 113.972 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.3 m -82.45 -9.77 11.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 118.061 0.392 . . . . 0.0 111.892 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.61 68.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.983 -0.448 . . . . 0.0 110.458 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -75.18 -17.77 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.291 -0.256 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.81 -25.62 37.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.5 -29.93 61.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 173.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.29 60.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.16 -13.51 57.06 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -95.52 14.76 21.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 110.14 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.17 31.41 19.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.421 1.089 . . . . 0.0 113.489 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.6 mt -122.23 108.69 33.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.9 162.71 38.66 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.628 2.885 . . . . 0.0 111.195 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -150.07 167.54 26.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.248 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.87 144.93 27.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 22.9 m-85 -87.05 153.13 21.78 Favored 'General case' 0 C--N 1.337 0.031 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.83 122.47 13.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -166.99 161.15 14.77 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.732 0.413 . . . . 0.0 110.425 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 134.06 12.13 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.93 -155.61 26.24 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 m -132.52 171.18 14.12 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.923 0.889 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.45 -10.27 54.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.89 2.58 55.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.791 0.436 . . . . 0.0 111.324 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -102.75 7.62 39.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.492 0.717 . . . . 0.0 111.108 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.4 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 5.2 m -139.48 154.83 25.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.972 0.909 . . . . 0.0 111.47 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.98 169.92 14.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.991 0.916 . . . . 0.0 111.547 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.5 p -61.51 -19.12 61.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -70.69 -24.5 62.68 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.379 0.536 . . . . 0.0 110.823 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 49.9 m-85 -89.01 -19.33 25.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.32 -7.87 56.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 111.111 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.92 -18.07 13.47 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.367 0.667 . . . . 0.0 111.229 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -107.35 158.16 33.81 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.235 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.18 151.98 82.27 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.154 2.569 . . . . 0.0 111.58 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.8 154.71 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.952 0.901 . . . . 0.0 110.562 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -139.16 155.09 48.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.566 0.746 . . . . 0.0 109.892 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -79.34 162.95 25.25 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.724 0.41 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 56.9 tptt -78.67 -47.68 1.82 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.591 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 88.7 Cg_endo -74.3 144.76 33.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.115 1.876 . . . . 0.0 110.256 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -115.83 147.21 41.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.034 0.533 . . . . 0.0 110.489 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.9 p -144.3 162.48 36.31 Favored 'General case' 0 N--CA 1.46 0.04 0 C-N-CA 124.443 1.097 . . . . 0.0 108.866 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -63.55 -31.87 73.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.91 -0.494 . . . . 0.0 111.207 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -84.62 -33.59 23.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.6 -27.03 57.94 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.9 -25.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.562 0.681 . . . . 0.0 110.527 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.9 -32.37 71.97 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.3 -29.25 38.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.524 0.33 . . . . 0.0 110.429 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.74 60.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 122.302 -0.249 . . . . 0.0 110.97 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.21 -30.2 54.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.83 -26.71 62.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.378 -0.201 . . . . 0.0 110.571 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -18.84 28.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.852 0.461 . . . . 0.0 112.119 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.89 -40.26 11.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.138 0.575 . . . . 0.0 110.92 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.59 18.29 3.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.871 0.469 . . . . 0.0 112.193 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.811 -1.09 . . . . 0.0 110.812 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.219 0.056 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m 53.97 25.94 5.89 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.62 155.86 40.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.825 0.45 . . . . 0.0 110.958 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.06 71.23 1.17 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.756 0.822 . . . . 0.0 109.209 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -72.09 -7.47 49.15 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.712 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.457 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 70.8 mt-30 -119.99 116.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.167 0.44 . . . . 0.0 112.141 -171.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.451 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.0 mm -122.29 128.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 123.932 0.77 . . . . 0.0 111.511 -172.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -86.6 142.24 28.41 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' H ' HD23 ' A' ' 8' ' ' LEU . 79.3 mt -112.78 130.92 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 t -124.27 125.08 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -152.14 163.63 38.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.693 0.397 . . . . 0.0 111.868 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.77 12.93 13.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.412 0.685 . . . . 0.0 110.601 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -146.87 121.5 5.23 Favored Pre-proline 0 N--CA 1.454 -0.248 0 C-N-CA 123.973 0.909 . . . . 0.0 108.565 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.81 -14.36 44.26 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.24 2.627 . . . . 0.0 112.451 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.7 -31.1 68.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.4 -26.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.02 78.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.027 -0.42 . . . . 0.0 110.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.42 -21.77 30.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.463 -0.148 . . . . 0.0 111.126 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.8 tpt -76.75 -33.93 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.298 -0.251 . . . . 0.0 110.43 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.78 -27.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.229 0.212 . . . . 0.0 110.746 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.96 -21.85 58.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.785 0.266 . . . . 0.0 110.41 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.27 -46.29 28.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.264 -0.272 . . . . 0.0 110.687 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.57 -15.99 58.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.581 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.42 -28.84 64.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -78.84 -23.96 44.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.393 0.277 . . . . 0.0 110.408 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.07 -28.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.31 -1.94 58.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.536 0.335 . . . . 0.0 110.248 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t0 50.11 33.0 6.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.747 1.219 . . . . 0.0 112.96 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HE3' HG12 ' A' ' 7' ' ' ILE . 59.1 pttt -104.47 -165.77 1.18 Allowed 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.285 -0.259 . . . . 0.0 111.664 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -103.2 124.99 36.41 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 112.043 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 164.58 20.27 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.622 2.881 . . . . 0.0 110.067 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 34.8 m -136.07 -28.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.16 178.6 37.8 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.573 0.624 . . . . 0.0 112.616 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -137.35 141.07 41.8 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.39 1.076 . . . . 0.0 108.598 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.15 155.53 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.98 0.419 . . . . 0.0 110.767 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -129.11 7.89 5.54 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.436 0.694 . . . . 0.0 111.749 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 p -132.61 157.73 44.04 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.393 0.677 . . . . 0.0 110.025 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.24 -23.72 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.13 -25.8 42.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.303 -0.248 . . . . 0.0 110.816 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.42 -30.26 58.74 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.6 56.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.332 0.566 . . . . 0.0 110.623 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.13 -24.52 47.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.09 -25.04 40.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.212 -0.305 . . . . 0.0 111.11 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -87.37 -26.7 23.21 Favored 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.96 -22.34 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.687 0.676 . . . . 0.0 110.825 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -79.97 -14.56 58.49 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.33 -0.231 . . . . 0.0 110.468 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.88 -12.74 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.178 0.591 . . . . 0.0 111.137 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.77 53.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.95 62.99 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.052 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mt -140.34 144.73 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.793 0.837 . . . . 0.0 109.217 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.42 -25.71 9.91 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.76 176.99 10.32 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.09 0.405 . . . . 0.0 110.52 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.68 166.73 27.49 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.04 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.39 119.6 29.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.599 0.237 . . . . 0.0 110.759 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -80.41 127.92 32.97 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.613 0.365 . . . . 0.0 110.298 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.8 t -97.19 -11.15 8.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.434 0.694 . . . . 0.0 110.496 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -71.48 9.16 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.76 0.424 . . . . 0.0 111.85 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 158.54 21.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.506 0.722 . . . . 0.0 109.927 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -62.49 146.54 51.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.98 0.512 . . . . 0.0 111.101 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.68 145.14 4.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.871 0.748 . . . . 0.0 112.11 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.83 -9.8 57.03 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.661 -0.522 . . . . 0.0 111.818 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -126.63 149.31 49.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.705 0.753 . . . . 0.0 110.147 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 50.74 29.27 4.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.006 0.923 . . . . 0.0 112.094 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.4 p -102.13 -3.36 27.62 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.346 0.659 . . . . 0.0 111.935 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.7 m -137.32 33.85 0.23 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 86.9 Cg_endo -75.12 -13.49 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.174 1.916 . . . . 0.0 111.5 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.39 -29.11 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 122.612 0.365 . . . . 0.0 110.738 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.24 80.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.792 0.329 . . . . 0.0 110.387 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.93 -17.77 45.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.168 -0.332 . . . . 0.0 110.863 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.87 64.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.63 -27.22 62.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.38 -24.74 62.13 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 117.65 0.204 . . . . 0.0 110.49 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.16 52.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.234 -0.292 . . . . 0.0 110.486 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -99.54 8.69 44.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.409 0.684 . . . . 0.0 111.246 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 57.79 35.83 25.87 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.208 1.003 . . . . 0.0 113.026 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.36 131.08 22.23 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.75 156.86 39.76 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.91 3.073 . . . . 0.0 111.502 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.1 167.68 29.03 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.852 0.461 . . . . 0.0 111.132 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -138.89 164.87 25.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.008 0.923 . . . . 0.0 109.625 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' ' CD2' ' A' ' 94' ' ' PHE . 36.5 m-85 -107.51 161.97 14.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.337 0.589 . . . . 0.0 111.921 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.24 17.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.0 m -148.54 150.53 33.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.466 0.306 . . . . 0.0 110.82 -171.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.76 129.99 9.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.2 -171.95 30.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.7 m -83.24 161.29 21.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.688 0.395 . . . . 0.0 110.706 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -76.02 2.53 12.5 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -122.46 11.81 10.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.978 0.511 . . . . 0.0 111.301 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 m -110.61 12.64 22.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.338 0.655 . . . . 0.0 111.849 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.27 154.59 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.404 0.682 . . . . 0.0 109.567 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.54 153.56 23.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.28 0.632 . . . . 0.0 111.979 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.0 m -62.89 -18.92 63.65 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -76.65 -20.5 56.6 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 118.599 0.636 . . . . 0.0 110.459 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.416 ' CD2' ' CD1' ' A' ' 81' ' ' PHE . 9.1 m-85 -85.8 -19.62 30.43 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -83.28 -19.03 37.08 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 122.419 0.288 . . . . 0.0 110.856 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.66 -21.33 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.102 0.561 . . . . 0.0 111.862 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -101.97 157.99 32.64 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 122.799 0.44 . . . . 0.0 110.414 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.12 149.94 76.8 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.43 2.753 . . . . 0.0 111.692 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.66 153.27 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.003 0.521 . . . . 0.0 110.465 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.75 157.48 46.01 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.205 1.002 . . . . 0.0 109.371 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.92 168.64 10.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 37.9 mtmm -60.64 -46.85 97.21 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.116 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 77.7 Cg_endo -71.93 138.16 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.835 1.69 . . . . 0.0 109.628 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 109' ' ' VAL . 2.2 m-30 -112.51 154.14 26.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.527 0.731 . . . . 0.0 110.325 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.7 p -138.01 160.76 38.48 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.428 0.691 . . . . 0.0 110.363 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.4 tpp -71.15 -28.86 64.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.152 0.426 . . . . 0.0 112.152 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.5 -43.56 14.45 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.968 -0.458 . . . . 0.0 111.931 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -30.18 48.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 119.845 -0.42 . . . . 0.0 112.527 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 104' ' ' PHE . 47.0 t -87.22 -30.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 CA-C-N 117.658 0.729 . . . . 0.0 111.01 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.66 68.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.871 -0.518 . . . . 0.0 110.021 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.31 -29.94 38.14 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.121 0.168 . . . . 0.0 110.707 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.6 37.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.295 -0.253 . . . . 0.0 111.417 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.92 -19.95 33.84 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 117.961 0.346 . . . . 0.0 111.115 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.02 -25.65 43.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.61 -25.86 41.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.65 29.92 1.43 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.036 0.935 . . . . 0.0 111.125 173.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.79 -16.47 7.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.425 0.29 . . . . 0.0 111.586 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.22 -177.343 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 4' ' ' LEU . 29.6 mt . . . . . 0 N--CA 1.458 -0.058 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -87.27 -11.56 49.26 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.16 0.584 . . . . 0.0 111.329 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.568 ' HB3' HG11 ' A' ' 32' ' ' VAL . 81.4 mt-30 -123.07 113.65 19.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.1 mm -122.47 131.55 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.626 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -89.87 149.81 22.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.635 ' H ' HD23 ' A' ' 8' ' ' LEU . 66.3 mt -115.17 135.59 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 118.115 0.416 . . . . 0.0 110.108 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.58 121.96 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 12.2 tp10 -150.55 157.49 43.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.806 -173.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.36 -10.49 19.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 112.508 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.552 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 48.0 mt-10 -133.2 132.92 22.44 Favored Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 121.919 -0.488 . . . . 0.0 110.369 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.41 -21.41 61.1 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.329 2.686 . . . . 0.0 113.2 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.94 -43.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.165 -0.335 . . . . 0.0 110.682 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.0 -25.63 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.76 -30.62 70.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.308 -0.245 . . . . 0.0 110.56 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mmt -82.42 -22.7 35.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.319 -0.238 . . . . 0.0 110.808 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mtp -73.94 -35.44 64.56 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.218 0.463 . . . . 0.0 110.179 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.37 -33.77 74.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.171 -0.331 . . . . 0.0 110.138 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.41 -25.53 60.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.297 -0.252 . . . . 0.0 110.359 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.76 -41.55 23.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.907 0.321 . . . . 0.0 111.136 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.16 -24.89 59.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.872 -0.518 . . . . 0.0 111.937 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.755 0.707 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -85.33 -21.4 28.94 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.554 0.616 . . . . 0.0 112.126 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.2 -26.0 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.25 0.477 . . . . 0.0 111.244 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.03 18.31 13.7 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 122.17 -0.331 . . . . 0.0 111.536 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.87 34.02 18.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.448 0.699 . . . . 0.0 112.388 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -85.64 162.49 18.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.907 0.883 . . . . 0.0 109.102 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m -111.32 85.22 5.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.116 -0.365 . . . . 0.0 110.393 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.27 156.97 62.41 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.732 2.288 . . . . 0.0 110.038 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.7 m -131.15 -9.14 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.18 173.82 33.27 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 119.302 0.955 . . . . 0.0 113.126 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -144.0 141.09 29.96 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.202 1.001 . . . . 0.0 109.014 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.48 162.18 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 122.892 0.477 . . . . 0.0 111.091 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.35 -11.79 29.27 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.524 0.73 . . . . 0.0 111.858 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -149.29 157.99 43.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.947 -0.471 . . . . 0.0 110.491 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -71.55 -22.47 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 122.574 0.35 . . . . 0.0 110.223 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.87 -26.51 66.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.978 -0.451 . . . . 0.0 109.983 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -26.15 55.62 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.49 -30.56 63.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.255 0.527 . . . . 0.0 109.839 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.47 -37.43 68.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.78 64.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.373 -0.204 . . . . 0.0 111.074 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -22.27 29.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.453 0.301 . . . . 0.0 111.062 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.19 -21.85 10.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.75 -14.92 62.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.335 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -100.02 -12.49 19.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.089 0.956 . . . . 0.0 110.681 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.11 -168.49 52.09 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.58 23.36 62.66 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.44 -0.447 . . . . 0.0 112.231 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 mt -135.57 148.01 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.697 0.748 . . . . 0.0 109.343 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -120.0 -30.32 4.73 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.59 178.83 9.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.811 0.444 . . . . 0.0 109.913 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.36 163.1 39.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 mm -113.21 140.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.4 tp -140.71 129.53 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.551 0.215 . . . . 0.0 110.996 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.16 154.08 26.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.421 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.94 -11.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 122.893 0.477 . . . . 0.0 109.903 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 124.159 0.984 . . . . 0.0 111.97 -177.421 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 CA--C 1.529 0.15 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.45 -11.96 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.601 2.867 . . . . 0.0 111.653 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.25 -22.7 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 122.046 -0.409 . . . . 0.0 110.797 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.29 75.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.06 -17.96 60.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.164 -0.335 . . . . 0.0 111.227 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.33 -29.41 57.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.56 -34.52 72.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.61 -21.06 60.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.053 -0.404 . . . . 0.0 110.81 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.25 -16.59 42.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.514 0.325 . . . . 0.0 111.459 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -104.08 23.81 12.4 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.447 0.699 . . . . 0.0 111.775 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 53.83 41.83 31.93 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.865 0.866 . . . . 0.0 112.662 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.96 87.83 23.67 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.12 164.47 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 124.844 3.696 . . . . 0.0 114.27 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.19 169.3 17.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.975 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.06 141.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.277 1.031 . . . . 0.0 109.27 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.04 150.14 22.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.572 0.225 . . . . 0.0 110.764 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.47 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.89 0.476 . . . . 0.0 110.017 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -160.67 158.73 29.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.212 -0.305 . . . . 0.0 111.112 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.92 113.26 4.14 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.88 -163.52 29.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.8 m -76.88 160.41 29.24 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.237 0.542 . . . . 0.0 110.753 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.99 -3.12 56.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.694 0.398 . . . . 0.0 111.96 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -92.73 -0.46 57.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.584 0.354 . . . . 0.0 111.441 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -84.23 8.35 16.11 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.43 0.692 . . . . 0.0 112.02 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.7 m -136.9 154.68 31.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.752 0.821 . . . . 0.0 110.728 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -72.33 169.27 16.62 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.384 0.673 . . . . 0.0 111.487 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.9 p -61.94 -15.83 46.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -74.82 -24.24 58.59 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.939 0.336 . . . . 0.0 110.268 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 10.1 m-85 -86.01 -22.48 27.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -84.39 -14.53 49.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.801 0.441 . . . . 0.0 110.895 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.69 -33.55 14.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.732 0.413 . . . . 0.0 110.475 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -83.0 160.65 60.07 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.48 152.15 69.9 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.24 2.627 . . . . 0.0 111.181 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.24 154.39 33.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.002 0.521 . . . . 0.0 111.102 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.06 154.63 48.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.711 0.804 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -86.94 165.63 15.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.062 0.545 . . . . 0.0 109.658 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.15 -49.38 12.59 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.33 140.01 21.51 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.052 1.835 . . . . 0.0 111.161 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -110.4 152.34 26.38 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.065 0.46 . . . . 0.0 110.54 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 108' ' ' GLY . 8.8 t -154.26 164.61 38.28 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.028 0.931 . . . . 0.0 108.849 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -58.59 -27.57 64.77 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -84.04 -36.01 23.41 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.084 0.402 . . . . 0.0 111.256 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.456 ' H ' HG23 ' A' ' 105' ' ' THR . . . -79.3 -25.24 59.62 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.12 -30.26 11.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.122 0.461 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.34 69.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.73 -20.81 30.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.684 0.394 . . . . 0.0 111.107 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.24 61.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.477 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.4 mt -77.5 -28.42 52.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.0 -20.28 61.05 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.977 0.353 . . . . 0.0 110.874 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.47 -20.6 26.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.534 0.333 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -91.32 -50.63 5.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.819 0.282 . . . . 0.0 110.546 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.96 2.92 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.328 1.051 . . . . 0.0 112.88 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.173 -1.394 . . . . 0.0 110.0 178.446 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.981 0.419 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -4.14 58.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 175.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.649 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.0 mp0 -120.37 109.68 15.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.671 0.789 . . . . 0.0 111.438 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 mm -116.62 130.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 O-C-N 123.514 0.509 . . . . 0.0 110.086 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 145.31 25.11 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.656 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.7 mt -113.33 130.57 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.769 0.828 . . . . 0.0 109.237 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.29 117.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -141.26 162.98 34.19 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.626 0.77 . . . . 0.0 110.512 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -84.02 -9.95 58.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.454 0.301 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.6 145.51 40.78 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.839 0.456 . . . . 0.0 109.836 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.07 -14.75 26.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.116 2.544 . . . . 0.0 111.202 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -74.89 -30.32 61.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 117.771 0.26 . . . . 0.0 110.626 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mm -84.91 -30.17 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.77 69.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.8 tpp -78.91 -28.23 43.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.9 ttt -70.39 -29.99 66.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 2.1 mm? -75.16 -29.48 60.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.499 0.32 . . . . 0.0 110.483 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.88 -23.79 61.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.893 0.315 . . . . 0.0 110.266 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.48 -40.72 42.05 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.438 -0.164 . . . . 0.0 111.432 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.74 -24.66 53.02 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.266 0.484 . . . . 0.0 111.96 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.66 -20.35 56.76 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.704 0.684 . . . . 0.0 110.364 176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.2 -27.66 35.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.875 0.307 . . . . 0.0 110.585 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.4 t -79.76 -22.59 12.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 122.504 0.322 . . . . 0.0 110.859 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.77 13.56 34.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.793 0.437 . . . . 0.0 111.815 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 53.49 29.2 8.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 112.4 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -85.62 161.05 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.629 0.772 . . . . 0.0 109.202 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.8 m -105.83 117.47 57.69 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.6 162.83 27.19 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.322 2.681 . . . . 0.0 110.107 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 6' ' ' GLN . 26.7 m -135.12 -18.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.47 172.75 32.33 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.136 0.425 . . . . 0.0 112.147 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.3 p -139.14 142.02 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 108.464 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.33 152.87 23.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.792 0.329 . . . . 0.0 110.297 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -100.83 1.32 39.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.24 0.616 . . . . 0.0 112.111 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -141.32 157.84 44.67 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 109.812 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.36 -22.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 122.416 -0.177 . . . . 0.0 110.8 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.85 -25.96 61.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.147 -0.346 . . . . 0.0 110.677 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.95 -27.12 60.96 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.24 -34.81 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.34 0.57 . . . . 0.0 110.066 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -69.36 -36.96 77.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.95 66.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.247 -0.283 . . . . 0.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -84.8 -20.84 30.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.77 0.259 . . . . 0.0 111.332 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.41 -24.2 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.855 0.298 . . . . 0.0 110.45 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -75.83 -14.57 60.29 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.249 -0.282 . . . . 0.0 110.79 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.85 -12.48 22.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.541 0.736 . . . . 0.0 111.035 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.94 53.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.61 11.33 84.17 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.67 147.99 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -121.94 -19.76 6.57 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.13 168.64 26.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.596 0.358 . . . . 0.0 110.097 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.35 34.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 111.49 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.04 129.3 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.68 130.37 56.8 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.806 0.442 . . . . 0.0 111.05 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.47 132.41 34.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.51 -11.26 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.737 0.415 . . . . 0.0 110.782 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.074 -179.847 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -11.69 31.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.669 2.913 . . . . 0.0 111.963 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.2 -19.33 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 O-C-N 122.118 -0.363 . . . . 0.0 110.237 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.75 -26.14 67.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.98 -17.98 59.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.159 -0.338 . . . . 0.0 110.555 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.37 -31.79 48.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.91 -34.12 76.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.06 -21.83 61.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.076 0.15 . . . . 0.0 110.691 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.89 -7.0 59.54 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.895 0.478 . . . . 0.0 110.826 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -114.7 15.01 17.64 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.708 0.803 . . . . 0.0 111.313 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.21 36.8 28.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.251 1.02 . . . . 0.0 112.927 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.7 mt -109.27 108.69 60.34 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.187 0.995 . . . . 0.0 108.366 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.74 154.85 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.733 2.955 . . . . 0.0 112.224 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.54 165.0 31.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.24 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.09 145.35 28.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.371 1.068 . . . . 0.0 108.416 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.14 153.24 18.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 111.308 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.17 148.17 37.8 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -159.95 170.97 20.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.63 0.253 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.77 95.31 0.23 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.71 -160.11 28.45 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.7 t -75.35 157.02 34.88 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.17 -4.43 29.62 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.071 0.549 . . . . 0.0 111.223 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.75 -1.4 34.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.9 11.28 33.8 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.676 0.79 . . . . 0.0 111.461 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 t -126.35 154.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.294 0.638 . . . . 0.0 109.795 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.0 152.46 23.76 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.172 0.589 . . . . 0.0 111.636 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.3 p -63.63 -17.45 62.92 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -77.56 -17.17 58.14 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 118.335 0.516 . . . . 0.0 110.729 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -89.75 -21.35 22.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -88.18 -11.21 47.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.977 0.511 . . . . 0.0 111.327 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.62 -27.26 12.43 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.281 0.632 . . . . 0.0 111.197 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.79 161.17 48.34 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 145.19 80.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.143 2.562 . . . . 0.0 112.608 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.2 m -140.62 154.27 21.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.699 0.8 . . . . 0.0 110.23 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 tp -145.87 146.45 31.12 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.1 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -85.01 158.77 20.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.878 0.471 . . . . 0.0 109.796 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -67.02 -36.22 10.62 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.82 125.32 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.402 2.068 . . . . 0.0 110.202 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 3.8 m-30 -112.29 151.96 29.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.745 0.418 . . . . 0.0 110.854 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.9 p -142.64 159.28 42.53 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.161 0.984 . . . . 0.0 109.087 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -66.04 -26.34 67.46 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.829 -0.544 . . . . 0.0 111.174 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.63 -37.1 21.49 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 117.788 0.267 . . . . 0.0 111.536 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.48 -27.25 59.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.929 -0.373 . . . . 0.0 112.185 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.57 -29.4 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 117.696 0.748 . . . . 0.0 110.464 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.02 69.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.97 -21.16 29.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.365 0.666 . . . . 0.0 110.819 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.39 38.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.66 0.209 . . . . 0.0 110.664 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.62 -28.69 60.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -26.37 63.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.96 41.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.051 0.54 . . . . 0.0 111.752 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -90.98 -33.81 15.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.353 0.261 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -94.08 0.23 55.77 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.901 0.48 . . . . 0.0 111.844 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.22 -1.372 . . . . 0.0 109.767 179.157 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.68 -5.47 37.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.39 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 63.5 mt-30 -119.94 111.77 18.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.803 0.335 . . . . 0.0 111.541 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.21 135.4 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.093 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -92.38 132.3 36.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' N ' HD23 ' A' ' 8' ' ' LEU . 84.0 mt -94.6 128.0 46.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.215 0.606 . . . . 0.0 109.487 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.41 115.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.066 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.89 162.98 32.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.057 0.543 . . . . 0.0 111.622 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.5 4.42 18.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.677 . . . . 0.0 110.374 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -141.11 110.69 6.51 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.804 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -55.75 -21.78 33.88 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.952 3.101 . . . . 0.0 113.875 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 tp -74.31 -33.7 63.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.214 0.461 . . . . 0.0 110.305 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.3 mm -77.73 -31.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.22 65.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.8 tpp -77.76 -31.83 52.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -74.52 -30.41 61.78 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.472 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.16 -29.95 68.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.2 -24.03 54.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.068 0.394 . . . . 0.0 110.193 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.9 -43.13 20.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.241 -0.287 . . . . 0.0 111.279 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.38 -28.33 59.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.188 0.449 . . . . 0.0 111.813 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -79.17 -17.65 54.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.514 0.597 . . . . 0.0 110.865 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.85 -26.16 27.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.039 0.381 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -82.86 -22.59 8.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 122.555 0.342 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.9 mt -101.11 16.35 25.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 51.97 37.36 20.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.862 0.865 . . . . 0.0 112.181 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.61 164.61 17.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.494 0.717 . . . . 0.0 109.528 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.0 m -117.46 71.8 7.02 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 122.537 0.335 . . . . 0.0 110.825 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.3 159.69 42.46 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.986 2.457 . . . . 0.0 110.114 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.2 m -123.81 -10.02 7.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.72 173.77 33.72 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 118.54 0.609 . . . . 0.0 112.291 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.3 m -140.25 139.24 35.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 109.337 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.32 158.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.231 0.612 . . . . 0.0 110.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -137.04 3.63 2.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.655 0.382 . . . . 0.0 111.763 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -139.04 149.71 44.94 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.04 -32.38 55.99 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 122.29 0.236 . . . . 0.0 111.311 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.85 69.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.953 -0.467 . . . . 0.0 110.945 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.49 -29.8 47.5 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.4 63.6 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.516 0.658 . . . . 0.0 110.541 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.92 -27.09 54.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.41 -24.67 61.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.149 -0.344 . . . . 0.0 110.883 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.07 -29.24 22.04 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.09 -21.95 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.564 0.62 . . . . 0.0 111.523 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -81.66 -14.72 56.3 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.07 -0.394 . . . . 0.0 111.021 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -91.9 -13.21 31.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.539 0.336 . . . . 0.0 111.519 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -164.8 42.18 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.61 24.98 61.58 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.306 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -127.79 144.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 117.433 0.616 . . . . 0.0 109.646 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -109.94 -27.87 9.02 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.23 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.06 178.56 7.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.156 0.583 . . . . 0.0 110.389 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.23 162.01 41.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.906 -0.496 . . . . 0.0 111.847 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.4 mt -116.22 126.62 73.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.11 133.06 56.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.876 0.47 . . . . 0.0 111.488 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.83 144.29 30.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -80.37 -11.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.8 t30 . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 122.754 0.422 . . . . 0.0 110.696 -176.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.71 -11.72 12.59 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.549 2.833 . . . . 0.0 111.494 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.47 -31.43 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 117.87 0.305 . . . . 0.0 110.775 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.99 86.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.956 -0.465 . . . . 0.0 110.289 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.0 -17.37 40.69 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.263 -0.273 . . . . 0.0 111.274 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -33.25 68.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.1 mt -73.88 -27.54 61.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.24 -23.0 61.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.928 0.331 . . . . 0.0 110.5 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.91 -19.37 40.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.315 0.246 . . . . 0.0 110.375 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -98.12 5.37 48.67 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.43 0.692 . . . . 0.0 111.491 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 57.37 27.6 14.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 112.534 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.6 mt -94.78 124.52 54.43 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.313 0.645 . . . . 0.0 109.327 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -59.89 150.26 78.92 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.894 3.063 . . . . 0.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -151.91 160.39 43.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.672 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.17 156.47 36.66 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.395 0.678 . . . . 0.0 109.498 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.73 160.62 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.35 0.595 . . . . 0.0 111.896 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.46 136.55 36.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.8 p -134.05 161.89 33.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.069 0.461 . . . . 0.0 111.96 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.04 -167.75 36.14 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.11 49.77 2.96 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -153.95 144.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.485 0.714 . . . . 0.0 110.033 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -105.42 -2.32 23.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.456 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.95 -2.87 33.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.042 0.537 . . . . 0.0 111.507 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -85.66 5.63 31.1 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.059 0.544 . . . . 0.0 111.813 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.64 154.73 19.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.137 0.575 . . . . 0.0 111.814 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.66 170.9 15.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.848 0.859 . . . . 0.0 111.179 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -62.85 -17.27 61.21 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -70.73 -29.78 66.12 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.778 -0.576 . . . . 0.0 110.195 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -81.02 -23.94 38.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -84.25 -10.37 57.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.82 0.448 . . . . 0.0 110.885 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -23.58 15.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.981 0.512 . . . . 0.0 110.913 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -97.19 163.86 19.01 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.286 0.634 . . . . 0.0 110.042 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.45 147.53 85.37 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.251 2.634 . . . . 0.0 112.084 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 m -140.36 154.07 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.486 0.714 . . . . 0.0 110.297 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.53 151.65 51.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.528 0.731 . . . . 0.0 109.953 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -74.35 156.76 36.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.53 ' HA ' ' CE ' ' A' ' 102' ' ' LYS . 1.9 tpmt? -71.1 -47.47 14.19 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.723 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 92.3 Cg_endo -73.52 142.43 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.902 1.735 . . . . 0.0 109.804 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -115.56 157.83 23.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.928 0.891 . . . . 0.0 110.75 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -141.91 162.53 35.24 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 124.058 0.943 . . . . 0.0 109.46 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -64.67 -32.52 74.22 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 122.255 -0.278 . . . . 0.0 111.149 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.45 -34.44 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.712 0.233 . . . . 0.0 111.597 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.03 56.16 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.628 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.27 -27.51 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.954 0.877 . . . . 0.0 110.729 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.02 71.79 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.222 0.465 . . . . 0.0 110.294 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -82.78 -29.62 29.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.327 0.251 . . . . 0.0 110.419 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.65 -31.57 46.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.732 0.242 . . . . 0.0 111.221 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.36 -39.81 58.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.96 -26.8 65.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.497 -0.127 . . . . 0.0 110.802 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.26 -14.41 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.567 0.347 . . . . 0.0 111.566 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -91.25 -35.85 14.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.761 0.424 . . . . 0.0 110.78 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 tp -88.67 -12.15 43.26 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.116 -1.421 . . . . 0.0 110.165 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -12.67 40.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.477 0.311 . . . . 0.0 110.774 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.577 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.7 mp0 -115.1 116.16 27.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.572 0.349 . . . . 0.0 111.469 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.42 128.76 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.418 0.687 . . . . 0.0 110.366 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -87.82 141.02 28.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.556 ' H ' HD23 ' A' ' 8' ' ' LEU . 90.0 mt -106.0 127.35 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.791 0.836 . . . . 0.0 109.21 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.0 126.87 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -155.07 165.87 35.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.255 0.622 . . . . 0.0 111.181 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -124.21 18.17 9.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.974 0.51 . . . . 0.0 110.242 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -137.77 126.86 14.85 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.727 0.811 . . . . 0.0 108.883 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.77 -18.68 32.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.411 2.741 . . . . 0.0 112.839 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.57 -25.5 35.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.26 0.482 . . . . 0.0 110.512 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.11 -26.05 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.43 84.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.011 -0.431 . . . . 0.0 110.843 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -77.26 -25.12 51.17 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 122.303 -0.248 . . . . 0.0 110.884 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 ttp -75.15 -32.17 61.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.429 -0.169 . . . . 0.0 110.688 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.67 -33.79 69.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.845 0.293 . . . . 0.0 110.68 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.71 -22.01 57.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.885 0.311 . . . . 0.0 110.451 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.75 -38.73 32.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.213 -0.305 . . . . 0.0 111.367 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -78.1 -23.44 47.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.562 0.619 . . . . 0.0 111.297 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.9 -18.54 58.25 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.439 0.563 . . . . 0.0 109.892 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.95 -28.04 35.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.05 0.386 . . . . 0.0 110.019 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -77.74 -23.59 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 122.615 0.366 . . . . 0.0 110.315 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.2 mt -93.04 8.2 40.98 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.793 0.437 . . . . 0.0 111.513 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.23 30.95 8.48 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.25 0.62 . . . . 0.0 111.47 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.72 161.12 19.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.4 m -107.97 98.99 28.31 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 122.357 0.263 . . . . 0.0 110.321 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.92 158.76 54.58 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.907 2.405 . . . . 0.0 109.26 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.577 HG11 ' HB3' ' A' ' 6' ' ' GLN . 34.2 m -127.94 -11.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.31 172.75 32.17 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.313 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -133.97 143.18 48.01 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.968 0.907 . . . . 0.0 108.755 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.69 140.2 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.72 1.53 57.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -140.78 157.06 45.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.119 0.568 . . . . 0.0 109.878 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.3 -22.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 122.47 -0.144 . . . . 0.0 110.779 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.86 63.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -19.58 68.95 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.96 -36.85 48.6 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.738 0.769 . . . . 0.0 110.746 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.76 -30.23 40.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.22 -25.66 59.79 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.187 -0.321 . . . . 0.0 111.266 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -87.39 -26.76 23.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.67 0.388 . . . . 0.0 111.827 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -82.77 -22.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 118.191 0.45 . . . . 0.0 111.604 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.35 -14.66 62.67 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.122 0.419 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.27 -12.52 59.61 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.684 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 -174.8 54.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.82 85.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -133.72 149.38 30.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -129.67 -12.03 4.36 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.57 169.25 20.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.841 0.456 . . . . 0.0 110.101 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 158.63 44.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.581 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.46 127.46 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.43 126.16 55.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.814 0.446 . . . . 0.0 110.888 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -77.85 132.83 38.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.56 -13.26 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.21 -0.306 . . . . 0.0 110.323 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.241 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.35 -10.91 29.12 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.364 2.71 . . . . 0.0 111.401 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.77 -16.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.022 0.529 . . . . 0.0 111.064 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 -23.3 62.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.957 -0.465 . . . . 0.0 109.881 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.19 -19.03 57.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.04 -30.8 39.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.51 -30.13 66.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.31 -20.95 54.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.266 0.226 . . . . 0.0 110.652 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.97 -18.46 59.3 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -90.34 12.83 17.12 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.42 0.688 . . . . 0.0 110.449 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.44 31.93 21.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.812 1.245 . . . . 0.0 112.824 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -113.8 126.17 28.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.68 160.31 38.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.213 3.275 . . . . 0.0 112.338 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.06 171.72 15.94 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.25 149.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.776 0.831 . . . . 0.0 108.967 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.82 154.31 17.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.185 0.517 . . . . 0.0 111.413 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.54 125.03 22.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.6 t -154.69 169.57 23.59 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.64 126.78 1.55 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.56 -164.82 29.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -74.02 159.11 33.15 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 110.307 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.48 -8.68 59.61 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.53 0.332 . . . . 0.0 111.44 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.22 0.76 20.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.215 0.606 . . . . 0.0 112.135 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.0 p -124.1 11.77 8.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.142 0.577 . . . . 0.0 111.948 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.81 160.99 17.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.355 0.597 . . . . 0.0 112.576 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -64.8 -16.2 62.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -78.16 -16.71 57.66 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.717 0.69 . . . . 0.0 111.238 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -85.89 -24.46 26.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -79.02 -15.95 57.54 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.342 0.257 . . . . 0.0 111.012 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.88 -24.69 13.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.045 0.538 . . . . 0.0 111.523 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -90.39 160.32 39.77 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 123.187 0.595 . . . . 0.0 109.53 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -63.71 144.49 89.38 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.83 2.353 . . . . 0.0 110.666 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.17 154.35 20.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.737 0.815 . . . . 0.0 110.806 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -139.96 153.8 47.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -69.41 158.72 34.58 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.438 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 13.8 mmmm -62.33 -47.63 89.04 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.23 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.6 Cg_endo -71.43 135.15 25.95 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.427 1.418 . . . . 0.0 108.849 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.6 156.62 17.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.122 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.6 p -141.11 160.77 39.39 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.382 1.073 . . . . 0.0 108.702 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -62.36 -28.78 70.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.304 -0.248 . . . . 0.0 111.043 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.85 -29.1 27.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.336 -0.228 . . . . 0.0 110.97 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.51 -32.98 49.34 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.052 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -82.28 -24.47 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 117.841 0.82 . . . . 0.0 111.151 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.11 65.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.25 0.477 . . . . 0.0 109.964 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.23 -25.82 27.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.793 0.437 . . . . 0.0 111.549 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.79 -37.35 41.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.781 0.264 . . . . 0.0 110.778 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.37 -27.52 52.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.84 60.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.149 0.431 . . . . 0.0 110.672 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.21 -17.42 32.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.23 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.23 -47.56 7.43 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.16 18.02 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.452 1.101 . . . . 0.0 111.588 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.155 -179.148 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -92.13 -14.28 29.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.043 0.937 . . . . 0.0 109.681 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.652 ' HB3' HG11 ' A' ' 32' ' ' VAL . 23.1 mp0 -114.57 111.84 21.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.798 0.439 . . . . 0.0 111.619 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mm -118.41 130.43 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.226 0.61 . . . . 0.0 110.128 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -90.73 141.18 29.07 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.524 ' H ' HD23 ' A' ' 8' ' ' LEU . 96.7 mt -105.31 130.55 56.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.478 0.711 . . . . 0.0 109.78 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 t -127.61 117.97 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.605 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 14.2 tp10 -145.62 156.18 43.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.474 0.71 . . . . 0.0 109.744 -173.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -124.35 15.64 8.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.418 0.687 . . . . 0.0 111.416 -176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.605 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 15.9 tp10 -136.08 107.22 9.58 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.28 -25.02 36.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.626 2.884 . . . . 0.0 114.152 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -77.16 -37.93 52.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.407 0.549 . . . . 0.0 110.465 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.5 mt -79.33 -24.33 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.85 0.296 . . . . 0.0 110.536 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.9 mtt -76.97 -31.3 56.45 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.7 mtp -72.94 -23.77 60.72 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -74.47 -34.25 63.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.327 -0.233 . . . . 0.0 110.666 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.34 -22.38 51.91 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.42 -37.46 57.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.69 -23.24 56.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.269 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -77.25 -23.46 51.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.926 0.33 . . . . 0.0 110.245 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.07 -32.27 26.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.303 0.241 . . . . 0.0 110.482 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -76.82 -19.77 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.6 tp -82.81 0.22 44.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.583 0.753 . . . . 0.0 110.542 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 53.89 28.8 8.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.861 0.865 . . . . 0.0 111.695 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -91.25 156.84 17.52 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.971 0.908 . . . . 0.0 110.74 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.0 m -92.64 121.61 65.8 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -78.59 161.68 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.168 3.245 . . . . 0.0 111.25 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -141.7 -18.7 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 173.07 32.58 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.398 0.545 . . . . 0.0 112.548 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.2 p -139.62 142.98 37.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.503 1.121 . . . . 0.0 108.46 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 156.03 21.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.83 -7.66 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.597 0.759 . . . . 0.0 111.563 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -152.61 161.22 42.87 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.668 0.387 . . . . 0.0 110.467 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.65 -22.55 26.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.186 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -27.23 63.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.72 -28.75 56.49 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.32 74.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.563 0.681 . . . . 0.0 109.496 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.94 -31.21 66.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 -24.92 63.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.372 -0.205 . . . . 0.0 111.08 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.348 0.259 . . . . 0.0 111.206 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -76.27 -25.23 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.899 0.318 . . . . 0.0 110.244 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -73.78 -14.78 61.17 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.352 -0.217 . . . . 0.0 110.856 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.4 -12.61 24.06 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.193 0.597 . . . . 0.0 111.007 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.82 -169.04 49.03 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.26 86.35 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.619 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.4 mt -129.16 147.97 33.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.78 -17.47 4.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.99 170.24 22.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.728 0.411 . . . . 0.0 110.43 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.93 162.53 41.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.624 0.249 . . . . 0.0 111.538 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.11 130.97 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.76 125.72 54.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.523 0.329 . . . . 0.0 110.958 -174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.54 129.9 34.85 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.53 -12.93 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.026 0.53 . . . . 0.0 110.9 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 123.163 0.585 . . . . 0.0 110.964 -177.218 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.471 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 42.1 p . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.6 Cg_exo -59.05 -16.49 33.15 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.976 1.784 . . . . 0.0 112.99 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.6 -21.67 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.038 0.381 . . . . 0.0 110.291 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.62 65.45 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.026 -0.421 . . . . 0.0 110.064 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.62 -19.66 60.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.339 -0.226 . . . . 0.0 110.66 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.92 51.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.42 -36.88 74.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.17 62.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.276 -0.265 . . . . 0.0 110.748 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 -15.19 54.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.405 0.282 . . . . 0.0 110.432 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -105.29 20.68 18.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.704 0.802 . . . . 0.0 111.403 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 59.02 35.76 24.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.035 0.934 . . . . 0.0 113.444 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.3 mt -118.59 97.62 50.84 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.97 161.14 26.89 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.079 3.186 . . . . 0.0 112.638 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -148.02 170.26 18.12 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.919 0.487 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.5 144.16 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -86.88 155.98 20.03 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.8 0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.05 125.98 18.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -161.93 164.71 28.34 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 110.618 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.45 95.61 0.57 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.43 165.04 12.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.7 m -147.58 28.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.55 0.34 . . . . 0.0 110.873 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -105.62 -50.88 3.11 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.71 -5.42 2.5 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.2 p -88.07 4.18 46.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.879 0.472 . . . . 0.0 112.131 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.43 154.44 30.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.336 0.588 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.98 179.86 7.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.0 108.972 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -57.53 -19.32 24.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.754 -0.591 . . . . 0.0 112.235 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -74.45 -24.63 59.09 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.991 -0.443 . . . . 0.0 110.749 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.56 -17.12 39.89 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.9 0.88 . . . . 0.0 109.396 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -88.26 -11.0 47.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.467 0.707 . . . . 0.0 110.37 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -111.98 -8.46 14.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.628 0.771 . . . . 0.0 111.785 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 26.1 tpt180 -137.84 139.56 26.82 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 79.0 Cg_exo -53.11 154.89 12.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.854 3.036 . . . . 0.0 114.238 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.83 155.14 32.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.136 0.974 . . . . 0.0 110.259 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.3 tp -133.57 149.71 51.65 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -74.08 160.97 30.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -70.45 -42.4 15.05 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.418 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.01 141.15 43.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.5 2.134 . . . . 0.0 109.645 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 4.6 m-30 -103.21 149.08 25.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 110.497 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.4 p -139.08 166.39 24.64 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.955 0.902 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mmm -65.65 -35.77 81.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.185 -0.322 . . . . 0.0 110.808 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.68 -28.38 26.43 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.388 0.275 . . . . 0.0 111.74 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.75 -28.81 64.36 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.6 t -83.91 -30.16 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.344 0.572 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.2 -27.84 60.98 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.39 -24.45 39.71 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.663 0.385 . . . . 0.0 110.244 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.24 64.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.183 -0.323 . . . . 0.0 110.394 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.21 -40.75 74.38 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.49 -18.89 61.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -23.27 24.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tt -91.79 -50.57 5.66 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.163 -0.336 . . . . 0.0 111.13 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.95 -1.12 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.913 -1.518 . . . . 0.0 110.06 178.669 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 N--CA 1.457 -0.103 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -79.93 -8.78 59.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.972 0.509 . . . . 0.0 111.585 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.438 ' HB3' HG11 ' A' ' 32' ' ' VAL . 65.2 mt-30 -121.04 114.62 21.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -119.88 131.98 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -91.39 145.03 24.97 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.559 ' H ' HD23 ' A' ' 8' ' ' LEU . 74.7 mt -113.34 130.95 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.1 117.71 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.19 163.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.21 -4.69 5.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.912 0.885 . . . . 0.0 110.538 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 44.5 tt0 -153.75 136.8 10.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 61.8 Cg_exo -56.74 -18.39 26.65 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.004 3.136 . . . . 0.0 114.52 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.62 -21.59 38.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.144 0.429 . . . . 0.0 111.671 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.11 -38.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.15 60.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.312 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.7 ttm -76.26 -32.8 59.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.0 tpt -81.5 -27.83 34.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.274 -0.266 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.48 -36.34 63.28 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -74.59 -21.69 59.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.82 -42.08 61.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.039 -0.413 . . . . 0.0 110.98 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -83.24 -22.78 33.0 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.91 -21.21 40.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.117 0.871 . . . . 0.0 111.076 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -85.58 -29.4 24.16 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.064 0.393 . . . . 0.0 111.314 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.39 -18.66 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 122.386 0.275 . . . . 0.0 111.23 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -99.33 18.15 18.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.119 0.567 . . . . 0.0 111.532 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 53.79 31.3 12.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.673 0.789 . . . . 0.0 112.227 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.51 165.72 16.89 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.639 0.776 . . . . 0.0 109.245 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -118.28 75.21 11.52 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 110.947 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.9 157.34 53.09 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.244 2.629 . . . . 0.0 109.78 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.1 m -122.75 -15.19 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.84 178.18 37.98 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.289 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 p -135.37 140.93 45.41 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.524 1.13 . . . . 0.0 108.876 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.51 147.16 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 110.431 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -92.1 2.19 56.73 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.41 0.684 . . . . 0.0 112.255 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -155.01 157.34 37.47 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.099 0.56 . . . . 0.0 110.065 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.48 -22.56 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.137 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.5 -26.04 64.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.36 59.27 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.02 67.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.714 0.757 . . . . 0.0 109.931 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.61 -37.54 68.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.79 -24.94 63.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -86.46 -22.7 26.33 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.314 0.506 . . . . 0.0 111.345 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.53 -28.22 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.52 -14.68 54.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.058 0.543 . . . . 0.0 111.559 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -108.16 -12.54 15.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.043 0.537 . . . . 0.0 112.197 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.71 165.82 38.94 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.15 136.06 18.82 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mt -144.7 146.1 20.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -101.09 -30.93 11.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 173.33 14.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.586 0.355 . . . . 0.0 110.343 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.1 158.23 43.95 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.98 128.27 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.64 119.09 34.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.182 0.593 . . . . 0.0 110.224 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.72 145.21 36.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.3 m -76.78 -11.79 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t30 . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m . . . . . 0 CA--C 1.529 0.151 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.69 -11.89 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.677 2.918 . . . . 0.0 112.499 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.61 -16.88 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.923 -0.486 . . . . 0.0 110.684 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.3 69.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.823 -0.548 . . . . 0.0 110.048 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.17 -18.07 60.26 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.389 0.276 . . . . 0.0 110.606 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.21 -30.34 38.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.22 -33.77 70.18 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.13 -23.11 61.26 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.063 0.145 . . . . 0.0 110.767 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.67 -16.83 56.82 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -99.57 16.87 21.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.684 0.794 . . . . 0.0 110.626 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.69 26.23 15.3 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 113.65 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.88 122.02 44.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.54 159.58 39.24 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.781 2.988 . . . . 0.0 111.453 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -147.3 164.5 33.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.56 144.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 124.048 0.939 . . . . 0.0 108.688 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -90.93 155.9 18.39 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.23 133.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -155.15 168.81 25.79 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.772 0.429 . . . . 0.0 111.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.95 118.4 0.95 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.57 -154.21 25.49 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -70.86 161.82 30.31 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.684 0.394 . . . . 0.0 110.337 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.99 -1.91 48.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.756 0.422 . . . . 0.0 112.043 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -100.88 0.55 38.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.231 0.612 . . . . 0.0 111.671 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -87.9 5.54 39.98 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.001 0.52 . . . . 0.0 112.12 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.0 m -123.08 154.58 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.488 0.715 . . . . 0.0 111.835 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.5 171.49 15.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.246 1.018 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -61.2 -18.18 56.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.164 0.586 . . . . 0.0 112.567 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -72.73 -24.7 61.01 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.735 0.698 . . . . 0.0 110.989 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 46.0 m-85 -84.43 -19.18 33.86 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.05 -10.37 50.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.064 0.546 . . . . 0.0 111.176 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.07 -15.06 14.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.349 0.66 . . . . 0.0 111.288 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -108.91 156.1 39.63 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 123.629 0.772 . . . . 0.0 109.585 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.91 151.58 83.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.197 2.598 . . . . 0.0 110.683 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.91 154.37 36.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.761 0.824 . . . . 0.0 110.688 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -135.64 157.2 47.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.821 0.848 . . . . 0.0 110.342 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -81.97 158.79 23.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -67.99 -53.44 20.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.816 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.44 141.71 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.048 1.832 . . . . 0.0 109.585 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -106.49 158.57 16.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.44 0.638 . . . . 0.0 111.681 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 p -137.49 164.25 29.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.768 1.227 . . . . 0.0 107.776 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.9 ttm -65.17 -29.12 69.92 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.001 -0.437 . . . . 0.0 110.883 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.32 -29.95 25.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.076 0.15 . . . . 0.0 110.904 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.95 -28.84 55.8 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.784 -0.453 . . . . 0.0 111.986 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.51 -24.65 8.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-N 117.864 0.832 . . . . 0.0 110.238 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 -28.98 65.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -85.11 -20.96 29.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.575 0.35 . . . . 0.0 110.983 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.89 -41.6 64.48 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.825 0.284 . . . . 0.0 110.314 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -78.92 -27.24 43.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.26 -20.1 60.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.939 0.336 . . . . 0.0 110.556 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.7 24.78 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.349 0.26 . . . . 0.0 111.3 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 tt -91.55 -51.81 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.875 0.307 . . . . 0.0 111.217 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.94 4.11 3.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.09 0.956 . . . . 0.0 113.214 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.828 -1.082 . . . . 0.0 109.966 178.86 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.375 0.607 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -74.28 -18.12 60.77 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.099 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 74.7 mt-30 -102.75 104.07 14.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.829 0.347 . . . . 0.0 110.713 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.23 130.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.573 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -89.41 129.61 35.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.406 ' N ' HD23 ' A' ' 8' ' ' LEU . 79.7 mt -94.34 129.68 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.473 0.709 . . . . 0.0 109.3 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -130.23 103.52 8.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 13' ' ' GLU . 82.0 tt0 -157.61 142.87 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -92.88 -7.48 46.07 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.498 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 15.9 tp10 -99.38 104.97 30.16 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.38 -18.32 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.122 2.548 . . . . 0.0 112.061 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.91 -40.17 48.27 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.281 0.491 . . . . 0.0 110.291 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.15 -25.92 6.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.43 -39.47 77.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -74.39 -27.4 60.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.2 ttt -65.8 -33.26 75.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.431 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 7.6 tt -77.21 -30.92 54.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.909 -0.495 . . . . 0.0 110.338 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.12 -21.83 64.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.926 0.33 . . . . 0.0 110.297 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.72 -41.61 62.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 104' ' ' PHE . 67.0 m-85 -73.65 -13.9 61.07 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.452 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.37 -27.17 52.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.309 0.504 . . . . 0.0 110.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -84.29 -24.72 29.75 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -80.49 -19.81 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.21 -6.73 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.186 0.594 . . . . 0.0 110.827 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.46 27.18 6.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.581 ' HG2' ' H ' ' A' ' 30' ' ' THR . 24.5 ttpt -91.07 -175.62 4.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.321 0.648 . . . . 0.0 110.206 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.581 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 89.6 m -109.46 119.53 47.89 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 122.301 -0.249 . . . . 0.0 110.607 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.79 164.48 20.49 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.976 3.117 . . . . 0.0 111.162 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 28.7 m -139.65 -30.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.26 173.85 33.38 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 118.159 0.436 . . . . 0.0 112.532 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.1 m -140.64 142.09 35.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 108.723 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.14 157.46 25.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.207 0.603 . . . . 0.0 110.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -98.32 -3.51 37.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.044 0.538 . . . . 0.0 112.334 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.7 p -142.71 157.58 44.51 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.328 0.651 . . . . 0.0 109.746 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.8 -22.59 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 O-C-N 122.389 -0.194 . . . . 0.0 110.8 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.03 -27.65 67.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.477 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.97 -21.27 74.46 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.66 -30.34 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.249 0.524 . . . . 0.0 110.338 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.4 mt -72.37 -34.1 67.73 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.78 -25.36 49.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -87.35 -31.61 20.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.13 -22.02 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 118.142 0.428 . . . . 0.0 111.752 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.56 -14.84 62.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.233 -0.292 . . . . 0.0 110.502 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.06 -12.43 41.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.59 . . . . 0.0 110.756 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 -167.58 48.22 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 13.89 82.66 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.253 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 mt -135.83 145.58 31.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.774 0.829 . . . . 0.0 109.108 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -106.81 -29.62 9.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 177.68 8.27 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.753 0.421 . . . . 0.0 110.69 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.17 165.34 28.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.01 -0.431 . . . . 0.0 112.06 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.6 mt -125.97 133.33 69.22 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.55 140.34 46.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.507 0.723 . . . . 0.0 109.937 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.94 158.82 16.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.07 -11.47 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 122.886 0.475 . . . . 0.0 112.106 -175.779 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 12.4 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.655 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.1 Cg_exo -58.18 -13.78 17.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 113.753 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.83 -18.58 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 118.299 0.5 . . . . 0.0 110.332 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -25.82 66.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 109.909 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.55 -17.38 54.1 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.859 -0.525 . . . . 0.0 109.979 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.48 -24.05 46.13 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.24 -30.79 63.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 171.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -22.6 59.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.55 -20.18 54.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -91.89 7.62 41.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.95 0.9 . . . . 0.0 110.724 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t70 59.12 32.04 21.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.378 1.071 . . . . 0.0 112.78 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.5 mt -111.94 126.16 28.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.04 161.32 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.429 2.753 . . . . 0.0 111.865 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.37 170.82 19.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.084 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.6 t -138.42 150.32 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.896 0.878 . . . . 0.0 108.92 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 20.2 m-85 -94.26 163.22 13.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.71 127.92 20.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -160.55 170.24 21.32 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.721 0.408 . . . . 0.0 110.534 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.18 132.93 4.26 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.77 -160.49 28.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -72.46 149.18 44.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.997 0.399 . . . . 0.0 110.039 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -75.8 -6.64 51.67 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -110.21 3.94 20.51 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.737 0.415 . . . . 0.0 111.246 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 t -98.48 12.49 34.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.441 0.696 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.01 153.84 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.488 0.715 . . . . 0.0 109.701 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.71 159.86 32.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.243 0.544 . . . . 0.0 112.394 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.1 p -63.2 -17.25 62.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -68.02 -28.02 67.05 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.686 0.675 . . . . 0.0 110.28 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 44.1 m-85 -85.13 -20.87 29.62 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -84.17 -7.99 59.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.905 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -118.62 -9.88 10.16 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.071 0.548 . . . . 0.0 112.14 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -125.29 156.78 69.47 Favored Pre-proline 0 C--N 1.341 0.236 0 C-N-CA 123.022 0.529 . . . . 0.0 110.568 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -54.3 144.18 61.66 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.638 2.892 . . . . 0.0 112.85 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.34 153.9 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.443 0.697 . . . . 0.0 110.077 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -130.69 155.53 46.45 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.927 0.891 . . . . 0.0 109.903 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -74.04 167.32 21.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.063 0.545 . . . . 0.0 110.902 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -75.89 -47.4 3.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.442 -0.789 . . . . 0.0 112.159 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.96 164.27 25.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.618 2.212 . . . . 0.0 110.456 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 10.9 m-85 -133.94 158.57 43.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.998 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.1 p -142.11 159.12 42.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.3 mtt -65.1 -27.99 69.14 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.137 -0.352 . . . . 0.0 111.126 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.26 -25.63 29.23 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.476 0.179 . . . . 0.0 110.633 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.43 -40.19 28.7 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.8 m -74.64 -21.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.559 0.679 . . . . 0.0 111.066 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.92 -31.43 51.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.12 0.418 . . . . 0.0 110.401 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -81.93 -31.76 31.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.55 60.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.85 -41.37 64.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.64 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.447 -0.158 . . . . 0.0 111.153 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.87 -21.06 25.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 tt -91.96 -38.69 12.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.203 0.601 . . . . 0.0 112.576 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.71 -10.83 59.74 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.935 -179.53 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 117' ' ' LEU . 76.0 mt . . . . . 0 N--CA 1.455 -0.189 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.38 -10.87 16.16 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.729 0.812 . . . . 0.0 110.852 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.489 ' HB3' HG11 ' A' ' 32' ' ' VAL . 80.9 mt-30 -134.16 120.11 19.68 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.93 132.15 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.636 0.585 . . . . 0.0 110.536 -172.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -88.97 143.49 26.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.559 ' H ' HD23 ' A' ' 8' ' ' LEU . 94.3 mt -112.06 134.2 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.114 0.566 . . . . 0.0 109.845 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 t -132.38 115.7 26.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 22.7 tp10 -145.56 157.69 43.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -106.79 -0.0 23.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.495 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 39.4 tt0 -139.95 129.4 13.68 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 118.307 0.503 . . . . 0.0 110.328 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 53.7 Cg_exo -57.48 -27.43 76.26 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.573 2.849 . . . . 0.0 113.655 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.39 -44.25 71.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.8 -26.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.37 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.623 0.192 . . . . 0.0 111.086 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.5 mtt -75.82 -26.7 57.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 tpt -76.25 -23.91 54.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -71.15 -35.62 71.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.03 -21.72 56.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.452 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.09 -41.46 70.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.015 -0.428 . . . . 0.0 110.574 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.99 -23.15 62.13 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -85.07 -28.53 25.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.351 0.26 . . . . 0.0 110.677 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.78 -23.57 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.61 5.24 50.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.955 0.502 . . . . 0.0 111.531 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.66 35.9 12.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.544 0.737 . . . . 0.0 111.273 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -85.73 156.85 20.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.018 0.927 . . . . 0.0 111.123 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -91.27 120.23 68.49 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.87 162.49 29.44 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.317 2.678 . . . . 0.0 111.455 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 6' ' ' GLN . 26.8 m -138.24 -31.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.094 0 C-N-CA 122.443 0.297 . . . . 0.0 111.235 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 176.08 35.79 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -140.26 143.08 35.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.46 155.54 37.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -100.44 1.52 41.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.407 0.683 . . . . 0.0 111.779 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -136.84 154.11 50.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.207 0.603 . . . . 0.0 109.933 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.34 -22.44 11.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.392 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.93 -26.21 61.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.568 0.167 . . . . 0.0 110.608 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.99 -23.27 66.81 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -28.59 35.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.415 0.608 . . . . 0.0 110.649 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.81 -39.02 52.84 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.66 61.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -87.32 -25.07 24.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.164 0.438 . . . . 0.0 111.83 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -83.32 -26.35 7.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.519 0.6 . . . . 0.0 110.402 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.93 -16.73 59.97 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.831 0.348 . . . . 0.0 110.243 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.59 -12.42 42.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.333 0.653 . . . . 0.0 110.98 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -171.22 51.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.02 11.37 85.24 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.8 mt -140.08 144.8 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -101.9 -30.41 11.26 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.71 177.14 9.61 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.742 0.417 . . . . 0.0 110.409 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.64 161.98 40.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.66 124.99 72.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.07 124.2 50.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 111.651 -172.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.32 136.16 38.45 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 169.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.53 -13.95 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 122.402 0.281 . . . . 0.0 110.94 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 . . . . . 0 CA--C 1.534 0.347 0 C-N-CA 124.27 1.028 . . . . 0.0 112.362 -177.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 67.2 p . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 51.1 Cg_exo -59.1 -19.56 49.64 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.451 2.101 . . . . 0.0 113.698 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.46 -26.66 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.053 -0.405 . . . . 0.0 111.091 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.92 62.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.34 -17.39 54.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -32.59 63.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.05 -28.15 65.23 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.26 -22.5 59.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.35 -13.64 59.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -100.28 6.19 44.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.792 0.837 . . . . 0.0 110.526 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 57.04 33.83 23.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.419 1.088 . . . . 0.0 112.857 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.46 121.99 41.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.372 0.669 . . . . 0.0 109.542 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.9 153.62 62.07 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.906 3.07 . . . . 0.0 113.332 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -151.8 165.15 35.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.31 159.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 C-N-CA 123.823 0.849 . . . . 0.0 109.311 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 25.4 m-85 -95.21 159.53 14.97 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.143 0.497 . . . . 0.0 111.99 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 136.36 28.47 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -155.6 158.83 39.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.62 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.49 177.81 54.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.9 116.35 7.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t -154.17 156.09 36.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.26 0.624 . . . . 0.0 110.692 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -105.4 -0.35 26.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.216 0.606 . . . . 0.0 111.464 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -134.05 -2.65 2.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 m -88.74 7.92 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.433 0.56 . . . . 0.0 111.658 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 m -134.89 154.15 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.307 0.643 . . . . 0.0 111.15 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.07 -178.44 6.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.925 1.29 . . . . 0.0 108.649 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.5 m -59.43 -16.62 24.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.488 -0.758 . . . . 0.0 112.031 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -65.86 -30.69 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 9.0 m-85 -90.4 -13.51 34.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.545 1.138 . . . . 0.0 109.836 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -88.53 -10.59 48.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.047 0.539 . . . . 0.0 110.426 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.28 -15.04 12.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.34 0.656 . . . . 0.0 111.433 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -126.03 149.82 67.48 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 123.292 0.637 . . . . 0.0 109.481 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.89 147.02 94.27 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.088 2.525 . . . . 0.0 112.561 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -150.61 150.15 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 123.636 0.774 . . . . 0.0 109.102 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.1 tp -144.39 150.38 37.64 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -75.95 165.81 24.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.444 0.298 . . . . 0.0 111.048 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -58.1 -50.42 88.21 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.931 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.29 110.14 2.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.468 1.445 . . . . 0.0 110.063 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 5.4 m-30 -82.18 153.28 26.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.625 0.37 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.8 p -139.66 159.62 41.74 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.971 0.908 . . . . 0.0 108.997 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -65.11 -26.14 68.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.117 -0.364 . . . . 0.0 110.848 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.55 -36.33 22.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.773 0.261 . . . . 0.0 111.621 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.74 -31.49 49.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.1 t -79.46 -30.4 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.305 0.552 . . . . 0.0 110.078 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.56 69.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.963 0.347 . . . . 0.0 110.728 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.18 -31.57 23.15 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.356 -0.215 . . . . 0.0 111.449 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.21 60.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.9 0.318 . . . . 0.0 110.868 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.49 -20.67 33.55 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.25 -22.5 59.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.823 0.738 . . . . 0.0 110.001 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -19.72 27.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.516 0.327 . . . . 0.0 111.471 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.4 -58.02 2.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.657 0.383 . . . . 0.0 110.958 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 4' ' ' LEU . 73.2 mt -69.19 -1.31 7.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.788 1.235 . . . . 0.0 113.351 -173.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.226 -1.369 . . . . 0.0 109.971 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 117' ' ' LEU . 77.1 mt . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.614 0.245 . . . . 0.0 110.458 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -4.98 45.15 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.456 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.0 mt-30 -125.51 119.1 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mm -122.09 137.22 56.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.978 0.911 . . . . 0.0 111.173 -173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -94.71 135.27 36.38 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' H ' HD23 ' A' ' 8' ' ' LEU . 76.4 mt -102.59 126.14 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.288 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.6 t -132.27 117.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.69 161.89 36.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.305 0.642 . . . . 0.0 110.455 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -97.11 0.39 48.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.06 0.544 . . . . 0.0 111.638 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' A' ' 15' ' ' LEU . 42.3 tt0 -147.24 132.96 9.34 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.878 -0.514 . . . . 0.0 110.304 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.6 -23.32 70.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.441 2.761 . . . . 0.0 113.615 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 9.3 tt -72.38 -40.45 67.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.99 -29.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.07 69.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.8 ttp -75.81 -27.83 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.7 ttp -73.46 -29.87 62.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.02 -36.7 75.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -73.14 -21.98 60.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.531 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.81 -42.84 63.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.134 -0.354 . . . . 0.0 111.152 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -75.23 -21.21 58.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.365 0.529 . . . . 0.0 111.376 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -82.79 -18.51 40.34 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.184 0.447 . . . . 0.0 111.344 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -85.07 -22.86 28.79 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.57 0.623 . . . . 0.0 110.388 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 -21.2 10.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -93.17 -0.09 57.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.296 0.638 . . . . 0.0 111.149 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t0 52.37 40.96 30.36 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.369 0.605 . . . . 0.0 110.885 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -85.5 165.18 17.34 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.943 0.897 . . . . 0.0 110.784 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.1 m -115.16 74.64 3.89 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.01 0.524 . . . . 0.0 110.151 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.33 156.95 57.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.894 2.396 . . . . 0.0 109.789 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 32.7 m -116.71 -7.75 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.7 171.53 31.05 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.287 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -137.96 139.88 39.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.78 158.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -120.29 -2.65 10.07 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.535 0.734 . . . . 0.0 111.58 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.0 p -138.83 161.04 38.23 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.404 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.55 -26.54 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.045 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.2 -28.33 48.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.68 -27.88 60.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.79 -42.43 73.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.344 0.572 . . . . 0.0 110.175 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.89 -24.58 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.83 61.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.744 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -84.11 -20.87 31.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.978 0.354 . . . . 0.0 111.366 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.84 -31.36 40.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.51 -14.82 54.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.642 0.377 . . . . 0.0 111.791 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -87.75 -13.32 42.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.891 0.477 . . . . 0.0 111.963 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.44 172.58 36.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.4 151.62 43.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -141.87 150.03 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -108.47 -26.81 10.27 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-N 118.045 0.384 . . . . 0.0 111.496 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 171.08 18.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.088 0.555 . . . . 0.0 110.169 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.8 160.4 43.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.145 -0.347 . . . . 0.0 111.097 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.99 127.37 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.88 130.92 56.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.963 0.505 . . . . 0.0 111.188 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -81.53 139.43 35.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.76 -16.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.669 0.271 . . . . 0.0 110.667 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.889 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--O 1.231 0.11 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.93 -9.15 14.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.592 2.861 . . . . 0.0 111.532 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.28 -29.04 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 O-C-N 122.162 -0.336 . . . . 0.0 110.93 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.48 90.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.293 -0.255 . . . . 0.0 110.622 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.21 -17.54 39.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.374 -0.204 . . . . 0.0 111.35 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.5 70.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.41 -28.08 61.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.6 -22.79 62.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.867 0.303 . . . . 0.0 110.204 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.92 41.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.5 0.32 . . . . 0.0 110.351 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.08 7.95 42.05 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 111.155 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.56 28.81 17.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 112.843 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.4 mt -101.33 128.26 29.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.511 0.724 . . . . 0.0 109.474 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.42 156.1 50.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 111.608 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -147.84 167.14 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.6 t -139.22 145.58 27.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.037 0 C-N-CA 124.108 0.963 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.02 150.91 19.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.522 0.329 . . . . 0.0 110.551 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 119.74 11.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -171.78 163.28 6.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.199 0.6 . . . . 0.0 110.647 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.04 147.34 19.6 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.7 -154.35 25.44 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 117.532 0.666 . . . . 0.0 111.812 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 t -137.81 169.47 17.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.845 0.858 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.44 -11.94 60.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.784 0.434 . . . . 0.0 111.484 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.02 -4.3 27.72 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.398 0.679 . . . . 0.0 111.3 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 m -93.03 2.27 56.87 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.158 0.583 . . . . 0.0 111.337 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.59 154.72 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 123.946 0.898 . . . . 0.0 110.702 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.38 -177.52 5.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.346 0.593 . . . . 0.0 111.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.5 p -61.99 -16.5 51.86 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -73.79 -31.8 63.45 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.332 0.969 . . . . 0.0 110.396 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -82.13 -22.71 36.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -88.44 -5.47 58.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.399 0.279 . . . . 0.0 111.132 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -105.08 -16.81 14.69 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.465 0.706 . . . . 0.0 111.128 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -109.45 158.86 33.43 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.537 0.735 . . . . 0.0 110.09 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.47 152.63 76.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.827 2.352 . . . . 0.0 111.303 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.9 154.49 21.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.159 0.584 . . . . 0.0 110.981 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -145.85 156.53 43.62 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.528 0.731 . . . . 0.0 109.128 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.61 164.48 24.82 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -65.17 -50.19 61.87 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.655 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.26 146.28 35.72 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.238 1.959 . . . . 0.0 109.469 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -105.44 153.72 21.31 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 121.006 0.432 . . . . 0.0 111.139 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.2 p -143.21 160.23 40.84 Favored 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 124.405 1.082 . . . . 0.0 108.739 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.6 mtt -66.55 -23.65 66.25 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.085 -0.384 . . . . 0.0 111.099 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.3 -37.76 21.26 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 122.174 -0.329 . . . . 0.0 111.279 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.97 -34.73 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.92 -29.64 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 117.501 0.651 . . . . 0.0 110.499 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.52 -29.49 63.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.191 -0.318 . . . . 0.0 110.755 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.31 -31.79 22.85 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.088 0.155 . . . . 0.0 111.279 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.13 -34.54 61.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.82 0.282 . . . . 0.0 110.552 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.08 -21.18 33.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.462 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.32 -19.89 59.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.205 0.457 . . . . 0.0 110.219 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.88 23.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.495 0.318 . . . . 0.0 111.464 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 tt -91.6 -59.39 2.14 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.645 0.378 . . . . 0.0 111.473 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 4' ' ' LEU . 48.9 mt -70.06 3.72 2.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.271 1.428 . . . . 0.0 113.55 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.783 -1.103 . . . . 0.0 109.94 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.534 0.683 . . . . 0.0 109.753 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.82 -6.42 54.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.332 0.653 . . . . 0.0 112.206 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.587 ' HB3' HG11 ' A' ' 32' ' ' VAL . 78.6 mt-30 -128.71 119.05 23.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.5 mm -120.9 131.41 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.609 0.764 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -88.52 140.94 28.95 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 8' ' ' LEU . 89.4 mt -109.99 135.14 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 110.117 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 t -129.07 121.56 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 16.9 tp10 -149.2 159.16 44.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.764 0.426 . . . . 0.0 110.656 -171.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.57 -12.74 12.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.438 0.695 . . . . 0.0 111.526 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 18.1 tp10 -120.16 110.38 36.26 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 123.438 0.695 . . . . 0.0 109.27 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.86 -23.7 35.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.636 2.891 . . . . 0.0 113.955 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.1 tp -73.43 -32.54 64.45 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.3 0.5 . . . . 0.0 110.202 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.77 -28.52 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.63 64.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.594 0.179 . . . . 0.0 110.557 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.0 -33.66 57.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.2 tpt -75.05 -23.95 58.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -38.01 75.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.13 -22.74 57.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.608 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.86 -43.66 68.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.202 -0.311 . . . . 0.0 110.557 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -76.46 -25.5 54.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.936 -0.477 . . . . 0.0 111.416 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 tp -73.0 -32.11 64.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.292 0.497 . . . . 0.0 111.024 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -85.57 -24.07 27.36 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.5 t -76.64 -20.6 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.337 0.517 . . . . 0.0 110.504 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.89 18.38 18.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.709 0.403 . . . . 0.0 111.685 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 54.18 27.66 8.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.9 0.88 . . . . 0.0 113.043 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.9 157.12 20.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.224 0.61 . . . . 0.0 109.518 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.3 m -99.43 120.93 56.62 Favored Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 122.014 -0.429 . . . . 0.0 110.231 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -79.24 162.89 25.4 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.65 2.9 . . . . 0.0 110.696 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -138.7 -27.11 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.69 173.58 33.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -140.73 143.33 34.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.56 154.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 122.584 0.354 . . . . 0.0 110.927 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.19 8.72 28.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.277 0.631 . . . . 0.0 111.634 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -150.63 158.77 44.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 122.826 0.45 . . . . 0.0 110.167 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.1 -22.84 21.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 122.941 0.496 . . . . 0.0 111.101 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.96 62.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 122.271 -0.268 . . . . 0.0 110.716 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.2 -21.58 70.09 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.49 -31.73 42.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.278 0.539 . . . . 0.0 110.498 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.12 -23.76 35.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.759 0.254 . . . . 0.0 110.97 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.18 -30.14 34.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.3 -0.25 . . . . 0.0 111.504 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -87.72 -29.1 21.33 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.18 -28.82 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 118.201 0.455 . . . . 0.0 111.313 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.16 -14.87 59.72 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.794 -0.566 . . . . 0.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.75 -12.54 41.89 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.34 0.656 . . . . 0.0 110.587 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 -173.05 54.28 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.55 74.06 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.203 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -139.17 147.16 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 108.777 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.09 -21.2 10.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.22 -0.419 . . . . 0.0 112.049 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 173.12 14.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.314 0.506 . . . . 0.0 110.532 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.51 164.25 34.0 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.84 133.32 69.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.42 129.11 56.63 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.353 . . . . 0.0 110.996 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -81.44 130.16 34.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.85 -11.28 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.629 0.252 . . . . 0.0 110.542 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 123.704 0.802 . . . . 0.0 110.465 177.281 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 66.3 p . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 118.14 -0.933 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 39.6 Cg_exo -64.96 -24.91 59.9 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.767 1.645 . . . . 0.0 111.889 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.96 -23.88 7.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 C-N-CA 122.333 0.253 . . . . 0.0 110.675 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.17 70.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.49 -17.72 61.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.223 -0.298 . . . . 0.0 110.487 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.78 -29.78 51.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.91 -31.41 69.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.86 61.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.91 -13.87 58.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.588 0.355 . . . . 0.0 110.477 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -102.71 12.27 36.53 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.82 0.848 . . . . 0.0 111.013 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 58.03 33.27 23.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.066 0.947 . . . . 0.0 113.423 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.2 mt -114.37 129.4 24.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 109.457 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.93 159.28 30.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 112.418 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -153.78 168.99 24.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.301 0.641 . . . . 0.0 110.742 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.04 159.76 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 124.006 0.922 . . . . 0.0 108.968 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -99.38 156.21 17.13 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.939 0.4 . . . . 0.0 111.779 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.37 119.53 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -172.61 156.62 3.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.721 0.408 . . . . 0.0 110.604 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.59 143.43 18.47 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.65 -158.09 29.88 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 117.358 0.579 . . . . 0.0 111.916 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.4 t -137.47 170.86 15.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.887 0.875 . . . . 0.0 110.063 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.04 -13.8 62.48 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.101 -0.374 . . . . 0.0 111.302 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.93 3.55 54.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.16 0.584 . . . . 0.0 111.332 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 98.4 p -126.12 20.2 7.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.827 0.451 . . . . 0.0 111.903 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 16.1 m -132.26 154.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.422 0.689 . . . . 0.0 111.779 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -81.93 170.84 15.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.26 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.5 p -61.09 -21.72 63.95 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.95 -21.42 59.19 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.673 0.669 . . . . 0.0 110.862 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.465 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 3.2 m-85 -80.97 -23.44 38.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -88.21 -8.15 55.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.448 0.699 . . . . 0.0 111.261 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -119.6 -3.96 10.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.199 0.599 . . . . 0.0 112.087 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -140.55 140.8 23.35 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 149.96 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.622 2.881 . . . . 0.0 114.345 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 m -142.75 154.62 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.535 1.134 . . . . 0.0 109.596 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -146.87 155.28 42.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.657 0.383 . . . . 0.0 110.097 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.26 158.12 35.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 44.8 mtpt -66.08 -43.82 57.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.907 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 67.6 Cg_endo -69.39 128.61 16.63 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.676 1.277 . . . . 0.0 108.881 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -100.03 154.08 18.69 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.766 0.426 . . . . 0.0 111.367 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.5 p -141.38 162.39 35.61 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.426 1.09 . . . . 0.0 108.711 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.08 -26.88 68.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.298 -0.251 . . . . 0.0 111.031 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -84.47 -38.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.932 0.333 . . . . 0.0 111.579 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.99 -31.76 59.5 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.18 -27.64 12.02 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.026 0 CA-C-N 117.24 0.52 . . . . 0.0 110.229 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.17 68.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.003 -0.436 . . . . 0.0 110.669 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.24 -33.77 25.99 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 122.321 -0.237 . . . . 0.0 110.939 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.86 66.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.34 -20.33 40.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.63 62.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.777 0.717 . . . . 0.0 109.886 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.41 -23.71 24.44 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.2 mt -91.56 -14.44 30.31 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -107.06 18.04 22.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.376 0.535 . . . . 0.0 111.137 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.442 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.399 0.142 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -70.42 -7.07 40.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.161 -0.337 . . . . 0.0 111.214 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.674 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.8 mp0 -106.27 114.31 28.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 122.807 0.443 . . . . 0.0 111.457 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 mm -123.88 127.35 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 123.636 0.585 . . . . 0.0 110.225 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -92.85 136.16 33.49 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.434 ' N ' HD23 ' A' ' 8' ' ' LEU . 96.8 mt -103.24 132.78 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.182 0.593 . . . . 0.0 109.937 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.7 t -131.97 118.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 34.8 tp10 -151.24 140.2 21.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.803 0.441 . . . . 0.0 109.945 -176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.66 4.67 48.76 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.561 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 59.0 mt-10 -135.68 138.67 28.8 Favored Pre-proline 0 CA--C 1.529 0.153 0 O-C-N 121.899 -0.5 . . . . 0.0 109.984 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.75 -22.0 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.341 2.694 . . . . 0.0 112.525 -174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -79.42 -36.47 38.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.239 0.472 . . . . 0.0 110.236 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.47 -27.75 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.49 -35.05 78.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.2 ttp -73.63 -30.17 62.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.4 ttp -74.82 -31.43 61.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.382 -0.199 . . . . 0.0 110.485 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.07 -29.97 67.1 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.168 -0.333 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.2 -21.79 56.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.55 -43.79 54.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.089 0.404 . . . . 0.0 110.411 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -74.52 -16.93 60.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.065 0.393 . . . . 0.0 111.167 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -69.05 -30.72 69.12 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -83.2 -23.73 32.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.387 0.275 . . . . 0.0 111.112 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.58 -24.61 23.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.2 tp -93.31 -1.64 55.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.919 0.487 . . . . 0.0 110.544 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.28 35.04 15.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.332 0.653 . . . . 0.0 110.716 -175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -85.6 155.57 21.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.217 1.007 . . . . 0.0 109.876 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -90.38 121.56 68.35 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.58 155.26 35.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.473 2.782 . . . . 0.0 110.573 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 6' ' ' GLN . 34.5 m -138.16 -18.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.584 0.354 . . . . 0.0 111.813 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.64 167.52 25.33 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -143.61 138.95 29.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.9 161.31 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.928 0.491 . . . . 0.0 110.501 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -113.34 5.25 16.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.196 0.598 . . . . 0.0 112.486 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 39' ' ' ALA . 29.6 m -137.12 143.79 42.7 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.01 -23.34 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 37' ' ' THR . . . -77.15 -25.68 52.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.42 63.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.42 -34.33 54.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.4 0.6 . . . . 0.0 110.135 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.69 -42.36 67.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.53 -24.8 64.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.437 0.295 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -81.53 -26.51 35.03 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 122.299 -0.25 . . . . 0.0 111.336 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.25 -25.38 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 118.272 0.487 . . . . 0.0 110.267 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -75.12 -14.74 60.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.077 -0.389 . . . . 0.0 110.898 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.32 -12.36 59.93 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 110.484 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.4 -176.12 54.81 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.519 0.58 . . . . 0.0 111.863 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.64 12.73 83.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.164 -0.374 . . . . 0.0 112.164 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.36 145.86 35.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.895 0.848 . . . . 0.0 109.696 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.22 -15.4 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.049 0.539 . . . . 0.0 112.007 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 172.39 12.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.751 0.82 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.09 31.59 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.127 -0.358 . . . . 0.0 111.558 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.03 131.27 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.61 133.84 55.64 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.105 0.478 . . . . 0.0 111.781 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -86.5 137.12 32.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.08 -11.88 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.1 t30 . . . . . 0 N--CA 1.452 -0.357 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.267 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.528 0.129 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.69 -7.15 20.32 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.652 2.901 . . . . 0.0 111.589 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.57 -22.77 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 O-C-N 122.142 -0.348 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.72 -28.73 69.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.26 -0.275 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.57 -20.93 61.23 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.338 -0.227 . . . . 0.0 110.614 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -29.82 41.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.24 -32.9 61.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.55 61.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.21 -12.13 55.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 110.395 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -94.31 17.61 12.52 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.871 0.868 . . . . 0.0 110.972 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t0 59.74 31.26 20.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.661 1.184 . . . . 0.0 114.024 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 pt -128.28 143.79 49.39 Favored Pre-proline 0 CA--C 1.532 0.251 0 O-C-N 122.094 -0.379 . . . . 0.0 110.228 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.77 161.61 24.38 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.785 2.99 . . . . 0.0 111.793 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -145.63 165.4 28.8 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.227 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.7 t -137.62 146.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 124.339 1.056 . . . . 0.0 108.542 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.65 155.58 18.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.935 0.397 . . . . 0.0 111.226 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 119.22 11.37 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -174.02 161.09 3.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 109.859 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.02 145.69 25.98 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.48 -159.33 30.78 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 117.455 0.628 . . . . 0.0 112.03 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.9 t -141.05 159.79 41.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.779 0.831 . . . . 0.0 109.972 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -71.8 -5.96 38.08 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.42 4.39 50.62 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.8 m -129.56 22.2 5.52 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.328 0.651 . . . . 0.0 111.696 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 15.3 m -131.25 154.66 40.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 122.973 0.509 . . . . 0.0 112.072 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.2 168.0 20.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.312 1.045 . . . . 0.0 111.307 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.8 p -62.23 -17.45 58.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -73.61 -25.88 60.52 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.218 0.463 . . . . 0.0 110.167 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.495 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 15.7 m-85 -80.38 -24.39 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.45 -9.33 52.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.997 0.519 . . . . 0.0 111.63 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.02 -18.01 12.72 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -135.16 157.84 75.99 Favored Pre-proline 0 C--O 1.232 0.166 0 C-N-CA 122.847 0.459 . . . . 0.0 110.055 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.33 154.08 25.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.384 3.39 . . . . 0.0 114.082 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.22 154.23 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.381 1.072 . . . . 0.0 109.293 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.7 mt -143.4 156.95 44.8 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.203 0.601 . . . . 0.0 110.754 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -87.05 170.5 11.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.05 -38.84 52.52 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.59 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.78 125.23 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.076 1.85 . . . . 0.0 110.738 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -111.1 152.11 27.32 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.219 0.608 . . . . 0.0 110.187 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.2 p -141.3 159.41 42.27 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.737 0.815 . . . . 0.0 109.147 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -67.55 -26.91 66.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.17 -0.331 . . . . 0.0 111.077 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.66 -35.77 22.38 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.019 0.372 . . . . 0.0 111.676 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.18 -31.21 43.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.66 -28.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.648 0.724 . . . . 0.0 110.578 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.61 66.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.059 -0.401 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.55 -27.94 26.98 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 117.647 0.203 . . . . 0.0 110.966 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.03 -36.5 48.54 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.202 -0.311 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.42 -23.46 40.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.27 -0.269 . . . . 0.0 110.481 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.2 -24.17 60.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.15 -13.86 42.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.089 0.556 . . . . 0.0 111.327 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.33 -33.79 42.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.04 7.3 11.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.37 -179.534 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 4' ' ' LEU . 1.1 pt? . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.269 0.557 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -77.29 -5.68 50.36 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.642 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 67.3 mt-30 -122.39 118.06 27.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -123.42 134.15 67.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.851 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -88.84 138.07 31.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.57 ' H ' HD23 ' A' ' 8' ' ' LEU . 77.2 mt -111.65 126.09 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.806 0.842 . . . . 0.0 109.558 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 35' ' ' VAL . 19.8 t -132.18 122.33 48.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 122.775 0.43 . . . . 0.0 110.23 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -141.65 155.32 45.71 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.919 0.488 . . . . 0.0 110.733 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.83 -6.97 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.663 0.385 . . . . 0.0 110.926 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.17 125.93 17.24 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.987 0.515 . . . . 0.0 109.676 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.17 -25.01 76.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.966 2.444 . . . . 0.0 112.804 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.97 -33.14 74.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.099 -0.376 . . . . 0.0 110.525 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.85 -26.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.98 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.807 0.276 . . . . 0.0 110.827 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.64 -31.74 62.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.3 tpt -75.01 -23.73 58.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -39.63 81.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.64 -22.39 60.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.68 -40.14 66.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.904 0.32 . . . . 0.0 111.052 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -74.69 -27.55 60.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.776 -0.577 . . . . 0.0 110.595 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.07 -17.66 58.58 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.917 -0.489 . . . . 0.0 110.606 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -78.58 -28.29 45.85 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.33 -20.74 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.374 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.27 12.22 36.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.296 0.638 . . . . 0.0 111.995 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.89 33.91 15.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.556 0.742 . . . . 0.0 112.291 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.85 163.68 17.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.877 0.871 . . . . 0.0 110.09 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -117.8 74.75 9.7 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 122.698 0.399 . . . . 0.0 110.46 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.94 154.57 65.88 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.941 2.427 . . . . 0.0 109.682 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 33.8 m -115.87 -12.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.337 0.055 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 175.34 35.11 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.248 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -132.49 143.49 49.79 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.737 0.815 . . . . 0.0 108.941 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.411 ' CG2' HG22 ' A' ' 10' ' ' VAL . 34.3 m -146.07 163.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.008 0.523 . . . . 0.0 110.206 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.65 6.92 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.001 0.521 . . . . 0.0 112.065 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -146.12 156.55 43.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.056 0.542 . . . . 0.0 110.183 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.97 -28.31 40.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.98 62.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 -30.77 56.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.36 -38.34 87.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.809 0.805 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.73 -19.32 57.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 -24.97 49.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.088 0.404 . . . . 0.0 111.013 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -77.75 -32.87 52.94 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.05 -26.09 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.464 0.306 . . . . 0.0 110.247 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.39 -15.11 53.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 111.043 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.98 -12.88 20.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.661 0.384 . . . . 0.0 111.582 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.97 172.31 38.47 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.15 154.61 48.14 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.0 mt -141.93 146.04 23.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -103.28 -24.34 13.53 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 174.31 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.695 0.398 . . . . 0.0 110.396 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.11 162.34 40.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.077 -0.39 . . . . 0.0 111.754 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.02 127.97 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.035 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.23 124.63 50.72 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.745 0.418 . . . . 0.0 111.192 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -85.97 124.47 32.46 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.43 -5.31 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.708 0.803 . . . . 0.0 111.95 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 0.0 112.636 -174.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.6 m . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 71.6 Cg_exo -55.41 -19.65 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.685 2.257 . . . . 0.0 114.578 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.95 -26.24 9.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-N 118.858 0.754 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.9 60.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.41 -17.68 53.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.264 0.225 . . . . 0.0 110.533 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.53 -32.66 58.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.8 -26.32 60.56 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.45 61.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.919 0.327 . . . . 0.0 110.357 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.8 -18.83 53.47 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.09 7.7 44.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.554 0.742 . . . . 0.0 111.025 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 58.66 29.53 18.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.408 1.083 . . . . 0.0 113.106 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.8 127.81 29.28 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.5 158.52 44.01 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.759 2.973 . . . . 0.0 111.588 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -150.73 168.29 24.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.873 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.18 146.78 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.113 0.965 . . . . 0.0 108.891 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 21.2 m-85 -89.62 157.79 17.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.101 0.477 . . . . 0.0 111.266 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 144.62 37.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -161.95 174.16 13.46 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.29 117.34 0.76 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.82 -159.27 28.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m -71.09 160.0 33.69 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.887 0.475 . . . . 0.0 110.29 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.82 -11.44 60.38 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.79 -1.82 44.56 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.133 0.424 . . . . 0.0 111.469 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.4 t -78.92 -7.18 57.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.723 0.409 . . . . 0.0 110.92 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 m -135.59 154.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.393 0.677 . . . . 0.0 110.506 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.27 -178.64 3.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.802 0.841 . . . . 0.0 111.351 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.3 p -60.36 -19.68 56.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -70.05 -27.01 64.29 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.194 0.452 . . . . 0.0 110.157 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.405 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 16.0 m-85 -89.17 -18.16 27.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.761 0.824 . . . . 0.0 109.903 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -88.06 -8.81 54.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.511 0.324 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.63 -19.64 13.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.57 0.748 . . . . 0.0 110.842 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -103.61 160.99 24.37 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.997 0.919 . . . . 0.0 110.034 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.02 150.74 82.69 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.859 2.373 . . . . 0.0 110.829 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.48 154.23 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.903 0.881 . . . . 0.0 110.557 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.1 mt -134.56 153.86 51.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.726 0.81 . . . . 0.0 109.886 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -85.37 163.08 18.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.32 -48.04 13.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.348 -0.834 . . . . 0.0 113.221 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.16 138.95 18.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.874 1.716 . . . . 0.0 111.152 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -111.52 157.64 20.1 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.967 0.507 . . . . 0.0 110.506 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.3 p -140.92 165.6 27.07 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.711 1.204 . . . . 0.0 108.039 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.93 -36.68 79.97 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.871 -0.518 . . . . 0.0 111.192 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -84.59 -29.0 26.17 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.281 -0.262 . . . . 0.0 111.306 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.92 -28.16 51.16 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.334 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.01 -25.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 117.898 0.849 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.33 70.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.62 -20.86 30.7 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.478 0.311 . . . . 0.0 110.972 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.9 -40.08 55.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.844 0.293 . . . . 0.0 110.598 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.21 -25.66 42.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.69 62.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.218 0.463 . . . . 0.0 110.378 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.57 -16.58 34.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.044 0.537 . . . . 0.0 111.894 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.27 -33.72 15.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.516 0.326 . . . . 0.0 110.906 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.01 -3.04 58.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.762 0.425 . . . . 0.0 111.987 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.743 -1.122 . . . . 0.0 110.117 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.955 0.407 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.21 -8.7 57.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.534 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.462 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.6 mp0 -112.22 110.11 20.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.149 0.579 . . . . 0.0 111.905 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.88 139.47 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.401 0.68 . . . . 0.0 110.315 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.85 133.43 47.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.9 mt -98.69 126.47 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.34 109.21 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -143.03 160.18 40.86 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -89.44 -4.54 57.94 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.966 0.506 . . . . 0.0 111.538 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -140.31 140.07 22.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 O-C-N 122.039 -0.413 . . . . 0.0 110.976 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.07 -14.45 10.89 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.767 2.978 . . . . 0.0 112.799 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.33 -45.11 66.85 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.517 0.599 . . . . 0.0 110.703 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.06 -25.4 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.3 66.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.283 -0.261 . . . . 0.0 110.581 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mmt -82.33 -26.25 33.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.5 mmm -75.23 -29.22 60.18 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 122.137 -0.352 . . . . 0.0 110.625 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.403 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 3.1 mm? -76.47 -30.05 57.15 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.69 -22.21 56.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.882 0.31 . . . . 0.0 110.224 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.39 -45.13 20.1 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.22 -0.3 . . . . 0.0 111.29 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -78.88 -24.04 44.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.558 0.617 . . . . 0.0 112.435 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.34 -22.19 48.42 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.376 0.989 . . . . 0.0 111.066 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -85.23 -23.43 28.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.438 0.563 . . . . 0.0 111.167 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.07 -18.53 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.616 0.366 . . . . 0.0 110.884 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.07 20.22 19.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.867 0.467 . . . . 0.0 111.753 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 53.94 30.29 11.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.931 0.892 . . . . 0.0 113.114 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.5 tmtm? -85.76 164.29 17.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.464 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 23.8 m -123.18 71.8 45.32 Favored Pre-proline 0 CA--C 1.53 0.199 0 O-C-N 122.239 -0.288 . . . . 0.0 111.0 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.19 151.61 81.06 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.725 2.284 . . . . 0.0 109.408 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 6' ' ' GLN . 33.1 m -112.57 -6.8 11.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.48 174.98 34.84 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -140.75 139.4 34.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.077 0.951 . . . . 0.0 108.684 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 156.02 29.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 122.877 0.471 . . . . 0.0 110.214 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -108.53 2.23 22.04 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 112.048 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.5 p -139.11 158.46 44.14 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 110.311 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.26 -22.93 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.654 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.32 -25.97 58.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.14 71.05 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.31 -30.89 48.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.39 0.595 . . . . 0.0 110.261 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.68 -32.46 53.09 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.51 56.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.172 -0.33 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -87.73 -25.91 23.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.1 -22.01 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.219 0.463 . . . . 0.0 111.293 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.99 -14.74 63.21 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.897 0.317 . . . . 0.0 110.802 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.28 -12.42 37.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.275 0.63 . . . . 0.0 110.81 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 -169.31 53.51 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 12.03 82.06 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.832 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.62 145.88 22.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.76 0.78 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.98 -22.24 5.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.625 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.3 171.07 15.34 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.571 0.748 . . . . 0.0 109.731 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.4 164.87 35.76 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.083 -0.386 . . . . 0.0 110.967 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.9 mt -122.64 133.16 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.25 142.71 45.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.296 0.638 . . . . 0.0 110.691 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -97.51 135.17 39.74 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.566 0.746 . . . . 0.0 109.169 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.35 -16.08 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 122.541 0.336 . . . . 0.0 110.718 177.16 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.1 p . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.8 -13.19 29.35 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.999 2.466 . . . . 0.0 112.245 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.06 -24.04 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.113 0.415 . . . . 0.0 110.326 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.07 65.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.08 -17.62 45.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.452 0.301 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.58 62.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.35 -28.97 64.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.99 -22.83 60.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.57 -19.58 55.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -92.33 10.6 29.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.347 0.659 . . . . 0.0 110.858 172.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t70 59.42 25.18 13.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 113.006 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.48 125.06 46.51 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 157.58 34.42 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.605 2.87 . . . . 0.0 111.113 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -149.39 167.52 25.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.214 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -138.45 141.94 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -82.93 148.46 27.64 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.53 129.68 33.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 169.73 22.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.601 0.36 . . . . 0.0 110.665 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.99 175.87 54.84 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.43 102.37 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -150.39 147.25 27.34 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.701 0.8 . . . . 0.0 109.929 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -105.63 -2.83 22.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 112.29 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.68 0.28 4.38 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.1 m -89.86 5.83 44.5 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.927 -0.483 . . . . 0.0 111.421 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.15 154.46 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.748 0.819 . . . . 0.0 111.118 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -102.86 175.54 5.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.709 0.804 . . . . 0.0 110.563 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -64.98 -11.35 37.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -75.77 -24.21 56.02 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.31 0.505 . . . . 0.0 109.938 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -86.8 -20.12 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -84.02 -12.93 54.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.74 0.416 . . . . 0.0 110.767 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -104.5 -16.69 14.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.355 0.662 . . . . 0.0 111.601 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -109.29 163.14 17.71 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.405 0.682 . . . . 0.0 110.402 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.87 148.2 68.57 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.572 2.848 . . . . 0.0 112.58 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.26 154.75 23.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.762 0.825 . . . . 0.0 110.328 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -145.89 154.26 41.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.744 0.818 . . . . 0.0 109.54 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -80.22 146.29 31.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 34.5 ttmt -72.33 -43.34 9.62 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.019 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 74.3 Cg_endo -69.59 142.26 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.197 1.463 . . . . 0.0 109.74 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.4 m-85 -117.3 150.01 39.52 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 121.376 0.607 . . . . 0.0 111.971 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.6 p -143.7 166.47 24.77 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.028 1.331 . . . . 0.0 107.519 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 55.2 ttm -65.76 -28.19 68.84 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.737 -0.602 . . . . 0.0 110.977 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.32 -31.28 24.93 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.263 -0.273 . . . . 0.0 110.637 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.37 -24.67 67.63 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.648 -0.529 . . . . 0.0 112.129 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.3 p -86.23 -27.51 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 118.155 0.978 . . . . 0.0 110.969 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.09 69.86 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.08 -20.94 29.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.355 0.662 . . . . 0.0 110.584 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.25 61.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.59 -26.41 45.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.02 63.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.923 0.329 . . . . 0.0 110.127 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.82 -17.47 31.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.764 0.425 . . . . 0.0 111.743 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.4 -36.16 13.96 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.599 0.36 . . . . 0.0 111.66 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.72 3.99 54.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.728 0.411 . . . . 0.0 112.055 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.377 -1.297 . . . . 0.0 110.244 179.29 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 121.654 0.74 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -4.15 42.61 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.075 0.55 . . . . 0.0 110.971 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.536 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.5 mt-30 -124.03 115.89 21.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mm -122.26 132.64 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.394 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 141.3 28.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.558 ' H ' HD23 ' A' ' 8' ' ' LEU . 69.5 mt -105.53 122.45 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.874 0.87 . . . . 0.0 109.251 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.25 113.25 21.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -145.39 163.26 35.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.252 0.548 . . . . 0.0 112.424 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.46 2.45 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.921 1.288 . . . . 0.0 112.153 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -137.8 134.19 18.08 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 123.021 0.528 . . . . 0.0 110.206 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.48 -16.92 14.85 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.344 2.696 . . . . 0.0 111.893 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.88 -41.74 29.02 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.235 -0.29 . . . . 0.0 110.404 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.9 mm -78.25 -30.0 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.46 -29.02 68.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.9 ttt -75.11 -33.86 61.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mtp -73.34 -24.28 60.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.502 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -70.17 -39.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.27 -29.38 66.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.113 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.43 -38.4 65.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -72.77 -23.43 60.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.318 0.508 . . . . 0.0 111.615 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.82 -21.74 54.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.696 0.68 . . . . 0.0 110.872 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.02 -21.47 29.42 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.452 0.569 . . . . 0.0 111.444 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.8 t -85.2 -23.09 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 117.99 0.359 . . . . 0.0 110.42 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.17 13.76 33.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.188 0.595 . . . . 0.0 111.218 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.14 35.44 19.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.75 0.82 . . . . 0.0 112.486 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.79 163.94 17.86 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.81 0.844 . . . . 0.0 109.817 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.4 m -110.4 89.34 8.57 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.293 -0.254 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.15 158.82 55.04 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.84 2.36 . . . . 0.0 110.466 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.6 m -130.17 -10.67 2.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.6 169.61 28.43 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 118.198 0.454 . . . . 0.0 112.093 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.9 m -142.12 136.63 30.27 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.27 150.59 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.181 0.515 . . . . 0.0 111.098 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -92.72 -3.73 54.33 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.96 0.904 . . . . 0.0 111.607 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -151.97 158.32 42.95 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.363 0.665 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.1 -23.09 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 121.936 0.094 . . . . 0.0 110.995 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.22 68.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.854 -0.529 . . . . 0.0 109.876 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.53 -22.39 72.86 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.4 -34.48 65.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.967 0.883 . . . . 0.0 109.932 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.49 -27.54 61.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.13 -24.67 59.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -87.16 -26.1 23.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.129 0.422 . . . . 0.0 111.309 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -77.51 -26.49 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.134 0.425 . . . . 0.0 110.12 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -82.45 -14.37 55.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.689 0.396 . . . . 0.0 111.561 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.79 -13.54 16.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.41 41.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.52 145.61 30.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.2 mt -142.85 145.46 23.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -101.17 -25.06 14.15 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 118.093 0.406 . . . . 0.0 111.913 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.21 173.06 10.53 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.946 0.498 . . . . 0.0 110.05 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.48 159.29 44.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.483 0.182 . . . . 0.0 111.161 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.0 123.8 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.28 130.63 56.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.042 0.537 . . . . 0.0 110.019 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.89 152.43 24.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.42 -11.52 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 123.027 0.531 . . . . 0.0 111.4 -177.851 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 24.9 m . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 52.0 Cg_exo -57.63 -5.43 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.652 2.901 . . . . 0.0 114.372 177.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.04 -22.96 32.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.862 0.755 . . . . 0.0 110.845 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.43 -26.64 67.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.189 -0.319 . . . . 0.0 110.154 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.53 ' CD ' HH12 ' A' ' 93' ' ' ARG . 50.7 mt-10 -79.03 -17.39 55.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.974 -0.454 . . . . 0.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.3 59.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.13 -34.64 75.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.01 62.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.276 -0.265 . . . . 0.0 110.724 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.34 53.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.54 0.336 . . . . 0.0 110.518 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -99.64 18.49 17.91 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.78 0.832 . . . . 0.0 110.691 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.43 32.22 18.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.367 1.067 . . . . 0.0 113.619 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.47 118.66 24.75 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 160.42 37.24 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.293 3.329 . . . . 0.0 112.615 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.54 166.86 24.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.457 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -141.08 155.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 109.042 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 23.9 m-85 -88.21 159.19 18.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.11 122.22 19.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.1 t -163.78 179.14 7.31 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.886 0.474 . . . . 0.0 110.511 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.19 137.4 5.25 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.15 29.5 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.1 t -76.84 162.41 27.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.004 0.522 . . . . 0.0 110.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.74 -9.65 58.88 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.663 0.385 . . . . 0.0 110.728 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.98 -4.76 59.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.001 0.52 . . . . 0.0 110.612 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -95.37 9.48 39.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.079 0.552 . . . . 0.0 111.938 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.76 154.48 36.86 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.23 0.612 . . . . 0.0 111.131 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -107.47 -176.15 2.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.103 0.961 . . . . 0.0 111.024 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -62.73 -14.46 44.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.53 HH12 ' CD ' ' A' ' 70' ' ' GLU . 85.9 mtt-85 -65.76 -31.87 73.1 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.558 0.343 . . . . 0.0 110.238 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 29.1 m-85 -89.54 -19.47 24.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.605 0.762 . . . . 0.0 109.948 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -88.52 -3.75 58.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.81 0.444 . . . . 0.0 111.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.82 -13.44 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.33 0.652 . . . . 0.0 111.951 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.52 153.45 81.42 Favored Pre-proline 0 C--N 1.34 0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.985 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.74 154.98 51.44 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.36 2.707 . . . . 0.0 113.119 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.28 153.5 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.983 0.913 . . . . 0.0 109.068 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.0 tp -138.09 153.7 49.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.603 0.761 . . . . 0.0 109.755 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -73.68 157.48 36.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.534 0.334 . . . . 0.0 110.512 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -74.56 -50.46 4.54 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.628 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.13 147.55 29.98 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.254 1.969 . . . . 0.0 110.197 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.502 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 4.0 m-30 -111.4 150.82 29.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.106 0.562 . . . . 0.0 110.545 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.7 p -143.26 167.19 22.72 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.093 0.957 . . . . 0.0 108.848 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 83.6 mmm -61.04 -39.48 89.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.036 -0.415 . . . . 0.0 110.791 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.37 -25.46 29.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.297 0.239 . . . . 0.0 111.301 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.71 -25.24 70.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.6 t -85.54 -28.1 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.37 0.585 . . . . 0.0 110.356 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.79 70.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -85.05 -20.69 30.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.797 0.439 . . . . 0.0 110.958 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.48 63.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.152 0.433 . . . . 0.0 110.379 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.12 -26.92 53.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.765 0.257 . . . . 0.0 110.708 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.58 -20.58 26.21 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.509 0.324 . . . . 0.0 111.604 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.25 -36.25 14.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.05 9.17 42.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -173.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.037 -1.458 . . . . 0.0 109.831 178.071 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.489 0.661 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -8.45 57.57 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.244 0.618 . . . . 0.0 111.984 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.0 mt-30 -119.37 114.65 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.698 0.681 . . . . 0.0 112.224 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.1 mm -120.24 130.25 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -87.91 142.86 27.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.617 ' H ' HD23 ' A' ' 8' ' ' LEU . 87.0 mt -110.52 120.89 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.908 0.883 . . . . 0.0 109.05 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.27 120.68 43.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.741 0.417 . . . . 0.0 110.875 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -156.91 158.3 36.42 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -73.84 -7.91 54.01 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.75 0.82 . . . . 0.0 112.132 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.93 132.0 24.09 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.049 0.54 . . . . 0.0 109.901 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.47 -18.79 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.35 2.7 . . . . 0.0 111.405 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.96 -34.73 71.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.082 0.401 . . . . 0.0 110.735 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.1 mm -86.3 -23.74 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.11 78.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.037 -0.414 . . . . 0.0 109.896 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.4 mtt -77.71 -27.29 50.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.0 ttt -69.07 -29.4 67.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 1.1 mm? -72.46 -33.02 66.72 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.14 -24.81 64.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.081 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.31 -43.45 60.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.9 0.318 . . . . 0.0 111.338 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -73.54 -22.29 60.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.845 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.18 -18.04 53.78 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.559 0.618 . . . . 0.0 110.838 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -85.31 -22.1 28.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.319 0.509 . . . . 0.0 110.449 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.45 -19.65 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.891 0.476 . . . . 0.0 110.317 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -105.37 16.28 25.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.338 0.655 . . . . 0.0 111.838 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.0 35.0 14.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.734 0.813 . . . . 0.0 112.499 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.07 165.73 16.4 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -115.19 77.83 5.53 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 122.75 0.42 . . . . 0.0 110.284 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.95 157.18 54.16 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.047 2.498 . . . . 0.0 110.203 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 6' ' ' GLN . 32.8 m -121.59 -14.6 7.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.46 176.47 36.26 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.666 0.666 . . . . 0.0 112.728 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 140.26 46.32 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.34 1.056 . . . . 0.0 108.885 175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.51 154.67 20.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.008 0.432 . . . . 0.0 110.128 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -102.89 -1.49 29.46 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.03 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.9 p -141.42 159.71 41.65 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.794 0.438 . . . . 0.0 110.49 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.82 -22.81 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.682 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.16 54.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.22 -27.63 61.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.18 78.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.16 -26.71 63.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.52 -24.73 62.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.305 0.242 . . . . 0.0 111.316 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -86.57 -23.85 25.66 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.757 0.253 . . . . 0.0 111.293 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.6 -29.66 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 117.923 0.329 . . . . 0.0 111.064 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.54 -14.36 55.03 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.983 -0.448 . . . . 0.0 112.009 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.03 -12.76 15.35 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.123 0.569 . . . . 0.0 112.286 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.92 164.28 37.71 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.69 140.36 24.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.5 mt -144.75 143.98 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -96.7 -32.31 12.24 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.449 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.55 11.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.578 0.351 . . . . 0.0 110.318 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.0 157.83 43.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.668 0.27 . . . . 0.0 111.256 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.0 mt -113.46 123.56 69.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.9 130.8 56.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.455 0.702 . . . . 0.0 110.226 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 170.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.29 -11.88 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 O-C-N 122.034 -0.416 . . . . 0.0 111.968 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 . . . . . 0 CA--C 1.529 0.171 0 O-C-N 121.952 -0.468 . . . . 0.0 110.159 179.438 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m . . . . . 0 C--O 1.234 0.238 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.82 -11.96 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.561 2.841 . . . . 0.0 111.741 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.38 -17.64 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 122.158 -0.339 . . . . 0.0 111.036 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.92 74.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.847 -0.533 . . . . 0.0 110.156 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.28 -18.26 60.74 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.176 -0.327 . . . . 0.0 111.082 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.46 -29.29 37.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 99.2 mt -72.85 -37.46 67.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.16 -22.37 62.06 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.05 -12.61 54.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.414 0.286 . . . . 0.0 110.721 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -103.91 17.88 23.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.984 0.914 . . . . 0.0 110.779 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 59.06 34.13 23.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.125 0.97 . . . . 0.0 113.264 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.4 mt -120.77 102.2 44.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.849 0.86 . . . . 0.0 108.689 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.57 158.9 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.919 3.079 . . . . 0.0 112.745 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.21 167.13 23.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 111.409 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.4 t -134.74 144.19 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.838 0.855 . . . . 0.0 109.399 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -90.81 151.49 21.15 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 111.124 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.43 143.13 33.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.599 0.76 . . . . 0.0 109.234 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -159.77 158.39 31.09 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 111.007 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.67 95.93 0.96 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 172.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.51 -162.15 33.67 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.3 p -81.48 164.52 21.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.407 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -4.17 49.23 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.585 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.83 -1.3 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.295 0.638 . . . . 0.0 111.05 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.7 m -85.12 7.88 20.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.114 0.566 . . . . 0.0 111.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.0 m -137.83 154.7 29.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.786 0.834 . . . . 0.0 110.981 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 169.15 17.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.791 0.836 . . . . 0.0 111.917 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 m -61.53 -16.73 50.3 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -75.91 -24.27 55.58 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.7 0.682 . . . . 0.0 110.373 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.427 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 11.8 m-85 -84.24 -20.57 32.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -86.89 -13.01 46.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.086 0.554 . . . . 0.0 110.818 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.73 -27.3 18.14 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.743 0.417 . . . . 0.0 110.354 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -91.46 160.98 35.69 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.96 154.44 61.74 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.873 2.382 . . . . 0.0 111.355 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.9 m -138.9 154.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.152 0.581 . . . . 0.0 110.594 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.9 tp -147.28 146.71 29.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.876 0.471 . . . . 0.0 110.038 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -79.86 163.74 24.13 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.277 0.231 . . . . 0.0 110.585 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.7 -39.12 2.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.11 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.94 133.58 48.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.9 m-85 -119.84 146.13 46.01 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.107 0.563 . . . . 0.0 110.477 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.8 t -153.34 159.04 42.39 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.787 0.835 . . . . 0.0 109.189 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -63.46 -28.9 70.28 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.62 -39.94 18.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.574 0.625 . . . . 0.0 111.905 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.547 ' H ' HG23 ' A' ' 105' ' ' THR . . . -80.19 -25.7 56.82 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 122.121 -0.362 . . . . 0.0 112.375 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.53 -28.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.685 0.743 . . . . 0.0 110.338 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -29.05 64.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.976 -0.452 . . . . 0.0 110.155 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -83.95 -25.33 30.16 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 110.668 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.32 -32.45 37.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.65 0.204 . . . . 0.0 110.724 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -34.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.44 63.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.059 -0.4 . . . . 0.0 110.567 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 -14.92 39.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.437 0.295 . . . . 0.0 111.345 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.99 -29.52 17.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.271 0.628 . . . . 0.0 110.865 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.3 tp -85.97 10.55 13.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 112.035 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.154 -1.403 . . . . 0.0 110.585 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 117' ' ' LEU . 88.4 mt . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -8.76 52.13 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 118.392 0.542 . . . . 0.0 111.191 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.503 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.8 mp0 -118.99 118.88 32.69 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.14 0.427 . . . . 0.0 111.642 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -119.04 131.22 72.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 O-C-N 123.737 0.648 . . . . 0.0 109.881 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -97.69 130.19 44.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 8' ' ' LEU . 86.3 mt -98.67 135.23 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -132.12 125.6 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -149.39 162.85 39.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.231 0.539 . . . . 0.0 112.423 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -123.46 11.86 9.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 109.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -145.03 113.78 4.92 Favored Pre-proline 0 N--CA 1.453 -0.311 0 C-N-CA 124.82 1.248 . . . . 0.0 107.944 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.86 -16.33 11.45 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.06 3.173 . . . . 0.0 114.655 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.47 -23.06 60.03 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.4 -27.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.61 -25.48 61.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.276 -0.265 . . . . 0.0 110.449 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.11 -35.17 28.82 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.448 -0.157 . . . . 0.0 110.779 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 98.1 mmm -75.43 -34.39 60.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.99 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.35 -28.18 42.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.131 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.52 -21.63 55.49 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.798 -0.564 . . . . 0.0 110.088 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.64 -41.32 46.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.194 -0.316 . . . . 0.0 111.447 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -82.08 -21.43 36.81 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.361 0.528 . . . . 0.0 112.368 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.21 -18.09 55.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.075 0.852 . . . . 0.0 110.137 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -85.28 -29.38 24.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.811 0.278 . . . . 0.0 110.774 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -83.28 -19.76 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 122.715 0.406 . . . . 0.0 110.774 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.09 14.53 28.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.793 0.437 . . . . 0.0 111.54 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 51.05 34.72 11.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.652 0.781 . . . . 0.0 111.461 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HD3' ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -85.55 162.7 18.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.849 0.86 . . . . 0.0 110.374 -176.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.4 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 56.8 m -114.42 88.02 14.91 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.951 0.5 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.76 157.94 58.68 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.83 2.354 . . . . 0.0 109.55 176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 6' ' ' GLN . 33.0 m -123.46 -16.9 4.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 174.21 33.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 118.329 0.513 . . . . 0.0 112.588 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -137.2 139.65 41.22 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.45 161.04 31.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 110.618 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -131.67 7.43 4.45 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.976 0.51 . . . . 0.0 112.188 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.9 p -136.39 156.69 48.27 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.968 0.507 . . . . 0.0 109.89 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.07 -29.9 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.8 65.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.157 -0.34 . . . . 0.0 110.363 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.33 -24.85 56.14 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.83 -34.99 60.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.614 0.707 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.37 -24.24 32.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.929 0.331 . . . . 0.0 110.393 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.75 57.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.207 0.458 . . . . 0.0 110.728 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -84.37 -31.11 24.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.463 0.705 . . . . 0.0 110.136 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.64 -25.27 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.66 0.384 . . . . 0.0 111.686 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -71.27 -19.08 62.39 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.651 -0.655 . . . . 0.0 111.153 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.91 -12.59 58.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.726 0.298 . . . . 0.0 110.999 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.99 -169.07 53.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.92 81.83 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.634 -0.536 . . . . 0.0 112.577 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.85 147.04 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 117.785 0.793 . . . . 0.0 109.536 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.6 -17.0 5.63 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.38 166.64 28.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.232 0.469 . . . . 0.0 110.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.04 165.53 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.28 -0.263 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.24 133.25 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.36 130.61 56.69 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.086 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -84.39 138.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.93 -12.24 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.443 0.297 . . . . 0.0 110.485 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.7 t30 . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.551 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.529 0.17 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.54 -11.83 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.741 2.961 . . . . 0.0 111.812 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -72.44 -13.65 16.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.344 0.258 . . . . 0.0 110.906 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.23 -24.47 63.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 122.221 -0.299 . . . . 0.0 110.388 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.55 -17.39 45.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.342 -0.224 . . . . 0.0 110.466 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.92 61.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.16 -27.02 60.64 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.76 57.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.15 -16.39 56.72 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -91.7 13.67 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.839 0.856 . . . . 0.0 110.026 172.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 60.71 30.5 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.551 1.141 . . . . 0.0 113.646 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.21 124.96 29.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.39 161.04 38.23 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.09 3.193 . . . . 0.0 111.062 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -152.12 171.25 18.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.218 0.533 . . . . 0.0 111.752 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.66 144.7 20.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 124.058 0.943 . . . . 0.0 109.017 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.03 154.46 22.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.408 0.283 . . . . 0.0 110.824 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.52 119.81 22.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -153.41 173.11 16.08 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 111.421 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 135.33 3.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.8 -156.12 26.52 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.1 p -79.26 175.37 10.66 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.954 0.502 . . . . 0.0 110.621 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.02 -6.6 34.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.73 0.412 . . . . 0.0 112.02 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -92.59 -7.64 46.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.021 0.528 . . . . 0.0 111.173 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.4 m -78.92 0.75 26.15 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.008 -0.432 . . . . 0.0 111.547 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 m -140.06 153.16 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.252 0.621 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.9 177.76 4.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.179 0.992 . . . . 0.0 110.485 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -61.63 -18.46 59.54 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.781 -0.575 . . . . 0.0 111.965 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -76.48 -20.74 56.66 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.862 0.755 . . . . 0.0 111.2 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -84.2 -19.29 34.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -88.15 -4.85 58.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.421 0.688 . . . . 0.0 110.264 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.84 -11.19 14.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.695 1.198 . . . . 0.0 111.572 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.75 163.12 41.04 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.92 0.888 . . . . 0.0 110.115 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.61 147.33 92.3 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.625 2.884 . . . . 0.0 112.53 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -140.19 151.36 21.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.603 0.761 . . . . 0.0 110.472 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -146.13 155.2 42.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.012 0.925 . . . . 0.0 108.662 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -85.7 162.03 18.95 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.332 -0.23 . . . . 0.0 110.884 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.68 -41.45 9.55 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.974 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.76 124.52 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.409 2.073 . . . . 0.0 110.875 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -107.33 143.15 36.02 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.3 t -155.7 163.67 39.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.99 -23.64 65.53 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -173.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.44 -38.74 21.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.379 0.536 . . . . 0.0 110.937 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.496 ' H ' HG23 ' A' ' 105' ' ' THR . . . -74.64 -26.75 66.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.6 t -81.44 -21.71 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.734 0.414 . . . . 0.0 109.913 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.18 -30.68 62.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.318 0.508 . . . . 0.0 110.703 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.24 -27.49 38.67 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.52 55.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -72.7 -32.75 66.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.944 0.498 . . . . 0.0 109.812 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.41 -17.97 40.34 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.641 0.376 . . . . 0.0 111.942 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.06 9.88 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -99.11 -58.35 1.96 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.891 0.314 . . . . 0.0 111.791 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 4' ' ' LEU . 3.2 mm? -65.86 -4.21 6.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.972 0.909 . . . . 0.0 112.768 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.244 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.605 0.717 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -2.13 21.11 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.683 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.5 mt-30 -124.03 111.18 15.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.118 0.417 . . . . 0.0 110.786 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.4 mm -119.4 128.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.085 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -88.99 135.07 33.75 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' N ' HD23 ' A' ' 8' ' ' LEU . 67.5 mt -102.88 134.58 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.02 0.528 . . . . 0.0 109.82 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.07 106.29 10.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -149.85 163.32 38.33 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 123.872 0.869 . . . . 0.0 110.531 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -112.76 -13.73 13.19 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.712 0.405 . . . . 0.0 110.912 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -84.69 127.28 65.98 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.71 -14.01 14.29 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.36 2.706 . . . . 0.0 112.757 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -93.73 -38.47 11.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.602 0.637 . . . . 0.0 111.881 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.8 mp -76.25 -28.39 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.82 63.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.852 0.061 . . . . 0.0 110.993 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.4 mtt -84.98 -27.86 26.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.395 -0.191 . . . . 0.0 110.672 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.7 mmm -77.94 -28.42 49.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.728 0.24 . . . . 0.0 110.494 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 21.9 tp -78.95 -30.96 44.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.222 -0.299 . . . . 0.0 110.326 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.65 -26.67 61.73 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.73 -35.19 52.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.361 -0.212 . . . . 0.0 110.485 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -73.35 -27.06 61.29 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.871 -0.518 . . . . 0.0 111.7 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -79.17 -17.8 54.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.613 0.642 . . . . 0.0 110.836 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.14 -29.46 24.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.854 0.297 . . . . 0.0 110.965 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.15 -21.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 122.584 0.353 . . . . 0.0 111.389 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 16.98 17.8 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.882 0.473 . . . . 0.0 111.648 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t0 52.02 34.46 13.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.975 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.79 165.45 16.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.698 0.799 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 77.95 6.52 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.199 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.11 160.55 41.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.54 2.827 . . . . 0.0 110.478 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.7 m -127.37 -25.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.1 176.79 36.29 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 118.527 0.603 . . . . 0.0 112.612 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.8 m -137.61 141.91 41.26 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.96 0.904 . . . . 0.0 108.708 176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.94 159.0 37.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 122.642 0.377 . . . . 0.0 110.152 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.61 -5.98 28.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.853 0.461 . . . . 0.0 111.994 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.7 p -143.06 161.08 39.11 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.085 0.554 . . . . 0.0 110.475 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.17 -22.72 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.787 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.46 -29.67 66.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.51 -27.56 65.23 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.4 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.323 0.562 . . . . 0.0 110.059 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.44 -23.25 50.55 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 177.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.37 45.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.728 0.24 . . . . 0.0 111.386 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 5.1 mmp_? -87.35 -21.92 25.4 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.131 -0.356 . . . . 0.0 111.696 175.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.53 -22.0 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.26 -16.19 60.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.08 -12.42 21.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.403 0.681 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 -167.68 54.03 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.17 24.33 61.63 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.631 -0.538 . . . . 0.0 112.609 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mt -137.22 147.66 26.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.386 0.674 . . . . 0.0 109.306 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -116.28 -26.98 6.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.63 12.49 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.045 0.384 . . . . 0.0 110.582 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.93 34.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.719 0.295 . . . . 0.0 111.388 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.1 mt -122.48 130.44 74.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.81 133.6 54.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.08 155.79 19.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.56 -11.87 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 N--CA 1.455 -0.194 0 C-N-CA 123.045 0.538 . . . . 0.0 110.656 177.678 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.446 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 7.9 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 66' ' ' THR . 77.7 Cg_exo -56.84 -12.79 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.908 2.406 . . . . 0.0 114.111 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.45 -13.89 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.47 -24.65 67.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.815 -0.553 . . . . 0.0 109.76 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.26 -17.99 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.457 0.303 . . . . 0.0 110.724 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.16 -27.23 39.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.03 -27.7 61.07 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -25.57 58.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.91 -16.46 56.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -92.67 6.6 46.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.754 0.821 . . . . 0.0 110.136 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.31 35.35 20.74 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.262 1.025 . . . . 0.0 113.199 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.79 129.73 25.18 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.64 157.51 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.602 2.868 . . . . 0.0 111.302 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -145.01 164.79 30.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.609 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -136.12 147.56 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 124.604 1.162 . . . . 0.0 108.837 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 28.9 m-85 -91.98 155.35 18.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.895 0.378 . . . . 0.0 111.682 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.87 128.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -165.28 158.85 16.73 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.657 0.265 . . . . 0.0 111.009 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.61 136.99 13.16 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.04 -151.91 23.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 82.8 p -119.36 176.05 5.53 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.443 0.697 . . . . 0.0 110.55 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.56 -1.92 12.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.833 0.453 . . . . 0.0 111.739 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.66 1.28 14.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.359 0.663 . . . . 0.0 111.187 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -87.16 7.64 27.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.348 0.659 . . . . 0.0 111.609 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.1 m -139.63 155.86 25.65 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 123.748 0.819 . . . . 0.0 111.628 -175.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.57 162.63 20.49 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.949 0.9 . . . . 0.0 111.36 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.8 m -59.1 -19.56 45.56 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -74.12 -25.43 59.76 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.987 0.812 . . . . 0.0 110.743 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 7.1 m-85 -79.98 -19.31 48.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -88.16 -10.22 50.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.827 0.451 . . . . 0.0 110.669 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.91 -11.58 15.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.647 0.779 . . . . 0.0 111.618 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -121.34 160.92 43.75 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.399 0.679 . . . . 0.0 110.118 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.33 148.89 84.37 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.996 2.464 . . . . 0.0 112.242 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.61 154.86 17.97 Favored 'Isoleucine or valine' 0 C--O 1.23 0.046 0 C-N-CA 124.139 0.976 . . . . 0.0 109.909 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.3 tp -138.55 145.16 40.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.821 0.449 . . . . 0.0 109.832 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -76.68 165.27 24.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.774 0.43 . . . . 0.0 110.38 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -79.19 -39.15 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.763 -177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.96 143.81 95.73 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.589 2.192 . . . . 0.0 110.567 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 1.7 m-85 -118.96 133.39 55.86 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.922 0.392 . . . . 0.0 111.348 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -143.33 155.53 44.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.783 1.233 . . . . 0.0 108.923 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.96 -28.6 66.78 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 122.199 -0.313 . . . . 0.0 111.61 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -84.5 -35.24 23.05 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.051 -0.406 . . . . 0.0 111.634 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.0 -38.93 29.09 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.307 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.89 -22.93 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 117.857 0.829 . . . . 0.0 111.162 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.2 64.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.503 -0.748 . . . . 0.0 110.306 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -78.8 -31.96 46.14 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.34 -26.68 46.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.183 0.193 . . . . 0.0 111.038 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.55 -38.7 65.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.25 -23.47 62.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.416 -0.177 . . . . 0.0 110.678 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.08 -13.84 43.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.84 0.456 . . . . 0.0 111.468 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.7 tt -90.89 -29.27 17.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.145 0.578 . . . . 0.0 110.699 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.4 tp -82.91 6.65 17.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.956 0.503 . . . . 0.0 111.887 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.802 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.03 -11.18 36.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.691 -0.631 . . . . 0.0 110.424 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.41 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.6 mp0 -111.49 104.6 13.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.779 0.432 . . . . 0.0 110.977 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.03 124.11 72.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.981 0.512 . . . . 0.0 110.434 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -86.79 146.99 26.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.618 ' H ' HD23 ' A' ' 8' ' ' LEU . 95.0 mt -110.53 128.1 67.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.922 0.889 . . . . 0.0 109.675 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.3 122.73 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.071 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.97 163.29 33.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.289 0.235 . . . . 0.0 111.262 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.32 -11.32 32.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.53 135.57 13.14 Favored Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.41 -17.32 44.07 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.089 2.526 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -77.87 -37.42 48.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.456 0.571 . . . . 0.0 110.01 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -77.55 -27.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.54 68.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.198 -0.314 . . . . 0.0 110.281 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -76.73 -27.3 55.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -73.22 -33.4 65.32 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.65 -31.65 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.23 -0.294 . . . . 0.0 110.409 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.93 -21.82 43.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.37 -42.96 42.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.094 -0.378 . . . . 0.0 110.15 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.94 -19.36 60.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.641 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.63 -29.29 66.75 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.164 0.438 . . . . 0.0 110.116 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -84.72 -29.58 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.491 0.316 . . . . 0.0 111.385 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -71.55 -24.24 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 6.57 48.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.173 0.589 . . . . 0.0 111.032 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t0 50.73 37.75 17.55 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.584 0.754 . . . . 0.0 111.49 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.6 tmtm? -85.69 158.84 19.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.855 0.862 . . . . 0.0 110.422 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.444 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 88.7 m -92.08 124.39 60.07 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.42 153.86 35.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.63 2.886 . . . . 0.0 110.872 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 6' ' ' GLN . 24.8 m -141.77 -21.86 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.409 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.66 163.05 16.92 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -143.96 134.86 25.3 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.57 161.2 24.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.898 0.38 . . . . 0.0 111.117 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -136.08 3.74 2.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.119 0.568 . . . . 0.0 111.546 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -139.3 161.72 36.75 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.357 0.663 . . . . 0.0 110.78 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.41 -32.99 52.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 122.437 0.295 . . . . 0.0 110.239 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.4 -29.51 53.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.347 -0.22 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.89 -33.0 52.04 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 -33.83 74.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.409 0.604 . . . . 0.0 110.511 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.21 -29.02 60.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.26 60.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.47 -26.96 22.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 118.328 0.513 . . . . 0.0 112.15 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -83.28 -21.69 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 118.04 0.382 . . . . 0.0 111.522 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -81.56 -23.05 37.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.41 -13.63 8.4 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.733 0.697 . . . . 0.0 112.316 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.39 -164.94 40.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.51 137.18 5.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.49 164.5 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.74 0.816 . . . . 0.0 110.802 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -124.13 -10.72 7.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.014 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.87 165.85 20.1 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.503 0.721 . . . . 0.0 109.056 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.09 158.0 43.48 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.729 -0.607 . . . . 0.0 111.903 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.7 mm -97.46 121.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.07 124.87 49.13 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.97 118.32 11.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 168.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.56 -29.27 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -171.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.2 t30 . . . . . 0 N--CA 1.454 -0.242 0 CA-C-N 118.197 0.453 . . . . 0.0 110.983 -177.418 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 119.939 -0.077 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -83.23 -10.33 10.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.625 2.884 . . . . 0.0 111.301 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.6 t -74.24 -29.85 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 117.799 0.272 . . . . 0.0 111.343 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.53 78.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.125 0.42 . . . . 0.0 110.45 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.03 -17.59 39.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.266 -0.272 . . . . 0.0 111.088 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.84 65.97 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.56 -26.49 58.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.49 -24.29 61.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.948 0.34 . . . . 0.0 110.113 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.71 44.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.317 0.247 . . . . 0.0 110.471 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -101.58 8.66 41.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.39 0.676 . . . . 0.0 110.962 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.97 37.12 28.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.652 1.181 . . . . 0.0 113.37 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -110.66 120.98 42.39 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 123.022 0.529 . . . . 0.0 109.767 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.95 154.24 39.83 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.227 3.285 . . . . 0.0 113.663 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.54 168.4 23.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -96.95 152.59 18.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.959 0.409 . . . . 0.0 111.927 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.18 119.61 10.3 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.1 t -172.17 164.48 6.01 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.023 0.929 . . . . 0.0 109.447 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.26 142.61 21.4 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.42 -160.46 32.7 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 117.424 0.612 . . . . 0.0 112.057 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.1 t -143.67 167.69 21.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.303 0.641 . . . . 0.0 110.518 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -3.77 17.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 112.602 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -114.37 10.61 17.1 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.281 0.632 . . . . 0.0 111.874 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.1 p -118.76 9.24 12.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 123.039 0.536 . . . . 0.0 112.017 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.14 154.69 25.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.631 0.773 . . . . 0.0 111.621 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.34 163.8 25.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.288 0.635 . . . . 0.0 111.316 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -59.95 -17.35 37.25 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -71.58 -26.68 62.71 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.852 0.751 . . . . 0.0 110.462 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -83.54 -22.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -88.09 -10.75 49.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.817 0.447 . . . . 0.0 111.319 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.96 -32.23 11.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 110.995 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.3 152.64 50.37 Favored Pre-proline 0 C--N 1.338 0.108 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.67 152.43 56.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.226 2.617 . . . . 0.0 111.413 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.58 153.19 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 122.842 0.457 . . . . 0.0 110.892 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.0 tp -149.06 153.73 38.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -84.85 167.07 16.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.656 0.383 . . . . 0.0 110.677 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 69.5 mmtt -63.6 -46.51 83.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.3 Cg_endo -71.71 137.05 29.24 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.673 1.582 . . . . 0.0 109.777 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -110.44 148.67 31.58 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.949 0.499 . . . . 0.0 110.331 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.8 p -144.01 161.4 38.87 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.125 0.97 . . . . 0.0 109.21 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.66 -27.14 68.72 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.088 -0.383 . . . . 0.0 111.083 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.78 -36.51 21.65 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.64 -30.42 44.35 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.7 t -82.43 -30.56 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.663 0.731 . . . . 0.0 110.335 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 -26.42 62.74 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.502 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -83.39 -33.75 25.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.401 0.28 . . . . 0.0 110.917 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.84 61.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.319 -0.238 . . . . 0.0 110.703 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.18 -20.61 40.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 119.564 -0.255 . . . . 0.0 110.784 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.43 55.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.37 0.532 . . . . 0.0 110.07 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.57 26.72 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.803 0.441 . . . . 0.0 111.513 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 tt -91.2 -51.88 5.09 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.989 0.515 . . . . 0.0 110.305 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.5 mt -79.13 17.37 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.1 . . . . 0.0 112.147 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.311 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.505 0.669 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -78.04 -6.77 55.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.943 0.497 . . . . 0.0 111.506 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.451 ' HB3' HG11 ' A' ' 32' ' ' VAL . 64.5 mt-30 -118.73 111.09 18.04 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.09 136.05 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.762 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -96.0 138.29 33.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.48 ' H ' HD23 ' A' ' 8' ' ' LEU . 79.8 mt -102.12 126.2 56.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.867 0.867 . . . . 0.0 109.716 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.37 110.04 15.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 162.67 35.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 111.629 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -98.19 -0.16 44.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.912 0.885 . . . . 0.0 111.32 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.61 105.59 15.72 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.89 -22.47 54.35 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.753 2.969 . . . . 0.0 113.592 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.32 -41.2 73.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.457 0.571 . . . . 0.0 110.427 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.418 HG13 ' HE3' ' A' ' 102' ' ' LYS . 43.6 mm -79.03 -25.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.51 66.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 mmt -80.92 -25.54 37.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mtp -73.33 -30.64 63.49 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.96 -32.11 71.46 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.102 -0.374 . . . . 0.0 110.053 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -74.62 -23.14 58.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.204 -0.31 . . . . 0.0 110.208 175.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.66 -43.3 20.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.301 -0.249 . . . . 0.0 111.14 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -74.35 -27.26 60.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.425 0.557 . . . . 0.0 111.754 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.83 -17.87 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.541 0.61 . . . . 0.0 110.894 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.862 0.301 . . . . 0.0 110.769 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.54 -20.1 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 122.766 0.426 . . . . 0.0 110.793 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -103.13 17.02 25.05 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.97 0.508 . . . . 0.0 111.687 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.88 36.13 17.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.061 0.944 . . . . 0.0 112.76 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.87 164.65 17.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.336 0.654 . . . . 0.0 109.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -117.47 72.18 7.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 O-C-N 122.06 -0.4 . . . . 0.0 110.873 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.92 158.28 48.1 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.845 2.364 . . . . 0.0 110.166 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 6' ' ' GLN . 31.4 m -121.58 -9.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -173.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.89 174.03 34.16 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 118.422 0.555 . . . . 0.0 112.374 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.1 m -141.17 137.64 32.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.378 1.071 . . . . 0.0 108.383 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.93 156.88 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.024 0.44 . . . . 0.0 111.077 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.74 -4.26 37.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.982 0.913 . . . . 0.0 111.732 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -151.4 157.5 42.5 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.88 0.472 . . . . 0.0 110.439 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.88 -22.92 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 122.792 0.437 . . . . 0.0 110.567 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.96 -26.09 63.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.949 -0.469 . . . . 0.0 110.245 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.57 -21.17 64.71 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.51 63.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.235 0.518 . . . . 0.0 109.924 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.23 -32.2 66.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.85 -24.68 64.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.443 -0.161 . . . . 0.0 110.919 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -82.94 -25.71 32.11 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.743 0.247 . . . . 0.0 110.949 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.5 t -71.94 -26.55 25.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.78 -14.34 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.674 0.39 . . . . 0.0 110.863 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -98.84 -14.61 19.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.435 0.694 . . . . 0.0 111.994 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.22 169.74 38.76 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.62 148.21 36.59 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.37 149.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.18 -30.66 11.42 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.193 0.452 . . . . 0.0 111.35 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 174.95 11.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.749 0.42 . . . . 0.0 110.582 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.58 161.48 41.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.675 0.274 . . . . 0.0 111.0 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.78 130.86 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.02 136.0 53.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.24 0.616 . . . . 0.0 110.203 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.56 144.99 29.98 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.78 -12.0 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 122.281 -0.262 . . . . 0.0 111.307 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 -179.367 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 28.2 p . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.4 Cg_exo -57.8 -18.72 35.47 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 113.972 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.3 m -82.45 -9.77 11.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 118.061 0.392 . . . . 0.0 111.892 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.61 68.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.983 -0.448 . . . . 0.0 110.458 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -75.18 -17.77 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.291 -0.256 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.81 -25.62 37.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.5 -29.93 61.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 173.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.29 60.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.16 -13.51 57.06 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -95.52 14.76 21.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 110.14 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.17 31.41 19.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.421 1.089 . . . . 0.0 113.489 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.6 mt -122.23 108.69 33.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.9 162.71 38.66 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.628 2.885 . . . . 0.0 111.195 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -150.07 167.54 26.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.248 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.87 144.93 27.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 22.9 m-85 -87.05 153.13 21.78 Favored 'General case' 0 C--N 1.337 0.031 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.83 122.47 13.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -166.99 161.15 14.77 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.732 0.413 . . . . 0.0 110.425 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 134.06 12.13 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.93 -155.61 26.24 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 m -132.52 171.18 14.12 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.923 0.889 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.45 -10.27 54.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.89 2.58 55.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.791 0.436 . . . . 0.0 111.324 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -102.75 7.62 39.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.492 0.717 . . . . 0.0 111.108 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.4 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 5.2 m -139.48 154.83 25.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.972 0.909 . . . . 0.0 111.47 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.98 169.92 14.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.991 0.916 . . . . 0.0 111.547 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.5 p -61.51 -19.12 61.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -70.69 -24.5 62.68 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.379 0.536 . . . . 0.0 110.823 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 49.9 m-85 -89.01 -19.33 25.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.32 -7.87 56.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 111.111 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.92 -18.07 13.47 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.367 0.667 . . . . 0.0 111.229 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -107.35 158.16 33.81 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.235 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.18 151.98 82.27 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.154 2.569 . . . . 0.0 111.58 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.8 154.71 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.952 0.901 . . . . 0.0 110.562 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -139.16 155.09 48.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.566 0.746 . . . . 0.0 109.892 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -79.34 162.95 25.25 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.724 0.41 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 56.9 tptt -78.67 -47.68 1.82 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.591 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 88.7 Cg_endo -74.3 144.76 33.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.115 1.876 . . . . 0.0 110.256 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -115.83 147.21 41.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.034 0.533 . . . . 0.0 110.489 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.9 p -144.3 162.48 36.31 Favored 'General case' 0 N--CA 1.46 0.04 0 C-N-CA 124.443 1.097 . . . . 0.0 108.866 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -63.55 -31.87 73.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.91 -0.494 . . . . 0.0 111.207 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -84.62 -33.59 23.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.6 -27.03 57.94 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.9 -25.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.562 0.681 . . . . 0.0 110.527 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.9 -32.37 71.97 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.3 -29.25 38.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.524 0.33 . . . . 0.0 110.429 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.74 60.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 122.302 -0.249 . . . . 0.0 110.97 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.21 -30.2 54.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.83 -26.71 62.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.378 -0.201 . . . . 0.0 110.571 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -18.84 28.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.852 0.461 . . . . 0.0 112.119 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.89 -40.26 11.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.138 0.575 . . . . 0.0 110.92 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.59 18.29 3.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.871 0.469 . . . . 0.0 112.193 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.811 -1.09 . . . . 0.0 110.812 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -72.09 -7.47 49.15 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.712 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.457 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 70.8 mt-30 -119.99 116.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.167 0.44 . . . . 0.0 112.141 -171.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.451 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.0 mm -122.29 128.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 123.932 0.77 . . . . 0.0 111.511 -172.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.531 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -86.6 142.24 28.41 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.531 ' H ' HD23 ' A' ' 8' ' ' LEU . 79.3 mt -112.78 130.92 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 t -124.27 125.08 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -152.14 163.63 38.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.693 0.397 . . . . 0.0 111.868 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.77 12.93 13.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.412 0.685 . . . . 0.0 110.601 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -146.87 121.5 5.23 Favored Pre-proline 0 N--CA 1.454 -0.248 0 C-N-CA 123.973 0.909 . . . . 0.0 108.565 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.81 -14.36 44.26 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.24 2.627 . . . . 0.0 112.451 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.7 -31.1 68.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.4 -26.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.02 78.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.027 -0.42 . . . . 0.0 110.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.42 -21.77 30.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.463 -0.148 . . . . 0.0 111.126 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.8 tpt -76.75 -33.93 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.298 -0.251 . . . . 0.0 110.43 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.78 -27.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.229 0.212 . . . . 0.0 110.746 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.96 -21.85 58.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.785 0.266 . . . . 0.0 110.41 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.27 -46.29 28.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.264 -0.272 . . . . 0.0 110.687 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.57 -15.99 58.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.581 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.42 -28.84 64.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -78.84 -23.96 44.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.393 0.277 . . . . 0.0 110.408 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.07 -28.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.31 -1.94 58.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.536 0.335 . . . . 0.0 110.248 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t0 50.11 33.0 6.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.747 1.219 . . . . 0.0 112.96 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HE3' HG12 ' A' ' 7' ' ' ILE . 59.1 pttt -104.47 -165.77 1.18 Allowed 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.285 -0.259 . . . . 0.0 111.664 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -103.2 124.99 36.41 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 112.043 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 164.58 20.27 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.622 2.881 . . . . 0.0 110.067 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 34.8 m -136.07 -28.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.16 178.6 37.8 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.573 0.624 . . . . 0.0 112.616 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -137.35 141.07 41.8 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.39 1.076 . . . . 0.0 108.598 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.15 155.53 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.98 0.419 . . . . 0.0 110.767 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -129.11 7.89 5.54 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.436 0.694 . . . . 0.0 111.749 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 p -132.61 157.73 44.04 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.393 0.677 . . . . 0.0 110.025 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.24 -23.72 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.13 -25.8 42.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.303 -0.248 . . . . 0.0 110.816 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.42 -30.26 58.74 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.6 56.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.332 0.566 . . . . 0.0 110.623 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.13 -24.52 47.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.09 -25.04 40.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.212 -0.305 . . . . 0.0 111.11 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -87.37 -26.7 23.21 Favored 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.96 -22.34 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.687 0.676 . . . . 0.0 110.825 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -79.97 -14.56 58.49 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.33 -0.231 . . . . 0.0 110.468 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.88 -12.74 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.178 0.591 . . . . 0.0 111.137 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.77 53.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.95 62.99 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.052 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mt -140.34 144.73 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.793 0.837 . . . . 0.0 109.217 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.42 -25.71 9.91 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.76 176.99 10.32 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.09 0.405 . . . . 0.0 110.52 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.68 166.73 27.49 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.04 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.39 119.6 29.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.599 0.237 . . . . 0.0 110.759 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -80.41 127.92 32.97 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.613 0.365 . . . . 0.0 110.298 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.8 t -97.19 -11.15 8.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.434 0.694 . . . . 0.0 110.496 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 122.76 0.424 . . . . 0.0 111.85 179.64 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.7 m . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 86.9 Cg_endo -75.12 -13.49 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.174 1.916 . . . . 0.0 111.5 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.39 -29.11 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 122.612 0.365 . . . . 0.0 110.738 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.24 80.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.792 0.329 . . . . 0.0 110.387 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.93 -17.77 45.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.168 -0.332 . . . . 0.0 110.863 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.87 64.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.63 -27.22 62.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.38 -24.74 62.13 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 117.65 0.204 . . . . 0.0 110.49 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.16 52.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.234 -0.292 . . . . 0.0 110.486 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -99.54 8.69 44.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.409 0.684 . . . . 0.0 111.246 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 57.79 35.83 25.87 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.208 1.003 . . . . 0.0 113.026 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.36 131.08 22.23 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.75 156.86 39.76 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.91 3.073 . . . . 0.0 111.502 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.1 167.68 29.03 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.852 0.461 . . . . 0.0 111.132 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -138.89 164.87 25.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.008 0.923 . . . . 0.0 109.625 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' ' CD2' ' A' ' 94' ' ' PHE . 36.5 m-85 -107.51 161.97 14.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.337 0.589 . . . . 0.0 111.921 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.24 17.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.0 m -148.54 150.53 33.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.466 0.306 . . . . 0.0 110.82 -171.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.76 129.99 9.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.2 -171.95 30.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.7 m -83.24 161.29 21.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.688 0.395 . . . . 0.0 110.706 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -76.02 2.53 12.5 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -122.46 11.81 10.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.978 0.511 . . . . 0.0 111.301 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 m -110.61 12.64 22.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.338 0.655 . . . . 0.0 111.849 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.27 154.59 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.404 0.682 . . . . 0.0 109.567 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.54 153.56 23.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.28 0.632 . . . . 0.0 111.979 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.0 m -62.89 -18.92 63.65 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -76.65 -20.5 56.6 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 118.599 0.636 . . . . 0.0 110.459 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.416 ' CD2' ' CD1' ' A' ' 81' ' ' PHE . 9.1 m-85 -85.8 -19.62 30.43 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -83.28 -19.03 37.08 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 122.419 0.288 . . . . 0.0 110.856 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.66 -21.33 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.102 0.561 . . . . 0.0 111.862 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -101.97 157.99 32.64 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 122.799 0.44 . . . . 0.0 110.414 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.12 149.94 76.8 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.43 2.753 . . . . 0.0 111.692 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.66 153.27 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.003 0.521 . . . . 0.0 110.465 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.75 157.48 46.01 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.205 1.002 . . . . 0.0 109.371 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.92 168.64 10.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 37.9 mtmm -60.64 -46.85 97.21 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.116 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 77.7 Cg_endo -71.93 138.16 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.835 1.69 . . . . 0.0 109.628 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 109' ' ' VAL . 2.2 m-30 -112.51 154.14 26.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.527 0.731 . . . . 0.0 110.325 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.7 p -138.01 160.76 38.48 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.428 0.691 . . . . 0.0 110.363 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.4 tpp -71.15 -28.86 64.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.152 0.426 . . . . 0.0 112.152 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.5 -43.56 14.45 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.968 -0.458 . . . . 0.0 111.931 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -30.18 48.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 119.845 -0.42 . . . . 0.0 112.527 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 104' ' ' PHE . 47.0 t -87.22 -30.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 CA-C-N 117.658 0.729 . . . . 0.0 111.01 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.66 68.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.871 -0.518 . . . . 0.0 110.021 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.31 -29.94 38.14 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.121 0.168 . . . . 0.0 110.707 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.6 37.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.295 -0.253 . . . . 0.0 111.417 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.92 -19.95 33.84 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 117.961 0.346 . . . . 0.0 111.115 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.02 -25.65 43.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.61 -25.86 41.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.65 29.92 1.43 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.036 0.935 . . . . 0.0 111.125 173.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.79 -16.47 7.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.425 0.29 . . . . 0.0 111.586 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.22 -177.343 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 ttp . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -133.63 -10.17 2.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.418 0.687 . . . . 0.0 110.6 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -153.26 -170.48 3.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.463 1.505 . . . . 0.0 107.31 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 4' ' ' LEU . 29.6 mt -141.94 30.55 1.63 Allowed 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.365 0.666 . . . . 0.0 109.894 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -87.27 -11.56 49.26 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.16 0.584 . . . . 0.0 111.329 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.568 ' HB3' HG11 ' A' ' 32' ' ' VAL . 81.4 mt-30 -123.07 113.65 19.3 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.1 mm -122.47 131.55 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.626 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -89.87 149.81 22.48 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.635 ' H ' HD23 ' A' ' 8' ' ' LEU . 66.3 mt -115.17 135.59 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-N 118.115 0.416 . . . . 0.0 110.108 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 t -131.58 121.96 49.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.552 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 12.2 tp10 -150.55 157.49 43.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.806 -173.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -102.36 -10.49 19.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.243 0.617 . . . . 0.0 112.508 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.552 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 48.0 mt-10 -133.2 132.92 22.44 Favored Pre-proline 0 CA--C 1.532 0.26 0 O-C-N 121.919 -0.488 . . . . 0.0 110.369 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.41 -21.41 61.1 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.329 2.686 . . . . 0.0 113.2 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.94 -43.54 71.41 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.165 -0.335 . . . . 0.0 110.682 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 mm -81.0 -25.63 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.76 -30.62 70.12 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.308 -0.245 . . . . 0.0 110.56 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 mmt -82.42 -22.7 35.21 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 122.319 -0.238 . . . . 0.0 110.808 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mtp -73.94 -35.44 64.56 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 118.218 0.463 . . . . 0.0 110.179 174.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.37 -33.77 74.85 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.171 -0.331 . . . . 0.0 110.138 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.41 -25.53 60.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.297 -0.252 . . . . 0.0 110.359 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -80.76 -41.55 23.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 117.907 0.321 . . . . 0.0 111.136 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -74.16 -24.89 59.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 121.872 -0.518 . . . . 0.0 111.937 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -78.78 -23.59 45.15 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.755 0.707 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -85.33 -21.4 28.94 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.554 0.616 . . . . 0.0 112.126 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.7 t -85.2 -26.0 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 CA-C-N 118.25 0.477 . . . . 0.0 111.244 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.03 18.31 13.7 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 122.17 -0.331 . . . . 0.0 111.536 178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.87 34.02 18.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.448 0.699 . . . . 0.0 112.388 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -85.64 162.49 18.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.907 0.883 . . . . 0.0 109.102 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.8 m -111.32 85.22 5.39 Favored Pre-proline 0 CA--C 1.531 0.23 0 O-C-N 122.116 -0.365 . . . . 0.0 110.393 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.27 156.97 62.41 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.732 2.288 . . . . 0.0 110.038 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.7 m -131.15 -9.14 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -174.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.18 173.82 33.27 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 119.302 0.955 . . . . 0.0 113.126 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.4 m -144.0 141.09 29.96 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.202 1.001 . . . . 0.0 109.014 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.48 162.18 24.01 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 122.892 0.477 . . . . 0.0 111.091 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -94.35 -11.79 29.27 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.524 0.73 . . . . 0.0 111.858 -177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.9 t -149.29 157.99 43.8 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.947 -0.471 . . . . 0.0 110.491 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -71.55 -22.47 21.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 122.574 0.35 . . . . 0.0 110.223 -177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.87 -26.51 66.06 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.978 -0.451 . . . . 0.0 109.983 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -26.15 55.62 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.49 -30.56 63.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.255 0.527 . . . . 0.0 109.839 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.47 -37.43 68.5 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.78 64.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 122.373 -0.204 . . . . 0.0 111.074 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -84.81 -22.27 29.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.453 0.301 . . . . 0.0 111.062 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.3 t -81.19 -21.85 10.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -71.75 -14.92 62.15 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 110.335 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -100.02 -12.49 19.68 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.089 0.956 . . . . 0.0 110.681 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.11 -168.49 52.09 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.58 23.36 62.66 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 122.44 -0.447 . . . . 0.0 112.231 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 mt -135.57 148.01 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.697 0.748 . . . . 0.0 109.343 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -120.0 -30.32 4.73 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.59 178.83 9.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.811 0.444 . . . . 0.0 109.913 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.36 163.1 39.7 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.992 0.425 . . . . 0.0 111.997 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 mm -113.21 140.25 34.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.4 tp -140.71 129.53 23.08 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.551 0.215 . . . . 0.0 110.996 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.16 154.08 26.91 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.741 0.305 . . . . 0.0 110.421 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.4 t -94.94 -11.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 122.893 0.477 . . . . 0.0 109.903 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -80.2 28.29 0.31 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.159 0.984 . . . . 0.0 111.97 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.17 155.42 14.12 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.333 0.653 . . . . 0.0 110.602 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -81.47 144.7 31.17 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.11 -174.5 26.16 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.54 -163.6 42.99 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -126.3 68.9 1.21 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.977 0.511 . . . . 0.0 110.41 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 49.53 29.17 2.82 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.936 0.895 . . . . 0.0 112.639 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -152.05 162.14 41.54 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.864 0.466 . . . . 0.0 109.924 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.1 t -147.28 133.92 9.89 Favored Pre-proline 0 CA--C 1.529 0.15 0 C-N-CA 122.958 0.503 . . . . 0.0 110.554 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -81.45 -11.96 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.601 2.867 . . . . 0.0 111.653 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.5 t -78.25 -22.7 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 122.046 -0.409 . . . . 0.0 110.797 -175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.34 -33.29 75.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.06 -17.96 60.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.164 -0.335 . . . . 0.0 111.227 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.33 -29.41 57.26 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.56 -34.52 72.3 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.61 -21.06 60.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.053 -0.404 . . . . 0.0 110.81 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.25 -16.59 42.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.514 0.325 . . . . 0.0 111.459 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -104.08 23.81 12.4 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.447 0.699 . . . . 0.0 111.775 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.6 t70 53.83 41.83 31.93 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.865 0.866 . . . . 0.0 112.662 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.96 87.83 23.67 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.12 164.47 8.38 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 124.844 3.696 . . . . 0.0 114.27 -176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -140.19 169.3 17.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.975 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.7 t -136.06 141.35 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 124.277 1.031 . . . . 0.0 109.27 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -89.04 150.14 22.91 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 120.572 0.225 . . . . 0.0 110.764 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.16 139.47 27.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.89 0.476 . . . . 0.0 110.017 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.3 t -160.67 158.73 29.33 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 122.212 -0.305 . . . . 0.0 111.112 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -105.92 113.26 4.14 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 173.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.88 -163.52 29.72 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 39.8 m -76.88 160.41 29.24 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.237 0.542 . . . . 0.0 110.753 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.99 -3.12 56.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.694 0.398 . . . . 0.0 111.96 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -92.73 -0.46 57.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.584 0.354 . . . . 0.0 111.441 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.4 m -84.23 8.35 16.11 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.43 0.692 . . . . 0.0 112.02 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.7 m -136.9 154.68 31.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.752 0.821 . . . . 0.0 110.728 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -72.33 169.27 16.62 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.384 0.673 . . . . 0.0 111.487 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.9 p -61.94 -15.83 46.41 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -74.82 -24.24 58.59 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.939 0.336 . . . . 0.0 110.268 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.406 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 10.1 m-85 -86.01 -22.48 27.27 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -84.39 -14.53 49.16 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.801 0.441 . . . . 0.0 110.895 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.69 -33.55 14.31 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.732 0.413 . . . . 0.0 110.475 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -83.0 160.65 60.07 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.48 152.15 69.9 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.24 2.627 . . . . 0.0 111.181 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.24 154.39 33.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.002 0.521 . . . . 0.0 111.102 -178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.4 mt -139.06 154.63 48.22 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.711 0.804 . . . . 0.0 110.361 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 pm0 -86.94 165.63 15.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.062 0.545 . . . . 0.0 109.658 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -71.15 -49.38 12.59 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -176.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.33 140.01 21.51 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.052 1.835 . . . . 0.0 111.161 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -110.4 152.34 26.38 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.065 0.46 . . . . 0.0 110.54 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 108' ' ' GLY . 8.8 t -154.26 164.61 38.28 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.028 0.931 . . . . 0.0 108.849 177.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -58.59 -27.57 64.77 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -84.04 -36.01 23.41 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-N 118.084 0.402 . . . . 0.0 111.256 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.456 ' H ' HG23 ' A' ' 105' ' ' THR . . . -79.3 -25.24 59.62 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.3 t -81.12 -30.26 11.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 117.122 0.461 . . . . 0.0 110.367 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.34 69.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.73 -20.81 30.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.684 0.394 . . . . 0.0 111.107 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.51 -41.24 61.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 117.777 0.262 . . . . 0.0 110.477 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.4 mt -77.5 -28.42 52.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.0 -20.28 61.05 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.977 0.353 . . . . 0.0 110.874 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.47 -20.6 26.34 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.534 0.333 . . . . 0.0 111.382 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -91.32 -50.63 5.71 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.819 0.282 . . . . 0.0 110.546 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.6 mp -70.96 2.92 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.328 1.051 . . . . 0.0 112.88 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.173 -1.394 . . . . 0.0 110.0 178.446 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -80.16 -6.58 57.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.505 0.322 . . . . 0.0 111.827 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.88 159.14 43.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.711 0.804 . . . . 0.0 109.941 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.8 68.42 0.66 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.35 0.66 . . . . 0.0 110.697 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.23 -4.14 58.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 175.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.649 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.0 mp0 -120.37 109.68 15.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.671 0.789 . . . . 0.0 111.438 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 mm -116.62 130.17 71.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 O-C-N 123.514 0.509 . . . . 0.0 110.086 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 145.31 25.11 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 176.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.656 ' H ' HD23 ' A' ' 8' ' ' LEU . 63.7 mt -113.33 130.57 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 123.769 0.828 . . . . 0.0 109.237 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.29 117.76 33.49 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -141.26 162.98 34.19 Favored 'General case' 0 C--O 1.227 -0.131 0 C-N-CA 123.626 0.77 . . . . 0.0 110.512 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -84.02 -9.95 58.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.454 0.301 . . . . 0.0 111.423 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -140.6 145.51 40.78 Favored Pre-proline 0 CA--C 1.528 0.127 0 C-N-CA 122.839 0.456 . . . . 0.0 109.836 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.07 -14.75 26.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.116 2.544 . . . . 0.0 111.202 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.5 mt -74.89 -30.32 61.27 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 117.771 0.26 . . . . 0.0 110.626 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mm -84.91 -30.17 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.04 -30.77 69.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.8 tpp -78.91 -28.23 43.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.9 ttt -70.39 -29.99 66.78 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 2.1 mm? -75.16 -29.48 60.44 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.499 0.32 . . . . 0.0 110.483 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -71.88 -23.79 61.56 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 117.893 0.315 . . . . 0.0 110.266 176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.48 -40.72 42.05 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 122.438 -0.164 . . . . 0.0 111.432 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -76.74 -24.66 53.02 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-N 118.266 0.484 . . . . 0.0 111.96 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.66 -20.35 56.76 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.704 0.684 . . . . 0.0 110.364 176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.2 -27.66 35.25 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.875 0.307 . . . . 0.0 110.585 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.4 t -79.76 -22.59 12.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 122.504 0.322 . . . . 0.0 110.859 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.77 13.56 34.53 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.793 0.437 . . . . 0.0 111.815 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t70 53.49 29.2 8.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.095 0.958 . . . . 0.0 112.4 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 tmtm? -85.62 161.05 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.629 0.772 . . . . 0.0 109.202 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.8 m -105.83 117.47 57.69 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -78.6 162.83 27.19 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.322 2.681 . . . . 0.0 110.107 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.649 HG11 ' HB3' ' A' ' 6' ' ' GLN . 26.7 m -135.12 -18.18 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.47 172.75 32.33 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 118.136 0.425 . . . . 0.0 112.147 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 47.3 p -139.14 142.02 38.04 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 108.464 176.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.33 152.87 23.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-O 120.792 0.329 . . . . 0.0 110.297 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -100.83 1.32 39.99 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.24 0.616 . . . . 0.0 112.111 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.3 p -141.32 157.84 44.67 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.222 0.609 . . . . 0.0 109.812 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -76.36 -22.88 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 122.416 -0.177 . . . . 0.0 110.8 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.85 -25.96 61.3 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.147 -0.346 . . . . 0.0 110.677 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.95 -27.12 60.96 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.24 -34.81 68.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.34 0.57 . . . . 0.0 110.066 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 42' ' ' LEU . 0.9 OUTLIER -69.36 -36.96 77.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.41 -24.95 66.54 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 122.247 -0.283 . . . . 0.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -84.8 -20.84 30.33 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.77 0.259 . . . . 0.0 111.332 176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.41 -24.2 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 117.855 0.298 . . . . 0.0 110.45 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -75.83 -14.57 60.29 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.249 -0.282 . . . . 0.0 110.79 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -97.85 -12.48 22.1 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.541 0.736 . . . . 0.0 111.035 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.05 -167.94 53.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.866 -0.494 . . . . 0.0 111.866 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.61 11.33 84.17 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 112.18 -0.368 . . . . 0.0 112.18 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.7 mt -134.67 147.99 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -121.94 -19.76 6.57 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.13 168.64 26.52 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.596 0.358 . . . . 0.0 110.097 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.92 165.35 34.85 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.769 0.319 . . . . 0.0 111.49 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.9 mt -119.04 129.3 75.37 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.079 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.68 130.37 56.8 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 122.806 0.442 . . . . 0.0 111.05 -172.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -87.47 132.41 34.02 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.51 -11.26 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 122.737 0.415 . . . . 0.0 110.782 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -85.08 26.18 0.89 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.77 0.828 . . . . 0.0 111.074 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 tp -59.54 148.72 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.724 0.81 . . . . 0.0 111.001 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.8 ptp180 -62.51 152.97 33.14 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.874 0.87 . . . . 0.0 112.13 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.24 -171.25 22.17 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.72 1.08 63.36 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.614 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -74.9 145.01 43.05 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 117.963 0.882 . . . . 0.0 110.829 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -140.47 15.12 2.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.669 0.787 . . . . 0.0 110.832 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.7 t -148.08 166.58 27.37 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.441 0.697 . . . . 0.0 110.045 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m -131.95 71.0 80.63 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.657 0.783 . . . . 0.0 109.364 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.43 -11.69 31.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.669 2.913 . . . . 0.0 111.963 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.0 t -74.2 -19.33 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 O-C-N 122.118 -0.363 . . . . 0.0 110.237 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.75 -26.14 67.59 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.98 -17.98 59.49 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.159 -0.338 . . . . 0.0 110.555 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.37 -31.79 48.61 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.6 mt -67.91 -34.12 76.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.06 -21.83 61.46 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.076 0.15 . . . . 0.0 110.691 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.89 -7.0 59.54 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.895 0.478 . . . . 0.0 110.826 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -114.7 15.01 17.64 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.708 0.803 . . . . 0.0 111.313 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.9 t0 56.21 36.8 28.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.251 1.02 . . . . 0.0 112.927 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.7 mt -109.27 108.69 60.34 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 124.187 0.995 . . . . 0.0 108.366 176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.74 154.85 52.31 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.733 2.955 . . . . 0.0 112.224 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -147.54 165.0 31.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 111.24 178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -138.09 145.35 28.8 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 124.371 1.068 . . . . 0.0 108.416 176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -94.14 153.24 18.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.168 0.509 . . . . 0.0 111.308 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.17 148.17 37.8 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -159.95 170.97 20.23 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.63 0.253 . . . . 0.0 110.789 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.77 95.31 0.23 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.71 -160.11 28.45 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.7 t -75.35 157.02 34.88 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -100.17 -4.43 29.62 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.071 0.549 . . . . 0.0 111.223 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -78.75 -1.4 34.46 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.0 p -104.9 11.28 33.8 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.676 0.79 . . . . 0.0 111.461 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.8 t -126.35 154.42 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.294 0.638 . . . . 0.0 109.795 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -60.0 152.46 23.76 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.172 0.589 . . . . 0.0 111.636 -178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.3 p -63.63 -17.45 62.92 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -172.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -77.56 -17.17 58.14 Favored 'General case' 0 CA--C 1.526 0.054 0 CA-C-N 118.335 0.516 . . . . 0.0 110.729 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -89.75 -21.35 22.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -88.18 -11.21 47.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.977 0.511 . . . . 0.0 111.327 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.62 -27.26 12.43 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.281 0.632 . . . . 0.0 111.197 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.79 161.17 48.34 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.39 145.19 80.16 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.143 2.562 . . . . 0.0 112.608 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.2 m -140.62 154.27 21.89 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.699 0.8 . . . . 0.0 110.23 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.3 tp -145.87 146.45 31.12 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.1 177.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 -85.01 158.77 20.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.878 0.471 . . . . 0.0 109.796 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -67.02 -36.22 10.62 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.82 125.32 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.402 2.068 . . . . 0.0 110.202 171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 3.8 m-30 -112.29 151.96 29.06 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 122.745 0.418 . . . . 0.0 110.854 -177.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 81.9 p -142.64 159.28 42.53 Favored 'General case' 0 C--N 1.335 -0.061 0 C-N-CA 124.161 0.984 . . . . 0.0 109.087 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -66.04 -26.34 67.46 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.829 -0.544 . . . . 0.0 111.174 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.63 -37.1 21.49 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 117.788 0.267 . . . . 0.0 111.536 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.48 -27.25 59.71 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.929 -0.373 . . . . 0.0 112.185 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.57 -29.4 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 117.696 0.748 . . . . 0.0 110.464 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.02 69.17 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 176.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -84.97 -21.16 29.66 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.365 0.666 . . . . 0.0 110.819 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -79.75 -35.39 38.84 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 117.66 0.209 . . . . 0.0 110.664 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -74.62 -28.69 60.99 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 175.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.17 -26.37 63.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -13.96 41.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.051 0.54 . . . . 0.0 111.752 177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 43.8 tp -90.98 -33.81 15.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.353 0.261 . . . . 0.0 111.107 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -94.08 0.23 55.77 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.901 0.48 . . . . 0.0 111.844 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.22 -1.372 . . . . 0.0 109.767 179.157 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.6 m 56.58 179.02 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.228 1.011 . . . . 0.0 112.862 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.57 165.21 29.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.386 0.675 . . . . 0.0 110.076 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.82 63.29 1.39 Allowed 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.534 0.683 . . . . 0.0 110.463 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.68 -5.47 37.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.39 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 63.5 mt-30 -119.94 111.77 18.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.803 0.335 . . . . 0.0 111.541 -176.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.8 mm -120.21 135.4 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.093 -172.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -92.38 132.3 36.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 174.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' N ' HD23 ' A' ' 8' ' ' LEU . 84.0 mt -94.6 128.0 46.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 123.215 0.606 . . . . 0.0 109.487 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -132.41 115.23 25.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.066 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -137.89 162.98 32.6 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.057 0.543 . . . . 0.0 111.622 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.5 4.42 18.8 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.677 . . . . 0.0 110.374 177.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -141.11 110.69 6.51 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 123.883 0.873 . . . . 0.0 108.804 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -55.75 -21.78 33.88 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.952 3.101 . . . . 0.0 113.875 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.8 tp -74.31 -33.7 63.26 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.214 0.461 . . . . 0.0 110.305 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.3 mm -77.73 -31.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.22 65.53 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.8 tpp -77.76 -31.83 52.28 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.5 mmm -74.52 -30.41 61.78 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.472 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.16 -29.95 68.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -76.2 -24.03 54.66 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.068 0.394 . . . . 0.0 110.193 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.9 -43.13 20.33 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.241 -0.287 . . . . 0.0 111.279 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.38 -28.33 59.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.188 0.449 . . . . 0.0 111.813 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.4 mt -79.17 -17.65 54.56 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.514 0.597 . . . . 0.0 110.865 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -84.85 -26.16 27.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.039 0.381 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.8 t -82.86 -22.59 8.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 C-N-CA 122.555 0.342 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.9 mt -101.11 16.35 25.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.86 0.464 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 51.97 37.36 20.91 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.862 0.865 . . . . 0.0 112.181 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.61 164.61 17.63 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.494 0.717 . . . . 0.0 109.528 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.0 m -117.46 71.8 7.02 Favored Pre-proline 0 CA--C 1.529 0.135 0 C-N-CA 122.537 0.335 . . . . 0.0 110.825 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.3 159.69 42.46 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.986 2.457 . . . . 0.0 110.114 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.433 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.2 m -123.81 -10.02 7.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.72 173.77 33.72 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 118.54 0.609 . . . . 0.0 112.291 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.3 m -140.25 139.24 35.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.788 0.835 . . . . 0.0 109.337 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.32 158.99 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 C-N-CA 123.231 0.612 . . . . 0.0 110.078 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -137.04 3.63 2.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.655 0.382 . . . . 0.0 111.763 -178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 85.6 m -139.04 149.71 44.94 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 93.5 t -63.04 -32.38 55.99 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 122.29 0.236 . . . . 0.0 111.311 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.85 69.38 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 121.953 -0.467 . . . . 0.0 110.945 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.49 -29.8 47.5 Favored Glycine 0 C--N 1.337 0.602 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -31.4 63.6 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 117.516 0.658 . . . . 0.0 110.541 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -76.92 -27.09 54.77 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.41 -24.67 61.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.149 -0.344 . . . . 0.0 110.883 177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.07 -29.24 22.04 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -83.09 -21.95 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 118.564 0.62 . . . . 0.0 111.523 -177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -81.66 -14.72 56.3 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.07 -0.394 . . . . 0.0 111.021 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -91.9 -13.21 31.61 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.539 0.336 . . . . 0.0 111.519 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.75 -164.8 42.18 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.61 24.98 61.58 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.939 -0.367 . . . . 0.0 112.306 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.6 mt -127.79 144.16 38.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.196 0 CA-C-N 117.433 0.616 . . . . 0.0 109.646 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -109.94 -27.87 9.02 Favored 'General case' 0 CA--C 1.527 0.09 0 CA-C-O 119.573 -0.251 . . . . 0.0 111.23 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.06 178.56 7.58 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.156 0.583 . . . . 0.0 110.389 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.23 162.01 41.31 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 121.906 -0.496 . . . . 0.0 111.847 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 88.4 mt -116.22 126.62 73.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.11 133.06 56.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.876 0.47 . . . . 0.0 111.488 -171.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.83 144.29 30.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -80.37 -11.53 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -122.7 40.45 3.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.754 0.422 . . . . 0.0 110.696 -176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.0 tp -58.86 153.51 17.01 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.524 0.73 . . . . 0.0 111.44 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.9 ttt180 -57.55 152.03 15.71 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.116 0.967 . . . . 0.0 110.98 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.61 5.64 84.2 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.98 -0.345 . . . . 0.0 112.471 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -168.91 176.38 43.1 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -126.57 138.32 53.45 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.828 0.451 . . . . 0.0 110.368 178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.1 pttt 47.72 10.97 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.811 2.044 . . . . 0.0 115.402 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.1 m -150.39 162.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.666 0.786 . . . . 0.0 109.988 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.9 t -144.17 135.14 12.4 Favored Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 122.843 0.457 . . . . 0.0 110.263 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -80.71 -11.72 12.59 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.549 2.833 . . . . 0.0 111.494 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.9 t -73.47 -31.43 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 117.87 0.305 . . . . 0.0 110.775 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.07 -39.99 86.97 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.956 -0.465 . . . . 0.0 110.289 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.0 -17.37 40.69 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 122.263 -0.273 . . . . 0.0 111.274 -177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -33.25 68.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 172.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.1 mt -73.88 -27.54 61.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.24 -23.0 61.91 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.928 0.331 . . . . 0.0 110.5 176.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.91 -19.37 40.95 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.315 0.246 . . . . 0.0 110.375 175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -98.12 5.37 48.67 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.43 0.692 . . . . 0.0 111.491 174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 57.37 27.6 14.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 112.534 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.6 mt -94.78 124.52 54.43 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.313 0.645 . . . . 0.0 109.327 177.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -59.89 150.26 78.92 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.894 3.063 . . . . 0.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -151.91 160.39 43.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.672 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.17 156.47 36.66 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.395 0.678 . . . . 0.0 109.498 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.73 160.62 14.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.35 0.595 . . . . 0.0 111.896 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -138.46 136.55 36.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.8 p -134.05 161.89 33.6 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.069 0.461 . . . . 0.0 111.96 -171.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.04 -167.75 36.14 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -77.11 49.77 2.96 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.2 t -153.95 144.28 22.21 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.485 0.714 . . . . 0.0 110.033 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -105.42 -2.32 23.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.412 0.685 . . . . 0.0 111.456 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.95 -2.87 33.54 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.042 0.537 . . . . 0.0 111.507 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 78.6 p -85.66 5.63 31.1 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.059 0.544 . . . . 0.0 111.813 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.64 154.73 19.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 123.137 0.575 . . . . 0.0 111.814 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -80.66 170.9 15.72 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.848 0.859 . . . . 0.0 111.179 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.5 p -62.85 -17.27 61.21 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -70.73 -29.78 66.12 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 121.778 -0.576 . . . . 0.0 110.195 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -81.02 -23.94 38.27 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -84.25 -10.37 57.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.82 0.448 . . . . 0.0 110.885 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -99.53 -23.58 15.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.981 0.512 . . . . 0.0 110.913 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -97.19 163.86 19.01 Favored Pre-proline 0 CA--C 1.53 0.183 0 C-N-CA 123.286 0.634 . . . . 0.0 110.042 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.45 147.53 85.37 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.251 2.634 . . . . 0.0 112.084 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.7 m -140.36 154.07 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 C-N-CA 123.486 0.714 . . . . 0.0 110.297 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -134.53 151.65 51.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.528 0.731 . . . . 0.0 109.953 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -74.35 156.76 36.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.53 ' HA ' ' CE ' ' A' ' 102' ' ' LYS . 1.9 tpmt? -71.1 -47.47 14.19 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.723 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 92.3 Cg_endo -73.52 142.43 32.88 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.902 1.735 . . . . 0.0 109.804 172.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -115.56 157.83 23.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.928 0.891 . . . . 0.0 110.75 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -141.91 162.53 35.24 Favored 'General case' 0 C--N 1.338 0.094 0 C-N-CA 124.058 0.943 . . . . 0.0 109.46 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.2 mmt -64.67 -32.52 74.22 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 122.255 -0.278 . . . . 0.0 111.149 -177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -84.45 -34.44 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 117.712 0.233 . . . . 0.0 111.597 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.02 -30.03 56.16 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.628 -175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -87.27 -27.51 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.954 0.877 . . . . 0.0 110.729 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -32.02 71.79 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.222 0.465 . . . . 0.0 110.294 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -82.78 -29.62 29.5 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 122.327 0.251 . . . . 0.0 110.419 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.65 -31.57 46.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.732 0.242 . . . . 0.0 111.221 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.36 -39.81 58.83 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.96 -26.8 65.23 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 122.497 -0.127 . . . . 0.0 110.802 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.26 -14.41 41.07 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.567 0.347 . . . . 0.0 111.566 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -91.25 -35.85 14.24 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.761 0.424 . . . . 0.0 110.78 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.8 tp -88.67 -12.15 43.26 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.116 -1.421 . . . . 0.0 110.165 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.324 0.107 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -146.36 166.07 27.44 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.243 0.617 . . . . 0.0 109.856 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.3 175.06 10.8 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.874 0.469 . . . . 0.0 111.04 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -75.16 33.11 0.1 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.315 1.046 . . . . 0.0 112.578 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 -12.67 40.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.477 0.311 . . . . 0.0 110.774 177.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.577 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.7 mp0 -115.1 116.16 27.95 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 122.572 0.349 . . . . 0.0 111.469 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.42 128.76 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.418 0.687 . . . . 0.0 110.366 -176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -87.82 141.02 28.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.556 ' H ' HD23 ' A' ' 8' ' ' LEU . 90.0 mt -106.0 127.35 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.791 0.836 . . . . 0.0 109.21 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.0 126.87 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -155.07 165.87 35.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.255 0.622 . . . . 0.0 111.181 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -124.21 18.17 9.11 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 122.974 0.51 . . . . 0.0 110.242 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -137.77 126.86 14.85 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 123.727 0.811 . . . . 0.0 108.883 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.77 -18.68 32.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.411 2.741 . . . . 0.0 112.839 -171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -81.57 -25.5 35.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.26 0.482 . . . . 0.0 110.512 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.11 -26.05 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.59 -43.43 84.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.011 -0.431 . . . . 0.0 110.843 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -77.26 -25.12 51.17 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 122.303 -0.248 . . . . 0.0 110.884 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 ttp -75.15 -32.17 61.25 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.429 -0.169 . . . . 0.0 110.688 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.67 -33.79 69.16 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.845 0.293 . . . . 0.0 110.68 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -75.71 -22.01 57.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.885 0.311 . . . . 0.0 110.451 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -79.75 -38.73 32.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 122.213 -0.305 . . . . 0.0 111.367 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -78.1 -23.44 47.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.562 0.619 . . . . 0.0 111.297 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.0 mt -76.9 -18.54 58.25 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.439 0.563 . . . . 0.0 109.892 174.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -80.95 -28.04 35.85 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.05 0.386 . . . . 0.0 110.019 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -77.74 -23.59 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 C-N-CA 122.615 0.366 . . . . 0.0 110.315 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.2 mt -93.04 8.2 40.98 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.793 0.437 . . . . 0.0 111.513 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.23 30.95 8.48 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.25 0.62 . . . . 0.0 111.47 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.72 161.12 19.34 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.555 1.142 . . . . 0.0 110.207 -177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.4 m -107.97 98.99 28.31 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 122.357 0.263 . . . . 0.0 110.321 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.92 158.76 54.58 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.907 2.405 . . . . 0.0 109.26 175.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.577 HG11 ' HB3' ' A' ' 6' ' ' GLN . 34.2 m -127.94 -11.24 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.31 172.75 32.17 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.313 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.9 p -133.97 143.18 48.01 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 123.968 0.907 . . . . 0.0 108.755 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.69 140.2 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.72 1.53 57.22 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.3 p -140.78 157.06 45.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.119 0.568 . . . . 0.0 109.878 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.3 -22.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 122.47 -0.144 . . . . 0.0 110.779 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.25 -26.86 63.09 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.28 -19.58 68.95 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.96 -36.85 48.6 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.738 0.769 . . . . 0.0 110.746 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.76 -30.23 40.69 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.22 -25.66 59.79 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.187 -0.321 . . . . 0.0 111.266 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -87.39 -26.76 23.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.67 0.388 . . . . 0.0 111.827 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -82.77 -22.59 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 118.191 0.45 . . . . 0.0 111.604 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -70.35 -14.66 62.67 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.122 0.419 . . . . 0.0 111.143 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.27 -12.52 59.61 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 122.917 0.487 . . . . 0.0 110.684 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 -174.8 54.96 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.82 85.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.8 mt -133.72 149.38 30.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -129.67 -12.03 4.36 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 113.016 0.746 . . . . 0.0 113.016 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.57 169.25 20.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.841 0.456 . . . . 0.0 110.101 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 158.63 44.2 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.011 0.434 . . . . 0.0 111.581 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 81.3 mt -110.46 127.46 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.43 126.16 55.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.814 0.446 . . . . 0.0 110.888 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -77.85 132.83 38.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 170.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.6 t -78.56 -13.26 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 O-C-N 122.21 -0.306 . . . . 0.0 110.323 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.43 146.19 47.11 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.8 tp -141.44 151.23 43.23 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 122.119 -0.363 . . . . 0.0 110.53 -176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -81.54 151.84 27.55 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.393 0.677 . . . . 0.0 110.973 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.31 -165.62 54.77 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -77.47 -3.22 82.38 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 119.72 -0.489 . . . . 0.0 112.408 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.38 156.85 39.01 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.051 0.926 . . . . 0.0 110.933 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -141.09 173.32 11.6 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.251 0.62 . . . . 0.0 110.838 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.3 t 58.8 -178.13 0.08 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.261 1.024 . . . . 0.0 112.125 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 m -138.87 58.63 13.78 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.074 0.55 . . . . 0.0 110.301 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.35 -10.91 29.12 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.364 2.71 . . . . 0.0 111.401 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.77 -16.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.022 0.529 . . . . 0.0 111.064 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.65 -23.3 62.49 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.957 -0.465 . . . . 0.0 109.881 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -77.19 -19.03 57.29 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.04 -30.8 39.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.4 tp -70.51 -30.13 66.82 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.31 -20.95 54.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.266 0.226 . . . . 0.0 110.652 175.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.97 -18.46 59.3 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -90.34 12.83 17.12 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.42 0.688 . . . . 0.0 110.449 171.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 59.44 31.93 21.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.812 1.245 . . . . 0.0 112.824 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -113.8 126.17 28.45 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.68 160.31 38.05 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 124.213 3.275 . . . . 0.0 112.338 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -149.06 171.72 15.94 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.017 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.25 149.13 19.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.776 0.831 . . . . 0.0 108.967 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -94.82 154.31 17.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.185 0.517 . . . . 0.0 111.413 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.54 125.03 22.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.6 t -154.69 169.57 23.59 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 120.784 0.326 . . . . 0.0 111.047 -173.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.64 126.78 1.55 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.56 -164.82 29.92 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.6 m -74.02 159.11 33.15 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.757 0.313 . . . . 0.0 110.307 176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.48 -8.68 59.61 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 122.53 0.332 . . . . 0.0 111.44 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -77.22 0.76 20.67 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.215 0.606 . . . . 0.0 112.135 -177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.0 p -124.1 11.77 8.89 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 123.142 0.577 . . . . 0.0 111.948 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.43 148.89 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.81 160.99 17.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.355 0.597 . . . . 0.0 112.576 -174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.2 m -64.8 -16.2 62.75 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtm180 -78.16 -16.71 57.66 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.717 0.69 . . . . 0.0 111.238 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -85.89 -24.46 26.63 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -79.02 -15.95 57.54 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.342 0.257 . . . . 0.0 111.012 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -101.88 -24.69 13.99 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.045 0.538 . . . . 0.0 111.523 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -90.39 160.32 39.77 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 123.187 0.595 . . . . 0.0 109.53 176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -63.71 144.49 89.38 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.83 2.353 . . . . 0.0 110.666 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -141.17 154.35 20.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 C-N-CA 123.737 0.815 . . . . 0.0 110.806 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.0 tp -139.96 153.8 47.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -69.41 158.72 34.58 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.438 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 13.8 mmmm -62.33 -47.63 89.04 Favored Pre-proline 0 CA--C 1.528 0.128 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.23 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.6 Cg_endo -71.43 135.15 25.95 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.427 1.418 . . . . 0.0 108.849 169.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -102.6 156.62 17.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.051 0.453 . . . . 0.0 111.122 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.6 p -141.11 160.77 39.39 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.382 1.073 . . . . 0.0 108.702 177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -62.36 -28.78 70.0 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 122.304 -0.248 . . . . 0.0 111.043 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.85 -29.1 27.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 122.336 -0.228 . . . . 0.0 110.97 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.51 -32.98 49.34 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-O 119.687 -0.507 . . . . 0.0 112.052 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.0 m -82.28 -24.47 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 CA-C-N 117.841 0.82 . . . . 0.0 111.151 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.28 -31.11 65.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.25 0.477 . . . . 0.0 109.964 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -85.23 -25.82 27.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 122.793 0.437 . . . . 0.0 111.549 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.79 -37.35 41.11 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 117.781 0.264 . . . . 0.0 110.778 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.37 -27.52 52.58 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.24 -20.84 60.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.149 0.431 . . . . 0.0 110.672 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.21 -17.42 32.66 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.565 0.346 . . . . 0.0 111.23 176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 tt -91.23 -47.56 7.43 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.16 18.02 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.452 1.101 . . . . 0.0 111.588 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 p . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.155 -179.148 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -142.01 161.89 36.86 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.128 0.571 . . . . 0.0 110.484 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 5' ' ' THR . . . -148.02 169.76 19.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.672 0.789 . . . . 0.0 109.393 176.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 90.1 mt -70.67 25.44 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -92.13 -14.28 29.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.043 0.937 . . . . 0.0 109.681 173.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.652 ' HB3' HG11 ' A' ' 32' ' ' VAL . 23.1 mp0 -114.57 111.84 21.98 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 122.798 0.439 . . . . 0.0 111.619 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mm -118.41 130.43 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 123.226 0.61 . . . . 0.0 110.128 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -90.73 141.18 29.07 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.524 ' H ' HD23 ' A' ' 8' ' ' LEU . 96.7 mt -105.31 130.55 56.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 123.478 0.711 . . . . 0.0 109.78 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.1 t -127.61 117.97 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.605 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 14.2 tp10 -145.62 156.18 43.5 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.474 0.71 . . . . 0.0 109.744 -173.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -124.35 15.64 8.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.418 0.687 . . . . 0.0 111.416 -176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.605 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 15.9 tp10 -136.08 107.22 9.58 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.28 -25.02 36.77 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.626 2.884 . . . . 0.0 114.152 -176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 tp -77.16 -37.93 52.86 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.407 0.549 . . . . 0.0 110.465 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 71.5 mt -79.33 -24.33 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.85 0.296 . . . . 0.0 110.536 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.9 mtt -76.97 -31.3 56.45 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.7 mtp -72.94 -23.77 60.72 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.412 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -74.47 -34.25 63.08 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 122.327 -0.233 . . . . 0.0 110.666 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.34 -22.38 51.91 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.42 -37.46 57.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -75.69 -23.24 56.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.269 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 tp -77.25 -23.46 51.24 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.926 0.33 . . . . 0.0 110.245 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -83.07 -32.27 26.88 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.303 0.241 . . . . 0.0 110.482 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -76.82 -19.77 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.6 tp -82.81 0.22 44.91 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.583 0.753 . . . . 0.0 110.542 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.9 t70 53.89 28.8 8.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.861 0.865 . . . . 0.0 111.695 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -91.25 156.84 17.52 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.971 0.908 . . . . 0.0 110.74 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.0 m -92.64 121.61 65.8 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -78.59 161.68 27.84 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 124.168 3.245 . . . . 0.0 111.25 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.652 HG11 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -141.7 -18.7 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 173.07 32.58 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 118.398 0.545 . . . . 0.0 112.548 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 51.2 p -139.62 142.98 37.03 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 124.503 1.121 . . . . 0.0 108.46 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 156.03 21.66 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.044 0.449 . . . . 0.0 110.658 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -95.83 -7.66 36.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.597 0.759 . . . . 0.0 111.563 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -152.61 161.22 42.87 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 122.668 0.387 . . . . 0.0 110.467 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 m -68.65 -22.55 26.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.974 0.51 . . . . 0.0 111.186 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.65 -27.23 63.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.72 -28.75 56.49 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.28 -34.32 74.57 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.563 0.681 . . . . 0.0 109.496 178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.3 tp -71.94 -31.21 66.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.22 -24.92 63.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 122.372 -0.205 . . . . 0.0 111.08 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -85.53 -21.96 28.36 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.348 0.259 . . . . 0.0 111.206 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.5 t -76.27 -25.23 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 117.899 0.318 . . . . 0.0 110.244 176.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -73.78 -14.78 61.17 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 122.352 -0.217 . . . . 0.0 110.856 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -96.4 -12.61 24.06 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.193 0.597 . . . . 0.0 111.007 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.82 -169.04 49.03 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.68 10.26 86.35 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.596 -0.558 . . . . 0.0 112.619 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.4 mt -129.16 147.97 33.33 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -127.78 -17.47 4.49 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.99 170.24 22.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.728 0.411 . . . . 0.0 110.43 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.93 162.53 41.2 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 120.624 0.249 . . . . 0.0 111.538 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 mm -112.11 130.97 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.76 125.72 54.03 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.523 0.329 . . . . 0.0 110.958 -174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -81.54 129.9 34.85 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 171.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.4 t -98.53 -12.93 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.026 0.53 . . . . 0.0 110.9 178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -84.44 42.28 0.89 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.163 0.585 . . . . 0.0 110.964 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.73 148.85 50.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.877 0.471 . . . . 0.0 110.953 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -81.9 152.39 26.83 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.532 0.733 . . . . 0.0 110.463 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.76 -7.38 27.79 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 123.168 0.413 . . . . 0.0 112.545 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.83 3.74 85.51 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.878 0.839 . . . . 0.0 113.747 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.29 173.61 9.18 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.384 1.092 . . . . 0.0 111.301 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -123.38 166.01 16.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.612 0.765 . . . . 0.0 111.134 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.3 m -130.07 22.5 5.3 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 123.326 0.65 . . . . 0.0 111.318 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.471 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 42.1 p -64.93 -25.86 1.62 Allowed Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.6 Cg_exo -59.05 -16.49 33.15 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.976 1.784 . . . . 0.0 112.99 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.3 t -81.6 -21.67 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.073 0 CA-C-N 118.038 0.381 . . . . 0.0 110.291 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 -26.62 65.45 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 122.026 -0.421 . . . . 0.0 110.064 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -74.62 -19.66 60.21 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.339 -0.226 . . . . 0.0 110.66 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.92 51.09 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.42 -36.88 74.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.17 62.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 122.276 -0.265 . . . . 0.0 110.748 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.09 -15.19 54.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.405 0.282 . . . . 0.0 110.432 175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -105.29 20.68 18.45 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.704 0.802 . . . . 0.0 111.403 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 59.02 35.76 24.13 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.035 0.934 . . . . 0.0 113.444 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.3 mt -118.59 97.62 50.84 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.97 161.14 26.89 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.079 3.186 . . . . 0.0 112.638 179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -148.02 170.26 18.12 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.919 0.487 . . . . 0.0 111.335 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.6 t -141.5 144.16 26.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -86.88 155.98 20.03 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.8 0.333 . . . . 0.0 111.427 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.05 125.98 18.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.2 t -161.93 164.71 28.34 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 122.666 0.386 . . . . 0.0 110.618 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -121.45 95.61 0.57 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.43 165.04 12.32 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.7 m -147.58 28.23 0.97 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.55 0.34 . . . . 0.0 110.873 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -105.62 -50.88 3.11 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -134.71 -5.42 2.5 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.2 p -88.07 4.18 46.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.879 0.472 . . . . 0.0 112.131 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -137.43 154.44 30.05 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.336 0.588 . . . . 0.0 111.201 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -146.98 179.86 7.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.97 1.308 . . . . 0.0 108.972 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 66.6 m -57.53 -19.32 24.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.754 -0.591 . . . . 0.0 112.235 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.7 mmm-85 -74.45 -24.63 59.09 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.991 -0.443 . . . . 0.0 110.749 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -84.56 -17.12 39.89 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.9 0.88 . . . . 0.0 109.396 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -88.26 -11.0 47.83 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.467 0.707 . . . . 0.0 110.37 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -111.98 -8.46 14.07 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.628 0.771 . . . . 0.0 111.785 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 26.1 tpt180 -137.84 139.56 26.82 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 79.0 Cg_exo -53.11 154.89 12.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.854 3.036 . . . . 0.0 114.238 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.2 m -136.83 155.14 32.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.136 0.974 . . . . 0.0 110.259 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.3 tp -133.57 149.71 51.65 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.598 0.759 . . . . 0.0 109.446 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -74.08 160.97 30.53 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -70.45 -42.4 15.05 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.418 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -70.01 141.15 43.45 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.5 2.134 . . . . 0.0 109.645 170.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 4.6 m-30 -103.21 149.08 25.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.98 0.419 . . . . 0.0 110.497 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.4 p -139.08 166.39 24.64 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.955 0.902 . . . . 0.0 109.288 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 58.3 mmm -65.65 -35.77 81.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.185 -0.322 . . . . 0.0 110.808 -175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.68 -28.38 26.43 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.388 0.275 . . . . 0.0 111.74 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.75 -28.81 64.36 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.6 t -83.91 -30.16 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.344 0.572 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.2 -27.84 60.98 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 176.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.39 -24.45 39.71 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.663 0.385 . . . . 0.0 110.244 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.34 -32.24 64.43 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.183 -0.323 . . . . 0.0 110.394 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.4 tt -70.21 -40.75 74.38 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.49 -18.89 61.06 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -23.27 24.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.972 0.351 . . . . 0.0 111.867 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 tt -91.79 -50.57 5.66 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.163 -0.336 . . . . 0.0 111.13 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -72.95 -1.12 15.72 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.913 -1.518 . . . . 0.0 110.06 178.669 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.591 0.234 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.0 p -148.83 160.39 43.28 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.967 0.507 . . . . 0.0 110.593 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.29 171.8 18.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.135 0.574 . . . . 0.0 110.314 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.3 mt -139.69 27.69 2.23 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.769 1.228 . . . . 0.0 110.153 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -79.93 -8.78 59.51 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.972 0.509 . . . . 0.0 111.585 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.438 ' HB3' HG11 ' A' ' 32' ' ' VAL . 65.2 mt-30 -121.04 114.62 21.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.4 mm -119.88 131.98 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 110.422 -174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -91.39 145.03 24.97 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.559 ' H ' HD23 ' A' ' 8' ' ' LEU . 74.7 mt -113.34 130.95 66.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.4 t -121.1 117.71 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.19 163.28 15.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -169.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -128.21 -4.69 5.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.912 0.885 . . . . 0.0 110.538 173.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 44.5 tt0 -153.75 136.8 10.0 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 61.8 Cg_exo -56.74 -18.39 26.65 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 124.004 3.136 . . . . 0.0 114.52 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.62 -21.59 38.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.144 0.429 . . . . 0.0 111.671 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.11 -38.48 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.15 60.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.312 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.7 ttm -76.26 -32.8 59.04 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.0 tpt -81.5 -27.83 34.33 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 122.274 -0.266 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.48 -36.34 63.28 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -74.59 -21.69 59.35 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.82 -42.08 61.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 122.039 -0.413 . . . . 0.0 110.98 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -83.24 -22.78 33.0 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.6 mt -80.91 -21.21 40.74 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.117 0.871 . . . . 0.0 111.076 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -85.58 -29.4 24.16 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 118.064 0.393 . . . . 0.0 111.314 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -85.39 -18.66 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 122.386 0.275 . . . . 0.0 111.23 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.0 tp -99.33 18.15 18.38 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.119 0.567 . . . . 0.0 111.532 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 53.79 31.3 12.77 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.673 0.789 . . . . 0.0 112.227 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.51 165.72 16.89 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.639 0.776 . . . . 0.0 109.245 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.8 m -118.28 75.21 11.52 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 122.322 -0.236 . . . . 0.0 110.947 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.9 157.34 53.09 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.244 2.629 . . . . 0.0 109.78 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.1 m -122.75 -15.19 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.075 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 -172.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.84 178.18 37.98 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.56 -0.829 . . . . 0.0 113.289 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 p -135.37 140.93 45.41 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.524 1.13 . . . . 0.0 108.876 176.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.8 m -138.51 147.16 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 CA-C-O 120.842 0.353 . . . . 0.0 110.431 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -92.1 2.19 56.73 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.41 0.684 . . . . 0.0 112.255 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -155.01 157.34 37.47 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 123.099 0.56 . . . . 0.0 110.065 178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.48 -22.56 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.137 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.5 -26.04 64.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.32 -24.36 59.27 Favored Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.02 67.34 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.714 0.757 . . . . 0.0 109.931 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.61 -37.54 68.07 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.79 -24.94 63.57 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -86.46 -22.7 26.33 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.314 0.506 . . . . 0.0 111.345 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -79.53 -28.22 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.52 -14.68 54.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.058 0.543 . . . . 0.0 111.559 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -108.16 -12.54 15.08 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.043 0.537 . . . . 0.0 112.197 -176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.71 165.82 38.94 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.15 136.06 18.82 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mt -144.7 146.1 20.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -101.09 -30.93 11.31 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 173.33 14.86 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.586 0.355 . . . . 0.0 110.343 178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.1 158.23 43.95 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.98 128.27 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.64 119.09 34.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.182 0.593 . . . . 0.0 110.224 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -77.72 145.21 36.68 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 22.3 m -76.78 -11.79 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -84.05 140.43 31.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.3 tp -149.86 149.55 30.64 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.823 0.344 . . . . 0.0 110.391 -177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -82.21 152.61 26.34 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.668 0.787 . . . . 0.0 111.433 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.61 8.17 87.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.913 -0.382 . . . . 0.0 112.738 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.84 -172.12 38.88 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -126.1 131.42 52.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.781 0.432 . . . . 0.0 110.53 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 50.74 -166.16 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.699 1.2 . . . . 0.0 112.886 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t 62.42 155.7 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.728 1.611 . . . . 0.0 113.846 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m -146.66 66.41 10.77 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.718 0.807 . . . . 0.0 109.249 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.69 -11.89 30.31 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.677 2.918 . . . . 0.0 112.499 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.61 -16.88 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 O-C-N 121.923 -0.486 . . . . 0.0 110.684 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.3 69.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.823 -0.548 . . . . 0.0 110.048 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.17 -18.07 60.26 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.389 0.276 . . . . 0.0 110.606 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.21 -30.34 38.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.22 -33.77 70.18 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.13 -23.11 61.26 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.063 0.145 . . . . 0.0 110.767 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.67 -16.83 56.82 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 174.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -99.57 16.87 21.95 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.684 0.794 . . . . 0.0 110.626 173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.69 26.23 15.3 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.631 1.172 . . . . 0.0 113.65 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.6 mt -104.88 122.02 44.73 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.54 159.58 39.24 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.781 2.988 . . . . 0.0 111.453 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -147.3 164.5 33.03 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.249 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.8 t -136.56 144.23 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 124.048 0.939 . . . . 0.0 108.688 178.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -90.93 155.9 18.39 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.826 0.346 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.23 133.75 31.76 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -155.15 168.81 25.79 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.772 0.429 . . . . 0.0 111.14 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.95 118.4 0.95 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.57 -154.21 25.49 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -70.86 161.82 30.31 Favored 'General case' 0 N--CA 1.458 -0.07 0 C-N-CA 122.684 0.394 . . . . 0.0 110.337 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -95.99 -1.91 48.04 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.756 0.422 . . . . 0.0 112.043 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -100.88 0.55 38.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.231 0.612 . . . . 0.0 111.671 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -87.9 5.54 39.98 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.001 0.52 . . . . 0.0 112.12 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.0 m -123.08 154.58 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.488 0.715 . . . . 0.0 111.835 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.5 171.49 15.03 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.246 1.018 . . . . 0.0 111.654 -179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -61.2 -18.18 56.95 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.164 0.586 . . . . 0.0 112.567 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -72.73 -24.7 61.01 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 118.735 0.698 . . . . 0.0 110.989 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.425 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 46.0 m-85 -84.43 -19.18 33.86 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -88.05 -10.37 50.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.064 0.546 . . . . 0.0 111.176 176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.07 -15.06 14.6 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.349 0.66 . . . . 0.0 111.288 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -108.91 156.1 39.63 Favored Pre-proline 0 C--O 1.232 0.181 0 C-N-CA 123.629 0.772 . . . . 0.0 109.585 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.91 151.58 83.73 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.197 2.598 . . . . 0.0 110.683 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.4 m -134.91 154.37 36.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.761 0.824 . . . . 0.0 110.688 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 93.6 mt -135.64 157.2 47.47 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.821 0.848 . . . . 0.0 110.342 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -81.97 158.79 23.74 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 173.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -67.99 -53.44 20.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.816 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.44 141.71 28.77 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.048 1.832 . . . . 0.0 109.585 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -106.49 158.57 16.81 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.44 0.638 . . . . 0.0 111.681 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.8 p -137.49 164.25 29.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.768 1.227 . . . . 0.0 107.776 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 51.9 ttm -65.17 -29.12 69.92 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 122.001 -0.437 . . . . 0.0 110.883 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.32 -29.95 25.93 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.076 0.15 . . . . 0.0 110.904 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.95 -28.84 55.8 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.784 -0.453 . . . . 0.0 111.986 -177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.51 -24.65 8.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 CA-C-N 117.864 0.832 . . . . 0.0 110.238 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.68 -28.98 65.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -85.11 -20.96 29.52 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.575 0.35 . . . . 0.0 110.983 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.89 -41.6 64.48 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.825 0.284 . . . . 0.0 110.314 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.2 mt -78.92 -27.24 43.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.26 -20.1 60.92 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.939 0.336 . . . . 0.0 110.556 176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -22.7 24.78 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.349 0.26 . . . . 0.0 111.3 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 tt -91.55 -51.81 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 117.875 0.307 . . . . 0.0 111.217 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -71.94 4.11 3.7 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.09 0.956 . . . . 0.0 113.214 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.828 -1.082 . . . . 0.0 109.966 178.86 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -145.24 158.09 43.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.115 0.566 . . . . 0.0 110.16 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.25 168.98 23.63 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.244 0.618 . . . . 0.0 110.254 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.9 66.98 1.45 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.347 0.659 . . . . 0.0 110.224 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -74.28 -18.12 60.77 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.099 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 74.7 mt-30 -102.75 104.07 14.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 120.829 0.347 . . . . 0.0 110.713 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.0 mm -117.23 130.12 72.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.573 -171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -89.41 129.61 35.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.406 ' N ' HD23 ' A' ' 8' ' ' LEU . 79.7 mt -94.34 129.68 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 123.473 0.709 . . . . 0.0 109.3 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.7 t -130.23 103.52 8.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.498 ' HG2' ' H ' ' A' ' 13' ' ' GLU . 82.0 tt0 -157.61 142.87 16.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.11 -0.329 . . . . 0.0 110.11 -177.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -92.88 -7.48 46.07 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.498 ' H ' ' HG2' ' A' ' 11' ' ' GLU . 15.9 tp10 -99.38 104.97 30.16 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.38 -18.32 44.09 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.122 2.548 . . . . 0.0 112.061 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.91 -40.17 48.27 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 118.281 0.491 . . . . 0.0 110.291 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.15 -25.92 6.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.43 -39.47 77.84 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.2 tpt -74.39 -27.4 60.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 28.2 ttt -65.8 -33.26 75.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 7.6 tt -77.21 -30.92 54.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.909 -0.495 . . . . 0.0 110.338 178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -69.12 -21.83 64.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.926 0.33 . . . . 0.0 110.297 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -73.72 -41.61 62.33 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 104' ' ' PHE . 67.0 m-85 -73.65 -13.9 61.07 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.452 176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.4 tp -77.37 -27.17 52.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.309 0.504 . . . . 0.0 110.237 178.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -84.29 -24.72 29.75 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -80.49 -19.81 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 30.2 tp -87.21 -6.73 58.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.186 0.594 . . . . 0.0 110.827 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 53.46 27.18 6.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.273 1.029 . . . . 0.0 112.712 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.581 ' HG2' ' H ' ' A' ' 30' ' ' THR . 24.5 ttpt -91.07 -175.62 4.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.321 0.648 . . . . 0.0 110.206 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.581 ' H ' ' HG2' ' A' ' 29' ' ' LYS . 89.6 m -109.46 119.53 47.89 Favored Pre-proline 0 CA--C 1.53 0.195 0 O-C-N 122.301 -0.249 . . . . 0.0 110.607 -174.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -80.79 164.48 20.49 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 123.976 3.117 . . . . 0.0 111.162 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 28.7 m -139.65 -30.42 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.26 173.85 33.38 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 118.159 0.436 . . . . 0.0 112.532 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.1 m -140.64 142.09 35.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.895 0.878 . . . . 0.0 108.723 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -140.14 157.46 25.39 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 123.207 0.603 . . . . 0.0 110.318 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -98.32 -3.51 37.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.044 0.538 . . . . 0.0 112.334 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.7 p -142.71 157.58 44.51 Favored 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 123.328 0.651 . . . . 0.0 109.746 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.4 p -74.8 -22.59 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 O-C-N 122.389 -0.194 . . . . 0.0 110.8 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.03 -27.65 67.58 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.996 -0.44 . . . . 0.0 110.477 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.97 -21.27 74.46 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.66 -30.34 36.57 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.249 0.524 . . . . 0.0 110.338 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.4 mt -72.37 -34.1 67.73 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.78 -25.36 49.0 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 111.425 0.157 . . . . 0.0 111.425 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -87.35 -31.61 20.06 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.788 0.292 . . . . 0.0 111.788 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 p -83.13 -22.02 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 CA-C-N 118.142 0.428 . . . . 0.0 111.752 -177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -71.56 -14.84 62.22 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 122.233 -0.292 . . . . 0.0 110.502 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.06 -12.43 41.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.174 0.59 . . . . 0.0 110.756 177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 -167.58 48.22 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.7 13.89 82.66 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.669 -0.517 . . . . 0.0 112.253 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.2 mt -135.83 145.58 31.01 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 123.774 0.829 . . . . 0.0 109.108 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -106.81 -29.62 9.41 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.05 177.68 8.27 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 122.753 0.421 . . . . 0.0 110.69 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.17 165.34 28.59 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.01 -0.431 . . . . 0.0 112.06 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.6 mt -125.97 133.33 69.22 Favored 'Isoleucine or valine' 0 C--N 1.339 0.124 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.55 140.34 46.24 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.507 0.723 . . . . 0.0 109.937 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.94 158.82 16.5 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.07 -11.47 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -90.96 18.4 6.72 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.886 0.475 . . . . 0.0 112.106 -175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.89 148.4 49.54 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.236 0.471 . . . . 0.0 110.53 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -82.24 152.29 26.44 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.101 0.561 . . . . 0.0 111.958 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.38 155.29 6.51 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.51 -13.63 81.33 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -126.63 155.12 43.05 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.852 0.861 . . . . 0.0 109.482 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -66.74 145.81 55.13 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.9 p -123.32 3.11 9.16 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.982 0.513 . . . . 0.0 112.211 -176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 12.4 m -63.32 -35.99 20.82 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 118.607 -0.711 . . . . 0.0 112.655 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.1 Cg_exo -58.18 -13.78 17.16 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.92 2.413 . . . . 0.0 113.753 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.83 -18.58 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-N 118.299 0.5 . . . . 0.0 110.332 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.45 -25.82 66.08 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.64 -0.663 . . . . 0.0 109.909 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.55 -17.38 54.1 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.859 -0.525 . . . . 0.0 109.979 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.48 -24.05 46.13 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.24 -30.79 63.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 171.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.06 -22.6 59.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.55 -20.18 54.52 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.1 mtt85 -91.89 7.62 41.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.95 0.9 . . . . 0.0 110.724 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t70 59.12 32.04 21.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.378 1.071 . . . . 0.0 112.78 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.5 mt -111.94 126.16 28.97 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -77.04 161.32 32.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.429 2.753 . . . . 0.0 111.865 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.37 170.82 19.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.084 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.6 t -138.42 150.32 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 123.896 0.878 . . . . 0.0 108.92 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 20.2 m-85 -94.26 163.22 13.53 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.928 0.394 . . . . 0.0 111.348 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.71 127.92 20.99 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.0 t -160.55 170.24 21.32 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 122.721 0.408 . . . . 0.0 110.534 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.18 132.93 4.26 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.954 -1.259 . . . . 0.0 109.954 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.77 -160.49 28.63 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -72.46 149.18 44.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 116.997 0.399 . . . . 0.0 110.039 176.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -75.8 -6.64 51.67 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -110.21 3.94 20.51 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.737 0.415 . . . . 0.0 111.246 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.3 t -98.48 12.49 34.92 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.441 0.696 . . . . 0.0 110.829 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.01 153.84 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 123.488 0.715 . . . . 0.0 109.701 -177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.71 159.86 32.38 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.243 0.544 . . . . 0.0 112.394 -175.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.1 p -63.2 -17.25 62.21 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.1 ptm85 -68.02 -28.02 67.05 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.686 0.675 . . . . 0.0 110.28 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 44.1 m-85 -85.13 -20.87 29.62 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -84.17 -7.99 59.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 119.708 -0.187 . . . . 0.0 110.905 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -118.62 -9.88 10.16 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.071 0.548 . . . . 0.0 112.14 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -125.29 156.78 69.47 Favored Pre-proline 0 C--N 1.341 0.236 0 C-N-CA 123.022 0.529 . . . . 0.0 110.568 177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -54.3 144.18 61.66 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.638 2.892 . . . . 0.0 112.85 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.34 153.9 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 123.443 0.697 . . . . 0.0 110.077 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -130.69 155.53 46.45 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.927 0.891 . . . . 0.0 109.903 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -74.04 167.32 21.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.063 0.545 . . . . 0.0 110.902 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -75.89 -47.4 3.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 118.442 -0.789 . . . . 0.0 112.159 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.96 164.27 25.18 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.618 2.212 . . . . 0.0 110.456 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.468 ' HB2' ' CE2' ' A' ' 23' ' ' PHE . 10.9 m-85 -133.94 158.57 43.13 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.863 0.363 . . . . 0.0 110.998 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.1 p -142.11 159.12 42.86 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.3 mtt -65.1 -27.99 69.14 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 122.137 -0.352 . . . . 0.0 111.126 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -84.26 -25.63 29.23 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.476 0.179 . . . . 0.0 110.633 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.43 -40.19 28.7 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 29.8 m -74.64 -21.94 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 CA-C-N 117.559 0.679 . . . . 0.0 111.066 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.92 -31.43 51.06 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.12 0.418 . . . . 0.0 110.401 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -81.93 -31.76 31.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.65 -26.55 60.81 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.85 -41.37 64.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.64 -27.55 69.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 122.447 -0.158 . . . . 0.0 111.153 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.87 -21.06 25.21 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.6 tt -91.96 -38.69 12.11 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.203 0.601 . . . . 0.0 112.576 -176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.71 -10.83 59.74 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m . . . . . 0 C--O 1.251 1.165 0 CA-C-O 117.103 -1.427 . . . . 0.0 110.935 -179.53 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 119.807 -0.14 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.8 p -136.44 163.08 31.31 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.0 0.52 . . . . 0.0 110.657 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.43 -5.13 13.52 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.158 0.583 . . . . 0.0 112.263 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.433 ' H ' ' HB3' ' A' ' 51' ' ' ASP . 76.0 mt 49.2 40.66 18.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.868 0.867 . . . . 0.0 112.069 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.38 -10.87 16.16 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.729 0.812 . . . . 0.0 110.852 173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.489 ' HB3' HG11 ' A' ' 32' ' ' VAL . 80.9 mt-30 -134.16 120.11 19.68 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.93 132.15 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 O-C-N 123.636 0.585 . . . . 0.0 110.536 -172.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -88.97 143.49 26.82 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.559 ' H ' HD23 ' A' ' 8' ' ' LEU . 94.3 mt -112.06 134.2 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.114 0.566 . . . . 0.0 109.845 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 t -132.38 115.7 26.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 22.7 tp10 -145.56 157.69 43.95 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.321 0.648 . . . . 0.0 110.043 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -106.79 -0.0 23.77 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.495 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 39.4 tt0 -139.95 129.4 13.68 Favored Pre-proline 0 CA--C 1.53 0.174 0 CA-C-N 118.307 0.503 . . . . 0.0 110.328 178.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 53.7 Cg_exo -57.48 -27.43 76.26 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.573 2.849 . . . . 0.0 113.655 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.39 -44.25 71.84 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.8 mm -77.8 -26.34 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.44 -39.37 71.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.623 0.192 . . . . 0.0 111.086 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.5 mtt -75.82 -26.7 57.47 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.5 tpt -76.25 -23.91 54.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -71.15 -35.62 71.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -76.03 -21.72 56.54 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.452 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.09 -41.46 70.61 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -74.17 -22.42 59.42 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.015 -0.428 . . . . 0.0 110.574 177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.99 -23.15 62.13 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -85.07 -28.53 25.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.351 0.26 . . . . 0.0 110.677 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.0 t -71.78 -23.57 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.61 5.24 50.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.955 0.502 . . . . 0.0 111.531 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.66 35.9 12.81 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.544 0.737 . . . . 0.0 111.273 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -85.73 156.85 20.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.018 0.927 . . . . 0.0 111.123 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.1 m -91.27 120.23 68.49 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.87 162.49 29.44 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.317 2.678 . . . . 0.0 111.455 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 6' ' ' GLN . 26.8 m -138.24 -31.87 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.094 0 C-N-CA 122.443 0.297 . . . . 0.0 111.235 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.34 176.08 35.79 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -140.26 143.08 35.75 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.4 m -135.46 155.54 37.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -100.44 1.52 41.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.407 0.683 . . . . 0.0 111.779 -177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.6 p -136.84 154.11 50.6 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.207 0.603 . . . . 0.0 109.933 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -80.34 -22.44 11.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.392 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.93 -26.21 61.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.568 0.167 . . . . 0.0 110.608 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.99 -23.27 66.81 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -81.02 -28.59 35.39 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 117.415 0.608 . . . . 0.0 110.649 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.81 -39.02 52.84 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.0 -26.66 61.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -87.32 -25.07 24.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 118.164 0.438 . . . . 0.0 111.83 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.4 t -83.32 -26.35 7.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 118.519 0.6 . . . . 0.0 110.402 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.93 -16.73 59.97 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.831 0.348 . . . . 0.0 110.243 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.59 -12.42 42.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.333 0.653 . . . . 0.0 110.98 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.64 -171.22 51.03 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.314 -0.715 . . . . 0.0 111.314 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.02 11.37 85.24 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 54.8 mt -140.08 144.8 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 4' ' ' LEU . 68.2 m-20 -101.9 -30.41 11.26 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.71 177.14 9.61 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.742 0.417 . . . . 0.0 110.409 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.64 161.98 40.63 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 79.9 mt -115.66 124.99 72.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.07 124.2 50.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.748 0.309 . . . . 0.0 111.651 -172.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.32 136.16 38.45 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 169.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.7 p -98.53 -13.95 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 C-N-CA 122.402 0.281 . . . . 0.0 110.94 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 54.91 -170.62 0.06 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.27 1.028 . . . . 0.0 112.362 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -78.78 159.37 27.92 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.04 -0.413 . . . . 0.0 110.537 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -81.55 152.42 27.26 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.855 0.462 . . . . 0.0 111.917 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.5 -160.5 13.82 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.58 3.39 34.01 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.746 -0.474 . . . . 0.0 112.832 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -126.32 168.79 13.65 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.689 0.744 . . . . 0.0 110.965 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -112.77 158.63 19.87 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.319 0.647 . . . . 0.0 110.579 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.2 p -145.86 7.65 1.09 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.109 0.564 . . . . 0.0 112.003 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 67.2 p -101.48 -26.39 0.22 Allowed Pre-proline 0 CA--C 1.534 0.331 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 51.1 Cg_exo -59.1 -19.56 49.64 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.451 2.101 . . . . 0.0 113.698 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 p -74.46 -26.66 20.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 O-C-N 122.053 -0.405 . . . . 0.0 111.091 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.92 62.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.34 -17.39 54.62 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -32.59 63.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -70.05 -28.15 65.23 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.26 -22.5 59.29 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.35 -13.64 59.0 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -100.28 6.19 44.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.792 0.837 . . . . 0.0 110.526 172.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 57.04 33.83 23.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.419 1.088 . . . . 0.0 112.857 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.4 mm -108.46 121.99 41.72 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 123.372 0.669 . . . . 0.0 109.542 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.9 153.62 62.07 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.906 3.07 . . . . 0.0 113.332 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -151.8 165.15 35.38 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.31 159.41 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.038 0 C-N-CA 123.823 0.849 . . . . 0.0 109.311 174.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 25.4 m-85 -95.21 159.53 14.97 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.143 0.497 . . . . 0.0 111.99 -177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.94 136.36 28.47 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 172.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.9 t -155.6 158.83 39.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.62 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -80.49 177.81 54.19 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 172.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.9 116.35 7.22 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 43.6 t -154.17 156.09 36.52 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.26 0.624 . . . . 0.0 110.692 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -105.4 -0.35 26.16 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.216 0.606 . . . . 0.0 111.464 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -134.05 -2.65 2.87 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.2 m -88.74 7.92 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.433 0.56 . . . . 0.0 111.658 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 m -134.89 154.15 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.118 0 C-N-CA 123.307 0.643 . . . . 0.0 111.15 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -147.07 -178.44 6.21 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.925 1.29 . . . . 0.0 108.649 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.5 m -59.43 -16.62 24.65 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.488 -0.758 . . . . 0.0 112.031 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -65.86 -30.69 71.35 Favored 'General case' 0 CA--C 1.528 0.107 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 9.0 m-85 -90.4 -13.51 34.85 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.545 1.138 . . . . 0.0 109.836 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 57.4 mtt85 -88.53 -10.59 48.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.047 0.539 . . . . 0.0 110.426 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -113.28 -15.04 12.77 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.34 0.656 . . . . 0.0 111.433 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -126.03 149.82 67.48 Favored Pre-proline 0 C--N 1.339 0.144 0 C-N-CA 123.292 0.637 . . . . 0.0 109.481 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.89 147.02 94.27 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.088 2.525 . . . . 0.0 112.561 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -150.61 150.15 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 C-N-CA 123.636 0.774 . . . . 0.0 109.102 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.1 tp -144.39 150.38 37.64 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.7 pm0 -75.95 165.81 24.43 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.444 0.298 . . . . 0.0 111.048 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -58.1 -50.42 88.21 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.931 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.29 110.14 2.89 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.468 1.445 . . . . 0.0 110.063 175.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.458 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 5.4 m-30 -82.18 153.28 26.07 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.625 0.37 . . . . 0.0 110.771 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.8 p -139.66 159.62 41.74 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 123.971 0.908 . . . . 0.0 108.997 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -65.11 -26.14 68.08 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.117 -0.364 . . . . 0.0 110.848 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -84.55 -36.33 22.22 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.773 0.261 . . . . 0.0 111.621 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.74 -31.49 49.34 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 73.1 t -79.46 -30.4 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 CA-C-N 117.305 0.552 . . . . 0.0 110.078 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.56 69.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 117.963 0.347 . . . . 0.0 110.728 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -85.18 -31.57 23.15 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 122.356 -0.215 . . . . 0.0 111.449 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.37 -38.21 60.17 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 117.9 0.318 . . . . 0.0 110.868 -178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.49 -20.67 33.55 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.39 -0.338 . . . . 0.0 110.499 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.25 -22.5 59.3 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.823 0.738 . . . . 0.0 110.001 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.46 -19.72 27.59 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.516 0.327 . . . . 0.0 111.471 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tt -91.4 -58.02 2.58 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.657 0.383 . . . . 0.0 110.958 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.425 ' HA ' HD13 ' A' ' 4' ' ' LEU . 73.2 mt -69.19 -1.31 7.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.788 1.235 . . . . 0.0 113.351 -173.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.25 1.08 0 CA-C-O 117.226 -1.369 . . . . 0.0 109.971 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.9 t 58.99 167.16 0.05 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.595 1.158 . . . . 0.0 112.121 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 55.03 -174.36 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 112.466 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' A' ' 117' ' ' LEU . 77.1 mt -137.17 29.19 2.78 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 124.525 1.13 . . . . 0.0 110.458 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.36 -4.98 45.15 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.456 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.0 mt-30 -125.51 119.1 27.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 mm -122.09 137.22 56.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.978 0.911 . . . . 0.0 111.173 -173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -94.71 135.27 36.38 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' H ' HD23 ' A' ' 8' ' ' LEU . 76.4 mt -102.59 126.14 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.602 0.761 . . . . 0.0 109.288 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 23.6 t -132.27 117.73 33.46 Favored 'Isoleucine or valine' 0 C--N 1.338 0.069 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -141.69 161.89 36.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.305 0.642 . . . . 0.0 110.455 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -97.11 0.39 48.43 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.06 0.544 . . . . 0.0 111.638 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' A' ' 15' ' ' LEU . 42.3 tt0 -147.24 132.96 9.34 Favored Pre-proline 0 CA--C 1.533 0.316 0 O-C-N 121.878 -0.514 . . . . 0.0 110.304 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.6 -23.32 70.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.441 2.761 . . . . 0.0 113.615 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' H ' ' HG2' ' A' ' 13' ' ' GLU . 9.3 tt -72.38 -40.45 67.24 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.6 mm -74.99 -29.05 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.99 -31.07 69.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.342 -0.244 . . . . 0.0 110.342 178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.8 ttp -75.81 -27.83 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.7 ttp -73.46 -29.87 62.81 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.02 -36.7 75.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -73.14 -21.98 60.61 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.531 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -72.81 -42.84 63.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.134 -0.354 . . . . 0.0 111.152 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -75.23 -21.21 58.79 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.365 0.529 . . . . 0.0 111.376 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.1 mt -82.79 -18.51 40.34 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.184 0.447 . . . . 0.0 111.344 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -85.07 -22.86 28.79 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.57 0.623 . . . . 0.0 110.388 173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 -21.2 10.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -93.17 -0.09 57.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.296 0.638 . . . . 0.0 111.149 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t0 52.37 40.96 30.36 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.369 0.605 . . . . 0.0 110.885 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -85.5 165.18 17.34 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.943 0.897 . . . . 0.0 110.784 -175.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.1 m -115.16 74.64 3.89 Favored Pre-proline 0 CA--C 1.531 0.221 0 C-N-CA 123.01 0.524 . . . . 0.0 110.151 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.33 156.95 57.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.894 2.396 . . . . 0.0 109.789 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 32.7 m -116.71 -7.75 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.084 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.7 171.53 31.05 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.287 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.1 m -137.96 139.88 39.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.78 158.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 122.917 0.487 . . . . 0.0 110.729 -177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -120.29 -2.65 10.07 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.535 0.734 . . . . 0.0 111.58 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.0 p -138.83 161.04 38.23 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.27 0.628 . . . . 0.0 110.404 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.55 -26.54 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.045 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.2 -28.33 48.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.68 -27.88 60.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.79 -42.43 73.77 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.344 0.572 . . . . 0.0 110.175 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.89 -24.58 60.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.66 -24.83 61.09 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 119.53 -0.271 . . . . 0.0 110.744 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -84.11 -20.87 31.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.978 0.354 . . . . 0.0 111.366 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 89.2 t -71.84 -31.36 40.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.51 -14.82 54.34 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.642 0.377 . . . . 0.0 111.791 175.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -87.75 -13.32 42.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.891 0.477 . . . . 0.0 111.963 -176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.44 172.58 36.96 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.4 151.62 43.67 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.6 mt -141.87 150.03 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -108.47 -26.81 10.27 Favored 'General case' 0 C--O 1.228 -0.044 0 CA-C-N 118.045 0.384 . . . . 0.0 111.496 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 171.08 18.57 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.088 0.555 . . . . 0.0 110.169 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.8 160.4 43.9 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 122.145 -0.347 . . . . 0.0 111.097 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.6 mt -119.99 127.37 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 175.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -113.88 130.92 56.44 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.963 0.505 . . . . 0.0 111.188 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -81.53 139.43 35.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 170.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.76 -16.21 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-O 120.669 0.271 . . . . 0.0 110.667 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.99 144.02 37.07 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.0 tp -154.51 159.55 41.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -67.17 151.95 46.63 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 122.641 0.377 . . . . 0.0 110.307 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.6 -167.15 51.52 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.75 -0.54 . . . . 0.0 111.75 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.63 68.61 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 119.572 -0.571 . . . . 0.0 112.869 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 65' ' ' SER . 9.7 tp10 -73.52 152.62 40.6 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.08 0.94 . . . . 0.0 110.656 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -133.14 15.12 4.2 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.073 0.549 . . . . 0.0 111.945 -175.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.443 ' H ' ' HG3' ' A' ' 63' ' ' GLU . 91.9 p -151.06 177.18 10.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.93 0.492 . . . . 0.0 110.571 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -137.46 138.21 24.15 Favored Pre-proline 0 C--O 1.231 0.11 0 C-N-CA 122.625 0.37 . . . . 0.0 110.359 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -79.93 -9.15 14.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.592 2.861 . . . . 0.0 111.532 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.28 -29.04 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 O-C-N 122.162 -0.336 . . . . 0.0 110.93 -176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.48 90.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.293 -0.255 . . . . 0.0 110.622 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -84.21 -17.54 39.51 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 122.374 -0.204 . . . . 0.0 111.35 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.23 -34.5 70.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.41 -28.08 61.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.6 -22.79 62.51 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.867 0.303 . . . . 0.0 110.204 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.93 -20.92 41.0 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.5 0.32 . . . . 0.0 110.351 174.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -93.08 7.95 42.05 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.829 0.852 . . . . 0.0 111.155 173.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.0 t70 58.56 28.81 17.58 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.147 0.979 . . . . 0.0 112.843 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.4 mt -101.33 128.26 29.7 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.511 0.724 . . . . 0.0 109.474 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.42 156.1 50.36 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.716 2.944 . . . . 0.0 111.608 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -147.84 167.14 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.197 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.6 t -139.22 145.58 27.12 Favored 'Isoleucine or valine' 0 C--O 1.23 0.037 0 C-N-CA 124.108 0.963 . . . . 0.0 109.194 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.02 150.91 19.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.522 0.329 . . . . 0.0 110.551 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.88 119.74 11.25 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.5 t -171.78 163.28 6.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.199 0.6 . . . . 0.0 110.647 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.04 147.34 19.6 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.7 -154.35 25.44 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 117.532 0.666 . . . . 0.0 111.812 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 t -137.81 169.47 17.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.845 0.858 . . . . 0.0 110.021 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -68.44 -11.94 60.45 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.784 0.434 . . . . 0.0 111.484 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.02 -4.3 27.72 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.398 0.679 . . . . 0.0 111.3 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.2 m -93.03 2.27 56.87 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.158 0.583 . . . . 0.0 111.337 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.1 m -138.59 154.72 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 123.946 0.898 . . . . 0.0 110.702 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -88.38 -177.52 5.66 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.346 0.593 . . . . 0.0 111.575 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.5 p -61.99 -16.5 51.86 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -172.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 49.8 mmm-85 -73.79 -31.8 63.45 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 119.332 0.969 . . . . 0.0 110.396 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -82.13 -22.71 36.03 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -88.44 -5.47 58.24 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 122.399 0.279 . . . . 0.0 111.132 177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -105.08 -16.81 14.69 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.465 0.706 . . . . 0.0 111.128 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -109.45 158.86 33.43 Favored Pre-proline 0 CA--C 1.53 0.174 0 C-N-CA 123.537 0.735 . . . . 0.0 110.09 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.47 152.63 76.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.827 2.352 . . . . 0.0 111.303 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.9 154.49 21.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.085 0 C-N-CA 123.159 0.584 . . . . 0.0 110.981 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 44.7 tp -145.85 156.53 43.62 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.528 0.731 . . . . 0.0 109.128 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -70.61 164.48 24.82 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -65.17 -50.19 61.87 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-O 118.511 -0.757 . . . . 0.0 111.655 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.26 146.28 35.72 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.238 1.959 . . . . 0.0 109.469 171.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -105.44 153.72 21.31 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-O 121.006 0.432 . . . . 0.0 111.139 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.2 p -143.21 160.23 40.84 Favored 'General case' 0 C--O 1.228 -0.055 0 C-N-CA 124.405 1.082 . . . . 0.0 108.739 178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.6 mtt -66.55 -23.65 66.25 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.085 -0.384 . . . . 0.0 111.099 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -84.3 -37.76 21.26 Favored 'General case' 0 N--CA 1.458 -0.062 0 O-C-N 122.174 -0.329 . . . . 0.0 111.279 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.97 -34.73 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -75.92 -29.64 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.099 0 CA-C-N 117.501 0.651 . . . . 0.0 110.499 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.52 -29.49 63.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 122.191 -0.318 . . . . 0.0 110.755 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.31 -31.79 22.85 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.088 0.155 . . . . 0.0 111.279 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.13 -34.54 61.68 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.82 0.282 . . . . 0.0 110.552 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.08 -21.18 33.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 119.585 -0.245 . . . . 0.0 110.462 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.32 -19.89 59.38 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.205 0.457 . . . . 0.0 110.219 173.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.48 -24.88 23.97 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.495 0.318 . . . . 0.0 111.464 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 tt -91.6 -59.39 2.14 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.645 0.378 . . . . 0.0 111.473 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.465 ' HA ' HD13 ' A' ' 4' ' ' LEU . 48.9 mt -70.06 3.72 2.57 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.271 1.428 . . . . 0.0 113.55 -173.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.783 -1.103 . . . . 0.0 109.94 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -144.77 163.61 33.51 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.149 0.58 . . . . 0.0 110.459 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.38 169.15 18.63 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.228 0.611 . . . . 0.0 111.174 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.38 79.6 1.89 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.544 0.738 . . . . 0.0 109.753 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.82 -6.42 54.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.332 0.653 . . . . 0.0 112.206 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.587 ' HB3' HG11 ' A' ' 32' ' ' VAL . 78.6 mt-30 -128.71 119.05 23.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -174.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.5 mm -120.9 131.41 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 123.609 0.764 . . . . 0.0 110.604 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -88.52 140.94 28.95 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.518 ' H ' HD23 ' A' ' 8' ' ' LEU . 89.4 mt -109.99 135.14 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 122.911 0.484 . . . . 0.0 110.117 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 t -129.07 121.56 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 16.9 tp10 -149.2 159.16 44.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.764 0.426 . . . . 0.0 110.656 -171.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.57 -12.74 12.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.438 0.695 . . . . 0.0 111.526 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.411 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 18.1 tp10 -120.16 110.38 36.26 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 123.438 0.695 . . . . 0.0 109.27 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.86 -23.7 35.34 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.636 2.891 . . . . 0.0 113.955 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.1 tp -73.43 -32.54 64.45 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.3 0.5 . . . . 0.0 110.202 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 mm -81.77 -28.52 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.63 64.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.594 0.179 . . . . 0.0 110.557 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 16.5 tpt -77.0 -33.66 57.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.2 tpt -75.05 -23.95 58.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.14 -38.01 75.41 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -75.13 -22.74 57.95 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.608 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -70.86 -43.66 68.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 122.202 -0.311 . . . . 0.0 110.557 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -76.46 -25.5 54.42 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.936 -0.477 . . . . 0.0 111.416 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.8 tp -73.0 -32.11 64.93 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.292 0.497 . . . . 0.0 111.024 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -85.57 -24.07 27.36 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.698 0.259 . . . . 0.0 111.698 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.5 t -76.64 -20.6 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 118.337 0.517 . . . . 0.0 110.504 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.89 18.38 18.5 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.709 0.403 . . . . 0.0 111.685 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 t70 54.18 27.66 8.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.9 0.88 . . . . 0.0 113.043 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.9 157.12 20.25 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 123.224 0.61 . . . . 0.0 109.518 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.3 m -99.43 120.93 56.62 Favored Pre-proline 0 CA--C 1.533 0.302 0 O-C-N 122.014 -0.429 . . . . 0.0 110.231 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -79.24 162.89 25.4 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.65 2.9 . . . . 0.0 110.696 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.587 HG11 ' HB3' ' A' ' 6' ' ' GLN . 28.9 m -138.7 -27.11 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.69 173.58 33.49 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 90.2 m -140.73 143.33 34.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.56 154.98 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 122.584 0.354 . . . . 0.0 110.927 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -108.19 8.72 28.09 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.277 0.631 . . . . 0.0 111.634 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -150.63 158.77 44.54 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 122.826 0.45 . . . . 0.0 110.167 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.2 m -72.1 -22.84 21.31 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 122.941 0.496 . . . . 0.0 111.101 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.96 62.91 Favored 'General case' 0 N--CA 1.453 -0.293 0 O-C-N 122.271 -0.268 . . . . 0.0 110.716 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.2 -21.58 70.09 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.49 -31.73 42.33 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 117.278 0.539 . . . . 0.0 110.498 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 91.8 mt -82.12 -23.76 35.49 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.759 0.254 . . . . 0.0 110.97 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.18 -30.14 34.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.3 -0.25 . . . . 0.0 111.504 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -87.72 -29.1 21.33 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.18 -28.82 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 118.201 0.455 . . . . 0.0 111.313 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.16 -14.87 59.72 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.794 -0.566 . . . . 0.0 110.733 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -88.75 -12.54 41.89 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.34 0.656 . . . . 0.0 110.587 176.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.23 -173.05 54.28 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -178.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.18 16.55 74.06 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.906 -0.386 . . . . 0.0 112.203 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.9 mt -139.17 147.16 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 123.897 0.879 . . . . 0.0 108.777 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -115.09 -21.2 10.12 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 119.22 -0.419 . . . . 0.0 112.049 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.76 173.12 14.22 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 118.314 0.506 . . . . 0.0 110.532 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.51 164.25 34.0 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.1 mt -125.84 133.32 69.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.42 129.11 56.63 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.353 . . . . 0.0 110.996 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -81.44 130.16 34.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.4 t -95.85 -11.28 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 120.629 0.252 . . . . 0.0 110.542 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -87.07 21.7 2.26 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.704 0.802 . . . . 0.0 110.465 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.05 150.25 21.44 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.802 0.841 . . . . 0.0 111.088 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -65.25 152.25 44.17 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.067 0.547 . . . . 0.0 111.422 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.95 12.24 82.88 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.958 -0.457 . . . . 0.0 111.958 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.43 -176.37 46.54 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 117.572 0.686 . . . . 0.0 111.605 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.38 116.77 10.18 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.417 -0.461 . . . . 0.0 110.167 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -151.91 11.06 0.56 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.191 0.596 . . . . 0.0 111.12 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.2 p -105.35 3.66 30.02 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.416 0.686 . . . . 0.0 112.262 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.477 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 66.3 p -93.9 -31.79 0.3 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.14 -0.933 . . . . 0.0 112.253 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 66' ' ' THR . 39.6 Cg_exo -64.96 -24.91 59.9 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.767 1.645 . . . . 0.0 111.889 176.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.96 -23.88 7.8 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 C-N-CA 122.333 0.253 . . . . 0.0 110.675 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.12 -34.17 70.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.49 -17.72 61.19 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.223 -0.298 . . . . 0.0 110.487 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.78 -29.78 51.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.4 mt -69.91 -31.41 69.18 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.62 -23.86 61.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.91 -13.87 58.51 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.588 0.355 . . . . 0.0 110.477 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -102.71 12.27 36.53 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.82 0.848 . . . . 0.0 111.013 174.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 58.03 33.27 23.0 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.066 0.947 . . . . 0.0 113.423 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.2 mt -114.37 129.4 24.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.853 0.861 . . . . 0.0 109.457 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.93 159.28 30.92 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.744 2.963 . . . . 0.0 112.418 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -153.78 168.99 24.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.301 0.641 . . . . 0.0 110.742 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 20.0 m -143.04 159.76 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 C-N-CA 124.006 0.922 . . . . 0.0 108.968 173.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -99.38 156.21 17.13 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.939 0.4 . . . . 0.0 111.779 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.37 119.53 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.5 t -172.61 156.62 3.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.721 0.408 . . . . 0.0 110.604 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.59 143.43 18.47 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.65 -158.09 29.88 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 117.358 0.579 . . . . 0.0 111.916 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.4 t -137.47 170.86 15.36 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.887 0.875 . . . . 0.0 110.063 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.04 -13.8 62.48 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.101 -0.374 . . . . 0.0 111.302 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -94.93 3.55 54.83 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.16 0.584 . . . . 0.0 111.332 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 98.4 p -126.12 20.2 7.57 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 122.827 0.451 . . . . 0.0 111.903 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 16.1 m -132.26 154.85 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 C-N-CA 123.422 0.689 . . . . 0.0 111.779 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -81.93 170.84 15.14 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.26 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.5 p -61.09 -21.72 63.95 Favored 'General case' 0 C--O 1.231 0.105 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.95 -21.42 59.19 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 118.673 0.669 . . . . 0.0 110.862 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.465 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 3.2 m-85 -80.97 -23.44 38.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -88.21 -8.15 55.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.448 0.699 . . . . 0.0 111.261 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -119.6 -3.96 10.33 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.199 0.599 . . . . 0.0 112.087 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -140.55 140.8 23.35 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -52.89 149.96 24.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.622 2.881 . . . . 0.0 114.345 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 m -142.75 154.62 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.535 1.134 . . . . 0.0 109.596 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.6 tp -146.87 155.28 42.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.657 0.383 . . . . 0.0 110.097 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -73.26 158.12 35.77 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 44.8 mtpt -66.08 -43.82 57.95 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-O 118.131 -0.938 . . . . 0.0 112.907 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 67.6 Cg_endo -69.39 128.61 16.63 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.676 1.277 . . . . 0.0 108.881 171.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -100.03 154.08 18.69 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.766 0.426 . . . . 0.0 111.367 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.5 p -141.38 162.39 35.61 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.426 1.09 . . . . 0.0 108.711 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.08 -26.88 68.75 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.298 -0.251 . . . . 0.0 111.031 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -84.47 -38.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.932 0.333 . . . . 0.0 111.579 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.99 -31.76 59.5 Favored Glycine 0 C--N 1.338 0.647 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.6 t -80.18 -27.64 12.02 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.026 0 CA-C-N 117.24 0.52 . . . . 0.0 110.229 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.78 -29.17 68.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.003 -0.436 . . . . 0.0 110.669 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -83.24 -33.77 25.99 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 122.321 -0.237 . . . . 0.0 110.939 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.86 66.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.34 -20.33 40.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.5 -24.63 62.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.777 0.717 . . . . 0.0 109.886 174.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.41 -23.71 24.44 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 176.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 92.2 mt -91.56 -14.44 30.31 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -107.06 18.04 22.27 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.376 0.535 . . . . 0.0 111.137 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.15 -0.929 . . . . 0.0 111.442 179.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -137.39 -0.86 2.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.095 0.558 . . . . 0.0 112.104 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.3 14.36 0.76 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.198 0.999 . . . . 0.0 113.018 -176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.2 56.17 2.62 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -70.42 -7.07 40.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 122.161 -0.337 . . . . 0.0 111.214 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.674 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.8 mp0 -106.27 114.31 28.35 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 122.807 0.443 . . . . 0.0 111.457 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.5 mm -123.88 127.35 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 123.636 0.585 . . . . 0.0 110.225 -174.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -92.85 136.16 33.49 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.434 ' N ' HD23 ' A' ' 8' ' ' LEU . 96.8 mt -103.24 132.78 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.182 0.593 . . . . 0.0 109.937 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.7 t -131.97 118.95 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 13' ' ' GLU . 34.8 tp10 -151.24 140.2 21.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.803 0.441 . . . . 0.0 109.945 -176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -89.66 4.67 48.76 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.561 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 59.0 mt-10 -135.68 138.67 28.8 Favored Pre-proline 0 CA--C 1.529 0.153 0 O-C-N 121.899 -0.5 . . . . 0.0 109.984 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.75 -22.0 18.29 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.341 2.694 . . . . 0.0 112.525 -174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -79.42 -36.47 38.95 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.239 0.472 . . . . 0.0 110.236 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.47 -27.75 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.49 -35.05 78.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 59.2 ttp -73.63 -30.17 62.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.4 ttp -74.82 -31.43 61.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 122.382 -0.199 . . . . 0.0 110.485 178.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -70.07 -29.97 67.1 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.168 -0.333 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -76.2 -21.79 56.05 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.55 -43.79 54.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 118.089 0.404 . . . . 0.0 110.411 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -74.52 -16.93 60.82 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 118.065 0.393 . . . . 0.0 111.167 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.4 tp -69.05 -30.72 69.12 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -83.2 -23.73 32.72 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.387 0.275 . . . . 0.0 111.112 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -71.58 -24.61 23.63 Favored 'Isoleucine or valine' 0 C--N 1.34 0.176 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.2 tp -93.31 -1.64 55.79 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.919 0.487 . . . . 0.0 110.544 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 52.28 35.04 15.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.332 0.653 . . . . 0.0 110.716 -175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 tptt -85.6 155.57 21.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.217 1.007 . . . . 0.0 109.876 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -90.38 121.56 68.35 Favored Pre-proline 0 CA--C 1.53 0.207 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.58 155.26 35.7 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.473 2.782 . . . . 0.0 110.573 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.674 HG11 ' HB3' ' A' ' 6' ' ' GLN . 34.5 m -138.16 -18.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.584 0.354 . . . . 0.0 111.813 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.64 167.52 25.33 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.7 m -143.61 138.95 29.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.9 161.31 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 122.928 0.491 . . . . 0.0 110.501 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -113.34 5.25 16.75 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.196 0.598 . . . . 0.0 112.486 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 39' ' ' ALA . 29.6 m -137.12 143.79 42.7 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.01 -23.34 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.44 ' H ' HG22 ' A' ' 37' ' ' THR . . . -77.15 -25.68 52.27 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.88 -21.42 63.43 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 176.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.42 -34.33 54.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.4 0.6 . . . . 0.0 110.135 178.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -71.69 -42.36 67.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.53 -24.8 64.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.437 0.295 . . . . 0.0 111.588 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 51.7 tpt85 -81.53 -26.51 35.03 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 122.299 -0.25 . . . . 0.0 111.336 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.25 -25.38 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 118.272 0.487 . . . . 0.0 110.267 178.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -75.12 -14.74 60.59 Favored 'General case' 0 CA--C 1.531 0.215 0 O-C-N 122.077 -0.389 . . . . 0.0 110.898 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.32 -12.36 59.93 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.603 0.361 . . . . 0.0 110.484 176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 79.4 -176.12 54.81 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.519 0.58 . . . . 0.0 111.863 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.64 12.73 83.93 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 112.164 -0.374 . . . . 0.0 112.164 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.36 145.86 35.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 117.895 0.848 . . . . 0.0 109.696 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -124.22 -15.4 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.049 0.539 . . . . 0.0 112.007 -174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.54 172.39 12.1 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.751 0.82 . . . . 0.0 109.741 173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.84 166.09 31.59 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.127 -0.358 . . . . 0.0 111.558 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.4 mt -124.03 131.27 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -115.61 133.84 55.64 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 121.105 0.478 . . . . 0.0 111.781 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -86.5 137.12 32.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 169.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 t -98.08 -11.88 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -84.17 136.73 33.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 tp -157.66 136.06 11.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -82.02 152.66 26.56 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 122.675 0.39 . . . . 0.0 110.647 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.99 -161.16 13.57 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -74.65 -6.38 76.92 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 119.737 -0.479 . . . . 0.0 112.702 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -83.87 153.58 23.93 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.944 0.872 . . . . 0.0 110.777 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -148.72 1.13 0.58 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.557 0.343 . . . . 0.0 111.782 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -139.28 167.75 21.36 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.749 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.7 m -134.29 72.47 70.93 Favored Pre-proline 0 CA--C 1.528 0.129 0 C-N-CA 122.982 0.513 . . . . 0.0 109.74 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.69 -7.15 20.32 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.652 2.901 . . . . 0.0 111.589 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.57 -22.77 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 O-C-N 122.142 -0.348 . . . . 0.0 110.733 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.72 -28.73 69.27 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.26 -0.275 . . . . 0.0 110.467 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -72.57 -20.93 61.23 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 122.338 -0.227 . . . . 0.0 110.614 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.61 -29.82 41.22 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.3 mt -75.24 -32.9 61.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.24 -23.55 61.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.21 -12.13 55.34 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.351 0.26 . . . . 0.0 110.395 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ttt-85 -94.31 17.61 12.52 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.871 0.868 . . . . 0.0 110.972 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.5 t0 59.74 31.26 20.74 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.661 1.184 . . . . 0.0 114.024 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.7 pt -128.28 143.79 49.39 Favored Pre-proline 0 CA--C 1.532 0.251 0 O-C-N 122.094 -0.379 . . . . 0.0 110.228 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.77 161.61 24.38 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.785 2.99 . . . . 0.0 111.793 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -145.63 165.4 28.8 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.227 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 50.7 t -137.62 146.2 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 C-N-CA 124.339 1.056 . . . . 0.0 108.542 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.65 155.58 18.02 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.935 0.397 . . . . 0.0 111.226 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.1 119.22 11.37 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -174.02 161.09 3.61 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.742 0.817 . . . . 0.0 109.859 178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.02 145.69 25.98 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.48 -159.33 30.78 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 117.455 0.628 . . . . 0.0 112.03 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.9 t -141.05 159.79 41.47 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.779 0.831 . . . . 0.0 109.972 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -71.8 -5.96 38.08 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -97.42 4.39 50.62 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.058 0.543 . . . . 0.0 111.088 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.8 m -129.56 22.2 5.52 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.328 0.651 . . . . 0.0 111.696 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.495 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 15.3 m -131.25 154.66 40.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 C-N-CA 122.973 0.509 . . . . 0.0 112.072 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -75.2 168.0 20.83 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.312 1.045 . . . . 0.0 111.307 -179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.8 p -62.23 -17.45 58.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -175.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -73.61 -25.88 60.52 Favored 'General case' 0 C--N 1.338 0.097 0 CA-C-N 118.218 0.463 . . . . 0.0 110.167 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.495 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 15.7 m-85 -80.38 -24.39 39.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.45 -9.33 52.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.997 0.519 . . . . 0.0 111.63 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -112.02 -18.01 12.72 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -135.16 157.84 75.99 Favored Pre-proline 0 C--O 1.232 0.166 0 C-N-CA 122.847 0.459 . . . . 0.0 110.055 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.33 154.08 25.17 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.384 3.39 . . . . 0.0 114.082 -173.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.3 m -144.22 154.23 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.381 1.072 . . . . 0.0 109.293 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 71.7 mt -143.4 156.95 44.8 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.203 0.601 . . . . 0.0 110.754 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -87.05 170.5 11.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.05 -38.84 52.52 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-O 118.097 -0.954 . . . . 0.0 112.59 -177.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -64.78 125.23 14.44 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.076 1.85 . . . . 0.0 110.738 173.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -111.1 152.11 27.32 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.219 0.608 . . . . 0.0 110.187 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.2 p -141.3 159.41 42.27 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 123.737 0.815 . . . . 0.0 109.147 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -67.55 -26.91 66.54 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.17 -0.331 . . . . 0.0 111.077 -177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -84.66 -35.77 22.38 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.019 0.372 . . . . 0.0 111.676 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.18 -31.21 43.3 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 112.154 -0.378 . . . . 0.0 112.154 -175.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.5 t -84.66 -28.65 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-N 117.648 0.724 . . . . 0.0 110.578 -179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.33 -29.61 66.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.059 -0.401 . . . . 0.0 110.675 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -84.55 -27.94 26.98 Favored 'General case' 0 C--N 1.338 0.082 0 CA-C-N 117.647 0.203 . . . . 0.0 110.966 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.03 -36.5 48.54 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.202 -0.311 . . . . 0.0 110.961 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -80.42 -23.46 40.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.27 -0.269 . . . . 0.0 110.481 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.2 -24.17 60.49 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.15 -13.86 42.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.089 0.556 . . . . 0.0 111.327 175.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.33 -33.79 42.8 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.0 mp -81.04 7.3 11.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--O 1.252 1.202 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.37 -179.534 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 110.702 -0.11 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 m 53.73 23.3 3.62 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.012 0.925 . . . . 0.0 113.287 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.63 163.0 38.58 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.296 0.638 . . . . 0.0 110.359 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 4' ' ' LEU . 1.1 pt? -145.9 74.1 1.36 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.229 0.612 . . . . 0.0 110.382 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -77.29 -5.68 50.36 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 122.897 0.479 . . . . 0.0 111.642 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.444 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 67.3 mt-30 -122.39 118.06 27.51 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -175.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mm -123.42 134.15 67.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.851 -175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -88.84 138.07 31.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 173.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.57 ' H ' HD23 ' A' ' 8' ' ' LEU . 77.2 mt -111.65 126.09 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 123.806 0.842 . . . . 0.0 109.558 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' CG2' ' A' ' 35' ' ' VAL . 19.8 t -132.18 122.33 48.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 122.775 0.43 . . . . 0.0 110.23 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -141.65 155.32 45.71 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.919 0.488 . . . . 0.0 110.733 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -84.83 -6.97 59.36 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.663 0.385 . . . . 0.0 110.926 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -135.17 125.93 17.24 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 122.987 0.515 . . . . 0.0 109.676 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.17 -25.01 76.51 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.966 2.444 . . . . 0.0 112.804 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.97 -33.14 74.93 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.099 -0.376 . . . . 0.0 110.525 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -83.85 -26.62 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.45 -38.98 65.31 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.807 0.276 . . . . 0.0 110.827 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 75.7 mtm -74.64 -31.74 62.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 13.3 tpt -75.01 -23.73 58.27 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -39.63 81.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -72.64 -22.39 60.95 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -72.68 -40.14 66.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.904 0.32 . . . . 0.0 111.052 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -74.69 -27.55 60.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.776 -0.577 . . . . 0.0 110.595 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.07 -17.66 58.58 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.917 -0.489 . . . . 0.0 110.606 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -78.58 -28.29 45.85 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.4 t -80.33 -20.74 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.628 0.371 . . . . 0.0 110.374 176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -99.27 12.22 36.85 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.296 0.638 . . . . 0.0 111.995 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 52.89 33.91 15.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.556 0.742 . . . . 0.0 112.291 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.85 163.68 17.96 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.877 0.871 . . . . 0.0 110.09 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -117.8 74.75 9.7 Favored Pre-proline 0 N--CA 1.463 0.215 0 C-N-CA 122.698 0.399 . . . . 0.0 110.46 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -62.94 154.57 65.88 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.941 2.427 . . . . 0.0 109.682 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 33.8 m -115.87 -12.14 11.72 Favored 'Isoleucine or valine' 0 C--N 1.337 0.055 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -172.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 175.34 35.11 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.248 176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -132.49 143.49 49.79 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.737 0.815 . . . . 0.0 108.941 175.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.411 ' CG2' HG22 ' A' ' 10' ' ' VAL . 34.3 m -146.07 163.05 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.008 0.523 . . . . 0.0 110.206 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -127.65 6.92 6.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.001 0.521 . . . . 0.0 112.065 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.0 t -146.12 156.55 43.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.056 0.542 . . . . 0.0 110.183 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.4 m -67.97 -28.31 40.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 -175.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.98 62.96 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 -30.77 56.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.36 -38.34 87.37 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.809 0.805 . . . . 0.0 109.975 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -76.73 -19.32 57.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.21 -0.306 . . . . 0.0 110.401 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.63 -24.97 49.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.088 0.404 . . . . 0.0 111.013 176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -77.75 -32.87 52.94 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.9 t -73.05 -26.09 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 122.464 0.306 . . . . 0.0 110.247 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -82.39 -15.11 53.91 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.578 0.351 . . . . 0.0 111.043 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -98.98 -12.88 20.21 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.661 0.384 . . . . 0.0 111.582 -177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.97 172.31 38.47 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.15 154.61 48.14 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 29.0 mt -141.93 146.04 23.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -103.28 -24.34 13.53 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.55 174.31 11.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.695 0.398 . . . . 0.0 110.396 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.11 162.34 40.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 122.077 -0.39 . . . . 0.0 111.754 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 65.1 mt -126.02 127.97 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.035 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -116.23 124.63 50.72 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.745 0.418 . . . . 0.0 111.192 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -85.97 124.47 32.46 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 172.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.43 -5.31 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.708 0.803 . . . . 0.0 111.95 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -75.22 52.17 0.57 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.677 0.791 . . . . 0.0 112.636 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.09 158.71 32.67 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 121.833 -0.542 . . . . 0.0 109.92 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -80.99 152.72 27.83 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.347 0.659 . . . . 0.0 111.087 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.73 6.5 89.0 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.504 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.91 8.16 87.36 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 117.837 0.819 . . . . 0.0 111.992 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -71.79 167.31 20.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.656 0.728 . . . . 0.0 110.527 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -122.79 166.0 15.68 Favored 'General case' 0 C--N 1.338 0.082 0 C-N-CA 123.019 0.528 . . . . 0.0 110.997 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.4 p -133.89 8.27 3.8 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.992 0.917 . . . . 0.0 110.434 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.6 m -54.56 -35.65 34.45 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 71.6 Cg_exo -55.41 -19.65 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.685 2.257 . . . . 0.0 114.578 -178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.95 -26.24 9.46 Favored 'Isoleucine or valine' 0 C--N 1.339 0.147 0 CA-C-N 118.858 0.754 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.62 -31.9 60.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -79.41 -17.68 53.84 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.264 0.225 . . . . 0.0 110.533 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.53 -32.66 58.37 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 172.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.8 -26.32 60.56 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.61 -24.45 61.07 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.919 0.327 . . . . 0.0 110.357 176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.8 -18.83 53.47 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.09 7.7 44.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.554 0.742 . . . . 0.0 111.025 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 58.66 29.53 18.69 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.408 1.083 . . . . 0.0 113.106 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.1 mt -102.8 127.81 29.28 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.5 158.52 44.01 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.759 2.973 . . . . 0.0 111.588 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -150.73 168.29 24.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.873 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.18 146.78 27.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 124.113 0.965 . . . . 0.0 108.891 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 21.2 m-85 -89.62 157.79 17.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.101 0.477 . . . . 0.0 111.266 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.7 144.62 37.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.9 t -161.95 174.16 13.46 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -162.29 117.34 0.76 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 175.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.82 -159.27 28.07 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.9 m -71.09 160.0 33.69 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.887 0.475 . . . . 0.0 110.29 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -73.82 -11.44 60.38 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -80.79 -1.82 44.56 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.133 0.424 . . . . 0.0 111.469 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.4 t -78.92 -7.18 57.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.723 0.409 . . . . 0.0 110.92 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 m -135.59 154.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.393 0.677 . . . . 0.0 110.506 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -106.27 -178.64 3.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.802 0.841 . . . . 0.0 111.351 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.3 p -60.36 -19.68 56.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -70.05 -27.01 64.29 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.194 0.452 . . . . 0.0 110.157 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.405 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 16.0 m-85 -89.17 -18.16 27.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.761 0.824 . . . . 0.0 109.903 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.8 mtt180 -88.06 -8.81 54.99 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.511 0.324 . . . . 0.0 110.673 177.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -104.63 -19.64 13.91 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.57 0.748 . . . . 0.0 110.842 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -103.61 160.99 24.37 Favored Pre-proline 0 CA--C 1.529 0.166 0 C-N-CA 123.997 0.919 . . . . 0.0 110.034 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -67.02 150.74 82.69 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.859 2.373 . . . . 0.0 110.829 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.48 154.23 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.903 0.881 . . . . 0.0 110.557 -176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.1 mt -134.56 153.86 51.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.726 0.81 . . . . 0.0 109.886 177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -85.37 163.08 18.75 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -71.32 -48.04 13.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-O 118.348 -0.834 . . . . 0.0 113.221 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.16 138.95 18.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.874 1.716 . . . . 0.0 111.152 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -111.52 157.64 20.1 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.967 0.507 . . . . 0.0 110.506 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.3 p -140.92 165.6 27.07 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 124.711 1.204 . . . . 0.0 108.039 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.3 mmt -60.93 -36.68 79.97 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 121.871 -0.518 . . . . 0.0 111.192 -177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -84.59 -29.0 26.17 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 122.281 -0.262 . . . . 0.0 111.306 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.92 -28.16 51.16 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.334 -176.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.0 p -86.01 -25.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-N 117.898 0.849 . . . . 0.0 110.879 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.21 -31.33 70.76 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -84.62 -20.86 30.7 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 122.478 0.311 . . . . 0.0 110.972 176.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.9 -40.08 55.08 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.844 0.293 . . . . 0.0 110.598 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.21 -25.66 42.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.69 62.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.218 0.463 . . . . 0.0 110.378 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.57 -16.58 34.17 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.044 0.537 . . . . 0.0 111.894 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.27 -33.72 15.23 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.516 0.326 . . . . 0.0 110.906 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.01 -3.04 58.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.762 0.425 . . . . 0.0 111.987 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.743 -1.122 . . . . 0.0 110.117 -179.224 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 110.778 -0.082 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.4 p -149.36 160.22 43.61 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 122.948 0.499 . . . . 0.0 109.917 178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 51.56 22.15 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.697 0.799 . . . . 0.0 112.668 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 42.29 58.13 3.11 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 125.865 1.666 . . . . 0.0 111.817 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.21 -8.7 57.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 119.356 -0.354 . . . . 0.0 110.534 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.462 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.6 mp0 -112.22 110.11 20.18 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.149 0.579 . . . . 0.0 111.905 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.3 mm -116.88 139.47 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.401 0.68 . . . . 0.0 110.315 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.85 133.43 47.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 92.9 mt -98.69 126.47 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -132.34 109.21 14.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -143.03 160.18 40.86 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -89.44 -4.54 57.94 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.966 0.506 . . . . 0.0 111.538 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -140.31 140.07 22.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 O-C-N 122.039 -0.413 . . . . 0.0 110.976 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -81.07 -14.45 10.89 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.767 2.978 . . . . 0.0 112.799 -174.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -70.33 -45.11 66.85 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.517 0.599 . . . . 0.0 110.703 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.8 mm -77.06 -25.4 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.3 66.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 122.283 -0.261 . . . . 0.0 110.581 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 26.2 mmt -82.33 -26.25 33.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 96.5 mmm -75.23 -29.22 60.18 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 122.137 -0.352 . . . . 0.0 110.625 175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.403 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 3.1 mm? -76.47 -30.05 57.15 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -75.69 -22.21 56.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.882 0.31 . . . . 0.0 110.224 175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.39 -45.13 20.1 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.22 -0.3 . . . . 0.0 111.29 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -78.88 -24.04 44.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.558 0.617 . . . . 0.0 112.435 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.34 -22.19 48.42 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.376 0.989 . . . . 0.0 111.066 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -85.23 -23.43 28.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.438 0.563 . . . . 0.0 111.167 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.07 -18.53 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 122.616 0.366 . . . . 0.0 110.884 178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.4 mt -105.07 20.22 19.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.867 0.467 . . . . 0.0 111.753 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 53.94 30.29 11.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.931 0.892 . . . . 0.0 113.114 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.5 tmtm? -85.76 164.29 17.67 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.464 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 23.8 m -123.18 71.8 45.32 Favored Pre-proline 0 CA--C 1.53 0.199 0 O-C-N 122.239 -0.288 . . . . 0.0 111.0 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -62.19 151.61 81.06 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.725 2.284 . . . . 0.0 109.408 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 6' ' ' GLN . 33.1 m -112.57 -6.8 11.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -172.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.48 174.98 34.84 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.661 176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.6 m -140.75 139.4 34.63 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.077 0.951 . . . . 0.0 108.684 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.26 156.02 29.84 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 C-N-CA 122.877 0.471 . . . . 0.0 110.214 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -108.53 2.23 22.04 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 112.048 -176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.5 p -139.11 158.46 44.14 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.075 0.55 . . . . 0.0 110.311 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.1 m -75.26 -22.93 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.654 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.32 -25.97 58.28 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.49 -25.14 71.05 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.31 -30.89 48.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.39 0.595 . . . . 0.0 110.261 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 93.3 mt -77.68 -32.46 53.09 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.51 56.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.172 -0.33 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -87.73 -25.91 23.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 p -83.1 -22.01 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 118.219 0.463 . . . . 0.0 111.293 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -67.99 -14.74 63.21 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.897 0.317 . . . . 0.0 110.802 174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.28 -12.42 37.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.275 0.63 . . . . 0.0 110.81 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 -169.31 53.51 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.73 12.03 82.06 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.526 -0.597 . . . . 0.0 112.832 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.0 mt -117.62 145.88 22.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 117.76 0.78 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.98 -22.24 5.76 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.625 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.3 171.07 15.34 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.571 0.748 . . . . 0.0 109.731 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.4 164.87 35.76 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.083 -0.386 . . . . 0.0 110.967 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 64.9 mt -122.64 133.16 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.25 142.71 45.94 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.296 0.638 . . . . 0.0 110.691 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -97.51 135.17 39.74 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.566 0.746 . . . . 0.0 109.169 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.35 -16.08 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -77.65 -2.86 38.05 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.541 0.336 . . . . 0.0 110.718 177.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.4 tp -108.39 98.72 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -82.34 144.04 30.84 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.07 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -80.31 -174.86 48.16 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.57 -24.05 68.69 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 122.119 -0.636 . . . . 0.0 111.552 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -126.66 166.54 17.16 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.869 0.868 . . . . 0.0 110.043 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.9 mttp 43.98 -115.19 0.4 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.593 0.757 . . . . 0.0 110.947 177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -139.62 -46.05 0.45 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.588 0.176 . . . . 0.0 111.328 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.1 p -143.01 47.15 0.78 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 122.937 0.495 . . . . 0.0 111.831 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -71.8 -13.19 29.35 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.999 2.466 . . . . 0.0 112.245 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.06 -24.04 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-N 118.113 0.415 . . . . 0.0 110.326 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.01 -27.07 65.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -82.08 -17.62 45.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.452 0.301 . . . . 0.0 110.712 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -32.58 62.79 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.35 -28.97 64.44 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.99 -22.83 60.62 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.585 -0.154 . . . . 0.0 110.585 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.57 -19.58 55.43 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -92.33 10.6 29.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.347 0.659 . . . . 0.0 110.858 172.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.4 t70 59.42 25.18 13.88 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.201 1.001 . . . . 0.0 113.006 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.4 mt -97.48 125.06 46.51 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.99 157.58 34.42 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.605 2.87 . . . . 0.0 111.113 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -149.39 167.52 25.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.214 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -138.45 141.94 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -82.93 148.46 27.64 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 177.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -135.53 129.68 33.42 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.9 t -160.41 169.73 22.46 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 122.601 0.36 . . . . 0.0 110.665 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.99 175.87 54.84 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.43 102.37 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.9 m -150.39 147.25 27.34 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.701 0.8 . . . . 0.0 109.929 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -105.63 -2.83 22.96 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 112.29 -178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -130.68 0.28 4.38 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.1 m -89.86 5.83 44.5 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 121.927 -0.483 . . . . 0.0 111.421 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 m -142.15 154.46 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.748 0.819 . . . . 0.0 111.118 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -102.86 175.54 5.45 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.709 0.804 . . . . 0.0 110.563 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -64.98 -11.35 37.74 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -75.77 -24.21 56.02 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.31 0.505 . . . . 0.0 109.938 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -86.8 -20.12 28.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 59.7 mtt85 -84.02 -12.93 54.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.74 0.416 . . . . 0.0 110.767 176.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -104.5 -16.69 14.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.355 0.662 . . . . 0.0 111.601 177.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -109.29 163.14 17.71 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.405 0.682 . . . . 0.0 110.402 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.87 148.2 68.57 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.572 2.848 . . . . 0.0 112.58 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.26 154.75 23.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 123.762 0.825 . . . . 0.0 110.328 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 52.3 tp -145.89 154.26 41.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.744 0.818 . . . . 0.0 109.54 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -80.22 146.29 31.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 34.5 ttmt -72.33 -43.34 9.62 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 118.135 -0.936 . . . . 0.0 113.019 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 74.3 Cg_endo -69.59 142.26 48.21 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 CA-C-N 121.197 1.463 . . . . 0.0 109.74 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.4 m-85 -117.3 150.01 39.52 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-O 121.376 0.607 . . . . 0.0 111.971 -175.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 66.6 p -143.7 166.47 24.77 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.028 1.331 . . . . 0.0 107.519 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 55.2 ttm -65.76 -28.19 68.84 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.737 -0.602 . . . . 0.0 110.977 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -84.32 -31.28 24.93 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.263 -0.273 . . . . 0.0 110.637 176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.37 -24.67 67.63 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-O 119.648 -0.529 . . . . 0.0 112.129 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.3 p -86.23 -27.51 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 118.155 0.978 . . . . 0.0 110.969 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.29 -30.09 69.86 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -85.08 -20.94 29.6 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.355 0.662 . . . . 0.0 110.584 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.16 -36.25 61.54 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 176.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.59 -26.41 45.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.91 -27.02 63.48 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.923 0.329 . . . . 0.0 110.127 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.82 -17.47 31.47 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.764 0.425 . . . . 0.0 111.743 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.4 -36.16 13.96 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.599 0.36 . . . . 0.0 111.66 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.72 3.99 54.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.728 0.411 . . . . 0.0 112.055 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.252 1.233 0 CA-C-O 117.377 -1.297 . . . . 0.0 110.244 179.29 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ptp . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.307 0.098 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t -150.63 165.0 34.7 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.784 0.434 . . . . 0.0 110.493 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.74 164.08 32.95 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.38 0.672 . . . . 0.0 110.554 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.28 74.1 1.45 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.654 0.74 . . . . 0.0 110.497 -178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -4.15 42.61 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.075 0.55 . . . . 0.0 110.971 175.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.536 ' HB3' HG11 ' A' ' 32' ' ' VAL . 82.5 mt-30 -124.03 115.89 21.93 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 -175.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mm -122.26 132.64 70.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.394 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -90.21 141.3 28.84 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.558 ' H ' HD23 ' A' ' 8' ' ' LEU . 69.5 mt -105.53 122.45 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.874 0.87 . . . . 0.0 109.251 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.25 113.25 21.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -145.39 163.26 35.14 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 121.252 0.548 . . . . 0.0 112.424 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -93.46 2.45 56.46 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.921 1.288 . . . . 0.0 112.153 -178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -137.8 134.19 18.08 Favored Pre-proline 0 N--CA 1.456 -0.171 0 C-N-CA 123.021 0.528 . . . . 0.0 110.206 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.48 -16.92 14.85 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.344 2.696 . . . . 0.0 111.893 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.88 -41.74 29.02 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 122.235 -0.29 . . . . 0.0 110.404 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.9 mm -78.25 -30.0 15.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.102 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.46 -29.02 68.37 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.9 ttt -75.11 -33.86 61.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.6 mtp -73.34 -24.28 60.33 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.502 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 0.5 OUTLIER -70.17 -39.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.27 -29.38 66.14 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.113 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -73.43 -38.4 65.55 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 119.747 -0.168 . . . . 0.0 111.102 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -72.77 -23.43 60.81 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.318 0.508 . . . . 0.0 111.615 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.1 mt -76.82 -21.74 54.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.696 0.68 . . . . 0.0 110.872 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.02 -21.47 29.42 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.452 0.569 . . . . 0.0 111.444 176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.8 t -85.2 -23.09 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 117.99 0.359 . . . . 0.0 110.42 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.17 13.76 33.11 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.188 0.595 . . . . 0.0 111.218 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.7 t0 53.14 35.44 19.77 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.75 0.82 . . . . 0.0 112.486 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.79 163.94 17.86 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.81 0.844 . . . . 0.0 109.817 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.4 m -110.4 89.34 8.57 Favored Pre-proline 0 CA--C 1.532 0.256 0 O-C-N 122.293 -0.254 . . . . 0.0 110.505 178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.15 158.82 55.04 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.84 2.36 . . . . 0.0 110.466 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.536 HG11 ' HB3' ' A' ' 6' ' ' GLN . 30.6 m -130.17 -10.67 2.4 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.6 169.61 28.43 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 118.198 0.454 . . . . 0.0 112.093 177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.9 m -142.12 136.63 30.27 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.27 150.59 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.181 0.515 . . . . 0.0 111.098 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -92.72 -3.73 54.33 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.96 0.904 . . . . 0.0 111.607 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.7 t -151.97 158.32 42.95 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.363 0.665 . . . . 0.0 109.608 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.1 -23.09 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 121.936 0.094 . . . . 0.0 110.995 -177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.91 -26.22 68.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.854 -0.529 . . . . 0.0 109.876 177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.53 -22.39 72.86 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.4 -34.48 65.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.967 0.883 . . . . 0.0 109.932 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.49 -27.54 61.44 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.13 -24.67 59.46 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -87.16 -26.1 23.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.129 0.422 . . . . 0.0 111.309 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 75.1 t -77.51 -26.49 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.134 0.425 . . . . 0.0 110.12 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -82.45 -14.37 55.19 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.689 0.396 . . . . 0.0 111.561 176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -103.79 -13.54 16.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -176.38 169.41 41.93 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -77.52 145.61 30.55 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.504 -0.638 . . . . 0.0 111.504 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.2 mt -142.85 145.46 23.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -101.17 -25.06 14.15 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 118.093 0.406 . . . . 0.0 111.913 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.21 173.06 10.53 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.946 0.498 . . . . 0.0 110.05 175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.48 159.29 44.43 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.483 0.182 . . . . 0.0 111.161 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.5 mt -114.0 123.8 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.28 130.63 56.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.042 0.537 . . . . 0.0 110.019 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -83.89 152.43 24.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.9 m -76.42 -11.52 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -110.26 151.11 27.76 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.027 0.531 . . . . 0.0 111.4 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.5 mt -143.38 159.81 41.69 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.662 1.185 . . . . 0.0 109.074 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -81.95 149.02 28.4 Favored 'General case' 0 C--O 1.23 0.072 0 O-C-N 122.347 -0.221 . . . . 0.0 111.407 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.72 -175.72 16.65 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.145 0.402 . . . . 0.0 112.629 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.55 2.19 84.54 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -79.86 163.92 23.99 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.374 0.67 . . . . 0.0 111.333 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt 58.22 175.3 0.06 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.827 1.251 . . . . 0.0 112.719 -177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.1 p -151.75 164.03 37.87 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.26 0.624 . . . . 0.0 109.758 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.444 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 24.9 m -63.35 -37.32 29.85 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -175.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' A' ' 66' ' ' THR . 52.0 Cg_exo -57.63 -5.43 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 123.652 2.901 . . . . 0.0 114.372 177.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.04 -22.96 32.0 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 CA-C-N 118.862 0.755 . . . . 0.0 110.845 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.43 -26.64 67.32 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.189 -0.319 . . . . 0.0 110.154 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.53 ' CD ' HH12 ' A' ' 93' ' ' ARG . 50.7 mt-10 -79.03 -17.39 55.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.974 -0.454 . . . . 0.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.39 -27.3 59.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.13 -34.64 75.34 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.01 62.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.276 -0.265 . . . . 0.0 110.724 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.25 -15.34 53.4 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.54 0.336 . . . . 0.0 110.518 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -99.64 18.49 17.91 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 123.78 0.832 . . . . 0.0 110.691 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t70 55.43 32.22 18.45 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.367 1.067 . . . . 0.0 113.619 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.47 118.66 24.75 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.89 160.42 37.24 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 124.293 3.329 . . . . 0.0 112.615 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -145.54 166.86 24.48 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.457 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -141.08 155.5 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 109.042 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 23.9 m-85 -88.21 159.19 18.26 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.392 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.11 122.22 19.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.1 t -163.78 179.14 7.31 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 122.886 0.474 . . . . 0.0 110.511 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -158.19 137.4 5.25 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.58 -162.15 29.5 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 36.1 t -76.84 162.41 27.66 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.004 0.522 . . . . 0.0 110.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.74 -9.65 58.88 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 122.663 0.385 . . . . 0.0 110.728 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -85.98 -4.76 59.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.001 0.52 . . . . 0.0 110.612 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -95.37 9.48 39.75 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.079 0.552 . . . . 0.0 111.938 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.76 154.48 36.86 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.23 0.612 . . . . 0.0 111.131 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -107.47 -176.15 2.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.103 0.961 . . . . 0.0 111.024 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.9 m -62.73 -14.46 44.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.53 HH12 ' CD ' ' A' ' 70' ' ' GLU . 85.9 mtt-85 -65.76 -31.87 73.1 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 122.558 0.343 . . . . 0.0 110.238 175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.443 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 29.1 m-85 -89.54 -19.47 24.97 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.605 0.762 . . . . 0.0 109.948 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 70.0 mtm-85 -88.52 -3.75 58.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.81 0.444 . . . . 0.0 111.305 175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -117.82 -13.44 10.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.33 0.652 . . . . 0.0 111.951 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.52 153.45 81.42 Favored Pre-proline 0 C--N 1.34 0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.985 177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.74 154.98 51.44 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.36 2.707 . . . . 0.0 113.119 -176.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.1 t -138.28 153.5 26.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.983 0.913 . . . . 0.0 109.068 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.0 tp -138.09 153.7 49.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.603 0.761 . . . . 0.0 109.755 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -73.68 157.48 36.47 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.534 0.334 . . . . 0.0 110.512 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -74.56 -50.46 4.54 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-O 118.508 -0.758 . . . . 0.0 111.628 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.13 147.55 29.98 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.254 1.969 . . . . 0.0 110.197 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.502 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 4.0 m-30 -111.4 150.82 29.25 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.106 0.562 . . . . 0.0 110.545 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.7 p -143.26 167.19 22.72 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.093 0.957 . . . . 0.0 108.848 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 83.6 mmm -61.04 -39.48 89.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.036 -0.415 . . . . 0.0 110.791 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -84.37 -25.46 29.12 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.297 0.239 . . . . 0.0 111.301 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.71 -25.24 70.29 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 -177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.6 t -85.54 -28.1 6.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 117.37 0.585 . . . . 0.0 110.356 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.03 -30.79 70.97 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -85.05 -20.69 30.03 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.797 0.439 . . . . 0.0 110.958 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.48 63.01 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.152 0.433 . . . . 0.0 110.379 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.5 mt -77.12 -26.92 53.76 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -20.61 59.39 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.765 0.257 . . . . 0.0 110.708 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.58 -20.58 26.21 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.509 0.324 . . . . 0.0 111.604 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.25 -36.25 14.01 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.9 mp -97.05 9.17 42.83 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -173.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.037 -1.458 . . . . 0.0 109.831 178.071 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.209 0.052 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 m -129.66 16.33 5.88 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.111 0.564 . . . . 0.0 111.614 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.93 164.52 26.11 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.287 0.565 . . . . 0.0 110.855 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.93 76.64 1.55 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.489 0.661 . . . . 0.0 109.798 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.19 -8.45 57.57 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.244 0.618 . . . . 0.0 111.984 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HB3' HG11 ' A' ' 32' ' ' VAL . 66.0 mt-30 -119.37 114.65 22.67 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.698 0.681 . . . . 0.0 112.224 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.1 mm -120.24 130.25 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.523 -174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER -87.91 142.86 27.47 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 174.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.617 ' H ' HD23 ' A' ' 8' ' ' LEU . 87.0 mt -110.52 120.89 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.908 0.883 . . . . 0.0 109.05 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.27 120.68 43.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 122.741 0.417 . . . . 0.0 110.875 -177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -156.91 158.3 36.42 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-O 120.679 0.276 . . . . 0.0 110.949 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -73.84 -7.91 54.01 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.75 0.82 . . . . 0.0 112.132 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.93 132.0 24.09 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 123.049 0.54 . . . . 0.0 109.901 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.47 -18.79 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.35 2.7 . . . . 0.0 111.405 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.6 mt -70.96 -34.73 71.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 118.082 0.401 . . . . 0.0 110.735 -177.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.1 mm -86.3 -23.74 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.11 78.89 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 122.037 -0.414 . . . . 0.0 109.896 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.4 mtt -77.71 -27.29 50.6 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.0 ttt -69.07 -29.4 67.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD21 ' CZ ' ' A' ' 104' ' ' PHE . 1.1 mm? -72.46 -33.02 66.72 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 176.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -69.14 -24.81 64.14 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.081 176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.31 -43.45 60.87 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.9 0.318 . . . . 0.0 111.338 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -73.54 -22.29 60.13 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.845 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.2 mp -79.18 -18.04 53.78 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.559 0.618 . . . . 0.0 110.838 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -85.31 -22.1 28.67 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.319 0.509 . . . . 0.0 110.449 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.6 t -83.45 -19.65 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 122.891 0.476 . . . . 0.0 110.317 176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.4 mt -105.37 16.28 25.85 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.338 0.655 . . . . 0.0 111.838 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.7 t70 52.0 35.0 14.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.734 0.813 . . . . 0.0 112.499 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.07 165.73 16.4 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.673 0.789 . . . . 0.0 110.214 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 m -115.19 77.83 5.53 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 122.75 0.42 . . . . 0.0 110.284 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -63.95 157.18 54.16 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.047 2.498 . . . . 0.0 110.203 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 6' ' ' GLN . 32.8 m -121.59 -14.6 7.17 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -174.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.46 176.47 36.26 Favored Glycine 0 C--N 1.335 0.526 0 CA-C-N 118.666 0.666 . . . . 0.0 112.728 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -134.26 140.26 46.32 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.34 1.056 . . . . 0.0 108.885 175.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.51 154.67 20.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.008 0.432 . . . . 0.0 110.128 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -102.89 -1.49 29.46 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.03 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 60.9 p -141.42 159.71 41.65 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.794 0.438 . . . . 0.0 110.49 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 m -75.82 -22.81 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.682 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.63 -26.16 54.6 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.22 -27.63 61.58 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.18 -40.18 78.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -71.16 -26.71 63.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -71.52 -24.73 62.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.305 0.242 . . . . 0.0 111.316 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -86.57 -23.85 25.66 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.757 0.253 . . . . 0.0 111.293 176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.3 t -78.6 -29.66 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 117.923 0.329 . . . . 0.0 111.064 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.54 -14.36 55.03 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.983 -0.448 . . . . 0.0 112.009 178.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -107.03 -12.76 15.35 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.123 0.569 . . . . 0.0 112.286 -174.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.92 164.28 37.71 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.69 140.36 24.99 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 38.5 mt -144.75 143.98 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -96.7 -32.31 12.24 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.449 -175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.41 176.55 11.01 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 122.578 0.351 . . . . 0.0 110.318 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.0 157.83 43.73 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.668 0.27 . . . . 0.0 111.256 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 68.0 mt -113.46 123.56 69.23 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.9 130.8 56.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.455 0.702 . . . . 0.0 110.226 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -84.87 147.71 26.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 170.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.29 -11.88 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 O-C-N 122.034 -0.416 . . . . 0.0 111.968 -176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -104.92 141.49 36.44 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 121.952 -0.468 . . . . 0.0 110.159 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.2 tp -156.78 133.87 10.42 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.753 0.821 . . . . 0.0 109.209 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -78.67 137.32 37.75 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.82 1.7 40.74 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 120.0 -0.333 . . . . 0.0 112.688 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.58 164.08 44.92 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 117.747 0.774 . . . . 0.0 111.668 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -126.84 147.7 50.02 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.359 0.663 . . . . 0.0 110.108 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm 49.48 43.04 23.52 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.508 0.723 . . . . 0.0 111.352 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 89.3 p 49.7 -97.32 0.04 OUTLIER 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.352 1.461 . . . . 0.0 112.787 -177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -133.53 78.57 62.1 Favored Pre-proline 0 C--O 1.234 0.238 0 C-N-CA 123.178 0.591 . . . . 0.0 109.988 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -80.82 -11.96 12.35 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.561 2.841 . . . . 0.0 111.741 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.8 t -78.38 -17.64 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 O-C-N 122.158 -0.339 . . . . 0.0 111.036 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.92 74.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.847 -0.533 . . . . 0.0 110.156 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -74.28 -18.26 60.74 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.176 -0.327 . . . . 0.0 111.082 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.46 -29.29 37.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 99.2 mt -72.85 -37.46 67.39 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.16 -22.37 62.06 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.05 -12.61 54.87 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.414 0.286 . . . . 0.0 110.721 174.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 56.0 ttt-85 -103.91 17.88 23.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.984 0.914 . . . . 0.0 110.779 176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.8 t0 59.06 34.13 23.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.125 0.97 . . . . 0.0 113.264 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.4 mt -120.77 102.2 44.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.849 0.86 . . . . 0.0 108.689 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.57 158.9 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.919 3.079 . . . . 0.0 112.745 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -144.21 167.13 23.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.016 0.436 . . . . 0.0 111.409 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.4 t -134.74 144.19 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.838 0.855 . . . . 0.0 109.399 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -90.81 151.49 21.15 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 121.032 0.444 . . . . 0.0 111.124 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.43 143.13 33.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.599 0.76 . . . . 0.0 109.234 175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.1 t -159.77 158.39 31.09 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 111.007 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.67 95.93 0.96 Allowed Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 172.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.51 -162.15 33.67 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -177.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.3 p -81.48 164.52 21.94 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.407 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.2 -4.17 49.23 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.585 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.83 -1.3 53.04 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.295 0.638 . . . . 0.0 111.05 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.7 m -85.12 7.88 20.1 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.114 0.566 . . . . 0.0 111.903 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 14.0 m -137.83 154.7 29.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 C-N-CA 123.786 0.834 . . . . 0.0 110.981 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.29 169.15 17.71 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.791 0.836 . . . . 0.0 111.917 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.3 m -61.53 -16.73 50.3 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 73.8 mtp180 -75.91 -24.27 55.58 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.7 0.682 . . . . 0.0 110.373 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.427 ' CG ' ' HB ' ' A' ' 90' ' ' VAL . 11.8 m-85 -84.24 -20.57 32.04 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -86.89 -13.01 46.07 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.086 0.554 . . . . 0.0 110.818 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.73 -27.3 18.14 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.743 0.417 . . . . 0.0 110.354 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -91.46 160.98 35.69 Favored Pre-proline 0 CA--C 1.527 0.093 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -61.96 154.44 61.74 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.873 2.382 . . . . 0.0 111.355 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.9 m -138.9 154.41 26.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.152 0.581 . . . . 0.0 110.594 -178.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.9 tp -147.28 146.71 29.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.876 0.471 . . . . 0.0 110.038 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 -79.86 163.74 24.13 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.277 0.231 . . . . 0.0 110.585 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -76.7 -39.12 2.27 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.11 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -60.94 133.58 48.37 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.9 m-85 -119.84 146.13 46.01 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.107 0.563 . . . . 0.0 110.477 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.547 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.8 t -153.34 159.04 42.39 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.787 0.835 . . . . 0.0 109.189 177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -63.46 -28.9 70.28 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.62 -39.94 18.07 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.574 0.625 . . . . 0.0 111.905 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.547 ' H ' HG23 ' A' ' 105' ' ' THR . . . -80.19 -25.7 56.82 Favored Glycine 0 CA--C 1.523 0.572 0 O-C-N 122.121 -0.362 . . . . 0.0 112.375 -175.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.9 t -86.53 -28.61 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.685 0.743 . . . . 0.0 110.338 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -29.05 64.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.976 -0.452 . . . . 0.0 110.155 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -83.95 -25.33 30.16 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 122.741 0.416 . . . . 0.0 110.668 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.32 -32.45 37.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.65 0.204 . . . . 0.0 110.724 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -34.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.43 -25.44 63.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.059 -0.4 . . . . 0.0 110.567 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.29 -14.92 39.56 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.437 0.295 . . . . 0.0 111.345 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.99 -29.52 17.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.271 0.628 . . . . 0.0 110.865 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 16.3 tp -85.97 10.55 13.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.239 0.616 . . . . 0.0 112.035 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.154 -1.403 . . . . 0.0 110.585 -179.024 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m -141.37 156.59 45.8 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.301 0.64 . . . . 0.0 110.254 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.27 -20.4 0.7 Allowed 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 117' ' ' LEU . 88.4 mt 50.63 25.1 1.89 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -8.76 52.13 Favored 'General case' 0 C--O 1.227 -0.114 0 CA-C-N 118.392 0.542 . . . . 0.0 111.191 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.503 ' HB3' HG11 ' A' ' 32' ' ' VAL . 25.8 mp0 -118.99 118.88 32.69 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.14 0.427 . . . . 0.0 111.642 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.4 mm -119.04 131.22 72.44 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 O-C-N 123.737 0.648 . . . . 0.0 109.881 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -97.69 130.19 44.7 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 8' ' ' LEU . 86.3 mt -98.67 135.23 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 t -132.12 125.6 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -149.39 162.85 39.27 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 121.231 0.539 . . . . 0.0 112.423 -176.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -123.46 11.86 9.31 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 109.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -145.03 113.78 4.92 Favored Pre-proline 0 N--CA 1.453 -0.311 0 C-N-CA 124.82 1.248 . . . . 0.0 107.944 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -54.86 -16.33 11.45 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 124.06 3.173 . . . . 0.0 114.655 -175.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.47 -23.06 60.03 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.816 -0.553 . . . . 0.0 110.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.0 mm -79.4 -27.97 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.61 -25.48 61.32 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.276 -0.265 . . . . 0.0 110.449 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 28.0 ttt -82.11 -35.17 28.82 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.448 -0.157 . . . . 0.0 110.779 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 98.1 mmm -75.43 -34.39 60.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 119.579 -0.248 . . . . 0.0 110.99 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.35 -28.18 42.01 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.131 -179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.52 -21.63 55.49 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.798 -0.564 . . . . 0.0 110.088 176.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.64 -41.32 46.28 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.194 -0.316 . . . . 0.0 111.447 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -82.08 -21.43 36.81 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.361 0.528 . . . . 0.0 112.368 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -78.21 -18.09 55.9 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.075 0.852 . . . . 0.0 110.137 174.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -85.28 -29.38 24.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.811 0.278 . . . . 0.0 110.774 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -83.28 -19.76 9.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 122.715 0.406 . . . . 0.0 110.774 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.09 14.53 28.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.793 0.437 . . . . 0.0 111.54 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 51.05 34.72 11.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.652 0.781 . . . . 0.0 111.461 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' HD3' ' H ' ' A' ' 30' ' ' THR . 0.8 OUTLIER -85.55 162.7 18.78 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.849 0.86 . . . . 0.0 110.374 -176.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.4 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 56.8 m -114.42 88.02 14.91 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 122.951 0.5 . . . . 0.0 110.382 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.76 157.94 58.68 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.83 2.354 . . . . 0.0 109.55 176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 6' ' ' GLN . 33.0 m -123.46 -16.9 4.81 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.38 174.21 33.9 Favored Glycine 0 CA--C 1.522 0.523 0 CA-C-N 118.329 0.513 . . . . 0.0 112.588 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.6 m -137.2 139.65 41.22 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.0 m -138.45 161.04 31.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 122.961 0.504 . . . . 0.0 110.618 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -131.67 7.43 4.45 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.976 0.51 . . . . 0.0 112.188 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.9 p -136.39 156.69 48.27 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 122.968 0.507 . . . . 0.0 109.89 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.07 -29.9 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.07 -30.8 65.49 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.157 -0.34 . . . . 0.0 110.363 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.33 -24.85 56.14 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.83 -34.99 60.13 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.614 0.707 . . . . 0.0 110.966 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -83.37 -24.24 32.1 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 117.929 0.331 . . . . 0.0 110.393 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.75 57.29 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.207 0.458 . . . . 0.0 110.728 176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -84.37 -31.11 24.92 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.463 0.705 . . . . 0.0 110.136 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 63.8 t -83.64 -25.27 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.66 0.384 . . . . 0.0 111.686 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -71.27 -19.08 62.39 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 121.651 -0.655 . . . . 0.0 111.153 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.91 -12.59 58.35 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.726 0.298 . . . . 0.0 110.999 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.99 -169.07 53.98 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.527 -0.629 . . . . 0.0 111.527 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.65 13.92 81.83 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.634 -0.536 . . . . 0.0 112.577 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.5 mt -122.85 147.04 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 117.785 0.793 . . . . 0.0 109.536 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.6 -17.0 5.63 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -174.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.38 166.64 28.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.232 0.469 . . . . 0.0 110.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.04 165.53 33.49 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 122.28 -0.263 . . . . 0.0 111.075 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 72.7 mt -127.24 133.25 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -114.36 130.61 56.69 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.762 0.425 . . . . 0.0 111.086 -174.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -84.39 138.56 32.78 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 172.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.3 t -87.93 -12.24 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 122.443 0.297 . . . . 0.0 110.485 -178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -70.58 134.47 47.66 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 tp -155.05 152.24 29.35 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.824 0.45 . . . . 0.0 110.107 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -75.31 152.9 38.13 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.055 0.542 . . . . 0.0 111.212 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.83 -172.85 48.54 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 111.97 -0.452 . . . . 0.0 111.97 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 0.62 73.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 123.377 0.513 . . . . 0.0 113.034 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.5 mp0 -68.51 151.39 46.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.915 0.857 . . . . 0.0 110.835 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -144.61 20.97 1.67 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.192 0.597 . . . . 0.0 110.641 -178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.7 p -135.29 163.01 30.96 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.105 0.562 . . . . 0.0 111.088 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 m -136.21 66.28 59.46 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 123.359 0.664 . . . . 0.0 109.416 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -70.54 -11.83 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.741 2.961 . . . . 0.0 111.812 -176.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 35.6 m -72.44 -13.65 16.66 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 C-N-CA 122.344 0.258 . . . . 0.0 110.906 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.23 -24.47 63.1 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 122.221 -0.299 . . . . 0.0 110.388 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.55 -17.39 45.13 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.342 -0.224 . . . . 0.0 110.466 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.92 61.94 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.6 mt -74.16 -27.02 60.64 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.37 -24.76 57.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.15 -16.39 56.72 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -91.7 13.67 17.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.839 0.856 . . . . 0.0 110.026 172.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 60.71 30.5 19.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.551 1.141 . . . . 0.0 113.646 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 65.9 mt -115.21 124.96 29.43 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.39 161.04 38.23 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 124.09 3.193 . . . . 0.0 111.062 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -152.12 171.25 18.18 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.218 0.533 . . . . 0.0 111.752 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.66 144.7 20.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 124.058 0.943 . . . . 0.0 109.017 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -85.03 154.46 22.07 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.408 0.283 . . . . 0.0 110.824 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.52 119.81 22.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 173.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -153.41 173.11 16.08 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.788 0.328 . . . . 0.0 111.421 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.59 135.33 3.66 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.8 -156.12 26.52 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 96.1 p -79.26 175.37 10.66 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 122.954 0.502 . . . . 0.0 110.621 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.02 -6.6 34.63 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.73 0.412 . . . . 0.0 112.02 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -92.59 -7.64 46.5 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.021 0.528 . . . . 0.0 111.173 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.4 m -78.92 0.75 26.15 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 122.008 -0.432 . . . . 0.0 111.547 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 m -140.06 153.16 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 123.252 0.621 . . . . 0.0 110.673 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -109.9 177.76 4.62 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.179 0.992 . . . . 0.0 110.485 -177.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.9 m -61.63 -18.46 59.54 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.781 -0.575 . . . . 0.0 111.965 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -76.48 -20.74 56.66 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.862 0.755 . . . . 0.0 111.2 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -84.2 -19.29 34.26 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -88.15 -4.85 58.69 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.421 0.688 . . . . 0.0 110.264 172.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -110.84 -11.19 14.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.695 1.198 . . . . 0.0 111.572 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -125.75 163.12 41.04 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 123.92 0.888 . . . . 0.0 110.115 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -59.61 147.33 92.3 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.625 2.884 . . . . 0.0 112.53 176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 96.4 t -140.19 151.36 21.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.603 0.761 . . . . 0.0 110.472 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -146.13 155.2 42.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.012 0.925 . . . . 0.0 108.662 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -85.7 162.03 18.95 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.332 -0.23 . . . . 0.0 110.884 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -71.68 -41.45 9.55 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 118.235 -0.888 . . . . 0.0 112.974 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.76 124.52 13.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.409 2.073 . . . . 0.0 110.875 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -107.33 143.15 36.02 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.983 0.421 . . . . 0.0 110.274 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 108' ' ' GLY . 9.3 t -155.7 163.67 39.58 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.99 -23.64 65.53 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -173.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.44 -38.74 21.48 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.379 0.536 . . . . 0.0 110.937 177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.496 ' H ' HG23 ' A' ' 105' ' ' THR . . . -74.64 -26.75 66.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 85.6 t -81.44 -21.71 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 122.734 0.414 . . . . 0.0 109.913 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -74.18 -30.68 62.35 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.318 0.508 . . . . 0.0 110.703 178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -80.24 -27.49 38.67 Favored 'General case' 0 C--N 1.338 0.102 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.32 -26.52 55.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 50.4 tp -72.7 -32.75 66.01 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.944 0.498 . . . . 0.0 109.812 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.41 -17.97 40.34 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.641 0.376 . . . . 0.0 111.942 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.6 -46.06 9.88 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.9 tt -99.11 -58.35 1.96 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.891 0.314 . . . . 0.0 111.791 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 4' ' ' LEU . 3.2 mm? -65.86 -4.21 6.41 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.972 0.909 . . . . 0.0 112.768 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 63.4 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.244 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ptm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 120.422 0.153 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 t -148.73 154.07 39.08 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.93 0.492 . . . . 0.0 110.127 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -154.45 165.51 36.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.088 0.555 . . . . 0.0 110.274 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.1 63.48 1.41 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.605 0.717 . . . . 0.0 110.41 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -2.13 21.11 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.683 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 61.5 mt-30 -124.03 111.18 15.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.118 0.417 . . . . 0.0 110.786 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.4 mm -119.4 128.11 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.085 -171.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 9' ' ' ILE . 1.0 OUTLIER -88.99 135.07 33.75 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 174.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' N ' HD23 ' A' ' 8' ' ' LEU . 67.5 mt -102.88 134.58 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 123.02 0.528 . . . . 0.0 109.82 -178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.07 106.29 10.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -149.85 163.32 38.33 Favored 'General case' 0 N--CA 1.461 0.081 0 C-N-CA 123.872 0.869 . . . . 0.0 110.531 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -112.76 -13.73 13.19 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.712 0.405 . . . . 0.0 110.912 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -84.69 127.28 65.98 Favored Pre-proline 0 CA--C 1.532 0.257 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.71 -14.01 14.29 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.36 2.706 . . . . 0.0 112.757 -175.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -93.73 -38.47 11.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.602 0.637 . . . . 0.0 111.881 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 16' ' ' ILE . 1.8 mp -76.25 -28.39 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.36 -23.82 63.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 121.852 0.061 . . . . 0.0 110.993 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 68.4 mtt -84.98 -27.86 26.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.395 -0.191 . . . . 0.0 110.672 177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.7 mmm -77.94 -28.42 49.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 117.728 0.24 . . . . 0.0 110.494 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 104' ' ' PHE . 21.9 tp -78.95 -30.96 44.88 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.222 -0.299 . . . . 0.0 110.326 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.65 -26.67 61.73 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.697 -0.627 . . . . 0.0 109.547 174.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.73 -35.19 52.2 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.361 -0.212 . . . . 0.0 110.485 177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -73.35 -27.06 61.29 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.871 -0.518 . . . . 0.0 111.7 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -79.17 -17.8 54.27 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.613 0.642 . . . . 0.0 110.836 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.14 -29.46 24.77 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.854 0.297 . . . . 0.0 110.965 176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.2 t -85.15 -21.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 C-N-CA 122.584 0.353 . . . . 0.0 111.389 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 16.98 17.8 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.882 0.473 . . . . 0.0 111.648 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t0 52.02 34.46 13.96 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.393 0.677 . . . . 0.0 111.975 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.79 165.45 16.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.698 0.799 . . . . 0.0 109.705 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 77.95 6.52 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 122.716 0.406 . . . . 0.0 110.199 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.11 160.55 41.27 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.54 2.827 . . . . 0.0 110.478 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 31.7 m -127.37 -25.1 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.095 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -175.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.1 176.79 36.29 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 118.527 0.603 . . . . 0.0 112.612 177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 58.8 m -137.61 141.91 41.26 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.96 0.904 . . . . 0.0 108.708 176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.94 159.0 37.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 122.642 0.377 . . . . 0.0 110.152 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -99.61 -5.98 28.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 122.853 0.461 . . . . 0.0 111.994 -176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.7 p -143.06 161.08 39.11 Favored 'General case' 0 CA--C 1.522 -0.122 0 C-N-CA 123.085 0.554 . . . . 0.0 110.475 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.17 -22.72 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.067 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.787 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.46 -29.67 66.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.51 -27.56 65.23 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.4 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.323 0.562 . . . . 0.0 110.059 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.2 mt -77.44 -23.25 50.55 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 177.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.62 -25.37 45.1 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 117.728 0.24 . . . . 0.0 111.386 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.407 ' NE ' ' HA ' ' A' ' 44' ' ' ARG . 5.1 mmp_? -87.35 -21.92 25.4 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 122.131 -0.356 . . . . 0.0 111.696 175.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.4 t -82.53 -22.0 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -74.26 -16.19 60.96 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -98.08 -12.42 21.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.403 0.681 . . . . 0.0 110.831 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.04 -167.68 54.03 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.17 24.33 61.63 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.631 -0.538 . . . . 0.0 112.609 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mt -137.22 147.66 26.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.386 0.674 . . . . 0.0 109.306 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -116.28 -26.98 6.98 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.55 175.63 12.49 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.045 0.384 . . . . 0.0 110.582 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.12 163.93 34.71 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 120.719 0.295 . . . . 0.0 111.388 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 76.1 mt -122.48 130.44 74.52 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -112.81 133.6 54.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.967 0.507 . . . . 0.0 109.761 -175.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -106.08 155.79 19.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.56 -11.87 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -107.97 141.84 39.0 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.045 0.538 . . . . 0.0 110.656 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 83.5 mt -143.53 172.6 12.56 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.475 1.11 . . . . 0.0 108.929 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -82.27 134.43 35.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 3.62 72.14 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 119.199 -0.779 . . . . 0.0 113.777 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -177.23 157.88 23.03 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 118.786 1.293 . . . . 0.0 112.267 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -128.52 164.48 22.7 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.426 0.691 . . . . 0.0 111.26 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.5 tttp 55.85 28.46 12.48 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.576 1.15 . . . . 0.0 113.072 176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -82.57 24.44 0.71 Allowed 'General case' 0 CA--C 1.529 0.142 0 O-C-N 121.952 -0.468 . . . . 0.0 111.388 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.446 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 7.9 m -56.82 -34.15 23.93 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 66' ' ' THR . 77.7 Cg_exo -56.84 -12.79 9.88 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.908 2.406 . . . . 0.0 114.111 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.45 -13.89 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.47 -24.65 67.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.815 -0.553 . . . . 0.0 109.76 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.26 -17.99 60.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.457 0.303 . . . . 0.0 110.724 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.16 -27.23 39.01 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.2 mt -74.03 -27.7 61.07 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -25.57 58.18 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.91 -16.46 56.98 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.1 tpm_? -92.67 6.6 46.81 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.754 0.821 . . . . 0.0 110.136 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t70 60.31 35.35 20.74 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.262 1.025 . . . . 0.0 113.199 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.8 mt -120.79 129.73 25.18 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -75.64 157.51 40.05 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.602 2.868 . . . . 0.0 111.302 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -145.01 164.79 30.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.609 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.0 t -136.12 147.56 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 C-N-CA 124.604 1.162 . . . . 0.0 108.837 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.483 ' CD2' ' CD1' ' A' ' 94' ' ' PHE . 28.9 m-85 -91.98 155.35 18.19 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.895 0.378 . . . . 0.0 111.682 -178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.87 128.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -165.28 158.85 16.73 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 120.657 0.265 . . . . 0.0 111.009 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.61 136.99 13.16 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 172.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.04 -151.91 23.81 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 82.8 p -119.36 176.05 5.53 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.443 0.697 . . . . 0.0 110.55 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.56 -1.92 12.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.833 0.453 . . . . 0.0 111.739 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -114.66 1.28 14.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.359 0.663 . . . . 0.0 111.187 178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -87.16 7.64 27.28 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.348 0.659 . . . . 0.0 111.609 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 11.1 m -139.63 155.86 25.65 Favored 'Isoleucine or valine' 0 C--O 1.23 0.075 0 C-N-CA 123.748 0.819 . . . . 0.0 111.628 -175.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -66.57 162.63 20.49 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.949 0.9 . . . . 0.0 111.36 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 45.8 m -59.1 -19.56 45.56 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -74.12 -25.43 59.76 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.987 0.812 . . . . 0.0 110.743 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD1' ' CD2' ' A' ' 81' ' ' PHE . 7.1 m-85 -79.98 -19.31 48.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -88.16 -10.22 50.63 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.827 0.451 . . . . 0.0 110.669 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -106.91 -11.58 15.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.647 0.779 . . . . 0.0 111.618 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -121.34 160.92 43.75 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.399 0.679 . . . . 0.0 110.118 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -59.33 148.89 84.37 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.996 2.464 . . . . 0.0 112.242 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.3 m -142.61 154.86 17.97 Favored 'Isoleucine or valine' 0 C--O 1.23 0.046 0 C-N-CA 124.139 0.976 . . . . 0.0 109.909 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 48.3 tp -138.55 145.16 40.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.821 0.449 . . . . 0.0 109.832 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -76.68 165.27 24.98 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.774 0.43 . . . . 0.0 110.38 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -79.19 -39.15 1.39 Allowed Pre-proline 0 CA--C 1.531 0.218 0 CA-C-O 118.252 -0.88 . . . . 0.0 112.763 -177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.96 143.81 95.73 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.589 2.192 . . . . 0.0 110.567 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 20' ' ' LEU . 1.7 m-85 -118.96 133.39 55.86 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.922 0.392 . . . . 0.0 111.348 -177.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.0 p -143.33 155.53 44.47 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.783 1.233 . . . . 0.0 108.923 178.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 67.7 mtt -68.96 -28.6 66.78 Favored 'General case' 0 C--N 1.333 -0.144 0 O-C-N 122.199 -0.313 . . . . 0.0 111.61 -176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -84.5 -35.24 23.05 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.051 -0.406 . . . . 0.0 111.634 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.0 -38.93 29.09 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.307 -174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.1 t -84.89 -22.93 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 CA-C-N 117.857 0.829 . . . . 0.0 111.162 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.11 -29.2 64.97 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.503 -0.748 . . . . 0.0 110.306 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -78.8 -31.96 46.14 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.34 -26.68 46.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.183 0.193 . . . . 0.0 111.038 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -73.55 -38.7 65.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.25 -23.47 62.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 122.416 -0.177 . . . . 0.0 110.678 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.08 -13.84 43.12 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.84 0.456 . . . . 0.0 111.468 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.7 tt -90.89 -29.27 17.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.145 0.578 . . . . 0.0 110.699 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 19.4 tp -82.91 6.65 17.8 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 122.956 0.503 . . . . 0.0 111.887 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 C--O 1.253 1.238 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.802 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.1 p -147.53 169.77 18.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.269 0.627 . . . . 0.0 110.222 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 5' ' ' THR . . . -147.61 179.13 7.91 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.985 0.514 . . . . 0.0 110.526 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.35 25.23 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.529 0.731 . . . . 0.0 112.677 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 ' H ' ' C ' ' A' ' 3' ' ' ALA . 0.8 OUTLIER -92.03 -11.18 36.65 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.691 -0.631 . . . . 0.0 110.424 176.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.41 ' HB3' HG11 ' A' ' 32' ' ' VAL . 24.6 mp0 -111.49 104.6 13.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.779 0.432 . . . . 0.0 110.977 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.8 mm -119.03 124.11 72.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.981 0.512 . . . . 0.0 110.434 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -86.79 146.99 26.02 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.434 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.618 ' H ' HD23 ' A' ' 8' ' ' LEU . 95.0 mt -110.53 128.1 67.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 123.922 0.889 . . . . 0.0 109.675 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.3 122.73 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.071 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -141.97 163.29 33.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.289 0.235 . . . . 0.0 111.262 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -93.32 -11.32 32.69 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -143.53 135.57 13.14 Favored Pre-proline 0 N--CA 1.454 -0.253 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -68.41 -17.32 44.07 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.089 2.526 . . . . 0.0 112.344 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.4 mt -77.87 -37.42 48.26 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.456 0.571 . . . . 0.0 110.01 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.7 mm -77.55 -27.21 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -28.54 68.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.198 -0.314 . . . . 0.0 110.281 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.6 mtt -76.73 -27.3 55.38 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -73.22 -33.4 65.32 Favored 'General case' 0 C--O 1.23 0.046 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -68.65 -31.65 70.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 122.23 -0.294 . . . . 0.0 110.409 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.93 -21.82 43.42 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 177.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -76.37 -42.96 42.89 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.094 -0.378 . . . . 0.0 110.15 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -73.94 -19.36 60.7 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.641 176.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 tp -69.63 -29.29 66.75 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.164 0.438 . . . . 0.0 110.116 176.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -84.72 -29.58 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.491 0.316 . . . . 0.0 111.385 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -71.55 -24.24 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -94.8 6.57 48.58 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.173 0.589 . . . . 0.0 111.032 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.9 t0 50.73 37.75 17.55 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.584 0.754 . . . . 0.0 111.49 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 30' ' ' THR . 1.6 tmtm? -85.69 158.84 19.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.855 0.862 . . . . 0.0 110.422 -176.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.444 ' H ' ' HD3' ' A' ' 29' ' ' LYS . 88.7 m -92.08 124.39 60.07 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.42 153.86 35.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.63 2.886 . . . . 0.0 110.872 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG11 ' HB3' ' A' ' 6' ' ' GLN . 24.8 m -141.77 -21.86 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.409 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.66 163.05 16.92 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 87.2 m -143.96 134.86 25.3 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.57 161.2 24.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-O 120.898 0.38 . . . . 0.0 111.117 -175.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -136.08 3.74 2.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.119 0.568 . . . . 0.0 111.546 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.4 p -139.3 161.72 36.75 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.357 0.663 . . . . 0.0 110.78 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.1 t -70.41 -32.99 52.06 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 C-N-CA 122.437 0.295 . . . . 0.0 110.239 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.4 -29.51 53.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.347 -0.22 . . . . 0.0 110.831 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.89 -33.0 52.04 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.7 -33.83 74.61 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.409 0.604 . . . . 0.0 110.511 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 56.2 tp -75.21 -29.02 60.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.08 -28.26 60.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -87.47 -26.96 22.97 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 118.328 0.513 . . . . 0.0 112.15 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 69.3 t -83.28 -21.69 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 118.04 0.382 . . . . 0.0 111.522 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -81.56 -23.05 37.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -121.41 -13.63 8.4 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.733 0.697 . . . . 0.0 112.316 177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.39 -164.94 40.73 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.51 137.18 5.75 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 176.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 pt -147.49 164.5 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 123.74 0.816 . . . . 0.0 110.802 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -124.13 -10.72 7.58 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.014 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.87 165.85 20.1 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.503 0.721 . . . . 0.0 109.056 175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -151.09 158.0 43.48 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.729 -0.607 . . . . 0.0 111.903 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.7 mm -97.46 121.14 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -118.07 124.87 49.13 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -68.97 118.32 11.73 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 168.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.56 -29.27 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -171.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -158.53 154.81 27.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.197 0.453 . . . . 0.0 110.983 -177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.556 HD13 ' H ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -151.25 170.35 19.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.203 1.001 . . . . 0.0 108.605 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.556 ' H ' HD13 ' A' ' 59' ' ' LEU . 79.9 ttt180 -58.37 135.51 57.22 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 121.861 -0.525 . . . . 0.0 110.158 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.01 -1.98 45.05 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.472 -0.627 . . . . 0.0 112.863 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.22 147.29 28.57 Favored Glycine 0 C--N 1.339 0.722 0 CA-C-N 118.256 1.028 . . . . 0.0 111.304 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -128.48 154.63 45.9 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 122.962 0.505 . . . . 0.0 111.17 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 53.15 17.26 0.93 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.966 1.307 . . . . 0.0 114.461 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 41.7 m 56.83 -179.26 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.226 1.01 . . . . 0.0 112.878 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.6 t -71.09 139.64 85.21 Favored Pre-proline 0 CA--C 1.532 0.255 0 O-C-N 121.9 -0.5 . . . . 0.0 111.188 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -83.23 -10.33 10.13 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.625 2.884 . . . . 0.0 111.301 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.6 t -74.24 -29.85 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 CA-C-N 117.799 0.272 . . . . 0.0 111.343 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.53 78.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.125 0.42 . . . . 0.0 110.45 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.03 -17.59 39.9 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.266 -0.272 . . . . 0.0 111.088 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.74 -32.84 65.97 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.8 mt -75.56 -26.49 58.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 175.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.49 -24.29 61.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 117.948 0.34 . . . . 0.0 110.113 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -83.4 -16.71 44.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.317 0.247 . . . . 0.0 110.471 175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -101.58 8.66 41.75 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.39 0.676 . . . . 0.0 110.962 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.3 t0 56.97 37.12 28.61 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.652 1.181 . . . . 0.0 113.37 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 50.1 mm -110.66 120.98 42.39 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 123.022 0.529 . . . . 0.0 109.767 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.95 154.24 39.83 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.227 3.285 . . . . 0.0 113.663 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -149.54 168.4 23.61 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -135.05 154.47 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -96.95 152.59 18.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.959 0.409 . . . . 0.0 111.927 -177.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.18 119.61 10.3 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.1 t -172.17 164.48 6.01 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.023 0.929 . . . . 0.0 109.447 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.26 142.61 21.4 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 173.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.42 -160.46 32.7 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 117.424 0.612 . . . . 0.0 112.057 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.1 t -143.67 167.69 21.66 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.303 0.641 . . . . 0.0 110.518 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.87 -3.77 17.31 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 112.602 -175.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -114.37 10.61 17.1 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.281 0.632 . . . . 0.0 111.874 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 96.1 p -118.76 9.24 12.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 123.039 0.536 . . . . 0.0 112.017 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.14 154.69 25.79 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.631 0.773 . . . . 0.0 111.621 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.34 163.8 25.83 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.288 0.635 . . . . 0.0 111.316 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.8 m -59.95 -17.35 37.25 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -71.58 -26.68 62.71 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 118.852 0.751 . . . . 0.0 110.462 176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -83.54 -22.86 32.28 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -88.09 -10.75 49.14 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.817 0.447 . . . . 0.0 111.319 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.96 -32.23 11.77 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.847 0.459 . . . . 0.0 110.995 176.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -88.3 152.64 50.37 Favored Pre-proline 0 C--N 1.338 0.108 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -58.67 152.43 56.18 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.226 2.617 . . . . 0.0 111.413 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.58 153.19 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 122.842 0.457 . . . . 0.0 110.892 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 40.0 tp -149.06 153.73 38.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -84.85 167.07 16.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.656 0.383 . . . . 0.0 110.677 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 69.5 mmtt -63.6 -46.51 83.27 Favored Pre-proline 0 CA--C 1.53 0.204 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 72.3 Cg_endo -71.71 137.05 29.24 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.673 1.582 . . . . 0.0 109.777 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -110.44 148.67 31.58 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.949 0.499 . . . . 0.0 110.331 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 80.8 p -144.01 161.4 38.87 Favored 'General case' 0 CA--C 1.523 -0.078 0 C-N-CA 124.125 0.97 . . . . 0.0 109.21 178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -64.66 -27.14 68.72 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.088 -0.383 . . . . 0.0 111.083 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.78 -36.51 21.65 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.64 -30.42 44.35 Favored Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.984 -0.446 . . . . 0.0 111.984 -175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.7 t -82.43 -30.56 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 117.663 0.731 . . . . 0.0 110.335 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 -26.42 62.74 Favored 'General case' 0 N--CA 1.455 -0.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.502 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -83.39 -33.75 25.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 122.401 0.28 . . . . 0.0 110.917 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.84 61.91 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.319 -0.238 . . . . 0.0 110.703 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.4 mt -81.18 -20.61 40.82 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 119.564 -0.255 . . . . 0.0 110.784 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.97 -23.43 55.32 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.37 0.532 . . . . 0.0 110.07 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.24 -20.57 26.72 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.803 0.441 . . . . 0.0 111.513 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.4 tt -91.2 -51.88 5.09 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.989 0.515 . . . . 0.0 110.305 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.5 mt -79.13 17.37 0.79 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.451 1.1 . . . . 0.0 112.147 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.311 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.9 m 53.96 21.89 3.09 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.879 0.872 . . . . 0.0 113.141 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.61 165.83 33.99 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.352 0.661 . . . . 0.0 110.269 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.56 75.52 1.49 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.505 0.669 . . . . 0.0 109.848 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -78.04 -6.77 55.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.943 0.497 . . . . 0.0 111.506 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.451 ' HB3' HG11 ' A' ' 32' ' ' VAL . 64.5 mt-30 -118.73 111.09 18.04 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -175.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.09 136.05 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.762 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -96.0 138.29 33.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.48 ' H ' HD23 ' A' ' 8' ' ' LEU . 79.8 mt -102.12 126.2 56.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.867 0.867 . . . . 0.0 109.716 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.6 t -132.37 110.04 15.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 162.67 35.91 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.043 0.449 . . . . 0.0 111.629 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -98.19 -0.16 44.73 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.912 0.885 . . . . 0.0 111.32 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -130.61 105.59 15.72 Favored Pre-proline 0 C--N 1.34 0.18 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.89 -22.47 54.35 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.753 2.969 . . . . 0.0 113.592 -178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 tp -70.32 -41.2 73.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.457 0.571 . . . . 0.0 110.427 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.418 HG13 ' HE3' ' A' ' 102' ' ' LYS . 43.6 mm -79.03 -25.95 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.73 -26.51 66.18 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.4 mmt -80.92 -25.54 37.41 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mtp -73.33 -30.64 63.49 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -68.96 -32.11 71.46 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.102 -0.374 . . . . 0.0 110.053 175.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -74.62 -23.14 58.66 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.204 -0.31 . . . . 0.0 110.208 175.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -80.66 -43.3 20.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 122.301 -0.249 . . . . 0.0 111.14 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -74.35 -27.26 60.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.425 0.557 . . . . 0.0 111.754 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.3 mt -78.83 -17.87 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.541 0.61 . . . . 0.0 110.894 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.46 -26.97 27.83 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.862 0.301 . . . . 0.0 110.769 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.54 -20.1 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 122.766 0.426 . . . . 0.0 110.793 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.9 mt -103.13 17.02 25.05 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.97 0.508 . . . . 0.0 111.687 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.88 36.13 17.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.061 0.944 . . . . 0.0 112.76 176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -85.87 164.65 17.36 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.336 0.654 . . . . 0.0 109.55 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.2 m -117.47 72.18 7.23 Favored Pre-proline 0 CA--C 1.53 0.186 0 O-C-N 122.06 -0.4 . . . . 0.0 110.873 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.92 158.28 48.1 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.845 2.364 . . . . 0.0 110.166 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.451 HG11 ' HB3' ' A' ' 6' ' ' GLN . 31.4 m -121.58 -9.62 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.076 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -173.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.89 174.03 34.16 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 118.422 0.555 . . . . 0.0 112.374 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 93.1 m -141.17 137.64 32.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.378 1.071 . . . . 0.0 108.383 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.5 m -137.93 156.88 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.024 0.44 . . . . 0.0 111.077 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -97.74 -4.26 37.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.982 0.913 . . . . 0.0 111.732 -176.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -151.4 157.5 42.5 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 122.88 0.472 . . . . 0.0 110.439 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.3 t -70.88 -22.92 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 122.792 0.437 . . . . 0.0 110.567 -177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.96 -26.09 63.95 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.949 -0.469 . . . . 0.0 110.245 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.57 -21.17 64.71 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 177.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.26 -38.51 63.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.235 0.518 . . . . 0.0 109.924 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.5 tp -72.23 -32.2 66.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.85 -24.68 64.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 122.443 -0.161 . . . . 0.0 110.919 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -82.94 -25.71 32.11 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.743 0.247 . . . . 0.0 110.949 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.5 t -71.94 -26.55 25.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -81.78 -14.34 56.53 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.674 0.39 . . . . 0.0 110.863 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -98.84 -14.61 19.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.435 0.694 . . . . 0.0 111.994 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.22 169.74 38.76 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.702 -0.559 . . . . 0.0 111.702 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.62 148.21 36.59 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.9 mt -144.37 149.29 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -101.18 -30.66 11.42 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.193 0.452 . . . . 0.0 111.35 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.69 174.95 11.06 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.749 0.42 . . . . 0.0 110.582 176.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.58 161.48 41.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.675 0.274 . . . . 0.0 111.0 177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 74.0 mt -118.78 130.86 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.02 136.0 53.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.24 0.616 . . . . 0.0 110.203 -174.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.56 144.99 29.98 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.78 -12.0 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 122.281 -0.262 . . . . 0.0 111.307 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -123.19 153.46 40.04 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.11 0.481 . . . . 0.0 111.052 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.2 tp -152.76 141.69 21.18 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.2 ptt-85 -81.93 132.6 35.27 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 117.748 0.249 . . . . 0.0 110.952 -178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 67.42 166.02 2.87 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.488 0.566 . . . . 0.0 112.132 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 60.8 -158.04 29.54 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 122.646 -0.326 . . . . 0.0 112.493 177.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -86.14 161.37 18.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.42 0.688 . . . . 0.0 110.07 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -62.25 -22.19 65.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.975 0.51 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.8 p 52.93 23.37 2.82 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.528 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 28.2 p -91.84 -24.77 0.27 Allowed Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 175.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.4 Cg_exo -57.8 -18.72 35.47 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 113.972 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 26.3 m -82.45 -9.77 11.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 118.061 0.392 . . . . 0.0 111.892 -178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.46 -26.61 68.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.983 -0.448 . . . . 0.0 110.458 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -75.18 -17.77 60.31 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.291 -0.256 . . . . 0.0 110.662 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.81 -25.62 37.7 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.4 mt -74.5 -29.93 61.61 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 173.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.94 -24.29 60.79 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.16 -13.51 57.06 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 172.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -95.52 14.76 21.7 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.448 1.099 . . . . 0.0 110.14 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.6 t70 61.17 31.41 19.6 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.421 1.089 . . . . 0.0 113.489 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.6 mt -122.23 108.69 33.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -73.9 162.71 38.66 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.628 2.885 . . . . 0.0 111.195 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -150.07 167.54 26.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.248 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.87 144.93 27.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 94' ' ' PHE . 22.9 m-85 -87.05 153.13 21.78 Favored 'General case' 0 C--N 1.337 0.031 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.83 122.47 13.32 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.4 t -166.99 161.15 14.77 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.732 0.413 . . . . 0.0 110.425 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -90.45 134.06 12.13 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 173.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 150.93 -155.61 26.24 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.4 m -132.52 171.18 14.12 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 123.923 0.889 . . . . 0.0 110.087 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -68.45 -10.27 54.29 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -94.89 2.58 55.43 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.791 0.436 . . . . 0.0 111.324 177.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 51.1 m -102.75 7.62 39.61 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.492 0.717 . . . . 0.0 111.108 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.4 ' HB ' ' CG ' ' A' ' 94' ' ' PHE . 5.2 m -139.48 154.83 25.09 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 C-N-CA 123.972 0.909 . . . . 0.0 111.47 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.98 169.92 14.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.991 0.916 . . . . 0.0 111.547 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.5 p -61.51 -19.12 61.74 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -70.69 -24.5 62.68 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.379 0.536 . . . . 0.0 110.823 177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.414 ' CD1' ' CD1' ' A' ' 81' ' ' PHE . 49.9 m-85 -89.01 -19.33 25.8 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 176.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -88.32 -7.87 56.03 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.955 0.502 . . . . 0.0 111.111 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -109.92 -18.07 13.47 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.367 0.667 . . . . 0.0 111.229 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -107.35 158.16 33.81 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.235 175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.18 151.98 82.27 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.154 2.569 . . . . 0.0 111.58 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.8 154.71 24.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 123.952 0.901 . . . . 0.0 110.562 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.4 tp -139.16 155.09 48.1 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.566 0.746 . . . . 0.0 109.892 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -79.34 162.95 25.25 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 122.724 0.41 . . . . 0.0 110.754 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 56.9 tptt -78.67 -47.68 1.82 Allowed Pre-proline 0 CA--C 1.533 0.314 0 CA-C-O 118.571 -0.728 . . . . 0.0 112.591 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 88.7 Cg_endo -74.3 144.76 33.42 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.115 1.876 . . . . 0.0 110.256 176.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -115.83 147.21 41.27 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.034 0.533 . . . . 0.0 110.489 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.9 p -144.3 162.48 36.31 Favored 'General case' 0 N--CA 1.46 0.04 0 C-N-CA 124.443 1.097 . . . . 0.0 108.866 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -63.55 -31.87 73.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.91 -0.494 . . . . 0.0 111.207 -176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -84.62 -33.59 23.28 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.6 -27.03 57.94 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.9 -25.87 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 117.562 0.681 . . . . 0.0 110.527 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.9 -32.37 71.97 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 176.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.3 -29.25 38.17 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.524 0.33 . . . . 0.0 110.429 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.6 -31.74 60.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 122.302 -0.249 . . . . 0.0 110.97 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.8 tp -77.21 -30.2 54.6 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.83 -26.71 62.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.378 -0.201 . . . . 0.0 110.571 177.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.52 -18.84 28.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.852 0.461 . . . . 0.0 112.119 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -90.89 -40.26 11.83 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.138 0.575 . . . . 0.0 110.92 -178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.5 tp -86.59 18.29 3.43 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.871 0.469 . . . . 0.0 112.193 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.811 -1.09 . . . . 0.0 110.812 -179.665 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.219 0.056 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.9 m 53.97 25.94 5.89 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.62 155.86 40.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.825 0.45 . . . . 0.0 110.958 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.06 71.23 1.17 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.756 0.822 . . . . 0.0 109.209 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -72.09 -7.47 49.15 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 119.177 -0.44 . . . . 0.0 111.712 -177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.457 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 70.8 mt-30 -119.99 116.01 24.91 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 118.167 0.44 . . . . 0.0 112.141 -171.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.451 HG12 ' HE3' ' A' ' 29' ' ' LYS . 21.0 mm -122.29 128.62 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 O-C-N 123.932 0.77 . . . . 0.0 111.511 -172.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.531 HD23 ' H ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -86.6 142.24 28.41 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.531 ' H ' HD23 ' A' ' 8' ' ' LEU . 79.3 mt -112.78 130.92 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.2 t -124.27 125.08 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -152.14 163.63 38.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.693 0.397 . . . . 0.0 111.868 -174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -118.77 12.93 13.13 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.412 0.685 . . . . 0.0 110.601 177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -146.87 121.5 5.23 Favored Pre-proline 0 N--CA 1.454 -0.248 0 C-N-CA 123.973 0.909 . . . . 0.0 108.565 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.81 -14.36 44.26 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.24 2.627 . . . . 0.0 112.451 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 tt -69.7 -31.1 68.94 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.3 mm -79.4 -26.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.28 -36.02 78.75 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.027 -0.42 . . . . 0.0 110.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -84.42 -21.77 30.64 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 122.463 -0.148 . . . . 0.0 111.126 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.8 tpt -76.75 -33.93 58.08 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.298 -0.251 . . . . 0.0 110.43 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -80.78 -27.73 36.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.229 0.212 . . . . 0.0 110.746 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -74.96 -21.85 58.91 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.785 0.266 . . . . 0.0 110.41 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -76.27 -46.29 28.65 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 122.264 -0.272 . . . . 0.0 110.687 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -77.57 -15.99 58.91 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 120.421 -0.511 . . . . 0.0 111.581 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 tt -71.42 -28.84 64.27 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -78.84 -23.96 44.68 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.393 0.277 . . . . 0.0 110.408 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.07 -28.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.31 -1.94 58.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.536 0.335 . . . . 0.0 110.248 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t0 50.11 33.0 6.42 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.747 1.219 . . . . 0.0 112.96 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HE3' HG12 ' A' ' 7' ' ' ILE . 59.1 pttt -104.47 -165.77 1.18 Allowed 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.285 -0.259 . . . . 0.0 111.664 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.6 m -103.2 124.99 36.41 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.951 0.5 . . . . 0.0 112.043 -168.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.86 164.58 20.27 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.622 2.881 . . . . 0.0 110.067 172.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 34.8 m -136.07 -28.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 164.16 178.6 37.8 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.573 0.624 . . . . 0.0 112.616 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -137.35 141.07 41.8 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.39 1.076 . . . . 0.0 108.598 175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.15 155.53 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.98 0.419 . . . . 0.0 110.767 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -129.11 7.89 5.54 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.436 0.694 . . . . 0.0 111.749 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.0 p -132.61 157.73 44.04 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 123.393 0.677 . . . . 0.0 110.025 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.24 -23.72 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.103 0 CA-C-N 116.734 -0.212 . . . . 0.0 110.839 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.13 -25.8 42.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 122.303 -0.248 . . . . 0.0 110.816 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.42 -30.26 58.74 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.6 56.88 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.332 0.566 . . . . 0.0 110.623 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.13 -24.52 47.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.09 -25.04 40.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.212 -0.305 . . . . 0.0 111.11 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -87.37 -26.7 23.21 Favored 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -82.96 -22.34 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 CA-C-N 118.687 0.676 . . . . 0.0 110.825 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -79.97 -14.56 58.49 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.33 -0.231 . . . . 0.0 110.468 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -100.88 -12.74 18.75 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.178 0.591 . . . . 0.0 111.137 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -162.77 53.98 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.78 22.95 62.99 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.624 -0.542 . . . . 0.0 112.052 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.1 mt -140.34 144.73 27.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.793 0.837 . . . . 0.0 109.217 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.42 -25.71 9.91 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.76 176.99 10.32 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.09 0.405 . . . . 0.0 110.52 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.68 166.73 27.49 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.04 139.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.39 119.6 29.68 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.599 0.237 . . . . 0.0 110.759 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -80.41 127.92 32.97 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 122.613 0.365 . . . . 0.0 110.298 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.8 t -97.19 -11.15 8.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 123.434 0.694 . . . . 0.0 110.496 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -71.48 9.16 0.87 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.76 0.424 . . . . 0.0 111.85 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.9 tp -63.8 158.54 21.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.506 0.722 . . . . 0.0 109.927 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -62.49 146.54 51.36 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.98 0.512 . . . . 0.0 111.101 -178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.68 145.14 4.79 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.871 0.748 . . . . 0.0 112.11 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.83 -9.8 57.03 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.661 -0.522 . . . . 0.0 111.818 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -126.63 149.31 49.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.705 0.753 . . . . 0.0 110.147 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.6 tttt 50.74 29.27 4.12 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.006 0.923 . . . . 0.0 112.094 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 79.4 p -102.13 -3.36 27.62 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.346 0.659 . . . . 0.0 111.935 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.497 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.7 m -137.32 33.85 0.23 Allowed Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 66' ' ' THR . 86.9 Cg_endo -75.12 -13.49 21.16 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.174 1.916 . . . . 0.0 111.5 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.7 t -70.39 -29.11 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 122.612 0.365 . . . . 0.0 110.738 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.58 -36.24 80.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.792 0.329 . . . . 0.0 110.387 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -81.93 -17.77 45.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 122.168 -0.332 . . . . 0.0 110.863 -178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.54 -32.87 64.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 172.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.1 mt -72.63 -27.22 62.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.38 -24.74 62.13 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 117.65 0.204 . . . . 0.0 110.49 176.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.6 -17.16 52.2 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.234 -0.292 . . . . 0.0 110.486 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -99.54 8.69 44.26 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.409 0.684 . . . . 0.0 111.246 174.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.6 t70 57.79 35.83 25.87 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.208 1.003 . . . . 0.0 113.026 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.6 mt -110.36 131.08 22.23 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.75 156.86 39.76 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.91 3.073 . . . . 0.0 111.502 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -154.1 167.68 29.03 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.852 0.461 . . . . 0.0 111.132 -179.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.4 m -138.89 164.87 25.03 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.008 0.923 . . . . 0.0 109.625 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.416 ' CD1' ' CD2' ' A' ' 94' ' ' PHE . 36.5 m-85 -107.51 161.97 14.36 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.337 0.589 . . . . 0.0 111.921 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.24 17.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 170.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.0 m -148.54 150.53 33.52 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.466 0.306 . . . . 0.0 110.82 -171.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.76 129.99 9.27 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 172.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 151.2 -171.95 30.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.7 m -83.24 161.29 21.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.688 0.395 . . . . 0.0 110.706 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -76.02 2.53 12.5 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -122.46 11.81 10.0 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.978 0.511 . . . . 0.0 111.301 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.2 m -110.61 12.64 22.68 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.338 0.655 . . . . 0.0 111.849 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.8 t -134.27 154.59 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 C-N-CA 123.404 0.682 . . . . 0.0 109.567 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -60.54 153.56 23.18 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.28 0.632 . . . . 0.0 111.979 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.0 m -62.89 -18.92 63.65 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -172.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -76.65 -20.5 56.6 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 118.599 0.636 . . . . 0.0 110.459 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.416 ' CD2' ' CD1' ' A' ' 81' ' ' PHE . 9.1 m-85 -85.8 -19.62 30.43 Favored 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.3 mtt180 -83.28 -19.03 37.08 Favored 'General case' 0 C--O 1.23 0.062 0 C-N-CA 122.419 0.288 . . . . 0.0 110.856 175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.66 -21.33 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.102 0.561 . . . . 0.0 111.862 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -101.97 157.99 32.64 Favored Pre-proline 0 C--N 1.339 0.138 0 C-N-CA 122.799 0.44 . . . . 0.0 110.414 176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -59.12 149.94 76.8 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.43 2.753 . . . . 0.0 111.692 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.66 153.27 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 123.003 0.521 . . . . 0.0 110.465 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.3 mt -138.75 157.48 46.01 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 124.205 1.002 . . . . 0.0 109.371 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.92 168.64 10.51 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 37.9 mtmm -60.64 -46.85 97.21 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-O 118.462 -0.78 . . . . 0.0 112.116 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 102' ' ' LYS . 77.7 Cg_endo -71.93 138.16 30.76 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.835 1.69 . . . . 0.0 109.628 172.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.427 ' CD1' HG21 ' A' ' 109' ' ' VAL . 2.2 m-30 -112.51 154.14 26.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.527 0.731 . . . . 0.0 110.325 -177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.7 p -138.01 160.76 38.48 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 123.428 0.691 . . . . 0.0 110.363 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.4 tpp -71.15 -28.86 64.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.152 0.426 . . . . 0.0 112.152 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -84.5 -43.56 14.45 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.968 -0.458 . . . . 0.0 111.931 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -30.18 48.48 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 119.845 -0.42 . . . . 0.0 112.527 -174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.427 HG21 ' CD1' ' A' ' 104' ' ' PHE . 47.0 t -87.22 -30.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.06 0 CA-C-N 117.658 0.729 . . . . 0.0 111.01 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.66 68.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.871 -0.518 . . . . 0.0 110.021 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -80.31 -29.94 38.14 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 122.121 0.168 . . . . 0.0 110.707 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.6 37.66 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 122.295 -0.253 . . . . 0.0 111.417 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.92 -19.95 33.84 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-N 117.961 0.346 . . . . 0.0 111.115 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.02 -25.65 43.24 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.61 -25.86 41.37 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.65 29.92 1.43 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.036 0.935 . . . . 0.0 111.125 173.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.79 -16.47 7.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.425 0.29 . . . . 0.0 111.586 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.857 -1.068 . . . . 0.0 111.22 -177.343 . . . . . . . . 0 0 . 1 stop_ save_